FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Brim, H
   Yooseph, S
   Zoetendal, EG
   Lee, E
   Torralbo, M
   Laiyemo, AO
   Shokrani, B
   Nelson, K
   Ashktorab, H
AF Brim, Hassan
   Yooseph, Shibu
   Zoetendal, Erwin G.
   Lee, Edward
   Torralbo, Manolito
   Laiyemo, Adeyinka O.
   Shokrani, Babak
   Nelson, Karen
   Ashktorab, Hassan
TI Microbiome Analysis of Stool Samples from African Americans with Colon
   Polyps
SO PLOS ONE
LA English
DT Article
ID BACTEROIDES-FRAGILIS ENTEROTOXIN; COLORECTAL-CANCER; RIBOSOMAL-RNA; GUT
   FLORA; PREVALENCE; BACTERIA; EXPRESSION; DIVERSITY; FEATURES; TRENDS
AB Background: Colonic polyps are common tumors occurring in similar to 50% of Western populations with similar to 10% risk of malignant progression. Dietary agents have been considered the primary environmental exposure to promote colorectal cancer (CRC) development. However, the colonic mucosa is permanently in contact with the microbiota and its metabolic products including toxins that also have the potential to trigger oncogenic transformation.
   Aim: To analyze fecal DNA for microbiota composition and functional potential in African Americans with pre-neoplastic lesions.
   Materials & Methods: We analyzed the bacterial composition of stool samples from 6 healthy individuals and 6 patients with colon polyps using 16S ribosomal RNA-based phylogenetic microarray; the Human intestinal Tract Chip (HITChip) and 16S rRNA gene barcoded 454 pyrosequencing. The functional potential was determined by sequence-based metagenomics using 454 pyrosequencing.
   Results: Fecal microbiota profiling of samples from the healthy and polyp patients using both a phylogenetic microarraying (HITChip) and barcoded 454 pyrosequencing generated similar results. A distinction between both sets of samples was only obtained when the analysis was performed at the sub-genus level. Most of the species leading to the dissociation were from the Bacteroides group. The metagenomic analysis did not reveal major differences in bacterial gene prevalence/abundances between the two groups even when the analysis and comparisons were restricted to available Bacteroides genomes.
   Conclusion: This study reveals that at the pre-neoplastic stages, there is a trend showing microbiota changes between healthy and colon polyp patients at the sub-genus level. These differences were not reflected at the genome/functions levels. Bacteria and associated functions within the Bacteroides group need to be further analyzed and dissected to pinpoint potential actors in the early colon oncogenic transformation in a large sample size.
C1 [Brim, Hassan; Lee, Edward; Laiyemo, Adeyinka O.; Shokrani, Babak; Ashktorab, Hassan] Howard Univ, Coll Med, Dept Pathol, Dept Med, Washington, DC 20059 USA.
   [Brim, Hassan; Lee, Edward; Laiyemo, Adeyinka O.; Shokrani, Babak; Ashktorab, Hassan] Howard Univ, Coll Med, Ctr Canc, Washington, DC USA.
   [Yooseph, Shibu] JCVI, San Diego, CA USA.
   [Torralbo, Manolito; Nelson, Karen] JCVI, Rockville, MD USA.
   [Zoetendal, Erwin G.] Wageningen Univ, Microbiol Lab, NL-6700 AP Wageningen, Netherlands.
C3 Howard University; Howard University; J. Craig Venter Institute; J.
   Craig Venter Institute; Wageningen University & Research
RP Brim, H (corresponding author), Howard Univ, Coll Med, Dept Pathol, Dept Med, Washington, DC 20059 USA.
EM hbrim@howard.edu
RI Ashktorab, hassan/AAJ-2908-2020
OI Yooseph, Shibu/0000-0001-5581-5002
FU Howard-Hopkins U54 from the National Institutes of Health; Howard
   University College of Medicine Bridge fund; National Institute on
   Minority Health and Health Disparities of the National Institutes of
   Health [G12MD007597]; Federal funds [UL1TR000101]; National Center for
   Advancing Translational Sciences (NCATS), National Institutes of Health
   (NIH), through the Clinical and Translational Science Awards Program
   (CTSA) [UL1RR031975]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL
   SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR
   RESEARCH RESOURCES [UL1RR031975] Funding Source: NIH RePORTER; National
   Institute on Minority Health and Health Disparities [G12MD007597]
   Funding Source: NIH RePORTER
FX This project was supported (in part) by a Howard-Hopkins U54 from the
   National Institutes of Health, by Howard University College of Medicine
   Bridge fund, by the National Institute on Minority Health and Health
   Disparities of the National Institutes of Health under Award Number
   G12MD007597. This project was also funded in part with Federal funds
   (Grant #UL1TR000101 previously UL1RR031975) from the National Center for
   Advancing Translational Sciences (NCATS), National Institutes of Health
   (NIH), through the Clinical and Translational Science Awards Program
   (CTSA), a trademark of DHHS, part of the Roadmap Initiative,
   "Re-Engineering the Clinical Research Enterprise. The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the National Institutes of Health. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashktorab H, 2012, DIGEST DIS SCI, V57, P905, DOI 10.1007/s10620-011-2026-y
   Ashktorab H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025314
   Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879
   Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Balter M, 2012, SCIENCE, V336, P1246, DOI 10.1126/science.336.6086.1246
   Berer K, 2012, ACTA NEUROPATHOL, V123, P639, DOI 10.1007/s00401-012-0949-9
   Blumenstein I, 2013, EUR J GASTROEN HEPAT, V25, P556, DOI 10.1097/MEG.0b013e32835d1ef4
   Bodaker I, 2010, ISME J, V4, P399, DOI 10.1038/ismej.2009.141
   Boleij A, 2012, MOL CELL PROTEOMICS, V11, P851, DOI 10.1074/mcp.M112.019315
   BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910, DOI 10.1128/AEM.61.5.1910-1916.1995
   Brim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040392
   Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216
   Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chandran P, 2003, SURG-J R COLL SURG E, V1, P63, DOI 10.1016/S1479-666X(03)80118-X
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Goto Y, 2012, IMMUNOL REV, V245, P147, DOI 10.1111/j.1600-065X.2011.01078.x
   Graham Alice, 2012, J Glob Health, V2, P020404, DOI 10.7189/jogh.02.020204
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   KUMAR K, 2009, CLIN CANC R IN PRESS, P68
   Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305
   Lyra A, 2012, WORLD J GASTROENTERO, V18, P4404, DOI 10.3748/wjg.v18.i32.4404
   Marteau P, 2011, DIGEST DIS, V29, P166, DOI 10.1159/000323879
   McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Nelson RL, 1999, J SURG ONCOL, V71, P123, DOI 10.1002/(SICI)1096-9098(199906)71:2<123::AID-JSO13>3.0.CO;2-C
   Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5
   Pick Marcelle, 2012, Adv NPs PAs, V3, P35
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x
   Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208
   Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747
   Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schutze T, 2011, ANAL BIOCHEM, V410, P155, DOI 10.1016/j.ab.2010.11.029
   Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001
   Sharon I, 2011, J COMPUT BIOL, V18, P495, DOI 10.1089/cmb.2010.0260
   Sinicrope PS, 2012, CANCER EPIDEM BIOMAR, V21, P347, DOI 10.1158/1055-9965.EPI-11-0818
   Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38
   Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x
   van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yoshino Y, 2012, INFECTION, V40, P63, DOI 10.1007/s15010-011-0159-8
   Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603
NR 60
TC 34
Z9 36
U1 2
U2 54
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 20
PY 2013
VL 8
IS 12
AR e81352
DI 10.1371/journal.pone.0081352
PG 10
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA 276IX
UT WOS:000328745100004
PM 24376500
OA Green Published, Green Submitted, gold
DA 2022-11-22
ER

PT J
AU Sze, MA
   Topcuoglu, BD
   Lesniak, NA
   Ruffin, MT
   Schloss, PD
AF Sze, Marc A.
   Topcuoglu, Begum D.
   Lesniak, Nicholas A.
   Ruffin, Mack T.
   Schloss, Patrick D.
TI Fecal Short-Chain Fatty Acids Are Not Predictive of Colonic Tumor Status
   and Cannot Be Predicted Based on Bacterial Community Structure
SO MBIO
LA English
DT Article
DE 16S rRNA; SCFA; colon cancer; machine learning; metagenomics; microbial
   ecology; microbiome; random forest
ID POPULATION; POLYPS; MODEL
AB Colonic bacterial populations are thought to have a role in the development of colorectal cancer with some protecting against inflammation and others exacerbating inflammation. Short-chain fatty acids (SCFAs) have been shown to have anti-inflammatory properties and are produced in large quantities by colonic bacteria that produce SCFAs by fermenting fiber. We assessed whether there was an association between fecal SCFA concentrations and the presence of colonic adenomas or carcinomas in a cohort of individuals using 16S rRNA gene and metagenomic shotgun sequence data. We measured the fecal concentrations of acetate, propionate, and butyrate within the cohort and found that there were no significant associations between SCFA concentration and tumor status. When we incorporated these concentrations into random forest classification models trained to differentiate between people with healthy colons and those with adenomas or carcinomas, we found that they did not significantly improve the ability of 16S rRNA gene or metagenomic gene sequence-based models to classify individuals. Finally, we generated random forest regression models trained to predict the concentration of each SCFA based on 16S rRNA gene or metagenomic gene sequence data from the same samples. These models performed poorly and were able to explain at most 14% of the observed variation in the SCFA concentrations. These results support the broader epidemiological data that questions the value of fiber consumption for reducing the risks of colorectal cancer. Although other bacterial metabolites may serve as biomarkers to detect adenomas or carcinomas, fecal SCFA concentrations have limited predictive power.
   IMPORTANCE Considering that colorectal cancer is the third leading cancer-related cause of death within the United States, it is important to detect colorectal tumors early and to prevent the formation of tumors. Short-chain fatty acids (SCFAs) are often used as a surrogate for measuring gut health and for being anticarcinogenic because of their anti-inflammatory properties. We evaluated the fecal SCFA concentrations of a cohort of individuals with different colonic tumor burdens who were previously analyzed to identify microbiome-based biomarkers of tumors. We were unable to find an association between SCFA concentration and tumor burden or use SCFAs to improve our microbiome-based models of classifying people based on their tumor status. Furthermore, we were unable to find an association between the fecal community structure and SCFA concentrations. Our results indicate that the association between fecal SCFAs, the gut microbiome, and tumor burden is weak.
C1 [Sze, Marc A.; Topcuoglu, Begum D.; Lesniak, Nicholas A.; Schloss, Patrick D.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.
   [Ruffin, Mack T.] Penn State Hershey Med Ctr, Dept Family Med & Community Med, Hershey, PA USA.
C3 University of Michigan System; University of Michigan; Pennsylvania
   Commonwealth System of Higher Education (PCSHE); Pennsylvania State
   University; Penn State Health
RP Schloss, PD (corresponding author), Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.
EM pschloss@umich.edu
OI Sze, Marc/0000-0002-3532-9653
FU Canadian Institute of Health Research; National Institutes of Health
   [UL1TR002240, P30DK034933, R01CA215574]; NATIONAL CANCER INSTITUTE
   [R01CA215574] Funding Source: NIH RePORTER; NATIONAL CENTER FOR
   ADVANCING TRANSLATIONAL SCIENCES [UL1TR002240] Funding Source: NIH
   RePORTER
FX Support for M.A.S. came from the Canadian Institute of Health Research
   and the National Institutes of Health (UL1TR002240). This work was also
   supported by the National Institutes of Health (P30DK034933 and
   R01CA215574).
CR Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Bishehsari F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020102
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Fliss-Isakov N, 2018, J CLIN GASTROENTEROL, V52, P805, DOI 10.1097/MCG.0000000000000935
   Gianfredi V, 2018, INT J FOOD SCI NUTR, V69, P904, DOI 10.1080/09637486.2018.1446917
   Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lee J, 2015, HEMATOL ONCOL CLIN N, V29, P1, DOI 10.1016/j.hoc.2014.09.005
   Meisel M, 2017, ISME J, V11, P15, DOI 10.1038/ismej.2016.114
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Shields CED, 2016, J INFECT DIS, V214, P122, DOI 10.1093/infdis/jiw069
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI [10.3322/caac.21387, 10.3322/caac.21332, 10.3322/caac.21551]
   Steinegger M, 2017, NAT BIOTECHNOL, V35, P1026, DOI 10.1038/nbt.3988
   Sze MA, 2018, MBIO, V9, DOI DOI 10.1128/MBIO.00630-18
   Sze MA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0366-3
   Tomkovich S, 2017, CANCER RES, V77, P2620, DOI 10.1158/0008-5472.CAN-16-3472
   Venkataraman A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0178-x
   WEAVER GA, 1988, GUT, V29, P1539, DOI 10.1136/gut.29.11.1539
   Yao YB, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003430.pub2
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
NR 25
TC 18
Z9 19
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2019
VL 10
IS 4
AR e01454-19
DI 10.1128/mBio.01454-19
PG 7
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA IR7JO
UT WOS:000481617000072
PM 31266879
OA gold, Green Submitted, Green Published
DA 2022-11-22
ER

PT J
AU Wolf, PG
   Cowley, ES
   Breister, A
   Matatov, S
   Lucio, L
   Polak, P
   Ridlon, JM
   Gaskins, HR
   Anantharaman, K
AF Wolf, Patricia G.
   Cowley, Elise S.
   Breister, Adam
   Matatov, Sarah
   Lucio, Luke
   Polak, Paige
   Ridlon, Jason M.
   Gaskins, H. Rex
   Anantharaman, Karthik
TI Diversity and distribution of sulfur metabolic genes in the human gut
   microbiome and their association with colorectal cancer
SO MICROBIOME
LA English
DT Article
DE Colorectal cancer; Sulfur metabolism; Human microbiome; Gut; Cysteine;
   Taurine; Hydrogen sulfide; Metagenomics
ID SULFATE-REDUCING BACTERIA; MULTIPLE SEQUENCE ALIGNMENT; HYDROGEN-SULFIDE
   PRODUCTION; FUSOBACTERIUM-NUCLEATUM; ELECTRON-ACCEPTORS; HUMAN COLON;
   DNA-DAMAGE; BILE-ACID; HEALTHY; CELL
AB Background: Recent evidence implicates microbial sulfidogenesis as a potential trigger of colorectal cancer (CRC), highlighting the need for comprehensive knowledge of sulfur metabolism within the human gut. Microbial sulfidogenesis produces genotoxic hydrogen sulfide (H2S) in the human colon using inorganic (sulfate) and organic (taurine/cysteine/methionine) substrates; however, the majority of studies have focused on sulfate reduction using dissimilatory sulfite reductases (Dsr).
   Results: Here, we show that genes for microbial sulfur metabolism are more abundant and diverse than previously observed and are statistically associated with CRC. Using similar to 17,000 bacterial genomes from publicly available stool metagenomes, we studied the diversity of sulfur metabolic genes in 667 participants across different health statuses: healthy, adenoma, and carcinoma. Sulfidogenic genes were harbored by 142 bacterial genera and both organic and inorganic sulfidogenic genes were associated with carcinoma. Significantly, the anaerobic sulfite reductase (asr) genes were twice as abundant as dsr, demonstrating that Asr is likely a more important contributor to sulfate reduction in the human gut than Dsr. We identified twelve potential pathways for reductive taurine metabolism and discovered novel genera harboring these pathways. Finally, the prevalence of metabolic genes for organic sulfur indicates that these understudied substrates may be the most abundant source of microbially derived H2S.
   Conclusions: Our findings significantly expand knowledge of microbial sulfur metabolism in the human gut. We show that genes for microbial sulfur metabolism in the human gut are more prevalent than previously known, irrespective of health status (i.e., in both healthy and diseased states). Our results significantly increase the diversity of pathways and bacteria that are associated with microbial sulfur metabolism in the human gut. Overall, our results have implications for understanding the role of the human gut microbiome and its potential contributions to the pathogenesis of CRC.
C1 [Wolf, Patricia G.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA.
   [Wolf, Patricia G.] Univ Illinois, Univ Illinois Canc Ctr, Chicago, IL USA.
   [Wolf, Patricia G.; Matatov, Sarah; Lucio, Luke; Polak, Paige; Ridlon, Jason M.; Gaskins, H. Rex] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.
   [Wolf, Patricia G.; Ridlon, Jason M.; Gaskins, H. Rex] Univ Illinois, Div Nutr Sci Ences, Urbana, IL 61801 USA.
   [Cowley, Elise S.; Breister, Adam; Anantharaman, Karthik] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.
   [Cowley, Elise S.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI USA.
   [Ridlon, Jason M.; Gaskins, H. Rex] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
   [Ridlon, Jason M.; Gaskins, H. Rex] Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.
   [Gaskins, H. Rex] Univ Illinois, Dept Biomed & Translat Sci, Urbana, IL 61801 USA.
   [Gaskins, H. Rex] Univ Illinois, Depa Rtment Pathobiol, Urbana, IL 61801 USA.
C3 University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign
RP Gaskins, HR (corresponding author), Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA.; Gaskins, HR (corresponding author), Univ Illinois, Div Nutr Sci Ences, Urbana, IL 61801 USA.; Anantharaman, K (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Gaskins, HR (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.; Gaskins, HR (corresponding author), Univ Illinois, Canc Ctr Illinois, Urbana, IL 61801 USA.; Gaskins, HR (corresponding author), Univ Illinois, Dept Biomed & Translat Sci, Urbana, IL 61801 USA.; Gaskins, HR (corresponding author), Univ Illinois, Depa Rtment Pathobiol, Urbana, IL 61801 USA.
EM hgaskins@illinois.edu; karthik@bact.wisc.edu
RI Anantharaman, Karthik/AGM-5680-2022
OI Anantharaman, Karthik/0000-0002-9584-2491; Gaskins, H.
   Rex/0000-0002-1249-535X
FU Medical Scientist Training Program [T32GM008692]; NLM training grant at
   UW-Madison [NLM 5T15LM007359]; UI-Chicago by the Cancer Education and
   Career Development Program [T32CA057699];  [RO1CA204808]
FX ESC is an MSTP student and was supported in part by Medical Scientist
   Training Program grant T32GM008692 and by an NLM training grant to the
   Computation and Informatics in Biology and Medicine Training Program
   (NLM 5T15LM007359) at UW-Madison. PGW was supported at UI-Chicago by the
   Cancer Education and Career Development Program grant T32CA057699. JMR
   and HRG were supported by RO1CA204808.
CR AHLMAN B, 1993, CLIN NUTR, V12, P266, DOI 10.1016/0261-5614(93)90044-5
   Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020
   Alnouti Y, 2009, TOXICOL SCI, V108, P225, DOI 10.1093/toxsci/kfn268
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anantharaman K, 2018, ISME J, V12, P1715, DOI 10.1038/s41396-018-0078-0
   Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219
   [Anonymous], 2019, ASPERA CONNECT
   Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439
   Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546
   Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126
   Bowers RM, 2017, NAT BIOTECHNOL, V35, P725, DOI 10.1038/nbt.3893
   Braccia DJ, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.705583
   Brown CT, 2016, NAT BIOTECHNOL, V34, P1256, DOI 10.1038/nbt.3704
   Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368
   Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   CHACKO A, 1988, GUT, V29, P809, DOI 10.1136/gut.29.6.809
   Chaumeil PA, 2020, BIOINFORMATICS, V36, P1925, DOI 10.1093/bioinformatics/btz848
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Deplancke B, 2003, FASEB J, V17, P1310, DOI 10.1096/fj.02-0883fje
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Dordevic D, 2021, J ADV RES, V27, P55, DOI 10.1016/j.jare.2020.03.003
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Fite A, 2004, GUT, V53, P523, DOI 10.1136/gut.2003.031245
   FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766
   FLORIN THJ, 1991, CLIN CHIM ACTA, V196, P127, DOI 10.1016/0009-8981(91)90065-K
   Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   GIBSON GR, 1988, J APPL BACTERIOL, V65, P103, DOI 10.1111/j.1365-2672.1988.tb01498.x
   Guo C, 2014, EUR J PHARMACOL, V725, P70, DOI 10.1016/j.ejphar.2014.01.009
   Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18
   HOROWITZ A, 1973, J PERIODONTOL, V44, P390, DOI 10.1902/jop.1973.44.7.390
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046
   Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Langmead B, 2019, BIOINFORMATICS, V35, P421, DOI 10.1093/bioinformatics/bty648
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Laue H, 1997, APPL ENVIRON MICROB, V63, P2016, DOI 10.1128/AEM.63.5.2016-2021.1997
   Lengeler J. W., 1999, BIOL PROKARYOTES
   Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239
   Lie TJ, 1999, APPL ENVIRON MICROB, V65, P4611
   Lie TJ, 1996, ARCH MICROBIOL, V166, P204, DOI 10.1007/s002030050376
   Liu G, 2017, ONCOTARGET, V8, P44511, DOI 10.18632/oncotarget.17812
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   Markowitz VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040151
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Muller AL, 2015, ISME J, V9, P1152, DOI 10.1038/ismej.2014.208
   Nava GM, 2012, ISME J, V6, P57, DOI 10.1038/ismej.2011.90
   NG W, 1984, J DENT RES, V63, P994, DOI 10.1177/00220345840630071701
   Nguyen LH, 2020, GASTROENTEROLOGY, V158, P1313, DOI 10.1053/j.gastro.2019.12.029
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Parks DH, 2020, NAT BIOTECHNOL, V38, P1079, DOI 10.1038/s41587-020-0501-8
   Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001
   Peck SC, 2019, P NATL ACAD SCI USA, V116, P3171, DOI 10.1073/pnas.1815661116
   Pruesse E, 2012, BIOINFORMATICS, V28, P1823, DOI 10.1093/bioinformatics/bts252
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rabus R., 2013, PROKARYOTES, P309, DOI DOI 10.1007/978-3-642-30141-4_70
   RAIBAUD O, 1973, J BIOL CHEM, V248, P3451
   Ridlon JM, 2016, GUT MICROBES, V7, P201, DOI 10.1080/19490976.2016.1150414
   RIZZO AA, 1967, PERIODONTICS, V5, P233
   Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x
   Shatalin K, 2011, SCIENCE, V334, P986, DOI 10.1126/science.1209855
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Thomas B., 2013, BCTHOMAS SHRINKSAM
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Warren YA, 2005, J CLIN MICROBIOL, V43, P4041, DOI 10.1128/JCM.43.8.4041-4045.2005
   Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wolf PG, 2018, THESIS U ILLINOIS UR
   Wu GQ, 2020, J AGR FOOD CHEM, V68, P7745, DOI 10.1021/acs.jafc.0c02965
   Yaegaki K, 2008, J PERIODONTAL RES, V43, P391, DOI 10.1111/j.1600-0765.2007.01052.x
   Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667
   Yazici C, 2017, GUT, V66, P1983, DOI 10.1136/gutjnl-2016-313321
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zheng JF, 2015, CHEM-BIOL INTERACT, V242, P353, DOI 10.1016/j.cbi.2015.10.021
   Zhou ZC, 2022, MICROBIOME, V10, DOI 10.1186/s40168-021-01213-8
   Zinkevich V, 2000, FEMS MICROBIOL ECOL, V34, P147, DOI 10.1111/j.1574-6941.2000.tb00764.x
NR 96
TC 3
Z9 3
U1 18
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD APR 19
PY 2022
VL 10
IS 1
AR 64
DI 10.1186/s40168-022-01242-x
PG 16
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 0Q5ZH
UT WOS:000784995900001
PM 35440042
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Hu, W
   Chen, ZM
   Li, XX
   Lu, L
   Yang, GH
   Lei, ZX
   You, LJ
   Cui, XB
   Lu, SC
   Zhai, ZY
   Zeng, ZY
   Chen, Y
   Huang, SL
   Gong, W
AF Hu, Wei
   Chen, Ze Min
   Li, Xia Xi
   Lu, Lan
   Yang, Gen Hua
   Lei, Zheng Xia
   You, Li Juan
   Cui, Xiao Bing
   Lu, Si Cun
   Zhai, Zhi Yong
   Zeng, Zhi Yu
   Chen, Ye
   Huang, Si Lin
   Gong, Wei
TI Faecal microbiome and metabolic signatures in rectal neuroendocrine
   tumors
SO THERANOSTICS
LA English
DT Article
DE Rectal neuroendocrine tumor; Gut microbiota; Metabolite; Shotgun
   metagenomic sequencing; Untargeted liquid chromatography-mass
   spectrometry (LC-MS) metabolomics
ID METHANOBREVIBACTER-SMITHII; GUT MICROBIOTA; EPIDEMIOLOGY; CANCER;
   ACETOGENINS; NEOPLASMS; METHANE; OBESITY; HEALTH; RISK
AB Background: The prevalence of rectal neuroendocrine tumors (RNET) has increased substantially over the past decades. Little is known on mechanistic alteration in the pathogenesis of such disease. We postulate that perturbations of human gut microbiome-metabolome interface influentially affect the development of RNET. The study aims to characterize the composition and function of faecal microbiome and metabolites in RNET individuals. Methods: We performed deep shotgun metagenomic sequencing and untargeted liquid chromatography-mass spectrometry (LC-MS) metabolomic profiling of faecal samples from the discovery cohort (18 RNET patients, 40 controls), and validated the microbiome and metabolite-based classifiers in an independent cohort (15 RNET participants, 19 controls). Results: We uncovered a dysbiotic gut ecological microenvironment in RNET patients, characterized by aberrant depletion and attenuated connection of microbial species, and abnormally aggregated lipids and lipid-like molecules. Functional characterization based on our in-house and Human Project Unified Metabolic Analysis Network 2 (HUMAnN2) pipelines further indicated a nutrient deficient gut microenvironment in RNET individuals, evidenced by diminished activities such as energy metabolism, vitamin biosynthesis and transportation. By integrating these data, we revealed 291 robust associations between representative differentially abundant taxonomic species and metabolites, indicating a tight interaction of gut microbiome with metabolites in RNET pathogenesis. Finally, we identified a cluster of gut microbiome and metabolite-based signatures, and replicated them in an independent cohort, showing accurate prediction of such neoplasm from healthy people. Conclusions: Our current study is the first to comprehensively characterize the perturbed interface of gut microbiome and metabolites in RNET patients, which may provide promising targets for microbiome-based diagnostics and therapies for this disorder.
C1 [Hu, Wei; Chen, Ze Min; Li, Xia Xi; Yang, Gen Hua; Lei, Zheng Xia; You, Li Juan; Cui, Xiao Bing; Lu, Si Cun; Zhai, Zhi Yong; Zeng, Zhi Yu; Chen, Ye; Gong, Wei] Southern Med Univ, Shenzhen Hosp, Dept Gastroenterol, Shenzhen, Guangdong, Peoples R China.
   [Hu, Wei; Chen, Ze Min; Li, Xia Xi; Yang, Gen Hua; Lei, Zheng Xia; You, Li Juan; Cui, Xiao Bing; Lu, Si Cun; Zhai, Zhi Yong; Zeng, Zhi Yu; Chen, Ye; Gong, Wei] Southern Med Univ, Sch Clin Med 3, Shenzhen, Guangdong, Peoples R China.
   [Lu, Lan] Chengdu Univ, Sch Pharm, Sichuan Ind Inst Antibiot, Antibiot Res & Re Evaluat Key Lab Sichuan Prov, Chengdu, Sichuan, Peoples R China.
   [Huang, Si Lin] Shenzhen Univ, South China Hosp, Hlth Sci Ctr, Dept Gastroenterol, Shenzhen, Guangdong, Peoples R China.
C3 Southern Medical University - China; Southern Medical University -
   China; Chengdu University; Shenzhen University
RP Chen, Y; Gong, W (corresponding author), Southern Med Univ, Shenzhen Hosp, Dept Gastroenterol, Shenzhen, Guangdong, Peoples R China.; Huang, SL (corresponding author), Shenzhen Univ, South China Hosp, Hlth Sci Ctr, Dept Gastroenterol, Shenzhen, Guangdong, Peoples R China.
EM yechen@smu.edu.cn; huangsilin214@163.com; gongwei@smu.edu.cn
FU National Key R&D Project of China [2018YFC0115301]; National Natural
   Science Foundation of China [81974070, 81800503, 81101610]; Guangdong
   Basic and Applied Basic Research Foundation [2020A1515011063]; Guangdong
   Young Innovative Talents Foundation [2020KQNCX013]; Shenzhen Science and
   Technology Program [JCYJ20210324131010027]; Research Foundation of
   Shenzhen Hospital of Southern Medical University [PT2018GZR05,
   PT2018GZR10]
FX This work was supported by National Key R&D Project of China (No.
   2018YFC0115301), National Natural Science Foundation of China (No.
   81974070 & 81800503 & 81101610), Guangdong Basic and Applied Basic
   Research Foundation (2020A1515011063), Guangdong Young Innovative
   Talents Foundation (2020KQNCX013), Shenzhen Science and Technology
   Program (JCYJ20210324131010027) and Research Foundation of Shenzhen
   Hospital of Southern Medical University (PT2018GZR05 & PT2018GZR10).
CR Anand PK, 2020, IMMUNOL REV, V297, P108, DOI 10.1111/imr.12891
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Balasubramaniam S, 2019, J INHERIT METAB DIS, V42, P608, DOI 10.1002/jimd.12058
   Bermejo A, 2005, NAT PROD REP, V22, P269, DOI 10.1039/b500186m
   Brown CT, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-30
   Calder PC, 2011, EUR J PHARMACOL, V668, pS50, DOI 10.1016/j.ejphar.2011.05.085
   Cives M, 2018, CA-CANCER J CLIN, V68, P471, DOI 10.3322/caac.21493
   Corredoira JC, 2005, EUR J CLIN MICROBIOL, V24, P250, DOI 10.1007/s10096-005-1314-x
   Dasari A, 2017, JAMA ONCOL, V3, P1335, DOI 10.1001/jamaoncol.2017.0589
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Fan JH, 2017, ONCOTARGET, V8, P71699, DOI 10.18632/oncotarget.17599
   Fraenkel M, 2014, ENDOCR-RELAT CANCER, V21, pR153, DOI 10.1530/ERC-13-0125
   Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Ghoshal U, 2016, GUT LIVER, V10, P932, DOI 10.5009/gnl15588
   Hauso O, 2008, CANCER, V113, P2655, DOI 10.1002/cncr.23883
   Heiss CN, 2018, J INNATE IMMUN, V10, P163, DOI 10.1159/000481519
   Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135
   Ito T, 2015, J GASTROENTEROL, V50, P58, DOI 10.1007/s00535-014-0934-2
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/fcimb.2015.00084, 10.3309/fcimb.2015.00004]
   Kawasaki K, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029595
   Kim G, 2012, DIGEST DIS SCI, V57, P3213, DOI 10.1007/s10620-012-2197-1
   Kosaloglu Z, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1213931
   Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z
   Lawrence B, 2011, ENDOCRIN METAB CLIN, V40, P1, DOI 10.1016/j.ecl.2010.12.005
   Leoncini E, 2016, ANN ONCOL, V27, P68, DOI 10.1093/annonc/mdv505
   Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358
   McLaughlin JL, 2008, J NAT PROD, V71, P1311, DOI 10.1021/np800191t
   Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2
   Nagtegaal ID, 2020, HISTOPATHOLOGY, V76, P182, DOI 10.1111/his.13975
   Norskov-Lauritsen N, 2014, CLIN MICROBIOL REV, V27, P214, DOI 10.1128/CMR.00103-13
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Pakiet A, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-0977-8
   Patel Natalie, 2019, Surg Pathol Clin, V12, P1021, DOI 10.1016/j.path.2019.08.007
   Powers HJ, 2003, AM J CLIN NUTR, V77, P1352
   Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103
   Starzynska T, 2017, ENDOKRYNOL POL, V68, P250, DOI 10.5603/EP.2017.0019
   Takakura W, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00664
   Tsai HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062487
   Wang ZY, 2019, FOOD SCI NUTR, V7, P579, DOI 10.1002/fsn3.868
   Watts SC, 2019, BIOINFORMATICS, V35, P1064, DOI 10.1093/bioinformatics/bty734
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335
   Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377
   Yoon YS, 2016, INT J CANCER, V139, P996, DOI 10.1002/ijc.30141
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4
   Zhang CP, 2018, ANALYST, V143, P4526, DOI 10.1039/c8an01046c
   Zschabitz S, 2013, AM J CLIN NUTR, V97, P332, DOI 10.3945/ajcn.112.034736
NR 49
TC 1
Z9 1
U1 10
U2 18
PU IVYSPRING INT PUBL
PI LAKE HAVEN
PA PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA
SN 1838-7640
J9 THERANOSTICS
JI Theranostics
PY 2022
VL 12
IS 5
BP 2015
EP 2027
DI 10.7150/thno.66464
PG 13
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA ZH9GB
UT WOS:000761236700005
PM 35265196
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Salahshouri, P
   Emadi-Baygi, M
   Jalili, M
   Khan, FM
   Wolkenhauer, O
   Salehzadeh-Yazdi, A
AF Salahshouri, Pejman
   Emadi-Baygi, Modjtaba
   Jalili, Mahdi
   Khan, Faiz M.
   Wolkenhauer, Olaf
   Salehzadeh-Yazdi, Ali
TI A Metabolic Model of Intestinal Secretions: The Link between Human
   Microbiota and Colorectal Cancer Progression
SO METABOLITES
LA English
DT Article
DE microbiome; genome-scale metabolic model; community metabolic modeling;
   colorectal cancer
ID GUT; DOPAMINE; SEROTONIN; PYRUVATE; BREAST; CELLS; RECEPTORS; APOPTOSIS;
   PROFILES; GENOME
AB The human gut microbiota plays a dual key role in maintaining human health or inducing disorders, for example, obesity, type 2 diabetes, and cancers such as colorectal cancer (CRC). High-throughput data analysis, such as metagenomics and metabolomics, have shown the diverse effects of alterations in dynamic bacterial populations on the initiation and progression of colorectal cancer. However, it is well established that microbiome and human cells constantly influence each other, so it is not appropriate to study them independently. Genome-scale metabolic modeling is a well-established mathematical framework that describes the dynamic behavior of these two axes at the system level. In this study, we created community microbiome models of three conditions during colorectal cancer progression, including carcinoma, adenoma and health status, and showed how changes in the microbial population influence intestinal secretions. Conclusively, our findings showed that alterations in the gut microbiome might provoke mutations and transform adenomas into carcinomas. These alterations include the secretion of mutagenic metabolites such as H2S, NO compounds, spermidine and TMA (trimethylamine), as well as the reduction of butyrate. Furthermore, we found that the colorectal cancer microbiome can promote inflammation, cancer progression (e.g., angiogenesis) and cancer prevention (e.g., apoptosis) by increasing and decreasing certain metabolites such as histamine, glutamine and pyruvate. Thus, modulating the gut microbiome could be a promising strategy for the prevention and treatment of CRC.
C1 [Salahshouri, Pejman; Emadi-Baygi, Modjtaba] Shahrekord Univ, Fac Basic Sci, Dept Genet, Shahrekord 8818634141, Iran.
   [Emadi-Baygi, Modjtaba] Shahrekord Univ, Biotechnol Res Inst, Shahrekord 8818634141, Iran.
   [Jalili, Mahdi] Univ Tehran Med Sci, Hematol Oncol & SCT Res Ctr, Tehran 14114, Iran.
   [Khan, Faiz M.; Wolkenhauer, Olaf; Salehzadeh-Yazdi, Ali] Univ Rostock, Dept Syst Biol & Bioinformat, D-18051 Rostock, Germany.
C3 Shahrekord University; Shahrekord University; Tehran University of
   Medical Sciences; University of Rostock
RP Salehzadeh-Yazdi, A (corresponding author), Univ Rostock, Dept Syst Biol & Bioinformat, D-18051 Rostock, Germany.
EM pejmansalahshouri@gmail.com; emadi-m@sku.ac.ir;
   mahjalili@sina.tums.ac.ir; faiz.khan3@uni-rostock.de;
   olaf.wolkenhauer@uni-rostock.de; ali.salehzadeh-yazdi@uni-rostock.de
RI Jalili, Mahdi/A-8484-2012
OI Jalili, Mahdi/0000-0002-5491-089X; Salehzadeh-Yazdi,
   Ali/0000-0002-1678-0051
FU German Federal Ministry of Education and Research (BMBF) [FKZ
   01ZX1903B]; Shahrekord University
FX The German Federal Ministry of Education and Research (BMBF) supported
   this work as part of the SASKit project (FKZ 01ZX1903B). Furthermore,
   this work was supported in part by Shahrekord University.
CR Adewiah S, 2018, GUT, V67, pA34, DOI 10.1136/gutjnl-2018-IDDFabstracts.72
   Anderson NM, 2018, PROTEIN CELL, V9, P216, DOI 10.1007/s13238-017-0451-1
   Asada M, 2009, NEOPLASIA, V11, P408, DOI 10.1593/neo.81630
   Borcherding DC, 2016, ONCOGENE, V35, P3103, DOI 10.1038/onc.2015.369
   Caneba CA, 2012, AM J PHYSIOL-ENDOC M, V303, pE1036, DOI 10.1152/ajpendo.00151.2012
   Cazzaniga P, 2014, METABOLITES, V4, P1034, DOI 10.3390/metabo4041034
   Celiktas M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw231
   Chan CWH, 2019, J CANCER, V10, P5874, DOI 10.7150/jca.31737
   Chong IG, 2005, CHEMOMETR INTELL LAB, V78, P103, DOI 10.1016/j.chemolab.2004.12.011
   Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Dalton-Griffin Lucy, 2009, Journal of Biology (London), V8, P67, DOI 10.1186/jbiol168
   Dang D., 2008, CANCER RES, V68, P4109
   De Jong S., 1990, J CHEMOMETR, V4, P441, DOI [10.1002/cem.1180040607, DOI 10.1002/CEM.1180040607]
   De Mey E, 2017, CRIT REV FOOD SCI, V57, P2909, DOI 10.1080/10408398.2015.1078769
   del Rio B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35125-9
   Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013
   Diers AR, 2012, BIOCHEM J, V444, P561, DOI 10.1042/BJ20120294
   EASTMENT HT, 1982, TECHNOMETRICS, V24, P73, DOI 10.2307/1267581
   Fan JJ, 2020, PHARMACOL RES, V159, DOI 10.1016/j.phrs.2020.104943
   Frank L.A., 2020, EC PHARM TOXICOL, P7
   Fung KYC, 2011, J PROTEOME RES, V10, P1860, DOI 10.1021/pr1011125
   Griffin JL, 2004, PHILOS T ROY SOC B, V359, P857, DOI 10.1098/rstb.2003.1411
   Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390
   Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2
   Hertel J, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1915673
   Ibanez-Sanz G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20349-6
   Janssens Y, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1197-5
   Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006
   Jonnakuty C, 2008, J CELL PHYSIOL, V217, P301, DOI 10.1002/jcp.21533
   Keshet R, 2018, NAT REV CANCER, V18, P634, DOI 10.1038/s41568-018-0054-z
   Kim HU, 2008, MOL BIOSYST, V4, P113, DOI 10.1039/b712395g
   Kim J, 2017, NATURE, V546, P168, DOI 10.1038/nature22359
   Kodama M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15136-9
   Krashin E, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00059
   Kumar M, 2018, METAB ENG, V49, P128, DOI 10.1016/j.ymben.2018.07.018
   Lee YY, 2014, TUMOR BIOL, V35, P11097, DOI 10.1007/s13277-014-2425-8
   Losurdo G, 2018, ANTI-CANCER AGENT ME, V18, P15, DOI 10.2174/1871520616666160321115349
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Luz Calle M., 2019, Genomics & Informatics, V17, pe6, DOI 10.5808/GI.2019.17.1.e6
   Machado D, 2018, NUCLEIC ACIDS RES, V46, P7542, DOI 10.1093/nar/gky537
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Mahey S, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2405-0
   Marchesi JR, 2011, ENVIRON MICROBIOL, V13, P3088, DOI 10.1111/j.1462-2920.2011.02574.x
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531
   Mendes-Soares H, 2017, FREE RADICAL BIO MED, V105, P102, DOI 10.1016/j.freeradbiomed.2016.12.017
   MGnify, HUM GUT ENV TARG LOC HUM GUT ENV TARG LOC
   Moreno-Smith M, 2013, NEOPLASIA, V15, P502, DOI 10.1593/neo.121412
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nava GM, 2012, ISME J, V6, P57, DOI 10.1038/ismej.2011.90
   Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8
   Noronha A, 2019, NUCLEIC ACIDS RES, V47, pD614, DOI 10.1093/nar/gky992
   Ohshima K, 2020, NAT METAB, V2, P81, DOI 10.1038/s42255-019-0156-2
   Oksanen J., 2017, R PACKAGE VERSION 2
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Palaniappan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156665
   Park H, 2018, LAB INVEST, V98, P449, DOI 10.1038/s41374-017-0017-0
   Patton AL, 2013, ANAL CHEM, V85, P9390, DOI 10.1021/ac4024704
   Peters MAM, 2020, PATHOL ONCOL RES, V26, P1539, DOI 10.1007/s12253-019-00734-w
   Peters MAM, 2014, DRUG RESIST UPDATE, V17, P96, DOI 10.1016/j.drup.2014.09.001
   Proctor LM, 2011, CELL HOST MICROBE, V10, P287, DOI 10.1016/j.chom.2011.10.001
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Robertson DG, 2011, TOXICOL SCI, V120, pS146, DOI 10.1093/toxsci/kfq358
   Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11
   Rosa L. S., 2016, Journal of Nutrition and Food Sciences, V6, P468
   Rosario D, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00775
   Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778
   Shaffer R.E., 2002, J CHEMOM, V16, P261, DOI [10.1002/cem.713, DOI 10.1002/CEM.713]
   Shoaie S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00086
   Sirakov M, 2011, BBA-MOL BASIS DIS, V1812, P938, DOI 10.1016/j.bbadis.2010.12.020
   Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131
   Sun XM, 2012, CHEMOMETR INTELL LAB, V115, P37, DOI 10.1016/j.chemolab.2012.04.006
   Tabata S, 2017, CELL REP, V19, P1313, DOI 10.1016/j.celrep.2017.04.061
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Tu S, 2018, ONCOL LETT, V15, P5473, DOI 10.3892/ol.2018.8036
   Weiss S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0237-y
   Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092
   Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329
   Xu KH, 2017, MED SCI MONITOR, V23, DOI 10.12659/MSM.904220
   Xu S, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2016.35
   Yao Y, 2009, WORLD J GASTROENTERO, V15, P1751, DOI 10.3748/wjg.15.1751
   Zamani A, 2012, FEBS LETT, V586, P2360, DOI 10.1016/j.febslet.2012.05.047
   Zhang XL, 2014, ACTA BIOCH BIOPH SIN, V46, P261, DOI 10.1093/abbs/gmu004
   Zhang XN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4295
NR 84
TC 2
Z9 2
U1 1
U2 9
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD JUL
PY 2021
VL 11
IS 7
AR 456
DI 10.3390/metabo11070456
PG 20
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TN3LD
UT WOS:000676138900001
PM 34357350
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Mizutani, S
   Yamada, T
   Yachida, S
AF Mizutani, Sayaka
   Yamada, Takuji
   Yachida, Shinichi
TI Significance of the gut microbiome in multistep colorectal
   carcinogenesis
SO CANCER SCIENCE
LA English
DT Review
DE adenoma-carcinoma sequence; colorectal cancer; gut microbiome;
   metabolome; metagenome
ID FUSOBACTERIUM-NUCLEATUM; MUCUS BARRIER; BILE-ACID; CANCER; COLON;
   BACTERIA; TUMORIGENESIS; CELLS; MICE
AB Colorectal cancer (CRC) is highly prevalent worldwide. In 2018, there were over 1.8 million new cases. Most sporadic CRC develop from polypoid adenomas and are preceded by intramucosal carcinoma (stage 0), which can progress into more malignant forms. This developmental process is known as the adenoma-carcinoma sequence. Early detection and endoscopic removal are crucial for CRC management. Accumulating evidence suggests that the gut microbiota is associated with CRC development in humans. Comprehensive characterization of this microbiota is of great importance to assess its potential as a diagnostic marker in the very early stages of CRC. In this review, we summarized recent studies on CRC-associated bacteria and their carcinogenic mechanisms in animal models, human cell lines and human cohorts. High-throughput technologies have facilitated the identification of CRC-associated bacteria in human samples. We have presented our metagenome and metabolome studies on fecal samples collected from a large Japanese cohort that revealed stage-specific phenotypes of the microbiota in CRC. Furthermore, we have discussed the potential carcinogenic mechanisms of the gut microbiota, from which we can infer whether changes in the gut microbiota are a cause or effect in the multi-step process of CRC carcinogenesis.
C1 [Mizutani, Sayaka; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.
   [Mizutani, Sayaka] Japan Soc Promot Sci, Tokyo, Japan.
   [Yachida, Shinichi] Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
C3 Tokyo Institute of Technology; Japan Society for the Promotion of
   Science; Osaka University
RP Yachida, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.
EM syachida@cgi.med.osaka-u.ac.jp
OI Yachida, Shinichi/0000-0001-5507-4566
FU Japan Science and Technology Agency [JPMJCR19U3]; Japan Agency for
   Medical Research and Development [JP18ek0109187, JP18jk0210009,
   JP19cm0106464]; National Cancer Center Research and Development Fund
   [25-A-4, 28-A-4, 29-A6]; Joint Research Project of the Institute of
   Medical Science, the University of Tokyo; Precursory Research for
   Embryonic Science and Technology [JPMJPR1507]; Takeda Science
   Foundation; Japan Society for the Promotion of Science [142558,
   16J10135, 221S0002]; Yasuda Medical Foundation; Yakult Bio-Science
   Foundation; Princess Takamatsu Cancer Research Fund
FX Japan Science and Technology Agency, Grant/Award Number: JPMJCR19U3;
   Japan Agency for Medical Research and Development, Grant/Award Number:
   JP18ek0109187, JP18jk0210009 and JP19cm0106464; National Cancer Center
   Research and Development Fund, Grant/Award Number: 25-A-4, 28-A-4 and
   29-A6; Joint Research Project of the Institute of Medical Science, the
   University of Tokyo; Precursory Research for Embryonic Science and
   Technology, Grant/Award Number: JPMJPR1507; the Takeda Science
   Foundation; Japan Society for the Promotion of Science, Grant/Award
   Number: 142558, 16J10135 and 221S0002; the Yasuda Medical Foundation;
   the Yakult Bio-Science Foundation; the Princess Takamatsu Cancer
   Research Fund
CR Aggeletopoulou I, 2019, MICROB PATHOGENESIS, V137, DOI 10.1016/j.micpath.2019.103774
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   BECHI P, 1987, GASTROENTEROLOGY, V93, P335, DOI 10.1016/0016-5085(87)91024-9
   Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001
   Cao HL, 2014, FAM CANCER, V13, P563, DOI 10.1007/s10689-014-9742-3
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000
   Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806
   Ijssennagger N, 2016, TRENDS MOL MED, V22, P190, DOI 10.1016/j.molmed.2016.01.002
   Ijssennagger N, 2015, P NATL ACAD SCI USA, V112, P10038, DOI 10.1073/pnas.1507645112
   Ishihara J, 2008, AM J CLIN NUTR, V88, P1576, DOI 10.3945/ajcn.2008.26195
   Johansson MEV, 2014, GUT, V63, P281, DOI 10.1136/gutjnl-2012-303207
   Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398
   Kolonel LN, 2004, NAT REV CANCER, V4, P519, DOI 10.1038/nrc1389
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kuriki Kiyonori, 2006, Asian Pac J Cancer Prev, V7, P495
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nishimoto Y, 2016, GUT, V65, P1574, DOI 10.1136/gutjnl-2016-311937
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Paduraru D N, 2016, J Med Life, V9, P130
   Pai R, 2004, MOL BIOL CELL, V15, P2156, DOI 10.1091/mbc.E03-12-0894
   Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139
   Ridlon JM, 2020, GUT MICROBES, V11, P381, DOI 10.1080/19490976.2019.1618173
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Shin S, 2018, CLIN NUTR, V37, P1019, DOI 10.1016/j.clnu.2017.04.015
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tsoi H, 2017, GASTROENTEROLOGY, V152, P1419, DOI 10.1053/j.gastro.2017.01.009
   Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096
   Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094
   Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yazici C, 2017, GUT, V66, P1983, DOI 10.1136/gutjnl-2016-313321
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   YU J, 2019, J CLIN ONCOL, V37
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 47
TC 29
Z9 31
U1 1
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1347-9032
EI 1349-7006
J9 CANCER SCI
JI Cancer Sci.
PD MAR
PY 2020
VL 111
IS 3
BP 766
EP 773
DI 10.1111/cas.14298
EA FEB 2020
PG 8
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA KS4KZ
UT WOS:000510551000001
PM 31910311
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Fang, CY
   Chen, JS
   Hsu, BM
   Hussain, B
   Rathod, J
   Lee, KH
AF Fang, Chuan-Yin
   Chen, Jung-Sheng
   Hsu, Bing-Mu
   Hussain, Bashir
   Rathod, Jagat
   Lee, Kuo-Hsin
TI Colorectal Cancer Stage-Specific Fecal Bacterial Community
   Fingerprinting of the Taiwanese Population and Underpinning of Potential
   Taxonomic Biomarkers
SO MICROORGANISMS
LA English
DT Article
DE colorectal cancer; gut microbiota; gut microbial dysbiosis; prognosis;
   biomarker; metagenomics; functional predictions
ID HUMAN GUT; INTESTINAL MICROBIOTA; METHANOGENIC ARCHAEA;
   STATISTICAL-ANALYSIS; INFLAMMATION; METABOLITES; DISEASE;
   MICROORGANISMS; PROBIOTICS; HEALTH
AB Despite advances in the characterization of colorectal cancer (CRC), it still faces a poor prognosis. There is growing evidence that gut microbiota and their metabolites potentially contribute to the development of CRC. Thus, microbial dysbiosis and their metabolites associated with CRC, based on stool samples, may be used to advantage to provide an excellent opportunity to find possible biomarkers for the screening, early detection, prevention, and treatment of CRC. Using 16S rRNA amplicon sequencing coupled with statistical analysis, this study analyzed the cause-effect shift of the microbial taxa and their metabolites that was associated with the fecal gut microbiota of 17 healthy controls, 21 polyps patients, and 21 cancer patients. The microbial taxonomic shift analysis revealed striking differences among the healthy control, polyps and cancer groups. At the phylum level, Synergistetes was reduced significantly in the polyps group compared to the healthy control and cancer group. Additionally, at the genus level and in association with the cancer group, a total of 12 genera were highly enriched in abundance. In contrast, only Oscillosprira was significantly higher in abundance in the healthy control group. Comparisons of the polyps and cancer groups showed a total of 18 significantly enriched genera. Among them, 78% of the genera associated with the cancer group were in higher abundance, whereas the remaining genera showed a higher abundance in the polyps group. Additionally, the comparison of healthy control and polyp groups showed six significantly abundant genera. More than 66% of these genera showed a reduced abundance in the polyps group than in healthy controls, whereas the remaining genera were highly abundant in the polyps group. Based on tumor presence and absence, the abundance of Olsenella and Lactobacillus at the genus level was significantly reduced in the patient group compared to healthy controls. The significant microbial function prediction revealed an increase in the abundance of metabolites in the polyps and cancer groups compared to healthy controls. A correlation analysis revealed a higher contribution of Dorea in the predicted functions. This study showed dysbiosis of gut microbiota at the taxonomic level and their metabolic functions among healthy subjects and in two stages of colorectal cancer, including adenoma and adenocarcinoma, which might serve as potential biomarkers for the early diagnosis and treatment of CRC.
C1 [Fang, Chuan-Yin] Ditmanson Med Fdn Chia Yi Christian Hosp, Div Colon & Rectal Surg, Chiayi 621, Taiwan.
   [Chen, Jung-Sheng] E Da Hosp, Dept Med Res, Kaohsiung 824, Taiwan.
   [Hsu, Bing-Mu; Hussain, Bashir] Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi 621, Taiwan.
   [Hsu, Bing-Mu] Natl Chung Cheng Univ, Ctr Innovat Aging Soc CIRAS, Chiayi 621, Taiwan.
   [Hussain, Bashir] Natl Chung Cheng Univ, Dept Biomed Sci, Chiayi 621, Taiwan.
   [Rathod, Jagat] Natl Cheng Kung Univ, Dept Earth Sci, Tainan 701, Taiwan.
   [Lee, Kuo-Hsin] I Shou Univ, E Da Hosp, Dept Emergency Med, Kaohsiung 824, Taiwan.
   [Lee, Kuo-Hsin] I Shou Univ, Sch Med, Kaohsiung 824, Taiwan.
C3 E-Da Hospital; National Chung Cheng University; National Chung Cheng
   University; National Chung Cheng University; National Cheng Kung
   University; E-Da Hospital; I Shou University; I Shou University
RP Hsu, BM (corresponding author), Natl Chung Cheng Univ, Dept Earth & Environm Sci, Chiayi 621, Taiwan.; Hsu, BM (corresponding author), Natl Chung Cheng Univ, Ctr Innovat Aging Soc CIRAS, Chiayi 621, Taiwan.
EM 04969@cych.org.tw; nicky071214@gmail.com; bmhsu@ccu.edu.tw;
   bashir.aku@gmail.com; jagat2006@gmail.com; peter1055@gmail.com
RI Hsu, Bing-Mu/AAN-5768-2021; Chen, Jung-Sheng/GWR-2603-2022
OI Hsu, Bing-Mu/0000-0002-2988-8408; Chen, Jung-Sheng/0000-0003-3187-9479;
   Lee, Kuo Hsin/0000-0003-3612-3523
FU Ministry of Science and Technology (MOST), Taiwan [108-2116-M-194-005,
   108-2811-M-194-507]; Ditmanson Medical Foundation Chia-Yi Christian
   Hospital [RCN007]; Center for Innovative Research on Aging Society
   (CIRAS) from The Featured Areas Research Center Program by the Ministry
   of Education (MOE), Taiwan
FX This research was supported by the Ministry of Science and Technology
   (MOST), Taiwan (108-2116-M-194-005 & 108-2811-M-194-507), the Ditmanson
   Medical Foundation Chia-Yi Christian Hospital (RCN007), and the Center
   for Innovative Research on Aging Society (CIRAS) from The Featured Areas
   Research Center Program within the framework of the Higher Education
   Sprout Project by the Ministry of Education (MOE), Taiwan.
CR Abell Guy C. J., 2006, Microbial Ecology in Health and Disease, V18, P154, DOI 10.1080/08910600601048969
   Abriouel H, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01197
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Anand S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01945
   Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011
   Balvociute M, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3501-4
   Bokulich N.A., 2018, PEERJ PREPR, V6
   Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343
   Bundgaard-Nielsen C, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5571-y
   Candela M, 2014, WORLD J GASTROENTERO, V20, P908, DOI 10.3748/wjg.v20.i4.908
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Chen YC, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.568012
   Cheng YW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.615056
   Cielo AB, 2013, CLIN KIDNEY J, V6, P552, DOI 10.1093/ckj/sft088
   Clos-Garcia M, 2020, CANCERS, V12, DOI 10.3390/cancers12051142
   Coltuc D, 2007, IEEE SIGNAL PROC LET, V14, P255, DOI 10.1109/LSP.2006.884895
   Cong J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02777
   Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   de Carvalho AC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00813
   de Macario EC, 2009, INT J MED MICROBIOL, V299, P99, DOI 10.1016/j.ijmm.2008.06.011
   Debesa-Tur G, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79874-y
   Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295
   Douglas GM, 2019, PICRUST2 IMPROVED EX, DOI [10.1101/672295, DOI 10.1101/672295]
   Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195
   Ewing I, 2014, FRONTLINE GASTROENTE, V5, P26, DOI 10.1136/flgastro-2013-100329
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Fong WN, 2020, ONCOGENE, V39, P4925, DOI 10.1038/s41388-020-1341-1
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gao ZG, 2015, MOL MED REP, V12, P6119, DOI 10.3892/mmr.2015.4124
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Garcia-Lopez R, 2021, GENES-BASEL, V12, DOI 10.3390/genes12040564
   Garcia-Lopez R, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8010134
   Ge YS, 2021, J EXP CLIN CANC RES, V40, DOI 10.1186/s13046-021-01845-6
   Geng JW, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-2
   Guinane CM, 2013, THER ADV GASTROENTER, V6, P295, DOI 10.1177/1756283X13482996
   Guo P, 2020, J EXP CLIN CANC RES, V39, DOI [10.1186/513046-020-01677-w, 10.1186/s13046-020-01677-w]
   Han SW, 2020, CANCER MANAG RES, V12, P8703, DOI 10.2147/CMAR.S268943
   Hibberd AA, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000145
   Huang TY, 2018, BIOGEOSCIENCES, V15, P1815, DOI 10.5194/bg-15-1815-2018
   Iyadorai T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228217
   Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1
   Kang MS, 2017, SEMIN IMMUNOL, V32, P3, DOI 10.1016/j.smim.2017.04.003
   Kim Y, 2015, METHODS, V79-80, P52, DOI 10.1016/j.ymeth.2014.10.022
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Kosumi Keisuke, 2018, J Lab Precis Med, V3, DOI 10.21037/jlpm.2018.09.05
   Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760
   Lim MY, 2018, SYST APPL MICROBIOL, V41, P151, DOI 10.1016/j.syapm.2017.11.008
   Liu WX, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7828392
   Long SP, 2020, NPJ BIOFILMS MICROME, V6, DOI 10.1038/s41522-020-0123-4
   Lu JN, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00900-2
   Magne F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051474
   Martin FPJ, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00113
   McBain AJ, 1998, J MED MICROBIOL, V47, P407, DOI 10.1099/00222615-47-5-407
   Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Mizutani S, 2020, CANCER SCI, V111, P766, DOI 10.1111/cas.14298
   MOELLERING RC, 1974, AM J MED, V57, P239, DOI 10.1016/0002-9343(74)90448-3
   Montalban-Arques A, 2019, EBIOMEDICINE, V48, P648, DOI 10.1016/j.ebiom.2019.09.050
   Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nistal E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00220
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Osman MA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82465-0
   Park CH, 2018, INTEST RES, V16, P338, DOI 10.5217/ir.2018.16.3.338
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]
   Peng Y, 2021, METABOLITES, V11, DOI 10.3390/metabo11030159
   Prodan A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227434
   Ranjbar M, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01886-z
   Rawla P, 2019, GASTROENTEROL REV, V14, P89, DOI 10.5114/pg.2018.81072
   Rezasoltani S, 2018, MICROB PATHOGENESIS, V124, P244, DOI 10.1016/j.micpath.2018.08.035
   Roccarina D, 2010, AM J GASTROENTEROL, V105, P1250, DOI 10.1038/ajg.2009.744
   Rosa BA, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0416-5
   Rossi T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165786
   Russo E, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02699
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sheng QS, 2019, ONCOL LETT, V18, P4834, DOI 10.3892/ol.2019.10841
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sun J, 2016, GENES DIS, V3, P130, DOI 10.1016/j.gendis.2016.03.004
   Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466
   Vettore L, 2020, BRIT J CANCER, V122, P150, DOI 10.1038/s41416-019-0620-5
   Wang FF, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/676724
   Wang G, 2019, J CELL PHYSIOL, V234, P17023, DOI 10.1002/jcp.28436
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Wang XX, 2017, EXP THER MED, V13, P2848, DOI 10.3892/etm.2017.4367
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Wong SH, 2017, GUT, V66, P1441, DOI 10.1136/gutjnl-2016-312766
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Xia YL, 2017, GENES DIS, V4, P138, DOI 10.1016/j.gendis.2017.06.001
   Xiao Q, 2021, CANCER LETT, V499, P201, DOI 10.1016/j.canlet.2020.11.030
   Xiong J, 2015, BLOOD CANCER J, V5, DOI 10.1038/bcj.2015.10
   Xue ZY, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00410-18, 10.1128/msphere.00410-18]
   Yang J, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0313-4
   Yang YZ, 2019, THERANOSTICS, V9, P4101, DOI 10.7150/thno.35186
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
   Zaytseva Y, 2021, CANCERS, V13, DOI 10.3390/cancers13020301
   Zeng HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051214
   Zhang H, 2019, FRONT MED-PRC, V13, P461, DOI 10.1007/s11684-019-0695-7
   Zhao QQ, 2018, CLIN PROTEOM, V15, DOI 10.1186/s12014-018-9182-4
   Zheng W, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0110-9
   Zhu QC, 2013, TUMOR BIOL, V34, P1285, DOI 10.1007/s13277-013-0684-4
NR 105
TC 3
Z9 3
U1 1
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD AUG
PY 2021
VL 9
IS 8
AR 1548
DI 10.3390/microorganisms9081548
PG 20
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA UI4EO
UT WOS:000690562800001
PM 34442626
OA Green Published
DA 2022-11-22
ER

PT J
AU Zeller, G
   Tap, J
   Voigt, AY
   Sunagawa, S
   Kultima, JR
   Costea, PI
   Amiot, A
   Boohm, J
   Brunetti, F
   Habermann, N
   Hercog, R
   Koch, M
   Luciani, A
   Mende, DR
   Schneider, MA
   Schrotz-King, P
   Tournigand, C
   Van Nhieu, JT
   Yamada, T
   Zimmermann, J
   Benes, V
   Kloor, M
   Ulrich, CM
   Doeberitz, MVK
   Sobhani, I
   Bork, P
AF Zeller, Georg
   Tap, Julien
   Voigt, Anita Y.
   Sunagawa, Shinichi
   Kultima, Jens Roat
   Costea, Paul I.
   Amiot, Aurelien
   Bohm, Jurgen
   Brunetti, Francesco
   Habermann, Nina
   Hercog, Rajna
   Koch, Moritz
   Luciani, Alain
   Mende, Daniel R.
   Schneider, Martin A.
   Schrotz-King, Petra
   Tournigand, Christophe
   Van Nhieu, Jeanne Tran
   Yamada, Takuji
   Zimmermann, Jurgen
   Benes, Vladimir
   Kloor, Matthias
   Ulrich, Cornelia M.
   Doeberitz, Magnus Von Knebel
   Sobhani, Iradj
   Bork, Peer
TI Potential of fecal microbiota for early-stage detection of colorectal
   cancer
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE cancer screening; colorectal cancer; fecal biomarkers; human gut;
   microbiome; metagenomics
ID HUMAN GUT MICROBIOME; OCCULT-BLOOD-TESTS; IN-VIVO; FUSOBACTERIUM; MUCIN;
   TUMORIGENESIS; METABOLISM; METAGENOME; SEQUENCES; RESOURCE
AB Several bacterial species have been implicated in the development of colorectal carcinoma (CRC), but CRC-associated changes of fecal microbiota and their potential for cancer screening remain to be explored. Here, we used metagenomic sequencing of fecal samples to identify taxonomic markers that distinguished CRC patients from tumor-free controls in a study population of 156 participants. Accuracy of metagenomic CRC detection was similar to the standard fecal occult blood test (FOBT) and when both approaches were combined, sensitivity improved > 45% relative to the FOBT, while maintaining its specificity. Accuracy of metagenomic CRC detection did not differ significantly between early- and late-stage cancer and could be validated in independent patient and control populations (N = 335) from different countries. CRC-associated changes in the fecal microbiome at least partially reflected microbial community composition at the tumor itself, indicating that observed gene pool differences may reveal tumor-related host-microbe interactions. Indeed, we deduced a metabolic shift from fiber degradation in controls to utilization of host carbohydrates and amino acids in CRC patients, accompanied by an increase of lipopolysaccharide metabolism.
C1 [Zeller, Georg; Tap, Julien; Voigt, Anita Y.; Sunagawa, Shinichi; Kultima, Jens Roat; Costea, Paul I.; Mende, Daniel R.; Bork, Peer] Struct & Computat Biol Unit, European Mol Biol Lab, Heidelberg, Germany.
   [Tap, Julien; Amiot, Aurelien; Sobhani, Iradj] AP HP, Dept Gastroenterol, Creteil, France.
   [Tap, Julien; Amiot, Aurelien; Van Nhieu, Jeanne Tran; Sobhani, Iradj] AP HP, LIC EA4393 EC2M3, Creteil, France.
   [Tap, Julien; Amiot, Aurelien; Brunetti, Francesco; Luciani, Alain; Tournigand, Christophe; Van Nhieu, Jeanne Tran; Sobhani, Iradj] UPEC, Creteil, France.
   [Voigt, Anita Y.; Kloor, Matthias; Doeberitz, Magnus Von Knebel] Univ Heidelberg Hosp, Inst Pathol, Dept Appl Tumor Biol, Heidelberg, Germany.
   [Voigt, Anita Y.; Kloor, Matthias; Doeberitz, Magnus Von Knebel] German Canc Res Ctr, Clin Cooperat Unit Appl Tumor Biol, Heidelberg, Germany.
   [Voigt, Anita Y.; Kloor, Matthias; Doeberitz, Magnus Von Knebel; Bork, Peer] Univ Heidelberg Hosp, MMPU, Heidelberg, Germany.
   [Voigt, Anita Y.; Kloor, Matthias; Doeberitz, Magnus Von Knebel; Bork, Peer] Univ Heidelberg Hosp, European Mol Biol Lab, Heidelberg, Germany.
   [Bohm, Jurgen; Habermann, Nina; Schrotz-King, Petra; Ulrich, Cornelia M.] Natl Ctr Tumor Dis NCT Heidelberg, Div Prevent Oncol, Heidelberg, Germany.
   [Bohm, Jurgen; Habermann, Nina; Schrotz-King, Petra; Ulrich, Cornelia M.] German Canc Res Ctr, Heidelberg, Germany.
   [Brunetti, Francesco] AP HP, Dept Surg, Creteil, France.
   [Hercog, Rajna; Zimmermann, Jurgen; Benes, Vladimir] Genom Core Facil, European Mol Biol Lab, Heidelberg, Germany.
   [Koch, Moritz; Schneider, Martin A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.
   [Luciani, Alain] AP HP, Dept Radiol, Creteil, France.
   [Tournigand, Christophe] AP HP, Dept Med Oncol, Creteil, France.
   [Van Nhieu, Jeanne Tran] AP HP, Dept Pathol, Creteil, France.
   [Yamada, Takuji] Tokyo Inst Technol, Dept Biol Informat, Tokyo 152, Japan.
   [Ulrich, Cornelia M.] FHCRC, Seattle, WA USA.
   [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany.
C3 European Molecular Biology Laboratory (EMBL); Assistance Publique
   Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC);
   Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux
   Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital
   Universitaire Henri-Mondor - APHP; Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Ruprecht Karls University
   Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ);
   Ruprecht Karls University Heidelberg; European Molecular Biology
   Laboratory (EMBL); Ruprecht Karls University Heidelberg; Helmholtz
   Association; German Cancer Research Center (DKFZ); Ruprecht Karls
   University Heidelberg; Helmholtz Association; German Cancer Research
   Center (DKFZ); Assistance Publique Hopitaux Paris (APHP); Universite
   Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire
   Henri-Mondor - APHP; European Molecular Biology Laboratory (EMBL);
   Ruprecht Karls University Heidelberg; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital
   Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital
   Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris
   (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital
   Universitaire Henri-Mondor - APHP; Tokyo Institute of Technology; Fred
   Hutchinson Cancer Center; Helmholtz Association; Max Delbruck Center for
   Molecular Medicine
RP Sobhani, I (corresponding author), AP HP, Dept Gastroenterol, Creteil, France.
EM iradj.sobhani@hmn.aphp.fr; bork@embl.de
RI Luciani, Alain/U-1429-2018; Bork, Peer/F-1813-2013; Tournigand,
   Christophe/Q-2831-2018; VAN NHIEU, Jeanne TRAN/R-5235-2018; Sunagawa,
   Shinichi/Q-5950-2019; Zeller, Georg/M-6484-2013; Mende, Daniel
   R/I-3662-2019; Tap, Julien/E-5760-2010; von Knebel Doeberitz,
   Magnus/D-2372-2016; AMIOT, Aurélien/ABL-6373-2022
OI Bork, Peer/0000-0002-2627-833X; Sunagawa, Shinichi/0000-0003-3065-0314;
   Zeller, Georg/0000-0003-1429-7485; Mende, Daniel R/0000-0001-6831-4557;
   Tap, Julien/0000-0001-8998-5413; von Knebel Doeberitz,
   Magnus/0000-0002-0498-6781; Costea, Paul Igor/0000-0003-1645-3947;
   Voigt, Anita Yvonne/0000-0002-6794-0385
FU CancerBiome project (European Research Council project) [268985];
   METACARDIS project [305312]; International Human Microbiome Standards
   project [HEALTH-F4-2010-261376]; French LNCC; ACD grants; PHRC Vatnimad
   grant; NATIONAL CANCER INSTITUTE [U01CA206110] Funding Source: NIH
   RePORTER
FX We are thankful to Wolfgang Huber, Athanasios Typas, Christian Widmer,
   Gunnar Ratsch, and members of the Bork group for inspiring discussions.
   Additionally, we thank Yan Ping Yuan and the EMBL Information Technology
   Core Facility for support with high-performance computing as well as
   Bettina Haase, Dinko Pavlinic, and Bianka Baying and the EMBL Genomics
   Core Facility for sequencing support. We acknowledge support with
   patient recruitment and characterization by Gilles Gatineau, Michel
   Azizi, Thomas Aparicio, Marjan Djabbari, Yann Le Baleur, Isabelle
   Baumgartner, Herve Hagege, Anne Courillon-Mallet, Laurent Costes, Robert
   Benamouzig, Michael Levy, Maryan Cavicchi, Elie Zrihen, Alain Rozenbaum,
   Gilles Trojmann, Damien Levoir, Olivier Pecriaux, Christophe Lochet,
   Marc Parieto, Karen Leroy, Bijan Ghaleh, Philippe Le Corvoisier, Mariane
   Mozer, Philippe Capelle, Benoit Coffin, Marc Gornet, Clare Abbenhardt,
   Verena Widmer, Stephanie Tosic, Christine Fink, Manja Ghajar Rahimi,
   Torsten Kolsch, Judith Kammer, and Janina Biazeck and technical support
   by Karine Le Roux, Sonia Garrigou, Julie Villemot, Sylvia Verdy,
   Philippe Langella, Jean Pierre Furet, Joel Dore, Jean Pierre Carrau, Lin
   Zielske, Renate Skatula, Anett Brendel, Hicham Mansour, Biba Nebbad, and
   Amine Amoura. This work has received funding through the CancerBiome
   project (European Research Council project reference 268985), the
   METACARDIS project (FP7-HEALTH-2012-INNOVATION-I-305312), the
   International Human Microbiome Standards project
   (HEALTH-F4-2010-261376), a French LNCC 2004 grant, ACD grants, and in
   part through the PHRC 2009 Vatnimad grant.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Allison JE, 2007, JNCI-J NATL CANCER I, V99, P1462, DOI 10.1093/jnci/djm150
   Allison JE, 1996, NEW ENGL J MED, V334, P155, DOI 10.1056/NEJM199601183340304
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Arumugam M, 2014, NATURE, V506, DOI 10.1038/nature13075
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536
   Bergstrom KSB, 2013, GLYCOBIOLOGY, V23, P1026, DOI 10.1093/glycob/cwt045
   Bernstein CN, 2001, CANCER-AM CANCER SOC, V91, P854, DOI 10.1002/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z
   Boleij A, 2012, BIOL REV, V87, P701, DOI 10.1111/j.1469-185X.2012.00218.x
   Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Cario E, 2000, J IMMUNOL, V164, P966, DOI 10.4049/jimmunol.164.2.966
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   de Vos WM, 2013, NATURE, V498, P48, DOI 10.1038/nature12251
   Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11
   Downes J, 2006, INT J SYST EVOL MICR, V56, P751, DOI 10.1099/ijs.0.64041-0
   Dutilh BE, 2013, BEST PRACT RES CL GA, V27, P85, DOI 10.1016/j.bpg.2013.03.008
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050
   Faivre J, 2004, GASTROENTEROLOGY, V126, P1674, DOI 10.1053/j.gastro.2004.02.018
   Fan RE, 2008, J MACH LEARN RES, V9, P1871
   Fasano A, 2002, GUT, V50, P9
   Fisher S, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r1
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538
   Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Hol L, 2010, GUT, V59, P62, DOI 10.1136/gut.2009.177089
   Hsu RYC, 2011, CANCER RES, V71, P1989, DOI 10.1158/0008-5472.CAN-10-2833
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20073, 10.3322/caac.20107]
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Knights D, 2011, CELL HOST MICROBE, V10, P292, DOI 10.1016/j.chom.2011.09.003
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kultima JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047656
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee BB, 2009, CLIN CANCER RES, V15, P6185, DOI 10.1158/1078-0432.CCR-09-0111
   Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018
   Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   Mansour H, 2009, Patent No. [WO 2009095596 A2, 2009095596]
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538
   Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/nmeth.2575, 10.1038/NMETH.2575]
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275
   Papa E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039242
   Park SN, 2013, ARCH MICROBIOL, V195, P473, DOI 10.1007/s00203-013-0896-4
   Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281
   Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051
   Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865
   Tang XY, 2010, AM J MED SCI, V339, P319, DOI 10.1097/MAJ.0b013e3181cef1b7
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Trosset MW, 2006, COMPUT STAT DATA AN, V52, P4635
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094
   Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zavoral M, 2009, WORLD J GASTROENTERO, V15, P5907, DOI 10.3748/wjg.15.5907
   Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275
NR 96
TC 553
Z9 579
U1 13
U2 127
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD NOV
PY 2014
VL 10
IS 11
AR 766
DI 10.15252/msb.20145645
PG 18
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA AX8PB
UT WOS:000347170000006
PM 25432777
OA Green Published, Green Accepted, gold
DA 2022-11-22
ER

PT J
AU Mima, K
   Ogino, S
   Nakagawa, S
   Sawayama, H
   Kinoshita, K
   Krashima, R
   Ishimoto, T
   Imai, K
   Iwatsuki, M
   Hashimoto, D
   Baba, Y
   Sakamoto, Y
   Yamashita, Y
   Yoshida, N
   Chikamoto, A
   Ishiko, T
   Baba, H
AF Mima, Kosuke
   Ogino, Shuji
   Nakagawa, Shigeki
   Sawayama, Hiroshi
   Kinoshita, Koichi
   Krashima, Ryuichi
   Ishimoto, Takatsugu
   Imai, Katsunori
   Iwatsuki, Masaaki
   Hashimoto, Daisuke
   Baba, Yoshifumi
   Sakamoto, Yasuo
   Yamashita, Yo-ichi
   Yoshida, Naoya
   Chikamoto, Akira
   Ishiko, Takatoshi
   Baba, Hideo
TI The role of intestinal bacteria in the development and progression of
   gastrointestinal tract neoplasms
SO SURGICAL ONCOLOGY-OXFORD
LA English
DT Review
DE Microorganism; Gastrointestinal carcinoma; Tumor location
ID HELICOBACTER-PYLORI CAGA; BACTEROIDES-FRAGILIS ENTEROTOXIN;
   COLORECTAL-CANCER PATIENTS; SQUAMOUS-CELL CARCINOMA; HUMAN GUT
   MICROBIOME; NF-KAPPA-B; FAECALIS-INFECTED MACROPHAGES; COLONIC
   EPITHELIAL-CELLS; CHAIN FATTY-ACIDS; FUSOBACTERIUM-NUCLEATUM
AB More than 100 trillion microorganisms inhabit the human intestinal tract and play important roles in health conditions and diseases, including cancer. Accumulating evidence demonstrates that specific bacteria and bacterial dysbiosis in the gastrointestinal tract can potentiate the development and progression of gastrointestinal tract neoplasms by damaging DNA, activating oncogenic signaling pathways, producing tumor-promoting metabolites such as secondary bile acids, and suppressing antitumor immunity. Other bacterial species have been shown to produce short-chain fatty acids such as butyrate, which can suppress inflammation and carcinogenesis in the gastrointestinal tract. Consistent with these lines of evidence, clinical studies using metagenomic analyses have shown associations of specific bacteria and bacterial dysbiosis with gastrointestinal tract cancers, including esophageal, gastric, and colorectal cancers. Emerging data demonstrate that intestinal bacteria can modulate the efficacy of cancer chemotherapies and novel targeted immunotherapies such as anti-CTLA4 and anti-CD274 therapies, the process of absorption, and the occurrence of complications after gastrointestinal surgery. A better understanding of the mechanisms by which the gut microbiota influence tumor development and progression in the intestine would provide opportunities to develop new prevention and treatment strategies for patients with gastrointestinal tract cancers by targeting the intestinal microflora. (C) 2017 Published by Elsevier Ltd.
C1 [Mima, Kosuke; Nakagawa, Shigeki; Sawayama, Hiroshi; Kinoshita, Koichi; Krashima, Ryuichi; Ishimoto, Takatsugu; Imai, Katsunori; Iwatsuki, Masaaki; Hashimoto, Daisuke; Baba, Yoshifumi; Sakamoto, Yasuo; Yamashita, Yo-ichi; Yoshida, Naoya; Chikamoto, Akira; Ishiko, Takatoshi; Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan.
   [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Div MPE Mol Pathol Epidemiol, 75 Francis St, Boston, MA 02115 USA.
   [Ogino, Shuji] Harvard Med Sch, Boston, MA USA.
   [Ogino, Shuji] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Ogino, Shuji] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA.
C3 Kumamoto University; Harvard University; Brigham & Women's Hospital;
   Harvard University; Harvard Medical School; Harvard University; Harvard
   T.H. Chan School of Public Health; Harvard University; Dana-Farber
   Cancer Institute
RP Baba, H (corresponding author), Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Chuo Ku, 1-1-1 Honjo, Kumamoto 8608556, Japan.
EM hdobaba@kumamoto-u.ac.jp
RI Hashimoto, Daisuke/AAE-7134-2020; Ishimoto, Takatsugu/AAP-1356-2020
OI Ishimoto, Takatsugu/0000-0003-1852-1835; Ogino,
   Shuji/0000-0002-3909-2323
FU U.S. National Institutes of Health (NIH) [R35 CA197735];
   Dana-Farber/Harvard Cancer Center; Takeda Science Foundation; Kanae
   Foundation for the Promotion of Medical Science; YOKOYAMA Foundation for
   Clinical Pharmacology; JSPS KAKENHI [17H05094]; Grants-in-Aid for
   Scientific Research [16K10504] Funding Source: KAKEN; NATIONAL CANCER
   INSTITUTE [R35CA197735] Funding Source: NIH RePORTER
FX This work was supported by grants from the U.S. National Institutes of
   Health (NIH) [R35 CA197735 to S.O.] and the Nodal Award (to S.O.) of the
   Dana-Farber/Harvard Cancer Center. K.M. is supported by grants from the
   Takeda Science Foundation, Kanae Foundation for the Promotion of Medical
   Science, YOKOYAMA Foundation for Clinical Pharmacology, and JSPS KAKENHI
   Grant Number 17H05094. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of NIH.
   The funders had no role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249
   Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Amieva M, 2016, GASTROENTEROLOGY, V150, P64, DOI 10.1053/j.gastro.2015.09.004
   Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Aviles-Jimenez F, 2014, SCI REP-UK, V4, DOI 10.1038/srep04202
   Baba Y, 2016, ANN SURG, V264, P305, DOI 10.1097/SLA.0000000000001510
   Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x
   Barrasa JI, 2013, TOXICOL IN VITRO, V27, P964, DOI 10.1016/j.tiv.2012.12.020
   Bartfeld S, 2015, GASTROENTEROLOGY, V148, P126, DOI 10.1053/j.gastro.2014.09.042
   Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051
   Bessede E, 2015, ONCOGENE, V34, P2547, DOI 10.1038/onc.2014.187
   Bessede E, 2014, ONCOGENE, V33, P4123, DOI 10.1038/onc.2013.380
   Biedermann L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059260
   Blackett KL, 2013, ALIMENT PHARM THER, V37, P1084, DOI 10.1111/apt.12317
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Boleij A, 2013, LANCET INFECT DIS, V13, P719, DOI 10.1016/S1473-3099(13)70107-5
   Boncristiano M, 2003, J EXP MED, V198, P1887, DOI 10.1084/jem.20030621
   Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343
   Brandt S, 2005, P NATL ACAD SCI USA, V102, P9300, DOI 10.1073/pnas.0409873102
   Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211
   Buda A, 2003, GUT, V52, P729, DOI 10.1136/gut.52.5.729
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107
   Chen WHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039039
   Chen XP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/241983
   Clarke JM, 2008, CARCINOGENESIS, V29, P2190, DOI 10.1093/carcin/bgn192
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236
   Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033
   Dupaul-Chicoine J, 2015, IMMUNITY, V43, P751, DOI 10.1016/j.immuni.2015.08.013
   Eun CS, 2014, HELICOBACTER, V19, P407, DOI 10.1111/hel.12145
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008
   Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707
   Gall A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129055
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x
   Gebert B, 2003, SCIENCE, V301, P1099, DOI 10.1126/science.1086871
   Graillot V, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00034
   Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465
   Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034
   Gupta A, 2010, COLORECTAL DIS, V12, P164, DOI 10.1111/j.1463-1318.2009.01814.x
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Halama N, 2011, CANCER RES, V71, P5670, DOI 10.1158/0008-5472.CAN-11-0268
   Hammer HF, 2012, DIGEST DIS, V30, P182, DOI 10.1159/000336681
   Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011
   Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848
   Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110
   Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108
   Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535
   Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529
   Iarashi K, 2010, INT J BIOCHEM CELL B, V42, P39, DOI 10.1016/j.biocel.2009.07.009
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109
   Ito M, 2015, INT J CANCER, V137, P1258, DOI 10.1002/ijc.29488
   Jackson MA, 2016, GUT, V65, P749, DOI 10.1136/gutjnl-2015-310861
   Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011
   Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398
   Kataoka K, 2017, ANN SURG, V265, P1152, DOI 10.1097/SLA.0000000000001828
   Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308
   Kohoutova D, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0733-7
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kountouras J, 2015, ONCOGENE, V34, P670, DOI 10.1038/onc.2013.602
   Kubota T, 2014, ANN SURG ONCOL, V21, P891, DOI 10.1245/s10434-013-3384-9
   Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65
   Kumar A, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0700-0
   Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808
   Law WL, 2007, J GASTROINTEST SURG, V11, P8, DOI 10.1007/s11605-006-0049-z
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Li QG, 2013, WORLD J GASTROENTERO, V19, P4060, DOI 10.3748/wjg.v19.i25.4060
   Liou AP, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005687
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26337
   McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863
   Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958
   Mima K, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.53
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Muhlbauer M, 2004, AM J PHYSIOL-GASTR L, V286, pG1000, DOI 10.1152/ajpgi.00338.2003
   Murata-Kamiya N, 2007, ONCOGENE, V26, P4617, DOI 10.1038/sj.onc.1210251
   Nasrollahzadeh D, 2015, SCI REP-UK, V5, DOI 10.1038/srep08820
   Nesic D, 2004, NATURE, V429, P429, DOI 10.1038/nature02532
   Nie S, 2014, DIS ESOPHAGUS, V27, P645, DOI 10.1111/dote.12194
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Oertli M, 2013, P NATL ACAD SCI USA, V110, P3047, DOI 10.1073/pnas.1211248110
   Olivas AD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044326
   Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164
   Ozben T, 2007, J PHARM SCI-US, V96, P2181, DOI 10.1002/jps.20874
   Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139
   Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565
   Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038
   Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674
   Quante M, 2012, CANCER CELL, V21, P36, DOI 10.1016/j.ccr.2011.12.004
   Rakoff-Nahoum S, 2009, NAT REV CANCER, V9, P57, DOI 10.1038/nrc2541
   Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
   Rosty C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065479
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Saeki H, 2017, ANN SURG, V265, P527, DOI 10.1097/SLA.0000000000001692
   Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360
   Shogan BD, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010658
   Shogan BD, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-35
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI [10.3322/caac.21387, 10.3322/caac.21332, 10.3322/caac.21551]
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95
   Sommovilla J, 2015, J GASTROINTEST SURG, V19, P56, DOI 10.1007/s11605-014-2631-0
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504
   Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164
   Strickertsson JAB, 2014, GENES-BASEL, V5, P726, DOI 10.3390/genes5030726
   Strickertsson JAB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063147
   SUMMERTON J, 1985, DIGESTION, V31, P77, DOI 10.1159/000199183
   Sundrud MS, 2004, P NATL ACAD SCI USA, V101, P7727, DOI 10.1073/pnas.0401528101
   Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010
   Szabo G, 2015, GASTROENTEROLOGY, V148, P30, DOI 10.1053/j.gastro.2014.10.042
   Takasuna K, 1998, CANCER CHEMOTH PHARM, V42, P280, DOI 10.1007/s002800050818
   Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Thangaraju M, 2009, CANCER RES, V69, P2826, DOI 10.1158/0008-5472.CAN-08-4466
   Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690
   Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x
   Tsugawa H, 2012, CELL HOST MICROBE, V12, P764, DOI 10.1016/j.chom.2012.10.014
   Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010
   Vanneman M, 2012, NAT REV CANCER, V12, P237, DOI 10.1038/nrc3237
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83
   Wang LL, 2016, EUR J GASTROEN HEPAT, V28, P261, DOI 10.1097/MEG.0000000000000542
   Wang L, 2009, J EXP MED, V206, P1457, DOI 10.1084/jem.20090207
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Wang XM, 2013, CANCER PREV RES, V6, P206, DOI 10.1158/1940-6207.CAPR-12-0350
   Wang XM, 2012, GASTROENTEROLOGY, V142, P543, DOI 10.1053/j.gastro.2011.11.020
   Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551
   Wei JX, 2015, GUT, V64, P1040, DOI 10.1136/gutjnl-2014-307295
   Wei ZL, 2016, ONCOTARGET, V7, P46158, DOI 10.18632/oncotarget.10064
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Wu SG, 2004, INFECT IMMUN, V72, P5832, DOI 10.1128/IAI.72.10.5832-5839.2004
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2007, J CELL SCI, V120, P1944, DOI 10.1242/jcs.03455
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yamamura K, 2016, CLIN CANCER RES, V22, P5574, DOI 10.1158/1078-0432.CCR-16-1786
   Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865
   Yu GQ, 2014, CANCER EPIDEM BIOMAR, V23, P735, DOI 10.1158/1055-9965.EPI-13-0855
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zaidi AH, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2093-8
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
   Zou WP, 2010, NAT REV IMMUNOL, V10, P248, DOI 10.1038/nri2742
NR 167
TC 39
Z9 45
U1 4
U2 43
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-7404
EI 1879-3320
J9 SURG ONCOL
JI Surg. Oncol.-Oxf.
PD DEC
PY 2017
VL 26
IS 4
BP 368
EP 376
DI 10.1016/j.suronc.2017.07.011
PG 9
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA FO6ZB
UT WOS:000417017500008
PM 29113654
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Shiroma, H
   Shiba, S
   Erawijantari, PP
   Takamaru, H
   Yamada, M
   Sakamoto, T
   Kanemitsu, Y
   Mizutani, S
   Soga, T
   Saito, Y
   Shibata, T
   Fukuda, S
   Yachida, S
   Yamada, T
AF Shiroma, Hirotsugu
   Shiba, Satoshi
   Erawijantari, Pande Putu
   Takamaru, Hiroyuki
   Yamada, Masayoshi
   Sakamoto, Taku
   Kanemitsu, Yukihide
   Mizutani, Sayaka
   Soga, Tomoyoshi
   Saito, Yutaka
   Shibata, Tatsuhiro
   Fukuda, Shinji
   Yachida, Shinichi
   Yamada, Takuji
TI Surgical Treatment for Colorectal Cancer Partially Restores Gut
   Microbiome and Metabolome Traits
SO MSYSTEMS
LA English
DT Article
DE colorectal cancer; surgery; metagenomics; human gut microbiome;
   metabolomics
ID ACID; SURGERY; COLON; DRIVER; RISK
AB Accumulating evidence indicates that the gut microbiome and metabolites are associated with colorectal cancer (CRC). However, the influence of surgery for CRC treatment on the gut microbiome and metabolites and how it relates to CRC risk in postoperative CRC patients remain partially understood. Here, we collected 170 fecal samples from 85 CRC patients pre- and approximately 1 year post-surgery and performed shotgun metagenomic sequencing and capillary electrophoresis-time of flight mass spectrometry-based metabolomics analyses to characterize alterations between pre- and postsurgery. We determined that the relative abundance of 114 species was altered postsurgery (P < 0.005). CRC-associated species, such as Fusobacterium nucleatum, were decreased postsurgery. On the other hand, Clostridium scindens, carcinogenesis-associated deoxycholate (DCA)-producing species, and its biotransformed genes (bai operon) were increased postsurgery. The concentration of 60 fecal metabolites was also altered postsurgery (P < 0.005). Two bile acids, cholate and DCA, were increased postsurgery. We developed methods to estimate postoperative CRC risk based on the gut microbiome and metabolomic compositions using a random forest machine-learning algorithm that classifies large adenoma or early-stage CRC and healthy controls from publicly available data sets. We applied methods to preoperative samples and then compared the estimated CRC risk between the two groups according to the presence of large adenoma or tumors 5 years postsurgery (P < 0.05). Overall, our results show that the gut microbiome and metabolites dynamically change from pre- to postsurgery. In postoperative CRC patients, potential CRC risk derived from gut microbiome and metabolites still remains, which indicates the importance of follow-up assessments.
   IMPORTANCE The gut microbiome and metabolites are associated with CRC progression and carcinogenesis. Postoperative CRC patients are reported to be at an increased CRC risk; however, how gut microbiome and metabolites are related to CRC risk in postoperative patients remains only partially understood. In this study, we investigated the influence of surgical CRC treatment on the gut microbiome and metabolites. We found that the CRC-associated species Fusobacterium nucleatum was decreased postsurgery, whereas carcinogenesis-associated DCA and its producing species and genes were increased postsurgery. We developed methods to estimate postoperative CRC risk based on the gut microbiome and metabolomic compositions. We applied methods to compare the estimated CRC risk between two groups according to the presence of large adenoma or tumors after 5 years postsurgery. To our knowledge, this study is the first report on differences between pre- and postsurgery using metagenomics and metabolomics data analysis. Our methods might be used for CRC risk assessment in postoperative patients.
C1 [Shiroma, Hirotsugu; Erawijantari, Pande Putu; Mizutani, Sayaka; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.
   [Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi] Natl Canc Ctr, Div Canc Genom, Res Inst, Tokyo, Japan.
   [Erawijantari, Pande Putu] Univ Turku, Fac Technol, Dept Comp, Turku, Finland.
   [Takamaru, Hiroyuki; Yamada, Masayoshi; Sakamoto, Taku; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan.
   [Kanemitsu, Yukihide] Natl Canc Ctr, Dept Colorectal Surg, Tokyo, Japan.
   [Soga, Tomoyoshi; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Yamagata, Japan.
   [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Yokohama, Kanagawa, Japan.
   [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Ibaraki, Japan.
   [Yachida, Shinichi] Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Suita, Osaka, Japan.
C3 Tokyo Institute of Technology; National Cancer Center - Japan;
   University of Turku; National Cancer Center - Japan; National Cancer
   Center - Japan; Keio University; University of Tsukuba; Osaka University
RP Yamada, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.; Yachida, S (corresponding author), Natl Canc Ctr, Div Canc Genom, Res Inst, Tokyo, Japan.; Yachida, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Suita, Osaka, Japan.
EM syachida@cgi.med.osaka-u.ac.jp; takuji@bio.titech.ac.jp
OI Erawijantari, Pande Putu/0000-0002-5173-6347; Fukuda,
   Shinji/0000-0001-5161-9880
FU National Cancer Center Research and Development Fund [2020-A-4]; Japan
   Agency for Medical Research and Development (AMED) [JP18ek0109187, JP19
   cm0106464, JP20gm1010009, JP20ck0106546, JP20 cm0106477, 20jk0210009];
   JST-ERATO [JPMJER1902]; JST-AIP Acceleration Research [JPMJCR19U3];
   Japan Society for the Promotion of Science (JSPS) KAKENHI [142558,
   221S0002, 18H04805, 20H03662]; Food Science Institute Foundation;
   Program for the Advancement of Research in Core Projects under Keio
   University; Integrated Frontier Research for Medical Science Division,
   Institute for Open and Transdisciplinary Research Initiatives, Osaka
   University; Joint Research Project of the Institute of Medical Science,
   the University of Tokyo; Takeda Science Foundation; Suzuken Memorial
   Foundation; Yasuda Memorial Medical Foundation; Yakult Bio-Science
   Foundation
FX This work was supported in part by grants from the National Cancer
   Center Research and Development Fund (2020-A-4); the Japan Agency for
   Medical Research and Development (AMED) (JP18ek0109187 to S.F., S.Y.,
   and T.Y.; JP19 cm0106464 to S.Y. and T.Y.; JP20gm1010009 to S.F.;
   JP20ck0106546 to Y.S., S.Y., and T.Y.; JP20 cm0106477 to S.S., S.Y., and
   T.Y.; and 20jk0210009 to T.S. and S.Y.); JST-ERATO (JPMJER1902 to S.F.);
   JST-AIP Acceleration Research (JPMJCR19U3 to S.Y. and T.Y.); Japan
   Society for the Promotion of Science (JSPS) KAKENHI (142558 and 221S0002
   to T.Y., 18H04805 to S.F., and 20H03662 to S.Y.); the Food Science
   Institute Foundation (to S.F.); the Program for the Advancement of
   Research in Core Projects under Keio University's Longevity Initiative
   (to S.F.); Integrated Frontier Research for Medical Science Division,
   Institute for Open and Transdisciplinary Research Initiatives, Osaka
   University (to S.Y.); Joint Research Project of the Institute of Medical
   Science, the University of Tokyo (T.S. and S.Y.); the Takeda Science
   Foundation (to S.Y. and S.F.); the Suzuken Memorial Foundation (to
   S.Y.); Yasuda Memorial Medical Foundation (to S.Y.); and Yakult
   Bio-Science Foundation (to S.Y.).
CR Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   Al Bandar MH, 2017, ONCOL REP, V37, P2553, DOI 10.3892/or.2017.5531
   Bertelsen CA, 2018, DIS COLON RECTUM, V61, P1063, DOI 10.1097/DCR.0000000000001154
   Bouvier AM, 2008, EUR J CANCER, V44, P522, DOI 10.1016/j.ejca.2008.01.007
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Breiman Leo, 2001, MACH LEARN, V45, P5
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Emiola A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07240-8
   Funabashi M, 2020, NATURE, V582, P566, DOI 10.1038/s41586-020-2396-4
   Geng JW, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-26
   Guyton K, 2017, NAT REV GASTRO HEPAT, V14, P43, DOI 10.1038/nrgastro.2016.139
   Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806
   Ishii C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124079
   Jordan KR, 2018, CANCER-AM CANCER SOC, V124, P3990, DOI 10.1002/cncr.31584
   Kakeji Y, 2018, ANN GASTROENT SURG, V2, P37, DOI 10.1002/ags3.12052
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kurien M, 2011, SCAND J GASTROENTERO, V46, P818, DOI 10.3109/00365521.2011.574728
   Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   Mal M, 2012, ANAL BIOANAL CHEM, V403, P483, DOI 10.1007/s00216-012-5870-5
   Milanese A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08844-4
   Mulder SA, 2012, DIS COLON RECTUM, V55, P522, DOI 10.1097/DCR.0b013e318249db00
   Negata N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40182-9
   Nishimoto Y, 2016, GUT, V65, P1574, DOI 10.1136/gutjnl-2016-311937
   Ohigashi S, 2013, J GASTROINTEST SURG, V17, P1657, DOI 10.1007/s11605-013-2270-x
   Ohshima K, 2020, NAT METAB, V2, P81, DOI 10.1038/s42255-019-0156-2
   Palleja A, 2018, NAT MICROBIOL, V3, P1255, DOI 10.1038/s41564-018-0257-9
   Ridlon JM, 2016, GUT MICROBES, V7, P201, DOI 10.1080/19490976.2016.1150414
   Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483
   Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200
   Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k
   Sze MA, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0366-3
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Thomas LA, 2000, GASTROENTEROLOGY, V119, P806, DOI 10.1053/gast.2000.16495
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Wang YJ, 2020, CANCER MANAG RES, V12, P11553, DOI 10.2147/CMAR.S275316
   Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Yabuuchi Y, 2018, GASTROINTEST ENDOSC, V88, P348, DOI 10.1016/j.gie.2018.03.011
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yan Y, 2020, CELL HOST MICROBE, V27, P585, DOI 10.1016/j.chom.2020.03.005
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yun JA, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003942
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 49
TC 0
Z9 0
U1 5
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD APR 26
PY 2022
VL 7
IS 2
AR e00018-22
DI 10.1128/msystems.00018-22
PG 18
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 0V0UH
UT WOS:000788061300040
PM 35311577
OA Green Submitted, Green Published
DA 2022-11-22
ER

PT J
AU Zhou, ZK
   Ge, SQ
   Li, Y
   Ma, WT
   Liu, YH
   Hu, SJ
   Zhang, RT
   Ma, YH
   Du, KJ
   Syed, A
   Chen, P
AF Zhou, Zhongkun
   Ge, Shiqiang
   Li, Yang
   Ma, Wantong
   Liu, Yuheng
   Hu, Shujian
   Zhang, Rentao
   Ma, Yunhao
   Du, Kangjia
   Syed, Ashikujaman
   Chen, Peng
TI Human Gut Microbiome-Based Knowledgebase as a Biomarker Screening Tool
   to Improve the Predicted Probability for Colorectal Cancer
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE biomarkers; colorectal cancer; database; diagnosis; microbiome
ID FECAL IMMUNOCHEMICAL TEST; BACTERIAL; CARCINOGENESIS; MARKERS; GENE;
   DNA; CONTRIBUTES; METABOLITES; METAGENOME; SIGNATURE
AB Colorectal cancer (CRC) is a common clinical malignancy globally ranked as the fourth leading cause of cancer mortality. Some microbes are known to contribute to adenoma-carcinoma transition and possess diagnostic potential. Advances in high-throughput sequencing technology and functional studies have provided significant insights into the landscape of the gut microbiome and the fundamental roles of its components in carcinogenesis. Integration of scattered knowledge is highly beneficial for future progress. In this study, literature review and information extraction were performed, with the aim of integrating the available data resources and facilitating comparative research. A knowledgebase of the human CRC microbiome was compiled to facilitate understanding of diagnosis, and the global signatures of CRC microbes, sample types, algorithms, differential microorganisms and various panels of markers plus their diagnostic performance were evaluated based on statistical and phylogenetic analyses. Additionally, prospects about current changelings and solution strategies were outlined for identifying future research directions. This type of data integration strategy presents an effective platform for inquiry and comparison of relevant information, providing a tool for further study about CRC-related microbes and exploration of factors promoting clinical transformation (available at: http://gsbios.com/index/experimental/dts_ mben?id=1).).
C1 [Zhou, Zhongkun; Li, Yang; Ma, Wantong; Liu, Yuheng; Hu, Shujian; Zhang, Rentao; Ma, Yunhao; Du, Kangjia; Syed, Ashikujaman; Chen, Peng] Lanzhou Univ, Sch Pharm, Lanzhou, Peoples R China.
   [Ge, Shiqiang] Lanzhou Vocat Tech Coll, Dept Elect Informat Engn, Lanzhou, Peoples R China.
C3 Lanzhou University
RP Chen, P (corresponding author), Lanzhou Univ, Sch Pharm, Lanzhou, Peoples R China.
EM chenpeng@lzu.edu.cn
OI Syed, Ashikujaman/0000-0001-8071-6807
FU Special Funding for Open and Shared Large-Scale Instruments and
   Equipments of Lanzhou University [LZU-GXJJ-2019C012]; Project of Lanzhou
   City for Innovative and Entrepreneurial Talents [2017-RC-73]; Science
   and Technology Project of Lanzhou City [2018-4-59]
FX This work was supported by Special Funding for Open and Shared
   Large-Scale Instruments and Equipments of Lanzhou University (Grant No.
   LZU-GXJJ-2019C012), the Project of Lanzhou City for Innovative and
   Entrepreneurial Talents (Grant No. 2017-RC-73), and Science and
   Technology Project of Lanzhou City (Grant No. 2018-4-59).
CR Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Arabameri A, 2020, IEEE ACM T COMPUT BI, V17, P547, DOI 10.1109/TCBB.2018.2870124
   Bardou M, 2013, GUT, V62, P933, DOI 10.1136/gutjnl-2013-304701
   Baxter NT, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0205-y
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Burns MB, 2019, GUT MICROBES, V10, P547, DOI 10.1080/19490976.2018.1549421
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chen YY, 2020, THERANOSTICS, V10, P323, DOI 10.7150/thno.38870
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Colnot S, 2004, LAB INVEST, V84, P1619, DOI 10.1038/labinvest.3700180
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Cross AJ, 2019, GUT, V68, P1642, DOI 10.1136/gutjnl-2018-317297
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295
   Dickinson BT, 2015, GUT, V64, P1485, DOI 10.1136/gutjnl-2014-308075
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Eklof V, 2017, INT J CANCER, V141, P2528, DOI 10.1002/ijc.31011
   Eslami M, 2019, J CELL PHYSIOL, V234, P17127, DOI 10.1002/jcp.28473
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Gies A, 2018, GASTROENTEROLOGY, V154, P93, DOI 10.1053/j.gastro.2017.09.018
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Gudra D, 2019, GUT, V68, P1723, DOI 10.1136/gutjnl-2018-316225
   Guo SH, 2018, CLIN CHEM, V64, P1327, DOI 10.1373/clinchem.2018.289728
   Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403
   Imperiale TF, 2014, NEW ENGL J MED, V370, P1287, DOI 10.1056/NEJMoa1311194
   Jones MB, 2015, P NATL ACAD SCI USA, V112, P14024, DOI 10.1073/pnas.1519288112
   Keum N, 2019, NAT REV GASTRO HEPAT, V16, P713, DOI 10.1038/s41575-019-0189-8
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kosumi K, 2018, AM J PATHOL, V188, P2839, DOI 10.1016/j.ajpath.2018.08.015
   Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Kwong TNY, 2018, GASTROENTEROLOGY, V155, P383, DOI 10.1053/j.gastro.2018.04.028
   Laudadio I, 2018, OMICS, V22, P248, DOI 10.1089/omi.2018.0013
   Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Liang JQ, 2020, GUT, V69, P1248, DOI 10.1136/gutjnl-2019-318532
   Liang QY, 2017, CLIN CANCER RES, V23, P2061, DOI 10.1158/1078-0432.CCR-16-1599
   Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992
   Loh K, 2008, GENE CHROMOSOME CANC, V47, P449, DOI 10.1002/gcc.20552
   Long XH, 2019, NAT MICROBIOL, V4, P2319, DOI 10.1038/s41564-019-0541-3
   Malagon M, 2019, ALIMENT PHARM THER, V49, P1410, DOI 10.1111/apt.15251
   Marchesi JR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0094-5
   Melotte V, 2009, JNCI-J NATL CANCER I, V101, P916, DOI 10.1093/jnci/djp131
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Minot SS, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0722-6
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nayfach S, 2016, CELL, V166, P1103, DOI 10.1016/j.cell.2016.08.007
   O'Brien CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062815
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Paramsothy S, 2019, GASTROENTEROLOGY, V156, P1440, DOI 10.1053/j.gastro.2018.12.001
   PITOT HC, 1993, CANCER-AM CANCER SOC, V72, P962, DOI 10.1002/1097-0142(19930801)72:3+<962::AID-CNCR2820721303>3.0.CO;2-H
   Pleguezuelos-Manzano C, 2020, NATURE, V580, P269, DOI 10.1038/s41586-020-2080-8
   Poore GD, 2020, NATURE, V579, P567, DOI 10.1038/s41586-020-2095-1
   Poyet M, 2019, NAT MED, V25, P1442, DOI 10.1038/s41591-019-0559-3
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rastelli M, 2019, ENDOCR REV, V40, P1271, DOI 10.1210/er.2018-00280
   Rezasoltani S, 2018, J MICROBIOL METH, V155, P82, DOI 10.1016/j.mimet.2018.11.007
   Routy B, 2018, NAT REV CLIN ONCOL, V15, P382, DOI 10.1038/s41571-018-0006-2
   Rubinstein MR, 2019, EMBO REP, V20, DOI 10.15252/embr.201847638
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Sacks D, 2018, INT J STROKE, V13, P612, DOI [10.1016/j.jvir.2017.11.026, 10.1177/1747493018778713]
   Saffarian A, 2019, MBIO, V10, DOI 10.1128/mBio.01315-19
   Sani, 2013, J CANC RES, V2013, P818675, DOI [10.1155/2013/818675, DOI 10.1155/2013/818675]
   Schloss PD, 2011, APPL ENVIRON MICROB, V77, P3219, DOI 10.1128/AEM.02810-10
   Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189
   Shi WY, 2019, NUCLEIC ACIDS RES, V47, pD637, DOI 10.1093/nar/gky1008
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Sze MA, 2018, MBIO, V9, DOI DOI 10.1128/MBIO.00630-18
   Tabib NSS, 2020, GUT, V69, P1520, DOI 10.1136/gutjnl-2019-320065
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462
   Villeger R, 2018, WORLD J GASTROENTERO, V24, P2327, DOI 10.3748/wjg.v24.i22.2327
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Wang LJ, 2020, GUT, V69, P1988, DOI 10.1136/gutjnl-2019-320105
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022
   Wong SH, 2017, GUT, V66, P1441, DOI 10.1136/gutjnl-2016-312766
   Wu J, 2019, TRANSL ONCOL, V12, P846, DOI 10.1016/j.tranon.2019.03.003
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Xia Y., 2018, STAT ANAL MICROBIOME
   Xie YH, 2017, EBIOMEDICINE, V25, P32, DOI 10.1016/j.ebiom.2017.10.005
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yang J, 2020, GUT MICROBES, V11, P918, DOI 10.1080/19490976.2020.1712986
   Yang YZ, 2019, THERANOSTICS, V9, P4101, DOI 10.7150/thno.35186
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yeoh YK, 2020, GUT, V69, P1998, DOI 10.1136/gutjnl-2019-319635
   Yim WW, 2016, JAMA ONCOL, V2, P797, DOI 10.1001/jamaoncol.2016.0213
   Youssef O, 2018, DIGEST DIS SCI, V63, P2950, DOI 10.1007/s10620-018-5190-5
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 105
TC 7
Z9 9
U1 1
U2 14
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 19
PY 2020
VL 11
AR 596027
DI 10.3389/fmicb.2020.596027
PG 15
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA PA8RH
UT WOS:000595896100001
PM 33329482
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Gsur, A
   Baierl, A
   Brezina, S
AF Gsur, Andrea
   Baierl, Andreas
   Brezina, Stefanie
TI Colorectal Cancer Study of Austria (CORSA): A Population-Based
   Multicenter Study
SO BIOLOGY-BASEL
LA English
DT Article
DE colorectal cancer; biomarker; genomics; proteomics; metagenomics;
   screening; biobank
ID QUALITY-OF-LIFE; WIDE ASSOCIATION; HUMAN TELOMERASE; RISK;
   POLYMORPHISMS; GENES; STYLE
AB Simple Summary The Colorectal cancer Study of Austria (CORSA), an ongoing multicenter prospective case-control study, was initiated to discover prognostic as well as diagnostic biomarkers for colorectal cancer (CRC) risk prediction mainly based on OMICS research, such as genomics, metabolomics, and metagenomics centered at the Institute of Cancer Research at the Medical University of Vienna; recruitment for CORSA started in 2003. Until now, we have generated genomics data, untargeted and targeted metabolomics data, folate-dependent one-carbon metabolism data, and leukocyte telomere length data using the CORSA biobank. The generated data, the collection of biological samples (genomic DNA, plasma, fecal samples) and the comprehensive CORSA database represents a valuable resource for ongoing and future national and international cooperation projects on CRC research. The Colorectal cancer Study of Austria (CORSA) is comprised more than 13,500 newly diagnosed colorectal cancer (CRC) patients, patients with high- and low-risk adenomas as well as population-based controls. The recruitment for the CORSA biobank is performed in close cooperation with the invited two-stage CRC screening project "Burgenland PREvention trial of colorectal Disease with ImmunologiCal Testing" (B-PREDICT). Annually, more than 150,000 inhabitants of the Austrian federal state Burgenland aged between 40 and 80 are invited to participate using FIT-tests as an initial screening. FIT-positive tested participants are offered a diagnostic colonoscopy and are asked to take part in CORSA, sign a written informed consent, complete questionnaires concerning dietary and lifestyle habits and provide an ethylenediaminetetraacetic acid (EDTA) blood sample as well as a stool sample. Additional CRC cases have been recruited at four hospitals in Vienna and a hospital in lower Austria. A major strength of CORSA is the population-based controls who are FIT-positive and colonoscopy-confirmed to be free of polyps and/or CRC.
C1 [Gsur, Andrea; Brezina, Stefanie] Med Univ Vienna, Inst Canc Res, Dept Med 1, A-1090 Vienna, Austria.
   [Baierl, Andreas] Univ Vienna, Dept Stat & Operat Res, A-1010 Vienna, Austria.
C3 Medical University of Vienna; University of Vienna
RP Gsur, A (corresponding author), Med Univ Vienna, Inst Canc Res, Dept Med 1, A-1090 Vienna, Austria.
EM andrea.gsur@meduniwien.ac.at; andreas.baierl@univie.ac.at;
   stefanie.brezina@meduniwien.ac.at
OI Brezina, Stefanie/0000-0001-5238-6900; Gsur, Andrea/0000-0002-9795-1528;
   Baierl, Andreas/0000-0002-5329-9507
FU FFG (Bridge) [829675]; FWF [I1542-B-13]; ERA-NET on Translational Cancer
   Research (TRANSCAN) [I1578-B19, I2104-B26]; Medical University of Vienna
FX Analyses or measurements conducted within the CORSA study have been
   supported by funding from FFG (Bridge, Project number: 829675), FWF
   (I1542-B-13), ERA-NET on Translational Cancer Research (TRANSCAN)
   (I1578-B19), TRANSCAN (I2104-B26), and the Medical University of Vienna.
   CORSA did not receive any funding awarding only the study itself.
CR Archambault AN, 2020, GASTROENTEROLOGY, V158, P1274, DOI 10.1053/j.gastro.2019.12.012
   Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19
   Bull CJ, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01855-9
   Cornish AJ, 2020, LANCET GASTROENTEROL, V5, P55, DOI 10.1016/S2468-1253(19)30294-8
   Coronell JAL, 2018, GENOM PROTEOM BIOINF, V16, P73, DOI 10.1016/j.gpb.2017.10.002
   Culliford R, 2021, BRIT J CANCER, V124, P1169, DOI 10.1038/s41416-020-01211-x
   Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235
   Feik E, 2010, CANCER CAUSE CONTROL, V21, P91, DOI 10.1007/s10552-009-9438-4
   Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937
   Geijsen AJMR, 2021, EUR J NUTR, V60, P3171, DOI 10.1007/s00394-021-02488-1
   Geijsen AJMR, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkaa051
   Geijsen AJMR, 2020, INT J CANCER, V146, P3256, DOI 10.1002/ijc.32666
   Geijsen AJMR, 2019, INT J CANCER, V145, P1221, DOI 10.1002/ijc.32146
   Gsur A, 2011, CANCER EPIDEMIOL, V35, pE38, DOI 10.1016/j.canep.2011.03.005
   Gumpenberger T, 2021, METABOLITES, V11, DOI 10.3390/metabo11020119
   Guo XY, 2021, GASTROENTEROLOGY, V160, P1164, DOI 10.1053/j.gastro.2020.08.062
   Heinzle C, 2012, CANCER RES, V72, P5767, DOI 10.1158/0008-5472.CAN-11-3654
   Hofer P, 2017, ONCOTARGET, V8, P98623, DOI 10.18632/oncotarget.21697
   Hofer P, 2012, MOL CARCINOGEN, V51, pE176, DOI 10.1002/mc.21911
   Hofer P, 2011, CARCINOGENESIS, V32, P866, DOI 10.1093/carcin/bgr053
   Holowatyj AN, 2020, CANCER PREV RES, V13, P817, DOI 10.1158/1940-6207.CAPR-19-0538
   Holowatyj AN, 2020, GASTROENTEROLOGY, V158, P1155, DOI 10.1053/j.gastro.2019.11.012
   Huyghe JR, 2021, GUT, V70, P1325, DOI 10.1136/gutjnl-2020-321534
   Huyghe JR, 2019, NAT GENET, V51, P76, DOI 10.1038/s41588-018-0286-6
   Jarvik G.P., 2020, HUM GENET GENOM ADV, V1, DOI [10.1016/j.xhgg.2020.100010, DOI 10.1016/J.XHGG.2020.100010]
   Jiraskova K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010097
   Koole JL, 2021, AM J CLIN NUTR, V113, P1468, DOI 10.1093/ajcn/nqaa422
   Law PJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09775-w
   Lu YC, 2020, CANCER EPIDEM BIOMAR, V29, P477, DOI 10.1158/1055-9965.EPI-19-0755
   Murphy N, 2020, GASTROENTEROLOGY, V158, P1300, DOI 10.1053/j.gastro.2019.12.020
   Nothlings U, 2007, J NUTR, V137, P2781, DOI 10.1093/jn/137.12.2781
   Nounu A, 2021, CANCER EPIDEM BIOMAR, V30, P564, DOI 10.1158/1055-9965.EPI-20-1176
   O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275
   Ose J, 2021, METABOLITES, V11, DOI 10.3390/metabo11030129
   Papadimitriou N, 2021, INT J CANCER, V149, P1659, DOI 10.1002/ijc.33725
   Papadimitriou N, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14389-8
   Passamonti B, 2018, GUT, V67, P485, DOI 10.1136/gutjnl-2016-312716
   Playdon MC, 2019, METABOLITES, V9, DOI 10.3390/metabo9070145
   Rosello S, 2019, TRANSL GASTROENT HEP, V4, DOI 10.21037/tgh.2019.12.13
   Sainz J, 2021, CANCERS, V13, DOI 10.3390/cancers13061258
   Schafmayer C, 2019, GUT, V68, P854, DOI 10.1136/gutjnl-2018-317619
   Schmit SL, 2019, JNCI-J NATL CANCER I, V111, P146, DOI 10.1093/jnci/djy099
   Thomas M, 2020, AM J HUM GENET, V107, P432, DOI 10.1016/j.ajhg.2020.07.006
   Tsilidis KK, 2021, AM J CLIN NUTR, V113, P1490, DOI 10.1093/ajcn/nqab003
   Ulrich CM, 2019, CANCER EPIDEM BIOMAR, V28, P591, DOI 10.1158/1055-9965.EPI-18-0773
   van Roekel EH, 2014, CANCER EPIDEM BIOMAR, V23, P1394, DOI 10.1158/1055-9965.EPI-13-1144
   White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010
   Winkels RM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-374
   Zaidi SH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17386-z
   Zheng TH, 2021, GUT, V70, P1538, DOI 10.1136/gutjnl-2020-323868
   Zochmeister Cornelia, 2018, Oncotarget, V9, P13582, DOI 10.18632/oncotarget.24431
NR 51
TC 3
Z9 3
U1 1
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD AUG
PY 2021
VL 10
IS 8
AR 722
DI 10.3390/biology10080722
PG 12
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA UF9IQ
UT WOS:000688880200001
PM 34439954
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Azimi, M
   Shahbaz, SK
   Mansourabadi, AH
   Khosroshahi, LM
   Pourkalhor, S
   Rezakhani, M
   Masoumi, F
AF Azimi, Maryam
   Shahbaz, Sanaz Keshavarz
   Mansourabadi, Amir Hossein
   Khosroshahi, Leila Mohamed
   Pourkalhor, Shahryar
   Rezakhani, Mehran
   Masoumi, Farimah
TI Intestinal Microbiota: Novel Personalized Cancer Immunotherapy in
   Colorectal Cancer
SO INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
LA English
DT Review; Early Access
DE Microbiota; Cancer immunotherapy; Colorectal cancer
ID INFLAMMATORY-BOWEL-DISEASE; LECTIN REGIII-GAMMA; SHORT-CHAIN FATTY; GUT
   MICROBIOTA; COMMENSAL BACTERIA; ULCERATIVE-COLITIS; EPITHELIAL-CELLS;
   GASTRIC-CANCER; COLON-CANCER; ANTITUMOR IMMUNITY
AB The human colon harbors a diverse array of microorganisms that play fundamental roles in colorectal cancer (CRC). Increasing evidence indicates that dysbiosis of the intestinal microbiome has been associated with the development of CRC. Interaction between host genetics, intestinal microbiota, and lifestyle is well-indicated in the influence, prevention, and treatment of CRC. Various microbiome compositions have reported anticancer and/or anti-inflammatory properties. The presence of our microbiota is integral to our development, but a change in its composition can often lead to adverse effects, increasing the propensity for serious diseases like cancers. Recently, molecular detection and metabolomic techniques have increased our knowledge of the role of microbiota in promoting tumorigenesis. Dietary interventions may be appropriate to regulate the growth of beneficial microbiota in the gut. Metagenomic approaches along with immunology and metabolomics will obvious a new path for the treatment of CRC. In this study, we summarized recent advances in understanding the mechanisms involved in microbiota-related colorectal carcinoma, based on evidence from immunotherapy studies.
C1 [Azimi, Maryam] Iran Univ Med Sci IUMS, Immunol Res Ctr, Inst Immunol & Infect Dis, Tehran, Iran.
   [Shahbaz, Sanaz Keshavarz] Qazvin Univ Med Sci, Cellular & Mol Res Ctr, Res Inst Prevent Noncommunicable Dis, Qazvin, Iran.
   [Mansourabadi, Amir Hossein; Khosroshahi, Leila Mohamed] Univ Tehran Med Sci, Sch Med, Dept Immunol, Tehran, Iran.
   [Mansourabadi, Amir Hossein] Universal Sci Educ & Res Network USERN, Immunogenet Res Network IgReN, Tehran, Iran.
   [Mansourabadi, Amir Hossein] Universal Sci Educ & Res Network USERN, Systemat Review & Meta Anal Expert Grp SRMEG, Tehran, Iran.
   [Pourkalhor, Shahryar; Rezakhani, Mehran; Masoumi, Farimah] Islamic Azad Univ, Sch Med, Tonekabon Branch, Tonekabon, Iran.
   [Rezakhani, Mehran] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Inst, Tehran, Iran.
C3 Iran University of Medical Sciences; Qazvin University of Medical
   Sciences (QUMS); Tehran University of Medical Sciences; Universal
   Scientific Education & Research Network (USERN); Universal Scientific
   Education & Research Network (USERN); Islamic Azad University; Tehran
   University of Medical Sciences
RP Masoumi, F (corresponding author), Islamic Azad Univ, Sch Med, Tonekabon Branch, Tonekabon, Iran.
EM farimah.masoumi@gmail.com
RI Mansourabadi, Amir Hossein/O-9370-2019
OI Mansourabadi, Amir Hossein/0000-0001-7352-2318
CR Acevedo N, 2021, NUTRIENTS, V13, DOI 10.3390/nu13030724
   Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6
   Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050
   Amatullah H, 2020, CURR OPIN MICROBIOL, V56, P97, DOI 10.1016/j.mib.2020.08.005
   Ansari I, 2020, NAT MICROBIOL, V5, P610, DOI 10.1038/s41564-019-0659-3
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316
   Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240
   Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Barbara G, 2020, GUT, V69, P795, DOI 10.1136/gutjnl-2019-320411
   Bastide NM, 2011, CANCER PREV RES, V4, P177, DOI 10.1158/1940-6207.CAPR-10-0113
   Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011
   BENNET JD, 1989, LANCET, V1, P164
   Bhatt AP, 2017, CA-CANCER J CLIN, V67, P327, DOI 10.3322/caac.21398
   Bindels LB, 2015, NAT REV GASTRO HEPAT, V12, P303, DOI 10.1038/nrgastro.2015.47
   Bird L, 2008, NAT REV MICROBIOL, V6, P259, DOI 10.1038/nrmicro1884
   Bland PW, 1998, CHEM IMMUNOL, V71, P40
   Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450
   Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563
   Cammarota G, 2015, ALIMENT PHARM THER, V41, P835, DOI 10.1111/apt.13144
   Campbell DJ, 2002, J CLIN INVEST, V110, P1079, DOI 10.1172/JCI200216946
   Carino A, 2016, ONCOTARGET, V7, P61021, DOI 10.18632/oncotarget.10477
   Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119
   Chalabi M, 2020, ANN ONCOL, V31, P525, DOI [10.1016/j.annonc.2020.01.006, 10.1016/j.annoc.2020.01.006]
   Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108
   Chen GY, 2014, EUR J IMMUNOL, V44, P321, DOI 10.1002/eji.201344135
   Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412
   Cianchi F, 2004, CLIN CANCER RES, V10, P2694, DOI 10.1158/1078-0432.CCR-03-0192
   Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006
   Costello SP, 2019, JAMA-J AM MED ASSOC, V321, P156, DOI 10.1001/jama.2018.20046
   Crowe W, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112673
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   Deng ZH, 2018, ONCOL LETT, V15, P6352, DOI 10.3892/ol.2018.8167
   Derosa L, 2018, ANN ONCOL, V29, P1437, DOI 10.1093/annonc/mdy103
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448
   Dwivedy A, 2011, INT J GEN MED, V4, P299, DOI 10.2147/IJGM.S17525
   Ebrahimi S, 2021, INT ARCH ALLERGY IMM, DOI 10.1159/000520510
   Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022
   Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051
   Feng WQ, 2018, CELL PHYSIOL BIOCHEM, V47, P1617, DOI 10.1159/000490981
   Finlay BB, 2020, NAT REV IMMUNOL, V20, P522, DOI 10.1038/s41577-020-0374-6
   Ford AC, 2018, ALIMENT PHARM THER, V48, P1044, DOI 10.1111/apt.15001
   Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703
   Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004
   Funda DP, 2001, INFECT IMMUN, V69, P3772, DOI 10.1128/IAI.69.6.3772-3781.2001
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228
   Garside P, 2004, ANN NY ACAD SCI, V1029, P9, DOI 10.1196/annals.1309.002
   Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378
   Geuking MB, 2014, GUT MICROBES, V5, P411, DOI 10.4161/gmic.29330
   Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8
   Gio-Batta M, 2021, INT ARCH ALLERGY IMM, DOI 10.1159/000520149
   Gomes AQ, 2007, EMBO REP, V8, P1024, DOI 10.1038/sj.embor.7401090
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Grehan MJ, 2010, J CLIN GASTROENTEROL, V44, P551, DOI 10.1097/MCG.0b013e3181e5d06b
   Halkjaer SI, 2018, GUT, V67, P2107, DOI 10.1136/gutjnl-2018-316434
   He Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04984-z
   Hemati M, 2019, NUCLEOS NUCLEOT NUCL, V38, P521, DOI 10.1080/15257770.2019.1573371
   Hermann C, 2002, EUR J IMMUNOL, V32, P541, DOI 10.1002/1521-4141(200202)32:2<541::AID-IMMU541>3.0.CO;2-P
   Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66
   Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330
   Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888
   Hu B, 2013, P NATL ACAD SCI USA, V110, P9862, DOI 10.1073/pnas.1307575110
   Huaman JW, 2018, GASTROENTEROLOGY, V155, P1004, DOI 10.1053/j.gastro.2018.06.045
   Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Ianiro G, 2019, ALIMENT PHARM THER, V50, P240, DOI 10.1111/apt.15330
   Ianiro G, 2018, UNITED EUR GASTROENT, V6, P1232, DOI 10.1177/2050640618780762
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Ismail AS, 2011, P NATL ACAD SCI USA, V108, P8743, DOI 10.1073/pnas.1019574108
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Ju JK, 2020, J INNATE IMMUN, V12, DOI 10.1159/000507931
   Juul FE, 2018, NEW ENGL J MED, V378, P2535, DOI 10.1056/NEJMc1803103
   Kachalaki S, 2016, EUR J PHARM SCI, V89, P20, DOI 10.1016/j.ejps.2016.03.025
   Kaderbhai C, 2017, ANTICANCER RES, V37, P3195, DOI 10.21873/anticanres.11680
   Kantono M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01132
   Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271
   Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914
   Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kunkel EJ, 2003, MICROCIRCULATION, V10, P313, DOI 10.1038/sj.mn.7800196
   Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434
   Lee C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174297
   Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187
   Levy M, 2015, SEMIN IMMUNOPATHOL, V37, P39, DOI 10.1007/s00281-014-0451-7
   Li WN, 2019, CANCER LETT, V447, P41, DOI 10.1016/j.canlet.2019.01.015
   Li YT, 2016, ALIMENT PHARM THER, V43, P445, DOI 10.1111/apt.13492
   Li Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09525-y
   Linden SK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000617
   Linden SK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003952
   Litvak Y, 2019, IMMUNITY, V51, P214, DOI 10.1016/j.immuni.2019.08.003
   Lloyd-Price J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0307-y
   Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681
   Lynch JB, 2019, SCIENCE, V365, P1405, DOI 10.1126/science.aay0240
   MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442
   Mahmoudi F, 2016, BRIT J BIOMED SCI, V73, P97, DOI 10.1080/09674845.2016.1188476
   Malik A, 2018, IMMUNITY, V49, P515, DOI 10.1016/j.immuni.2018.08.024
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   Mbulaiteye SM, 2009, FRONT BIOSCI-LANDMRK, V14, P1490, DOI 10.2741/3320
   McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98
   Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x
   Mehta M, 2014, J NATL COMPR CANC NE, V12, P1721, DOI 10.6004/jnccn.2014.0174
   Mehta RS, 2017, GASTROENTEROLOGY, V152, P1944, DOI 10.1053/j.gastro.2017.02.015
   Milly PCD, 2020, SCIENCE, V367, P1252, DOI 10.1126/science.aay9187
   Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107
   Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001
   MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1
   Nakanishi Y, 2015, MUCOSAL IMMUNOL, V8, P152, DOI 10.1038/mi.2014.53
   Neish AS, 2000, SCIENCE, V289, P1560, DOI 10.1126/science.289.5484.1560
   Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114
   Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Palm NW, 2015, CLIN IMMUNOL, V159, P122, DOI 10.1016/j.clim.2015.05.014
   Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205
   Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608
   Peterson SN, 2020, CURR OPIN NEUROBIOL, V62, P48, DOI 10.1016/j.conb.2019.09.016
   Pflug N, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1150399
   Francino MP, 2014, PATHOGENS, V3, P769, DOI 10.3390/pathogens3030769
   Purchiaroni F, 2013, EUR REV MED PHARMACO, V17, P323
   Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011
   Rea Domenica, 2018, Oncotarget, V9, P17915, DOI 10.18632/oncotarget.24681
   REDDY BS, 1980, MUTAT RES, V72, P511, DOI 10.1016/0027-5107(80)90122-0
   Rooks MG, 2011, SCIENTIST, V25, P38, DOI 10.3410/B3-12
   Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973
   Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107
   Routy B, 2018, NAT REV CLIN ONCOL, V15, P382, DOI 10.1038/s41571-018-0006-2
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684
   Saretzki G, 2010, CURR PHARM DESIGN, V16, P79, DOI 10.2174/138161210789941874
   Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001
   Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610
   Sharon G, 2014, CELL METAB, V20, P719, DOI 10.1016/j.cmet.2014.10.016
   Shaw MH, 2012, J EXP MED, V209, P251, DOI 10.1084/jem.20111703
   Shigematsu Y, 2018, HEPATOBIL SURG NUTR, V7, P479, DOI 10.21037/hbsn.2018.10.02
   Shono Y, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2311
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Song M, 2019, CLIN GASTROENTEROL H, V17, P275, DOI 10.1016/j.cgh.2018.07.012
   Stevenson A, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2018.36.15_suppl.e15006
   Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816
   Sugimura T, 2004, CANCER SCI, V95, P290, DOI 10.1111/j.1349-7006.2004.tb03205.x
   Suzuki R, 2002, INT IMMUNOL, V14, P339, DOI 10.1093/intimm/14.4.339
   Takahashi D, 2015, INFLAMM REGEN, V35, P129
   Takahashi Kyoko, 2020, Immunohorizons, V4, P178, DOI 10.4049/immunohorizons.1900086
   Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z
   Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Torii T, 2019, CHROMATOGRAPHY, V40, P49, DOI 10.15583/jpchrom.2018.022
   Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003
   Uribe-Herranz M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.94952
   Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791
   Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105
   van Esch BCAM, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02141
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Vande Voorde J, 2014, J BIOL CHEM, V289, P13054, DOI 10.1074/jbc.M114.558924
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Viaud S, 2011, CANCER RES, V71, P661, DOI 10.1158/0008-5472.CAN-10-1259
   Vieira AR, 2017, ANN ONCOL, V28, P1788, DOI 10.1093/annonc/mdx171
   Vieira SM, 2018, SCIENCE, V359, P1156, DOI 10.1126/science.aar7201
   Vijay-Kumar M, 2009, MUCOSAL IMMUNOL, V2, P197, DOI 10.1038/mi.2009.9
   Villeger R, 2018, WORLD J GASTROENTERO, V24, P2327, DOI 10.3748/wjg.v24.i22.2327
   Wang YH, 2019, NAT MED, V25, P188, DOI 10.1038/s41591-018-0305-2
   Warren JR, 2006, CHEMMEDCHEM, V1, P672, DOI 10.1002/cmdc.200600121
   Watts AM, 2021, INT ARCH ALLERGY IMM, V182, P94, DOI 10.1159/000510536
   Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991
   Woo V, 2022, GUT MICROBES, V14, DOI 10.1080/19490976.2021.2022407
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Wu SE, 2020, NATURE, V586, P108, DOI 10.1038/s41586-020-2604-2
   Xiao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020592
   Yang ZY, 2020, DIGEST DIS SCI, V65, P150, DOI 10.1007/s10620-019-05751-y
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003
   Zaki MH, 2010, J IMMUNOL, V185, P4912, DOI 10.4049/jimmunol.1002046
   Zaph C, 2008, J EXP MED, V205, P2191, DOI 10.1084/jem.20080720
   Zenewicz LA, 2011, INT IMMUNOL, V23, P159, DOI 10.1093/intimm/dxr001
   Zhang Yong, 2018, Exp Mol Med, V50, P1, DOI 10.1038/s12276-017-0002-0
   Zhu YM, 2011, CANCER LETT, V309, P119, DOI 10.1016/j.canlet.2011.06.004
   Zitvogel L, 2012, NAT IMMUNOL, V13, P343, DOI 10.1038/ni.2224
   Zou SM, 2018, GASTROENTEROL REP, V6, P1, DOI 10.1093/gastro/gox031
NR 194
TC 1
Z9 1
U1 4
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-2438
EI 1423-0097
J9 INT ARCH ALLERGY IMM
JI Int. Arch. Allergy Immunol.
DI 10.1159/000525695
EA AUG 2022
PG 19
WC Allergy; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy; Immunology
GA 3Z4BO
UT WOS:000844361300001
PM 35988536
OA Bronze
DA 2022-11-22
ER

PT J
AU Zhao, YT
   Shi, L
   Hu, CL
   Sang, SM
AF Zhao, Yantao
   Shi, Lei
   Hu, Changling
   Sang, Shengmin
TI Wheat Bran for Colon Cancer Prevention: The Synergy between
   Phytochemical Alkylresorcinol C21 and Intestinal Microbial Metabolite
   Butyrate
SO JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
LA English
DT Article
DE colorectal cancer; wheat bran; alkylresorcinols; butyrate; synergy
ID CHAIN FATTY-ACIDS; ENDOPLASMIC-RETICULUM STRESS; DIETARY FIBER INTAKE;
   COLORECTAL-CANCER; CELL-GROWTH; APOPTOSIS; AUTOPHAGY; NUTRIENTS;
   PATHWAY; ADENOMA
AB There is convincing evidence that consuming whole grains (WGs) may decrease the risk of colorectal cancer (CRC). Wheat bran (WB) is a rich source of dietary fiber and phytochemicals with health-promoting properties. However, the active components especially the interaction between different components in WG wheat have not been fully explored. Here, we investigated whether one of the major WB phytochemicals, alkylresorcinol (AR) C21, and the major active intestinal microbial metabolite of fiber, butyrate, could synergistically suppress human colon cancer cells. Our results demonstrated for the first time that the combination of C21 and butyrate synergistically inhibited the growth of human colon cancer cells and induced apoptosis. Further mechanistic studies demonstrated that the cotreatment of C21 and butyrate induced significant upregulations in cleaved Poly(ADP-ribose) polymerase (PARP), cleaved caspase 3, p53 upregulated modulator of apoptosis (PUMA), cytochrome C, lipid-conjugated membrane-bound form of microtubule-associated protein 1A/1B-light chain 3 (LC3-II), and C/EBP homologous protein (CHOP) expressions, indicating the synergistic anticancer effects of C21 and butyrate were associated with induction of apoptosis, autophagy, and ER stress pathways. Notably, the C21 concentrations in the large intestinal tract of mice treated with human relevant doses of C21, were from 0.86 to 1.78 mu mol/g, suggesting the C21 doses used in vitro may be achievable after daily WG wheat intake. These results provide novel insights into the dietary prevention of CRC regarding the potential interaction of bioactive WG wheat phytochemicals and the microbial metabolites of fiber.
C1 [Zhao, Yantao; Shi, Lei; Hu, Changling; Sang, Shengmin] North Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, Lab Funct Foods & Human Hlth, North Carolina Res Campus,500 Laureate Way, Kannapolis, NC 28081 USA.
   [Shi, Lei] Ningxia Med Univ, Gen Hosp, Dept Colorectal Surg, Yinchuan 750004, Peoples R China.
C3 University of North Carolina; North Carolina A&T State University;
   Ningxia Medical University
RP Sang, SM (corresponding author), North Carolina Agr & Tech State Univ, Ctr Excellence Postharvest Technol, Lab Funct Foods & Human Hlth, North Carolina Res Campus,500 Laureate Way, Kannapolis, NC 28081 USA.
EM ssang@ncat.edu
RI Hu, Changling/P-7012-2019
OI Sang, Shengmin/0000-0002-5005-3616
FU United States Department of Agriculture (USDA) National Institute of
   Food and Agriculture (NIFA) R01 grant [2018-67001-28265]
FX This work was supported by funding from The United States Department of
   Agriculture (USDA) National Institute of Food and Agriculture (NIFA) R01
   grant 2018-67001-28265 to S.S.
CR Abraha AM, 2016, WORLD J GASTRO ONCOL, V8, P583, DOI 10.4251/wjgo.v8.i8.583
   Aune D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6617
   Ben QW, 2014, GASTROENTEROLOGY, V146, P689, DOI 10.1053/j.gastro.2013.11.003
   Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1
   CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   DeVorkin L., 2014, AUTOPHAGY CANC OTHER, P369, DOI [10.1016/B978-0-12-405529-2.00024-X, DOI 10.1016/B978-0-12-405529-2.00024-X]
   FISHER DE, 1994, CELL, V78, P539, DOI 10.1016/0092-8674(94)90518-5
   Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149
   Fu JS, 2018, J AGR FOOD CHEM, V66, P11935, DOI 10.1021/acs.jafc.8b04442
   Fung KYC, 2011, J PROTEOME RES, V10, P1860, DOI 10.1021/pr1011125
   Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697
   Gomes SD, 2020, CURR MED CHEM, V27, P4087, DOI 10.2174/0929867325666180530102050
   Gross MD, 2009, AM J CLIN NUTR, V89, p1543S, DOI DOI 10.3945/AJCN.2009.26736B
   HAGUE A, 1993, INT J CANCER, V55, P498, DOI 10.1002/ijc.2910550329
   Harris PJ, 1999, MUTAT RES-GEN TOX EN, V443, P95, DOI 10.1016/S1383-5742(99)00013-7
   Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200
   Jacobs DR, 2003, AM J CLIN NUTR, V78, p508S, DOI 10.1093/ajcn/78.3.508S
   Kruk J, 2017, EUR FOOD RES TECHNOL, V243, P1693, DOI 10.1007/s00217-017-2890-6
   Kunzmann AT, 2015, AM J CLIN NUTR, V102, P881, DOI 10.3945/ajcn.115.113282
   Kyro C, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt352
   Luo SL, 2019, J PHYSIOL BIOCHEM, V75, P53, DOI 10.1007/s13105-018-0651-z
   Mandal M, 2001, GASTROENTEROLOGY, V120, P71, DOI 10.1053/gast.2001.20897
   Mattila P, 2005, J AGR FOOD CHEM, V53, P8290, DOI 10.1021/jf051437z
   McNabney SM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121348
   Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568
   Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703
   Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06
   Qian HR, 2017, ONCOTARGET, V8, P62759, DOI 10.18632/oncotarget.18663
   REDDY B, 1989, CANCER RES, V49, P4629
   REDDY BS, 1992, GASTROENTEROLOGY, V102, P1475, DOI 10.1016/0016-5085(92)91704-8
   Reddy BS, 1999, AM J MED, V106, P16, DOI DOI 10.1016/S0002-9343(98)00341-6
   Research WCRFAIfC, 2018, CONTINUOUS UPDATE PR
   Rodriguez-Carrio J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00823
   Ross AB, 2003, J AGR FOOD CHEM, V51, P4111, DOI 10.1021/jf0340456
   Ross AB, 2009, J AGR FOOD CHEM, V57, P5187, DOI 10.1021/jf900239t
   Ruemmele FM, 2003, GUT, V52, P94, DOI 10.1136/gut.52.1.94
   Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307
   Sang SM, 2006, J AGR FOOD CHEM, V54, P9792, DOI 10.1021/jf0620665
   Sang SM, 2018, J AGR FOOD CHEM, V66, P10347, DOI 10.1021/acs.jafc.8b04110
   Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028
   SCHEPPACH W, 1995, EUR J CANCER, V31A, P1077, DOI 10.1016/0959-8049(95)00165-F
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Stevenson L, 2012, INT J FOOD SCI NUTR, V63, P1001, DOI 10.3109/09637486.2012.687366
   Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779
   Tallarida RJ, 2006, J PHARMACOL EXP THER, V319, P1, DOI 10.1124/jpet.106.104117
   Tanida Isei, 2008, V445, P77, DOI 10.1007/978-1-59745-157-4_4
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   Watson AJM, 2004, GUT, V53, P1701, DOI 10.1136/gut.2004.052704
   Wolczuk K, 2011, FOLIA MORPHOL, V70, P252
   Wu XQ, 2018, J CANCER, V9, P2510, DOI 10.7150/jca.25324
   Zhang JT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147218
   Zhao YT, 2015, J AGR FOOD CHEM, V63, P4843, DOI 10.1021/acs.jafc.5b01246
   Zhu YD, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600852
   Zhu YD, 2014, J NUTR, V144, P114, DOI 10.3945/jn.113.184663
   Zhu YD, 2012, J AGR FOOD CHEM, V60, P8624, DOI 10.1021/jf302872a
   Zhu YD, 2011, BIOORGAN MED CHEM, V19, P3973, DOI 10.1016/j.bmc.2011.05.025
NR 58
TC 10
Z9 11
U1 8
U2 42
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0021-8561
EI 1520-5118
J9 J AGR FOOD CHEM
JI J. Agric. Food Chem.
PD NOV 20
PY 2019
VL 67
IS 46
BP 12761
EP 12769
DI 10.1021/acs.jafc.9b05666
PG 9
WC Agriculture, Multidisciplinary; Chemistry, Applied; Food Science &
   Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Chemistry; Food Science & Technology
GA JR6OX
UT WOS:000499743400017
PM 31675233
DA 2022-11-22
ER

PT J
AU Broadfield, LA
   Saigal, A
   Szamosi, JC
   Hammill, JA
   Bezverbnaya, K
   Wang, DD
   Gautam, J
   Tsakiridis, EE
   Di Pastena, F
   McNicol, J
   Wu, JH
   Syed, S
   Lally, JSV
   Raphenya, AR
   Blouin, MJ
   Pollak, M
   Sacconi, A
   Blandino, G
   McArthur, AG
   Schertzer, JD
   Surette, MG
   Collins, SM
   Bramson, JL
   Muti, P
   Tsakiridis, T
   Steinberg, GR
AF Broadfield, Lindsay A.
   Saigal, Amna
   Szamosi, Jake C.
   Hammill, Joanne A.
   Bezverbnaya, Ksenia
   Wang, Dongdong
   Gautam, Jaya
   Tsakiridis, Evangelia E.
   Di Pastena, Fiorella
   McNicol, Jamie
   Wu, Jianhan
   Syed, Saad
   Lally, James S. V.
   Raphenya, Amogelang R.
   Blouin, Marie-Jose
   Pollak, Michael
   Sacconi, Andrea
   Blandino, Giovanni
   McArthur, Andrew G.
   Schertzer, Jonathan D.
   Surette, Michael G.
   Collins, Stephen M.
   Bramson, Jonathan L.
   Muti, Paola
   Tsakiridis, Theodoros
   Steinberg, Gregory R.
TI Metformin-induced reductions in tumor growth involves modulation of the
   gut microbiome
SO MOLECULAR METABOLISM
LA English
DT Article
DE Gut microbiome; Metformin; High-fat diet; Obesity; Colon cancer
ID CHAIN FATTY-ACIDS; METAGENOME-WIDE ASSOCIATION; INTESTINAL MICROBIOTA;
   EXPRESSION; CANCER; ALTERS
AB Background/Purpose: Type 2 diabetes and obesity increase the risk of developing colorectal cancer. Metformin may reduce colorectal cancer but the mechanisms mediating this effect remain unclear. In mice and humans, a high-fat diet (HFD), obesity and metformin are known to alter the gut microbiome but whether this is important for influencing tumor growth is not known.Methods: Mice with syngeneic MC38 colon adenocarcinomas were treated with metformin or feces obtained from control or metformin treated mice.Results: We find that compared to chow-fed controls, tumor growth is increased when mice are fed a HFD and that this acceleration of tumor growth can be partially recapitulated through transfer of the fecal microbiome or in vitro treatment of cells with fecal filtrates from HFD-fed animals. Treatment of HFD-fed mice with orally ingested, but not intraperitoneally injected, metformin suppresses tumor growth and increases the expression of short-chain fatty acid (SCFA)-producing microbes Alistipes, Lachnospiraceae and Ruminococcaceae. The transfer of the gut microbiome from mice treated orally with metformin to drug naive, conventionalized HFD-fed mice increases circulating propionate and butyrate, reduces tumor proliferation, and suppresses the expression of sterol response element binding protein (SREBP) gene targets in the tumor.Conclusion: These data indicate that in obese mice fed a HFD, metformin reduces tumor burden through changes in the gut microbiome. (c) 2022 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
C1 [Broadfield, Lindsay A.; Saigal, Amna; Wang, Dongdong; Gautam, Jaya; Tsakiridis, Evangelia E.; Di Pastena, Fiorella; Wu, Jianhan; Syed, Saad; Lally, James S. V.; McArthur, Andrew G.; Schertzer, Jonathan D.; Surette, Michael G.; Muti, Paola; Tsakiridis, Theodoros; Steinberg, Gregory R.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada.
   [Broadfield, Lindsay A.; Wang, Dongdong; Gautam, Jaya; Tsakiridis, Evangelia E.; Di Pastena, Fiorella; Wu, Jianhan; Syed, Saad; Lally, James S. V.; Surette, Michael G.; Collins, Stephen M.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada.
   [Szamosi, Jake C.; Syed, Saad; Schertzer, Jonathan D.; Surette, Michael G.; Collins, Stephen M.] McMaster Univ, Farncombe Family Digest Res Inst, Hamilton, ON, Canada.
   [Hammill, Joanne A.; Bezverbnaya, Ksenia; McNicol, Jamie; Bramson, Jonathan L.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.
   [Szamosi, Jake C.; McArthur, Andrew G.; Schertzer, Jonathan D.; Surette, Michael G.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.
   [Muti, Paola; Tsakiridis, Theodoros] McMaster Univ, Dept Oncol, Hamilton, ON, Canada.
   [Blouin, Marie-Jose; Pollak, Michael] Jewish Gen Hosp, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada.
   [Blouin, Marie-Jose; Pollak, Michael] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada.
   [Blandino, Giovanni] Italian Natl Canc Inst Regina Elena, Oncogen & Epigenet Unit, Rome, Italy.
   [Steinberg, Gregory R.] HSC 4N63, 1280 Main St, Hamilton, ON L8S 4K1, Canada.
C3 McMaster University; McMaster University; McMaster University; McMaster
   University; McMaster University; McMaster University; Lady Davis
   Institute; McGill University; McGill University
RP Steinberg, GR (corresponding author), McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada.; Steinberg, GR (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Steinberg, GR (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.; Steinberg, GR (corresponding author), HSC 4N63, 1280 Main St, Hamilton, ON L8S 4K1, Canada.
EM gsteinberg@mcmaster.ca
RI sacconi, andrea/J-3669-2018; Wang, Dongdong/P-7257-2016; Schertzer,
   Jonathan/P-3395-2017
OI sacconi, andrea/0000-0002-8276-0438; Wang, Dongdong/0000-0002-6195-4428;
   Broadfield, Lindsay A/0000-0002-7878-5712; Di Pastena,
   Fiorella/0000-0003-3509-8936; Schertzer, Jonathan/0000-0002-1547-5856
FU Canadian Cancer Society; Canadian Institutes of Health Research
   [201709FDN-CEBA-116200, 144625-1]; Diabetes Canada [DI-5-17-5302-GS]
FX Authors would like to thank Dr. Jun Han of the University of Victoria
   Genome BC Pro-teomics center, a node of The Metabolomics Innovation
   Centre (TMIC) for metabolomics measurements. G.R.S is a Canada Research
   Chair and the J. Bruce Duncan Chair in Metabolic Diseases. This study
   was supported by research grants from the Canadian Cancer Society,
   Canadian Institutes of Health Research (201709FDN-CEBA-116200 and
   144625-1 to GRS) and Diabetes Canada (DI-5-17-5302-GS) .
CR Algire C, 2011, ONCOGENE, V30, P1174, DOI 10.1038/onc.2010.483
   Algire C, 2010, ENDOCR-RELAT CANCER, V17, P351, DOI 10.1677/ERC-09-0252
   Alvaro A, 2008, IUBMB LIFE, V60, P757, DOI 10.1002/iub.110
   Angelova M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0620-6
   Bachem A, 2019, IMMUNITY, V51, P285, DOI 10.1016/j.immuni.2019.06.002
   Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10
   Bauer PV, 2018, CELL METAB, V27, P101, DOI 10.1016/j.cmet.2017.09.019
   Bruggner RV, 2014, P NATL ACAD SCI USA, V111, pE2770, DOI 10.1073/pnas.1408792111
   Cha JH, 2018, MOL CELL, V71, P606, DOI 10.1016/j.molcel.2018.07.030
   Chandel NS, 2016, CELL METAB, V23, P569, DOI 10.1016/j.cmet.2016.03.010
   Coll AP, 2020, NATURE, V578, P444, DOI 10.1038/s41586-019-1911-y
   Day EA, 2019, NAT METAB, V1, P1202, DOI 10.1038/s42255-019-0146-4
   de la Cuesta-Zuluaga J, 2017, DIABETES CARE, V40, P54, DOI 10.2337/dc16-1324
   De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016
   Ding X, 2019, AM J CANCER RES, V9, P219
   Dong YL, 2017, BIOSCIENCE REP, V37, DOI [10.1042/BSR20170945, 10.1042/bsr20170945]
   Dowling RJO, 2016, CELL METAB, V23, P567, DOI 10.1016/j.cmet.2016.03.006
   Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33
   Efremova M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02424-0
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Garber AJ, 2015, ENDOCR PRACT, V21, P438, DOI 10.4158/EP15693.CS
   Gerstein HC, 2017, DIABETES CARE, V40, P280, DOI 10.2337/dc16-1682
   Gonzalez N, 2017, ONCOTARGET, V8, P18456, DOI 10.18632/oncotarget.14472
   Han J, 2015, ANAL CHIM ACTA, V854, P86, DOI 10.1016/j.aca.2014.11.015
   Husaini Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233846
   Jakobsdottir G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080476
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Klil-Drori AJ, 2017, NAT REV CLIN ONCOL, V14, P85, DOI 10.1038/nrclinonc.2016.120
   Kyrgiou M, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j477
   Lee H, 2014, APPL ENVIRON MICROB, V80, P5935, DOI 10.1128/AEM.01357-14
   Ma YA, 2018, BRIT J CANCER, V119, P1436, DOI 10.1038/s41416-018-0314-4
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Neuwirth Erich, 2014, CRAN
   Ocvirk Soeren, 2019, Curr Gastroenterol Rep, V21, P62, DOI 10.1007/s11894-019-0725-2
   Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4
   Pernicova I, 2014, NAT REV ENDOCRINOL, V10, P143, DOI 10.1038/nrendo.2013.256
   Pollak M, 2013, J CLIN INVEST, V123, P3693, DOI 10.1172/JCI67232
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   R Core Team, 2013, R LANG ENV STAT COMP
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   Ulrich CM, 2018, NAT REV GASTRO HEPAT, V15, P683, DOI 10.1038/s41575-018-0053-2
   Vital M, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00130-17
   Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Walter J, 2020, CELL, V180, P221, DOI 10.1016/j.cell.2019.12.025
   Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83
   Whelan FJ, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0314-2
   Wickham H., 2017, J STAT SOFTW, V77, P3, DOI [10.18637/jss.v077.b02, DOI 10.18637/JSS.V077.B02]
   Wickham H., 2017, TIDYVERSE
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Zhang CY, 2020, CELL METAB, V31, P148, DOI 10.1016/j.cmet.2019.10.013
NR 58
TC 1
Z9 1
U1 1
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2212-8778
J9 MOL METAB
JI Mol. Metab.
PD JUL
PY 2022
VL 61
AR 101498
DI 10.1016/j.molmet.2022.101498
PG 11
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 1T2BK
UT WOS:000804540600008
PM 35452877
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Garza, DR
   Taddese, R
   Wirbel, J
   Zeller, G
   Boleij, A
   Huynen, MA
   Dutilh, BE
AF Garza, Daniel R.
   Taddese, Rahwa
   Wirbel, Jakob
   Zeller, Georg
   Boleij, Annemarie
   Huynen, Martijn A.
   Dutilh, Bas E.
TI Metabolic models predict bacterial passengers in colorectal cancer
SO CANCER & METABOLISM
LA English
DT Article
DE Genome-scale metabolic models; Colorectal cancer microbiome; Colorectal
   cancer metabolome; Bacterial driver-passenger model
ID MAS NMR-SPECTROSCOPY; HUMAN RECTAL ADENOCARCINOMA; COLON-CANCER;
   DECREASED LEVELS; MICROBIOTA; DISCRIMINATION; INSTABILITY; EXPRESSION;
   STOMACH; SPECTRA
AB Background Colorectal cancer (CRC) is a complex multifactorial disease. Increasing evidence suggests that the microbiome is involved in different stages of CRC initiation and progression. Beyond specific pro-oncogenic mechanisms found in pathogens, metagenomic studies indicate the existence of a microbiome signature, where particular bacterial taxa are enriched in the metagenomes of CRC patients. Here, we investigate to what extent the abundance of bacterial taxa in CRC metagenomes can be explained by the growth advantage resulting from the presence of specific CRC metabolites in the tumor microenvironment. Methods We composed lists of metabolites and bacteria that are enriched on CRC samples by reviewing metabolomics experimental literature and integrating data from metagenomic case-control studies. We computationally evaluated the growth effect of CRC enriched metabolites on over 1500 genome-based metabolic models of human microbiome bacteria. We integrated the metabolomics data and the mechanistic models by using scores that quantify the response of bacterial biomass production to CRC-enriched metabolites and used these scores to rank bacteria as potential CRC passengers. Results We found that metabolic networks of bacteria that are significantly enriched in CRC metagenomic samples either depend on metabolites that are more abundant in CRC samples or specifically benefit from these metabolites for biomass production. This suggests that metabolic alterations in the cancer environment are a major component shaping the CRC microbiome. Conclusion Here, we show with in sillico models that supplementing the intestinal environment with CRC metabolites specifically predicts the outgrowth of CRC-associated bacteria. We thus mechanistically explain why a range of CRC passenger bacteria are associated with CRC, enhancing our understanding of this disease. Our methods are applicable to other microbial communities, since it allows the systematic investigation of how shifts in the microbiome can be explained from changes in the metabolome.
C1 [Garza, Daniel R.; Huynen, Martijn A.; Dutilh, Bas E.] Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.
   [Taddese, Rahwa; Boleij, Annemarie] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.
   [Wirbel, Jakob; Zeller, Georg] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany.
   [Dutilh, Bas E.] Univ Utrecht, Theoret Biol & Bioinformat, Sience4Life, Room Z-509,Padualaan 8, Utrecht, Netherlands.
C3 Radboud University Nijmegen; Radboud University Nijmegen; European
   Molecular Biology Laboratory (EMBL); Utrecht University
RP Garza, DR (corresponding author), Radboud Univ Nijmegen, Med Ctr, Ctr Mol & Biomol Informat, Postbus 9101, NL-6500 HB Nijmegen, Netherlands.
EM danielriosgarza@gmail.com
RI Boleij, Annemarie/L-3975-2013; Garza, Daniel/AAN-8016-2021; Dutilh, Bas
   E./B-9719-2011
OI Boleij, Annemarie/0000-0003-4495-5880; Garza,
   Daniel/0000-0003-3865-2146; Dutilh, Bas E./0000-0003-2329-7890; Wirbel,
   Jakob/0000-0002-4073-3562
FU Science Without Borders program of CNPQ/BRASIL; Netherlands Organization
   for Scientific Research (NWO) [864.14.004, 016.166.089]
FX D.R.G. is supported by the Science Without Borders program of
   CNPQ/BRASIL. B.E.D. and A.B. are supported by the Netherlands
   Organization for Scientific Research (NWO) Vidi grant 864.14.004. and
   Veni grant no. 016.166.089, respectively.
CR Akin H, 2014, J CLIN GASTROENTEROL, V48, pS67, DOI 10.1097/MCG.0000000000000252
   ALI MM, 1978, J MULTIVARIATE ANAL, V8, P405, DOI 10.1016/0047-259X(78)90063-5
   [Anonymous], CARC BACT PATH HEL P
   Belcheva A, 2015, BIOESSAYS, V37, P403, DOI 10.1002/bies.201400204
   BERDINSKIKH NK, 1991, INT J CANCER, V47, P496, DOI 10.1002/ijc.2910470404
   Bertini I, 2012, CANCER RES, V72, P356, DOI 10.1158/0008-5472.CAN-11-1543
   Boleij A, 2013, LANCET INFECT DIS, V13, P719, DOI 10.1016/S1473-3099(13)70107-5
   Boleij A, 2012, MOL CELL PROTEOMICS, V11, P851, DOI 10.1074/mcp.M112.019315
   Boleij A, 2012, BIOL REV, V87, P701, DOI 10.1111/j.1469-185X.2012.00218.x
   Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839
   Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Chae YK, 2010, B KOREAN CHEM SOC, V31, P379, DOI 10.5012/bkcs.2010.31.02.379
   Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232
   Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a
   Chiche J, 2010, J CELL MOL MED, V14, P771, DOI 10.1111/j.1582-4934.2009.00994.x
   Coleman OI, 2016, BIORESEARCH OPEN ACC, V5, P279, DOI 10.1089/biores.2016.0028
   Dejea C, 2013, FUTURE MICROBIOL, V8, P445, DOI [10.2217/FMB.13.17, 10.2217/fmb.13.17]
   Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72
   Dzik-Jurasz ASK, 2002, MAGNET RESON MED, V47, P809, DOI 10.1002/mrm.10108
   ELITSUR Y, 1992, LIFE SCI, V50, P1417, DOI 10.1016/0024-3205(92)90260-V
   Farshidfar F, 2016, BRIT J CANCER, V115, P848, DOI 10.1038/bjc.2016.243
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Frampton M, 2017, GENET MED, V19, P314, DOI 10.1038/gim.2016.101
   GALONS JP, 1989, BIOCHIMIE, V71, P949, DOI 10.1016/0300-9084(89)90077-1
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Garza DR, 2018, NAT MICROBIOL, V3, P456, DOI 10.1038/s41564-018-0124-8
   Geng JW, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-26
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806
   Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430
   Jans C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00603
   Jimenez B, 2013, J PROTEOME RES, V12, P959, DOI 10.1021/pr3010106
   Jordan KW, 2009, DIS COLON RECTUM, V52, P520, DOI 10.1007/DCR.0b013e31819c9a2c
   KASIMOS JN, 1990, CANCER RES, V50, P527
   KINGSNORTH AN, 1984, BRIT J SURG, V71, P791, DOI 10.1002/bjs.1800711019
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lucas C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061310
   Ludwig C, 2009, MAGN RESON CHEM, V47, pS68, DOI 10.1002/mrc.2519
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Mal M, 2012, ANAL BIOANAL CHEM, V403, P483, DOI 10.1007/s00216-012-5870-5
   Mal M, 2009, RAPID COMMUN MASS SP, V23, P487, DOI 10.1002/rcm.3898
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   MERCHANT TE, 1991, INT J COLORECTAL DIS, V6, P121, DOI 10.1007/BF00300208
   Milanese A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08844-4
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Moreno A, 1996, NMR BIOMED, V9, P33, DOI 10.1002/(SICI)1099-1492(199602)9:1<33::AID-NBM391>3.3.CO;2-7
   OCHIAI AKIRA, 1957, BULL JAPANESE SOC SCI FISH, V22, P522
   Ong Eng Shi, 2010, Mol Cell Proteomics
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020
   PHAN SC, 1991, CANCER RES, V51, P1571
   Piotto M, 2009, METABOLOMICS, V5, P292, DOI 10.1007/s11306-008-0151-1
   Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7
   Qiu YP, 2010, J PROTEOME RES, V9, P1627, DOI 10.1021/pr901081y
   Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162
   Raay TV, 2017, MICROBIOL SPECTR, V5, DOI [10.1128/microbiolspec, DOI 10.1128/MICR0BI0LSPEC.BAD-0004-2016]
   Righi V, 2009, J PROTEOME RES, V8, P1859, DOI 10.1021/pr801094b
   Ritchie SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-13
   Schneider EB, 2012, J AM COLL SURGEONS, V214, P390, DOI 10.1016/j.jamcollsurg.2011.12.025
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08
   Seierstad T, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-33
   Sinha R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152126
   Song N, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3886-0
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Tessem MB, 2010, J PROTEOME RES, V9, P3664, DOI 10.1021/pr100176g
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Wang Y, 2007, J PROTEOME RES, V6, P3944, DOI 10.1021/pr0702565
   Williams MD, 2013, ANAL BIOANAL CHEM, V405, P5013, DOI 10.1007/s00216-013-6777-5
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zackular JP, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00001-15
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zamani Z, 2014, BIOCHEM RES INT, V2014, DOI 10.1155/2014/348712
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhou ZW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00371
   Zhu JJ, 2014, J PROTEOME RES, V13, P4120, DOI 10.1021/pr500494u
NR 86
TC 16
Z9 16
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2049-3002
J9 CANCER METAB
JI Cancer Metab.
PD FEB 10
PY 2020
VL 8
IS 1
AR 3
DI 10.1186/s40170-020-0208-9
PG 13
WC Oncology; Cell Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Cell Biology
GA KM8EI
UT WOS:000514372500001
PM 32055399
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Brim, H
   Yooseph, S
   Lee, E
   Sherif, ZA
   Abbas, M
   Laiyemo, AO
   Varma, S
   Torralba, M
   Dowd, SE
   Nelson, KE
   Pathmasiri, W
   Sumner, S
   de Vos, W
   Liang, Q
   Yu, J
   Zoetendal, E
   Ashktorab, H
AF Brim, Hassan
   Yooseph, Shibu
   Lee, Edward
   Sherif, Zaki A.
   Abbas, Muneer
   Laiyemo, Adeyinka O.
   Varma, Sudhir
   Torralba, Manolito
   Dowd, Scot E.
   Nelson, Karen E.
   Pathmasiri, Wimal
   Sumner, Susan
   de Vos, Willem
   Liang, Qiaoyi
   Yu, Jun
   Zoetendal, Erwin
   Ashktorab, Hassan
TI A Microbiomic Analysis in African Americans with Colonic Lesions Reveals
   Streptococcus sp.VT162 as a Marker of Neoplastic Transformation
SO GENES
LA English
DT Article
DE colorectal cancer; microbiota; African Americans; metabolomics;
   metagenomic linkage groups
ID HUMAN GUT MICROBIOME; COLORECTAL-CANCER; GASTROINTESTINAL-TRACT;
   DISEASE; BACTERIA; PREVALENCE; EXPRESSION; DIVERSITY; CARCINOMA;
   RESPONSES
AB Increasing evidence suggests a role of the gut microbiota in colorectal carcinogenesis (CRC). To detect bacterial markers of colorectal cancer in African Americans a metabolomic analysis was performed on fecal water extracts. DNA from stool samples of adenoma and healthy subjects and from colon cancer and matched normal tissues was analyzed to determine the microbiota composition (using 16S rDNA) and genomic content (metagenomics). Metagenomic functions with discriminative power between healthy and neoplastic specimens were established. Quantitative Polymerase Chain Reaction (q-PCR) using primers and probes specific to Streptococcus sp. VT_162 were used to validate this bacterium association with neoplastic transformation in stool samples from two independent cohorts of African Americans and Chinese patients with colorectal lesions. The metabolomic analysis of adenomas revealed low amino acids content. The microbiota in both cancer vs. normal tissues and adenoma vs. normal stool samples were different at the 16S rRNA gene level. Cross-mapping of metagenomic data led to 9 markers with significant discriminative power between normal and diseased specimens. These markers identified with Streptococcus sp. VT_162. Q-PCR data showed a statistically significant presence of this bacterium in advanced adenoma and cancer samples in an independent cohort of CRC patients. We defined metagenomic functions from Streptococcus sp. VT_162 with discriminative power among cancers vs. matched normal and adenomas vs. healthy subjects' stools. Streptococcus sp. VT_162 specific 16S rDNA was validated in an independent cohort. These findings might facilitate non-invasive screening for colorectal cancer.
C1 [Brim, Hassan; Lee, Edward; Sherif, Zaki A.; Abbas, Muneer; Laiyemo, Adeyinka O.; Ashktorab, Hassan] Howard Univ, Dept Pathol, Dept Med, Dept Biochem & Mol Biol,Dept Microbiol, 2041 Georgia Ave, Washington, DC 20060 USA.
   [Brim, Hassan; Lee, Edward; Sherif, Zaki A.; Abbas, Muneer; Laiyemo, Adeyinka O.; Ashktorab, Hassan] Howard Univ, Ctr Canc, Coll Med, 2041 Georgia Ave, Washington, DC 20060 USA.
   [Yooseph, Shibu; Torralba, Manolito] J Craig Venter Inst, La Jolla, CA 92037 USA.
   [Varma, Sudhir] HiThru Analyt, Laurel, MD 20877 USA.
   [Dowd, Scot E.] MRDNA Mol Res LP, Shallowater, TX 79363 USA.
   [Nelson, Karen E.] J Craig Venter Inst, Rockville, MD 20850 USA.
   [Pathmasiri, Wimal; Sumner, Susan] RTI Int, Syst & Translat Sci, Res Triangle Pk, NC 27709 USA.
   [de Vos, Willem; Zoetendal, Erwin] Wageningen Univ, Dept Agrotechnol & Food Sci, Lab Microbiol, NL-6708 PB Wageningen, Netherlands.
   [Liang, Qiaoyi; Yu, Jun] Chinese Univ Hong Kong, CUHK Shenzhen Res Inst, Inst Digest Dis, Hong Kong, Hong Kong, Peoples R China.
   [Liang, Qiaoyi; Yu, Jun] Chinese Univ Hong Kong, Dept Med & Therapeut, State Key Lab Digest Dis, Li Ka Shing Inst Hlth Sci,CUHK Shenzhen Res Inst, Hong Kong, Hong Kong, Peoples R China.
   [Pathmasiri, Wimal; Sumner, Susan] Univ North Carolina Chapel Hill, Common Fund Eastern Reg Comprehens Metabol Resour, Chapel Hill, NC 27599 USA.
C3 Howard University; Howard University; J. Craig Venter Institute; J.
   Craig Venter Institute; Research Triangle Institute; Wageningen
   University & Research; Chinese University of Hong Kong; Chinese
   University of Hong Kong; University of North Carolina; University of
   North Carolina Chapel Hill; University of North Carolina School of
   Medicine
RP Brim, H (corresponding author), Howard Univ, Dept Pathol, Dept Med, Dept Biochem & Mol Biol,Dept Microbiol, 2041 Georgia Ave, Washington, DC 20060 USA.; Brim, H (corresponding author), Howard Univ, Ctr Canc, Coll Med, 2041 Georgia Ave, Washington, DC 20060 USA.
EM hbrim@howard.edu; syooseph@jcvi.org; ellee@howard.edu;
   zaki.sherif@howard.edu; m_abbas@howard.edu; adeyinka.laiyemo@howard.edu;
   sudhir.varma@hithru.com; mtorralba@jcvi.org; sdowd@mrdnalab.com;
   knelson@jcvi.org; wpathmasiri@rti.org; ssumner@rti.org;
   willem.devos@wur.nl; JessieQY@cuhk.edu.hk; junyu@cuhk.edu.hk;
   erwin.zoetendal@wur.nl; hashktorab@howard.edu
RI Yu, Jun/D-8569-2015; Ashktorab, hassan/AAJ-2908-2020; Liang, Qiaoyi
   Jessie/G-9612-2019; , Zaki/AAC-9991-2019
OI Yu, Jun/0000-0001-5008-2153; Liang, Qiaoyi Jessie/0000-0001-8496-3442;
   Sumner, Susan/0000-0003-3381-6084; Pathmasiri,
   Wimal/0000-0002-5199-5744; Yooseph, Shibu/0000-0001-5581-5002
FU Howard University College of Medicine; RCMI US Public Health Service
   [G12 MD007597]; National Center for Advancing Translational Sciences
   [UL1TR001409]
FX This project has been funded in part by Howard University College of
   Medicine Bridge Fund, by the RCMI US Public Health Service grant G12
   MD007597 and by Federal funds (UL1TR001409 previously UL1TR000101) from
   the National Center for Advancing Translational Sciences (NCATS),
   National Institutes of Health, through the Clinical and Translational
   Science Awards Program (CTSA), a trademark of DHHS, part of the Roadmap
   Initiative, "Re-Engineering the Clinical Research Enterprise".
CR Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashktorab H, 2012, DIGEST DIS SCI, V57, P905, DOI 10.1007/s10620-011-2026-y
   Ashktorab H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025314
   Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879
   Ashktorab H, 2009, DIGEST DIS SCI, V54, P2109, DOI 10.1007/s10620-008-0601-7
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Balter M, 2012, SCIENCE, V336, P1246, DOI 10.1126/science.336.6086.1246
   Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20
   Blumenstein I., 2012, EUR J GASTROEN HEPAT, DOI [10.1097/MEG.0b013e32835d1ef423283303, DOI 10.1097/MEG.0B013E32835D1EF423283303]
   BOND PL, 1995, APPL ENVIRON MICROB, V61, P1910, DOI 10.1128/AEM.61.5.1910-1916.1995
   Brim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081352
   Brim H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040392
   Brim H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020216
   Brim H, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-68
   Corredoira J, 2013, INT J CLIN PRACT, V67, P1358, DOI 10.1111/ijcp.12190
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Dai ZL, 2013, AMINO ACIDS, V45, P501, DOI 10.1007/s00726-012-1264-4
   Dai ZL, 2012, AMINO ACIDS, V42, P1597, DOI 10.1007/s00726-011-0846-x
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Friedenberg FK, 2012, DIGEST DIS SCI, V57, P489, DOI 10.1007/s10620-011-1952-z
   Galdy S., 2012, B MJ CASE REP 2012, V2012, DOI [10.1136/bcr-2012-00696123220436, DOI 10.1136/BCR-2012-00696123220436]
   Gong H., 2014, APPL ENVIRON MICROB, DOI [10.1128/AEM.02329-1425239901, DOI 10.1128/AEM.02329-1425239901]
   Goodman AL, 2011, P NATL ACAD SCI USA, V108, P6252, DOI 10.1073/pnas.1102938108
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Irrazabal T, 2014, MOL CELL, V54, P309, DOI 10.1016/j.molcel.2014.03.039
   Jeraldo P, 2011, ENVIRON MICROBIOL, V13, P3000, DOI 10.1111/j.1462-2920.2011.02577.x
   Kumar K, 2009, CLIN CANCER RES, V15, P1155, DOI 10.1158/1078-0432.CCR-08-1029
   Lax AJ, 2002, TRENDS MICROBIOL, V10, P293, DOI 10.1016/S0966-842X(02)02360-0
   Liang J. Q., 2016, CLIN CANCER RES, DOI [10.1016/S0016-5085(16)30349-3, DOI 10.1016/S0016-5085(16)30349-3]
   Liu P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085280
   Lopez-Boado YS, 2000, J CELL BIOL, V148, P1305, DOI 10.1083/jcb.148.6.1305
   Magrone T, 2013, CURR PHARM DESIGN, V19, P1329
   McAllister F, 2014, CANCER J, V20, P232, DOI 10.1097/PPO.0000000000000051
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Nelson RL, 1999, J SURG ONCOL, V71, P123, DOI 10.1002/(SICI)1096-9098(199906)71:2<123::AID-JSO13>3.0.CO;2-C
   Nouraie M, 2010, DIGEST DIS SCI, V55, P1442, DOI 10.1007/s10620-010-1133-5
   O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x
   Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Shelburne SA, 2014, EMERG INFECT DIS, V20, P762, DOI 10.3201/eid2005.130953
   Sinicrope PS, 2012, CANCER EPIDEM BIOMAR, V21, P347, DOI 10.1158/1055-9965.EPI-11-0818
   Smith RA, 2001, CA-CANCER J CLIN, V51, P38, DOI 10.3322/canjclin.51.1.38
   Sumner S, 2009, J APPL TOXICOL, V29, P703, DOI 10.1002/jat.1462
   Sumner SJ, 2010, METABOLOMICS, V6, P238, DOI 10.1007/s11306-010-0197-8
   Takamura N., 2014, BMJ CASE REP, V2014, DOI [10.1136/bcr-2013-20347624798358, DOI 10.1136/BCR-2013-20347624798358]
   Van den Bogert B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083418
   van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10
   Vecherkovskaya M. F., 2014, COMPLETE GENOME SEQU, V2, DOI [10.1128/genomeA.00647-1425013137, DOI 10.1128/GENOMEA.00647-1425013137]
   Wilke A, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-141
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yatabe J, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-203
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zackular J. P., 2014, CANC PREV RES, DOI [10.1158/1940-6207.CAPR-14-012925104642, DOI 10.1158/1940-6207.CAPR-14-012925104642]
   Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275
   Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603
NR 67
TC 12
Z9 12
U1 1
U2 7
PU MDPI AG
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2073-4425
J9 GENES-BASEL
JI Genes
PD NOV
PY 2017
VL 8
IS 11
AR 314
DI 10.3390/genes8110314
PG 16
WC Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Genetics & Heredity
GA FO4GS
UT WOS:000416800600024
PM 29120399
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Daniel, SG
   Ball, CL
   Besselsen, DG
   Doetschman, T
   Hurwitz, BL
AF Daniel, Scott G.
   Ball, Corbie L.
   Besselsen, David G.
   Doetschman, Tom
   Hurwitz, Bonnie L.
TI Functional Changes in the Gut Microbiome Contribute to Transforming
   Growth Factor beta-Deficient Colon Cancer
SO MSYSTEMS
LA English
DT Article
DE Helicobacter hepaticus; Smad3; bioinformatics; butyrate; colon cancer;
   gut inflammation; gut microbiome; host-pathogen interactions;
   metagenomics; metatranscriptomics; polyamines
ID INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; FUSOBACTERIUM-NUCLEATUM;
   POLYAMINE TRANSPORTER; ULCERATIVE-COLITIS; EXTRACELLULAR-SUPEROXIDE;
   BUTYRATE; RECEPTOR; GENE; TUMORIGENESIS
AB Colorectal cancer (CRC) is one of the most treatable cancers, with a 5-year survival rate of similar to 64%, yet over 50,000 deaths occur yearly in the United States. In 15% of cases, deficiency in mismatch repair leads to null mutations in transforming growth factor beta (TGF-beta) type II receptor, yet genotype alone is not responsible for tumorigenesis. Previous work in mice shows that disruptions in TGF-beta signaling combined with Helicobacter hepaticus cause tumorigenesis, indicating a synergistic effect between genotype and microbial environment. Here, we examine functional shifts in the gut microbiome in CRC using integrated - omics approaches to untangle the role of host genotype, inflammation, and microbial ecology. We profile the gut microbiome of 40 mice with/without deficiency in TGF-beta signaling from a Smad3 (mothers against decapentaplegic homolog-3) knockout and with/without inoculation with H. hepaticus. Clear functional differences in the microbiome tied to specific bacterial species emerge from four pathways related to human colon cancer: lipopolysaccharide (LPS) production, polyamine synthesis, butyrate metabolism, and oxidative phosphorylation (OXPHOS). Specifically, an increase in Mucispirillum schaedleri drives LPS production, which is associated with an inflammatory response. We observe a commensurate decrease in butyrate production from Lachnospiraceae bacterium A4, which could promote tumor formation. H. hepaticus causes an increase in OXPHOS that may increase DNA-damaging free radicals. Finally, multiple bacterial species increase polyamines that are associated with colon cancer, implicating not just diet but also the microbiome in polyamine levels. These insights into cross talk between the microbiome, host genotype, and inflammation could promote the development of diagnostics and therapies for CRC.
   IMPORTANCE Most research on the gut microbiome in colon cancer focuses on taxonomic changes at the genus level using 16S rRNA gene sequencing. Here, we develop a new methodology to integrate DNA and RNA data sets to examine functional shifts at the species level that are important to tumor development. We uncover several metabolic pathways in the microbiome that, when perturbed by host genetics and H. hepaticus inoculation, contribute to colon cancer. The work presented here lays a foundation for improved bioinformatics methodologies to closely examine the cross talk between specific organisms and the host, important for the development of diagnostics and pre/probiotic treatment.
C1 [Daniel, Scott G.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA.
   [Ball, Corbie L.; Doetschman, Tom] Univ Arizona, Univ Arizona Canc Ctr, Tucson, AZ 85721 USA.
   [Besselsen, David G.] Univ Arizona, Univ Anim Care, Tucson, AZ 85721 USA.
   [Doetschman, Tom] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.
   [Doetschman, Tom; Hurwitz, Bonnie L.] Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.
   [Hurwitz, Bonnie L.] Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.
C3 University of Arizona; University of Arizona; University of Arizona;
   University of Arizona; University of Arizona; University of Arizona
RP Hurwitz, BL (corresponding author), Univ Arizona, BIO5 Inst, Tucson, AZ 85721 USA.; Hurwitz, BL (corresponding author), Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.
EM bhurwitz@email.arizona.edu
RI Daniel, Scott Garrett/AAC-8868-2022; Daniel, Scott Garrett/AAC-8913-2022
OI Daniel, Scott Garrett/0000-0002-7441-923X; Hurwitz,
   Bonnie/0000-0001-8699-957X
FU Gordon and Betty Moore Foundation [GBMF4491]; Cancer Biology training
   grant [CA09213];  [HD026471];  [AI067903];  [CA084291]; EUNICE KENNEDY
   SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT
   [R01HD026471] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE
   [U01CA084291, T32CA009213, P30CA023074] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067903]
   Funding Source: NIH RePORTER
FX This work was supported by the Gordon and Betty Moore Foundation
   (GBMF4491) to B.L.H.; a Cancer Biology training grant (CA09213) to
   C.L.B.; and HD026471, AI067903, and CA084291 to T.D.
CR Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249
   Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Ahmad MS, 2000, GUT, V46, P493, DOI 10.1136/gut.46.4.493
   An J, 2016, J MICROBIOL BIOTECHN, V26, P1490, DOI 10.4014/jmb.1605.05024
   Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Augenlicht L, 2003, ONCOGENE, V22, P4983, DOI 10.1038/sj.onc.1206521
   Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7
   Berry D, 2012, ISME J, V6, P2091, DOI 10.1038/ismej.2012.39
   Bommireddy R, 2007, TRENDS MOL MED, V13, P492, DOI 10.1016/j.molmed.2007.08.005
   Brand MW, 2015, ILAR J, V56, P169, DOI 10.1093/ilar/ilv012
   Cabiscol Elisa, 2000, International Microbiology, V3, P3
   Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4
   Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8
   Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485
   Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033
   Drazenovich NL, 2002, COMPARATIVE MED, V52, P347
   DREYFUSS F, 1975, ISRAEL J MED SCI, V11, P785
   Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526
   El Aidy S, 2014, BENEF MICROBES, V5, P67, DOI 10.3920/BM2013.0018
   Engle SJ, 1999, CANCER RES, V59, P3379
   Engle SJ, 2002, CANCER RES, V62, P6362
   Fleming NI, 2013, CANCER RES, V73, P725, DOI 10.1158/0008-5472.CAN-12-2706
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Fujimura K, 2015, J BIOL CHEM, V290, P29907, DOI 10.1074/jbc.M115.687418
   Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9
   Gerner EW, 2007, AMINO ACIDS, V33, P189, DOI 10.1007/s00726-007-0515-2
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Gutierrez E, 2013, MOL CELL, V51, P35, DOI 10.1016/j.molcel.2013.04.021
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Hannon G.J., 2010, FASTX TOOLKIT
   Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7
   Hoffmann C, 2009, INFECT IMMUN, V77, P4668, DOI 10.1128/IAI.00493-09
   Hoshino K, 1999, J IMMUNOL, V162, P3749
   HOWARD JG, 1958, IMMUNOLOGY, V1, P181
   Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529
   Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004
   Kaiser S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r131
   Kalac P, 2006, MEAT SCI, V73, P1, DOI 10.1016/j.meatsci.2005.11.001
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kverka M, 2011, CLIN EXP IMMUNOL, V163, P250, DOI 10.1111/j.1365-2249.2010.04286.x
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039
   Li FZ, 2005, WORLD J SURG, V29, P306, DOI 10.1007/s00268-004-7813-6
   Liu M, 2012, BIOL CHEM, V393, P123, DOI 10.1515/hsz-2011-0247
   LOSER C, 1990, CANCER, V65, P958, DOI 10.1002/1097-0142(19900215)65:4<958::AID-CNCR2820650423>3.0.CO;2-Z
   Lutgens MWMD, 2008, GUT, V57, P1246, DOI 10.1136/gut.2007.143453
   Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448
   Mancuso G, 2005, INFECT IMMUN, V73, P5620, DOI 10.1128/IAI.73.9.5620-5627.2005
   Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011
   MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852
   Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434
   Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068
   Monteleone G, 2001, J CLIN INVEST, V108, P601, DOI 10.1172/JCI200112821
   Munoz NM, 2006, CANCER RES, V66, P9837, DOI 10.1158/0008-5472.CAN-06-0890
   Nakano K, 1997, J BIOL CHEM, V272, P22199, DOI 10.1074/jbc.272.35.22199
   Newcomb TG, 1998, CONT CANC RES, P65
   Newman JV, 2001, J INFECT DIS, V184, P227, DOI 10.1086/321998
   Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385
   ORCUTT RP, 1987, MICROECOL T, V17, P59
   Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259
   Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7
   Pendeville H, 2001, MOL CELL BIOL, V21, P6549, DOI 10.1128/MCB.21.19.6549-6558.2001
   Place RF, 2005, BIOCHEM PHARMACOL, V70, P394, DOI 10.1016/j.bcp.2005.04.030
   Pongor LS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103441
   R Core Team, 2016, R LANG ENV STAT COMP
   Rai AN, 2016, SCI REP-UK, V6, DOI 10.1038/srep26964
   Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12
   Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Rogler G, 2014, CANCER LETT, V345, P235, DOI 10.1016/j.canlet.2013.07.032
   Rooks MG, 2014, ISME J, V8, P1403, DOI 10.1038/ismej.2014.3
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   RUSSELL DH, 1969, MOL PHARMACOL, V5, P253
   Sakata K, 2000, BIOCHEM J, V347, P297, DOI 10.1042/0264-6021:3470297
   Sanapareddy N, 2012, ISME J, V6, P1858, DOI 10.1038/ismej.2012.43
   SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K
   Schulmann K, 2005, GASTROENTEROLOGY, V129, P74, DOI 10.1053/j.gastro.2005.04.011
   Seamons A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079182
   Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI [10.3322/caac.21654, 10.3322/caac.21551]
   Souza R F, 1996, Hum Cell, V9, P229
   Svrcek M, 2007, HISTOPATHOLOGY, V50, P574, DOI 10.1111/j.1365-2559.2007.02663.x
   Svrcek M, 2007, J CLIN ONCOL, V25, P4231, DOI 10.1200/JCO.2007.10.9744
   Takai N, 2004, CLIN CANCER RES, V10, P1141, DOI 10.1158/1078-0432.CCR-03-0100
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120
   Uemura T, 2005, J BIOL CHEM, V280, P9646, DOI 10.1074/jbc.M410274200
   Walia S, 2015, NUTR CANCER, V67, P603, DOI 10.1080/01635581.2015.1011788
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014
   Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wiseman H, 1996, BIOCHEM J, V313, P17, DOI 10.1042/bj3130017
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Zhu YA, 1998, CELL, V94, P703, DOI 10.1016/S0092-8674(00)81730-4
NR 102
TC 37
Z9 40
U1 2
U2 22
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD SEP-OCT
PY 2017
VL 2
IS 5
AR e00065-17
DI 10.1128/mSystems.00065-17
PG 17
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA FL1WC
UT WOS:000414004100009
PM 28951889
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Vipperla, K
   O'Keefe, SJ
AF Vipperla, Kishore
   O'Keefe, Stephen J.
TI The Microbiota and Its Metabolites in Colonic Mucosal Health and Cancer
   Risk
SO NUTRITION IN CLINICAL PRACTICE
LA English
DT Review
DE colon; metagenome; fatty acids; inflammation; colonic neoplasms;
   irritable bowel syndrome; inflammatory bowel diseases; autoimmune
   diseases; allergy and immunology; obesity
ID CHAIN FATTY-ACIDS; INFLAMMATORY-BOWEL-DISEASE; SULFATE-REDUCING
   BACTERIA; HUMAN LARGE-INTESTINE; DIET-INDUCED OBESITY;
   COLORECTAL-CANCER; GUT MICROBIOTA; PROPIONIC-ACID; BILE-ACIDS; RAT COLON
AB Recent advances in our ability to identify and characterize the human microbiota have transformed our appreciation of the function of the colon from an organ principally involved in the reabsorption of secretory fluids to a metabolic organ on a par with the liver. High-throughput technology has been applied to the identification of specific differences in microbial DNA, allowing the identification of trillions of microbes belonging to more than 1000 different species, with a metabolic mass of approximately 1.5 kg. The close proximity of these microbes with the mucosa and gut lymphoid tissue helps explain why a balanced microbiota is likely to preserve mucosal health, whereas an unbalanced composition, as seen in dysbiosis, may increase the prevalence of diseases not only of the mucosa but also within the body due to the strong interactions with the gut immune system, the largest immune organ of the body. Such abnormalities have been pinpointed as etiological factors in a wide range of diseases, including autoimmune disorders, allergy, irritable bowel syndrome, inflammatory bowel disease, obesity, and colon cancer. Recognition of the strong potential for food to manipulate microbiota composition has opened up new therapeutic strategies against these diseases based on dietary intervention. (Nutr Clin Pract. 2012;27:624-635)
C1 [O'Keefe, Stephen J.] Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, PUH, Pittsburgh, PA 15213 USA.
   [Vipperla, Kishore] Univ Pittsburgh, Med Ctr, Div Gen Internal Med, Pittsburgh, PA 15213 USA.
C3 Pennsylvania Commonwealth System of Higher Education (PCSHE); University
   of Pittsburgh; Pennsylvania Commonwealth System of Higher Education
   (PCSHE); University of Pittsburgh
RP O'Keefe, SJ (corresponding author), Univ Pittsburgh, Sch Med, Div Gastroenterol Hepatol & Nutr, PUH, 200 Lothrop St,Mezzanine Level C Wing, Pittsburgh, PA 15213 USA.
EM sjokeefe@pitt.edu
OI O'Keefe, Stephen/0000-0003-4422-3145
FU NCI NIH HHS [R01 CA135379] Funding Source: Medline
CR Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11
   Abeysuriya V, 2008, HEPATOB PANCREAT DIS, V7, P633
   Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707
   Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172
   Al-Lahham SH, 2010, BBA-MOL CELL BIOL L, V1801, P1175, DOI 10.1016/j.bbalip.2010.07.007
   Al-Lahham SH, 2010, EUR J CLIN INVEST, V40, P401, DOI 10.1111/j.1365-2362.2010.02278.x
   Andoh A, 2002, CANCER IMMUNOL IMMUN, V50, P663, DOI 10.1007/s262-001-0239-1
   Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439
   Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09
   Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x
   Bartholome AL, 2004, JPEN-PARENTER ENTER, V28, P210, DOI 10.1177/0148607104028004210
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Capoor MR, 2008, BRAZ J INFECT DIS, V12, P222, DOI 10.1590/S1413-86702008000300012
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Cebra J J, 1998, Dev Immunol, V6, P13, DOI 10.1155/1998/68382
   Cheng KR, 2005, BIOCHEM PHARMACOL, V70, P1035, DOI 10.1016/j.bcp.2005.07.023
   Cox MA, 2009, WORLD J GASTROENTERO, V15, P5549, DOI 10.3748/wjg.15.5549
   Cryan JF, 2011, NEUROGASTROENT MOTIL, V23, P187, DOI 10.1111/j.1365-2982.2010.01664.x
   CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763
   DANNHARDT G, 1993, ARCH PHARM, V326, P157, DOI 10.1002/ardp.19933260308
   Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S
   de Vogel J, 2005, CARCINOGENESIS, V26, P387, DOI 10.1093/carcin/bgh331
   de Vogel J, 2008, CARCINOGENESIS, V29, P398, DOI 10.1093/carcin/bgm278
   Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000
   Drossman DA, 1998, PSYCHOSOM MED, V60, P258, DOI 10.1097/00006842-199805000-00007
   Ebert MN, 2003, CARCINOGENESIS, V24, P1637, DOI 10.1093/carcin/bgg122
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557
   GIBSON GR, 1988, J APPL BACTERIOL, V65, P241, DOI 10.1111/j.1365-2672.1988.tb01891.x
   GIBSON GR, 1993, GUT, V34, P437, DOI 10.1136/gut.34.4.437
   Greer JB, 2011, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00168
   Greiner T, 2011, TRENDS ENDOCRIN MET, V22, P117, DOI 10.1016/j.tem.2011.01.002
   Grubben MJAL, 2001, DIGEST DIS SCI, V46, P750, DOI 10.1023/A:1010787931002
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02
   KIEN CL, 1992, GASTROENTEROLOGY, V102, P1458, DOI 10.1016/0016-5085(92)91702-6
   Kim YS, 2007, J NUTR, V137, p2576S, DOI 10.1093/jn/137.11.2576S
   Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x
   Lee BJ, 2011, J NEUROGASTROENTEROL, V17, P252, DOI 10.5056/jnm.2011.17.3.252
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li JV, 2011, GUT, V60, P1214, DOI 10.1136/gut.2010.234708
   Liu Q, 2004, HEPATOLOGY, V39, P1441, DOI 10.1002/hep.20194
   Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063
   Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x
   Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207
   Mackie RI, 1999, AM J CLIN NUTR, V69, p1035S, DOI 10.1093/ajcn/69.5.1035s
   Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x
   McLean MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015366
   McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012
   McMillan L, 2000, BIOCHEM BIOPH RES CO, V273, P45, DOI 10.1006/bbrc.2000.2899
   Mutlu E, 2009, ALCOHOL CLIN EXP RES, V33, P1836, DOI 10.1111/j.1530-0277.2009.01022.x
   NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6
   Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x
   Nguyen KA, 2006, ANN SURG, V243, P619, DOI 10.1097/01.sla.0000216783.85214.c1
   Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095
   NORDGAARD I, 1995, NUTRITION, V11, P37
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3
   O'Keefe SJD, 2007, J NUTR, V137, p175S, DOI 10.1093/jn/137.1.175S
   O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380
   OKEEFE SJD, 1994, S AFR MED J, V84, P376
   Onoue M, 1997, CANCER LETT, V113, P179, DOI 10.1016/S0304-3835(97)04698-3
   Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Payne CM, 2010, NUTR CANCER, V62, P825, DOI 10.1080/01635581003695756
   Penders J, 2007, ALLERGY, V62, P1223, DOI 10.1111/j.1398-9995.2007.01462.x
   Penders J, 2006, CLIN EXP ALLERGY, V36, P1602, DOI 10.1111/j.1365-2222.2006.02599.x
   Piche T, 2003, GASTROENTEROLOGY, V124, P894, DOI 10.1053/gast.2003.50159
   Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x
   Puchowicz MA, 1999, AM J PHYSIOL-ENDOC M, V277, pE1022, DOI 10.1152/ajpendo.1999.277.6.E1022
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043
   Reeves AE, 2011, GUT MICROBES, V2, P145, DOI 10.4161/gmic.2.3.16333
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Roberfroid MB, 2005, BRIT J NUTR, V93, pS13, DOI 10.1079/BJN20041350
   Rodriguez-Cabezas ME, 2002, J NUTR, V132, P3263, DOI 10.1093/jn/132.11.3263
   Rodwell V W, 1976, Adv Lipid Res, V14, P1
   ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424
   ROEDIGER WEW, 1993, GASTROENTEROLOGY, V104, P802, DOI 10.1016/0016-5085(93)91016-B
   Ruijschop RMAJ, 2008, INT DAIRY J, V18, P945, DOI 10.1016/j.idairyj.2008.01.004
   Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072
   Schloss PD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-229
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259
   Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388
   Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5
   Toden S, 2006, CANCER BIOL THER, V5, P267, DOI 10.4161/cbt.5.3.2382
   Tsilidis KK, 2008, INT J CANCER, V123, P1133, DOI 10.1002/ijc.23606
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   VENTER CS, 1990, AM J GASTROENTEROL, V85, P549
   Wang M, 2008, J ALLERGY CLIN IMMUN, V121, P129, DOI 10.1016/j.jaci.2007.09.011
   Wardwell Leslie H, 2011, Curr Infect Dis Rep, V13, P28, DOI 10.1007/s11908-010-0147-7
   WARGOVICH MJ, 1984, CANCER LETT, V23, P253, DOI 10.1016/0304-3835(84)90091-0
   Watson AJM, 2006, CRIT REV ONCOL HEMAT, V57, P107, DOI 10.1016/j.critrevonc.2005.06.005
   Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107
   Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442
   Wu K, 2006, CANCER EPIDEM BIOMAR, V15, P1120, DOI 10.1158/1055-9965.EPI-05-0782
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Young VB, 2004, J CLIN MICROBIOL, V42, P1203, DOI 10.1128/JCM.42.3.1203-1206.2004
   Zapolska-Downar D, 2009, J PHYSIOL PHARMACOL, V60, P123
   Zgouras D, 2003, BIOCHEM BIOPH RES CO, V300, P832, DOI 10.1016/S0006-291X(02)02916-9
   Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106
   Zhao Hai Ying, 2004, Chin J Dig Dis, V5, P64, DOI 10.1111/j.1443-9573.2004.00157.x
   Zhou J, 2006, OBESITY, V14, P683, DOI 10.1038/oby.2006.77
NR 109
TC 81
Z9 87
U1 0
U2 56
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0884-5336
EI 1941-2452
J9 NUTR CLIN PRACT
JI Nutr. Clin. Pract.
PD OCT
PY 2012
VL 27
IS 5
BP 624
EP 635
DI 10.1177/0884533612452012
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 000UC
UT WOS:000308413300007
PM 22868282
DA 2022-11-22
ER

PT J
AU Loftus, M
   Hassouneh, SA
   Yooseph, S
AF Loftus, Mark
   Hassouneh, Sayf Al-Deen
   Yooseph, Shibu
TI Bacterial community structure alterations within the colorectal cancer
   gut microbiome
SO BMC MICROBIOLOGY
LA English
DT Article
DE Colorectal; Cancer; Microbiome; Metagenomics; Networks; Oral; Pathogens;
   Associations
ID FUSOBACTERIUM-NUCLEATUM; FILIFACTOR-ALOCIS; DIALISTER-PNEUMOSINTES;
   PERIODONTAL-DISEASE; TOOTH LOSS; SEQUENCE; METABOLISM; PROTEIN; MODEL;
   RISK
AB Background Colorectal cancer is a leading cause of cancer-related deaths worldwide. The human gut microbiome has become an active area of research for understanding the initiation, progression, and treatment of colorectal cancer. Despite multiple studies having found significant alterations in the carriage of specific bacteria within the gut microbiome of colorectal cancer patients, no single bacterium has been unequivocally connected to all cases. Whether alterations in species carriages are the cause or outcome of cancer formation is still unclear, but what is clear is that focus should be placed on understanding changes to the bacterial community structure within the cancer-associated gut microbiome. Results By applying a novel set of analyses on 252 previously published whole-genome shotgun sequenced fecal samples from healthy and late-stage colorectal cancer subjects, we identify taxonomic, functional, and structural changes within the cancer-associated human gut microbiome. Bacterial association networks constructed from these data exhibited widespread differences in the underlying bacterial community structure between healthy and colorectal cancer associated gut microbiomes. Within the cancer-associated ecosystem, bacterial species were found to form associations with other species that are taxonomically and functionally dissimilar to themselves, as well as form modules functionally geared towards potential changes in the tumor-associated ecosystem. Bacterial community profiling of these samples revealed a significant increase in species diversity within the cancer-associated gut microbiome, and an elevated relative abundance of species classified as originating from the oral microbiome including, but not limited to, Fusobacterium nucleatum, Peptostreptococcus stomatis, Gemella morbillorum, and Parvimonas micra. Differential abundance analyses of community functional capabilities revealed an elevation in functions linked to virulence factors and peptide degradation, and a reduction in functions involved in amino-acid biosynthesis within the colorectal cancer gut microbiome. Conclusions We utilize whole-genome shotgun sequenced fecal samples provided from a large cohort of late-stage colorectal cancer and healthy subjects to identify a number of potentially important taxonomic, functional, and structural alterations occurring within the colorectal cancer associated gut microbiome. Our analyses indicate that the cancer-associated ecosystem influences bacterial partner selection in the native microbiota, and we highlight specific oral bacteria and their associations as potentially relevant towards aiding tumor progression.
C1 [Loftus, Mark; Hassouneh, Sayf Al-Deen] Univ Cent Florida, Burnett Sch Biomed Sci, Genom & Bioinformat Cluster, Orlando, FL 32816 USA.
   [Yooseph, Shibu] Univ Cent Florida, Dept Comp Sci, Genom & Bioinformat Cluster, Orlando, FL 32816 USA.
C3 State University System of Florida; University of Central Florida; State
   University System of Florida; University of Central Florida
RP Yooseph, S (corresponding author), Univ Cent Florida, Dept Comp Sci, Genom & Bioinformat Cluster, Orlando, FL 32816 USA.
EM Shibu.Yooseph@ucf.edu
OI Loftus, Mark/0000-0002-6279-6855; , Sayf H.
   Abdalhakeem/0000-0001-6288-4970
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Ai DM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00826
   AITCHISON J, 1982, J ROY STAT SOC B MET, V44, P139
   Aruni AW, 2015, MICROBES INFECT, V17, P517, DOI 10.1016/j.micinf.2015.03.011
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839
   Bottery MJ, 2021, ISME J, V15, P939, DOI 10.1038/s41396-020-00832-7
   Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]
   Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850
   Chattopadhyay I, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819867354
   Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111
   Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138
   Contreras A, 2000, ORAL MICROBIOL IMMUN, V15, P269, DOI 10.1034/j.1399-302x.2000.150410.x
   Corbet C, 2017, NAT REV CANCER, V17, P577, DOI 10.1038/nrc.2017.77
   Cordasco G, 2011, P IEEE INT WORKSH BU
   D'Souza G, 2018, NAT PROD REP, V35, P455, DOI 10.1039/c8np00009c
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   DIXIT SN, 1977, EUR J BIOCHEM, V81, P599, DOI 10.1111/j.1432-1033.1977.tb11987.x
   Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3
   Dzutsev A, 2015, EUR J IMMUNOL, V45, P17, DOI 10.1002/eji.201444972
   Edgar RC, 2018, PEERJ, V6, DOI 10.7717/peerj.4652
   Edgar RC, 2017, PEERJ, V5, DOI 10.7717/peerj.3889
   El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995
   Escapa IF, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00187-18
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Finicle BT, 2018, NAT REV CANCER, V18, P619, DOI 10.1038/s41568-018-0048-x
   Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045
   Garsin DA, 2010, NAT REV MICROBIOL, V8, P290, DOI 10.1038/nrmicro2334
   Genome Reference Consortium, GRCH38P12 HUMAN GENO
   Gloor GB, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02224
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Gould AL, 2018, P NATL ACAD SCI USA, V115, pE11951, DOI 10.1073/pnas.1809349115
   Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41
   Hagberg A., 2008, P 7 PYTHON SCI C SCI
   Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704
   Heiden MGV, 2016, HUMAN PANCREATIC CAN, V20
   Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259
   Hopkins MJ, 2003, APPL ENVIRON MICROB, V69, P6354, DOI 10.1128/AEM.69.11.6354-6360.2003
   Horiuchi A, 2020, ANAEROBE, V62, DOI 10.1016/j.anaerobe.2019.102100
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Jalava J, 1999, INT J SYST BACTERIOL, V49, P1375, DOI 10.1099/00207713-49-4-1375
   Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054
   Johnson KVA, 2016, GUT MICROBES, V7, P455, DOI 10.1080/19490976.2016.1241933
   Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031
   Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105
   Kho ZY, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01835
   Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kou Y., 2020, REVIEW
   Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lauritano D, 2017, Oral Implantol (Rome), V10, P229, DOI 10.11138/orl/2017.10.3.229
   Li S, 2017, TRENDS MOL MED, V23, P18, DOI 10.1016/j.molmed.2016.11.004
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Liu Han, 2010, Adv Neural Inf Process Syst, V24, P1432
   Loftus M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82449-0
   Loomba R, 2017, CELL METAB, V25, P1054, DOI 10.1016/j.cmet.2017.04.001
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Michaud DS, 2017, EPIDEMIOL REV, V39, P49, DOI 10.1093/epirev/mxx006
   Mima K, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.53
   Momen-Heravi F, 2017, INT J CANCER, V140, P646, DOI 10.1002/ijc.30486
   Neilands J, 2019, ANAEROBE, V55, P54, DOI 10.1016/j.anaerobe.2018.10.007
   Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930
   Newman M E J, 2010, NETWORKS INTRO, P168, DOI [DOI 10.1093/ACPROF:OSO/9780199206650.001.0001, 10.1093/acprof:oso/9780199206650.001.0001]
   O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189
   Oswal P, 2020, J INTERDISCIP DENT, V10, P17, DOI DOI 10.4103/JID.JID_4_19
   Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086
   Phang JM, 2015, CURR OPIN CLIN NUTR, V18, P71, DOI 10.1097/MCO.0000000000000121
   Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Rousee JM, 2002, J CLIN MICROBIOL, V40, P3871, DOI 10.1128/JCM.40.10.3871-3873.2002
   Rubinstein MR, 2019, EMBO REP, V20, DOI 10.15252/embr.201847638
   Schlafer S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-66
   Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Shannon CE, MATH THEORY COMMUNIC, P55
   Siegel RL, 2020, CA-CANCER J CLIN, V70, P145, DOI [10.3322/caac.21601, 10.3322/caac.21708, 10.3322/caac.21590]
   Socransky SS, 2002, PERIODONTOL 2000, V28, P12, DOI 10.1034/j.1600-0757.2002.280102.x
   Steele JA, 2011, ISME J, V5, P1414, DOI 10.1038/ismej.2011.24
   Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25
   Takahashi N., 2005, INT C SER, V1284, P103, DOI [10.1016/j.ics.2005.06.071, DOI 10.1016/J.ICS.2005.06.071]
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Thanikachalam K, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010164
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Tsoy O, 2009, J BACTERIOL, V191, P7157, DOI 10.1128/JB.00838-09
   Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519
   Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16
   Wasserman L, 2016, HUGE PACKAGE HIGH DI, V6
   Xia LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027992
   Xu MH, 2007, J BIOL CHEM, V282, P25000, DOI 10.1074/jbc.M611567200
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yilmaz P, 2014, NUCLEIC ACIDS RES, V42, pD643, DOI 10.1093/nar/gkt1209
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
NR 106
TC 8
Z9 9
U1 5
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAR 31
PY 2021
VL 21
IS 1
AR 98
DI 10.1186/s12866-021-02153-x
PG 18
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA RH8JA
UT WOS:000636456500001
PM 33789570
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Ai, DM
   Pan, HF
   Li, XX
   Wu, M
   Xia, L
AF Ai, Dongmei
   Pan, Hongfei
   Li, Xiaoxin
   Wu, Min
   Xia, Li C.
TI Association network analysis identifies enzymatic components of gut
   microbiota that significantly differ between colorectal cancer patients
   and healthy controls
SO PEERJ
LA English
DT Article
DE Human gut microbiome; Colorectal cancer; Topological analysis; HUMAnN2;
   Enzymatic
ID METABOLISM; DIVERSITY
AB The human gut microbiota plays a major role in maintaining human health and was recently recognized as a promising target for disease prevention and treatment. Many diseases are traceable to microbiota dysbiosis, implicating altered gut microbial ecosystems, or, in many cases, disrupted microbial enzymes carrying out essential physio-biochemical reactions. Thus, the changes of essential microbial enzyme levels may predict human disorders. With the rapid development of high-throughput sequencing technologies, metagenomics analysis has emerged as an important method to explore the microbial communities in the human body, as well as their functionalities. In this study, we analyzed 156 gut metagenomics samples from patients with colorectal cancer (CRC) and adenoma, as well as that from healthy controls. We estimated the abundance of microbial enzymes using the HMP Unified Metabolic Analysis Network method and identified the differentially abundant enzymes between CRCs and controls. We constructed enzymatic association networks using the extended local similarity analysis algorithm. We identified CRC-associated enzymic changes by analyzing the topological features of the enzymatic association networks, including the clustering coefficient, the betweenness centrality, and the closeness centrality of network nodes. The network topology of enzymatic association network exhibited a difference between the healthy and the CRC environments. The ABC (ATP binding cassette) transporter and small subunit ribosomal protein S19 enzymes, had the highest clustering coefficient in the healthy enzymatic networks. In contrast, the Adenosylhomocysteinase enzyme had the highest clustering coefficient in the CRC enzymatic networks. These enzymic and metabolic differences may serve as risk predictors for CRCs and are worthy of further research.
C1 [Ai, Dongmei] Univ Sci & Technol Beijing, Basic Expt Ctr Nat Sci, Beijing, Peoples R China.
   [Ai, Dongmei; Pan, Hongfei; Li, Xiaoxin; Wu, Min] Univ Sci & Technol Beijing, Sch Math & Phys, Beijing, Peoples R China.
   [Xia, Li C.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
C3 University of Science & Technology Beijing; University of Science &
   Technology Beijing; Stanford University
RP Ai, DM (corresponding author), Univ Sci & Technol Beijing, Basic Expt Ctr Nat Sci, Beijing, Peoples R China.; Ai, DM (corresponding author), Univ Sci & Technol Beijing, Sch Math & Phys, Beijing, Peoples R China.; Xia, L (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.
EM aidongmei@ustb.edu.cn; l.c.xia@stanford.edu
RI Xia, Li (Charlie)/AAD-8271-2020
OI Xia, Li (Charlie)/0000-0003-0868-1923
FU National Natural Science Foundation of China [61873027, 61370131];
   Innovation in Cancer Informatics Fund
FX This work was supported by grants from the National Natural Science
   Foundation of China (61873027, 61370131). Li C. Xia was supported by the
   Innovation in Cancer Informatics Fund. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001
   Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Andersen V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072119
   Borenstein E, 2012, BRIEF BIOINFORM, V13, P769, DOI 10.1093/bib/bbs022
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Cipe G, 2015, WORLD J GASTRO ONCOL, V7, P233, DOI 10.4251/wjgo.v7.i10.233
   Cotter PD, 2013, NAT REV MICROBIOL, V11, P95, DOI 10.1038/nrmicro2937
   De Iudicibus S, 2008, ANTICANCER RES, V28, P3921
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700
   Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Ki BM, 2018, J ENVIRON SCI HEAL A, V53, P718, DOI 10.1080/10934529.2018.1439856
   Kim HJ, 2009, J PROTEOME RES, V8, P1368, DOI 10.1021/pr8007573
   Nistal E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00220
   Petry KG, 1998, TRENDS GENET, V14, P98, DOI 10.1016/S0168-9525(97)01379-6
   Santhanam S, 2016, TRANSL RES, V167, P67, DOI 10.1016/j.trsl.2015.07.003
   Shade A, 2010, ENVIRON MICROBIOL, V12, P455, DOI 10.1111/j.1462-2920.2009.02087.x
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sung J, 2016, APPL TRANSL GENOM, V10, P10, DOI 10.1016/j.atg.2016.02.001
   Tsuda H, 2010, J PERIODONTAL RES, V45, P626, DOI 10.1111/j.1600-0765.2010.01277.x
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Weiss S, 2016, ISME J, V10, P1669, DOI 10.1038/ismej.2015.235
   Xia LC, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S2-S15
   Yin HR, 2013, J PROTEOME RES, V12, P3912, DOI 10.1021/pr4005025
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 31
TC 9
Z9 9
U1 1
U2 11
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JUL 29
PY 2019
VL 7
AR e7315
DI 10.7717/peerj.7315
PG 12
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA IM0RN
UT WOS:000477696400008
PM 31392094
OA gold, Green Published, Green Submitted
DA 2022-11-22
ER

PT J
AU Khankari, NK
   Banbury, BL
   Borges, MC
   Haycock, P
   Albanes, D
   Arndt, V
   Berndt, SI
   Bezieau, S
   Brenner, H
   Campbell, PT
   Casey, G
   Chan, AT
   Chang-Claude, J
   Conti, DV
   Cotterchio, M
   English, DR
   Figueiredo, JC
   Giles, GG
   Giovannucci, EL
   Gunter, MJ
   Hampe, J
   Hoffmeister, M
   Hopper, JL
   Jenkins, MA
   Joshi, AD
   Le Marchand, L
   Lemire, M
   Li, CI
   Li, L
   Lindblom, A
   Martin, V
   Moreno, V
   Newcomb, PA
   Offit, K
   Pharoah, PDP
   Rennert, G
   Sakoda, LC
   Schafmayer, C
   Schmit, SL
   Slattery, ML
   Song, MY
   Thibodeau, SN
   Ulrich, CM
   Weinstein, SJ
   White, E
   Win, AK
   Wolk, A
   Woods, MO
   Wu, AH
   Cai, QY
   Denny, JC
   Edwards, TL
   Murff, HJ
   Gruber, SB
   Peters, U
   Zheng, W
AF Khankari, Nikhil K.
   Banbury, Barbara L.
   Borges, Maria C.
   Haycock, Philip
   Albanes, Demetrius
   Arndt, Volker
   Berndt, Sonja I.
   Bezieau, Stephane
   Brenner, Hermann
   Campbell, Peter T.
   Casey, Graham
   Chan, Andrew T.
   Chang-Claude, Jenny
   Conti, David V.
   Cotterchio, Michelle
   English, Dallas R.
   Figueiredo, Jane C.
   Giles, Graham G.
   Giovannucci, Edward L.
   Gunter, Marc J.
   Hampe, Jochen
   Hoffmeister, Michael
   Hopper, John L.
   Jenkins, Mark A.
   Joshi, Amit D.
   Le Marchand, Loic
   Lemire, Mathieu
   Li, Christopher I.
   Li, Li
   Lindblom, Annika
   Martin, Vicente
   Moreno, Victor
   Newcomb, Polly A.
   Offit, Kenneth
   Pharoah, Paul D. P.
   Rennert, Gad
   Sakoda, Lori C.
   Schafmayer, Clemens
   Schmit, Stephanie L.
   Slattery, Martha L.
   Song, Mingyang
   Thibodeau, Stephen N.
   Ulrich, Cornelia M.
   Weinstein, Stephanie J.
   White, Emily
   Win, Aung Ko
   Wolk, Alicia
   Woods, Michael O.
   Wu, Anna H.
   Cai, Qiuyin
   Denny, Joshua C.
   Edwards, Todd L.
   Murff, Harvey J.
   Gruber, Stephen B.
   Peters, Ulrike
   Zheng, Wei
TI Mendelian Randomization of Circulating Polyunsaturated Fatty Acids and
   Colorectal Cancer Risk
SO CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
LA English
DT Article
ID PLEIOTROPIC GENETIC-VARIANTS; GENOME-WIDE ASSOCIATION; PROSTAGLANDIN
   E-2; DIETARY-INTAKE; COLON-CANCER; ASPIRIN; STRATIFICATION;
   EPIDEMIOLOGY; PREVENTION; ADENOMAS
AB Background: Results from epidemiologic studies examining polyunsaturated fatty acids (PUFA) and colorectal cancer risk are inconsistent. Mendelian randomization may strengthen causal inference from observational studies. Given their shared metabolic pathway, examining the combined effects of aspirin/NSAID use with PUFAs could help elucidate an association between PUFAs and colorectal cancer risk.
   Methods: Information was leveraged from genome-wide association studies (GWAS) regarding PUFA-associated SNPs to create weighted genetic scores (wGS) representing genetically predicted circulating blood PUFAs for 11,016 non-Hispanic white colorectal cancer cases and 13,732 controls in the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). Associations per SD increase in the wGS were estimated using unconditional logistic regression. Interactions between PUFA wGSs and aspirin/NSAID use on colorectal cancer risk were also examined.
   Results: Modest colorectal cancer risk reductions were observed per SD increase in circulating linoleic acid [ORLA = 0.96; 95% confidence interval (CI) = 0.93-0.98; P = 5.2 x 10(-4)] and alpha-linolenic acid (ORA(LA) = 0.95; 95% CI = 0.92-0.97; P = 5.4 x 10(-5)), whereas modest increased risks were observed for arachidonic (ORAA = 1.06; 95% CI = 1.03-1.08; P = 3.3 x 10(-5)), eicosapentaenoic (OREPA = 1.04; 95% CI = 1.01-1.07; P = 2.5 x 10(-3)), and docosapentaenoic acids (ORDPA = 1.03; 95% CI = 1.01-1.06; P = 1.2 x 10(-2)). Each of these effects was stronger among aspirin/NSAID nonusers in the stratified analyses.
   Conclusions: Our study suggests that higher circulating shorter-chain PUFAs (i.e., LA and ALA) were associated with reduced colorectal cancer risk, whereas longer-chain PUFAs (i.e., AA, EPA, and DPA) were associated with an increased colorectal cancer risk.
   Impact: The interaction of PUFAs with aspirin/NSAID use indicates a shared colorectal cancer inflammatory pathway. Future research should continue to improve PUFA genetic instruments to elucidate the independent effects of PUFAs on colorectal cancer.
C1 [Khankari, Nikhil K.; Cai, Qiuyin; Edwards, Todd L.; Murff, Harvey J.; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Ingram Canc Ctr,Div Epidemiol, Nashville, TN USA.
   [Banbury, Barbara L.; Li, Christopher I.; Newcomb, Polly A.; Sakoda, Lori C.; White, Emily; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.
   [Borges, Maria C.; Haycock, Philip] Univ Bristol, Integrat Epidemiol Unit, Med Res Council MRC, Bristol, Avon, England.
   [Borges, Maria C.; Haycock, Philip] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England.
   [Albanes, Demetrius; Berndt, Sonja I.; Weinstein, Stephanie J.] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.
   [Arndt, Volker; Brenner, Hermann; Hoffmeister, Michael] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Bezieau, Stephane] CHU Nantes, Serv Genet Med, Nantes, France.
   [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany.
   [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany.
   [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany.
   [Campbell, Peter T.] Amer Canc Soc, Behav & Epidemiol Res Grp, Atlanta, GA 30329 USA.
   [Casey, Graham] Univ Virginia, Ctr Publ Hlth Genom, Charlottesville, VA USA.
   [Chan, Andrew T.; Song, Mingyang] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Chan, Andrew T.; Giovannucci, Edward L.; Joshi, Amit D.; Song, Mingyang] Harvard Med Sch, Boston, MA 02115 USA.
   [Chan, Andrew T.; Giovannucci, Edward L.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Chan, Andrew T.; Joshi, Amit D.; Song, Mingyang] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA.
   [Chan, Andrew T.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Chan, Andrew T.; Giovannucci, Edward L.; Joshi, Amit D.; Song, Mingyang] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Chan, Andrew T.] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Chang-Claude, Jenny] Univ Canc Ctr Hamburg UCCH, Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   [Chang-Claude, Jenny] German Canc Res Ctr, Div Canc Epidemiol, Heidelberg, Germany.
   [Conti, David V.; Figueiredo, Jane C.; Schmit, Stephanie L.; Wu, Anna H.] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA 90007 USA.
   [Cotterchio, Michelle] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada.
   [English, Dallas R.; Giles, Graham G.; Hopper, John L.; Jenkins, Mark A.; Win, Aung Ko] Univ Melbourne, Sch Populat & Global Hlth, Ctr Biostat & Epidemiol, Melbourne, Vic, Australia.
   [English, Dallas R.; Giles, Graham G.] Canc Council Victoria, Canc Epidemiol & Intelligence Div, Melbourne, Vic, Australia.
   [Figueiredo, Jane C.] Cedars Sinai Med Ctr, Dept Med, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.
   [Giovannucci, Edward L.; Song, Mingyang] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.
   [Gunter, Marc J.] WHO, Int Agcy Res Canc, Nutr & Metab Sect, Lyon, France.
   [Hampe, Jochen] Tech Univ Dresden TU Dresden, Univ Hosp Dresden, Dept Med, Dresden, Germany.
   [Le Marchand, Loic] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.
   [Lemire, Mathieu] PanCuRx Translat Res Initiat, Inst Canc Res, Toronto, ON, Canada.
   [Li, Li] Univ Virginia, Dept Family Med, Charlottesville, VA USA.
   [Lindblom, Annika] Karolinska Univ Hosp, Dept Clin Med, Stockholm, Sweden.
   [Lindblom, Annika] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden.
   [Martin, Vicente] Univ Leon, Area Med Prevent & Salud Publ, Leon, Spain.
   [Moreno, Victor] IDIBELL, Catalan Inst Oncol, Canc Prevent & Control Program, Barcelona, Spain.
   [Moreno, Victor] CIBER Epidemiol & Salad Publ CIBERESP, Madrid, Spain.
   [Moreno, Victor] Univ Barcelona, Fac Med, Dept Clin Sci, Barcelona, Spain.
   [Newcomb, Polly A.; White, Emily; Peters, Ulrike] Univ Washington, Sch Publ Hlth & Community Med, Dept Epidemiol, Seattle, WA 98195 USA.
   [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, 1275 York Ave, New York, NY 10021 USA.
   [Offit, Kenneth] Weill Cornell Med Coll, Dept Med, New York, NY USA.
   [Pharoah, Paul D. P.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.
   [Rennert, Gad] Lady Davis Carmel Med Ctr, Dept Community Med & Epidemiol, Haifa, Israel.
   [Rennert, Gad] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel.
   [Rennert, Gad] Clalit Natl Canc Control Ctr, Haifa, Israel.
   [Sakoda, Lori C.] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA.
   [Schafmayer, Clemens] Univ Hosp Schleswig Holstein, Dept Gen & Thorac Surg, Kiel, Germany.
   [Schmit, Stephanie L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, Tampa, FL USA.
   [Slattery, Martha L.] Univ Utah, Dept Internal Med, Div Epidemiol, Salt Lake City, UT 84112 USA.
   [Thibodeau, Stephen N.] Mayo Clin, Dept Lab Med & Pathol, Div Lab Genet, Rochester, MN USA.
   [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.
   [Ulrich, Cornelia M.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA.
   [Wolk, Alicia] Karolinska Inst, Inst Environm Med, Stockholm, Sweden.
   [Woods, Michael O.] Mem Univ Newfoundland, Discipline Genet, St John, NF, Canada.
   [Denny, Joshua C.; Edwards, Todd L.] Vanderbilt Univ, Med Ctr, Vanderbilt Genet Inst, Nashville, TN USA.
   [Denny, Joshua C.] Vanderbilt Univ, Med Ctr, Dept Biomed Informat, Nashville, TN USA.
   [Gruber, Stephen B.] City Hope Natl Med Ctr, Dept Med Oncol, 1500 E Duarte Rd, Duarte, CA 91010 USA.
C3 Vanderbilt University; Fred Hutchinson Cancer Center; University of
   Bristol; University of Bristol; National Institutes of Health (NIH) -
   USA; NIH National Cancer Institute (NCI); Helmholtz Association; German
   Cancer Research Center (DKFZ); Nantes Universite; CHU de Nantes;
   Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz
   Association; German Cancer Research Center (DKFZ); Ruprecht Karls
   University Heidelberg; Helmholtz Association; German Cancer Research
   Center (DKFZ); American Cancer Society; University of Virginia; Harvard
   University; Massachusetts General Hospital; Harvard University; Harvard
   Medical School; Harvard University; Brigham & Women's Hospital; Harvard
   University; Massachusetts General Hospital; Harvard University;
   Massachusetts Institute of Technology (MIT); Broad Institute; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; University of
   Hamburg; University Medical Center Hamburg-Eppendorf; Helmholtz
   Association; German Cancer Research Center (DKFZ); University of
   Southern California; Cancer Care Ontario; University of Melbourne;
   Cancer Council Victoria; Cedars Sinai Medical Center; Harvard
   University; Harvard T.H. Chan School of Public Health; World Health
   Organization; International Agency for Research on Cancer (IARC);
   Technische Universitat Dresden; Carl Gustav Carus University Hospital;
   Cancer Research Center of Hawaii; University of Hawaii System;
   University of Toronto; University Toronto Affiliates; University of
   Virginia; Karolinska Institutet; Karolinska University Hospital;
   Karolinska Institutet; Universidad de Leon; Catalan Institute of
   Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL);
   University of Barcelona; CIBER - Centro de Investigacion Biomedica en
   Red; CIBERESP; University of Barcelona; University of Washington;
   University of Washington Seattle; Memorial Sloan Kettering Cancer
   Center; Cornell University; University of Cambridge; Clalit Health
   Services; Carmel Medical Center; Technion Israel Institute of
   Technology; Rappaport Faculty of Medicine; Kaiser Permanente; University
   of Kiel; Schleswig Holstein University Hospital; H Lee Moffitt Cancer
   Center & Research Institute; Utah System of Higher Education; University
   of Utah; Mayo Clinic; Huntsman Cancer Institute; Utah System of Higher
   Education; University of Utah; Utah System of Higher Education;
   University of Utah; Karolinska Institutet; Memorial University
   Newfoundland; Vanderbilt University; Vanderbilt University; City of Hope
RP Khankari, NK (corresponding author), Vanderbilt Univ, Med Ctr, 2525 West End Ave,Suite 600, Nashville, TN 37203 USA.
EM nikhil.khankari@vumc.org
RI Brenner, Hermann/B-4627-2017; Hoffmeister, Michael/AAB-2321-2022;
   Brenner, Hermann/ABE-6383-2020; Martin, Vicente/A-1597-2008;
   Hoffmeister, Michael/T-7187-2019; Martin, Vicente/GRE-8306-2022; Martin,
   Vicente/ABF-2276-2021; Sakoda, Lori/ABD-6828-2020; Denny,
   Josh/AAL-3359-2021; Weinstein, Stephanie J/P-1627-2017; Win, Aung
   K./J-6204-2015; Zheng, Wei/GQQ-8951-2022; Schmit,
   Stephanie/AAW-8980-2020; Arndt, Volker/B-4999-2014; Moreno,
   Victor/A-1697-2010; Borges, Maria Carolina/F-1980-2014
OI Brenner, Hermann/0000-0002-6129-1572; Hoffmeister,
   Michael/0000-0002-8307-3197; Brenner, Hermann/0000-0002-6129-1572;
   Martin, Vicente/0000-0003-0552-2804; Hoffmeister,
   Michael/0000-0002-8307-3197; Martin, Vicente/0000-0003-0552-2804;
   Sakoda, Lori/0000-0002-0900-5735; Denny, Josh/0000-0002-3049-7332;
   Weinstein, Stephanie J/0000-0002-3834-1535; Win, Aung
   K./0000-0002-2794-5261; Rennert, Gad/0000-0002-8512-068X; Arndt,
   Volker/0000-0001-9320-8684; Moreno, Victor/0000-0002-2818-5487; Borges,
   Maria Carolina/0000-0001-7785-4547; Haycock, Philip/0000-0001-5001-3350;
   Gunter, Marc/0000-0001-5472-6761; , Zhong/0000-0001-7494-9655
FU NIH-NCI [K99 CA215360]; Skills Development Fellowship from the UK
   Medical Research Council [MR/P014054/1]; CRUK Population Research
   Postdoctoral Fellowship [C52724/A20138]; American Cancer Society
   [MRSG-17-220-01 -NEC]; USNIH [K99 CA215314, R00 CA215314]; Fred
   Hutchinson Cancer Research Center; Centers for Disease Control and
   PreventionNational Program of Cancer Registries; National Cancer
   Institute Surveillance Epidemiology and End Results program; Hospital
   Clinical Research Program from the University Hospital Center of Nantes
   (CHU de Nantes) [PHRC-BRD09/C]; Regional Council of Pays de la Loire;
   Groupement des Entreprises Francaises dans la Lutte contre le Cancer
   (GEFLUC); Association Anne de Bretagne Genetique; Ligue RegionaleContre
   le Cancer (LRCC); NIH [R01 CA60987, R01 CA48998, P01 CA055075, UM1
   CA167552, U01 CA167552, R01 CA137178, R01 CA151993, R35 CA197735, K07
   CA190673]; NCI, NIH [U01 CA122839, R01 CA143247, U19 CA148107, U01
   CA167551]; Australasian Colorectal Cancer Family Registry (NCI/NIH) [U01
   CA074778, U01/U24 CA097735]; USC Consortium Colorectal Cancer Family
   Registry (NCI/NIH) [U01/U24 CA074799]; Mayo Clinic Cooperative Family
   Registry for Colon Cancer Studies (NCI/NIH) [U01/U24 CA074800]; Ontario
   Familial Colorectal Cancer Registry (NCI/NIH) [U01/U24 CA074783];
   Seattle Colorectal Cancer Family Registry (NCI/NIH) [U01/U24 CA074794];
   University of Hawaii Colorectal Cancer Family Registry (NCI/NIH)
   [U01/U24 CA074806]; Surveillance, Epidemiology and End Results (SEER)
   Program of the NCI [N01-CN-67009, N01PC-35142, HHSN2612013000121];
   Hawai'i Department of Health [N01-PC-67001, N01-PC-35137,
   HHSN26120100037C]; California Department of Public Health
   [HHSN261201000035C]; German Research Council [BR 1704/6-1, BR 1704/6-3,
   BR 1704/6-4, CH117/1-1, HO5117/2-1, HE 5998/2-1, KL 2354/3-1, RO
   2270/8-1, BR 1704/17-1]; Interdisciplinary Research Program of the
   National Center for Tumor Diseases (NCT), Germany; German Federal
   Ministry of Education and Research [01KH0404, 01ER0814, 01ER0815,
   01ER1505A, 01ER1505B]; NCI, NIH, U.S. Department of Health and Human
   Services [U01 CA164930, U01 CA137088, R01 CA059045]; NIH/NCI Cancer
   Center Support Grant [P30 CA015704]; Ontario Research Fund; Canadian
   Institutes of Health Research; Ontario Institute for Cancer Research,
   through Ontario Ministry of Research and Innovation; Division of Cancer
   Prevention, National Cancer Institute, NIH, DHHS; NIH, Genes,
   Environment and Health Initiative (GEI) [Z01 CP 010200, NIHU01 HG004446,
   NIHGEI U01 HG 004438]; National Heart, Lung, and Blood Institute, NIH,
   U.S. Department of Health and Human Services [HHSN268201100046C,
   HHSN268201100001C, HHSN268201100002C, HHSN268201100003C,
   HHSN268201100004C, HHSN271201100004C]; U.S. Public Health Service
   contracts from the National Cancer Institute [N01-CN-45165,
   N01-RC-45035, N01-RC-37004, HHSN261201000006C]; Matthias
   Lackas-Foundation; German Consortium for Translational Cancer Research;
   EU TRANSCAN initiative; NCI/NIH, U.S. Department of Health and Human
   Services [U19 CA148107, R01 CA81488, P30 CA014089, R01 CA197350, P01
   CA196569, R01 CA201407]; National Institutes of Environmental Health
   Sciences, NIH [T32 ES013678]; American Cancer Society; Baden-Wurttemberg
   Ministry of Science, Research and Arts; German Cancer Aid; Damon Runyon
   Cancer Research Foundation [CI-8]; NCI [R01CA136726]; VicHealth; Cancer
   Council Victoria; Australian NHMRC [509348, 209057, 251553, 504711];
   NIH, U.S. Department of Health and Human Services [R01 CA81488]; Robert
   and Kate Niehaus Center for Inherited Cancer Genomics; Romeo Milio
   Foundation; Florida Department of Health Bankhead-Coley Grant [09BN-13];
   University of South Florida Oehler Foundation; Total Cancer Care
   Initiative; Collaborative Data Services Core; Tissue Core at the H. Lee
   Moffitt Cancer Center & Research Institute, a National Cancer
   Institute-designated Comprehensive Cancer Center [P30 CA076292];
   Interdisciplinary Health Research Team award from the Canadian
   Institutes of Health Research [CRT 43821]; NIH, U.S. Department of
   Health and Human Serivces [U01 CA74783]; National Cancer Institute of
   Canada [18223, 18226]; Canadian Cancer Society Research Institute;
   Cancer Research UK [C490/A16561]; Instituto de Salud Carlos III; FEDER
   funds -a way to build Europe [PI14-613, PI09-1286]; Agency for
   Management of University and Research Grants (AGAUR) of the Catalan
   Government [2017SGR723]; Junta de Castilla y Leon [LE22A10-2]; Xarxa de
   Bancs de Tumors de Catalunya - Pla Director d'Oncologia de Catalunya
   (XBTC), Plataforma Biobancos [PT13/0010/0013]; ICOBIOBANC - Catalan
   Institute of Oncology; Swedish research council [K2015-55X-22674-01-4,
   K2008-55X-20157-03-3, K2006-72X-20157-01-2]; Stockholm County Council
   (ALF project); Swedish Research Council/Infrastructure grant; Swedish
   Cancer Foundation; Karolinska Institute's Distinguished Professor Award;
   UK National Institute for Health Research Biomedical Research Centers at
   the University of Cambridge;  [P50 CA127003];  [P01 CA087969];  [UM1
   CA186107];  [R01 CA042182];  [R37 CA54281];  [P01 CA033619];  [R01
   CA063464];  [U01 CA164973];  [U01 CA074783];  [R01 CA076366];  [K05
   CA154337];  [R01 CA189184];  [U01 CA206110];  [2P30CA015704-40];  [R01
   CA207371]; MRC [MR/P014054/1, MC_UU_00011/6] Funding Source: UKRI
FX N.K. Khankari is supported by NIH-NCI K99 CA215360. M.C. Borges is
   supported by a Skills Development Fellowship from the UK Medical
   Research Council (Grant number MR/P014054/1). P.C. Haycock is supported
   by CRUK Population Research Postdoctoral Fellowship C52724/A20138. M.
   Song is supported by the American Cancer Society (grant
   numberMRSG-17-220-01 -NEC) and the USNIH grants (K99 CA215314, R00
   CA215314).The following acknowledgements are for GECCO:; The following
   acknowledgments are for CORECT:; ColoCare: Biospecimens were provided by
   the ColoCare Consortium, funded by the Fred Hutchinson Cancer Research
   Center. Other investigators may have received specimens from the same
   subjects.; CPS-II (American Cancer Society Cancer Prevention Study II):
   The authors thank the CPS-II participants and Study Management Group for
   their invaluable contributions to this research. The authors also
   acknowledge the contribution to this study from central cancer
   registries supported through the Centers for Disease Control and
   PreventionNational Program of Cancer Registries, and cancer registries
   supported by the National Cancer Institute Surveillance Epidemiology and
   End Results program.; MCCS (Melbourne Collaborative Cohort Study): This
   study was made possible by the contribution of many people, including
   the original investigators and the diligent team who recruited
   participants and continue to work on follow-up. The authors also are
   grateful to the many thousands of Melbourne residents who took part in
   the study and provided blood samples.; SEARCH (Studies of Epidemiology
   and Risk Factors in Cancer Heredity): The authors acknowledge the
   contributions of Mitul Shah, Val Rhenius, Sue Irvine, Craig Luccarini,
   Patricia Harrington, Don Conroy, Rebecca Mayes, and Caroline Baynes.;
   The Swedish Low-risk Colorectal Cancer Study: The authors thank Berith
   Wejderot and the Swedish Low-risk Colorectal Cancer Study group.; The
   following funding information is for GECCO:; ASTERISK: a Hospital
   Clinical Research Program (PHRC-BRD09/C) from the University Hospital
   Center of Nantes (CHU de Nantes) and supported by the Regional Council
   of Pays de la Loire, the Groupement des Entreprises Francaises dans la
   Lutte contre le Cancer (GEFLUC), the Association Anne de Bretagne
   Genetique and the Ligue RegionaleContre le Cancer (LRCC).; COLO2&3
   (Hawaiian Colorectal Cancer Studies 2 and 3): NIH (R01 CA60987). CCFR:
   Illumina GWAS was supported by funding from the NCI, NIH (grant numbers
   U01 CA122839, R01 CA143247, to G. Casey). The Colon CFR/CORECT
   Affymetrix Axiom GWAS and OncoArray GWAS were supported by funding from
   NCI, NIH (grant number U19 CA148107, to S.B. Gruber). The Colon CFR
   participant recruitment and collection of data and biospecimens used in
   this study were supported by the NCI, NIH (grant number U01 CA167551)
   and through cooperative agreements with the following Colon CFR centers:
   Australasian Colorectal Cancer Family Registry (NCI/NIH grant numbers
   U01 CA074778 and U01/U24 CA097735), USC Consortium Colorectal Cancer
   Family Registry (NCI/NIH grant numbers U01/U24 CA074799), Mayo Clinic
   Cooperative Family Registry for Colon Cancer Studies (NCI/NIH grant
   number U01/U24 CA074800), Ontario Familial Colorectal Cancer Registry
   (NCI/NIH grant number U01/U24 CA074783), Seattle Colorectal Cancer
   Family Registry (NCI/NIH grant number U01/U24 CA074794), and University
   of Hawaii Colorectal Cancer Family Registry (NCI/NIH grant number
   U01/U24 CA074806). Additional support for case ascertainment was
   provided from the Surveillance, Epidemiology and End Results (SEER)
   Program of the NCI to Fred Hutchinson Cancer Research Center (control
   nos. N01-CN-67009 and N01PC-35142 and contract no. HHSN2612013000121),
   the Hawai'i Department of Health (control nos. N01-PC-67001 and
   N01-PC-35137 and contract no. HHSN26120100037C), and the California
   Department of Public Health (contracts HHSN261201000035C awarded to the
   University of Southern California, and the following state cancer
   registries: AZ, CO, MN, NC, NH, and by the Victoria Cancer Registry and
   Ontario Cancer Registry).; DACHS: This work was supported by the German
   Research Council (BR 1704/6-1, BR 1704/6-3, BR 1704/6-4, CH117/1-1,
   HO5117/2-1, HE 5998/2-1, KL 2354/3-1, RO 2270/8-1 and BR 1704/17-1), the
   Interdisciplinary Research Program of the National Center for Tumor
   Diseases (NCT), Germany, and the German Federal Ministry of Education
   and Research (01KH0404, 01ER0814, 01ER0815, 01ER1505A and 01ER1505B).;
   DALS (Diet, Activity, and Lifestyle Study): NIH (R01 CA48998, to M.L.
   Slattery). Harvard cohorts (HPFS, NHS, PHS): HPFS is supported by the
   NIH (P01 CA055075, UM1 CA167552, U01 CA167552, R01 CA137178, R01
   CA151993, R35 CA197735, K07 CA190673, and P50 CA127003), NHS by the NIH
   (R01 CA137178, P01 CA087969, UM1 CA186107, R01 CA151993, R35 CA197735,
   K07 CA190673, and P50 CA127003), and PHS by the NIH (R01 CA042182).;
   GECCO: NCI, NIH, U.S. Department of Health and Human Services (U01
   CA164930, U01 CA137088, R01 CA059045). This research was funded in part
   through the NIH/NCI Cancer Center Support Grant P30 CA015704.; MEC
   (Multiethnic Cohort): NIH (R37 CA54281, P01 CA033619, R01 CA063464, U01
   CA164973). Also part of CORECT funding acknowledgments.; OFCCR (Ontario
   Familial Colorectal Cancer Registry): NIH, through funding allocated to
   the Ontario Registry for Studies of Familial Colorectal Cancer (U01
   CA074783); see CCFR section above. Additional funding toward genetic
   analyses of OFCCR includes the Ontario Research Fund, the Canadian
   Institutes of Health Research, and the Ontario Institute for Cancer
   Research, through generous support from the Ontario Ministry of Research
   and Innovation.; PLCO: Intramural Research Program of the Division of
   Cancer Epidemiology and Genetics and supported by contracts from the
   Division of Cancer Prevention, National Cancer Institute, NIH, DHHS.
   Funding was provided by NIH, Genes, Environment and Health Initiative
   (GEI) Z01 CP 010200, NIHU01 HG004446, and NIHGEI U01 HG 004438.; PMH:
   NIH (R01 CA076366, to P.A. Newcomb).; VITAL (Vitamins and Lifestyle):
   NIH (K05 CA154337).; WHI: The WHI program is funded by the National
   Heart, Lung, and Blood Institute, NIH, U.S. Department of Health and
   Human Services through contracts HHSN268201100046C, HHSN268201100001C,
   HHSN268201100002C, HHSN268201100003C, HHSN268201100004C, and
   HHSN271201100004C.; The following funding information is for studies
   included in CORECT:; ATBC (Alpha-Tocopherol, Beta Carotene Cancer
   Prevention Study): The ATBC Study was supported by the U.S. Public
   Health Service contracts (N01-CN-45165, N01-RC-45035, N01-RC-37004, and
   HHSN261201000006C) from the National Cancer Institute.; ColoCare: This
   work was supported by the NIH [grant numbers R01 CA189184 (to Li/C.M.
   Ulrich), U01 CA206110 (C.M. Ulrich/Li/Siegel/Figueireido/Colditz,
   2P30CA015704-40 (Gilliland), R01 CA207371 (C.M. Ulrich/Li)], the
   Matthias Lackas-Foundation, the German Consortium for Translational
   Cancer Research, and the EU TRANSCAN initiative.; CORECT Study: The
   CORECT Study was supported by the NCI/NIH, U.S. Department of Health and
   Human Services (grant numbers U19 CA148107, R01 CA81488, P30 CA014089,
   R01 CA197350; P01 CA196569; R01 CA201407) and National Institutes of
   Environmental Health Sciences, NIH (grant number T32 ES013678).; CPS-II:
   The American Cancer Society funds the creation, maintenance, and
   updating of the Cancer Prevention Study-II (CPS-II) cohort. This study
   was conducted with Institutional Review Board approval.; ESTHER/VERDI
   (Epidemiologische Studie zu Chancen der Verhutung, Fruherkennung und
   optimierten Therapie chronischer Erkrankungen in der alteren
   Bevolkerung; Verlauf der diagnotischen Abklarung bei Krebspatienten):
   This work was supported by grants from the Baden-Wurttemberg Ministry of
   Science, Research and Arts and the German Cancer Aid.; Kentucky: This
   work was supported by the following: (i) Clinical Investigator Award
   from Damon Runyon Cancer Research Foundation (CI-8) and (ii)
   NCIR01CA136726; the authors acknowledge the staff at the Kentucky Cancer
   Registry.; MCCS: Cohort recruitment was funded by VicHealth and Cancer
   Council Victoria. The MCCS was further supported by Australian NHMRC
   grants 509348, 209057, 251553, and 504711 and by infrastructure provided
   by Cancer Council Victoria. Cases and their vital status were
   ascertained through the Victorian Cancer Registry (VCR) and the
   Australian Institute of Health and Welfare (AIHW), including the
   National Death Index and the Australian Cancer Database.; MECC
   (Molecular Epidemiology of Colorectal Cancer Study): This work was
   supported by the NIH, U.S. Department of Health and Human Services (R01
   CA81488, to S.B. Gruber and G. Rennert).; MSKCC: The work at Sloan
   Kettering in New York was supported by the Robert and Kate Niehaus
   Center for Inherited Cancer Genomics and the Romeo Milio Foundation.
   Moffitt: This work was supported by funding from the NIH (grant numbers
   R01 CA189184, P30 CA076292), Florida Department of Health Bankhead-Coley
   Grant 09BN-13, and the University of South Florida Oehler Foundation.
   Moffitt contributions were supported in part by the Total Cancer Care
   Initiative, Collaborative Data Services Core, and Tissue Core at the H.
   Lee Moffitt Cancer Center & Research Institute, a National Cancer
   Institute-designated Comprehensive Cancer Center (grant number P30
   CA076292).; NFCCR (Newfoundland Case-Control Study): This work was
   supported by an Interdisciplinary Health Research Team award from the
   Canadian Institutes of Health Research (CRT 43821); the NIH, U.S.
   Department of Health and Human Serivces (U01 CA74783); and National
   Cancer Institute of Canada grants (18223 and 18226). The authors
   acknowledge the contribution of Alexandre Belisle and the genotyping
   team of the McGill University and Genome Quebec Innovation Centre,
   Montreal, Canada, for genotyping the Sequenom panel in the NFCCR
   samples.; Funding was provided to M.O. Woods by the Canadian Cancer
   Society Research Institute.; SEARCH: The University of Cambridge has
   received salary support in respect of PDPP from the NHS in the East of
   England through the Clinical Academic Reserve. Cancer Research UK
   (C490/A16561); the UK National Institute for Health Research Biomedical
   Research Centers at the University of Cambridge.; SPAIN [The Spanish
   study (University Hospital of Bellvitge, L'Hospitalet, Barcelona;
   Hospital of Leon, Leon; Spain)]: The Spanish study was supported by
   Instituto de Salud Carlos III, cofunded by FEDER funds -a way to build
   Europe-(grants PI14-613 and PI09-1286), Agency for Management of
   University and Research Grants (AGAUR) of the Catalan Government (grant
   2017SGR723), and Junta de Castilla y Leon (grant LE22A10-2). Sample
   collection of this work was supported by the Xarxa de Bancs de Tumors de
   Catalunya sponsored by Pla Director d'Oncologia de Catalunya (XBTC),
   Plataforma Biobancos PT13/0010/0013 and ICOBIOBANC, sponsored by the
   Catalan Institute of Oncology.; The Swedish Low-risk Colorectal Cancer
   Study: The study was supported by grants from the Swedish research
   council; K2015-55X-22674-01-4, K2008-55X-20157-03-3,
   K2006-72X-20157-01-2 and the Stockholm County Council (ALF project).;
   Swedish Mammography Cohort and Cohort of Swedish Men: This work is
   supported by the Swedish Research Council/Infrastructure grant, the
   Swedish Cancer Foundation, and the Karolinska Institute's Distinguished
   Professor Award (to A. Wolk).
CR Bezawada N, 2014, CANCER PREV RES, V7, P758, DOI 10.1158/1940-6207.CAPR-14-0120
   Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965
   Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080
   Burgess S, 2015, AM J EPIDEMIOL, V181, P290, DOI 10.1093/aje/kwv017
   Burgess S, 2015, AM J EPIDEMIOL, V181, P251, DOI 10.1093/aje/kwu283
   Burgess S, 2014, INT J EPIDEMIOL, V43, P922, DOI 10.1093/ije/dyu005
   Burgess S, 2013, GENET EPIDEMIOL, V37, P658, DOI 10.1002/gepi.21758
   Campbell CD, 2005, NAT GENET, V37, P868, DOI 10.1038/ng1607
   Chan AT, 2005, JAMA-J AM MED ASSOC, V294, P914, DOI 10.1001/jama.294.8.914
   Chubak J, 2016, ANN INTERN MED, V164, P814, DOI 10.7326/M15-2117
   EBERHART CE, 1994, GASTROENTEROLOGY, V107, P1183, DOI 10.1016/0016-5085(94)90246-1
   Flossmann E, 2007, LANCET, V369, P1603, DOI 10.1016/S0140-6736(07)60747-8
   Gerber M, 2012, BRIT J NUTR, V107, pS228, DOI 10.1017/S0007114512001614
   Guan WH, 2014, CIRC-CARDIOVASC GENE, V7, P321, DOI 10.1161/CIRCGENETICS.113.000208
   Gunter BR, 2017, J CLIN PHARM THER, V42, P27, DOI 10.1111/jcpt.12484
   Hall MN, 2007, CANCER EPIDEM BIOMAR, V16, P314, DOI 10.1158/1055-9965.EPI-06-0346
   Haycock PC, 2016, AM J CLIN NUTR, V103, P965, DOI 10.3945/ajcn.115.118216
   Hemani G, 2018, ELIFE, V7, DOI 10.7554/eLife.34408
   HOSMER DW, 1992, EPIDEMIOLOGY, V3, P452, DOI 10.1097/00001648-199209000-00012
   Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067
   Kawamori T, 2003, CARCINOGENESIS, V24, P985, DOI 10.1093/carcin/bgg033
   Knol MJ, 2012, INT J EPIDEMIOL, V41, P514, DOI 10.1093/ije/dyr218
   Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193
   Lippi G, 2016, CRIT REV ONCOL HEMAT, V97, P1, DOI 10.1016/j.critrevonc.2015.11.008
   May-Wilson S, 2017, EUR J CANCER, V84, P228, DOI 10.1016/j.ejca.2017.07.034
   Nan HM, 2015, JAMA-J AM MED ASSOC, V313, P1133, DOI 10.1001/jama.2015.1815
   Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648
   Orido T, 2010, ARCH BIOCHEM BIOPHYS, V494, P78, DOI 10.1016/j.abb.2009.11.025
   Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020
   Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847
   Rothman K.J., 2008, MODERN EPIDEMIOLOGY, V3
   Sakai M, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-606
   Shen XJ, 2012, BRIT J NUTR, V108, P1550, DOI 10.1017/S0007114512003546
   Shim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120758
   Song MY, 2014, INT J CANCER, V135, P2413, DOI 10.1002/ijc.28878
   Swamy MV, 2004, MOL CANCER THER, V3, P215
   Theodoratou E, 2017, ANNU REV NUTR, V37, P293, DOI 10.1146/annurev-nutr-071715-051004
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Wang DZ, 2013, CANCER J, V19, P502, DOI 10.1097/PPO.0000000000000003
   Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011
   Xia DR, 2012, NAT MED, V18, P224, DOI 10.1038/nm.2608
   Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089
   Zhang H, 2002, AM J GASTROENTEROL, V97, P1037
   Zock PL, 1998, AM J CLIN NUTR, V68, P142, DOI 10.1093/ajcn/68.1.142
NR 44
TC 13
Z9 13
U1 1
U2 9
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1055-9965
EI 1538-7755
J9 CANCER EPIDEM BIOMAR
JI Cancer Epidemiol. Biomarkers Prev.
PD APR
PY 2020
VL 29
IS 4
BP 860
EP 870
DI 10.1158/1055-9965.EPI-19-0891
PG 11
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA LX7GM
UT WOS:000539995800021
PM 32051193
OA Green Submitted, Green Accepted
DA 2022-11-22
ER

PT J
AU Yachida, S
   Mizutani, S
   Shiroma, H
   Shiba, S
   Nakajima, T
   Sakamoto, T
   Watanabe, H
   Masuda, K
   Nishimoto, Y
   Kubo, M
   Hosoda, F
   Rokutan, H
   Matsumoto, M
   Takamaru, H
   Yamada, M
   Matsuda, T
   Iwasaki, M
   Yamaji, T
   Yachida, T
   Soga, T
   Kurokawa, K
   Toyoda, A
   Ogura, Y
   Hayashi, T
   Hatakeyama, M
   Nakagama, H
   Saito, Y
   Fukuda, S
   Shibata, T
   Yamada, T
AF Yachida, Shinichi
   Mizutani, Sayaka
   Shiroma, Hirotsugu
   Shiba, Satoshi
   Nakajima, Takeshi
   Sakamoto, Taku
   Watanabe, Hikaru
   Masuda, Keigo
   Nishimoto, Yuichiro
   Kubo, Masaru
   Hosoda, Fumie
   Rokutan, Hirofumi
   Matsumoto, Minori
   Takamaru, Hiroyuki
   Yamada, Masayoshi
   Matsuda, Takahisa
   Iwasaki, Motoki
   Yamaji, Taiki
   Yachida, Tatsuo
   Soga, Tomoyoshi
   Kurokawa, Ken
   Toyoda, Atsushi
   Ogura, Yoshitoshi
   Hayashi, Tetsuya
   Hatakeyama, Masanori
   Nakagama, Hitoshi
   Saito, Yutaka
   Fukuda, Shinji
   Shibata, Tatsuhiro
   Yamada, Takuji
TI Metagenomic and metabolomic analyses reveal distinct stage-specific
   phenotypes of the gut microbiota in colorectal cancer
SO NATURE MEDICINE
LA English
DT Article
ID FUSOBACTERIUM-NUCLEATUM; MOLECULAR-FEATURES; CATABOLIC PATHWAY;
   FERMENTATION; METABOLITES; BACTERIA; ACIDS; 16S
AB In most cases of sporadic colorectal cancers, tumorigenesis is a multistep process, involving genomic alterations in parallel with morphologic changes. In addition, accumulating evidence suggests that the human gut microbiome is linked to the development of colorectal cancer. Here we performed fecal metagenomic and metabolomic studies on samples from a large cohort of 616 participants who underwent colonoscopy to assess taxonomic and functional characteristics of gut microbiota and metabolites. Microbiome and metabolome shifts were apparent in cases of multiple polypoid adenomas and intramucosal carcinomas, in addition to more advanced lesions. We found two distinct patterns of microbiome elevations. First, the relative abundance of Fusobacterium nucleatum spp. was significantly (P < 0.005) elevated continuously from intramucosal carcinoma to more advanced stages. Second, Atopobium parvulum and Actinomyces odontolyticus, which co-occurred in intramucosal carcinomas, were significantly (P < 0.005) increased only in multiple polypoid adenomas and/or intramucosal carcinomas. Metabolome analyses showed that branched-chain amino acids and phenylalanine were significantly (P < 0.005) increased in intramucosal carcinomas and bile acids, including deoxycholate, were significantly (P < 0.005) elevated in multiple polypoid adenomas and/or intramucosal carcinomas. We identified metagenomic and metabolomic markers to discriminate cases of intramucosal carcinoma from the healthy controls. Our large-cohort multi-omics data indicate that shifts in the microbiome and metabolome occur from the very early stages of the development of colorectal cancer, which is of possible etiological and diagnostic importance.
C1 [Yachida, Shinichi; Toyoda, Atsushi] Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan.
   [Yachida, Shinichi; Shiba, Satoshi; Hosoda, Fumie; Rokutan, Hirofumi; Shibata, Tatsuhiro] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan.
   [Mizutani, Sayaka; Shiroma, Hirotsugu; Watanabe, Hikaru; Masuda, Keigo; Nishimoto, Yuichiro; Kubo, Masaru; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.
   [Nakajima, Takeshi; Sakamoto, Taku; Matsumoto, Minori; Takamaru, Hiroyuki; Yamada, Masayoshi; Matsuda, Takahisa; Saito, Yutaka] Natl Canc Ctr, Endoscopy Div, Tokyo, Japan.
   [Iwasaki, Motoki; Yamaji, Taiki] Natl Canc Ctr, Epidemiol & Prevent Grp, Ctr Publ Hlth Sci, Tokyo, Japan.
   [Yachida, Tatsuo] Kagawa Univ, Dept Gastroenterol & Neurol, Fac Med, Takamatsu, Kagawa, Japan.
   [Soga, Tomoyoshi; Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Yamagata, Japan.
   [Kurokawa, Ken] Natl Inst Genet, Genome Evolut Lab, Shizuoka, Japan.
   [Toyoda, Atsushi] Natl Inst Genet, Comparat Genom Lab, Shizuoka, Japan.
   [Ogura, Yoshitoshi; Hayashi, Tetsuya] Kyushu Univ, Dept Bacteriol, Fac Med Sci, Fukuoka, Fukuoka, Japan.
   [Hatakeyama, Masanori] Univ Tokyo, Grad Sch Med, Dept Microbiol, Tokyo, Japan.
   [Nakagama, Hitoshi] Natl Canc Ctr, Tokyo, Japan.
   [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Ebina, Kanagawa, Japan.
   [Fukuda, Shinji] Univ Tsukuba, Med Res Ctr, Ibaraki, Japan.
   [Fukuda, Shinji; Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.
   [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med, Tokyo, Japan.
C3 Osaka University; National Cancer Center - Japan; Tokyo Institute of
   Technology; National Cancer Center - Japan; National Cancer Center -
   Japan; Kagawa University; Keio University; Research Organization of
   Information & Systems (ROIS); National Institute of Genetics (NIG) -
   Japan; Research Organization of Information & Systems (ROIS); National
   Institute of Genetics (NIG) - Japan; Kyushu University; University of
   Tokyo; National Cancer Center - Japan; University of Tsukuba; Japan
   Science & Technology Agency (JST); University of Tokyo
RP Yachida, S (corresponding author), Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan.; Yachida, S (corresponding author), Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan.; Yamada, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.
EM syachida@cgi.med; takuji@bio.titech.ac.jp
RI NAKAJIMA, Takeshi/HCH-0703-2022; shiba, satoshi/AAL-4953-2021; Shibata,
   Tatsuhiro/ABA-8234-2020; Shiba, Satoshi/AAJ-2157-2021; Hayashi,
   Tetsuya/ABA-1074-2020; Shibata, Tatsuhiro/AAO-1278-2021
OI Shiba, Satoshi/0000-0001-5159-5719; Yachida,
   Shinichi/0000-0001-5507-4566; NAKAJIMA, TAKESHI/0000-0002-6825-3165;
   Fukuda, Shinji/0000-0001-5161-9880; Yuichiro,
   Nishimoto/0000-0002-4522-8717; Yamada, Masayoshi/0000-0003-3979-5560
FU National Cancer Center Research and Development Fund [25-A-4, 28-A-4,
   29-A-6]; Practical Research Project for Rare/Intractable Diseases from
   the Japan Agency for Medical Research and Development (AMED)
   [JP18ek0109187, JP18jk0210009]; AMED-CREST [JP18gm0710003]; JST (Japan
   Science and Technology Agency)-PRESTO [JPMJPR1537, JPMJPR1507]; JSPS
   (Japan Society for the Promotion of Science) KAKENHI [16H04901,
   17H05654, 18H04805, 16J10135, 142558, 221S0002]; Joint Research Project
   of the Institute of Medical Science, the University of Tokyo
   [2017-2107]; Integrated Frontier Research for Medical Science Division,
   Institute for Open and Transdisciplinary Research Initiatives, Osaka
   University; Takeda Science Foundation; Suzuken Memorial Foundation
   [H25-2-11]
FX We thank all patients and their families who participated in this study,
   S. Goto for technical advice and A. Kaya, C. Shima, K. Igarashi, R.
   Usui, K. Murakami, I. Take, M. Sezawa, M. Iwahara, M. Komori, Z.
   Nakagawa, Y. Ohara and K. Kamezaki for expert technical assistance.
   Computations were partially performed on the NIG supercomputer at the
   ROIS National Institute of Genetics. This work was supported by grants
   from the National Cancer Center Research and Development Fund (25-A-4
   and 28-A-4 to S.Y., S.F and T. Yamada and 29-A-6 to T. Yamada and T.
   Shibata); Practical Research Project for Rare/Intractable Diseases from
   the Japan Agency for Medical Research and Development (AMED)
   (JP18ek0109187 to S.Y., S.M., Y.S., S.F. and T. Yamada; JP18jk0210009 to
   S.Y. and T. Shibata); AMED-CREST (JP18gm0710003 to S.Y. and T. Soga.);
   JST (Japan Science and Technology Agency)-PRESTO (JPMJPR1537 to S.F. and
   JPMJPR1507 to T. Yamada); JSPS (Japan Society for the Promotion of
   Science) KAKENHI (16H04901, 17H05654 and 18H04805 to S.F.; 16J10135,
   142558 and 221S0002 to T. Yamada); Joint Research Project of the
   Institute of Medical Science, the University of Tokyo (2017-2107 to S.Y.
   and T. Shibata); Integrated Frontier Research for Medical Science
   Division, Institute for Open and Transdisciplinary Research Initiatives,
   Osaka University (to S.Y.); the Takeda Science Foundation (to S.Y.) and
   Suzuken Memorial Foundation (H25-2-11 to S.Y.).
CR Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashktorab H, 2017, GASTROENTEROLOGY, V153, P910, DOI 10.1053/j.gastro.2017.08.018
   Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029
   Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126
   Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329
   Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911
   Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9
   Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Ding T, 2014, NATURE, V509, P357, DOI 10.1038/nature13178
   Emiola A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07240-8
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x
   Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806
   Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126
   Ito M, 2015, INT J CANCER, V137, P1258, DOI 10.1002/ijc.29488
   Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105
   Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398
   Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260
   Kononen E, 2015, CLIN MICROBIOL REV, V28, P419, DOI 10.1128/CMR.00100-14
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Liao M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17851-8
   Loubinoux J, 2002, ORAL MICROBIOL IMMUN, V17, P321, DOI 10.1034/j.1399-302X.2002.170510.x
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mishima E, 2017, KIDNEY INT, V92, P634, DOI 10.1016/j.kint.2017.02.011
   Mori H, 2018, DIGEST ENDOSC, V30, P25, DOI 10.1111/den.13042
   Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419
   Nishimoto Y, 2016, GUT, V65, P1574, DOI 10.1136/gutjnl-2016-311937
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174
   Prieto MA, 1996, J BACTERIOL, V178, P111, DOI 10.1128/jb.178.1.111-120.1996
   Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594
   Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188
   Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   SUZUKI K, 1986, J NATL CANCER I, V76, P1129
   Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865
   Teufel R, 2010, P NATL ACAD SCI USA, V107, P14390, DOI 10.1073/pnas.1005399107
   Bui TPN, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10062
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Tsugane S, 2014, JPN J CLIN ONCOL, V44, P777, DOI 10.1093/jjco/hyu096
   Vandeputte D, 2017, NATURE, V551, P507, DOI 10.1038/nature24460
   Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542
   Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015
   Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yarza P, 2014, NAT REV MICROBIOL, V12, P635, DOI 10.1038/nrmicro3330
   Yarza P, 2010, SYST APPL MICROBIOL, V33, P291, DOI 10.1016/j.syapm.2010.08.001
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   ZARLING EJ, 1987, J LAB CLIN MED, V109, P566
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 60
TC 360
Z9 381
U1 38
U2 296
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JUN
PY 2019
VL 25
IS 6
BP 968
EP +
DI 10.1038/s41591-019-0458-7
PG 27
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA IC3FK
UT WOS:000470844400029
PM 31171880
OA Green Published
DA 2022-11-22
ER

PT J
AU Zou, SM
   Fang, LK
   Lee, MH
AF Zou, Shaomin
   Fang, Lekun
   Lee, Mong-Hong
TI Dysbiosis of gut microbiota in promoting the development of colorectal
   cancer
SO GASTROENTEROLOGY REPORT
LA English
DT Review
DE gut microbiota; microbiome dysbiosis; colorectal cancer; tumorigenesis
ID CYTOLETHAL-DISTENDING TOXIN; HUMAN COLON-CANCER; ENTEROTOXIGENIC
   BACTEROIDES-FRAGILIS; URSODEOXYCHOLIC ACID UDCA; TOLL-LIKE RECEPTORS;
   BILE-ACIDS; FUSOBACTERIUM-NUCLEATUM; DEOXYCHOLIC-ACID; ESCHERICHIA-COLI;
   EPITHELIAL-CELLS
AB Gastrointestinal microbiome, containing at least 100 trillion bacteria, resides in the mucosal surface of human intestine. Recent studies show that perturbations in the microbiota may influence physiology and link to a number of diseases, including colon tumorigenesis. Colorectal cancer (CRC), the third most common cancer, is the disease resulting from multi-genes and multi-factors, but the mechanistic details between gut microenvironment and CRC remain poorly characterized. Thanks to new technologies such as metagenome sequencing, progress in large-scale analysis of the genetic and metabolic profile of gut microbial has been possible, which has facilitated studies about microbiota composition, taxonomic alterations and host interactions. Different bacterial species and their metabolites play critical roles in the development of CRC. Also, microbiota is important in the inflammatory response and immune processes deregulation during the development and progression of CRC. This review summarizes current studies regarding the association between gastrointestinal microbiota and the development of CRC, which provides insights into the therapeutic strategy of CRC.
C1 [Zou, Shaomin; Fang, Lekun; Lee, Mong-Hong] Sun Yat Sen Univ, Res Inst Gastroenterol, Guangzhou 510020, Guangdong, Peoples R China.
   [Zou, Shaomin; Fang, Lekun; Lee, Mong-Hong] Sun Yat Sen Univ, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Affiliated Hosp 6, Guangzhou 510020, Guangdong, Peoples R China.
C3 Sun Yat Sen University; Sun Yat Sen University
RP Lee, MH (corresponding author), Sun Yat Sen Univ, Res Inst Gastroenterol, Affiliated Hosp 6, 26 Yuanchun Er Heng Rd, Guangzhou 510020, Guangdong, Peoples R China.
EM limh33@mail.sysu.edu.cn
RI Fang, Lekun/Q-2345-2015
OI Fang, Lekun/0000-0002-0296-292X
CR Abdel-Latif MM, 2016, EUR J CANCER PREV, V25, P368, DOI 10.1097/CEJ.0000000000000198
   Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001
   Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   Akin H, 2014, J CLIN GASTROENTEROL, V48, pS67, DOI 10.1097/MCG.0000000000000252
   Ambalam P, 2016, BEST PRACT RES CL GA, V30, P119, DOI 10.1016/j.bpg.2016.02.009
   Annacker O, 2000, J IMMUNOL, V164, P3573, DOI 10.4049/jimmunol.164.7.3573
   Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724
   Arthur JC, 2013, GUT MICROBES, V4, P253, DOI 10.4161/gmic.24220
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Augenlicht LH, 2002, J NUTR, V132, p3804S, DOI 10.1093/jn/132.12.3804S
   Bae S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835
   Baek MK, 2010, CANCER LETT, V290, P123, DOI 10.1016/j.canlet.2009.08.030
   Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x
   Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38
   Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20
   Belcheva A, 2015, BIOESSAYS, V37, P403, DOI 10.1002/bies.201400204
   Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051
   Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011
   Bernstein AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135959
   Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091
   Boccellato F, 2015, CELL HOST MICROBE, V17, P728, DOI 10.1016/j.chom.2015.05.016
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343
   Boonanantanasarn K, 2012, INFECT IMMUN, V80, P3545, DOI 10.1128/IAI.00479-12
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Bultman SJ, 2014, CELL HOST MICROBE, V16, P143, DOI 10.1016/j.chom.2014.07.011
   Butel MJ, 2014, MED MALADIES INFECT, V44, P1, DOI 10.1016/j.medmal.2013.10.002
   Byrne AM, 2010, CARCINOGENESIS, V31, P737, DOI 10.1093/carcin/bgq011
   Cani PD, 2016, NAT REV ENDOCRINOL, V12, P133, DOI 10.1038/nrendo.2015.211
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Centuori SM, 2016, BBA-MOL CELL BIOL L, V1861, P663, DOI 10.1016/j.bbalip.2016.04.006
   Centuori SM, 2014, DIGEST DIS SCI, V59, P2367, DOI 10.1007/s10620-014-3190-7
   Chen CC, 2012, BRIT J NUTR, V107, P1623, DOI 10.1017/S0007114511004934
   Chen GY, 2011, J IMMUNOL, V186, P7187, DOI 10.4049/jimmunol.1100412
   Chen WQ, 2015, CHINESE J CANCER RES, V27, P2, DOI 10.3978/j.issn.1000-9604.2015.01.06
   Cheng KR, 2002, BBA-MOL BASIS DIS, V1588, P48, DOI 10.1016/S0925-4439(02)00115-1
   Ciorba MA, 2012, GUT, V61, P829, DOI 10.1136/gutjnl-2011-300367
   Claesson MH, 1999, J IMMUNOL, V162, P3702
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004
   Dong L, 2012, J GASTROEN HEPATOL, V27, P110, DOI 10.1111/j.1440-1746.2011.06839.x
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Dulal S, 2014, CANCER J, V20, P225, DOI 10.1097/PPO.0000000000000050
   Duparc T, 2017, GUT, V66, P620, DOI 10.1136/gutjnl-2015-310904
   EARNEST DL, 1994, CANCER RES, V54, P5071
   Epplein M, 2013, CANCER EPIDEM BIOMAR, V22, P1964, DOI 10.1158/1055-9965.EPI-13-0702
   Erdman SE, 2015, BBA-REV CANCER, V1856, P86, DOI 10.1016/j.bbcan.2015.05.007
   Evrard B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018735
   Faith JJ, 2013, SCIENCE, V341, P44, DOI 10.1126/science.1237439
   Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760
   Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x
   Farhana L, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0439-4
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Fung KYC, 2011, J PROTEOME RES, V10, P1860, DOI 10.1021/pr1011125
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gamallat Y, 2016, BIOMED PHARMACOTHER, V83, P536, DOI 10.1016/j.biopha.2016.07.001
   Ge ZM, 2008, CELL MICROBIOL, V10, P1599, DOI 10.1111/j.1462-5822.2008.01173.x
   Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x
   Ge ZM, 2005, INFECT IMMUN, V73, P3559, DOI 10.1128/IAI.73.6.3559-3567.2005
   Geis AL, 2015, CANCER DISCOV, V5, P1098, DOI 10.1158/2159-8290.CD-15-0447
   Lopes JAG, 2016, WORLD J HEPATOL, V8, P162, DOI 10.4254/wjh.v8.i3.162
   Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Ha Yun-Hyung, 2010, J Korean Soc Coloproctol, V26, P254, DOI 10.3393/jksc.2010.26.4.254
   Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639
   He Q, 2016, APPL MICROBIOL BIOT, V100, P4485, DOI 10.1007/s00253-015-7205-x
   He X, 2012, ANN ONCOL, V23, P1771, DOI 10.1093/annonc/mdr534
   He XX, 2011, ANN ONCOL, V22, P2640, DOI 10.1093/annonc/mdr020
   Hester CM, 2015, WORLD J GASTROENTERO, V21, P2759, DOI 10.3748/wjg.v21.i9.2759
   Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006
   Holton John, 2008, Curr Infect Dis Rep, V10, P99, DOI 10.1007/s11908-008-0018-7
   Huang JY, 2011, ANAEROBE, V17, P137, DOI 10.1016/j.anaerobe.2011.05.017
   Barrasa JI, 2011, APOPTOSIS, V16, P1054, DOI 10.1007/s10495-011-0633-x
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Im E, 2004, J NUTR, V134, P483, DOI 10.1093/jn/134.2.483
   Inan MS, 2000, GASTROENTEROLOGY, V118, P724, DOI 10.1016/S0016-5085(00)70142-9
   Keku TO, 2013, TRENDS MICROBIOL, V21, P506, DOI 10.1016/j.tim.2013.08.004
   Khare S, 2003, CANCER RES, V63, P3517
   Khare S, 2008, NUTR CANCER, V60, P389, DOI 10.1080/01635580701883003
   Kim Y, 2008, ARCH PHARM RES, V31, P468, DOI 10.1007/s12272-001-1180-y
   Kocarnik JM, 2015, GASTROENTEROL REP, V3, P269, DOI 10.1093/gastro/gov046
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kong Y, 2012, INT J BIOCHEM CELL B, V44, P2321, DOI 10.1016/j.biocel.2012.08.006
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025
   Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60
   Kummen M, 2017, GUT, V66, P611, DOI 10.1136/gutjnl-2015-310500
   Kuugbee ED, 2016, DIGEST DIS SCI, V61, P2908, DOI 10.1007/s10620-016-4238-7
   Lee HY, 2010, INT J ONCOL, V36, P941, DOI 10.3892/ijo_00000573
   Lee SH, 2010, NAT MED, V16, P665, DOI 10.1038/nm.2143
   Leung A, 2015, EXPERT REV GASTROENT, V9, P651, DOI 10.1586/17474124.2015.1001745
   Li TG, 2015, CURR OPIN GASTROEN, V31, P159, DOI 10.1097/MOG.0000000000000156
   Li Y, 2015, INT J CLIN EXP MED, V8, P5310
   Liu D, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003342
   Loddo I, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00551
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11
   Lowe EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013027
   Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990
   Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nazareth N, 2015, MED MICROBIOL IMMUN, V204, P681, DOI 10.1007/s00430-015-0420-3
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   O'Neill AM, 2016, NUTR RES, V36, P1325, DOI 10.1016/j.nutres.2016.10.005
   O'Neill LAJ, 2013, NAT REV IMMUNOL, V13, P453, DOI 10.1038/nri3446
   Orberg ET, 2017, MUCOSAL IMMUNOL, V10, P421, DOI 10.1038/mi.2016.53
   Orlich MJ, 2015, JAMA INTERN MED, V175, P767, DOI 10.1001/jamainternmed.2015.59
   Peuker K, 2016, NAT MED, V22, P506, DOI 10.1038/nm.4072
   Pratt JS, 2006, INFECT IMMUN, V74, P4496, DOI 10.1128/IAI.00503-06
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010
   Reimers MS, 2013, GASTROENTEROL REP, V1, P166, DOI 10.1093/gastro/got022
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Robizadeh S, 2007, INFLAMM BOWEL DIS, V13, P1475, DOI 10.1002/ibd.20265
   Rodriguez-Cabezas ME, 2002, J NUTR, V132, P3263, DOI 10.1093/jn/132.11.3263
   Roncucci L, 2015, EUR J INTERN MED, V26, P752, DOI 10.1016/j.ejim.2015.08.019
   Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002
   Ryz NR, 2012, AM J PHYSIOL-GASTR L, V303, pG1299, DOI 10.1152/ajpgi.00320.2012
   Savari S, 2014, WORLD J GASTROENTERO, V20, P968, DOI 10.3748/wjg.v20.i4.968
   Scatena R, 2008, PPAR RES, V2008, DOI 10.1155/2008/256251
   Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Selmin OI, 2016, J NUTR, V146, P236, DOI 10.3945/jn.115.216580
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Singh PP, 2015, GASTROENTEROL REP, V3, P289, DOI 10.1093/gastro/gov053
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Snyder A, 2015, SCIENCE, V350, P1031, DOI 10.1126/science.aad7706
   Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903
   Strauss J, 2011, INFLAMM BOWEL DIS, V17, P1971, DOI 10.1002/ibd.21606
   Taieb Frederic, 2016, EcoSal Plus, V7, DOI 10.1128/ecosalplus.ESP-0008-2016
   Tang WHW, 2014, J CLIN INVEST, V124, P4204, DOI 10.1172/JCI72331
   Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400
   TAUROG JD, 1994, J EXP MED, V180, P2359, DOI 10.1084/jem.180.6.2359
   Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003
   Todoric J, 2016, CANCER PREV RES, V9, P895, DOI 10.1158/1940-6207.CAPR-16-0209
   Tong LC, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00253
   Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262
   Tsilimigras MCB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.8
   Uchiyama K, 2016, SCI REP-UK, V6, DOI 10.1038/srep32094
   van Helden SFG, 2010, J IMMUNOL, V184, P1280, DOI 10.4049/jimmunol.0900764
   Vander Heiden MG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001210
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Wali RK, 2002, CANCER EPIDEM BIOMAR, V11, P1653
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Wang AC, 2009, EUR J CLIN INVEST, V39, P157, DOI 10.1111/j.1365-2362.2008.02070.x
   Wang EL, 2010, BRIT J CANCER, V102, P908, DOI 10.1038/sj.bjc.6605558
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353
   Xu R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S4
   Yesudhas D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00334
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yu YN, 2015, GASTROINTEST TUMORS, V2, P26, DOI 10.1159/000380892
   Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229
NR 165
TC 109
Z9 111
U1 4
U2 38
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2052-0034
J9 GASTROENTEROL REP
JI Gastroenterol. Rep.
PD FEB
PY 2018
VL 6
IS 1
BP 1
EP 12
DI 10.1093/gastro/gox031
PG 12
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA GC7RV
UT WOS:000429991500001
PM 29479437
OA Green Published, gold, Green Submitted
DA 2022-11-22
ER

PT J
AU Li, J
   Li, JT
   Lyu, N
   Ma, Y
   Liu, F
   Feng, YQ
   Yao, L
   Hou, ZY
   Song, XF
   Zhao, HC
   Li, XY
   Wang, YD
   Xiao, C
   Zhu, BL
AF Li, Jing
   Li, Jingtao
   Lyu, Na
   Ma, Yue
   Liu, Fei
   Feng, Yuqing
   Yao, Li
   Hou, Zhiyong
   Song, Xiaofeng
   Zhao, Hongchuan
   Li, Xiaoya
   Wang, Yingdian
   Xiao, Cheng
   Zhu, Baoli
TI Composition of fecal microbiota in low-set rectal cancer patients
   treated with FOLFOX
SO THERAPEUTIC ADVANCES IN CHRONIC DISEASE
LA English
DT Article
DE chemotherapy; FOLFOX treatment; gut microbiota; low-set rectal cancer;
   metagenomic sequencing analysis
ID HUMAN GUT MICROBIOME; COLORECTAL-CANCER; SOLOBACTERIUM-MOOREI;
   INTESTINAL MICROBIOTA; 1ST-LINE TREATMENT; BACTERIA; FLUOROURACIL;
   SUSCEPTIBILITY; METABOLISM; DIVERSITY
AB Background:
   FOLFOX treatment is a method used widely to reduce tumor size in low-set rectal cancer, with variable clinical results. FOLFOX agents comprise a mixture of oxaliplatin and 5-fluorouracil, the efficacy of which might be modulated by the gut microbiome in humans. This study aimed to determine whether the bowel microbiota is a factor that influences FOLFOX treatment.
   Methods:
   To investigate the role of gut microbiota during FOLFOX treatment, we carried out comprehensive metagenomic and metabolomic analyses on 62 fecal samples collected from 37 low-set rectal cancer patients. A set of 31 samples was collected before the patients underwent treatment; another 31 samples were obtained after the treatment was completed. Among these samples, 50 were paired samples collected before and after FOLFOX treatment. The patients were divided into responder and nonresponder groups according to the treatment outcome. Metagenomic sequencing was performed on these fecal samples. Diverse bacterial taxa were identified by MetaGeneMark, Soapaligner, and DIAMOND; microbiotal data analyses were carried out in the R environment. Differences in microbial taxa and metagenomic linkage groups were observed in multiple comparative analyses.
   Results:
   The gut microbiota was altered after treatment. Compared with before treatment, the changes in bacterial diversity and microbiotal composition after treatment were more apparent in the responder group than in the nonresponder group. Bacterial species analysis revealed a group of gut bacteria in multiple comparisons, with a group of eight specific species being associated with the outcome of FOLFOX treatment. Responders and nonresponders before treatment were clearly separated based on this bacterial subset. Finally, the metagenomic linkage group network and metabolomic analyses based on the genomic data confirmed a more significant change in the gut microbiota during FOLFOX treatment in the responder group than in the nonresponder group.
   Conclusions:
   Overall, our results describe a dynamic process of gut microbiotal changes from the start to the end of FOLFOX treatment, and verified a close relationship between microbiota and treatment outcome. Recognition of the significance of microbiotal intervention before FOLFOX treatment for low-set rectal cancer may improve the effects of these agents.
C1 [Li, Jing; Wang, Yingdian] Beijing Normal Univ, Coll Life Sci, Beijing, Peoples R China.
   [Li, Jing; Lyu, Na; Ma, Yue; Liu, Fei; Feng, Yuqing; Song, Xiaofeng; Zhu, Baoli] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol, Beijing 100101, Peoples R China.
   [Yao, Li; Hou, Zhiyong] China Japan Friendship Hosp, Dept Surg, Beijing, Peoples R China.
   [Li, Jingtao; Zhao, Hongchuan] China Japan Friendship Hosp, Dept Gastroenterol, Beijing 100029, Peoples R China.
   [Li, Xiaoya; Xiao, Cheng] China Japan Friendship Hosp, Inst Clin Med, Beijing 100029, Peoples R China.
   [Li, Xiaoya] Chinese Acad Med Sci & Peking Union Med Coll, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China.
C3 Beijing Normal University; Chinese Academy of Sciences; Institute of
   Microbiology, CAS; China-Japan Friendship Hospital; China-Japan
   Friendship Hospital; China-Japan Friendship Hospital; Chinese Academy of
   Medical Sciences - Peking Union Medical College; Peking Union Medical
   College
RP Zhu, BL (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Zhu, BL (corresponding author), Beijing Key Lab Antimicrobial Resistance & Pathog, Beijing, Peoples R China.; Zhu, BL (corresponding author), Southwest Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Luzhou, Sichuan, Peoples R China.; Zhu, BL (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol, Beijing 100101, Peoples R China.; Li, JT (corresponding author), China Japan Friendship Hosp, Dept Gastroenterol, Beijing 100029, Peoples R China.; Xiao, C (corresponding author), China Japan Friendship Hosp, Inst Clin Med, Beijing 100029, Peoples R China.; Xiao, C (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China.
EM lijingtao@zryhyy.com.cn; xc2002812@126.com; zhubaoli@im.ac.cn
RI Xiao, Cheng/AAM-7764-2020; Feng, Yuqing/M-1589-2019; Song,
   Xiaofeng/AAP-4087-2020
OI Feng, Yuqing/0000-0002-7742-5272; Song, Xiaofeng/0000-0002-6789-6820;
   liu, fei/0000-0003-1175-4070; Ma, Yue/0000-0001-8989-2786
FU China-Japan Friendship Hospital Research Funding [2016-1-MS-5]; Beijing
   Municipal Natural Science Foundation [5174037]; Major State Basic
   Research Development Program [2015CB554200]; National High Technology
   Research and Development Program [2014AA020801]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and publication of this article: This study
   was partially supported by the China-Japan Friendship Hospital Research
   Funding (2016-1-MS-5), Beijing Municipal Natural Science Foundation
   (5174037), Major State Basic Research Development Program
   (2015CB554200), and National High Technology Research and Development
   Program (2014AA020801).
CR Andrade-Navarro MA, 2014, PLOS ONE, V9, P6
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]
   BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Calinski T., 1974, COMMUN STAT, V3, P1, DOI [DOI 10.1080/03610927408827101, 10.1080/03610927408827101]
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   CHAO A, 1984, SCAND J STAT, V11, P265
   Coker OO, 2018, GUT, V67, P1024, DOI 10.1136/gutjnl-2017-314281
   Deng XM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01607
   Dingemanse C, 2015, CARCINOGENESIS, V36, P1388, DOI 10.1093/carcin/bgv120
   Douillard JY, 2000, LANCET, V355, P1041, DOI 10.1016/S0140-6736(00)02034-1
   Drewes JL, 2016, BRIT J CANCER, V115, P273, DOI 10.1038/bjc.2016.189
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Ferreira RM, 2018, GUT, V67, P226, DOI 10.1136/gutjnl-2017-314205
   Finegold SM, 2004, J CLIN MICROBIOL, V42, P5298, DOI 10.1128/JCM.42.11.5298-5301.2004
   Fujii R, 2009, ORAL MICROBIOL IMMUN, V24, P502, DOI 10.1111/j.1399-302X.2009.00534.x
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Giacchetti S, 2000, J CLIN ONCOL, V18, P136, DOI 10.1200/JCO.2000.18.1.136
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109
   Herran AR, 2017, RES MICROBIOL, V168, P673, DOI 10.1016/j.resmic.2017.04.008
   Huang MJ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009394
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Jobin C, 2017, GASTROENTEROLOGY, V153, P1475, DOI 10.1053/j.gastro.2017.10.030
   Johnston PG, 2001, ANTI-CANCER DRUG, V12, P639, DOI 10.1097/00001813-200109000-00001
   Kageyama A, 2000, MICROBIOL IMMUNOL, V44, P223, DOI 10.1111/j.1348-0421.2000.tb02487.x
   Karisson F. H., 2013, NATURE, V498, P99, DOI 10.1038/nature
   Koehne CH, 1999, ANN ONCOL, V10, P877, DOI 10.1023/A:1008348904180
   Kong C, 2018, INT J SURG-ONCOL, V3, DOI 10.1097/IJ9.0000000000000051
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kozovska Z, 2014, BIOMED PHARMACOTHER, V68, P911, DOI 10.1016/j.biopha.2014.10.019
   LABIANCA R, 1995, LANCET, V345, P939
   Lau SKP, 2006, J CLIN MICROBIOL, V44, P3031, DOI 10.1128/JCM.00555-06
   Li J, 2017, MICROBIOME, V5, DOI 10.1186/s40168-016-0222-x
   Liang QY, 2017, CLIN CANCER RES, V23, P2061, DOI 10.1158/1078-0432.CCR-16-1599
   Lin Y, 2016, ONCOTARGET, V7, P11
   Liu JZ, 2018, INT J CLIN EXP PATHO, V11, P2214
   Martin Claire A, 2007, J Med Case Rep, V1, P40, DOI 10.1186/1752-1947-1-40
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   National Comprehensive Cancer Network, RECT CANC VERS 1 201
   O'Donnell PH, 2009, CLIN CANCER RES, V15, P4806, DOI 10.1158/1078-0432.CCR-09-0344
   Offer SM, 2016, J CLIN ONCOL, V34, P205, DOI 10.1200/JCO.2015.64.2546
   Pedersen RM, 2011, J CLIN MICROBIOL, V49, P2766, DOI 10.1128/JCM.02525-10
   Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Ryffel B, 2013, PLOS ONE, V8, pe74963
   Santacruz A, 2010, BRIT J NUTR, V104, P83, DOI 10.1017/S0007114510000176
   Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610
   Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040
   Segre JA, 2015, SCIENCE, V349, P1058, DOI 10.1126/science.aad0781
   Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725
   Pham TT, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3449-4
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Wang JF, 2018, GUT, V67, P1614, DOI 10.1136/gutjnl-2018-315988
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
   Zhao HL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05267-3
   Zheng GL, 2010, J CLIN MICROBIOL, V48, P873, DOI 10.1128/JCM.01381-09
NR 75
TC 5
Z9 6
U1 2
U2 16
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 2040-6223
EI 2040-6231
J9 THER ADV CHRONIC DIS
JI Ther. Adv. Chronic Dis.
PD FEB
PY 2020
VL 11
AR 2040622320904293
DI 10.1177/2040622320904293
PG 17
WC Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Pharmacology & Pharmacy
GA KR3NA
UT WOS:000517523900001
PM 32153743
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Yang, YZ
   Du, LT
   Shi, DB
   Kong, C
   Liu, JQ
   Liu, G
   Li, XX
   Ma, YL
AF Yang, Yongzhi
   Du, Lutao
   Shi, Debing
   Kong, Cheng
   Liu, Jianqiang
   Liu, Guang
   Li, Xinxiang
   Ma, Yanlei
TI Dysbiosis of human gut microbiome in young-onset colorectal cancer
SO NATURE COMMUNICATIONS
LA English
DT Article
ID OCCULT BLOOD-TEST; TASK-FORCE; INTESTINAL PERMEABILITY;
   SCREENING-PROGRAM; SENSITIVITY; TESTS; COLON
AB The incidence of young-onset sporadic colorectal cancer (yCRC) is rapidly rising and frequently associated with an aggressive disease. Here the authors show that gut microbial diversity is increased in patients with yCRC compared to old-onset CRC and that fecal microbial markers could be used to detect individuals with yCRC.
   The incidence of sporadic young-onset colorectal cancer (yCRC) is increasing. A significant knowledge gap exists in the gut microbiota and its diagnostic value for yCRC patients. Through 16S rRNA gene sequencing, 728 samples are collected to identify microbial markers, and an independent cohort of 310 samples is used to validate the results. Furthermore, species-level and functional analysis are performed by metagenome sequencing using 200 samples. Gut microbial diversity is increased in yCRC. Flavonifractor plautii is an important bacterial species in yCRC, while genus Streptococcus contains the key phylotype in the old-onset colorectal cancer. Functional analysis reveals that yCRC has unique characteristics of bacterial metabolism characterized by the dominance of DNA binding and RNA-dependent DNA biosynthetic process. The random forest classifier model achieves a powerful classification potential. This study highlights the potential of the gut microbiota biomarkers as a promising non-invasive tool for the accurate detection and distinction of individuals with yCRC.
C1 [Yang, Yongzhi; Shi, Debing; Li, Xinxiang; Ma, Yanlei] Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China.
   [Yang, Yongzhi; Shi, Debing; Li, Xinxiang; Ma, Yanlei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.
   [Du, Lutao] Shandong Univ, Hosp 2, Dept Clin Lab, Jinan 250033, Shandong, Peoples R China.
   [Kong, Cheng] Tongji Univ, Shanghai Peoples Hosp 10, Dept GI Surg, Shanghai, Peoples R China.
   [Liu, Jianqiang] Fudan Univ, Shanghai Canc Ctr, Dept Endoscopy, Shanghai, Peoples R China.
   [Liu, Guang] Quantum Hitech Microecol Med Guangdong Co Ltd, Guangzhou, Peoples R China.
C3 Fudan University; Fudan University; Shandong University; Tongji
   University; Fudan University
RP Ma, YL (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Colorectal Surg, Shanghai, Peoples R China.; Ma, YL (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.
EM yanleima@fudan.edu.cn
FU National Natural Science Foundation of China [81920108026, 81871964,
   81802412]; National Ten Thousand Plan Young Top Talents; Shanghai Young
   Top Talents [QNBJ1701]; Shanghai Science and Technology Development Fund
   [19410713300]; Shanghai Sailing Program [18YF1414900]; CSCO-Roche Tumor
   Research Fund [Y-2019Roche-079]; Fudan University Excellence 2025 Talent
   Cultivation Plan
FX The authors take this opportunity to thank all of the participating
   patients and healthy volunteers for supporting this study by donating
   the precious samples used in this research. This work was supported by
   grants from the National Natural Science Foundation of China (Nos.
   81920108026 and 81871964 for Y.M.; 81802412 for Y.Y.), the National Ten
   Thousand Plan Young Top Talents (for Y.M.), the Shanghai Young Top
   Talents (No. QNBJ1701 for for Y.M.), the Shanghai Science and Technology
   Development Fund (No. 19410713300 for for Y.M.), the Shanghai Sailing
   Program (No. 18YF1414900 for Y.Y.), the CSCO-Roche Tumor Research Fund
   (No. Y-2019Roche-079 for for Y.M.) and the Fudan University Excellence
   2025 Talent Cultivation Plan (for Y.M. and Y.Y.).
CR Afra K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-264
   Ahmadi S, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.132055
   Bailey CE, 2015, JAMA SURG, V150, P17, DOI 10.1001/jamasurg.2014.1756
   Bailey SER, 2021, BRIT J CANCER, V124, P1231, DOI 10.1038/s41416-020-01221-9
   Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2564, DOI 10.1001/jama.2016.5989
   Bowerman KL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19701-0
   Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6
   Buford TW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0296-0
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Cani PD, 2017, SCIENCE, V357, P548, DOI 10.1126/science.aao2202
   Chang GJ, 2020, JNCI-J NATL CANCER I, V112, P1170, DOI 10.1093/jnci/djaa019
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   DeJong EN, 2020, CELL HOST MICROBE, V28, P180, DOI 10.1016/j.chom.2020.07.013
   Demb J, 2021, GUT, V70, P1529, DOI 10.1136/gutjnl-2020-321849
   Devaraj S, 2013, CLIN CHEM, V59, P617, DOI 10.1373/clinchem.2012.187617
   Dharwadkar P, 2021, CLIN GASTROENTEROL H, V19, P192, DOI 10.1016/j.cgh.2019.10.028
   Duran-Sanchon S, 2020, GASTROENTEROLOGY, V158, P947, DOI 10.1053/j.gastro.2019.10.005
   Elsafi SH, 2015, CLIN EXP GASTROENTER, V8, P279, DOI 10.2147/CEG.S86419
   Franceschi C, 2018, NAT REV ENDOCRINOL, V14, P576, DOI 10.1038/s41574-018-0059-4
   Gupta A, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00438-19
   Hewitson P, 2008, AM J GASTROENTEROL, V103, P1541, DOI 10.1111/j.1572-0241.2008.01875.x
   Hofseth LJ, 2020, NAT REV GASTRO HEPAT, V17, P352, DOI 10.1038/s41575-019-0253-4
   Imperiale TF, 2019, ANN INTERN MED, V170, P319, DOI 10.7326/M18-2390
   Jeffery IB, 2016, ISME J, V10, P170, DOI 10.1038/ismej.2015.88
   Karl JP, 2017, AM J PHYSIOL-GASTR L, V312, pG559, DOI 10.1152/ajpgi.00066.2017
   Kim M, 2020, MBIO, V11, DOI 10.1128/mBio.03186-19
   Kwong TNY, 2018, GASTROENTEROLOGY, V155, P383, DOI 10.1053/j.gastro.2018.04.028
   Ladabaum U, 2020, GASTROENTEROLOGY, V158, P418, DOI 10.1053/j.gastro.2019.06.043
   Ladabaum U, 2019, GASTROENTEROLOGY, V157, P137, DOI 10.1053/j.gastro.2019.03.023
   Lang S, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1785251
   Lavelle A, 2015, GUT, V64, P1553, DOI 10.1136/gutjnl-2014-307873
   Lohsiriwat V, 2014, ASIAN PAC J CANCER P, V15, P7981, DOI 10.7314/APJCP.2014.15.18.7981
   Lui RN, 2019, CANCER EPIDEM BIOMAR, V28, P1275, DOI [10.1158/1055-9965.EPI-18-1111, 10.1158/1055-9965.epi-18-1111]
   Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771
   Murphy CC, 2019, GASTROENTEROLOGY, V156, P958, DOI [10.1053/j.gastro.2018.11.060, 10.1053/j.gastro.2018.08.063]
   Murphy CC, 2018, GASTROENTEROLOGY, V155, P1716, DOI 10.1053/j.gastro.2018.07.045
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nieuwdorp M, 2014, GASTROENTEROLOGY, V146, P1525, DOI 10.1053/j.gastro.2014.02.008
   O'Toole PW, 2015, SCIENCE, V350, P1214, DOI 10.1126/science.aac8469
   Ogita T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00379
   Ramdzan AR, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2466
   Redwood D, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130281
   Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084
   Robertson DJ, 2017, GASTROENTEROLOGY, V152, P1217, DOI 10.1053/j.gastro.2016.08.053
   Salazar N, 2017, GUT MICROBES, V8, P82, DOI 10.1080/19490976.2016.1256525
   Scott KP, 2014, FEMS MICROBIOL ECOL, V87, P30, DOI 10.1111/1574-6941.12186
   Selby K, 2019, GASTROENTEROLOGY, V157, P1494, DOI 10.1053/j.gastro.2019.08.023
   Shapiro JA, 2017, AM J GASTROENTEROL, V112, P1728, DOI 10.1038/ajg.2017.285
   Stoffel EM, 2020, GASTROENTEROLOGY, V158, P341, DOI 10.1053/j.gastro.2019.07.055
   Sung JJY, 2019, AM J GASTROENTEROL, V114, P322, DOI 10.14309/ajg.0000000000000133
   Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Tinmouth J, 2015, GUT, V64, P1327, DOI 10.1136/gutjnl-2014-308074
   Toes-Zoutendijk E, 2017, GASTROENTEROLOGY, V152, P767, DOI 10.1053/j.gastro.2016.11.022
   Vuik FER, 2019, GUT, V68, P1820, DOI 10.1136/gutjnl-2018-317592
   Wei YR, 2020, GUT, V69, P569, DOI 10.1136/gutjnl-2018-317836
   Werner S, 2016, CLIN CANCER RES, V22, P1725, DOI 10.1158/1078-0432.CCR-15-1268
   Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457
   Wong HK, 2019, GASTROENTEROLOGY, V156, P291, DOI 10.1053/j.gastro.2018.07.059
   Wu SR, 2018, CANCER RES, V78, P4549, DOI 10.1158/0008-5472.CAN-17-4047
   Yang GH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20974-2
   Yeasmin F, 2013, Bangladesh Med Res Counc Bull, V39, P52
   Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11
NR 64
TC 11
Z9 11
U1 13
U2 31
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD NOV 19
PY 2021
VL 12
IS 1
AR 6757
DI 10.1038/s41467-021-27112-y
PG 13
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA XA5JJ
UT WOS:000720682600021
PM 34799562
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Rajagopala, SV
   Vashee, S
   Oldfield, LM
   Suzuki, Y
   Venter, JC
   Telenti, A
   Nelson, KE
AF Rajagopala, Seesandra V.
   Vashee, Sanjay
   Oldfield, Lauren M.
   Suzuki, Yo
   Venter, J. Craig
   Telenti, Amalio
   Nelson, Karen E.
TI The Human Microbiome and Cancer
SO CANCER PREVENTION RESEARCH
LA English
DT Review
ID HELICOBACTER-PYLORI INFECTION; TOLL-LIKE RECEPTOR-3; HUMAN GUT
   MICROBIOME; FUSOBACTERIUM-NUCLEATUM; COLORECTAL-CANCER; INTESTINAL
   MICROBIOTA; COMMENSAL MICROBIOTA; COLON CARCINOGENESIS; MOUSE MODEL;
   INFLAMMATION
AB Recent scientific advances have significantly contributed to our understanding of the complex connection between the microbiome and cancer. Our bodies are continuously exposed to microbial cells, both resident and transient, as well as their byproducts, including toxic metabolites. Circulation of toxic metabolites may contribute to cancer onset or progression at locations distant from where a particular microbe resides. Moreover, microbes may migrate to other locations in the human body and become associated with tumor development. Several case-control metagenomics studies suggest that dysbiosis in the commensal microbiota is also associated with inflammatory disorders and various cancer types throughout the body. Although the microbiome influences carcinogenesis through mechanisms independent of inflammation and immune system, the most recognizable link is between the microbiome and cancer via the immune system, as the resident microbiota plays an essential role in activating, training, and modulating the host immune response. Immunologic dysregulation is likely to provide mechanistic explanations as to how our microbiome influences cancer development and cancer therapies. In this review, we discuss recent developments in understanding the human gut microbiome's relationship with cancer and the feasibility of developing novel cancer diagnostics based onmicrobiome profiles. (C) 2017 AACR.
C1 [Rajagopala, Seesandra V.; Vashee, Sanjay; Oldfield, Lauren M.; Suzuki, Yo; Venter, J. Craig; Telenti, Amalio; Nelson, Karen E.] JCVI, Rockville, MD USA.
   [Venter, J. Craig; Telenti, Amalio; Nelson, Karen E.] Human Longev Inc, San Diego, CA USA.
C3 J. Craig Venter Institute
RP Nelson, KE (corresponding author), J Craig Venter Inst, San Diego, CA 92130 USA.
EM Kenelson@jcvi.org
RI Telenti, Amalio/AAY-1674-2021
OI Rajagopala, Seesandra/0000-0001-7176-5770
FU Hyundai Motor America and Hyundai Hope on Wheels; J. Craig Venter
   Institute
FX S.V. Rajagopala was funded by Hyundai Motor America and Hyundai Hope on
   Wheels and K. E. Nelson by the J. Craig Venter Institute.
CR Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Anderton E, 2008, ONCOGENE, V27, P421, DOI 10.1038/sj.onc.1210668
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Belcheva A, 2014, CELL, V158, P288, DOI 10.1016/j.cell.2014.04.051
   Bergstrom K, 2016, GASTROENTEROLOGY, V151, P152, DOI 10.1053/j.gastro.2016.03.039
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chen GY, 2008, CANCER RES, V68, P10060, DOI 10.1158/0008-5472.CAN-08-2061
   Columpsi P, 2016, J MED VIROL, V88, P1467, DOI 10.1002/jmv.24508
   Machado AMD, 2009, CLIN CANCER RES, V15, P2995, DOI 10.1158/1078-0432.CCR-08-2686
   Dapito DH, 2012, CANCER CELL, V21, P504, DOI 10.1016/j.ccr.2012.02.007
   de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Dove WF, 1997, CANCER RES, V57, P812
   Dowd JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064921
   Fernandez-Garcia B, 2014, J IMMUNOTHER, V37, P77, DOI 10.1097/CJI.0000000000000016
   Gall A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129055
   Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Greenfield LK, 2013, TRENDS MICROBIOL, V21, P602, DOI 10.1016/j.tim.2013.09.004
   Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465
   Guidi R, 2013, CELL MICROBIOL, V15, P98, DOI 10.1111/cmi.12034
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Hamm AK, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.07.16
   Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15
   Hardbower DM, 2013, GUT MICROBES, V4, P475, DOI 10.4161/gmic.25583
   HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883
   Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848
   Huang J, 2014, NAT REV MICROBIOL, V12, P101, DOI 10.1038/nrmicro3160
   Huhta H, 2016, ONCOTARGET, V7, P23658, DOI 10.18632/oncotarget.8151
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010
   Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105
   Kado S, 2001, CANCER RES, V61, P2395
   Karin M, 2014, NAT MED, V20, P126, DOI 10.1038/nm.3473
   Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844
   Kauppila JH, 2013, APMIS, V121, P511, DOI 10.1111/apm.12016
   Kayama H, 2016, J BIOCHEM, V159, P141, DOI 10.1093/jb/mvv119
   Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2
   Koeppel M, 2015, CELL REP, V11, P1703, DOI 10.1016/j.celrep.2015.05.030
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lertpiriyapong K, 2014, GUT, V63, P54, DOI 10.1136/gutjnl-2013-305178
   Levy J, 2015, NAT CELL BIOL, V17, P1062, DOI 10.1038/ncb3206
   Levy M, 2016, GENE DEV, V30, P1589, DOI 10.1101/gad.284091.116
   Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137
   Lin JE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031686
   Liu W, 2016, CURR OPIN VIROL, V20, P20, DOI 10.1016/j.coviro.2016.07.011
   Lofgren JL, 2011, GASTROENTEROLOGY, V140, P210, DOI 10.1053/j.gastro.2010.09.048
   Lopetuso LR, 2016, INFLAMM BOWEL DIS, V22, P1708, DOI 10.1097/MIB.0000000000000807
   Lupton JR, 2004, J NUTR, V134, P479, DOI 10.1093/jn/134.2.479
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Moons LMG, 2008, CARCINOGENESIS, V29, P926, DOI 10.1093/carcin/bgm241
   Muller A, 2012, J CLIN INVEST, V122, P1192, DOI 10.1172/JCI61578
   Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009
   Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731
   Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
   Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020
   Pimentel-Nunes P, 2013, HELICOBACTER, V18, P22, DOI 10.1111/hel.12008
   Pimentel-Nunes P, 2011, PATHOL ONCOL RES, V17, P677, DOI 10.1007/s12253-011-9368-9
   Polk DB, 2010, NAT REV CANCER, V10, P403, DOI 10.1038/nrc2857
   Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169
   Prindiville TP, 2000, EMERG INFECT DIS, V6, P171, DOI 10.3201/eid0602.000210
   Rajagopala SV, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2965-y
   REDDY BS, 1975, CANCER RES, V35, P287
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Salzman NH, 2007, SEMIN IMMUNOL, V19, P70, DOI 10.1016/j.smim.2007.04.002
   Schmausser B, 2005, INT J MED MICROBIOL, V295, P179, DOI 10.1016/j.ijmm.2005.02.009
   Schmidt BL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098741
   Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610
   Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Snider EJ, 2016, DIGEST DIS SCI, V61, P2217, DOI 10.1007/s10620-016-4155-9
   Souza RF, 2009, GASTROENTEROLOGY, V137, P1776, DOI 10.1053/j.gastro.2009.07.055
   Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542
   Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142
   Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015
   Torgbor C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004170
   Touati E, 2003, GASTROENTEROLOGY, V124, P1408, DOI 10.1016/S0016-5085(03)00266-X
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999
   Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094
   Warren RL, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-16
   Weitzman MD, 2014, CELL HOST MICROBE, V15, P283, DOI 10.1016/j.chom.2014.02.010
   Wroblewski LE, 2013, GASTROENTEROL CLIN N, V42, P285, DOI 10.1016/j.gtc.2013.01.006
   Wu JH, 2016, VIRUS GENES, V52, P397, DOI 10.1007/s11262-016-1304-3
   Xie FJ, 2013, WORLD J GASTROENTERO, V19, P6098, DOI 10.3748/wjg.v19.i36.6098
   Xu WJ, 2015, GASTROINTEST TUMORS, V2, P2, DOI 10.1159/000380897
   Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009
   Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046
   Yu LX, 2010, HEPATOLOGY, V52, P1322, DOI 10.1002/hep.23845
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 100
TC 150
Z9 158
U1 5
U2 77
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1940-6207
EI 1940-6215
J9 CANCER PREV RES
JI Cancer Prev. Res.
PD APR
PY 2017
VL 10
IS 4
BP 226
EP 234
DI 10.1158/1940-6207.CAPR-16-0249
PG 9
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA ER5AU
UT WOS:000398814400003
PM 28096237
DA 2022-11-22
ER

PT J
AU Nguyen, LH
   Ma, WJ
   Wang, DD
   Cao, Y
   Mallick, H
   Gerbaba, TK
   Lloyd-Price, J
   Abu-Ali, G
   Hall, AB
   Sikavi, D
   Drew, DA
   Mehta, RS
   Arze, C
   Joshi, AD
   Yan, Y
   Branck, T
   DuLong, C
   Ivey, KL
   Ogino, S
   Rimm, EB
   Song, MY
   Garrett, WS
   Izard, J
   Huttenhower, C
   Chan, AT
AF Nguyen, Long H.
   Ma, Wenjie
   Wang, Dong D.
   Cao, Yin
   Mallick, Himel
   Gerbaba, Teklu K.
   Lloyd-Price, Jason
   Abu-Ali, Galeb
   Hall, A. Brantley
   Sikavi, Daniel
   Drew, David A.
   Mehta, Raaj S.
   Arze, Cesar
   Joshi, Amit D.
   Yan, Yan
   Branck, Tobyn
   DuLong, Casey
   Ivey, Kerry L.
   Ogino, Shuji
   Rimm, Eric B.
   Song, Mingyang
   Garrett, Wendy S.
   Izard, Jacques
   Huttenhower, Curtis
   Chan, Andrew T.
TI Association Between Sulfur-Metabolizing Bacterial Communities in Stool
   and Risk of Distal Colorectal Cancer in Men
SO GASTROENTEROLOGY
LA English
DT Article
DE Colorectal Carcinogenesis; Cancer Biogeography; Fecal Microbes; FFQ
ID MAJOR DIETARY PATTERNS; GUT MICROBIOTA; SULFIDOGENIC BACTERIA;
   CELL-PROLIFERATION; SULFIDE PRODUCTION; MUCUS BARRIER; HUMAN COLON;
   DISEASE; COHORT; METATRANSCRIPTOME
AB BACKGROUND & AIMS: Sulfur-metabolizing microbes, which convert dietary sources of sulfur into genotoxic hydrogen sulfide (H 2 S), have been associated with development of colorectal cancer (CRC). We identified a dietary pattern associated with sulfur-metabolizing bacteria in stool and then investigated its association with risk of incident CRC using data from a large prospective study of men. METHODS: We collected data from 51,529 men enrolled in the Health Professionals Follow-up Study since 1986 to determine the association between sulfur-metabolizing bacteria in stool and risk of CRC over 26 years of follow-up. First, in a subcohort of 307 healthy men, we profiled serial stool metagenomes and metatranscriptomes and assessed diet using semiquantitative food frequency questionnaires to identify food groups associated with 43 bacterial species involved in sulfur metabolism. We used these data to develop a sulfur microbial dietary score. We then used Cox proportional hazards modeling to evaluate adherence to this pattern among eligible individuals (n = 48,246) from 1986 through 2012 with risk for incident CRC. RESULTS: Foods associated with higher sulfur microbial diet scores included increased consumption of processed meats and low-calorie drinks and lower consumption of vegetables and legumes. Increased sulfur microbial diet scores were associated with risk of distal colon and rectal cancers, after adjusting for other risk factors (multivariable relative risk, highest vs lowest quartile, 1.43; 95% confidence interval 1.14-1.81; P-trend = .002). In contrast, sulfur microbial diet scores were not associated with risk of proximal colon cancer (multivariable relative risk 0.86; 95% CI 0.65-1.14; P-trend = .31). CONCLUSIONS: In an analysis of participants in the Health Professionals Follow-up Study, we found that long-term adherence to a dietary pattern associated with sulfur-metabolizing bacteria in stool was associated with an increased risk of distal CRC. Further studies are needed to determine how sulfur-metabolizing bacteria might contribute to CRC pathogenesis.
C1 [Nguyen, Long H.; Ma, Wenjie; Drew, David A.; Mehta, Raaj S.; Joshi, Amit D.; Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Nguyen, Long H.; Ma, Wenjie; Cao, Yin; Sikavi, Daniel; Drew, David A.; Mehta, Raaj S.; Joshi, Amit D.; Ogino, Shuji; Song, Mingyang; Chan, Andrew T.] Harvard Med Sch, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.
   [Nguyen, Long H.; Ma, Wenjie; Cao, Yin; Sikavi, Daniel; Drew, David A.; Mehta, Raaj S.; Joshi, Amit D.; Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.
   [Nguyen, Long H.; Wang, Dong D.; Mallick, Himel; Lloyd-Price, Jason; Abu-Ali, Galeb; Arze, Cesar; Yan, Yan; Branck, Tobyn; DuLong, Casey; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, 677 Huntington Ave, Boston, MA 02115 USA.
   [Wang, Dong D.; Ivey, Kerry L.; Rimm, Eric B.; Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Cao, Yin] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA.
   [Cao, Yin] Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA.
   [Mallick, Himel; Lloyd-Price, Jason; Hall, A. Brantley; Ogino, Shuji; Garrett, Wendy S.; Huttenhower, Curtis; Chan, Andrew T.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Gerbaba, Teklu K.; Izard, Jacques] Univ Nebraska, Dept Food Sci & Technol, Lincoln, NE 68583 USA.
   [Drew, David A.; Ogino, Shuji; Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Ivey, Kerry L.] South Australian Hlth & Med Res Inst, Microbiome & Host Hlth Programme, Precis Med Theme, Adelaide, SA, Australia.
   [Ogino, Shuji] Dana Farber Harvard Canc Ctr, Canc Immunol Program, Boston, MA USA.
   [Ogino, Shuji] Dana Farber Harvard Canc Ctr, Canc Epidemiol Program, Boston, MA USA.
   [Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, 75 Francis St, Boston, MA 02115 USA.
   [Garrett, Wendy S.] Dana Farber Canc Inst, Dept Med, Boston, MA 02115 USA.
   [Izard, Jacques] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE USA.
   [Chan, Andrew T.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Harvard Medical School; Harvard University; Massachusetts General
   Hospital; Harvard University; Harvard T.H. Chan School of Public Health;
   Harvard University; Harvard T.H. Chan School of Public Health;
   Washington University (WUSTL); Siteman Cancer Center; Washington
   University (WUSTL); Harvard University; Massachusetts Institute of
   Technology (MIT); Broad Institute; University of Nebraska System;
   University of Nebraska Lincoln; Harvard University; Harvard T.H. Chan
   School of Public Health; South Australian Health & Medical Research
   Institute (SAHMRI); Harvard University; Dana-Farber Cancer Institute;
   Harvard University; Dana-Farber Cancer Institute; Harvard University;
   Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer
   Institute; University of Nebraska System; University of Nebraska Medical
   Center; Harvard University; Harvard T.H. Chan School of Public Health
RP Chan, AT (corresponding author), Harvard Med Sch, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.; Chan, AT (corresponding author), Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.; Huttenhower, C (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Biostat, 677 Huntington Ave, Boston, MA 02115 USA.; Huttenhower, C (corresponding author), Broad Inst MIT & Harvard, 677 Huntington Ave, Boston, MA 02115 USA.
EM chuttenh@hsph.harvard.edu; achan@partners.org
RI Mallick, Himel/L-7702-2018; Cao, Yin/ABE-2332-2021; Wang, Dong
   D./AAU-2951-2021
OI Mallick, Himel/0000-0003-4956-2429; Cao, Yin/0000-0001-9835-7662; Wang,
   Dong D./0000-0002-0897-3048; Nguyen, Long/0000-0002-5436-4219; Arze,
   Cesar/0000-0002-3606-4183; Gerbaba, Teklu/0000-0002-0319-2824; Ivey,
   Kerry/0000-0001-9855-2599; Izard, Jacques/0000-0002-5904-5436; Garrett,
   Wendy/0000-0002-5092-0150
FU National Institutes of Health (NIH) [U54DE023798, UM1CA167552,
   U01CA167552, P01CA055075, U01CA152904, T32CA009001, K99DK119412,
   K07CA218377, R00CA215314, R01CA202704, K24DK098311, P30DK043351,
   R35CA197735, R01CA151993]; Crohn's and Colitis Foundation; US Department
   of Agriculture National Institute of Food and Agriculture Hatch
   Multistate Research Capacity Funding Program grant [W4122]; National
   Health and Medical Research Council; Cancer Research UK Grand Challenge
   Award [C10674/A27140]; Dana-Farber Harvard Cancer Center Nodal Award;
   STARR Cancer Consortium; Massachusetts General Hospital Stuart and
   Suzanne Steel Research Scholars Award; American Cancer Society Mentored
   Research Scholar Grant
FX Funding Grant Support: National Institutes of Health (NIH) grants
   U54DE023798, UM1CA167552, U01CA167552, P01CA055075, U01CA152904,
   T32CA009001 (to LHN and DAD), Loan Repayment Program (to LHN and DAD),
   and K99DK119412 (to DW), K07CA218377 (to YC), R00CA215314 (to MS),
   R01CA202704 (to WSG, JI, CH, and ATC), K24DK098311 (to ATC), P30DK043351
   (Pilot & Feasibility Study Award to DAD), R35CA197735 (to SO), and
   R01CA151993 (to SO); Crohn's and Colitis Foundation Research Fellowship
   Award (to LHN) and Senior Investigator Award (to ATC); American Cancer
   Society Mentored Research Scholar Grant (to MS); the US Department of
   Agriculture National Institute of Food and Agriculture Hatch Multistate
   Research Capacity Funding Program grant W4122 (to JI); National Health
   and Medical Research Council (to KLI); Cancer Research UK Grand
   Challenge Award (C10674/A27140; to WSG, SO, and CH); Dana-Farber Harvard
   Cancer Center Nodal Award (to SO); STARR Cancer Consortium; and the
   Massachusetts General Hospital Stuart and Suzanne Steel Research
   Scholars Award (to ATC).
CR Abu-Ali GS, 2018, NAT MICROBIOL, V3, P356, DOI 10.1038/s41564-017-0084-4
   Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Ananthakrishnan AN, 2013, GASTROENTEROLOGY, V145, P970, DOI 10.1053/j.gastro.2013.07.050
   Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439
   Bianchini F, 2004, DRUG METAB REV, V36, P655, DOI 10.1081/DMR-200033468
   Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513
   Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Cai WJ, 2010, CELL BIOL INT, V34, P565, DOI 10.1042/CBI20090368
   Carbonero F, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00448
   Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935
   Chen WHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039039
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Doubeni CA, 2012, CANCER-AM CANCER SOC, V118, P3636, DOI 10.1002/cncr.26677
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111
   Fung T, 2003, ARCH INTERN MED, V163, P309, DOI 10.1001/archinte.163.3.309
   Hashem FA, 2012, PHYTOTHER RES, V26, P743, DOI 10.1002/ptr.3591
   Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042
   Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44
   Ijssennagger N, 2016, TRENDS MOL MED, V22, P190, DOI 10.1016/j.molmed.2016.01.002
   Ijssennagger N, 2015, P NATL ACAD SCI USA, V112, P10038, DOI 10.1073/pnas.1507645112
   Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105
   Kaplan GG, 2017, GASTROENTEROLOGY, V152, P313, DOI 10.1053/j.gastro.2016.10.020
   Kesse E, 2006, AM J EPIDEMIOL, V164, P1085, DOI 10.1093/aje/kwj324
   Kong J, 2008, AM J PHYSIOL-GASTR L, V294, pG208, DOI 10.1152/ajpgi.00398.2007
   Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb04882.x
   Magalhaes B, 2012, EUR J CANCER PREV, V21, P15, DOI 10.1097/CEJ.0b013e3283472241
   Magee EA, 2000, AM J CLIN NUTR, V72, P1488
   Makambi KH, 2011, CANCER EPIDEM BIOMAR, V20, P818, DOI 10.1158/1055-9965.EPI-10-1213
   Martinez-Guryn K, 2019, CELL HOST MICROBE, V26, P314, DOI 10.1016/j.chom.2019.08.011
   McIver LJ, 2018, BIOINFORMATICS, V34, P1235, DOI 10.1093/bioinformatics/btx754
   Mehta RS, 2018, NAT MICROBIOL, V3, P347, DOI 10.1038/s41564-017-0096-0
   Mehta RS, 2017, GASTROENTEROLOGY, V152, P1944, DOI 10.1053/j.gastro.2017.02.015
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Nava GM, 2012, ENV MICROBIOL REP, V4, P307, DOI 10.1111/j.1758-2229.2012.00334.x
   Needham BD, 2013, P NATL ACAD SCI USA, V110, P1464, DOI 10.1073/pnas.1218080110
   Placzek S, 2017, NUCLEIC ACIDS RES, V45, pD380, DOI 10.1093/nar/gkw952
   Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647
   Ramasamy S, 2006, AM J PHYSIOL-GASTR L, V291, pG288, DOI 10.1152/ajpgi.00324.2005
   Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211
   Rimm EB, 1992, AM J EPIDEMIOL, V135, P1127, DOI DOI 10.1093/OXFORDJOURNALS.AJE.A116211
   ROEDIGER WEW, 1993, GASTROENTEROLOGY, V104, P802, DOI 10.1016/0016-5085(93)91016-B
   Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x
   Schroeder BO, 2018, CELL HOST MICROBE, V23, P27, DOI 10.1016/j.chom.2017.11.004
   Shen W, 2014, J NUTR, V144, P1181, DOI 10.3945/jn.114.194332
   Sodir NM, 2006, CANCER RES, V66, P8430, DOI 10.1158/0008-5472.CAN-06-1437
   Song M, 2019, CLIN GASTROENTEROL H, V17, P275, DOI 10.1016/j.cgh.2018.07.012
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16
   Su WD, 2007, PHYSIOL GENOMICS, V30, P342, DOI 10.1152/physiolgenomics.00042.2007
   Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739
   Tabung FK, 2016, J NUTR, V146, P1560, DOI 10.3945/jn.115.228718
   Terry P, 2001, AM J EPIDEMIOL, V154, P1143, DOI 10.1093/aje/154.12.1143
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Wang YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013607
   Washio J, 2014, APPL ENVIRON MICROB, V80, P4184, DOI 10.1128/AEM.00606-14
   WERNER H, 1975, ZBL BAKT-INT J MED M, V231, P133
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wirfalt E, 2009, EUR J CLIN NUTR, V63, P707, DOI 10.1038/ejcn.2008.40
   WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865
   Yazici C, 2017, GUT, V66, P1983, DOI 10.1136/gutjnl-2016-313321
   Zeng HW, 2008, J NUTR BIOCHEM, V19, P1, DOI 10.1016/j.jnutbio.2007.02.005
NR 81
TC 47
Z9 51
U1 5
U2 13
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0016-5085
EI 1528-0012
J9 GASTROENTEROLOGY
JI Gastroenterology
PD APR
PY 2020
VL 158
IS 5
BP 1313
EP 1325
DI 10.1053/j.gastro.2019.12.029
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA KW4IK
UT WOS:000521129300026
PM 31972239
OA Green Accepted, Green Published
DA 2022-11-22
ER

PT J
AU Dumitru, FA
   Micu, SI
   Popoiag, RE
   Musat, M
   Caloian, AD
   Calu, V
   Constantin, VD
   Balan, DG
   Nitipir, C
   Enache, F
AF Dumitru, Florinela-Andrada
   Micu, Sergiu Ioan
   Popoiag, Roxana Emanuela
   Musat, Marilena
   Caloian, Andreea Daniela
   Calu, Valentin
   Constantin, Vlad Denis
   Balan, Daniela Gabriela
   Nitipir, Cornelia
   Enache, Florin
TI Intestinal dysbiosis - a new treatment target in the prevention of
   colorectal cancer
SO JOURNAL OF MIND AND MEDICAL SCIENCES
LA English
DT Article
DE intestinal dysbiosis; colorectal cancer; therapy; prevention
ID GUT MICROBIOTA; FUSOBACTERIUM-NUCLEATUM; DISEASE; HOST; RISK;
   INFLAMMATION; POPULATION; BIOMARKERS; PATTERNS; PATIENT
AB The gastrointestinal microbiome contains at least 100 trillion microorganisms (bacteria, viruses, fungi), whose distribution varies from the mouth to the rectum spatially and temporally throughout one's lifetime. The microbiome benefits from advancing research due to its major role in human health. Studies indicate that its functions are immunity, metabolic processes and mucosal barrier. The disturbances of these functions, dysbiosis, influence physiology, lead to diabetes, inflammatory bowel disease, obesity and colon tumorigenesis. The third most common form of cancer, colorectal cancer, is the result of many factors and genes, and although the link between dysbiosis and this type of cancer is poorly characterized, it has been shown that some bacterial species and their metabolites have a critical role in developing colorectal cancer. Also, gut microbiota plays a role in the inflammatory response and immune process perturbations during the progression of colorectal cancer. Some new technologies, such as metagenome sequencing, facilitated the progress by analyzing the metabolic and genetic profile of microbiota, revealing details about the bacterial composition, host interactions, and taxonomic alterations. This review summarizes the studies regarding the link between gut microbiota and colorectal cancer, targeting new therapeutic strategies.
C1 [Dumitru, Florinela-Andrada; Micu, Sergiu Ioan; Musat, Marilena] Emergency Hosp Constanta, Dept Gastroenterol, Constanta, Romania.
   [Popoiag, Roxana Emanuela] Ovidius Univ, Fac Med, Constanta, Romania.
   [Caloian, Andreea Daniela] Emergency Hosp Constanta, Dept Oncol, Constanta, Romania.
   [Calu, Valentin; Constantin, Vlad Denis] Carol Davila Univ Med & Pharm, Dept Gen Surg, Bucharest, Romania.
   [Balan, Daniela Gabriela] Carol Davila Univ Med & Pharm, Fac Dent Med, Bucharest, Romania.
   [Nitipir, Cornelia] Carol Davila Univ Med & Pharm, Elias Hosp, Dept Oncol, Bucharest, Romania.
   [Enache, Florin] Emergency Hosp Constanta, Dept Pediat Surg, Constanta, Romania.
C3 Ovidius University; Carol Davila University of Medicine & Pharmacy;
   Carol Davila University of Medicine & Pharmacy; Carol Davila University
   of Medicine & Pharmacy
RP Dumitru, FA (corresponding author), Emergency Hosp Constanta, Dept Gastroenterol, Constanta, Romania.
EM dandrada92@gmail.com
RI Caloian (Gheorghe), Andreea Daniela/AAI-4249-2020; Calu,
   Valentin/AAN-8374-2020
OI Calu, Valentin/0000-0001-7710-9109
CR Aarts E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183509
   Aguiar-Pulido V, 2016, EVOL BIOINFORM, V12, P5, DOI 10.4137/EBO.S36436
   Ai LY, 2017, ONCOTARGET, V8, P9546, DOI 10.18632/oncotarget.14488
   Alius C, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10100742
   Allali I, 2015, GUT MICROBES, V6, P161, DOI 10.1080/19490976.2015.1039223
   Arnold JW, 2016, TRENDS MICROBIOL, V24, P887, DOI 10.1016/j.tim.2016.06.008
   Bao NR, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02981
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Branescu C, 2013, CHIRURGIA-BUCHAREST, V108, P206
   Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6
   Camp ER, 2017, CANCER BIOL THER, V18, P640, DOI 10.1080/15384047.2017.1345396
   Cao HL, 2017, INT J CANCER, V140, P2545, DOI 10.1002/ijc.30643
   Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047
   Chang CW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00983
   Chirca A, 2017, MED-SURG J, V121, P395
   Coghlin C, 2015, PROTEOM CLIN APPL, V9, P64, DOI 10.1002/prca.201400082
   Ding CB, 2018, ONCOTARGETS THER, V11, P4797, DOI 10.2147/OTT.S170626
   Farshidfar F, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3923-z
   Filip Mihaela, 2018, Clujul Med, V91, P259, DOI 10.15386/cjmed-946
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Frunza TC, 2019, J MIND MED SCI, V6, P278, DOI 10.22543/7674.62.P278285
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gao R, 2017, EUR J CLIN MICROBIOL, V36, P2073, DOI 10.1007/s10096-017-3026-4
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Gradisteanu GP, 2019, J MIND MED SCI, V6, P130, DOI 10.22543/7674.61.P130136
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Juul FE, 2018, NEW ENGL J MED, V378, P2535, DOI 10.1056/NEJMc1803103
   Khan AA, 2017, LIFE SCI, V180, P60, DOI 10.1016/j.lfs.2017.05.016
   Kirov KG, 2019, J CLIN INVEST SURG, V4, P88
   Konishi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12365
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Laamiri G, 2020, J CLIN INVEST SURG, V5, P109, DOI [10.25083/2559.5555/5.2/109.112, DOI 10.25083/2559.5555/5.2/109.112]
   Lee DW, 2018, ANN SURG ONCOL, V25, P3389, DOI 10.1245/s10434-018-6681-5
   Lee V, 2016, IMMUNOTHERAPY-UK, V8, P1, DOI 10.2217/imt.15.97
   Lin CZ, 2019, DIGESTION, V100, P72, DOI 10.1159/000494052
   Lv Y, 2017, WORLD J GASTROENTERO, V23, P603, DOI 10.3748/wjg.v23.i4.603
   Mazilu L, 2013, CHIRURGIA-BUCHAREST, V108, P478
   Mazilu L, 2020, METFORMIN ITS IMPLIC, P113
   Mazilu L, 2019, FARMACIA, V67, P472, DOI 10.31925/farmacia.2019.3.14
   Mirzaei MK, 2017, NAT REV MICROBIOL, V15, P397, DOI 10.1038/nrmicro.2017.30
   Moraru D, P 35 BALK MED WEEK 2, P182
   Moskal A, 2016, BRIT J CANCER, V115, P1430, DOI 10.1038/bjc.2016.334
   Motofei IG, 2018, CANCER INVEST, V36, P309, DOI 10.1080/07357907.2018.1477955
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Navarro M, 2017, WORLD J GASTROENTERO, V23, P3632, DOI 10.3748/wjg.v23.i20.3632
   Pantea-Stoian A, 2018, FARMACIA, V66, P1
   Partty A, 2015, PEDIATR RES, V77, P823, DOI 10.1038/pr.2015.51
   Puca BM, 2019, J MIND MED SCI, V6, P340, DOI 10.22543/7674.62.P340345
   Raskov H, 2017, J CANCER, V8, P3378, DOI 10.7150/jca.20497
   Sarhadi V, 2020, ANTICANCER RES, V40, P1325, DOI 10.21873/anticanres.14074
   Savlovschi C, 2013, CHIRURGIA-BUCHAREST, V108, P177
   Savlovschi C, 2013, CHIRURGIA-BUCHAREST, V108, P43
   Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189
   Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71
   Stevens AJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46146-3
   Stoian AP, 2018, REV CHIM-BUCHAREST, V69, P2515
   Suceveanu AI, 2019, METFORMIN MONOGRAPHY, P45, DOI [10.5772/intechopen.88749, DOI 10.5772/INTECHOPEN.88749]
   Suceveanu AI, 2019, REV CHIM-BUCHAREST, V70, P1808
   Suceveanu AI, 2018, REV CHIM-BUCHAREST, V69, P2260
   Suceveanu AI, 2020, METABOLITES, V10, DOI 10.3390/metabo10110448
   Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003
   Todoric J, 2016, CANCER PREV RES, V9, P895, DOI 10.1158/1940-6207.CAPR-16-0209
   Tofolean DE, 2015, ROM J MORPHOL EMBRYO, V56, P1205
   Tsilimigras MCB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.8
   Tudosie MS, 2013, FARMACIA, V61, P53
   Tulin A, 2018, J MIND MED SCI, V5, P101, DOI 10.22543/7674.51.P101108
   Tuta LA, 2015, INT MULTIDDISCIP SCI, P487
   West NR, 2015, CANCER CELL, V28, P687, DOI 10.1016/j.ccell.2015.11.010
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zhang XY, 2019, CANCER MED-US, V8, P480, DOI 10.1002/cam4.1850
NR 70
TC 1
Z9 1
U1 2
U2 2
PU VALPOSCHOLAR-VALPRAISO UNIV
PI BUCHAREST
PA STRADA DIONISE LUPU 37, BUCHAREST, 70183, ROMANIA
SN 2392-7674
J9 J MIND MED SCI
JI J. Mind Med. Sci.
PY 2021
VL 8
IS 2
AR 8
DI 10.22543/7674.82.P221228
PG 10
WC Medicine, General & Internal
WE Emerging Sources Citation Index (ESCI)
SC General & Internal Medicine
GA WG7SS
UT WOS:000707195500009
OA gold
DA 2022-11-22
ER

PT J
AU Wynendaele, E
   Debunne, N
   Janssens, Y
   De Spiegeleer, A
   Verbeke, F
   Tack, L
   Van Welden, S
   Goossens, E
   Knappe, D
   Hoffmann, R
   Van De Wiele, C
   Laukens, D
   Van Eenoo, P
   Vereecke, L
   Van Immerseel, F
   De Wever, O
   De Spiegeleer, B
AF Wynendaele, Evelien
   Debunne, Nathan
   Janssens, Yorick
   De Spiegeleer, Anton
   Verbeke, Frederick
   Tack, Liesa
   Van Welden, Sophie
   Goossens, Evy
   Knappe, Daniel
   Hoffmann, Ralf
   Van De Wiele, Christophe
   Laukens, Debby
   Van Eenoo, Peter
   Vereecke, Lars
   Van Immerseel, Filip
   De Wever, Olivier
   De Spiegeleer, Bart
TI The quorum sensing peptide EntF* promotes colorectal cancer metastasis
   in mice: a new factor in the host-microbiome interaction
SO BMC BIOLOGY
LA English
DT Article
DE Quorum sensing peptides; Microbiota; Colorectal cancer metastasis;
   Orthotopic mice model; LC-MS
ID ENTEROCOCCUS-FAECIUM; BACTERIOCIN PRODUCTION; GUT MICROBIOTA
AB Background Colorectal cancer, one of the most common malignancies worldwide, is associated with a high mortality rate, mainly caused by metastasis. Comparative metagenome-wide association analyses of healthy individuals and cancer patients suggest a role for the human intestinal microbiota in tumor progression. However, the microbial molecules involved in host-microbe communication are largely unknown, with current studies mainly focusing on short-chain fatty acids and amino acid metabolites as potential mediators. Quorum sensing peptides are not yet considered in this context since their presence in vivo and their ability to affect host cells have not been reported so far. Results Here, we show that EntF*, a metabolite of the quorum sensing peptide EntF produced by Enterococcus faecium, is naturally present in mice bloodstream. Moreover, by using an orthotopic mouse model, we show that EntF* promotes colorectal cancer metastasis in vivo, with metastatic lesions in liver and lung tissues. In vitro tests suggest that EntF* regulates E-cadherin expression and consequently the epithelial-mesenchymal transition, via the CXCR4 receptor. In addition, alanine-scanning analysis indicates that the first, second, sixth, and tenth amino acid of EntF* are critical for epithelial-mesenchymal transition and tumor metastasis. Conclusion Our work identifies a new class of molecules, quorum sensing peptides, as potential regulators of host-microbe interactions. We prove, for the first time, the presence of a selected quorum sensing peptide metabolite in a mouse model, and we demonstrate its effects on colorectal cancer metastasis. We believe that our work represents a starting point for future investigations on the role of microbiome in colorectal cancer metastasis and for the development of novel bio-therapeutics in other disease areas.
C1 [Wynendaele, Evelien; Debunne, Nathan; Janssens, Yorick; De Spiegeleer, Anton; Verbeke, Frederick; Tack, Liesa; De Spiegeleer, Bart] Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat Grp, Ghent, Belgium.
   [De Spiegeleer, Anton; Van Welden, Sophie; Laukens, Debby] Univ Ghent, Dept Internal Med & Pediat, Fac Med & Hlth Sci, Ghent, Belgium.
   [Goossens, Evy; Van Immerseel, Filip] Univ Ghent, Dept Pathol Bacteriol & Poultry Dis, Fac Vet Med, Ghent, Belgium.
   [Knappe, Daniel; Hoffmann, Ralf] Univ Leipzig, Fac Chem & Mineral, Ctr Biotechnol & Biomed, Leipzig, Germany.
   [Van De Wiele, Christophe; Van Eenoo, Peter] Univ Ghent, Dept Diagnost Sci, Fac Med & Hlth Sci, Ghent, Belgium.
   [Vereecke, Lars] Fac Med & Hlth Sci, Dept Rheumatol, Ghent, Belgium.
   [De Wever, Olivier] Univ Ghent, Dept Human Struct & Repair, Fac Med & Hlth Sci, Ghent, Belgium.
C3 Ghent University; Ghent University; Ghent University; Leipzig
   University; Ghent University; Ghent University; Ghent University
RP De Spiegeleer, B (corresponding author), Univ Ghent, Fac Pharmaceut Sci, Drug Qual & Registrat Grp, Ghent, Belgium.
EM Bart.DeSpiegeleer@UGent.be
RI Goossens, Evy/AAI-8202-2020
OI Goossens, Evy/0000-0001-6476-5932
FU Research Foundation Flanders [1S21017N, 1158818N]; Institute for the
   Promotion of Innovation through Science and Technology in Flanders
   [131356]
FX This work was supported by the Research Foundation Flanders (1S21017N to
   ND and 1158818N to ADS) and by the Institute for the Promotion of
   Innovation through Science and Technology in Flanders (131356 to FV).
CR Aymerich T, 1996, APPL ENVIRON MICROB, V62, P1676, DOI 10.1128/AEM.62.5.1676-1682.1996
   Bates RC, 2005, CANCER BIOL THER, V4, P365
   Darkoh C, 2015, MBIO, V6, DOI 10.1128/mBio.02569-14
   De Spiegeleer A, 2020, BBA-MOL BASIS DIS, V1866, DOI 10.1016/j.bbadis.2019.165646
   De Spiegeleer B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119471
   Dubin K, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.BAD-0014-2016
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Franz CMAP, 2000, MICROBIOL-SGM, V146, P621, DOI 10.1099/00221287-146-3-621
   Fumagalli A, 2018, NAT PROTOC, V13, P235, DOI 10.1038/nprot.2017.137
   Gilmore MS, 2014, ENTEROCOCCI COMMENSA
   Gingras D, 2011, CANCER MICROENVIRON, V4, P133, DOI 10.1007/s12307-010-0060-5
   Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6
   HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915
   Huang LT, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/185179
   Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303
   Janssens Y, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1197-5
   Janssens Y, 2018, PEPTIDES, V101, P150, DOI 10.1016/j.peptides.2018.01.013
   Kang S, 2010, INFLAMM BOWEL DIS, V16, P2034, DOI 10.1002/ibd.21319
   Kopetz S, 2019, NAT REV GASTRO HEPAT, V16, P79, DOI 10.1038/s41575-018-0100-z
   Layton BA, 2010, J APPL MICROBIOL, V109, P539, DOI 10.1111/j.1365-2672.2010.04675.x
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep26337
   Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88
   Nilsen T, 1998, J BACTERIOL, V180, P1848, DOI 10.1128/JB.180.7.1848-1854.1998
   Pascal V, 2017, GUT, V66, P813, DOI 10.1136/gutjnl-2016-313235
   Smith MD, 2009, BRIT J SURG, V96, P1101, DOI 10.1002/bjs.6735
   Treitman AN, 2005, J CLIN MICROBIOL, V43, P462, DOI 10.1128/JCM.43.1.462-463.2005
   van Belkum MJ, 2007, MICROBIOL-SGM, V153, P3660, DOI 10.1099/mic.0.2007/009183-0
   Verbeke F, 2020, ANAL CHEM, V92, P1712, DOI 10.1021/acs.analchem.9b01840
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Wynendaele E., PROTEOMEXCHANGE CONS
   Wynendaele E, 2015, PEPTIDES, V64, P40, DOI 10.1016/j.peptides.2014.12.009
   Wynendaele E, 2013, NUCLEIC ACIDS RES, V41, pD655, DOI 10.1093/nar/gks1137
   Zaheer R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61002-5
   Zhou Y, 2018, CHIN J NAT MEDICINES, V16, P801, DOI 10.1016/S1875-5364(18)30122-5
NR 35
TC 1
Z9 1
U1 7
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD JUN 27
PY 2022
VL 20
IS 1
AR 151
DI 10.1186/s12915-022-01317-z
PG 16
WC Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics
GA 2O8ME
UT WOS:000819305800004
PM 35761265
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Casimiro-Soriguer, CS
   Loucera, C
   Pena-Chilet, M
   Dopazo, J
AF Casimiro-Soriguer, Carlos S.
   Loucera, Carlos
   Pena-Chilet, Maria
   Dopazo, Joaquin
TI Towards a metagenomics machine learning interpretable model for
   understanding the transition from adenoma to colorectal cancer
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN MICROBIOME; READ ALIGNMENT; METABOLISM; DIVERSITY; HEALTH;
   TUMORIGENESIS; GROWTH
AB Gut microbiome is gaining interest because of its links with several diseases, including colorectal cancer (CRC), as well as the possibility of being used to obtain non-intrusive predictive disease biomarkers. Here we performed a meta-analysis of 1042 fecal metagenomic samples from seven publicly available studies. We used an interpretable machine learning approach based on functional profiles, instead of the conventional taxonomic profiles, to produce a highly accurate predictor of CRC with better precision than those of previous proposals. Moreover, this approach is also able to discriminate samples with adenoma, which makes this approach very promising for CRC prevention by detecting early stages in which intervention is easier and more effective. In addition, interpretable machine learning methods allow extracting features relevant for the classification, which reveals basic molecular mechanisms accounting for the changes undergone by the microbiome functional landscape in the transition from healthy gut to adenoma and CRC conditions. Functional profiles have demonstrated superior accuracy in predicting CRC and adenoma conditions than taxonomic profiles and additionally, in a context of explainable machine learning, provide useful hints on the molecular mechanisms operating in the microbiota behind these conditions.
C1 [Casimiro-Soriguer, Carlos S.; Loucera, Carlos; Pena-Chilet, Maria; Dopazo, Joaquin] Hosp Virgen Rocio, Fdn Progreso Salud FPS, Clin Bioinformat Area, Seville 41013, Spain.
   [Loucera, Carlos; Pena-Chilet, Maria; Dopazo, Joaquin] Hosp Virgen Rocio, Inst Biomed Seville IBIS, Computat Syst Med, Seville 41013, Spain.
   [Pena-Chilet, Maria; Dopazo, Joaquin] Hosp Virgen Rocio, Ctr Invest Biomed Red Enfermedades Raras CIBERER, FPS, Seville 41013, Spain.
   [Dopazo, Joaquin] Hosp Virgen Rocio, FPS, ELIXIRES INB, Seville 41013, Spain.
C3 Virgen del Rocio University Hospital; Consejo Superior de
   Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE -
   Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University
   Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBERER;
   Virgen del Rocio University Hospital; Virgen del Rocio University
   Hospital
RP Dopazo, J (corresponding author), Hosp Virgen Rocio, Fdn Progreso Salud FPS, Clin Bioinformat Area, Seville 41013, Spain.; Dopazo, J (corresponding author), Hosp Virgen Rocio, Inst Biomed Seville IBIS, Computat Syst Med, Seville 41013, Spain.; Dopazo, J (corresponding author), Hosp Virgen Rocio, Ctr Invest Biomed Red Enfermedades Raras CIBERER, FPS, Seville 41013, Spain.; Dopazo, J (corresponding author), Hosp Virgen Rocio, FPS, ELIXIRES INB, Seville 41013, Spain.
EM joaquin.dopazo@juntadeandalucia.es
RI Peña-Chilet, Maria/A-8387-2015
OI Peña-Chilet, Maria/0000-0002-6445-9617; Sanchez Casimiro-Soriguer,
   Carlos/0000-0003-1774-2580
FU Spanish Ministry of Science and Innovation [PID2020-117979RB-I00];
   ISCIII [PI20/01305, IMP/0019]; European Regional Development Funds
   (ERDF); H2020 Programme of the European Union Grant Marie Curie
   Innovative Training Network "Machine Learning Frontiers in Precision
   Medicine" (MLFPM) [GA 813533]; H2020 Programme of the European Union
   Grant Marie Curie Innovative Training Network "ELIXIR-EXCELERATE
   fast-track ELIXIR implementation and drive early user exploitation
   across the life sciences" [GA 676559]; Junta de Andalucia
   [PAIDI2020-DOC_00350]; European Social Fund (FSE) 2014-2020
   [PAIDI2020-DOC_00350]
FX This work is supported by Grants PID2020-117979RB-I00 from the Spanish
   Ministry of Science and Innovation and PI20/01305 and IMP/0019 from the
   ISCIII, both co-funded with European Regional Development Funds (ERDF)
   as well as H2020 Programme of the European Union Grants Marie Curie
   Innovative Training Network "Machine Learning Frontiers in Precision
   Medicine" (MLFPM) (GA 813533) and "ELIXIR-EXCELERATE fast-track ELIXIR
   implementation and drive early user exploitation across the life
   sciences" (GA 676559). The postdoctoral contract for CL
   PAIDI2020-DOC_00350 is funded by Junta de Andalucia and co-funded by the
   European Social Fund (FSE) 2014-2020.
CR Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Beane J, 2017, LANCET ONCOL, V18, pE494, DOI 10.1016/S1470-2045(17)30373-X
   Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y
   Bleich RM, 2019, SCIENCE, V363, P689, DOI 10.1126/science.aaw5475
   Bornigen D, 2013, GENOME MED, V5, DOI 10.1186/gm469
   Caruana R, 2015, KDD'15: PROCEEDINGS OF THE 21ST ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1721, DOI 10.1145/2783258.2788613
   Casimiro-Soriguer CS, 2019, BIOL DIRECT, V14, DOI 10.1186/s13062-019-0246-9
   Chakraborty S., 2017 IEEE SMARTWORLD
   Chen L., 2018, J MED ARTIF INTELL, V1, P5
   Chernomoretz A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0168-z
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Coelho LP, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0684-8
   Costea PI, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177589
   Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Fazzari J, 2017, CURR NEUROPHARMACOL, V15, P620, DOI 10.2174/1570159X14666160509123042
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Findley K, 2016, TRENDS MICROBIOL, V24, P847, DOI 10.1016/j.tim.2016.08.001
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18
   Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2
   HASTIE T, 1987, J AM STAT ASSOC, V82, P371, DOI 10.2307/2289439
   Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]
   Huerta-Cepas J, 2019, NUCLEIC ACIDS RES, V47, pD309, DOI 10.1093/nar/gky1085
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260
   Kojima M, 2000, ONCOGENE, V19, P1225, DOI 10.1038/sj.onc.1203427
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Lloyd-Price J, 2017, NATURE, V550, P61, DOI 10.1038/nature23889
   Lou Y, 2012, P 18 ACM SIGKDD INT, P150
   Lou Y, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P623, DOI 10.1145/2487575.2487579
   Lundberg SM, 2017, ADV NEUR IN, V30
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Murdoch WJ, 2019, P NATL ACAD SCI USA, V116, P22071, DOI 10.1073/pnas.1900654116
   Ng O, 2016, WIEN MED WOCHENSCHR, V166, P431, DOI 10.1007/s10354-016-0508-4
   Nogueira S., 2017, J MACH LEARN RES, V18, P6345
   Nori H., 2019, ARXIV190909223, P1
   Ojala M, 2010, J MACH LEARN RES, V11, P1833
   Pasolli E, 2017, NAT METHODS, V14, P1023, DOI 10.1038/nmeth.4468
   Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935
   R Core Team, R LANG ENV STAT COMP
   Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Scholz M, 2016, NAT METHODS, V13, P435, DOI [10.1038/NMETH.3802, 10.1038/nmeth.3802]
   Segata N, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00190-17
   Shieh GS, 1998, STAT PROBABIL LETT, V39, P17, DOI 10.1016/S0167-7152(98)00006-6
   Snel B, 1999, NAT GENET, V21, P108, DOI 10.1038/5052
   Snoek J., 2012, PRACTICAL BAYESIAN O, DOI DOI 10.5555/2999325.2999464
   Ternes D, 2020, TRENDS MICROBIOL, V28, P401, DOI 10.1016/j.tim.2020.01.001
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tian JS, 2020, ONCOTARGETS THER, V13, P6093, DOI 10.2147/OTT.S247393
   Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340
   Vigna S, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1166, DOI 10.1145/2736277.2741088
   Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yang JH, 2019, CELL, V177, P1649, DOI 10.1016/j.cell.2019.04.016
   Yoshioka T, 2001, J INT MED RES, V29, P409, DOI 10.1177/147323000102900505
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yu MK, 2018, CELL, V173, P1562, DOI 10.1016/j.cell.2018.05.056
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zaneveld JR, 2010, NUCLEIC ACIDS RES, V38, P3869, DOI 10.1093/nar/gkq066
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhang S, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-018-0985-y
NR 78
TC 3
Z9 3
U1 4
U2 7
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 10
PY 2022
VL 12
IS 1
AR 450
DI 10.1038/s41598-021-04182-y
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA YF2LV
UT WOS:000741645800016
PM 35013454
OA Green Submitted, Green Published, gold
DA 2022-11-22
ER

PT J
AU Touchefeu, Y
   Duchalais, E
   des Varannes, SB
   Alameddine, J
   Mirallie, E
   Matysiak-Budnik, T
   Le Bastard, Q
   Javaudin, F
   Rimbert, M
   Jotereau, F
   Montassier, E
AF Touchefeu, Yann
   Duchalais, Emilie
   des Varannes, Stanislas Bruley
   Alameddine, Joudy
   Mirallie, Eric
   Matysiak-Budnik, Tamara
   Le Bastard, Quentin
   Javaudin, Francois
   Rimbert, Marie
   Jotereau, Francine
   Montassier, Emmanuel
TI Concomitant decrease of double-positive lymphocyte population CD4CD8
   alpha alpha and Faecalibacterium prausnitzii in patients with colorectal
   cancer
SO EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
LA English
DT Article
DE CD4CD8 alpha alpha; colorectal cancer; Faecalibacterium prausnitzii; gut
   microbiota
ID FATTY-ACID-METABOLISM; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; GUT
   MICROBIOTA; COLITIS; INFLAMMATION; DIVERSITY; DISEASE
AB Introduction and aims Changes in the composition of the gut microbiota in patients with colorectal cancer (CRC) compatible with a contribution of the gut microbiota in carcinogenesis have been reported. In particular, a decrease Faecalibacterium prausnitzii has been identified. A CD4CD8 alpha alpha, double-positive lymphocyte population (DP8 alpha) has recently been demonstrated in the human colon and blood with regulatory functions and specificity for F. prausnitzii. Here, we aimed to detect dysbiosis in the fecal microbiome of patients with CRC by metagenomic analysis, and to look for changes in the levels of DP8 alpha circulating T cells specific for F. prausnitzii in these patients.
   Patients and methods Patients with CRC and control subjects were prospectively included. None had received antibiotics in the previous month or any anti-tumor treatment. A stool sample was collected for each participant, and analyzed by shotgun sequencing. The DP8 alpha T cell population was identified and quantified on fresh whole blood by flow cytometry with anti-CD45, anti-CD3, anti-CD4 and anti-CD8 alpha co-labeling.
   Results Twenty-one patients with CRC and 20 controls subjects were included. We found that mean relative abundance of five species was significantly decreased in CRC patients compared with controls, including F. prausnitzii, Barnesiella intestinihominis, Alistipes finegoldii, Bacteroides eggerthii and Eubacterium siraeum. We also found that the DP8 alpha T cell population was significantly decreased in the blood of CRC patients compared with controls.
   Conclusion In our work, we showed that a reduced abundance of F. prausnitzii in CRC patients was associated to a significant decrease in the circulating DP8 alpha Treg population, suggesting a potential involvement of reduced activity of DP8 alpha T cells in colonic carcinogenesis. These findings open new diagnostic and therapeutic strategies for CRC. Copyright (C) 2020 Wolters Kluwer Health, Inc. All rights reserved.
C1 [Touchefeu, Yann; Duchalais, Emilie; des Varannes, Stanislas Bruley; Mirallie, Eric; Matysiak-Budnik, Tamara] CHU Nantes, Inst Malad Appareil Digestif, Nantes, France.
   [Touchefeu, Yann; Duchalais, Emilie; des Varannes, Stanislas Bruley; Matysiak-Budnik, Tamara] Univ Nantes, INSERM, Univ Angers, U1235, Nantes, France.
   [Alameddine, Joudy; Jotereau, Francine] Univ Nantes, Univ Angers, INSERM, CRCINA, Nantes, France.
   [Le Bastard, Quentin; Javaudin, Francois; Montassier, Emmanuel] Univ Nantes, Microbiotas Hosts Antibiot & Bacterial Resistance, F-44000 Nantes, France.
   [Le Bastard, Quentin; Javaudin, Francois; Montassier, Emmanuel] CHU Nantes, Dept Emergency Med, Nantes, France.
   [Rimbert, Marie] CHU Nantes, Lab Immunol, CIMNA, Nantes, France.
   [Rimbert, Marie] Med Univ Nantes, INSERM, UMR 1064, Ctr Rech Transplantat & Immunol CRTI, Nantes, France.
   [Montassier, Emmanuel] Med Univ Nantes, Inst Rech Sante Nantes Biotech 2, EA3826 Therapeut Antiinfect, Nantes, France.
   [Montassier, Emmanuel] CHU Nantes, Surg Intens Care Unit, Hotel Dieu, Nantes, France.
C3 Nantes Universite; CHU de Nantes; Institut National de la Sante et de la
   Recherche Medicale (Inserm); Nantes Universite; Universite d'Angers;
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Nantes Universite; Universite d'Angers; Nantes Universite; Nantes
   Universite; CHU de Nantes; Nantes Universite; CHU de Nantes; Institut
   National de la Sante et de la Recherche Medicale (Inserm); Nantes
   Universite; Nantes Universite; Nantes Universite; CHU de Nantes
RP Montassier, E (corresponding author), Univ Nantes, Microbiotas Hosts Antibiot & Bacterial Resistance, F-44000 Nantes, France.
EM emmanuel.montassier@chu-nantes.fr
RI Jotereau, Francine/AAU-1735-2020; Touchefeu, Yann/AGH-7655-2022;
   Touchefeu, Yann/M-2969-2015
OI Jotereau, Francine/0000-0002-2508-4875; Touchefeu,
   Yann/0000-0001-8421-3182
FU Biocodex SNFGE grant; SNFGE
FX The work was supported by the Biocodex SNFGE grant. E.M. received for
   this work the Robert Tournut grant from the SNFGE.
CR Al-Ghalith GA, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00202-17
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0
   Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017
   Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009
   Danese S, 2011, GUT, V60, P1609, DOI 10.1136/gutjnl-2011-300953
   Daniel SG, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00065-17
   Daniels VW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106913
   de La Cuesta-Zuluag J, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00261-19
   Dziarski R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146162
   Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Eeckhaut V, 2014, GUT, V63, P367, DOI 10.1136/gutjnl-2013-305293
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Godefroy E, 2018, GASTROENTEROLOGY, V155, P1205, DOI 10.1053/j.gastro.2018.06.078
   Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005
   Hopkins MJ, 2002, DIGEST LIVER DIS, V34, pS12, DOI 10.1016/S1590-8658(02)80157-8
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Koundouros N, 2020, BRIT J CANCER, V122, P4, DOI 10.1038/s41416-019-0650-z
   Le Cao KA, 2008, STAT APPL GENET MOL, V7, DOI 10.2202/1544-6115.1390
   Li F, 2013, RAPID COMMUN MASS SP, V27, P24, DOI 10.1002/rcm.6420
   Lo Sasso G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102495
   Lopez-Siles M, 2016, INFLAMM BOWEL DIS, V22, P28, DOI 10.1097/MIB.0000000000000590
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Reeves AE, 2012, INFECT IMMUN, V80, P3786, DOI 10.1128/IAI.00647-12
   Rossi O, 2016, SCI REP-UK, V6, DOI 10.1038/srep18507
   Sarrabayrouse G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001833
   Scholz M, 2016, NAT METHODS, V13, P435, DOI [10.1038/NMETH.3802, 10.1038/nmeth.3802]
   SCHUERERMALY CC, 1994, IMMUNOLOGY, V81, P85
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Tian Y, 2017, GASTROENTEROLOGY, V152, pS354, DOI 10.1016/S0016-5085(17)31445-2
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Yoon K, 2018, J CANCER PREV, V23, P117, DOI 10.15430/JCP.2018.23.3.117
NR 46
TC 4
Z9 4
U1 2
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0954-691X
EI 1473-5687
J9 EUR J GASTROEN HEPAT
JI Eur. J. Gastroenterol. Hepatol.
PD FEB
PY 2021
VL 33
IS 2
BP 149
EP 156
DI 10.1097/MEG.0000000000001842
PG 8
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA ZB6TD
UT WOS:000756971300004
PM 32675782
DA 2022-11-22
ER

PT J
AU Guthrie, L
   Gupta, S
   Daily, J
   Kelly, L
AF Guthrie, Leah
   Gupta, Sanchit
   Daily, Johanna
   Kelly, Libusha
TI Human microbiome signatures of differential colorectal cancer drug
   metabolism
SO NPJ BIOFILMS AND MICROBIOMES
LA English
DT Article
ID BETA-GLUCURONIDASE; ALGORITHM; ALIGNMENT; SEQUENCE; DATABASE; GENES
AB It is well appreciated that microbial metabolism of drugs can influence treatment efficacy. Microbial beta-glucuronidases in the gut can reactivate the excreted, inactive metabolite of irinotecan, a first-line chemotherapeutic for metastatic colorectal cancer. Reactivation causes adverse drug responses, including severe diarrhea. However, a direct connection between irinotecan metabolism and the composition of an individual's gut microbiota has not previously been made. Here, we report quantitative evidence of interindividual variability in microbiome metabolism of the inactive metabolite of irinotecan to its active form. We identify a high turnover microbiota metabotype with potentially elevated risk for irinotecan-dependent adverse drug responses. We link the high turnover metabotype to unreported microbial beta-glucuronidases; inhibiting these enzymes may decrease irinotecan-dependent adverse drug responses in targeted subsets of patients. In total, this study reveals metagenomic mining of the microbiome, combined with metabolomics, as a non-invasive approach to develop biomarkers for colorectal cancer treatment outcomes.
C1 [Guthrie, Leah; Kelly, Libusha] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA.
   [Gupta, Sanchit; Daily, Johanna; Kelly, Libusha] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.
C3 Yeshiva University; Albert Einstein College of Medicine; Yeshiva
   University; Albert Einstein College of Medicine
RP Kelly, L (corresponding author), Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA.; Kelly, L (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA.
EM libusha.kelly@einstein.yu.edu
OI Guthrie, Leah/0000-0002-9144-0110
FU National Science Foundation [OCE 1435993]; predoctoral Training Program
   in Cellular and Molecular Biology and Genetics [5T32GM007491-41];
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007491] Funding
   Source: NIH RePORTER
FX We thank the Albert Einstein College of Medicine Proteomics Core for
   their role in the LC-MS/MS analysis. We would like to thank Sridhar Mani
   (Albert Einstein College of Medicine) and Matt Redinbo (UNC Chapel Hill)
   for helpful comments on the work. This work was supported by a grant
   from the National Science Foundation OCE 1435993 to Libusha Kelly. Leah
   Guthrie is supported by the predoctoral Training Program in Cellular and
   Molecular Biology and Genetics 5T32GM007491-41.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Alexander JL, 2017, NAT REV GASTRO HEPAT, V14, P356, DOI 10.1038/nrgastro.2017.20
   [Anonymous], 2014, INT J CLIN MED, DOI DOI 10.4236/IJCM.2014.57054
   Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P304, DOI 10.1093/nar/28.1.304
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Borenstein E, 2008, P NATL ACAD SCI USA, V105, P14482, DOI 10.1073/pnas.0806162105
   Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249
   Brestoff JR, 2013, NAT IMMUNOL, V14, P676, DOI 10.1038/ni.2640
   Bruno-Barcena JM, 2015, J FUNCT FOODS, V12, P92, DOI 10.1016/j.jff.2014.10.029
   Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Cao Y, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/167249
   Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106
   Core Team R., 2021, R LANG ENV STAT COMP
   Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flores R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039745
   Fujita K.-I., 2015, PHARM RES
   Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107
   Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109
   Greer AK, 2014, DRUG METAB DISPOS, V42, P1392, DOI 10.1124/dmd.114.058016
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Inoue Y, 2009, JPN J CLIN ONCOL, V39, P367, DOI 10.1093/jjco/hyp031
   Kaivosaari S, 2011, XENOBIOTICA, V41, P652, DOI 10.3109/00498254.2011.563327
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Leung JW, 2001, GASTROINTEST ENDOSC, V54, P346, DOI 10.1067/mge.2001.117546
   Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044
   Maroun J A, 2007, Curr Oncol, V14, P13, DOI 10.3747/co.2007.96
   McInnes P., 2010, MANUAL PROCEDURES HU
   Miquel S, 2014, GUT MICROBES, V5, P146, DOI 10.4161/gmic.27651
   Mullangi R, 2010, BIOMED CHROMATOGR, V24, P104, DOI 10.1002/bmc.1345
   Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169
   Ross C. L., 2016, ANAEROBE
   Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097
   Sakurama H, 2014, APPL MICROBIOL BIOT, V98, P4021, DOI 10.1007/s00253-013-5325-8
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011
   Shipkova M, 2005, CLIN CHIM ACTA, V358, P2, DOI 10.1016/j.cccn.2005.02.023
   Simpson E.H., 1949, NATURE
   Slatter JG, 2000, DRUG METAB DISPOS, V28, P423
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051
   Stein Alexander, 2010, Ther Adv Med Oncol, V2, P51, DOI 10.1177/1758834009355164
   Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113
   Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6
   Van Cutsem E, 2015, J CLIN ONCOL, V33, P692, DOI 10.1200/JCO.2014.59.4812
   Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Zerillo MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072572
   Zheng XJ, 2011, J PROTEOME RES, V10, P5512, DOI 10.1021/pr2007945
   Zhong ZY, 2016, ACTA PHARMACOL SIN, V37, P1002, DOI 10.1038/aps.2016.54
NR 60
TC 61
Z9 67
U1 4
U2 32
PU NATURE RESEARCH
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
EI 2055-5008
J9 NPJ BIOFILMS MICROBI
JI npj Biofilms Microbomes
PD NOV 1
PY 2017
VL 3
AR 27
DI 10.1038/s41522-017-0034-1
PG 8
WC Biotechnology & Applied Microbiology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology
GA FO3YV
UT WOS:000416774700001
PM 29104759
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Guindo, CO
   Drancourt, M
   Grine, G
AF Guindo, C. O.
   Drancourt, M.
   Grine, G.
TI Digestive tract methanodrome: Physiological roles of human
   microbiota-associated methanogens
SO MICROBIAL PATHOGENESIS
LA English
DT Article
DE Digestive tract; Human microbiota; Methanogens
ID DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; CULTURED HUMAN
   METHANOGENS; METHANOBREVIBACTER-SMITHII; HUMAN GUT;
   METHANOMASSILIICOCCUS-LUMINYENSIS; RAPID IDENTIFICATION; GENOME
   SEQUENCE; SP NOV.; ARCHAEA
AB Methanogens are the archaea most commonly found in humans, in particular in the digestive tract and are an integral part of the digestive microbiota. They are present in humans from the earliest moments of life and represent the only known source of methane production to date. They are notably detected in humans by microscopy, fluorescent in situ hybridization, molecular biology including PCR-sequencing, metagenomics, matrix-assisted laser desorption ionization time-of-flight mass spectrometry and culture. Methanogens present in the human digestive tract play major roles, in particular the use of hydrogen from the fermentation products of bacteria, thus promoting digestion. They are also involved in the transformation of heavy metals and in the use of trimethylamine produced by intestinal bacteria, thus preventing major health problems, in particular cardiovascular diseases. Several pieces of evidence suggest their close physical contacts with bacteria support symbiotic metabolism. Their imbalance during dysbiosis is associated with many pathologies in humans, particularly digestive tract diseases such as Crohn's disease, ulcerative colitis, diverticulosis, inflammatory bowel disease, irritable bowel syndrome, colonic polyposis, and colorectal cancer. There is a huge deficit of knowledge and partially contradictory information concerning human methanogens, so much remains to be done to fully understand their physiological role in humans. It is necessary to develop new methods for the identification and culture of methanogens from clinical samples. This will permit to isolate new methanogens species as well as their phenotypic characterization, to explore their genome by sequencing and to study the population dynamics of methanogens by specifying in particular their exact role within the complex flora associated with the mucous microbiota of human.
C1 [Guindo, C. O.; Drancourt, M.] IHU Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
   [Guindo, C. O.; Grine, G.] Aix Marseille Univ, IHU Mediterranee Infect, MEPHI, IRD, Marseille, France.
   [Grine, G.] Aix Marseille Univ, UFR Odontol, Marseille, France.
C3 UDICE-French Research Universities; Aix-Marseille Universite; Institut
   de Recherche pour le Developpement (IRD); UDICE-French Research
   Universities; Aix-Marseille Universite; UDICE-French Research
   Universities; Aix-Marseille Universite
RP Grine, G (corresponding author), IHU Mediterranee Infect, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
EM grineghiles@gmail.com
OI Physician, Microbiologist, Project manager in R&D, Postdoc researcher at
   Sorbonne University, Dr Cheick Oumar GUINDO/0000-0002-8436-0825
CR Attaluri A, 2010, AM J GASTROENTEROL, V105, P1407, DOI 10.1038/ajg.2009.655
   Bang C, 2018, EMERG TOP LIFE SCI, V2, P459, DOI 10.1042/ETLS20180035
   BELAY N, 1990, J CLIN MICROBIOL, V28, P1666, DOI 10.1128/JCM.28.7.1666-1668.1990
   Belkacemi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27862-8
   Borrel G, 2013, GENOME ANNOUNCEMENTS, V1, DOI 10.1128/genomeA.00453-13
   Borrel G, 2012, J BACTERIOL, V194, P6944, DOI 10.1128/JB.01867-12
   Brugere JF, 2014, GUT MICROBES, V5, P5, DOI 10.4161/gmic.26749
   Cayrou C, 2010, ENV MICROBIOL REP, V2, P752, DOI 10.1111/j.1758-2229.2010.00176.x
   Chatterjee S, 2007, AM J GASTROENTEROL, V102, P837, DOI 10.1111/j.1572-0241.2007.01072.x
   CHEESEMAN P, 1972, J BACTERIOL, V112, P527, DOI 10.1128/JB.112.1.527-531.1972
   Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017
   Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233
   Dermoumi HL, 2001, CHEMOTHERAPY, V47, P177, DOI 10.1159/000063219
   Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08
   Drancourt M, 2017, CLIN INFECT DIS, V65, P1, DOI 10.1093/cid/cix286
   Dridi B, 2012, CLIN MICROBIOL INFEC, V18, P825, DOI 10.1111/j.1469-0691.2012.03952.x
   Dridi B, 2012, APMIS, V120, P773, DOI 10.1111/j.1600-0463.2012.02899.x
   Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0
   Dridi B, 2012, APMIS, V120, P85, DOI 10.1111/j.1600-0463.2011.02833.x
   Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251
   Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063
   Duca FA, 2014, DIABETES OBES METAB, V16, P68, DOI 10.1111/dom.12340
   Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33
   Faveri M, 2011, J PERIODONTAL RES, V46, P338, DOI 10.1111/j.1600-0765.2011.01347.x
   FERRARI A, 1994, CURR MICROBIOL, V29, P7, DOI 10.1007/BF01570184
   FIEDOREK SC, 1990, J PEDIATR GASTR NUTR, V10, P473, DOI 10.1097/00005176-199005000-00010
   Fournier PE, 2009, J MED MICROBIOL, V58, P1154, DOI 10.1099/jmm.0.009647-0
   Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062
   Garcia JL, 2000, ANAEROBE, V6, P205, DOI 10.1006/anae.2000.0345
   Ghoshal UC, 2011, J NEUROGASTROENTEROL, V17, P185, DOI 10.5056/jnm.2011.17.2.185
   Grine G, 2017, EUR J CLIN MICROBIOL, V36, P2449, DOI 10.1007/s10096-017-3084-7
   Grine G, 2019, EBIOMEDICINE, V43, P333, DOI 10.1016/j.ebiom.2019.04.037
   Grine G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27372-7
   Guindo CO, 2020, ANAEROBE, V61, DOI 10.1016/j.anaerobe.2019.102128
   Haag AM, 1998, J MASS SPECTROM, V33, P750, DOI 10.1002/(SICI)1096-9888(199808)33:8<750::AID-JMS680>3.0.CO;2-1
   Harwood VJ, 2014, FEMS MICROBIOL REV, V38, P1, DOI 10.1111/1574-6976.12031
   Huynh Hong T T, 2017, BMC Res Notes, V10, P657, DOI 10.1186/s13104-017-2980-3
   Juneau D.M., 2016, ATHEROSCLEROSE ROLE
   Khelaifia S., 2017, New Microbes and New Infections, V15, P44, DOI 10.1016/j.nmni.2016.11.012
   Khelaifia S., 2016, New Microbes and New Infections, V12, P96, DOI 10.1016/j.nmni.2016.05.007
   Khelaifia S, 2016, EUR J CLIN MICROBIOL, V35, P985, DOI 10.1007/s10096-016-2627-7
   Khelaifia S, 2012, CLIN MICROBIOL INFEC, V18, P841, DOI 10.1111/j.1469-0691.2012.03913.x
   Khelaifia S, 2013, INT J ANTIMICROB AG, V41, P544, DOI 10.1016/j.ijantimicag.2013.02.013
   Kim G, 2012, DIGEST DIS SCI, V57, P3213, DOI 10.1007/s10620-012-2197-1
   Kulik EM, 2001, FEMS MICROBIOL LETT, V196, P129, DOI 10.1111/j.1574-6968.2001.tb10553.x
   Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]
   Lecours PB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087734
   Lee KM, 2013, EUR J GASTROEN HEPAT, V25, P726, DOI 10.1097/MEG.0b013e32835eb916
   Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101
   Luton P.E., MCRA GENE ALTERNATIV, P10
   Lyu Z, 2018, CURR BIOL, V28, pR727, DOI 10.1016/j.cub.2018.05.021
   Lyu Z, 2018, ISME J, V12, P411, DOI 10.1038/ismej.2017.173
   Marklein G, 2009, J CLIN MICROBIOL, V47, P2912, DOI 10.1128/JCM.00389-09
   Mbakwa CA, 2015, OBESITY, V23, P2508, DOI 10.1002/oby.21266
   MCKAY LF, 1985, GUT, V26, P69, DOI 10.1136/gut.26.1.69
   Meyer J, 2008, SYST APPL MICROBIOL, V31, P81, DOI 10.1016/j.syapm.2008.02.001
   MILLER TL, 1982, ARCH MICROBIOL, V131, P14, DOI 10.1007/BF00451492
   Million M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26051
   Moissl-Eichinger C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04197-4
   Nagy E, 2009, CLIN MICROBIOL INFEC, V15, P796, DOI 10.1111/j.1469-0691.2009.02788.x
   Nkamga VD, 2018, CLIN MICROBIOL INFEC, V24, P207, DOI 10.1016/j.cmi.2017.08.021
   Nkamga VD, 2016, CLIN MICROBIOL INFEC, V22, P1008, DOI 10.1016/j.cmi.2016.09.007
   Nkamga VD, 2017, INT J ANTIMICROB AG, V49, P176, DOI 10.1016/j.ijantimicag.2016.09.026
   Nkamga VD, 2017, HUM MICROBIOME J, V3, P1, DOI [10.1016/j.humic.2016.11.005, DOI 10.1016/J.HUMIC.2016.11.005]
   NOTTINGHAM PM, 1968, J BACTERIOL, V96, P2178, DOI 10.1128/JB.96.6.2178-2179.1968
   Oxley APA, 2010, ENVIRON MICROBIOL, V12, P2398, DOI 10.1111/j.1462-2920.2010.02212.x
   Pignone M, 2006, J CLIN MICROBIOL, V44, P1963, DOI 10.1128/JCM.01959-05
   Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6
   Pimentel M, 2003, DIGEST DIS SCI, V48, P86, DOI 10.1023/A:1021738515885
   PIQUE JM, 1984, GASTROENTEROLOGY, V87, P601
   Randrianarisoa E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26745
   RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994
   Ruaud A, 2020, MBIO, V11, DOI 10.1128/mBio.03235-19
   Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   Sereme Y, 2019, CLIN REV ALLERG IMMU, V57, P456, DOI 10.1007/s12016-019-08766-5
   Sogodogo E, 2019, EUR J CLIN MICROBIOL, V38, P811, DOI 10.1007/s10096-019-03510-5
   Sogodogo E, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0929-8
   Sogodogo E, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00038
   Stewart JA, 2006, LETT APPL MICROBIOL, V43, P58, DOI 10.1111/j.1472-765X.2006.01906.x
   Stingu CS, 2008, ORAL MICROBIOL IMMUN, V23, P372, DOI 10.1111/j.1399-302X.2008.00438.x
   Togo AH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54759-x
   Triantafyllou K, 2014, J NEUROGASTROENTEROL, V20, P31, DOI 10.5056/jnm.2014.20.1.31
   Tung NH, 2013, APMIS, V121, P467, DOI 10.1111/apm.12015
   Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618
   Vanwonterghem I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.170, 10.1038/nmicrobiol.2016.170]
   Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006
   WEAVER GA, 1986, GUT, V27, P698, DOI 10.1136/gut.27.6.698
   Yamaguchi Y, 2016, DIGESTION, V94, P66, DOI 10.1159/000447690
   Yazici C, 2016, DIGEST DIS SCI, V61, P2648, DOI 10.1007/s10620-016-4174-6
   Zeppa SD, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010017
   Zhang HS, 2009, P NATL ACAD SCI USA, V106, P2365, DOI 10.1073/pnas.0812600106
NR 92
TC 4
Z9 4
U1 2
U2 14
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0882-4010
J9 MICROB PATHOGENESIS
JI Microb. Pathog.
PD DEC
PY 2020
VL 149
AR 104425
DI 10.1016/j.micpath.2020.104425
PG 8
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA PG4MS
UT WOS:000599711600002
PM 32745665
OA Green Published, Bronze
DA 2022-11-22
ER

PT J
AU Olszewska, J
   Jagusztyn-Krynicka, EK
AF Olszewska, Joanna
   Jagusztyn-Krynicka, Elzbieta Katarzyna
TI Human Microbiome Project - influence of gut microbiota on human
   physiology and health
SO POSTEPY MIKROBIOLOGII
LA Polish
DT Article
DE HMP (Human Microbiome Project); gut microbiota; cancer; obesity
ID BUTYRATE-PRODUCING BACTERIA; 16S RIBOSOMAL-RNA; LACTIC-ACID BACTERIA;
   DIET-INDUCED OBESITY; TIME PCR ANALYSIS; GENOME SEQUENCE; COLON-CANCER;
   METAGENOMIC ANALYSIS; ANAEROBIC-BACTERIA; COLORECTAL-CANCER
AB The HMP (Human Microbiome Project) is one of several international projects which use metagenomic analysis to study human health. The HMP is a logical conceptual and experimental extension of Human Genome Project. The first part of the review presents general characteristic of the project, its goals and implementation phases.
   The gastrointestinal tract microbiota is extremely dense and diverse. Microbiota genes encode many biochemical pathways that humans have not evolved. Gut microbiota composition is influenced by human age, diet and genotype and its shifts are associated with many diseases. This review summarizes the latest research concerning the association of gut microbial ecology with the mechanisms by which microbes in the gut may mediate host physiology and metabolism in the context of obesity and cancer.
C1 [Olszewska, Joanna; Jagusztyn-Krynicka, Elzbieta Katarzyna] Uniwersytetu Warszawskiego, Zaklad Genetyki Bakterii, Inst Mikrobiol, PL-02096 Warsaw, Poland.
C3 University of Warsaw
RP Jagusztyn-Krynicka, EK (corresponding author), Uniwersytetu Warszawskiego, Zaklad Genetyki Bakterii, Inst Mikrobiol, Ul Miecznikowa 1, PL-02096 Warsaw, Poland.
EM kjkryn@biol.uw.edu.pl
OI Banasiewicz, Joanna/0000-0001-7626-422X; Jagusztyn-Krynicka,
   Elzbieta/0000-0003-0484-9290
CR Aziz RK, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-21
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x
   Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000
   Bauer Eva, 2006, Current Issues in Intestinal Microbiology, V7, P35
   Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006
   BENNO Y, 1989, APPL ENVIRON MICROB, V55, P1100, DOI 10.1128/AEM.55.5.1100-1105.1989
   Carroll IM, 2009, MAMM GENOME, V20, P395, DOI 10.1007/s00335-009-9204-7
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Davies J, 2001, SCIENCE, V291, P2316
   Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
   Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013
   Di Sabatino A, 2005, ALIMENT PHARM THER, V22, P789, DOI 10.1111/j.1365-2036.2005.02639.x
   Dove W.F., 1977, CANCER RES, V57, P812
   Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x
   Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Engle SJ, 2002, CANCER RES, V62, P6362
   Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106
   Favier CF, 2003, ANAEROBE, V9, P219, DOI 10.1016/j.anaerobe.2003.07.001
   Florin THJ, 2000, AM J GASTROENTEROL, V95, P2872, DOI 10.1016/S0002-9270(00)01111-4
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336
   Fricke WF, 2006, J BACTERIOL, V188, P642, DOI 10.1128/JB.188.2.642-658.2006
   Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020
   Gantois I, 2006, APPL ENVIRON MICROB, V72, P946, DOI 10.1128/AEM.72.1.946-949.2006
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Goodacre R, 2007, J NUTR, V137, p259S, DOI 10.1093/jn/137.1.259S
   Haarman M, 2006, APPL ENVIRON MICROB, V72, P2359, DOI 10.1128/AEM.72.4.2359-2365.2006
   Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004
   Harmsen HJM, 2000, J PEDIATR GASTR NUTR, V30, P61, DOI 10.1097/00005176-200001000-00019
   Hattori M, 2009, DNA RES, V16, P1, DOI 10.1093/dnares/dsn033
   Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x
   Hebuterne X, 2003, CURR OPIN CLIN NUTR, V6, P49, DOI 10.1097/00075197-200301000-00008
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002
   Hold GL, 2002, FEMS MICROBIOL ECOL, V39, P33, DOI 10.1111/j.1574-6941.2002.tb00904.x
   Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08
   Hughes DT, 2010, P NATL ACAD SCI USA, V107, P9831, DOI 10.1073/pnas.1002551107
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Ivanov II, 2011, CURR OPIN MICROBIOL, V14, P106, DOI 10.1016/j.mib.2010.12.003
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Jacobasch G, 1999, INT J COLORECTAL DIS, V14, P201, DOI 10.1007/s003840050212
   JENSEN NS, 1986, APPL ENVIRON MICROB, V52, P880, DOI 10.1128/AEM.52.4.880-887.1986
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Khachatryan ZA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003064
   Kitahara M, 2005, INT J SYST EVOL MICR, V55, P2143, DOI 10.1099/ijs.0.63788-0
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018
   Lederberg J, 2001, SCIENTIST, V15, P8
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Lunn JC, 2007, CARCINOGENESIS, V28, P685, DOI 10.1093/carcin/bgl192
   Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448
   Mai V, 2004, NUTR REV, V62, P235, DOI 10.1301/nr2004.jun235-242
   Mai V, 2003, CANCER RES, V63, P1752
   Mai V, 2009, WORLD J GASTROENTERO, V15, P81, DOI 10.3748/wjg.15.81
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Martin R, 2003, J PEDIATR-US, V143, P754, DOI 10.1016/j.jpeds.2003.09.028
   Matsuki T, 2004, APPL ENVIRON MICROB, V70, P7220, DOI 10.1128/AEM.70.12.7220-7228.2004
   Matsumiya Yoshiko, 2002, Journal of Infection and Chemotherapy, V8, P43
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98
   MCNEIL NI, 1984, AM J CLIN NUTR, V39, P338, DOI 10.1093/ajcn/39.2.338
   Mihajlovski A, 2008, RES MICROBIOL, V159, P516, DOI 10.1016/j.resmic.2008.06.007
   Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Relman DA, 2002, J INFECT DIS, V186, pS254, DOI 10.1086/344935
   Relman DA, 2001, TRENDS MICROBIOL, V9, P206, DOI 10.1016/S0966-842X(01)02041-8
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005
   SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79
   Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08
   Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105
   Shade A, 2012, ENVIRON MICROBIOL, V14, P4, DOI 10.1111/j.1462-2920.2011.02585.x
   STAMS AJM, 1994, ANTON LEEUW INT J G, V66, P271, DOI 10.1007/BF00871644
   Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026
   VANDEMERWE JP, 1983, A VAN LEEUW J MICROB, V49, P119, DOI 10.1007/BF00393669
   Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x
   Watson AJM, 2006, CRIT REV ONCOL HEMAT, V57, P107, DOI 10.1016/j.critrevonc.2005.06.005
   Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z
   Zoetendal EG, 2006, MOL MICROBIOL, V59, P1639, DOI 10.1111/j.1365-2958.2006.05056.x
   Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854
   Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669
NR 96
TC 13
Z9 15
U1 2
U2 79
PU POLSKIE TOWARZYSTWO MIKROBIOLOGOW-POLISH SOCIETY OF MICROBIOLOGISTS
PI WARSAW
PA CHELMSKA STR 30-34, WARSAW, 00-725, POLAND
SN 0079-4252
EI 2545-3149
J9 POSTEP MIKROBIOL
JI Postep. Mikrobiol.
PD OCT-DEC
PY 2012
VL 51
IS 4
BP 243
EP 256
PG 14
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 068XP
UT WOS:000313399800002
DA 2022-11-22
ER

PT J
AU Hamada, T
   Nowak, JA
   Milner, DA
   Song, MY
   Ogino, S
AF Hamada, Tsuyoshi
   Nowak, Jonathan A.
   Milner, Danny A., Jr.
   Song, Mingyang
   Ogino, Shuji
TI Integration of microbiology, molecular pathology, and epidemiology: a
   new paradigm to explore the pathogenesis of microbiome-driven neoplasms
SO JOURNAL OF PATHOLOGY
LA English
DT Review
DE biobank; bioinformatics; causal inference; cohort study; immunity;
   inflammation; microbiota; population health science; statistics;
   translational research
ID COLORECTAL-CANCER DIAGNOSIS; ISLAND METHYLATOR PHENOTYPE; SQUAMOUS-CELL
   CARCINOMA; LIFE-STYLE FACTORS; BODY-MASS INDEX; FUSOBACTERIUM-NUCLEATUM;
   HUMAN-PAPILLOMAVIRUS; GUT MICROBIOTA; MICROSATELLITE INSTABILITY;
   HEPATOCELLULAR-CARCINOMA
AB Molecular pathological epidemiology (MPE) is an integrative transdisciplinary field that addresses heterogeneous effects of exogenous and endogenous factors (collectively termed 'exposures'), including microorganisms, on disease occurrence and consequences, utilising molecular pathological signatures of the disease. In parallel with the paradigm of precision medicine, findings from MPE research can provide aetiological insights into tailored strategies of disease prevention and treatment. Due to the availability of molecular pathological tests on tumours, the MPE approach has been utilised predominantly in research on cancers including breast, lung, prostate, and colorectal carcinomas. Mounting evidence indicates that the microbiome (inclusive of viruses, bacteria, fungi, and parasites) plays an important role in a variety of human diseases including neoplasms. An alteration of the microbiome may be not only a cause of neoplasia but also an informative biomarker that indicates or mediates the association of an epidemiological exposure with health conditions and outcomes. To adequately educate and train investigators in this emerging area, we herein propose the integration of microbiology into the MPE model (termed 'microbiology-MPE'), which could improve our understanding of the complex interactions of environment, tumour cells, the immune system, and microbes in the tumour microenvironment during the carcinogenic process. Using this approach, we can examine how lifestyle factors, dietary patterns, medications, environmental exposures, and germline genetics influence cancer development and progression through impacting the microbial communities in the human body. Further integration of other disciplines (e.g. pharmacology, immunology, nutrition) into microbiology-MPE would expand this developing research frontier. With the advent of high-throughput next-generation sequencing technologies, researchers now have increasing access to large-scale metagenomics as well as other omics data (e.g. genomics, epigenomics, proteomics, and metabolomics) in population-based research. The integrative field of microbiology-MPE will open new opportunities for personalised medicine and public health. Copyright (c) 2019 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.
C1 [Hamada, Tsuyoshi; Ogino, Shuji] Dana Farber Canc Inst, Dept Oncol Pathol, Boston, MA 02115 USA.
   [Hamada, Tsuyoshi; Nowak, Jonathan A.; Song, Mingyang; Ogino, Shuji] Harvard Med Sch, Boston, MA 02215 USA.
   [Hamada, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.
   [Nowak, Jonathan A.; Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, 75 Francis St, Boston, MA 02115 USA.
   [Milner, Danny A., Jr.] Amer Soc Clin Pathologists, Chicago, IL USA.
   [Song, Mingyang; Ogino, Shuji] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Song, Mingyang] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA 02114 USA.
   [Song, Mingyang] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Ogino, Shuji] Broad Inst Massachusetts Inst Technol & Harvard, Cambridge, MA USA.
C3 Harvard University; Dana-Farber Cancer Institute; Harvard University;
   Harvard Medical School; University of Tokyo; Harvard University; Brigham
   & Women's Hospital; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard T.H. Chan School of Public
   Health; Harvard University; Massachusetts General Hospital; Harvard
   University; Massachusetts General Hospital; Harvard University;
   Massachusetts Institute of Technology (MIT); Broad Institute
RP Ogino, S (corresponding author), Brigham & Womens Hosp, Program MPE Mol Pathol Epidemiol, 450 Brookline Ave,Room SM1036, Boston, MA 02215 USA.
EM sogino@bwh.harvard.edu
OI Ogino, Shuji/0000-0002-3909-2323
FU US National Institutes of Health (NIH) [K99 CA215314, R00 CA215314, R35
   CA197735]; American Cancer Society [MRSG-17-220-01-NEC]; Nodal Award
   from the Dana-Farber Harvard Cancer Center [2016-02]; Friends of the
   Dana-Farber Cancer Institute; NATIONAL CANCER INSTITUTE [R00CA215314,
   K99CA215314, R35CA197735] Funding Source: NIH RePORTER
FX This work was supported by US National Institutes of Health (NIH) grants
   (K99 CA215314 and R00 CA215314 to MS; R35 CA197735 to SO); by the
   American Cancer Society (MRSG-17-220-01-NEC to MS); by a Nodal Award
   (2016-02) from the Dana-Farber Harvard Cancer Center (to SO); and by The
   Friends of the Dana-Farber Cancer Institute. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of NIH. The funding source had no role in the decision to
   submit the manuscript to publication or preparation, review, and
   approval of the manuscript.
CR Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Akshintala VS, 2019, CLIN GASTROENTEROL H, V17, P290, DOI 10.1016/j.cgh.2018.08.045
   Alexander JL, 2018, ECANCERMEDICALSCIENC, V12, DOI 10.3332/ecancer.2018.865
   Alexander JL, 2017, NAT REV GASTRO HEPAT, V14, P356, DOI 10.1038/nrgastro.2017.20
   Alnabulsi A, 2016, EXPERT REV PROTEOMIC, V13, P917, DOI 10.1080/14789450.2016.1233062
   Amitay EL, 2019, JNCI-J NATL CANCER I, V111, P475, DOI 10.1093/jnci/djy170
   [Anonymous], CANC PREV RES PHILA
   Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449
   Bae JM, 2013, BRIT J CANCER, V109, P1004, DOI 10.1038/bjc.2013.430
   Bashir A, 2016, TUMOR BIOL, V37, P2805, DOI 10.1007/s13277-015-4724-0
   Begg CB, 2015, CANCER MED-US, V4, P1432, DOI 10.1002/cam4.456
   Begg CB, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-138
   Begg CB, 2013, STAT MED, V32, P5039, DOI 10.1002/sim.5902
   Benelli R, 2018, TRANSL RES, V196, P42, DOI 10.1016/j.trsl.2018.01.003
   Berntsson J, 2017, INT J CANCER, V141, P1654, DOI 10.1002/ijc.30869
   Bomhof MR, 2019, EUR J NUTR, V58, P1735, DOI 10.1007/s00394-018-1721-2
   Brandi G, 2017, CARCINOGENESIS, V38, P231, DOI 10.1093/carcin/bgx007
   Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513
   Brenner H, 2018, BRIT J CANCER, V119, P785, DOI 10.1038/s41416-018-0264-x
   Buchanan DD, 2013, CANCER EPIDEM BIOMAR, V22, P917, DOI 10.1158/1055-9965.EPI-12-1211
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Bullman S, 2017, ANNU REV PATHOL-MECH, V12, P217, DOI 10.1146/annurev-pathol-012615-044305
   Campbell P, 2017, CANCER CAUSE CONTROL, V28, P167, DOI 10.1007/s10552-016-0845-z
   Campbell PT, 2015, CANCER EPIDEM BIOMAR, V24, P1229, DOI 10.1158/1055-9965.EPI-15-0094
   Campbell PT, 2014, CANCER EPIDEM BIOMAR, V23, P2694, DOI 10.1158/1055-9965.EPI-14-0541
   Cani PD, 2018, NAT REV GASTRO HEPAT, V15, P671, DOI 10.1038/s41575-018-0025-6
   Cao Y, 2016, GASTROENTEROLOGY, V151, P879, DOI 10.1053/j.gastro.2016.07.030
   Capurso G, 2017, BEST PRACT RES CL GA, V31, P579, DOI 10.1016/j.bpg.2017.10.006
   Carr PR, 2018, ANN ONCOL, V29, P825, DOI 10.1093/annonc/mdy059
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chatterjee N, 2010, BIOMETRIKA, V97, P683, DOI 10.1093/biomet/asq036
   Chen J, 2017, SEMIN IMMUNOL, V32, P25, DOI 10.1016/j.smim.2017.08.001
   Chen J, 2017, SEMIN IMMUNOL, V32, P43, DOI 10.1016/j.smim.2017.09.006
   Chen LL, 2018, GASTROENTEROLOGY, V155, P1177, DOI 10.1053/j.gastro.2018.06.034
   Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137
   Coleman HG, 2018, GASTROENTEROLOGY, V154, P390, DOI 10.1053/j.gastro.2017.07.046
   Cremonesi E, 2018, GUT, V67, P1984, DOI 10.1136/gutjnl-2016-313498
   Cummings P, 2013, JAMA PEDIATR, V167, P656, DOI 10.1001/jamapediatrics.2013.1329
   Curtin K., 2011, PATHOL RES INT
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Degasperi E, 2016, LANCET GASTROENTEROL, V1, P156, DOI 10.1016/S2468-1253(16)30018-8
   Delaune V, 2018, EXPERT OPIN BIOL TH, V18, P1061, DOI 10.1080/14712598.2018.1518424
   Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126
   Dillon MT, 2015, J CLIN ONCOL, V33, P3251, DOI 10.1200/JCO.2015.60.7804
   Ding CB, 2018, ONCOTARGETS THER, V11, P4797, DOI 10.2147/OTT.S170626
   Dong TS, 2019, CLIN GASTROENTEROL H, V17, P231, DOI 10.1016/j.cgh.2018.08.067
   Efremova M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01679
   Epplein M, 2014, CANCER EPIDEM BIOMAR, V23, P2613, DOI 10.1158/1055-9965.EPI-14-0848
   Fakhry C, 2014, JAMA-J AM MED ASSOC, V312, P1465, DOI 10.1001/jama.2014.13183
   Fathi N, 2019, BIOMED PHARMACOTHER, V109, P391, DOI 10.1016/j.biopha.2018.10.102
   Feng QQ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00151
   Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501
   Finotello F, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00430
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Fletcher R, 2018, BBA-REV CANCER, V1869, P138, DOI 10.1016/j.bbcan.2017.12.002
   Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0
   Franzen A, 2018, ONCOTARGET, V9, P641, DOI 10.18632/oncotarget.23080
   Fridman WH, 2017, NAT REV CLIN ONCOL, V14, P717, DOI 10.1038/nrclinonc.2017.101
   Fujiwara N, 2018, J HEPATOL, V68, P526, DOI 10.1016/j.jhep.2017.09.016
   Fuks G, 2018, MICROBIOME, V6, DOI 10.1186/s40168-017-0396-x
   Fung N, 2017, CANCER METAST REV, V36, P449, DOI 10.1007/s10555-017-9686-9
   Galipeau PC, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0520-y
   Gao C, 2016, WORLD J HEPATOL, V8, P1119, DOI 10.4254/wjh.v8.i27.1119
   Germano G, 2017, NATURE, V552, P116, DOI 10.1038/nature24673
   Gholizadeh P, 2017, BIOMED PHARMACOTHER, V89, P918, DOI 10.1016/j.biopha.2017.02.102
   Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Gopalakrishnan V, 2018, CANCER CELL, V33, P570, DOI 10.1016/j.ccell.2018.03.015
   Grasso CS, 2018, CANCER DISCOV, V8, P730, DOI 10.1158/2159-8290.CD-17-1327
   Grizzi F, 2018, INFLAMM RES, V67, P375, DOI 10.1007/s00011-017-1128-1
   Gronich N, 2013, NAT REV CLIN ONCOL, V10, P625, DOI 10.1038/nrclinonc.2013.169
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Hadrich D, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00212
   Haendel MA, 2018, NEW ENGL J MED, V379, P1452, DOI 10.1056/NEJMra1615014
   Hamada T, 2019, JNCI-J NATL CANCER I, V111, P42, DOI 10.1093/jnci/djy137
   Hamada T, 2018, CANCER IMMUNOL RES, V6, P1327, DOI 10.1158/2326-6066.CIR-18-0174
   Hamada T, 2018, EUR J CANCER, V103, P98, DOI 10.1016/j.ejca.2018.07.130
   Hamada T, 2017, ONCOTARGET, V8, P73370, DOI 10.18632/oncotarget.20877
   Hamada T, 2017, J CLIN ONCOL, V35, P1836, DOI 10.1200/JCO.2016.70.7547
   Hamada T, 2017, J GASTROENTEROL, V52, P265, DOI 10.1007/s00535-016-1272-3
   Hanyuda A, 2016, INT J CANCER, V139, P854, DOI 10.1002/ijc.30122
   Healey GR, 2017, NUTR REV, V75, P1059, DOI 10.1093/nutrit/nux062
   Hendler Robert, 2018, Medicines (Basel), V5, DOI 10.3390/medicines5030101
   Hoyles L, 2018, NAT MED, V24, P1070, DOI 10.1038/s41591-018-0061-3
   Hughes LAE, 2017, CURR COLORECT CANC R, V13, P455, DOI 10.1007/s11888-017-0395-0
   Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005
   Inamura K, 2018, CANCERS, V10, DOI 10.3390/cancers10010026
   Ishitsuka K, 2014, LANCET ONCOL, V15, pE517, DOI 10.1016/S1470-2045(14)70202-5
   Jackson MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05184-7
   Jacobi C, 2015, ONCOTARGET, V6, P3462, DOI 10.18632/oncotarget.3062
   Janakiram NB, 2016, MOL NUTR FOOD RES, V60, P1275, DOI 10.1002/mnfr.201500884
   Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119
   Jiang MJ, 2016, BBA-REV CANCER, V1866, P163, DOI 10.1016/j.bbcan.2016.08.002
   Kai K, 2018, WORLD J GASTROENTERO, V24, P58, DOI 10.3748/wjg.v24.i1.58
   Kaplan CW, 2010, INFECT IMMUN, V78, P4773, DOI 10.1128/IAI.00567-10
   Kensler TW, 2016, CANCER PREV RES, V9, P2, DOI 10.1158/1940-6207.CAPR-15-0406
   Khalili H, 2015, CARCINOGENESIS, V36, P999, DOI 10.1093/carcin/bgv086
   Kjellberg L, 2000, BRIT J CANCER, V82, P1332, DOI 10.1054/bjoc.1999.1100
   Koh H, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky058
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kosumi Keisuke, 2018, J Lab Precis Med, V3, DOI 10.21037/jlpm.2018.09.05
   Kosumi K, 2018, AM J PATHOL, V188, P2839, DOI 10.1016/j.ajpath.2018.08.015
   Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65
   Kuller LH, 2013, AM J EPIDEMIOL, V178, P1350, DOI 10.1093/aje/kwt239
   Kurnit KC, 2018, CLIN CANCER RES, V24, P2719, DOI 10.1158/1078-0432.CCR-17-2494
   Kuroiwa-Trzmielina J, 2016, CLIN CANCER RES, V22, P6266, DOI 10.1158/1078-0432.CCR-15-2765
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lasry A, 2016, NAT IMMUNOL, V17, P230, DOI 10.1038/ni.3384
   Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733
   Lee DH, 2016, AM J PUBLIC HEALTH, V106, P1599, DOI 10.2105/AJPH.2016.303320
   Leemans CR, 2018, NAT REV CANCER, V18, P269, DOI 10.1038/nrc.2018.11
   Lesseur C, 2016, NAT GENET, V48, P1544, DOI 10.1038/ng.3685
   Levine A, 2018, GUT, V67, P1726, DOI 10.1136/gutjnl-2017-315866
   Li SKH, 2016, TRENDS MOL MED, V22, P274, DOI 10.1016/j.molmed.2016.02.003
   Li WB, 2015, ONCOTARGET, V6, P39607, DOI 10.18632/oncotarget.5551
   Li YY, 2016, WORLD J GASTROENTERO, V22, P3227, DOI 10.3748/wjg.v22.i11.3227
   Lin JH, 2014, CURR COLORECT CANC R, V10, P94, DOI 10.1007/s11888-014-0208-7
   Liu CX, 2018, J OTOLARYNGOL-HEAD N, V47, DOI 10.1186/s40463-018-0302-y
   Liu L, 2018, EUR J EPIDEMIOL, V33, P381, DOI 10.1007/s10654-017-0346-8
   Liu L, 2018, CLIN GASTROENTEROL H, V16, P1622, DOI 10.1016/j.cgh.2018.04.030
   Liu L, 2017, GASTROENTEROLOGY, V153, P1517, DOI 10.1053/j.gastro.2017.08.045
   Low GM, 2016, ORAL ONCOL, V61, P27, DOI 10.1016/j.oraloncology.2016.08.002
   Maier L, 2017, CURR OPIN MICROBIOL, V39, P128, DOI 10.1016/j.mib.2017.11.001
   Manieri NA, 2017, TRENDS IMMUNOL, V38, P20, DOI 10.1016/j.it.2016.10.002
   Martinez-Useros J, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0772-5
   Massarelli E, 2019, JAMA ONCOL, V5, P67, DOI 10.1001/jamaoncol.2018.4051
   Masugi Y, 2017, CANCER IMMUNOL RES, V5, P1046, DOI 10.1158/2326-6066.CIR-17-0122
   Masugi Y, 2017, GUT, V66, P1463, DOI 10.1136/gutjnl-2016-311421
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Mehta RS, 2017, JAMA ONCOL, V3, P921, DOI 10.1001/jamaoncol.2016.6374
   Michel P, 2018, DIGEST LIVER DIS, V50, P305, DOI 10.1016/j.dld.2017.12.023
   Mima K, 2017, SURG ONCOL, V26, P368, DOI 10.1016/j.suronc.2017.07.011
   Mima K, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.53
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Molloy MP, 2018, EXPERT REV GASTROENT, V12, P1179, DOI 10.1080/17474124.2018.1535897
   Morgillo F, 2018, NEOPLASIA, V20, P721, DOI 10.1016/j.neo.2018.05.002
   Morris LGT, 2017, JAMA ONCOL, V3, P244, DOI 10.1001/jamaoncol.2016.1790
   Murphy N, 2018, NAT REV GASTRO HEPAT, V15, P659, DOI 10.1038/s41575-018-0038-1
   Myte R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196233
   Nevo D, 2018, LIFETIME DATA ANAL, V24, P425, DOI 10.1007/s10985-017-9401-8
   Ng JMK, 2015, INT J MOL SCI, V16, P2472, DOI 10.3390/ijms16022472
   Nguyen A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01553
   Nichols AC, 2013, JAMA OTOLARYNGOL, V139, P617, DOI 10.1001/jamaoto.2013.3210
   Niederreiter L, 2018, DIGEST LIVER DIS, V50, P647, DOI 10.1016/j.dld.2018.03.030
   Nishihara R, 2015, EUR J EPIDEMIOL, V30, P1129, DOI 10.1007/s10654-015-0088-4
   Nosho K, 2016, WORLD J GASTROENTERO, V22, P557, DOI 10.3748/wjg.v22.i2.557
   Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774
   Nosrati N, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102050
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244
   Ogino S, 2019, ANNU REV PATHOL-MECH, V14, P83, DOI 10.1146/annurev-pathmechdis-012418-012818
   Ogino S, 2018, LANCET, V391, P2084, DOI 10.1016/S0140-6736(18)30953-X
   Ogino S, 2018, GUT, V67, P1168, DOI 10.1136/gutjnl-2017-315537
   Ogino S, 2017, NPJ PRECIS ONCOL, V1, DOI 10.1038/s41698-017-0042-x
   Ogino S, 2017, CANCER RES, V77, DOI 10.1158/1538-7445.CRC16-IA28
   Ogino S, 2016, EPIDEMIOLOGY, V27, P602, DOI 10.1097/EDE.0000000000000471
   Ogino S, 2015, CANCER CAUSE CONTROL, V26, P959, DOI 10.1007/s10552-015-0596-2
   Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214
   Ogino S, 2012, AM J EPIDEMIOL, V176, P659, DOI 10.1093/aje/kws226
   Ogino S, 2012, INT J EPIDEMIOL, V41, P1072, DOI 10.1093/ije/dys076
   Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]
   Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122
   Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182
   Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031
   Ogino S, 2009, CLIN CANCER RES, V15, P6412, DOI 10.1158/1078-0432.CCR-09-1438
   Osman MA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00767
   Outh-Gauer S, 2018, CANCER TREAT REV, V65, P54, DOI 10.1016/j.ctrv.2018.02.008
   Overman MJ, 2017, LANCET ONCOL, V18, P1182, DOI 10.1016/S1470-2045(17)30422-9
   Pandolfi F, 2017, CLIN THER, V39, P884, DOI 10.1016/j.clinthera.2017.03.012
   Patil H, 2017, DRUG DISCOV TODAY, V22, P111, DOI 10.1016/j.drudis.2016.09.022
   Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109
   Petrosino JF, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0525-6
   Phipps AI, 2015, GASTROENTEROLOGY, V148, P77, DOI 10.1053/j.gastro.2014.09.038
   Phipps AI, 2012, CANCER EPIDEM BIOMAR, V21, P1792, DOI 10.1158/1055-9965.EPI-12-0674
   Prakadan SM, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.15
   Psyrri A, 2014, ANN ONCOL, V25, P2101, DOI 10.1093/annonc/mdu265
   Punt CJA, 2017, NAT REV CLIN ONCOL, V14, P235, DOI 10.1038/nrclinonc.2016.171
   Rajpoot M, 2018, SEMIN CANCER BIOL, V52, P1, DOI 10.1016/j.semcancer.2018.02.003
   Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084
   Rescigno T, 2017, MOLECULES, V22, DOI 10.3390/molecules22010105
   Rettig EM, 2015, SURG ONCOL CLIN N AM, V24, P379, DOI 10.1016/j.soc.2015.03.001
   Richiardi L, 2017, EUR J EPIDEMIOL, V32, P353, DOI 10.1007/s10654-017-0253-z
   Riley JM, 2018, CANCER-AM CANCER SOC, V124, P1650, DOI 10.1002/cncr.31214
   Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348
   Rosner B, 2013, AM J EPIDEMIOL, V178, P296, DOI 10.1093/aje/kws457
   Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240
   Routy B, 2018, NAT REV CLIN ONCOL, V15, P382, DOI 10.1038/s41571-018-0006-2
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Russo E, 2016, THER ADV GASTROENTER, V9, P594, DOI 10.1177/1756283X16635082
   Sarkaria JN, 1999, CANCER RES, V59, P4375
   Schramm C, 2018, NEW ENGL J MED, V379, P888, DOI 10.1056/NEJMcibr1807106
   Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971
   Schwartz SM, 1998, JNCI-J NATL CANCER I, V90, P1626, DOI 10.1093/jnci/90.21.1626
   Schwenger KJP, 2019, EUR J NUTR, V58, P1771, DOI 10.1007/s00394-018-1844-5
   Seaman SR, 2013, STAT METHODS MED RES, V22, P278, DOI 10.1177/0962280210395740
   Serafino A, 2017, EXPERT OPIN DRUG DIS, V12, P169, DOI 10.1080/17460441.2017.1271321
   Serrano B, 2018, BEST PRACT RES CL OB, V47, P14, DOI 10.1016/j.bpobgyn.2017.08.006
   Sethi V, 2018, GASTROENTEROLOGY, V155, P33, DOI 10.1053/j.gastro.2018.04.001
   Sia D, 2017, GASTROENTEROLOGY, V153, P812, DOI 10.1053/j.gastro.2017.06.007
   Slattery ML, 2017, MODERN PATHOL, V30, P1152, DOI 10.1038/modpathol.2017.38
   Song MY, 2018, GASTROENTEROLOGY, V155, P596, DOI 10.1053/j.gastro.2018.07.038
   Song M, 2019, CLIN GASTROENTEROL H, V17, P275, DOI 10.1016/j.cgh.2018.07.012
   Song MY, 2016, JAMA ONCOL, V2, P1197, DOI 10.1001/jamaoncol.2016.0605
   Song MY, 2016, GUT, V65, P296, DOI 10.1136/gutjnl-2014-308852
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Spallanzani A., 2018, J CANC METASTASIS TR, V4, P28, DOI [10.20517/2394-4722.2018.31, DOI 10.20517/2394-4722.2018.31]
   Spira A, 2017, CANCER RES, V77, P1510, DOI 10.1158/0008-5472.CAN-16-2346
   Spranger S, 2018, NAT REV CANCER, V18, P139, DOI 10.1038/nrc.2017.117
   Taube JM, 2018, MODERN PATHOL, V31, P214, DOI 10.1038/modpathol.2017.156
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Tsabar M, 2015, NUCLEIC ACIDS RES, V43, P6889, DOI 10.1093/nar/gkv520
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2017, CELL HOST MICROBE, V21, P278, DOI 10.1016/j.chom.2017.02.021
   Tytgat HLP, 2019, TRENDS MICROBIOL, V27, P17, DOI 10.1016/j.tim.2018.08.009
   Valeria M, 2018, OBM GENETICS, V2, DOI [10.21926/obm.genet.1804048, DOI 10.21926/OBM.GENET.1804048]
   Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3
   Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2
   Waluga M, 2018, J PHYSIOL PHARMACOL, V69, P325, DOI 10.26402/jpp.2018.3.02
   Wang C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00830
   Wang J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0479-3
   Wang ML, 2016, STAT MED, V35, P782, DOI 10.1002/sim.6793
   Wang ML, 2015, AM J EPIDEMIOL, V182, P263, DOI 10.1093/aje/kwv040
   Wieringa HW, 2016, CANCER TREAT REV, V42, P30, DOI 10.1016/j.ctrv.2015.11.008
   Yamaoka Y, 2018, J GASTROENTEROL, V53, P517, DOI 10.1007/s00535-017-1382-6
   Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014
   Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865
   Yarchoan R, 2018, NEW ENGL J MED, V378, P1029, DOI 10.1056/NEJMra1615896
   Ye XC, 2017, CANCER PREV RES, V10, P398, DOI 10.1158/1940-6207.CAPR-16-0178
   Younossi Z, 2019, HEPATOLOGY, V69, P2672, DOI 10.1002/hep.30251
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Yu MW, 2017, GASTROENTEROLOGY, V153, P1006, DOI 10.1053/j.gastro.2017.07.001
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zabor EC, 2017, STAT MED, V36, P4050, DOI 10.1002/sim.7405
   Zakhari S, 2018, CANCERS, V10, DOI 10.3390/cancers10100349
   Zhang S, 2018, J CANCER, V9, P1652, DOI 10.7150/jca.24048
   Zhernakova DV, 2018, NAT GENET, V50, P1524, DOI 10.1038/s41588-018-0224-7
   Zinocker MK, 2018, NUTRIENTS, V10, DOI 10.3390/nu10030365
   Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918
   Zitvogel L, 2017, NAT IMMUNOL, V18, P843, DOI 10.1038/ni.3754
NR 244
TC 58
Z9 58
U1 4
U2 73
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0022-3417
EI 1096-9896
J9 J PATHOL
JI J. Pathol.
PD APR
PY 2019
VL 247
IS 5
BP 615
EP 628
DI 10.1002/path.5236
PG 14
WC Oncology; Pathology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Pathology
GA HO6VE
UT WOS:000461069900008
PM 30632609
OA Green Accepted, Bronze
DA 2022-11-22
ER

PT J
AU Katsaounou, K
   Nicolaou, E
   Vogazianos, P
   Brown, C
   Stavrou, M
   Teloni, S
   Hatzis, P
   Agapiou, A
   Fragkou, E
   Tsiaoussis, G
   Potamitis, G
   Zaravinos, A
   Andreou, C
   Antoniades, A
   Shiammas, C
   Apidianakis, Y
AF Katsaounou, Kyriaki
   Nicolaou, Elpiniki
   Vogazianos, Paris
   Brown, Cameron
   Stavrou, Marios
   Teloni, Savvas
   Hatzis, Pantelis
   Agapiou, Agapios
   Fragkou, Elisavet
   Tsiaoussis, Georgios
   Potamitis, George
   Zaravinos, Apostolos
   Andreou, Chrysafis
   Antoniades, Athos
   Shiammas, Christos
   Apidianakis, Yiorgos
TI Colon Cancer: From Epidemiology to Prevention
SO METABOLITES
LA English
DT Review
DE colorectal cancer; epidemiology; prevention; risk factors; intestinal
   microbiota; inter-individual diversity; intra-individual variation;
   regenerative inflammation; multi-omics; gut-on-chip
ID COLORECTAL-CANCER; GUT MICROBIOTA; ANALYSIS REVEALS; INTESTINAL
   INFLAMMATION; BACTERIAL-INFECTION; GENE-EXPRESSION; DIETARY FIBER; RISK;
   TISSUE; GENDER
AB Colorectal cancer (CRC) is one of the most prevalent cancers affecting humans, with a complex genetic and environmental aetiology. Unlike cancers with known environmental, heritable, or sex-linked causes, sporadic CRC is hard to foresee and has no molecular biomarkers of risk in clinical use. One in twenty CRC cases presents with an established heritable component. The remaining cases are sporadic and associated with partially obscure genetic, epigenetic, regenerative, microbiological, dietary, and lifestyle factors. To tackle this complexity, we should improve the practice of colonoscopy, which is recommended uniformly beyond a certain age, to include an assessment of biomarkers indicative of individual CRC risk. Ideally, such biomarkers will be causal to the disease and potentially modifiable upon dietary or therapeutic interventions. Multi-omics analysis, including transcriptional, epigenetic as well as metagenomic, and metabolomic profiles, are urgently required to provide data for risk analyses. The aim of this article is to provide a perspective on the multifactorial derailment of homeostasis leading to the initiation of CRC, which may be explored via multi-omics and Gut-on-Chip analysis to identify much-needed predictive biomarkers.
C1 [Katsaounou, Kyriaki; Teloni, Savvas; Apidianakis, Yiorgos] Univ Cyprus, Dept Biol Sci, CY-2109 Nicosia, Cyprus.
   [Nicolaou, Elpiniki; Shiammas, Christos] AVVA Pharmaceut Ltd, CY-4001 Limassol, Cyprus.
   [Vogazianos, Paris; Brown, Cameron; Antoniades, Athos] Stremble Ventures Ltd, CY-4042 Limassol, Cyprus.
   [Stavrou, Marios; Andreou, Chrysafis] Univ Cyprus, Dept Elect & Comp Engn, CY-2109 Nicosia, Cyprus.
   [Hatzis, Pantelis] Inst Fundamental Biomed Res, Biomed Sci Res Ctr Alexander Fleming, Vari 16672, Greece.
   [Agapiou, Agapios] Univ Cyprus, Dept Chem, CY-2109 Nicosia, Cyprus.
   [Fragkou, Elisavet; Tsiaoussis, Georgios] Nicosia Gen Hosp, CY-2029 Nicosia, Cyprus.
   [Potamitis, George] Potamitis Gastroenterol & Nutr, CY-1082 Nicosia, Cyprus.
   [Zaravinos, Apostolos] European Univ Cyprus, Dept Life Sci, CY-1516 Nicosia, Cyprus.
   [Zaravinos, Apostolos] Basic & Translat Canc Res Ctr, CY-1516 Nicosia, Cyprus.
C3 University of Cyprus; University of Cyprus; Alexander Fleming Biomedical
   Sciences Research Center; University of Cyprus; European University
   Cyprus
RP Apidianakis, Y (corresponding author), Univ Cyprus, Dept Biol Sci, CY-2109 Nicosia, Cyprus.
EM katsaounou.kyriaki@ucy.ac.cy; e.nikolaou@avvapharma.com;
   paris.vogazianos@stremble.com; cameron.brown@stremble.com;
   stavrou.g.marios@ucy.ac.cy; teloni.savvas@ucy.ac.cy; hatzis@fleming.gr;
   agapiou.agapios@ucy.ac.cy; elislida@cytanet.com.cy;
   tsiaoussisgeorgios@yahoo.com; g.potamitis@logos.cy.net;
   a.zaravinos@euc.ac.cy; andreou.chrysafis@ucy.ac.cy;
   athos.antoniades@stremble.com; c.shammas@avvapharma.com;
   apidiana@ucy.ac.cy
OI Andreou, Chrysafis/0000-0002-3464-9110; Brown,
   Cameron/0000-0002-6736-0620; Antoniades, Athos/0000-0002-5789-5103;
   Vogazianos, Paris/0000-0001-9991-6059; Zaravinos,
   Apostolos/0000-0003-4625-5562; Agapiou, Agapios/0000-0001-8371-0910
FU Republic of Cyprus "Restart 2016-2020 Programmes" through the Research
   and Innovation Foundation (MoCo Project) [EXCELLENCE/1216/0523]
FX This work was funded by the Republic of Cyprus "Restart 2016-2020
   Programmes" through the Research and Innovation Foundation (MoCo
   Project: EXCELLENCE/1216/0523).
CR Abed J, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00400
   Abotchie PN, 2012, J WOMENS HEALTH, V21, P393, DOI 10.1089/jwh.2011.2992
   Ahmed I, 2016, MICROORGANISMS, V4, DOI 10.3390/microorganisms4020020
   Al-Hassi HO, 2018, GUT, V67, DOI 10.1136/gutjnl-2017-314219
   Al-Tassan NA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10442
   Ala-Korpela M, 2012, GENOME MED, V4, DOI 10.1186/gm335
   American Cancer Society, US
   Amitay EL, 2020, BRIT J CANCER, V122, P1604, DOI 10.1038/s41416-020-0803-0
   [Anonymous], SURVEILLANCE EPIDEMI
   Apidianakis Y, 2011, DIS MODEL MECH, V4, P21, DOI 10.1242/dmm.003970
   Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106
   Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   ATKIN WS, 1992, NEW ENGL J MED, V326, P658, DOI 10.1056/NEJM199203053261002
   Aune D, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d6617
   Aykan Nuri Faruk, 2015, Oncol Rev, V9, P288, DOI 10.4081/oncol.2015.288
   Bailey M, 2013, VET IMMUNOL IMMUNOP, V152, P13, DOI 10.1016/j.vetimm.2012.09.022
   Barderas MG, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/790132
   Basson M. D., 2007, Inflammopharmacology, V15, P109, DOI 10.1007/s10787-007-1562-8
   Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849
   Baxter BA, 2020, WORLD J GASTROENTERO, V26, P335, DOI 10.3748/wjg.v26.i3.335
   Beggs AD, 2013, J PATHOL, V229, P697, DOI 10.1002/path.4132
   Bein A, 2018, CELL MOL GASTROENTER, V5, P659, DOI 10.1016/j.jcmgh.2017.12.010
   Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989
   Biragyn A, 2018, LANCET ONCOL, V19, pE295, DOI 10.1016/S1470-2045(18)30095-0
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]
   Botteri E, 2008, JAMA-J AM MED ASSOC, V300, P2765, DOI 10.1001/jama.2008.839
   Boussios S, 2019, J PERS MED, V9, DOI 10.3390/jpm9010012
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Brown JC, 2020, JNCI-J NATL CANCER I, V112, P377, DOI 10.1093/jnci/djz150
   Brugmann SA, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt362
   Buchberger AR, 2018, ANAL CHEM, V90, P240, DOI 10.1021/acs.analchem.7b04733
   Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Burke CM, 2016, PEERJ, V4, DOI 10.7717/peerj.2492
   Carethers JM, 2015, GASTROENTEROLOGY, V149, P1177, DOI 10.1053/j.gastro.2015.06.047
   Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850
   Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111
   Chen LC, 2004, CANCER RES, V64, P3694, DOI 10.1158/0008-5472.CAN-03-3264
   Cheng YW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.615056
   Choi YJ, 2018, CANCER RES TREAT, V50, P474, DOI 10.4143/crt.2017.094
   Clish CB, 2015, CSH MOL CASE STUD, V1, DOI 10.1101/mcs.a000588
   Clos-Garcia M, 2020, CANCERS, V12, DOI 10.3390/cancers12051142
   Cole LM, 2015, BIOMARK MED, V9, P863, DOI 10.2217/bmm.15.61
   Comelli EM, 2008, GENOMICS, V91, P70, DOI 10.1016/j.ygeno.2007.09.006
   Corpet DE, 2011, MEAT SCI, V89, P310, DOI 10.1016/j.meatsci.2011.04.009
   Couzin-Frankel J, 2021, SCIENCE, V373, P480, DOI 10.1126/science.373.6554.480
   Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164
   de Jong AE, 2005, AM J GASTROENTEROL, V100, P139, DOI 10.1111/j.1572-0241.2005.41000.x
   De Preter Vicky, 2013, World J Gastrointest Pharmacol Ther, V4, P97, DOI 10.4292/wjgpt.v4.i4.97
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
   Dos Santos Silva I., 1999, CANC EPIDEMIOLOGY PR
   Dunn WB, 2013, METABOLOMICS, V9, pS44, DOI 10.1007/s11306-012-0434-4
   Dunn WB, 2005, ANALYST, V130, P606, DOI 10.1039/b418288j
   Ellis SR, 2014, ANAL BIOANAL CHEM, V406, P1275, DOI 10.1007/s00216-013-7478-9
   Elsea Sarah H, 2002, ILAR J, V43, P66
   Encarnacao JC, 2015, CANCER METAST REV, V34, P465, DOI 10.1007/s10555-015-9578-9
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Flynn KJ, 2018, CANCER PREV RES, V11, P393, DOI 10.1158/1940-6207.CAPR-17-0370
   Friedenreich CM, 2021, MOL ONCOL, V15, P790, DOI 10.1002/1878-0261.12772
   Frucht H.L., 2020, MOL GENETICS COLOREC
   Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948
   Garrett WS, 2019, SCIENCE, V364, P1133, DOI 10.1126/science.aaw2367
   Gayer CP, 2009, CELL SIGNAL, V21, P1237, DOI 10.1016/j.cellsig.2009.02.011
   Ghosh S, 2021, ARCH MICROBIOL, V203, P5281, DOI 10.1007/s00203-021-02516-y
   Grassart A, 2019, CELL HOST MICROBE, V26, P435, DOI [10.1016/j.chom.2019.08.007, 10.1016/j.chom.2019.09.007]
   Gray CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203301
   Guinane CM, 2013, MBIO, V4, DOI 10.1128/mBio.00366-12
   Haggar Fatima A, 2009, Clin Colon Rectal Surg, V22, P191, DOI 10.1055/s-0029-1242458
   Halldorsson S, 2015, BIOSENS BIOELECTRON, V63, P218, DOI 10.1016/j.bios.2014.07.029
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002
   Hennig EE, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10060465
   Hinsch A, 2017, J MASS SPECTROM, V52, P165, DOI 10.1002/jms.3916
   Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019
   Hoffmann F, 2019, PROTEOM CLIN APPL, V13, DOI 10.1002/prca.201700173
   Hong Y, 2007, CLIN CANCER RES, V13, P1107, DOI 10.1158/1078-0432.CCR-06-1633
   Horvath I, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.00965-2016
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hullings AG, 2020, AM J CLIN NUTR, V112, P603, DOI 10.1093/ajcn/nqaa161
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Iacopetta B, 2002, INT J CANCER, V101, P403, DOI 10.1002/ijc.10635
   Issitt T, 2022, J BREATH RES, V16, DOI 10.1088/1752-7163/ac5230
   Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014
   Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011
   Kabeerdoss J, 2014, J NUTR SCI, V3, DOI 10.1017/jns.2013.6
   Kamiyama H, 2012, ONCOGENE, V31, P5029, DOI 10.1038/onc.2011.652
   Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039
   Kaz AM, 2014, EPIGENETICS-US, V9, P492, DOI 10.4161/epi.27650
   Kertesz V, 2021, ANAL BIOANAL CHEM, V413, P2619, DOI 10.1007/s00216-020-02964-3
   Keum N, 2019, NAT REV GASTRO HEPAT, V16, P713, DOI 10.1038/s41575-019-0189-8
   Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209
   Kim HI, 2018, BIOMOL THER, V26, P335, DOI 10.4062/biomolther.2018.103
   Kim H, 2019, CURR ALLERGY ASTHM R, V19, DOI 10.1007/s11882-019-0851-9
   Kim HJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54344
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021
   Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167
   KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562
   Kinzler KW, 1997, NATURE, V386, P761, DOI 10.1038/386761a0
   Kirwan JA, 2013, ANAL BIOANAL CHEM, V405, P5147, DOI 10.1007/s00216-013-6856-7
   Klampfer L, 2014, WORLD J GASTRO ONCOL, V6, P430, DOI 10.4251/wjgo.v6.i11.430
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kuehnbaum NL, 2013, CHEM REV, V113, P2437, DOI 10.1021/cr300484s
   Lai C, 1999, J NUTR, V129, p552S, DOI 10.1093/jn/129.2.552S
   Lee MS, 2017, J NATL COMPR CANC NE, V15, P411, DOI 10.6004/jnccn.2017.0038
   Levin AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31775
   Li K, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-019-1091-8
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Lian T, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123810
   Lin JH, 2013, CLIN GASTROENTEROL H, V11, P419, DOI 10.1016/j.cgh.2012.11.012
   Lochhead P, 2015, MODERN PATHOL, V28, P14, DOI 10.1038/modpathol.2014.81
   Long XH, 2019, NAT MICROBIOL, V4, P2319, DOI 10.1038/s41564-019-0541-3
   Lopez-Lazaro M, 2018, CRIT REV ONCOL HEMAT, V123, P95, DOI 10.1016/j.critrevonc.2018.01.010
   Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886
   Markou P, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00115
   Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588
   Martincorena I, 2015, SCIENCE, V349, P1483, DOI 10.1126/science.aab4082
   McRae MP, 2018, J CHIROPR MED, V17, P90, DOI 10.1016/j.jcm.2017.12.001
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Missiaglia E, 2014, ANN ONCOL, V25, P1995, DOI 10.1093/annonc/mdu275
   Mohandas KM, 2011, INDIAN J GASTROENTER, V30, P3, DOI 10.1007/s12664-010-0076-2
   Moore RE, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190128
   Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006
   Murphy EC, 2013, FEMS MICROBIOL REV, V37, P520, DOI 10.1111/1574-6976.12005
   Murphy N, 2019, MOL ASPECTS MED, V69, P2, DOI 10.1016/j.mam.2019.06.005
   Murphy N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv210
   Natividad JMM, 2013, PHARMACOL RES, V69, P42, DOI 10.1016/j.phrs.2012.10.007
   Naughton SS, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/361895
   Nazemalhosseini Mojarad Ehsan, 2013, Gastroenterol Hepatol Bed Bench, V6, P120
   Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008
   Nogueira LM, 2020, CA-CANCER J CLIN, V70, P239, DOI 10.3322/caac.21610
   OHGAKI H, 1984, CARCINOGENESIS, V5, P921, DOI 10.1093/carcin/5.7.921
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   Ohri A, 2020, DIGEST DIS SCI, V65, P1838, DOI 10.1007/s10620-019-05913-y
   Onyeaghala G, 2020, CANCER-AM CANCER SOC, V126, P1041, DOI 10.1002/cncr.32616
   Osman MA, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82465-0
   Panagi Myrofora, 2019, Oncotarget, V10, P4224, DOI 10.18632/oncotarget.6463
   Panayidou S, 2013, PATHOGENS, V2, P209, DOI 10.3390/pathogens2020209
   Parker TW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59899-z
   Peterse EFP, 2018, CANCER-AM CANCER SOC, V124, P2964, DOI 10.1002/cncr.31543
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Ramautar R, 2013, ELECTROPHORESIS, V34, P86, DOI 10.1002/elps.201200390
   Rawla P, 2019, GASTROENTEROL REV, V14, P89, DOI 10.5114/pg.2018.81072
   Rees WD, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.583919
   Russell AB, 2014, CELL HOST MICROBE, V16, P227, DOI 10.1016/j.chom.2014.07.007
   Salaspuro M, 1997, ADDICT BIOL, V2, P35, DOI 10.1080/13556219772840
   Sanchez-Alcoholado L, 2020, CANCERS, V12, DOI 10.3390/cancers12061406
   Santarelli RL, 2008, NUTR CANCER, V60, P131, DOI 10.1080/01635580701684872
   Sanz-Pamplona R, 2011, CLIN CANCER RES, V17, P7303, DOI 10.1158/1078-0432.CCR-11-1570
   Saoi M, 2021, METABOLITES, V11, DOI 10.3390/metabo11100672
   Sassone-Corsi M, 2015, J IMMUNOL, V194, P4081, DOI 10.4049/jimmunol.1403169
   Sawicki T, 2021, CANCERS, V13, DOI 10.3390/cancers13092025
   Selber-Hnatiw S, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.017E5, 10.3389/fmicb.2017.01265]
   Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442
   Siegel TP, 2018, MOL IMAGING BIOL, V20, P888, DOI 10.1007/s11307-018-1267-y
   Singhal R, 2020, J BIOL CHEM, V295, P10493, DOI 10.1074/jbc.REV120.011188
   Sipos F, 2011, WORLD J GASTROENTERO, V17, P2981, DOI 10.3748/wjg.v17.i25.2981
   Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054
   Spalinger MR, 2018, CELL REP, V22, P1835, DOI 10.1016/j.celrep.2018.01.052
   Stringer KA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00044
   Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865
   Tamamouna V, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.189472
   Tanikawa C, 2018, CARCINOGENESIS, V39, P652, DOI 10.1093/carcin/bgy026
   Thelin C.S.S., 2015, SCREENING COLORECTAL
   Thorning TK, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.32527
   Tierney BT, 2019, CELL HOST MICROBE, V26, P283, DOI 10.1016/j.chom.2019.07.008
   Tomasetti C, 2017, SCIENCE, V355, P1330, DOI 10.1126/science.aaf9011
   Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825
   Valle L, 2019, J PATHOL, V247, P574, DOI 10.1002/path.5229
   van Berlo D, 2021, CURR OPIN TOXICOL, V27, P8, DOI 10.1016/j.cotox.2021.05.001
   van der Greef J, 2004, CURR OPIN CHEM BIOL, V8, P559, DOI 10.1016/j.cbpa.2004.08.013
   Vancamelbeke M, 2017, EXPERT REV GASTROENT, V11, P821, DOI 10.1080/17474124.2017.1343143
   Vernocchi P, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01144
   Vuik FER, 2019, GUT, V68, P1820, DOI 10.1136/gutjnl-2018-317592
   Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484
   Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785
   Wong MCS, 2020, CLIN GASTROENTEROL H, V18, P553, DOI 10.1016/j.cgh.2019.07.016
   World Health Organization, GLOBAL CANC OBSERVAT
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Xi Y, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2021.101174
   Xia ZY, 2020, CANCER MED-US, V9, P3563, DOI 10.1002/cam4.2971
   Yamamoto M, 2016, GENES ENVIRON, V38, DOI 10.1186/s41021-016-0038-8
   Yang L, 2019, JAMA-J AM MED ASSOC, V321, P1587, DOI 10.1001/jama.2019.3636
   Yang YZ, 2019, THERANOSTICS, V9, P4101, DOI 10.7150/thno.35186
   Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812
   Zheng C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176035
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
NR 197
TC 1
Z9 1
U1 6
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-1989
J9 METABOLITES
JI Metabolites
PD JUN
PY 2022
VL 12
IS 6
AR 499
DI 10.3390/metabo12060499
PG 26
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA 2M2PQ
UT WOS:000817548500001
PM 35736432
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Dalal, N
   Jalandra, R
   Sharma, M
   Prakash, H
   Makharia, GK
   Solanki, PR
   Singh, R
   Kumar, A
AF Dalal, Nishu
   Jalandra, Rekha
   Sharma, Minakshi
   Prakash, Hridayesh
   Makharia, Govind K.
   Solanki, Pratima R.
   Singh, Rajeev
   Kumar, Anil
TI Omics technologies for improved diagnosis and treatment of colorectal
   cancer: Technical advancement and major perspectives
SO BIOMEDICINE & PHARMACOTHERAPY
LA English
DT Review
DE Colorectal cancer; Omics; Transcriptomics; Biomarkers; Microbiota
ID PROTEOMIC ANALYSIS REVEALS; LYMPH-NODE METASTASIS; MASS-SPECTROMETRY;
   TRANSCRIPTOME ANALYSIS; PEPTIDE IDENTIFICATION; PROMOTES TUMORIGENESIS;
   HUMAN COLON; GEN. NOV.; BIOMARKERS; CELL
AB Colorectal cancer (CRC) ranks third among the most commonly occurring cancers worldwide, and it causes half a million deaths annually. Alongside mechanistic study for CRC detection and treatment by conventional techniques, new technologies have been developed to study CRC. These technologies include genomics, transcriptomics, proteomics, and metabolomics which elucidate DNA markers, RNA transcripts, protein and, metabolites produced inside the colon and rectum part of the gut. All these approaches form the omics arena, which presents a remarkable opportunity for the discovery of novel prognostic, diagnostic and therapeutic biomarkers and also delineate the underlying mechanism of CRC causation, which may further help in devising treatment strategies. This review also mentions the latest developments in metagenomics and culturomics as emerging evidence suggests that metagenomics of gut microbiota has profound implications in the causation, prognosis, and treatment of CRC. A majority of bacteria cannot be studied as they remain unculturable, so culturomics has also been strengthened to develop culture conditions suitable for the growth of unculturable bacteria and identify unknown bacteria. The overall purpose of this review is to succinctly evaluate the application of omics technologies in colorectal cancer research for improving the diagnosis and treatment strategies.
C1 [Dalal, Nishu; Jalandra, Rekha; Kumar, Anil] Natl Inst Immunol, Gene Regulat Lab, New Delhi 110067, India.
   [Dalal, Nishu; Singh, Rajeev] Delhi Univ, Satyawati Coll, Dept Environm Sci, Delhi 110052, India.
   [Jalandra, Rekha; Sharma, Minakshi] Maharshi Dayanand Univ, Dept Zool, Rohtak 124001, Haryana, India.
   [Prakash, Hridayesh] Amity Univ, Amity Inst Virol & Immunol, Sect 125, Noida 201313, Uttar Pradesh, India.
   [Makharia, Govind K.] All India Inst Med Sci, Dept Gastroenterol & Human Nutr, New Delhi 110029, India.
   [Solanki, Pratima R.] Jawaharlal Nehru Univ, Special Ctr Nanosci, New Delhi 110067, India.
C3 Department of Biotechnology (DBT) India; National Institute of
   Immunology (NII); University of Delhi; Maharshi Dayanand University;
   Amity University Noida; All India Institute of Medical Sciences (AIIMS)
   New Delhi; Jawaharlal Nehru University, New Delhi
RP Kumar, A (corresponding author), Natl Inst Immunol, Gene Regulat Lab, New Delhi 110067, India.; Singh, R (corresponding author), Delhi Univ, Satyawati Coll, Dept Environm Sci, Delhi 110052, India.
EM 10rsingh@gmail.com; anilk@nii.ac.in
RI Hridayesh, Prakash/W-9478-2019; Solanki, Pratima R./N-1041-2013; Kumar,
   Anil/AAT-4547-2020; Kumar, Anil/L-3294-2016
OI Hridayesh, Prakash/0000-0001-5269-2481; Kumar, Anil/0000-0002-8785-6033;
   Kumar, Anil/0000-0002-8785-6033
FU Core grant of the National Institute of Immunology, New Delhi; SERB-DST
   [CRG/2018/002957]
FX This work was supported by the Core grant of the National Institute of
   Immunology, New Delhi, and SERB-DST (Grant No. CRG/2018/002957).
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Aguiar-Pulido V, 2016, EVOL BIOINFORM, V12, P5, DOI 10.4137/EBO.S36436
   Alomair AO, 2018, GASTROENT RES PRACT, V2018, DOI 10.1155/2018/5284754
   Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912
   Barresi V, 2018, J CELL BIOCHEM, V119, P9707, DOI 10.1002/jcb.27285
   Barresi V, 2016, FEBS OPEN BIO, V6, P794, DOI 10.1002/2211-5463.12060
   Bashiardes S, 2016, BIOINFORM BIOL INSIG, V10, P19, DOI 10.4137/BBI.S34610
   Beghini F, 2017, ISME J, V11, P2848, DOI 10.1038/ismej.2017.139
   Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y
   Berndt U, 2008, CANCER RES, V68, P880, DOI 10.1158/0008-5472.CAN-07-2923
   Berridge MJ, 2016, PHYSIOL REV, V96, P1261, DOI 10.1152/physrev.00006.2016
   Bertini I, 2012, CANCER RES, V72, P356, DOI 10.1158/0008-5472.CAN-11-1543
   Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]
   Bikel S, 2015, COMPUT STRUCT BIOTEC, V13, P390, DOI 10.1016/j.csbj.2015.06.001
   Bilegsaikhan E, 2018, J DIGEST DIS, V19, P404, DOI 10.1111/1751-2980.12643
   Bond A, 2019, ALIMENT PHARM THER, V49, P1005, DOI 10.1111/apt.15140
   Bonnet M., 2019, New Microbes and New Infections, V29, P100520, DOI 10.1016/j.nmni.2019.100520
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Cai QY, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695015
   Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232
   Chen EF, 2018, BIOMED PHARMACOTHER, V106, P1046, DOI 10.1016/j.biopha.2018.07.050
   Chen EF, 2018, BIOMED PHARMACOTHER, V106, P1370, DOI 10.1016/j.biopha.2018.07.098
   Chen MX, 2019, PATHOL RES PRACT, V215, P1033, DOI 10.1016/j.prp.2019.02.011
   Clark AE, 2013, CLIN MICROBIOL REV, V26, P547, DOI 10.1128/CMR.00072-12
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8
   Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Dasari S, 2012, J PROTEOME RES, V11, P1686, DOI 10.1021/pr200874e
   de Wit M, 2014, J PROTEOMICS, V99, P26, DOI 10.1016/j.jprot.2014.01.001
   Drancourt M, 2000, J CLIN MICROBIOL, V38, P3623, DOI 10.1128/JCM.38.10.3623-3630.2000
   Duan BJ, 2018, EBIOMEDICINE, V37, P134, DOI 10.1016/j.ebiom.2018.10.036
   Dutilh BE, 2013, BEST PRACT RES CL GA, V27, P85, DOI 10.1016/j.bpg.2013.03.008
   EDWARD DGF, 1951, J GEN MICROBIOL, V5, P576, DOI 10.1099/00221287-5-3-576
   Escobar-Zepeda A, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00348
   Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   FIEHN O, 2002, FUNCTIONAL GENOMICS, V48, P155, DOI DOI 10.1007/978-94-010-0448-0_11
   Fung KYC, 2009, J PROTEOME RES, V8, P1220, DOI 10.1021/pr8009929
   Gan Y, 2014, J CANCER RES THER, V10, P89, DOI 10.4103/0973-1482.131396
   Gemoll T, 2013, ANAL CELL PATHOL, V36, P149, DOI [10.1155/2013/249054, 10.3233/ACP-140088]
   Ghosh D, 2011, J PROTEOME RES, V10, P4373, DOI 10.1021/pr2005617
   Graziani V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23704-9
   Griffin JL, 2004, NAT REV CANCER, V4, P551, DOI 10.1038/nrc1390
   Gu JP, 2019, DIS MARKERS, V2019, DOI 10.1155/2019/3491852
   Gu SM, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0628-y
   Guo YC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18040722
   He YL, 2019, MICROSYST TECHNOL, V25, P499, DOI 10.1007/s00542-018-3986-z
   Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777
   Huang WS, 2012, PROTEOMICS, V12, P810, DOI 10.1002/pmic.201100270
   Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x
   Jang JE, 2019, CANCER RES TREAT, V51, P391, DOI 10.4143/crt.2018.103
   Kaeberlein T, 2002, SCIENCE, V296, P1127, DOI 10.1126/science.1070633
   Kather JN, 2018, SEMIN CANCER BIOL, V52, P189, DOI 10.1016/j.semcancer.2018.02.010
   Kim HY, 2015, MOLECULES, V20, P18066, DOI 10.3390/molecules201018066
   Kim Mincheol, 2013, Genomics & Informatics, V11, P102, DOI 10.5808/GI.2013.11.3.102
   Kim RR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41216-y
   Klein-Scory S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-70
   Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236
   Koshiyama A, 2013, BIOMED CHROMATOGR, V27, P440, DOI 10.1002/bmc.2811
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kuipers EJ, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.65
   Kukurba K.R., 2015, COLD SPRING HARB PRO, V2015, DOI [10.1101/pdb.top084970pdb.top084970, DOI 10.1101/PDB.TOP084970PDB.TOP084970]
   Kume H., DISCOVERY COLORECTAL
   Lagier JC, 2012, CLIN MICROBIOL INFEC, V18, P1185, DOI 10.1111/1469-0691.12023
   Lagier JC, 2015, CLIN MICROBIOL REV, V28, P237, DOI 10.1128/CMR.00014-14
   Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173
   Lee HN, 2012, BIOCHEM BIOPH RES CO, V427, P171, DOI 10.1016/j.bbrc.2012.09.036
   Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805
   Li HP, 2019, J CELL BIOCHEM, V120, P8086, DOI 10.1002/jcb.28087
   Li XL, 2018, J NONDESTRUCT EVAL, V37, DOI 10.1007/s10921-018-0473-5
   Lin Y, 2016, ONCOTARGET, V7, P29454, DOI 10.18632/oncotarget.8762
   Liu GH, 2013, TUMOR BIOL, V34, P2175, DOI 10.1007/s13277-013-0753-8
   Liu HN, 2018, CANCER SCI, V109, P1185, DOI 10.1111/cas.13514
   Liu L, 2007, CELL BIOL INT, V31, P805, DOI 10.1016/j.cellbi.2007.01.014
   Liu XX, 2019, J CANCER, V10, P43, DOI 10.7150/jca.26723
   Liu Y, 2018, THORAC CANCER, V9, P785, DOI 10.1111/1759-7714.12645
   Lo C. I., 2017, New Microbes and New Infections, V16, P63, DOI 10.1016/j.nmni.2017.01.004
   Lo CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0366-2
   Loke MF, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208584
   Lowe R, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005457
   Ma YL, 2009, DIGEST DIS SCI, V54, P2655, DOI 10.1007/s10620-008-0665-4
   Ma YM, 2010, J CELL BIOCHEM, V110, P1512, DOI 10.1002/jcb.22726
   Ma ZQ, 2011, BIOINFORMATICS, V27, P3214, DOI 10.1093/bioinformatics/btr544
   Ma ZQ, 2009, J PROTEOME RES, V8, P3872, DOI 10.1021/pr900360j
   Manor O, 2014, CELL METAB, V20, P742, DOI 10.1016/j.cmet.2014.07.021
   Mantione KJ, 2014, MED SCI MONIT BASIC, V20, P138, DOI 10.12659/MSMBR.892101
   Martin-Blazquez A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55952-8
   Meng CY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207039
   Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626
   Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038
   Mori K, 2017, INT J CANCER, V140, P1425, DOI 10.1002/ijc.30557
   Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252
   Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605
   Ngom I. I., 2018, New Microbes and New Infections, V21, P105, DOI 10.1016/j.nmni.2017.11.009
   Nishiumi S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040459
   Nome T, 2013, TRANSL ONCOL, V6, P546, DOI 10.1593/tlo.13457
   Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314
   Perez-Riesgo E, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050922
   Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38
   Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b
   Rosen MJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-283
   Sartor ITS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210762
   Schee K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066165
   Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844
   Seo AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098528
   Shi Yi-jiu, 2008, Zhonghua Zhongliu Zazhi, V30, P910
   Slaby O, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-102
   Slebos RJC, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.22
   Smith CA, 2005, THER DRUG MONIT, V27, P747, DOI 10.1097/01.ftd.0000179845.53213.39
   Song X, 2018, MED SCI MONITOR, V24, P7820, DOI 10.12659/MSM.908656
   Sun B, 2019, J CELL PHYSIOL, V234, P1416, DOI 10.1002/jcp.26936
   Sun YN, 2014, OMICS, V18, P54, DOI 10.1089/omi.2012.0132
   Tabb DL, 2007, J PROTEOME RES, V6, P654, DOI 10.1021/pr0604054
   Tan H.T., QUANTITATIVE TEMPORA
   Thierolf M, 2008, PROTEOM CLIN APPL, V2, P11, DOI 10.1002/prca.200780046
   Torres S, 2013, CLIN CANCER RES, V19, P6006, DOI 10.1158/1078-0432.CCR-13-1130
   Tu CJ, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201600155
   Uchiyama K, 2017, J GASTROENTEROL, V52, P677, DOI 10.1007/s00535-016-1261-6
   Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957
   Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Wang JJ, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22379
   Wang LL, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108758
   Wang S, 2017, CANCER MED-US, V6, P1976, DOI 10.1002/cam4.1147
   Wang ZN, 2017, ONCOTARGET, V8, P105819, DOI 10.18632/oncotarget.22402
   Watany MM, 2018, CLIN CHIM ACTA, V483, P151, DOI 10.1016/j.cca.2018.04.038
   Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065
   Wu W, 2014, MOL CANCER RES, V12, P1717, DOI 10.1158/1541-7786.MCR-14-0088-T
   Wu WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033200
   Xiao Y, 2019, CLIN CHIM ACTA, V490, P186, DOI 10.1016/j.cca.2018.09.007
   Xiao Zhen, 2008, V428, P181
   Xu HC, 2019, MOL CANCER, V18, DOI 10.1186/s12943-018-0932-8
   Xu L, 2016, ONCOTARGET, V7, P43868, DOI 10.18632/oncotarget.9701
   Xu L, 2018, BRAZ J MED BIOL RES, V51, DOI [10.1590/1414-431X20187588, 10.1590/1414-431x20187588]
   Yamada A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18407-6
   Yang C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-4
   Yang SX, 2018, CANCER MANAG RES, V10, P2249, DOI 10.2147/CMAR.S166308
   Yin XF, 2015, SCI REP-UK, V5, DOI 10.1038/srep12120
   Yoo BC, 2017, RADIAT ONCOL J, V35, P281, DOI 10.3857/roj.2017.00255
   Yu JK, 2004, WORLD J GASTROENTERO, V10, P3127
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yuan Y, 2018, BIOCHEM BIOPH RES CO, V503, P870, DOI 10.1016/j.bbrc.2018.06.089
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhang H, 2019, GENE, V687, P246, DOI 10.1016/j.gene.2018.11.055
   Zhang ZY, 2018, J CELL BIOCHEM, V119, P9957, DOI 10.1002/jcb.27319
   Zhu DX, 2013, J CELL BIOCHEM, V114, P448, DOI 10.1002/jcb.24384
   Zhu ZF, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1773-5
NR 148
TC 20
Z9 20
U1 3
U2 12
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0753-3322
EI 1950-6007
J9 BIOMED PHARMACOTHER
JI Biomed. Pharmacother.
PD NOV
PY 2020
VL 131
AR 110648
DI 10.1016/j.biopha.2020.110648
PG 15
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA OH6KI
UT WOS:000582699600027
PM 33152902
OA gold
DA 2022-11-22
ER

PT J
AU Johns, MS
   Petrelli, NJ
AF Johns, Michael S.
   Petrelli, Nicholas J.
TI Microbiome and colorectal cancer: A review of the past, present, and
   future
SO SURGICAL ONCOLOGY-OXFORD
LA English
DT Review
DE Colorectal; Cancer; Microbiome; Microorganisms; Bacteria;
   Gastrointestinal
ID CLOSTRIDIUM-DIFFICILE INFECTION; ESCHERICHIA-COLI; INTESTINAL BACTERIA;
   BILE-ACIDS; PROMOTES; CARCINOGENESIS; RISK; TRANSPLANTATION;
   TUMORIGENESIS; METAGENOMICS
AB The gastrointestinal tract is home to diverse and abundant microorganisms, collectively referred to as the microbiome. This ecosystem typically contains trillions of microbial cells that play an important role in regulation of human health. The microbiome has been implicated in host immunity, nutrient absorption, digestion, and metabolism. In recent years, researchers have shown that alteration of the microbiome is associated with disease development, such as obesity, inflammatory bowel disease, and cancer.
   This review discusses the five decades of research into the human microbiome and the development of colorectal cancer-the historical context including experiments that sparked interest, the explosion of research that has occurred in the last decade, and finally the future of testing and treatment.
C1 [Johns, Michael S.; Petrelli, Nicholas J.] Helen F Graham Canc Ctr, Dept Surg Oncol, Newark, DE USA.
C3 Helen F. Graham Cancer Center & Research Institute
RP Johns, MS (corresponding author), 114 Shinn Circle, Wilmington, DE 19808 USA.
EM michael.s.johns@christianacare.org
CR Abu-Ali GS, 2018, NAT MICROBIOL, V3, P356, DOI 10.1038/s41564-017-0084-4
   Aguiar-Pulido V, 2016, EVOL BIOINFORM, V12, P5, DOI 10.4137/EBO.S36436
   Allen J, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0621-2
   Alonso C., 2020, SSRN ELECT J, P1, DOI [10.2139/ssrn.3520024, DOI 10.2139/SSRN.3520024]
   Appleyard CB, 2011, AM J PHYSIOL-GASTR L, V301, pG1004, DOI 10.1152/ajpgi.00167.2011
   ARIES V, 1970, BIOCHIM BIOPHYS ACTA, V202, P526, DOI 10.1016/0005-2760(70)90123-2
   ARIES V, 1970, BIOCHIM BIOPHYS ACTA, V202, P535, DOI 10.1016/0005-2760(70)90124-4
   ARIES V, 1969, GUT, V10, P334, DOI 10.1136/gut.10.5.334
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Beimfohr C., 2016, INT J BACTERIOL, V2016, P3535621, DOI [10.1155/2016/3535621, DOI 10.1155/2016/3535621]
   Belluz LD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005528
   Belusica, 2012, J MED LIFE, V5
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Boleij A, 2012, BIOL REV, V87, P701, DOI 10.1111/j.1469-185X.2012.00218.x
   Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609
   Bury S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00929
   Cao HL, 2017, INT J CANCER, V140, P2545, DOI 10.1002/ijc.30643
   Cao Y, 2018, GUT, V67, P672, DOI 10.1136/gutjnl-2016-313413
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Charbonneau MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15508-1
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Cheng WT, 2020, MALAYS J MED SCI, V27, P9, DOI 10.21315/mjms2020.27.4.2
   Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182
   Chowdhury S, 2019, NAT MED, V25, P1057, DOI 10.1038/s41591-019-0498-z
   Coker OO, 2019, GUT, V68, P654, DOI 10.1136/gutjnl-2018-317178
   Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Daly K, 2005, BIOCHEM SOC T, V33, P733, DOI 10.1042/BST0330733
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   DRASAR BS, 1973, BRIT J CANCER, V27, P167, DOI 10.1038/bjc.1973.20
   Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3
   Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]
   Eetemadi A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00393
   Erben V, 2018, CANCERS, V10, DOI 10.3390/cancers10080246
   Fardini Y, 2011, MOL MICROBIOL, V82, P1468, DOI 10.1111/j.1365-2958.2011.07905.x
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Filip Mihaela, 2018, Clujul Med, V91, P259, DOI 10.15386/cjmed-946
   Flynn C, 2007, MOL CARCINOGEN, V46, P60, DOI 10.1002/mc.20253
   Forsgard RA, 2017, CANCER CHEMOTH PHARM, V80, P317, DOI 10.1007/s00280-017-3364-z
   Fritz JV, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-14
   Garza DR, 2020, CANCER METAB, V8, DOI 10.1186/s40170-020-0208-9
   Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Grasso F, 2015, BIOMOLECULES, V5, P1762, DOI 10.3390/biom5031762
   Guyton K, 2017, NAT REV GASTRO HEPAT, V14, P43, DOI 10.1038/nrgastro.2016.139
   Hale VL, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0586-6
   Hale VL, 2018, METHODS, V149, P59, DOI 10.1016/j.ymeth.2018.04.024
   Hamada T, 2018, CANCER IMMUNOL RES, V6, P1327, DOI 10.1158/2326-6066.CIR-18-0174
   Han Anna, 2018, Oncotarget, V9, P27280, DOI 10.18632/oncotarget.25546
   Han YW, 2000, INFECT IMMUN, V68, P3140, DOI 10.1128/IAI.68.6.3140-3146.2000
   Hashim NAA, 2019, MOL CLIN ONCOL, V11, P3, DOI 10.3892/mco.2019.1853
   Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002
   HILL MJ, 1971, LANCET, V1, P95
   Ho CL, 2018, NAT BIOMED ENG, V2, P27, DOI 10.1038/s41551-017-0181-y
   Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756
   Hota SS, 2017, CLIN INFECT DIS, V64, P265, DOI 10.1093/cid/ciw731
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   IMRAY CHE, 1992, GUT, V33, P1239, DOI 10.1136/gut.33.9.1239
   Isabella VM, 2018, NAT BIOTECHNOL, V36, P857, DOI 10.1038/nbt.4222
   Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1
   Jorgensen B., 1962, P SOC EXP BIOL MED, DOI [10.3181/00379727-109- 27391, DOI 10.3181/00379727-109-27391]
   Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Krishnan S, 2014, COLORECTAL DIS, V16, P672, DOI 10.1111/codi.12662
   Kurtz CB, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau7975
   Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098
   Lee PY, 2017, J BIOMED SCI, V24, DOI 10.1186/s12929-017-0342-z
   Lehouritis P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14554
   Liang JQ, 2020, GUT, V69, P1248, DOI 10.1136/gutjnl-2019-318532
   Liang QY, 2017, CLIN CANCER RES, V23, P2061, DOI 10.1158/1078-0432.CCR-16-1599
   Liu WX, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7828392
   Long SP, 2020, NPJ BIOFILMS MICROME, V6, DOI 10.1038/s41522-020-0123-4
   Long XH, 2019, NAT MICROBIOL, V4, P2319, DOI 10.1038/s41564-019-0541-3
   Louca S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0420-9
   Lu R, 2017, ONCOTARGET, V8, P55104, DOI 10.18632/oncotarget.19052
   Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   McGuire AL, 2008, GENOME RES, V18, P1861, DOI 10.1101/gr.081653.108
   Miquel S, 2013, CURR OPIN MICROBIOL, V16, P255, DOI 10.1016/j.mib.2013.06.003
   MOORE WEC, 1995, APPL ENVIRON MICROB, V61, P3202, DOI 10.1128/AEM.61.9.3202-3207.1995
   Mughini-Gras L, 2018, FOOD MICROBIOL, V71, P60, DOI 10.1016/j.fm.2017.03.002
   Nakamura T, 2002, BIOSCI BIOTECH BIOCH, V66, P2362, DOI 10.1271/bbb.66.2362
   Nakatsu G, 2018, GASTROENTEROLOGY, V155, P529, DOI 10.1053/j.gastro.2018.04.018
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   NARISAWA T, 1974, JNCI-J NATL CANCER I, V53, P1093, DOI 10.1093/jnci/53.4.1093
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ohigashi S, 2011, SURG TODAY, V41, P1200, DOI 10.1007/s00595-010-4450-6
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Panebianco C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0483-7
   Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977
   Peng C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01387
   Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8
   Purcell RV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171602
   Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488
   Raghavendra P., 2018, ADV CELL MOL DIAGN, P161, DOI [10.1016/B978-0-12-813679-9.00007-5, DOI 10.1016/B978-0-12-813679-9.00007-5]
   Ranjan R, 2016, BIOCHEM BIOPH RES CO, V469, P967, DOI 10.1016/j.bbrc.2015.12.083
   REDDY BS, 1973, J NATL CANCER I, V50, P1437, DOI 10.1093/jnci/50.6.1437
   Rhee KJ, 2009, INFECT IMMUN, V77, P1708, DOI 10.1128/IAI.00814-08
   Roller M, 2007, BRIT J NUTR, V97, P676, DOI 10.1017/S0007114507450292
   Rosner J., 2014, MICROBE, V9, P47, DOI DOI 10.1128/MICROBE.9.47.2
   Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Saus E, 2019, MOL ASPECTS MED, V69, P93, DOI 10.1016/j.mam.2019.05.001
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005
   Schultz M, 2008, INFLAMM BOWEL DIS, V14, P1012, DOI 10.1002/ibd.20377
   Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Shields CED, 2016, J INFECT DIS, V214, P122, DOI 10.1093/infdis/jiw069
   Sinha R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152126
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sonnenborn U, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw212
   Spano S, 2016, ADV EXP MED BIOL, V915, P283, DOI 10.1007/978-3-319-32189-9_17
   Srinivasan R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117617
   Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5
   Taieb F, 2016, ECOSAL PLUS, V7, P1, DOI [DOI 10.1128/ECOSALPLUS.ESP-0008-2016, 10.1128/ecosalplus.ESP-0008-2016]
   Taylor WS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233170
   Ternes D, 2020, TRENDS MICROBIOL, V28, P401, DOI 10.1016/j.tim.2020.01.001
   Tsoi H, 2017, GASTROENTEROLOGY, V152, P1419, DOI 10.1053/j.gastro.2017.01.009
   Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026
   Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462
   Vincent AT, 2017, J MICROBIOL METH, V138, P60, DOI 10.1016/j.mimet.2016.02.016
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Wang WL, 2015, WORLD J GASTROENTERO, V21, P803, DOI 10.3748/wjg.v21.i3.803
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Watson KM, 2020, ANN GASTROENTEROL, V33, P223, DOI 10.20524/aog.2020.0467
   Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022
   Wong SH, 2017, GUT, V66, P1441, DOI 10.1136/gutjnl-2016-312766
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Wu XQ, 2018, J CANCER, V9, P2510, DOI 10.7150/jca.25324
   Xu L, 2017, ONCOTARGET, V8, P74703, DOI 10.18632/oncotarget.20345
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zhang X, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0767-6
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
   Zhou ZW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00371
   Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7
NR 146
TC 4
Z9 4
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0960-7404
EI 1879-3320
J9 SURG ONCOL
JI Surg. Oncol.-Oxf.
PD JUN
PY 2021
VL 37
AR 101560
DI 10.1016/j.suronc.2021.101560
EA APR 2021
PG 9
WC Oncology; Surgery
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Surgery
GA TE7XY
UT WOS:000670222200004
PM 33848761
DA 2022-11-22
ER

PT J
AU Viennois, E
   Merlin, D
   Gewirtz, AT
   Chassaing, B
AF Viennois, Emilie
   Merlin, Didier
   Gewirtz, Andrew T.
   Chassaing, Benoit
TI Dietary Emulsifier-Induced Low-Grade Inflammation Promotes Colon
   Carcinogenesis
SO CANCER RESEARCH
LA English
DT Article
ID COLITIS-ASSOCIATED CANCER; ALTERED GUT MICROBIOTA; LACTIC-ACID BACTERIA;
   COLORECTAL-CANCER; ESCHERICHIA-COLI; CROHNS-DISEASE; BOWEL-DISEASE;
   ULCERATIVE-COLITIS; METABOLIC SYNDROME; DEFICIENT MICE
AB The increased risks conferred by inflammatory bowel disease (IBD) to the development of colorectal cancer gave rise to the term "colitis-associated cancer" and the concept that inflammation promotes colon tumorigenesis. A condition more common than IBD is low-grade inflammation, which correlates with altered gut microbiota composition and metabolic syndrome, both present in many cases of colorectal cancer. Recent findings suggest that low-grade inflammation in the intestine is promoted by consumption of dietary emulsifiers, a ubiquitous component of processed foods, which alter the composition of gut microbiota. Here, we demonstrate in a preclinical model of colitis-induced colorectal cancer that regular consumption of dietary emulsifiers, carboxymethylcellulose or polysorbate-80, exacerbated tumor development. Enhanced tumor development was associated with an altered microbiota metagenome characterized by elevated levels of lipopolysaccharide and flagellin. We found that emulsifier-induced alterations in the microbiome were necessary and sufficient to drive alterations in major proliferation and apoptosis signaling pathways thought to govern tumor development. Overall, our findings support the concept that perturbations in host-microbiota interactions that cause low-grade gut inflammation can promote colon carcinogenesis. (C) 2016 AACR.
C1 [Viennois, Emilie; Merlin, Didier; Gewirtz, Andrew T.; Chassaing, Benoit] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.
   [Merlin, Didier] Vet Affairs Med Ctr, Decatur, GA 30033 USA.
C3 University System of Georgia; Georgia State University; US Department of
   Veterans Affairs; Veterans Health Administration (VHA)
RP Chassaing, B (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.
EM bchassaing@gsu.edu
RI Chassaing, Benoit/R-3819-2017
OI Viennois, Emilie/0000-0002-3104-620X
FU NIH grant [DK099071, DK083890]; Career Development Award from the
   Crohn's and Colitis Foundation of America (CCFA); Research Fellowship
   Award from the CCFA; Research Career Scientist Award from the Department
   of Veterans Affairs; Crohn&quot;s & Colitis Foundation of America
   [276509, 370295] Funding Source: researchfish; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083890, R01DK099071,
   R01DK071594] Funding Source: NIH RePORTER; Veterans Affairs
   [IK6BX004476] Funding Source: NIH RePORTER
FX This work was supported by NIH grants DK099071 and DK083890 (A.T.
   Gewirtz). B. Chassaing is a recipient of the Career Development Award
   from the Crohn's and Colitis Foundation of America (CCFA). E. Viennois
   is a recipient of the Research Fellowship Award from the CCFA. D. Merlin
   is a recipient of a Research Career Scientist Award from the Department
   of Veterans Affairs.
CR Ahmadi A, 2009, WORLD J GASTROENTERO, V15, P61, DOI 10.3748/wjg.15.61
   Arthur JC, 2013, GUT MICROBES, V4, P253, DOI 10.4161/gmic.24220
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   BAR A, 1995, FOOD CHEM TOXICOL, V33, P901, DOI 10.1016/0278-6915(95)00068-D
   Berger NA, 2014, ANN NY ACAD SCI, V1311, P57, DOI 10.1111/nyas.12416
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Chassaing B, 2015, NATURE, V519, P92, DOI 10.1038/nature14232
   Chassaing B, 2014, GUT, V63, P1837, DOI 10.1136/gutjnl-2014-306890
   Chassaing B, 2014, GUT, V63, P1069, DOI 10.1136/gutjnl-2013-304909
   Chassaing B, 2014, TOXICOL PATHOL, V42, P49, DOI 10.1177/0192623313508481
   Chassaing B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044328
   Chassaing B, 2011, GASTROENTEROLOGY, V140, P1720, DOI 10.1053/j.gastro.2011.01.054
   Chow MT, 2012, CANCER RES, V72, P5721, DOI 10.1158/0008-5472.CAN-12-0509
   Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257
   Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526
   EKBOM A, 1990, LANCET, V336, P357, DOI 10.1016/0140-6736(90)91889-I
   Engle SJ, 2002, CANCER RES, V62, P6362
   Food and Agriculture Organization of the United Nations, 1999, FOOD ADD SER
   Fukata M, 2007, GASTROENTEROLOGY, V133, P1869, DOI 10.1053/j.gastro.2007.09.008
   Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322
   Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013
   Jess T, 2005, AM J GASTROENTEROL, V100, P2724, DOI 10.1111/j.1572-0241.2005.00287.x
   Klimesova K, 2013, INFLAMM BOWEL DIS, V19, P1266, DOI 10.1097/MIB.0b013e318281330a
   Kong SY, 2016, CANCER EPIDEM BIOMAR, V25, P291, DOI 10.1158/1055-9965.EPI-15-0798
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   LAQUEUR GL, 1981, J NATL CANCER I, V67, P1053
   Maddocks ODK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005517
   MATSUZAKI T, 1988, CANCER IMMUNOL IMMUN, V26, P209
   Merlin D, 2001, GASTROENTEROLOGY, V120, P1666, DOI 10.1053/gast.2001.24845
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   Prorok-Hamon M, 2014, GUT, V63, P761, DOI 10.1136/gutjnl-2013-304739
   Roberts CL, 2013, J CROHNS COLITIS, V7, P338, DOI 10.1016/j.crohns.2013.01.004
   Roberts CL, 2010, GUT, V59, P1331, DOI 10.1136/gut.2009.195370
   Sanapareddy N, 2012, ISME J, V6, P1858, DOI 10.1038/ismej.2012.43
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Swidsinski A, 2009, INFLAMM BOWEL DIS, V15, P359, DOI 10.1002/ibd.20763
   Thirabunyanon M, 2013, APPL BIOCHEM BIOTECH, V169, P511, DOI 10.1007/s12010-012-9995-y
   Thorsteinsdottir S, 2011, NAT REV GASTRO HEPAT, V8, P395, DOI 10.1038/nrgastro.2011.96
   Treon J, 1967, CHEM PHYS APPL SURFA
   Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026
   Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721
   Wang XM, 2007, GASTROENTEROLOGY, V132, P551, DOI 10.1053/j.gastro.2006.11.040
   Weir HK, 2003, JNCI-J NATL CANCER I, V95, P1276, DOI 10.1093/jnci/djg040
   Wojtal KA, 2009, DRUG METAB DISPOS, V37, P1871, DOI 10.1124/dmd.109.027367
   Zhong L, 2014, WORLD J GASTROENTERO, V20, P7878, DOI 10.3748/wjg.v20.i24.7878
NR 45
TC 115
Z9 120
U1 2
U2 58
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JAN 1
PY 2017
VL 77
IS 1
BP 27
EP 40
DI 10.1158/0008-5472.CAN-16-1359
PG 14
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA EJ4LF
UT WOS:000393187900003
PM 27821485
OA Bronze, Green Accepted
DA 2022-11-22
ER

PT J
AU Nadia
   Ramana, J
AF Nadia
   Ramana, Jayashree
TI The Human OncoBiome Database: A Database of Cancer Microbiome Datasets
SO CURRENT BIOINFORMATICS
LA English
DT Article
DE Microbiome; cancer; database; metagenomics; HOBD; metabolism
AB Background: The microbiome plays a very important role in many physiological processes including metabolism, inflammation, homeostasis and many biological pathways. Therefore, dysbiosis of the microbiome disrupts these pathways in different ways that may result in causing cancer. There is a complex connection between the microbiome and cancer. The human bodies are continuously exposed to microbial cells, both resident and transient, as well as their byproducts, including toxic metabolites.
   Objective: To develop the manually curated, searchable and metagenomic resource to facilitate the investigation of Human Cancer microbiota and make it publicly accessible through a web interface which will help further in metagenomic studies.
   Methods: In HOBD, the information on different cancers (Oral Cancer, Breast Cancer, Liver Cancer, and Colorectal Cancer) has been compiled. The main purpose of creating HOBD was to provide the scientific community with comprehensive information on the species that play a crucial role in various Human Cancers.
   Result: Over time, this resource will grow to become a unique community resource of human cancer bacteria, providing an extra level of annotation for the analysis of metagenomic datasets.
   Conclusion: The HOBD site offers easy to use tools for viewing all publicly available Human Cancer microbiota. The freely accessible website is available at http://www.juit.ac.in/hcmd/home.
C1 [Nadia; Ramana, Jayashree] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan 173234, HP, India.
C3 Jaypee University of Information Technology
RP Ramana, J (corresponding author), Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan 173234, HP, India.
EM jayashree.ramana13@gmail.com
RI Ramana, Jayashree/GQQ-5678-2022
CR Amer A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02391
   Asmaa E, 2014, J GASTROINTESTINAL D, V4, P228
   Burns MB, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007376
   Dahmus JD, 2018, J GASTROINTEST ONCOL, V9, P769, DOI 10.21037/jgo.2018.04.07
   Farhana L, 2018, METHODS MOL BIOL, V1856, P35, DOI 10.1007/978-1-4939-8751-1_3
   Fernandez MF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081747
   Fulbright LE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006480
   Gianoulis TA, 2009, P NATL ACAD SCI USA, V106, P1374, DOI 10.1073/pnas.0808022106
   Goodman B, 2018, J PATHOL, V244, P667, DOI 10.1002/path.5047
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Kinross J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08150-3
   Lee WH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43825
   Loo TM, 2017, CANCER DISCOV, V7, P522, DOI 10.1158/2159-8290.CD-16-0932
   Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133
   Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931
   Mendonca LABM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00325
   Meng S, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00318
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   Ohtani N, 2015, SEMIN IMMUNOPATHOL, V37, P65, DOI 10.1007/s00281-014-0457-1
   Park CH, 2018, INTEST RES, V16, P338, DOI 10.5217/ir.2018.16.3.338
   Ravel J, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-16
   Sellner KG, 2003, J IND MICROBIOL BIOT, V30, P383, DOI 10.1007/s10295-003-0074-9
   Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075
   Thompson KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188873
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 26
TC 8
Z9 8
U1 2
U2 8
PU BENTHAM SCIENCE PUBL LTD
PI SHARJAH
PA EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB
   EMIRATES
SN 1574-8936
EI 2212-392X
J9 CURR BIOINFORM
JI Curr. Bioinform.
PY 2020
VL 15
IS 5
BP 472
EP 477
DI 10.2174/1574893614666190902152727
PG 6
WC Biochemical Research Methods; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA OF3QR
UT WOS:000581127300010
DA 2022-11-22
ER

PT J
AU McIntosh, FM
   Maison, N
   Holtrop, G
   Young, P
   Stevens, VJ
   Ince, J
   Johnstone, AM
   Lobley, GE
   Flint, HJ
   Louis, P
AF McIntosh, Freda M.
   Maison, Nathalie
   Holtrop, Grietje
   Young, Pauline
   Stevens, Valerie J.
   Ince, Jennifer
   Johnstone, Alexandra M.
   Lobley, Gerald E.
   Flint, Harry J.
   Louis, Petra
TI Phylogenetic distribution of genes encoding beta-glucuronidase activity
   in human colonic bacteria and the impact of diet on faecal glycosidase
   activities
SO ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID BUTYRATE-PRODUCING BACTERIA; HUMAN GUT; POLYPHENOLS; METABOLISM;
   EVOLUTION
AB Bacterial beta-glucuronidase in the human colon plays an important role in cleaving liver conjugates of dietary compounds and xenobiotics, while other glycosidase activities are involved in the conversion of dietary plant glycosides. Here we detected an increase in beta-glucuronidase activity in faecal samples from obese volunteers following a high-protein moderate carbohydrate weight-loss diet, compared with a weight maintenance diet, but little or no changes were observed when the type of fermentable carbohydrate was varied. Other faecal glycosidase activities showed little or no change over a fivefold range of dietary NSP intake, although a-glucosidase increased on a resistant starch-enriched diet. Two distinct groups of gene, gus and BG, have been reported to encode beta-glucuronidase activity among human colonic bacteria. Degenerate primers were designed against these genes. Overall, Firmicutes were found to account for 96% of amplified gus sequences, with three operational taxonomic units particularly abundant, whereas 59% of amplified BG sequences belonged to Bacteroidetes and 41% to Firmicutes. A similar distribution of operational taxonomic units was found in a published metagenome dataset involving a larger number of volunteers. Seven cultured isolates of human colonic bacteria that carried only the BG gene gave relatively low beta-glucuronidase activity that was not induced by 4-nitrophenyl-beta-D-glucuronide. By comparison, in three of five isolates that possessed only the gus gene, beta-glucuronidase activity was induced.
C1 [McIntosh, Freda M.; Maison, Nathalie; Young, Pauline; Stevens, Valerie J.; Ince, Jennifer; Johnstone, Alexandra M.; Lobley, Gerald E.; Flint, Harry J.; Louis, Petra] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen AB21 9SB, Scotland.
   [Holtrop, Grietje] Biomath & Stat Scotland, Aberdeen AB21 9SB, Scotland.
C3 University of Aberdeen; James Hutton Institute
RP Louis, P (corresponding author), Univ Aberdeen, Rowett Inst Nutr & Hlth, Greenburn Rd, Aberdeen AB21 9SB, Scotland.
EM p.louis@abdn.ac.uk
RI Louis, Petra/Y-3779-2019; Holtrop, Grietje/J-6061-2013
OI Louis, Petra/0000-0003-2115-2399; Holtrop, Grietje/0000-0002-1488-6610;
   Johnstone, Alexandra/0000-0002-5484-292X
FU World Cancer Research Fund; Scottish Government Rural and Environment
   Science and Analytical Services
FX We acknowledge support for the human dietary trial from the World Cancer
   Research Fund. The Rowett Institute of Nutrition and Health and
   Biomathematics and Statistics Scotland receive financial support from
   the Scottish Government Rural and Environment Science and Analytical
   Services. We thank Claire Fyfe, David Bremner and the RINH Human Studies
   Unit. We also thank Tony Travis for help with bioinformatic analysis and
   Sylvia Duncan for strain 80/4.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Avila M, 2009, MICROBIOL-SGM, V155, P2739, DOI 10.1099/mic.0.027789-0
   Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000
   Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679
   Bravo L, 1998, NUTR REV, V56, P317, DOI 10.1111/j.1753-4887.1998.tb01670.x
   Cohen O, 2011, MOL BIOL EVOL, V28, P1481, DOI 10.1093/molbev/msq333
   Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x
   Dayhoff M., 1978, ATLAS PROTEIN SEQ S3, V5, P345
   De Preter V, 2011, MOL NUTR FOOD RES, V55, P46, DOI 10.1002/mnfr.201000451
   Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06
   ERIYAMREMU GE, 1995, ANN NUTR METAB, V39, P42, DOI 10.1159/000177841
   Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x
   Gill CIR, 2002, BRIT J NUTR, V88, pS73, DOI 10.1079/BJN2002632
   Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107
   Holma R, 2010, J NUTR, V140, P534, DOI 10.3945/jn.109.118570
   Le Leu RK, 2007, CARCINOGENESIS, V28, P240, DOI 10.1093/carcin/bgl245
   Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x
   Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004
   Louis P, 2010, ENVIRON MICROBIOL, V12, P304, DOI 10.1111/j.1462-2920.2009.02066.x
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Matsumura I, 2001, J MOL BIOL, V305, P331, DOI 10.1006/jmbi.2000.4259
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rafter J, 2004, EUR J NUTR, V43, P47, DOI 10.1007/s00394-004-1203-6
   *ROYAL SOC CHEM FO, 2002, MCCANC WIDD COMP FOO
   Russell WM, 2001, APPL ENVIRON MICROB, V67, P1253, DOI 10.1128/AEM.67.3.1253-1261.2001
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Shin HY, 2003, APPL ENVIRON MICROB, V69, P7116, DOI 10.1128/AEM.69.12.7116-7123.2003
   Smith Wendy S, 2011, BMC Res Notes, V4, P138, DOI 10.1186/1756-0500-4-138
   Walker AW, 2011, ISME J, V5, P220, DOI [10.1038/ismej.2010.118, 10.1038/ISMEJ.2010.118]
NR 29
TC 72
Z9 77
U1 2
U2 38
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-2912
J9 ENVIRON MICROBIOL
JI Environ. Microbiol.
PD AUG
PY 2012
VL 14
IS 8
SI SI
BP 1876
EP 1887
DI 10.1111/j.1462-2920.2012.02711.x
PG 12
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 980NK
UT WOS:000306899900006
PM 22364273
DA 2022-11-22
ER

PT J
AU Chen, YS
   Li, J
   Menon, R
   Jayaraman, A
   Lee, K
   Huang, Y
   Dashwood, WM
   Zhang, K
   Sun, DQ
   Dashwood, RH
AF Chen, Ying-Shiuan
   Li, Jia
   Menon, Rani
   Jayaraman, Arul
   Lee, Kyongbum
   Huang, Yun
   Dashwood, Wan Mohaiza
   Zhang, Ke
   Sun, Deqiang
   Dashwood, Roderick H.
TI Dietary spinach reshapes the gut microbiome in an Apc-mutant genetic
   background: mechanistic insights from integrated multi-omics
SO GUT MICROBES
LA English
DT Article
DE Microbiome; transcriptome; metabolome; anticancer mechanisms; spinach
ID RAT COLON TUMORS; PLASMINOGEN-ACTIVATOR INHIBITOR-1; BETA-CATENIN;
   GERM-FREE; CHLOROPHYLLIN; CANCER; RISK; CARCINOGENESIS; TRANSCRIPTOME;
   APOPTOSIS
AB Complex interrelationships govern the dynamic interactions between gut microbes, the host, and exogenous drivers of disease outcome. A multi-omics approach to cancer prevention by spinach (SPI) was pursued for the first time in the polyposis in rat colon (Pirc) model. SPI fed for 26 weeks (10% w/w, freeze-dried in the diet) exhibited significant antitumor efficacy and, in the Apc-mutant genetic background, beta-catenin remained highly overexpressed in adenomatous polyps. However, in both wild type and Apc-mutant rats, increased gut microbiome diversity after SPI consumption coincided with reversal of taxonomic composition. Metagenomic prediction implicated linoleate and butanoate metabolism, tricarboxylic acid cycle, and pathways in cancer, which was supported by transcriptomic and metabolomic analyses. Thus, tumor suppression by SPI involved marked reshaping of the gut microbiome along with changes in host RNA-miRNA networks. When colon polyps were compared with matched normal-looking tissues via metabolomics, anticancer outcomes were linked to SPI-derived linoleate bioactives with known anti-inflammatory/ proapoptotic mechanisms, as well as N-aceto-2-hydroxybutanoate, consistent with altered butanoate metabolism stemming from increased alpha-diversity of the gut microbiome. In colon tumors from SPI-fed rats, L-glutamate and N-acetylneuraminate also were reduced, implicating altered mitochondrial energetics and cell surface glycans involved in oncogenic signaling networks and immune evasion. In conclusion, a multi-omics approach to cancer prevention by SPI provided mechanistic support for linoleate and butanoate metabolism, as well as tumor-associated changes in L-glutamate and N-acetylneuraminate. Additional factors, such as the fiber content, also warrant further investigation with a view to delaying colectomy and drug intervention in at-risk patients.
C1 [Chen, Ying-Shiuan; Li, Jia; Huang, Yun; Dashwood, Wan Mohaiza; Zhang, Ke; Sun, Deqiang; Dashwood, Roderick H.] Texas A&M Hlth, Houston, TX 77030 USA.
   [Menon, Rani; Jayaraman, Arul] Texas A&M Univ, Dept Chem Engn, Coll Engn, College Stn, TX 77843 USA.
   [Lee, Kyongbum] Tufts Univ, Dept Chem & Biol Engn, Medford, MA 02155 USA.
   [Dashwood, Roderick H.] Texas A&M Coll Med, Dept Translat Med Sci, Houston, TX USA.
C3 Texas A&M University System; Texas A&M University College Station; Tufts
   University; Texas A&M University System; Texas A&M University College
   Station; Texas A&M Health Science Center
RP Dashwood, RH (corresponding author), Texas A&M Hlth, Ctr Epigenet & Dis Prevent, 2121 W Holcombe Blvd, Houston, TX 77030 USA.
EM rdashwood@tamu.edu
OI Lee, Kyongbum/0000-0002-0699-8057
FU Division of Cancer Prevention, National Cancer Institute [CA122959]
FX This work was supported by the Division of Cancer Prevention, National
   Cancer Institute (grant CA122959).
CR Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Amos-Landgraf JM, 2007, P NATL ACAD SCI USA, V104, P4036, DOI 10.1073/pnas.0611690104
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Blum CA, 2001, CARCINOGENESIS, V22, P315, DOI 10.1093/carcin/22.2.315
   Carmody RN, 2015, CELL HOST MICROBE, V17, P72, DOI 10.1016/j.chom.2014.11.010
   Chakraborty C, 2017, MOL THER-NUCL ACIDS, V8, P132, DOI 10.1016/j.omtn.2017.06.005
   Chen DF, 2020, CANCER LETT, V469, P456, DOI 10.1016/j.canlet.2019.11.019
   Chen Q, 2014, CELL MOL BIOL LETT, V19, P52, DOI 10.2478/s11658-013-0115-y
   Chen YS, 2017, ARCH TOXICOL, V91, P3415, DOI 10.1007/s00204-017-1945-6
   Cheng K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0375-2
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Coklo M, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1779002
   DASHWOOD R, 1992, CARCINOGENESIS, V13, P1121, DOI 10.1093/carcin/13.7.1121
   DASHWOOD RH, 1991, CARCINOGENESIS, V12, P939, DOI 10.1093/carcin/12.5.939
   Dashwood RH, 1999, P SOC EXP BIOL MED, V220, P239, DOI 10.1046/j.1525-1373.1999.d01-41.x
   DASHWOOD RH, 1989, FOOD CHEM TOXICOL, V27, P385, DOI 10.1016/0278-6915(89)90144-0
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   DeDecker L, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2020.1854641
   Diaz GD, 2003, CANCER RES, V63, P1254
   Egner PA, 2001, P NATL ACAD SCI USA, V98, P14601, DOI 10.1073/pnas.251536898
   Ertem F, 2016, GASTROINTEST ENDOSC, V83, P1272, DOI 10.1016/j.gie.2015.11.030
   Ertem FU, 2017, INT J CANCER, V140, P460, DOI 10.1002/ijc.30458
   Flemer B, 2017, GUT MICROBES, V8, P428, DOI 10.1080/19490976.2017.1334033
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   GANESH S, 1994, CANCER RES, V54, P4065
   Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783
   Giron LB, 2020, MUCOSAL IMMUNOL, V13, P753, DOI 10.1038/s41385-020-0279-5
   GUO DX, 1995, CANCER LETT, V95, P161, DOI 10.1016/0304-3835(95)03882-W
   Gupta S, 2016, THER ADV GASTROENTER, V9, P229, DOI 10.1177/1756283X15607414
   Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436
   Higdon JV, 2007, PHARMACOL RES, V55, P224, DOI 10.1016/j.phrs.2007.01.009
   Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756
   Irving AA, 2014, DIS MODEL MECH, V7, P1215, DOI 10.1242/dmm.016980
   Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263
   Jubert C, 2009, CANCER PREV RES, V2, P1015, DOI 10.1158/1940-6207.CAPR-09-0099
   Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271
   Kotsias M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223270
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larsen CA, 2010, ARCH BIOCHEM BIOPHYS, V501, P52, DOI 10.1016/j.abb.2010.03.017
   Lee SI, 2011, CANCER METAST REV, V30, P481, DOI 10.1007/s10555-011-9321-0
   Li J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5427
   Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123
   Lin YF, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2020.1832856
   Liu FY, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108049
   Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]
   Myhrstad MCW, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030859
   Myzak MC, 2004, CANCER RES, V64, P5767, DOI 10.1158/0008-5472.CAN-04-1326
   Nian H, 2009, CARCINOGENESIS, V30, P1416, DOI 10.1093/carcin/bgp147
   Nomura AMY, 2008, AM J CLIN NUTR, V88, P730, DOI 10.1093/ajcn/88.3.730
   Ocvirk S, 2020, AM J CLIN NUTR, V111, P406, DOI 10.1093/ajcn/nqz301
   Okonkwo A, 2018, MOL NUTR FOOD RES, V62, DOI 10.1002/mnfr.201800228
   Oliver A, 2021, MSYSTEMS, V6, DOI 10.1128/mSystems.00115-21
   Orner GA, 2002, MUTAT RES-FUND MOL M, V506, P121, DOI 10.1016/S0027-5107(02)00158-6
   Parasramka MA, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-16
   Parasramka MA, 2012, MOL NUTR FOOD RES, V56, P1259, DOI 10.1002/mnfr.201200117
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Patel NV, 2010, CANCER EPIDEM BIOMAR, V19, P2631, DOI 10.1158/1055-9965.EPI-10-0677
   Gutierrez RMP, 2019, MINI-REV MED CHEM, V19, P1666, DOI 10.2174/1389557519666190603090347
   Rajendran P, 2019, CANCER RES, V79, P918, DOI 10.1158/0008-5472.CAN-18-2003
   Rajendran P, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0132-y
   Rajendran P, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-68
   Rey FE, 2013, P NATL ACAD SCI USA, V110, P13582, DOI 10.1073/pnas.1312524110
   Roberts JL, 2016, FOOD FUNCT, V7, P3337, DOI [10.1039/C6FO00051G, 10.1039/c6fo00051g]
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Sakakibara T, 2005, BRIT J CANCER, V93, P799, DOI 10.1038/sj.bjc.6602743
   Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63
   Samadder NJ, 2018, JAMA ONCOL, V4, P671, DOI 10.1001/jamaoncol.2017.5431
   Scheithauer TPM, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1875109
   Schmidt S, 2019, NAT CELL BIOL, V21, P1413, DOI 10.1038/s41556-019-0408-0
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Simonich MT, 2007, CARCINOGENESIS, V28, P1294, DOI 10.1093/carcin/bgm027
   Singh A, 2019, NAT PROD RES, V33, P2253, DOI 10.1080/14786419.2018.1489395
   Son JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127985
   Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67
   Tsilimigras MCB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.8
   Vangaveti VN, 2016, EUR J PHARMACOL, V785, P70, DOI 10.1016/j.ejphar.2015.03.096
   Vannucci L, 2008, INT J ONCOL, V32, P609
   Villadsen SB, 2012, BRIT J CANCER, V106, P366, DOI 10.1038/bjc.2011.520
   Wang R, 2008, CANCER SCI, V99, P1754, DOI 10.1111/j.1349-7006.2008.00887.x
   Wang R, 2013, INT J CANCER, V132, P1004, DOI 10.1002/ijc.27762
   Wang R, 2011, INT J CANCER, V128, P2581, DOI 10.1002/ijc.25610
   Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319
   Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356
   Xu J, 2008, J CANCER RES CLIN, V134, P891, DOI 10.1007/s00432-008-0353-y
   Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025
   Yi YX, 2021, CLIN CANCER RES, V27, P1329, DOI 10.1158/1078-0432.CCR-20-3445
   Zhou XM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020273
NR 90
TC 3
Z9 3
U1 5
U2 19
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PD JAN 1
PY 2021
VL 13
IS 1
AR 1972756
DI 10.1080/19490976.2021.1972756
PG 21
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA UP6XK
UT WOS:000695521000001
PM 34494932
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Holzl-Armstrong, L
   Moody, S
   Kucab, JE
   Zwart, EP
   Bellamri, M
   Luijten, M
   Turesky, RJ
   Stratton, MR
   Arlt, VM
   Phillips, DH
AF Holzl-Armstrong, Lisa
   Moody, Sarah
   Kucab, Jill E.
   Zwart, Edwin P.
   Bellamri, Medjda
   Luijten, Mirjam
   Turesky, Robert J.
   Stratton, Michael R.
   Arlt, Volker M.
   Phillips, David H.
TI Mutagenicity of 2-hydroxyamino-1-methyl-6-phenylimidazo [4,5-b] pyridine
   (N-OH-PhIP) in human TP53 knock-in (Hupki) mouse embryo fibroblasts
SO FOOD AND CHEMICAL TOXICOLOGY
LA English
DT Article
DE TP53; Mutation; Whole genome sequencing; Dietary carcinogen; PhIP; DNA
   adducts
ID HETEROCYCLIC AROMATIC-AMINES; MUTATIONAL SIGNATURES; ENVIRONMENTAL
   CARCINOGEN; DIFFERENTIAL METABOLISM; P53 MUTATIONS; DNA-ADDUCTS; RAT;
   COLON; FOOD; IDENTIFICATION
AB 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is a possible human carcinogen formed in cooked fish and meat. PhIP is bioactivated by cytochrome P450 enzymes to form 2-hydroxyamino-1-methyl-6-phenylimidazo [4,5-b]pyridine (N-OH-PhIP), a genotoxic metabolite that reacts with DNA leading to the mutation-prone DNA adduct N-(deoxyguanosin-8-yl)-PhIP (dG-C8-PhIP). Here, we studied N-OH-PhIP-induced whole genome mutagenesis in human TP53 knock-in (Hupki) mouse embryo fibroblasts (HUFs) immortalised and subjected to whole genome sequencing (WGS). In addition, mutagenicity of N-OH-PhIP in TP53 and the lacZ reporter gene were assessed. TP53 mutant frequency in HUF cultures treated with N-OH-PhIP (2.5 mu M for 24 h, n = 90) was 10% while no TP53 mutations were found in untreated controls (DMSO for 24 h, n = 6). All N-OH-PhIP-induced TP53 mutations occurred at G:C base pairs with G > T/C > A transversions accounting for 58% of them. TP53 mutations characteristic of those induced by N-OH-PhIP have been found in human tumours including breast and colorectal, which are cancer types that have been associated with PhIP exposure. LacZ mutant frequency increased 25-fold at 5 mu M N-OH-PHIP and up to similar to 350 dG-C8-PhIP adducts/10(8) nucleosides were detected by ultra-performance liquid chromatography-electrospray ionisation multistage scan mass spectrometry (UPLC-ESI-MS3) at this concentration. In addition, a WGS mutational signature defined by G > T/C > A transversions was present in N-OH-PhIP-treated immortalised clones, which showed similarity to COSMIC 5B54, 18 and 29 signatures found in human tumours.
C1 [Holzl-Armstrong, Lisa; Kucab, Jill E.; Arlt, Volker M.; Phillips, David H.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Dept Analyt Environm & Forens Sci, London SE1 9NH, England.
   [Moody, Sarah; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Ageing & Somat Mutat, Hinxton CB10 1SA, England.
   [Zwart, Edwin P.; Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, 3720 BA, NL-3720 BA Bilthoven, Netherlands.
   [Bellamri, Medjda; Turesky, Robert J.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN USA.
   [Bellamri, Medjda; Turesky, Robert J.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA.
   [Arlt, Volker M.] GAB Consulting GmbH, Toxicol Dept, D-69126 Heidelberg, Germany.
C3 University of London; King's College London; Wellcome Trust Sanger
   Institute; Netherlands National Institute for Public Health & the
   Environment; University of Minnesota System; University of Minnesota
   Twin Cities; University of Minnesota System; University of Minnesota
   Twin Cities
RP Arlt, VM (corresponding author), GAB Consulting GmbH, Toxicol Dept, D-69126 Heidelberg, Germany.
EM volker.arlt@kcl.ac.uk
RI Bellamri, Madjda/AAX-9938-2021
OI Luijten, Mirjam/0000-0002-5277-1443; Phillips,
   David/0000-0001-8509-3485; Arlt, Volker Manfred/0000-0003-4314-9318;
   Bellamri, Madjda/0000-0002-6477-967X
FU MRC Centre for Environment and Health; Cancer Research UK Grand
   Challenge Award "Mutographs of Cancer" [C98/A24032]; National Cancer
   Institute of the National Institutes of Health [R01CA122320]; Cancer
   Center Support [CA-077598]
FX Lisa FlEdzl-Armstrong was supported by a PhD studentship from the MRC
   Centre for Environment and Health. Work at King's College London and the
   Wellcome Trust Sanger Institute was supported by the Cancer Research UK
   Grand Challenge Award "Mutographs of Cancer" (grant C98/A24032). Other
   funding was from the National Cancer Institute of the National
   Institutes of Health (R01CA122320 to R.J.T.); Mass spectrometry was
   carried out in the Analytical Biochemistry Shared Resource of the
   Masonic Cancer Center, University of Minnesota, funded in part by Cancer
   Center Support (CA-077598).
CR Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3
   Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299
   Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477
   [Anonymous], 2018, IARC MON EV CARC RIS
   Arlt VM, 2002, CARCINOGENESIS, V23, P1937, DOI 10.1093/carcin/23.11.1937
   Bellamri M, 2018, TOXICOL SCI, V163, P543, DOI 10.1093/toxsci/kfy060
   CAROTHRS AM, 1994, CHEM RES TOXICOL, V7, P209, DOI 10.1021/tx00038a015
   Carvalho AM, 2015, BRIT J NUTR, V113, P1301, DOI 10.1017/S0007114515000628
   Cheung C, 2005, CHEM RES TOXICOL, V18, P1471, DOI 10.1021/tx050136g
   Christenser S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12594-8
   Crofts FG, 1998, CARCINOGENESIS, V19, P1969, DOI 10.1093/carcin/19.11.1969
   DOOLEY KL, 1992, CANCER LETT, V62, P205, DOI 10.1016/0304-3835(92)90097-F
   ESUMI H, 1989, JPN J CANCER RES, V80, P1176, DOI 10.1111/j.1349-7006.1989.tb01651.x
   Felton JS, 2004, TOXICOLOGY, V198, P135, DOI 10.1016/j.tox.2004.01.024
   FRANDSEN H, 1992, CARCINOGENESIS, V13, P629, DOI 10.1093/carcin/13.4.629
   Glass-Holmes M, 2015, AM J CANCER RES, V5, P191
   Gooderham NJ, 2002, MUTAT RES-FUND MOL M, V506, P91, DOI 10.1016/S0027-5107(02)00155-0
   Hainaut P, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026179
   Holzl-Armstrong L, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2040085
   Hollstein M, 2013, MUTAT RES-REV MUTAT, V753, P41, DOI 10.1016/j.mrrev.2013.02.003
   Holzl-Armstrong L, 2020, ARCH TOXICOL, V94, P4173, DOI 10.1007/s00204-020-02878-0
   Huang MN, 2017, GENOME RES, V27, P1475, DOI 10.1101/gr.220038.116
   IARC, 1993, IARC MONOGRAPHS EVAL
   IARC, 2020, GLOBOCAN 2018
   Ito N, 1997, MUTAT RES-FUND MOL M, V376, P107, DOI 10.1016/S0027-5107(97)00032-8
   ITO N, 1991, CARCINOGENESIS, V12, P1503, DOI 10.1093/carcin/12.8.1503
   Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001
   Kucab JE, 2017, INT J CANCER, V140, P877, DOI 10.1002/ijc.30504
   Kucab JE, 2016, DNA REPAIR, V39, P21, DOI 10.1016/j.dnarep.2015.11.004
   Kucab JE, 2015, MUTAT RES-FUND MOL M, V773, P48, DOI 10.1016/j.mrfmmm.2015.01.013
   Kucab JE, 2010, FEBS J, V277, P2567, DOI [10.1111/j.1742-464X.2010.07676.x, 10.1111/j.1742-4658.2010.07676.x]
   Langouet S, 2002, CARCINOGENESIS, V23, P115, DOI 10.1093/carcin/23.1.115
   Leroy B, 2014, HUM MUTAT, V35, P672, DOI 10.1002/humu.22552
   Letouze E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01358-x
   Li RJ, 2013, FOOD CHEM TOXICOL, V55, P182, DOI 10.1016/j.fct.2012.12.054
   LIN DX, 1992, CHEM RES TOXICOL, V5, P691, DOI 10.1021/tx00029a016
   Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101
   Lynch AM, 1998, MUTAGENESIS, V13, P601, DOI 10.1093/mutage/13.6.601
   Mahabir AG, 2009, MUTAT RES-FUND MOL M, V666, P50, DOI 10.1016/j.mrfmmm.2009.04.005
   MAKINO H, 1994, JPN J CANCER RES, V85, P510, DOI 10.1111/j.1349-7006.1994.tb02388.x
   Malfatti MA, 2006, CANCER RES, V66, P10541, DOI 10.1158/0008-5472.CAN-06-1573
   MORGENTHALER PML, 1995, CARCINOGENESIS, V16, P713, DOI 10.1093/carcin/16.4.713
   Nakayama M, 2019, J MOL CELL BIOL, V11, P267, DOI 10.1093/jmcb/mjy075
   Nauwelaers G, 2011, CHEM RES TOXICOL, V24, P913, DOI 10.1021/tx200091y
   Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073
   Okonogi H, 1997, MUTAT RES-GEN TOX EN, V395, P93, DOI 10.1016/S1383-5718(97)00146-0
   Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482
   Pilati C, 2017, J PATHOL, V242, P10, DOI 10.1002/path.4880
   Shirai T, 1997, CANCER RES, V57, P195
   Stuart GR, 2000, MUTAT RES-FUND MOL M, V452, P101, DOI 10.1016/S0027-5107(00)00058-0
   Tomkova M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1509-y
   Turesky RJ, 1998, CHEM RES TOXICOL, V11, P925, DOI 10.1021/tx980022n
   Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s
   USHIJIMA T, 1994, MOL CARCINOGEN, V10, P38, DOI 10.1002/mc.2940100107
   Xiao S, 2016, ANAL CHEM, V88, P12508, DOI 10.1021/acs.analchem.6b04157
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
   Yu MS, 2000, MOL CARCINOGEN, V27, P76, DOI 10.1002/(SICI)1098-2744(200002)27:2<76::AID-MC3>3.0.CO;2-7
   Zhivagui M, 2019, GENOME RES, V29, P521, DOI 10.1101/gr.242453.118
NR 58
TC 2
Z9 2
U1 0
U2 9
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0278-6915
EI 1873-6351
J9 FOOD CHEM TOXICOL
JI Food Chem. Toxicol.
PD JAN
PY 2021
VL 147
AR 111855
DI 10.1016/j.fct.2020.111855
PG 14
WC Food Science & Technology; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology; Toxicology
GA PN8UQ
UT WOS:000604748100003
PM 33189884
DA 2022-11-22
ER

PT J
AU Xing, CS
   Du, Y
   Duan, TH
   Nim, K
   Chu, JJ
   Wang, HY
   Wang, RF
AF Xing, Changsheng
   Du, Yang
   Duan, Tianhao
   Nim, Kelly
   Chu, Junjun
   Wang, Helen Y.
   Wang, Rong-Fu
TI Interaction between microbiota and immunity and its implication in
   colorectal cancer
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE colorectal cancer; microbiota; innate immunity; adaptive immunity;
   colitis; metabolites; immune signaling; immunotherapy
ID INFLAMMATORY-BOWEL-DISEASE; ARYL-HYDROCARBON RECEPTOR; INNATE
   LYMPHOID-CELLS; REGULATORY T-CELLS; HELICOBACTER-PYLORI INFECTION;
   TOLL-LIKE RECEPTORS; CHAIN FATTY-ACIDS; NF-KAPPA-B;
   FUSOBACTERIUM-NUCLEATUM; GUT MICROBIOTA
AB Colorectal cancer (CRC) is one of the leading causes of cancer-related death in the world. Besides genetic causes, colonic inflammation is one of the major risk factors for CRC development, which is synergistically regulated by multiple components, including innate and adaptive immune cells, cytokine signaling, and microbiota. The complex interaction between CRC and the gut microbiome has emerged as an important area of current CRC research. Metagenomic profiling has identified a number of prominent CRC-associated bacteria that are enriched in CRC patients, linking the microbiota composition to colitis and cancer development. Some microbiota species have been reported to promote colitis and CRC development in preclinical models, while a few others are identified as immune modulators to induce potent protective immunity against colitis and CRC. Mechanistically, microbiota regulates the activation of different immune cell populations, inflammation, and CRC via crosstalk between innate and adaptive immune signaling pathways, including nuclear factor kappa B (NF-kappa B), type I interferon, and inflammasome. In this review, we provide an overview of the potential interactions between gut microbiota and host immunity and how their crosstalk could synergistically regulate inflammation and CRC, thus highlighting the potential roles and mechanisms of gut microbiota in the development of microbiota-based therapies to prevent or alleviate colitis and CRC.
C1 [Xing, Changsheng; Du, Yang; Duan, Tianhao; Nim, Kelly; Chu, Junjun; Wang, Helen Y.; Wang, Rong-Fu] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA.
   [Wang, Rong-Fu] Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90007 USA.
   [Wang, Rong-Fu] Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA.
C3 University of Southern California; University of Southern California;
   Children's Hospital Los Angeles; University of Southern California
RP Wang, RF (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA.; Wang, RF (corresponding author), Univ Southern Calif, Norris Comprehens Canc Ctr, Keck Sch Med, Los Angeles, CA 90007 USA.; Wang, RF (corresponding author), Univ Southern Calif, Childrens Hosp Los Angeles, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA.
EM rongfuwa@usc.edu
FU NCI, NIH [R01CA101795, R01CA246547, U54CA210181]; Department of Defense
   (DoD) CDMRP BCRP [BC151081]; Department of Defense (DoD) LCRP [LC200368]
FX This work was in part supported by grants from the NCI, NIH
   (R01CA101795, R01CA246547, and U54CA210181), Department of Defense (DoD)
   CDMRP BCRP (BC151081) and LCRP (LC200368) to R-FW.
CR Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001
   Ai DM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00826
   Alam A, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2015.21, 10.1038/NMICROBIOL.2015.21]
   Alexander KL, 2014, IMMUNOL REV, V260, P206, DOI 10.1111/imr.12180
   Almeida-Lousada H, 2021, CURR ONCOL, V28, P4874, DOI 10.3390/curroncol28060411
   Amicarella F, 2017, GUT, V66, P692, DOI 10.1136/gutjnl-2015-310016
   Aoudia N, 2016, FOOD MICROBIOL, V53, P51, DOI 10.1016/j.fm.2015.04.009
   Appunni S, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.718389
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058
   Athan E, 2019, MED J AUSTRALIA, V210, P86, DOI 10.5694/mja2.12027
   Aymeric L, 2018, P NATL ACAD SCI USA, V115, pE283, DOI 10.1073/pnas.1715112115
   Baek MK, 2010, CANCER LETT, V290, P123, DOI 10.1016/j.canlet.2009.08.030
   Bai XW, 2022, GUT, DOI 10.1136/gutjnl-2021-325021
   Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x
   Balish E, 2002, AM J PATHOL, V160, P2253, DOI 10.1016/S0002-9440(10)61172-8
   Baran B, 2018, GASTROENTEROL RES, V11, P264, DOI 10.14740/gr1062w
   Barzegari A, 2020, INFECT DRUG RESIST, V13, P659, DOI 10.2147/IDR.S232982
   Baxter NT, 2019, MBIO, V10, DOI [10.1128/mBio.02566-18, 10.1128/mbio.02566-18]
   Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20
   Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011
   Bell HN, 2022, CANCER CELL, V40, P185, DOI 10.1016/j.ccell.2021.12.001
   Bendell JC, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.3_suppl.704
   Benitez-Paez A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00383
   Bian XY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02259
   Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091
   Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003
   Bishehsari F, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01029
   Bishehsari F, 2018, GENES-BASEL, V9, DOI 10.3390/genes9020102
   Blachier F, 2010, AMINO ACIDS, V39, P335, DOI 10.1007/s00726-009-0445-2
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609
   Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6
   Briukhovetska D, 2021, NAT REV CANCER, V21, P481, DOI 10.1038/s41568-021-00363-z
   Cao Y, 2018, GUT, V67, P672, DOI 10.1136/gutjnl-2016-313413
   Casasanta MA, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aba9157
   Casero RA, 2018, NAT REV CANCER, V18, P681, DOI 10.1038/s41568-018-0050-3
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chae WJ, 2010, P NATL ACAD SCI USA, V107, P5540, DOI 10.1073/pnas.0912675107
   Chagneau CV, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00414-19
   Chan CWH, 2019, J CANCER, V10, P5874, DOI 10.7150/jca.31737
   Chan JL, 2019, MUCOSAL IMMUNOL, V12, P164, DOI 10.1038/s41385-018-0085-5
   Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111
   Chen DF, 2020, CANCER LETT, V469, P456, DOI 10.1016/j.canlet.2019.11.019
   Chen H, 2022, FRONT ENDOCRINOL, V13, DOI 10.3389/fendo.2022.855197
   Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607
   Chen MX, 2016, MOL CELL, V64, P105, DOI 10.1016/j.molcel.2016.08.025
   Cheng YW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.615056
   Cho CE, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600324
   Chu JJ, 2021, NAT METAB, V3, P1466, DOI 10.1038/s42255-021-00479-4
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Chung Y, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01071-4
   Conti HR, 2010, MICROBES INFECT, V12, P518, DOI 10.1016/j.micinf.2010.03.013
   Cousin FJ, 2016, ONCOTARGET, V7, P7161, DOI 10.18632/oncotarget.6881
   Cui J, 2014, CELL RES, V24, P400, DOI 10.1038/cr.2013.170
   Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040
   Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009
   De Simone V, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.26617
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0
   Deriu E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005572
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Deweerdt S, 2015, NATURE, V521, pS10, DOI 10.1038/521S10a
   Dharmani P, 2011, INFECT IMMUN, V79, P2597, DOI 10.1128/IAI.05118-11
   Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295
   Du Y, 2022, ADV SCI, V9, DOI 10.1002/advs.202103701
   Du Y, 2018, EMBO J, V37, P351, DOI 10.15252/embj.201796781
   Duan TH, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.812774
   Dvorak Z, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911621
   Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059
   Elamin EE, 2013, NUTR REV, V71, P483, DOI 10.1111/nure.12027
   Ellmerich S, 2000, CARCINOGENESIS, V21, P753, DOI 10.1093/carcin/21.4.753
   Engin AB, 2010, GENET TEST MOL BIOMA, V14, P559, DOI 10.1089/gtmb.2009.0195
   Ercolano G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22764-2
   Erttmann SF, 2022, IMMUNITY, V55, P847, DOI 10.1016/j.immuni.2022.04.006
   Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228
   Eugene J, 2020, MODERN PATHOL, V33, P468, DOI 10.1038/s41379-019-0322-9
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110
   Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051
   Farhana L, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0439-4
   FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I
   Feller M, 2007, LANCET INFECT DIS, V7, P607, DOI 10.1016/S1473-3099(07)70211-6
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Feng YC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12573-3
   Feng Z, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0208-7
   Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041
   Forkel M, 2019, J CROHNS COLITIS, V13, P67, DOI 10.1093/ecco-jcc/jjy119
   Forssell J, 2007, CLIN CANCER RES, V13, P1472, DOI 10.1158/1078-0432.CCR-06-2073
   Freeman HJ, 2008, WORLD J GASTROENTERO, V14, P1810, DOI 10.3748/wjg.14.1810
   Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010
   Fujimori S, 2005, J GASTROENTEROL, V40, P887, DOI 10.1007/s00535-005-1649-1
   Furumatsu K, 2011, DIGEST DIS SCI, V56, P2532, DOI 10.1007/s10620-011-1643-9
   Fuszek P, 2006, ANTICANCER RES, V26, P527
   Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175
   Galon J, 2007, CANCER RES, V67, P1883, DOI 10.1158/0008-5472.CAN-06-4806
   Cano PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041079
   Germann M, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910681
   Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447
   Gianfredi V, 2018, INT J FOOD SCI NUTR, V69, P904, DOI 10.1080/09637486.2018.1446917
   Gianotti L, 2010, WORLD J GASTROENTERO, V16, P167, DOI 10.3748/wjg.v16.i2.167
   Golkhalkhali B, 2018, ASIA-PAC J CLIN ONCO, V14, P179, DOI 10.1111/ajco.12758
   Gomes AC, 2017, OBESITY, V25, P30, DOI 10.1002/oby.21671
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Governa V, 2017, CLIN CANCER RES, V23, P3847, DOI 10.1158/1078-0432.CCR-16-2047
   Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001
   Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465
   Grizotte-Lake M, 2018, IMMUNITY, V49, P1103, DOI 10.1016/j.immuni.2018.11.018
   Gu ZY, 2021, CHINESE MED J-PEKING, V134, P2841, DOI 10.1097/CM9.0000000000001829
   Gui XH, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.673341
   Guo L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01052
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Hansen CHF, 2012, DIABETOLOGIA, V55, P2285, DOI 10.1007/s00125-012-2564-7
   Hanus M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.612826
   Haram A, 2017, J SURG ONCOL, V115, P470, DOI 10.1002/jso.24523
   Hartwich A, 2001, INT J COLORECTAL DIS, V16, P202, DOI 10.1007/s003840100288
   Hatakka K, 2008, INT J FOOD MICROBIOL, V128, P406, DOI 10.1016/j.ijfoodmicro.2008.09.010
   Hayashi A, 2013, CELL HOST MICROBE, V13, P711, DOI 10.1016/j.chom.2013.05.013
   He C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00639
   He Z, 2019, GUT, V68, P289, DOI 10.1136/gutjnl-2018-317200
   Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190
   Hepworth MR, 2013, NATURE, V498, P113, DOI 10.1038/nature12240
   Hibberd AA, 2017, BMJ OPEN GASTROENTER, V4, DOI 10.1136/bmjgast-2017-000145
   Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Huang DD, 2018, CANCER METAST REV, V37, P173, DOI 10.1007/s10555-017-9726-5
   Huang QT, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03080
   Huber S, 2004, J IMMUNOL, V173, P6526, DOI 10.4049/jimmunol.173.11.6526
   Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535
   Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529
   Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Ikuta T, 2013, CARCINOGENESIS, V34, P1620, DOI 10.1093/carcin/bgt083
   Irrazabal T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15549-6
   Islami F, 2018, CA-CANCER J CLIN, V68, P31, DOI 10.3322/caac.21440
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Jacquelot N, 2022, NAT IMMUNOL, V23, P371, DOI 10.1038/s41590-022-01127-z
   Jess T, 2012, CLIN GASTROENTEROL H, V10, P639, DOI 10.1016/j.cgh.2012.01.010
   Jeyanathan M, 2007, MICROBES INFECT, V9, P1567, DOI 10.1016/j.micinf.2007.09.001
   Ji J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24838
   Jia YP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186179
   Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011
   Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15
   Kaiko GE, 2016, CELL, V165, P1708, DOI 10.1016/j.cell.2016.05.018
   Kalina U, 2002, EUR J IMMUNOL, V32, P2635, DOI 10.1002/1521-4141(200209)32:9<2635::AID-IMMU2635>3.0.CO;2-N
   Karimi K, 2009, AM J RESP CRIT CARE, V179, P186, DOI 10.1164/rccm.200806-951OC
   Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488
   Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106
   Kawashima T, 2013, IMMUNITY, V38, P1187, DOI 10.1016/j.immuni.2013.02.024
   Kayama H, 2020, ANNU REV IMMUNOL, V38, P23, DOI 10.1146/annurev-immunol-070119-115104
   Kim JC, 2022, J CANCER RES CLIN, V148, P533, DOI 10.1007/s00432-021-03888-w
   Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713
   Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009
   Kim SJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1557-9
   Kim SO, 2006, CELL MICROBIOL, V8, P1958, DOI 10.1111/j.1462-5822.2006.00763.x
   KLEIN RS, 1977, NEW ENGL J MED, V297, P800, DOI 10.1056/NEJM197710132971503
   Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kountz DJ, 2020, J BIOL CHEM, V295, P11971, DOI 10.1074/jbc.RA120.012934
   Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010
   Kuczma MP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz3186
   Kuenstner JT, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00208
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   Kumar R, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19941-7
   Kumar R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006440
   Kushkevych I, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120752
   Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8
   Lakatos L, 2006, INFLAMM BOWEL DIS, V12, P205, DOI 10.1097/01.MIB.0000217770.21261.ce
   Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354
   Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434
   Lavoie S, 2020, GASTROENTEROLOGY, V158, P1359, DOI 10.1053/j.gastro.2019.12.027
   Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596
   Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931
   Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003
   Lee JY, 2017, J CANCER, V8, P1249, DOI 10.7150/jca.18230
   Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026
   Lee SJ, 2010, INT J BIOCHEM CELL B, V42, P1907, DOI 10.1016/j.biocel.2010.09.021
   Li JX, 2021, GENE DEV, V35, P787, DOI 10.1101/gad.348226.120
   Liang SY, 2020, INT J BIOL SCI, V16, P135, DOI 10.7150/ijbs.37399
   Lim SY, 2015, HEPATOLOGY, V62, P521, DOI 10.1002/hep.27838
   Lima SF, 2022, GASTROENTEROLOGY, V162, P166, DOI 10.1053/j.gastro.2021.09.061
   Limagne E, 2016, CANCER RES, V76, P5241, DOI 10.1158/0008-5472.CAN-15-3164
   Lin M, 2016, MOL CELL, V64, P267, DOI 10.1016/j.molcel.2016.08.029
   Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076
   Liu L, 2018, FOOD FUNCT, V9, P5588, DOI [10.1039/c8fo01143e, 10.1039/C8FO01143E]
   Liu M, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106862
   Loddenkemper C, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-52
   Loke YL, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.603086
   Long XH, 2019, NAT MICROBIOL, V4, P2319, DOI 10.1038/s41564-019-0541-3
   Lopez-Siles M, 2017, ISME J, V11, P841, DOI 10.1038/ismej.2016.176
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Ma QQ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1434-3
   Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421
   Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754
   Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437
   Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054
   Martinez-Jimenez F, 2020, NAT REV CANCER, V20, P555, DOI 10.1038/s41568-020-0290-x
   Marvel D, 2015, J CLIN INVEST, V125, P3356, DOI 10.1172/JCI80005
   Marzullo P, 2021, INT J OBESITY, V45, P2291, DOI 10.1038/s41366-021-00866-7
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Matsui A, 2014, INFECT IMMUN, V82, P4068, DOI 10.1128/IAI.02256-14
   Mazaki J, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07429-5
   McQuade JL, 2019, LANCET ONCOL, V20, pE77, DOI 10.1016/S1470-2045(18)30952-5
   Mezheyeuski A, 2021, CANCERS, V13, DOI 10.3390/cancers13215545
   Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Mizuno R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030529
   Monteleone I, 2012, CURR OPIN GASTROEN, V28, P310, DOI 10.1097/MOG.0b013e328352ad69
   Mroz MS, 2018, AM J PHYSIOL-GASTR L, V314, pG378, DOI 10.1152/ajpgi.00435.2016
   Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x
   Mutala LB, 2021, CANCERS, V13, DOI 10.3390/cancers13020189
   N The Cancer Genome Atlas, 2012, NATURE, V487, P330, DOI DOI 10.1038/NATURE11252
   Nagorsen D, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-62
   Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052
   Naito Y, 1998, CANCER RES, V58, P3491
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nastasi C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16148
   Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661
   Nosho K, 2016, WORLD J GASTROENTERO, V22, P557, DOI 10.3748/wjg.v22.i2.557
   O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112
   OBISO RJ, 1995, INFECT IMMUN, V63, P3820, DOI 10.1128/IAI.63.10.3820-3826.1995
   Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013
   Oh Byeong Seob, 2021, Front Microbiol, V12, P736343, DOI 10.3389/fmicb.2021.736343
   Oh NS, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1785803
   Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4
   Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79
   Okada Y, 2006, GUT, V55, P681, DOI 10.1136/gut.2005.070490
   Olguin JE, 2020, CANCERS, V12, DOI 10.3390/cancers12071888
   OuYang LY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0410-7
   Pai R, 2004, MOL BIOL CELL, V15, P2156, DOI 10.1091/mbc.E03-12-0894
   Parkhurst MR, 2011, MOL THER, V19, P620, DOI 10.1038/mt.2010.272
   Pasquereau-Kotula E, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00614
   Pericas JM, 2017, REV ESP CARDIOL, V70, P451, DOI [10.1016/j.rec.2016.10.013, 10.1016/j.recesp.2016.09.055]
   Perkins DJ, 2015, J IMMUNOL, V195, P2461, DOI 10.4049/jimmunol.1500105
   Pierce ES, 2010, GUT PATHOG, V2, DOI 10.1186/1757-4749-2-21
   Pujo J, 2021, GUT, V70, P1088, DOI 10.1136/gutjnl-2020-321173
   Raj KP, 2013, BRIT J CANCER, V108, P512, DOI 10.1038/bjc.2013.15
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rhodes JM, 2002, TRENDS MOL MED, V8, P10, DOI 10.1016/S1471-4914(01)02194-3
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
   Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016
   Rossi M, 2018, CANCERS, V10, DOI 10.3390/cancers10020038
   Rossi T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165786
   Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Roy UKB, 2008, MOL CARCINOGEN, V47, P538, DOI 10.1002/mc.20414
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730
   Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766
   Saffarian A, 2019, MBIO, V10, DOI 10.1128/mBio.01315-19
   Sahin U, 2018, SCIENCE, V359, P1355, DOI 10.1126/science.aar7112
   Salcedo R, 2010, J EXP MED, V207, P1625, DOI 10.1084/jem.20100199
   Salem ME, 2017, ONCOTARGET, V8, P86356, DOI 10.18632/oncotarget.21169
   Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061
   Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711
   Sarrabayrouse G, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001833
   Sasada T, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1005512
   Sato E, 2005, P NATL ACAD SCI USA, V102, P18538, DOI 10.1073/pnas.0509182102
   Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486
   Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018
   Schulz C, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819894062
   Sears CL, 2018, NAT MED, V24, P254, DOI 10.1038/nm.4511
   Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061
   Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420
   Semin I, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.644333
   Sepich-Poore GD, 2021, SCIENCE, V371, P1331, DOI 10.1126/science.abc4552
   Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360
   Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571
   Speranza B, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8020177
   Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003
   Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]
   Sumransub N, 2021, MOL THER-ONCOLYTICS, V22, P1, DOI 10.1016/j.omto.2021.05.001
   Sun HL, 2012, WORLD J GASTROENTERO, V18, P3303, DOI 10.3748/wjg.v18.i25.3303
   Sun LY, 2020, INTEGR CANCER THER, V19, DOI 10.1177/1534735420969820
   Sun XL, 2012, GASTROENTEROLOGY, V142, P86, DOI 10.1053/j.gastro.2011.09.042
   Sun YY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21241-z
   Surana NK, 2017, NATURE, V552, P244, DOI 10.1038/nature25019
   Swidsinski A, 1998, GASTROENTEROLOGY, V115, P281, DOI 10.1016/S0016-5085(98)70194-5
   Tada K, 2016, CANCER IMMUNOL RES, V4, P592, DOI 10.1158/2326-6066.CIR-15-0298
   Tallerico R, 2013, J IMMUNOL, V190, P2381, DOI 10.4049/jimmunol.1201542
   Tan P, 2017, MOL CELL, V68, P293, DOI 10.1016/j.molcel.2017.09.035
   Tan TG, 2016, P NATL ACAD SCI USA, V113, pE8141, DOI 10.1073/pnas.1617460113
   Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605
   Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003
   Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z
   Ternes D, 2020, TRENDS MICROBIOL, V28, P401, DOI 10.1016/j.tim.2020.01.001
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Nguyen TT, 2017, J CELL BIOCHEM, V118, P2958, DOI 10.1002/jcb.25955
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907
   Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279
   Tremaroli V, 2015, CELL METAB, V22, P228, DOI 10.1016/j.cmet.2015.07.009
   Tsoi H, 2017, GASTROENTEROLOGY, V152, P1419, DOI 10.1053/j.gastro.2017.01.009
   Tsuruya A, 2016, ALCOHOL ALCOHOLISM, V51, P395, DOI 10.1093/alcalc/agv135
   Tsuruya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27923
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057
   Valentini M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/586939
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Veziant J, 2016, WORLD J CLIN ONCOL, V7, P293, DOI 10.5306/wjco.v7.i3.293
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Vizcaino MI, 2015, NAT CHEM, V7, P411, DOI [10.1038/nchem.2221, 10.1038/NCHEM.2221]
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Wang C, 2017, ONCOTARGET, V8, P1092, DOI 10.18632/oncotarget.13582
   Wang H, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168470
   Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009
   Wang LJ, 2020, GUT, V69, P1988, DOI 10.1136/gutjnl-2019-320105
   Wang Q, 2020, APPL MICROBIOL BIOT, V104, P5915, DOI 10.1007/s00253-020-10621-z
   Wang RF, 2017, CELL RES, V27, P11, DOI 10.1038/cr.2016.155
   Wang T, 2022, EUR J NUTR, V61, P85, DOI 10.1007/s00394-021-02627-8
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Wang XM, 2008, CANCER RES, V68, P9909, DOI 10.1158/0008-5472.CAN-08-1551
   Ward-Hartstonge KA, 2017, CANCER IMMUNOL IMMUN, V66, P515, DOI 10.1007/s00262-016-1951-1
   West NR, 2015, NAT REV IMMUNOL, V15, P615, DOI 10.1038/nri3896
   Wiechers C, 2021, CELL MOL IMMUNOL, V18, P1211, DOI 10.1038/s41423-021-00647-2
   Wikberg ML, 2017, HUM PATHOL, V68, P193, DOI 10.1016/j.humpath.2017.08.028
   Wirusanti NI, 2022, TRENDS MICROBIOL, V30, P778, DOI 10.1016/j.tim.2022.01.007
   Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Wu CL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02073-3
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Wu XQ, 2018, J CANCER, V9, P2510, DOI 10.7150/jca.25324
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
   Xi Y, 2021, TRANSL ONCOL, V14, DOI 10.1016/j.tranon.2021.101174
   Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022
   Xie GF, 2015, CANCERS, V7, P1436, DOI 10.3390/cancers7030847
   Xing CS, 2021, CELL HOST MICROBE, V29, P959, DOI 10.1016/j.chom.2021.03.016
   Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500
   Xu R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S4
   Xu ZS, 2019, P NATL ACAD SCI USA, V116, P10447, DOI 10.1073/pnas.1814336116
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yang HX, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4116
   Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978
   Yang YH, 2019, INT J CANCER, V144, P2381, DOI 10.1002/ijc.31941
   Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279
   Yang YZ, 2019, THERANOSTICS, V9, P4101, DOI 10.7150/thno.35186
   Yeong J, 2017, BREAST CANCER RES TR, V163, P21, DOI 10.1007/s10549-017-4161-4
   Yomoda T, 2019, ANN SURG ONCOL, V26, P415, DOI 10.1245/s10434-018-07110-z
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zagato E, 2020, NAT MICROBIOL, V5, P511, DOI 10.1038/s41564-019-0649-5
   Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003
   Zhang B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057114
   Zhang DY, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/4657928
   Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172
   Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918
   Zitvogel L, 2016, CELL, V165, P276, DOI 10.1016/j.cell.2016.03.001
   Zygulska AL, 2022, INT J MOL SCI, V23, DOI 10.3390/ijms23020852
NR 366
TC 0
Z9 0
U1 8
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUL 29
PY 2022
VL 13
AR 963819
DI 10.3389/fimmu.2022.963819
PG 24
WC Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology
GA 3U0IL
UT WOS:000840653600001
PM 35967333
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Pandey, K
   Umar, S
AF Pandey, Kavita
   Umar, Shahid
TI Microbiome in drug resistance to colon cancer
SO CURRENT OPINION IN PHYSIOLOGY
LA English
DT Article
ID FUSOBACTERIUM-NUCLEATUM; COLORECTAL-CANCER; T-CELLS; INFLAMMATION
AB Metagenomic analyses have revealed microbial dysbiosis in the gut of patients with colorectal cancer (CRC). The gut microbiota influences CRC via a variety of mechanisms, including microbial-derived factors such as metabolites or genotoxins. Pathogenic drivers and opportunistic passenger bacteria may underlie direct effect of the gut microbiota on carcinogenesis. We posit that metabolites generated by gut microbiota can influence CRC through a multitude of epigenetic or genetic effects on malignant transformation. A closer look at the cross talks between the commensals, epithelial cells, immune regulators and so on, needs to be established with more substantiated studies. The recurrence of chemoresistant disease following therapy undoubtedly provides the impetus for morbidity and mortality; yet, the role of gut microbiome in drug resistance remains to be fully investigated. We review the current literature on microbial dysbiosis during CRC and discuss the mechanistic basis of CRC-associated bacteria in tumor initiation, progression and drug resistance.
C1 [Pandey, Kavita] GN Khalsa Coll, Dept Bioanal Sci Integrated, Mumbai, Maharashtra, India.
   [Umar, Shahid] Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA.
C3 University of Kansas; University of Kansas Medical Center
RP Umar, S (corresponding author), Univ Kansas, Med Ctr, Dept Surg, Kansas City, KS 66160 USA.
EM sumar@kumc.edu
FU NCI [R01CA185322]; University of Kansas Cancer Center
FX We would like to acknowledge R01CA185322 to SU from NCI and the startup
   funds from The University of Kansas Cancer Center.
CR Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11
   Abed J, 2016, CELL HOST MICROBE, V20, P215, DOI 10.1016/j.chom.2016.07.006
   Ai LY, 2017, ONCOTARGET, V8, P9546, DOI 10.18632/oncotarget.14488
   Arnold CE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232905
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Bertocchi A, 2021, CANCER CELL, V39, P708, DOI 10.1016/j.ccell.2021.03.004
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Chang CW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00983
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257
   Cronin M, 2010, MOL THER, V18, P1397, DOI 10.1038/mt.2010.59
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2
   Elliott MJ, 2020, NPJ BREAST CANCER, V6, DOI 10.1038/s41523-020-0166-y
   Favoriti P, 2016, UPDATES SURG, V68, P7, DOI 10.1007/s13304-016-0359-y
   Fornaro L, 2012, CLIN COLORECTAL CANC, V11, P71, DOI 10.1016/j.clcc.2011.06.013
   Garajova I, 2021, EXPERT REV ANTICANC, V21, P165, DOI 10.1080/14737140.2021.1844007
   Geller LT, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2017.1405139
   Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043
   Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025
   Heshiki Y, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00811-2
   Irrazabal T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15549-6
   Iyadorai T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228217
   Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054
   Jia W, 2018, NAT REV GASTRO HEPAT, V15, P111, DOI 10.1038/nrgastro.2017.119
   Kaakoush NO, 2015, CLIN MICROBIOL REV, V28, P687, DOI 10.1128/CMR.00006-15
   Kadosh E, 2020, NATURE, V586, P133, DOI 10.1038/s41586-020-2541-0
   Khaja ASS, 2017, ONCOTARGET, V8, P33159, DOI 10.18632/oncotarget.16565
   Kumar R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006440
   Lasry A, 2016, NAT IMMUNOL, V17, P230, DOI 10.1038/ni.3384
   Li YY, 2016, WORLD J GASTROENTERO, V22, P3227, DOI 10.3748/wjg.v22.i11.3227
   Lucas C, 2020, GASTROENTEROLOGY, V158, P1373, DOI 10.1053/j.gastro.2019.12.026
   Maindrault-Goebel F, 2004, ANN ONCOL, V15, P1210, DOI 10.1093/annonc/mdh305
   Mendonca LABM, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00325
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Murphy C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180034
   Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189
   Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111
   Ocvirk Soren, 2017, Curr Nutr Rep, V6, P315, DOI 10.1007/s13668-017-0219-5
   Pandey K, 2020, BIOMED J SCI TECH RE, V30, P23624
   Pandey KR, 2015, J FOOD SCI TECH MYS, V52, P7577, DOI 10.1007/s13197-015-1921-1
   Purcell RV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11237-6
   Purcell RV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171602
   Raisch J, 2015, LAB INVEST, V95, P296, DOI 10.1038/labinvest.2014.161
   Raskov H, 2018, UGESKR LAEGER, P180
   Ruan WC, 2018, COMB CHEM HIGH T SCR, V21, P718, DOI 10.2174/1386207322666190119162352
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Saito T, 2016, NAT MED, V22, P679, DOI 10.1038/nm.4086
   Samavat H, 2015, CANCER LETT, V356, P231, DOI 10.1016/j.canlet.2014.04.018
   Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061
   Shin A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023196
   Tanaka Takuji, 2009, J Carcinog, V8, P5
   Ternes D, 2020, TRENDS MICROBIOL, V28, P401, DOI 10.1016/j.tim.2020.01.001
   Terzic J, 2010, GASTROENTEROLOGY, V138, P2101, DOI 10.1053/j.gastro.2010.01.058
   Tirandaz H, 2013, MED HYPOTHESES, V80, P675, DOI 10.1016/j.mehy.2013.01.024
   Tjalsma H, 2012, COLORECTAL CANC BIOL, P391
   Van der Jeught K, 2018, WORLD J GASTROENTERO, V24, P3834, DOI 10.3748/wjg.v24.i34.3834
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Wargo JA, 2020, SCIENCE, V369, P1302, DOI 10.1126/science.abc3965
   Wilson MR, 2019, SCIENCE, V363, P709, DOI 10.1126/science.aar7785
   Xu S, 2021, DIGEST DIS SCI, V66, P2964, DOI 10.1007/s10620-020-06637-0
   Yan DM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15749-z
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zhang YC, 2018, BIOCHEM BIOPH RES CO, V506, P907, DOI 10.1016/j.bbrc.2018.10.136
   Zhou JB, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00343
NR 66
TC 4
Z9 4
U1 2
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 2468-8673
J9 CURR OPIN PHYSIOL
JI Curr. Opin. Physiol.
PD OCT
PY 2021
VL 23
AR 100472
DI 10.1016/j.cophys.2021.100472
EA AUG 2021
PG 7
WC Physiology
WE Emerging Sources Citation Index (ESCI)
SC Physiology
GA WC7JD
UT WOS:000704429400005
PM 34514218
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Moskowitz, JE
   Doran, AG
   Lei, ZT
   Busi, SB
   Hart, ML
   Franklin, CL
   Sumner, LW
   Keane, TM
   Amos-Landgraf, JM
AF Moskowitz, Jacob E.
   Doran, Anthony G.
   Lei, Zhentian
   Busi, Susheel B.
   Hart, Marcia L.
   Franklin, Craig L.
   Sumner, Lloyd W.
   Keane, Thomas M.
   Amos-Landgraf, James M.
TI Integration of genomics, metagenomics, and metabolomics to identify
   interplay between susceptibility alleles and microbiota in adenoma
   initiation
SO BMC CANCER
LA English
DT Article
DE Genetics; Gut microbiota; Colorectal cancer; Metabolomics; Apc; Min
ID BILE-ACID; HYDROGEN-SULFIDE; COLORECTAL-CANCER; MASS-SPECTROMETRY;
   MOUSE; DNA; GENES; LOCUS; RISK; MICE
AB BackgroundColorectal cancer (CRC) is a multifactorial disease resulting from both genetic predisposition and environmental factors including the gut microbiota (GM), but deciphering the influence of genetic variants, environmental variables, and interactions with the GM is exceedingly difficult. We previously observed significant differences in intestinal adenoma multiplicity between C57BL/6J-Apc(Min) (B6-Min/J) from The Jackson Laboratory (JAX), and original founder strain C57BL/6JD-Apc(Min) (B6-Min/D) from the University of Wisconsin.MethodsTo resolve genetic and environmental interactions and determine their contributions we utilized two genetically inbred, independently isolated Apc(Min) mouse colonies that have been separated for over 20 generations. Whole genome sequencing was used to identify genetic variants unique to the two substrains. To determine the influence of genetic variants and the impact of differences in the GM on phenotypic variability, we used complex microbiota targeted rederivation to generate two Apc mutant mouse colonies harboring complex GMs from two different sources (GMJAX originally from JAX or GMHSD originally from Envigo), creating four Apc(Min) groups. Untargeted metabolomics were used to characterize shifts in the fecal metabolite profile based on genetic variation and differences in the GM.ResultsWGS revealed several thousand high quality variants unique to the two substrains. No homozygous variants were present in coding regions, with the vast majority of variants residing in noncoding regions. Host genetic divergence between Min/J and Min/D and the complex GM additively determined differential adenoma susceptibility. Untargeted metabolomics revealed that both genetic lineage and the GM collectively determined the fecal metabolite profile, and that each differentially regulates bile acid (BA) metabolism. Metabolomics pathway analysis facilitated identification of a functionally relevant private noncoding variant associated with the bile acid transporter Fatty acid binding protein 6 (Fabp6). Expression studies demonstrated differential expression of Fabp6 between Min/J and Min/D, and the variant correlates with adenoma multiplicity in backcrossed mice.ConclusionsWe found that both genetic variation and differences in microbiota influences the quantitiative adenoma phenotype in Apc(Min) mice. These findings demonstrate how the use of metabolomics datasets can aid as a functional genomic tool, and furthermore illustrate the power of a multi-omics approach to dissect complex disease susceptibility of noncoding variants.
C1 [Moskowitz, Jacob E.; Busi, Susheel B.; Franklin, Craig L.; Amos-Landgraf, James M.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65201 USA.
   [Moskowitz, Jacob E.] Cedars Sinai Med Ctr, F Widjaja Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.
   [Doran, Anthony G.; Keane, Thomas M.] Wellcome Genome Campus, Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.
   [Doran, Anthony G.; Keane, Thomas M.] Wellcome Genome Campus, European Bioinformat Inst, Hinxton CB10 1SD, England.
   [Lei, Zhentian; Sumner, Lloyd W.] Univ Missouri, Bond Life Sci Ctr, MU Metabol Ctr, Dept Biochem, Columbia, MO 65201 USA.
   [Hart, Marcia L.; Franklin, Craig L.; Amos-Landgraf, James M.] Univ Missouri, Mutant Mouse Resource & Res Ctr, 4011 Discovery Dr, Columbia, MO 65201 USA.
C3 University of Missouri System; University of Missouri Columbia; Cedars
   Sinai Medical Center; Wellcome Trust Sanger Institute; European
   Molecular Biology Laboratory (EMBL); University of Missouri System;
   University of Missouri Columbia; University of Missouri System;
   University of Missouri Columbia
RP Amos-Landgraf, JM (corresponding author), Univ Missouri, Dept Vet Pathobiol, Columbia, MO 65201 USA.; Amos-Landgraf, JM (corresponding author), Univ Missouri, Mutant Mouse Resource & Res Ctr, 4011 Discovery Dr, Columbia, MO 65201 USA.
EM amoslandgrafj@missouri.edu
RI Sumner, Lloyd W/A-3270-2013; Amos-Landgraf, James/K-9288-2013
OI Sumner, Lloyd W/0000-0002-4086-663X; Keane, Thomas/0000-0001-7532-6898;
   Amos-Landgraf, James/0000-0003-2535-7746
FU National Institutes of Health [U42 OD010918]; NIH [T32 OD011126];
   University of Missouri; MRC [MR/R017565/1] Funding Source: UKRI
FX This research was funded by grants from the National Institutes of
   Health to the Mutant Mouse Resource and Research Center at the
   University of Missouri (U42 OD010918), and by the University of Missouri
   to Dr. James Amos-Landgraf (Startup-funding). JEM was supported by NIH
   T32 OD011126.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amos-Landgraf JM, 2014, P NATL ACAD SCI USA, V111, P16514, DOI 10.1073/pnas.1323064111
   Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439
   Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126
   Baran AA, 2007, GENOME RES, V17, P566, DOI 10.1101/gr.6089707
   Bertagnolli MM, 2010, CANCER PREV RES, V3, P588, DOI 10.1158/1940-6207.CAPR-09-0271
   Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281
   Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004
   Birt DF, 2014, TOXICOL PATHOL, V42, P182, DOI 10.1177/0192623313506791
   Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Bultman SJ, 2014, CELL HOST MICROBE, V16, P143, DOI 10.1016/j.chom.2014.07.011
   Cao HL, 2014, FAM CANCER, V13, P563, DOI 10.1007/s10689-014-9742-3
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Carbonero F, 2012, FRONT PHYSIOL, P1
   Cormier RT, 2000, ONCOGENE, V19, P3182, DOI 10.1038/sj.onc.1203646
   Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   de la Chapelle A, 2004, NAT REV CANCER, V4, P769, DOI 10.1038/nrc1453
   Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010
   Dossa AY, 2016, AM J PHYSIOL-GASTR L, V310, pG81, DOI 10.1152/ajpgi.00065.2015
   Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704
   Farhana L, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0439-4
   Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4
   Fuchs M, 2003, AM J PHYSIOL-GASTR L, V284, pG551, DOI 10.1152/ajpgi.00468.2002
   Guo FF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00156
   Harter M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27470-6
   Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated
   Hellmich MR, 2015, HANDB EXP PHARMACOL, V230, P233, DOI 10.1007/978-3-319-18144-8_12
   Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004
   Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kuczynski J, 2012, CURR PROTOC CHEM BIO, V1, P1, DOI DOI 10.1002/9780471729259.MC01E05S27.USING
   Kwong LN, 2009, ADV EXP MED BIOL, V656, P85, DOI 10.1007/978-1-4419-1145-2_8
   Laue H, 2001, J BACTERIOL, V183, P1727, DOI 10.1128/JB.183.5.1727-1733.2001
   Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008
   Li YH, 2012, CARCINOGENESIS, V33, P1231, DOI 10.1093/carcin/bgs137
   Melnik AV, 2017, ANAL CHEM, V89, P7549, DOI 10.1021/acs.analchem.7b01381
   Ohmachi T, 2006, CLIN CANCER RES, V12, P5090, DOI 10.1158/1078-0432.CCR-05-2045
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Ritari J, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2265-y
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shoemaker AR, 1997, BBA-REV CANCER, V1332, pF25, DOI 10.1016/S0304-419X(96)00041-8
   Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y
   Smith DLH, 2010, CARCINOGENESIS, V31, P1100, DOI 10.1093/carcin/bgq050
   Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536
   Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619
   Thune I, 1996, BRIT J CANCER, V73, P1134, DOI 10.1038/bjc.1996.218
   Travaglione S., 2008, INFECT AGENTS CANCER, V3, P4, DOI [DOI 10.1186/1750-9378-3-4], DOI 10.1186/1750-9378-3-4]
   Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09
   Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380
NR 53
TC 6
Z9 6
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2407
J9 BMC CANCER
JI BMC Cancer
PD JUN 29
PY 2020
VL 20
IS 1
DI 10.1186/s12885-020-07007-9
PG 16
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA MG7ME
UT WOS:000546212500001
PM 32600361
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Ulrich, CM
   Gigic, B
   Bohm, J
   Ose, J
   Viskochil, R
   Schneider, M
   Colditz, GA
   Figueiredo, JC
   Grady, WM
   Li, CI
   Shibata, D
   Siegel, EM
   Toriola, AT
   Ulrich, A
AF Ulrich, Cornelia M.
   Gigic, Biljana
   Bohm, Juergen
   Ose, Jennifer
   Viskochil, Richard
   Schneider, Martin
   Colditz, Graham A.
   Figueiredo, Jane C.
   Grady, William M.
   Li, Christopher I.
   Shibata, David
   Siegel, Erin M.
   Toriola, Adetunji T.
   Ulrich, Alexis
TI The ColoCare Study: A Paradigm of Transdisciplinary Science in
   Colorectal Cancer Outcomes
SO CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
LA English
DT Article
ID SUBCUTANEOUS ADIPOSE-TISSUE; BODY-MASS INDEX; COLON-CANCER;
   PHYSICAL-ACTIVITY; SURVIVAL; OPPORTUNITIES; EPIDEMIOLOGY; ASSOCIATIONS;
   STATISTICS; BIOMARKERS
AB Background: Colorectal cancer is a leading cause of cancer death. Biomarkers to predict treatment outcomes are needed, as is evidence whether postdiagnosis diet and lifestyle can affect well-being and clinical outcomes. The international ColoCare Consortium aims to identify new biologic markers (e. g., metabolomic, transcriptomic, metagenomic, genetic, epigenetic, proteomic markers) that predict clinical outcomes, and to characterize associations between modifiable risk factors (e. g., diet, supplement use, physical activity) with shortterm and long-term patient-reported and clinical outcomes among patients with colorectal cancer.
   Methods/Results: ColoCare is recruiting newly diagnosed patients with colorectal cancer across six sites in the United States and one site in Germany. As of April 2018, we have recruited > 2,000 patients across all sites. Our projected enrollment is > 4,000 multiethnic patients with colorectal cancer. The study includes uniformly collected, comprehensive sets of data and biospecimens at multiple time points up to 5 years after diagnosis. Treatment and clinical data are abstracted from medical records and centrally harmonized. Biospecimens are archived according to standardized procedures. Our initial studies demonstrated metabolic differences in adipose tissue types. We further reported on associations of biological factors (e. g., inflammation, DNA methylation, metabolomics) with lifestyle factors (e. g., adiposity, smoking, physical activity, dietary supplement use) or joint associations with clinical outcomes.
   Conclusions: ColoCare is a consortium for the investigation of multilevel factors relevant to colorectal cancer survivorship. Impact: The combination of a comprehensive set of biospecimens collected at multiple time points, jointly with detailed assessments of health behaviors and other prognostic factors, results in aunique resource that facilitates wide-ranging, innovative, and impactful research on colorectal cancer.
C1 [Ulrich, Cornelia M.; Bohm, Juergen; Ose, Jennifer; Viskochil, Richard] Huntsman Canc Inst, 2000 Circle Hope Dr,Room 4725, Salt Lake City, UT 84112 USA.
   [Ulrich, Cornelia M.; Bohm, Juergen; Ose, Jennifer; Viskochil, Richard] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA.
   [Ulrich, Cornelia M.; Grady, William M.; Li, Christopher I.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.
   [Gigic, Biljana; Schneider, Martin; Ulrich, Alexis] Univ Hosp Heidelberg, Dept Gen Visceral & Transplantat Surg, Heidelberg, Germany.
   [Colditz, Graham A.; Toriola, Adetunji T.] Washington Univ, Sch Med, Dept Surg, Div Publ Hlth Sci, St Louis, MO 63110 USA.
   [Colditz, Graham A.; Toriola, Adetunji T.] Siteman Canc Ctr, St Louis, MO USA.
   [Figueiredo, Jane C.] Cedars Sinai Med Ctr, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA.
   [Grady, William M.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA.
   [Grady, William M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.
   [Shibata, David] Univ Tennessee, Ctr Hlth Sci, Dept Surg, Memphis, TN 38163 USA.
   [Siegel, Erin M.] H Lee Moffitt Canc Ctr & Res Inst, Canc Epidemiol Program, Tampa, FL USA.
C3 Huntsman Cancer Institute; Utah System of Higher Education; University
   of Utah; Fred Hutchinson Cancer Center; Ruprecht Karls University
   Heidelberg; Washington University (WUSTL); Siteman Cancer Center; Cedars
   Sinai Medical Center; University of Washington; University of Washington
   Seattle; Fred Hutchinson Cancer Center; University of Tennessee System;
   University of Tennessee Health Science Center; H Lee Moffitt Cancer
   Center & Research Institute
RP Ulrich, CM (corresponding author), Huntsman Canc Inst, 2000 Circle Hope Dr,Room 4725, Salt Lake City, UT 84112 USA.
EM neli.ulrich@hci.utah.edu
RI Colditz, Graham/A-3963-2009
OI Colditz, Graham/0000-0002-7307-0291; Ose, Jennifer/0000-0002-2030-9676;
   Toriola, Adetunji/0000-0003-1079-2606; Grady,
   William/0000-0002-0129-7809
FU Huntsman Cancer Foundation; NCI [R01 CA189184, R01 CA207371, U01
   CA206110]; Lackas Foundation; ERA-NET on Translational Cancer Research
   (TRANSCAN) project [01KT1503]; Stiftung Lebensblicke; Fred Hutchinson
   Cancer Research Center; Seattle Translational Tumor Research Program;
   Cottrell Family; NIH [P30CA015704, U01CA152756, R01CA194663,
   R01CA220004]; Florida Department of Health Bankhead Coley New
   Investigator Award [09BN-13]; Tissue Core Facility; Survey Methods Core
   at the H. Lee Moffitt Cancer Center & Research Institute, an NCI
   designated Comprehensive Cancer Center [P30 CA076292]; Alvin J. Siteman
   Cancer Center; NCI Cancer Center Support Grant [P30 CA091842];  [P30
   CA042014]; NATIONAL CANCER INSTITUTE [R01CA194663, P30CA042014,
   U01CA206110, P30CA091842, R01CA220004, U01CA152756, P30CA015704,
   R01CA189184, P30CA076292, R01CA207371] Funding Source: NIH RePORTER
FX C.M. Ulrich and J. Ose are funded by the Huntsman Cancer Foundation and
   the NCI projects R01 CA189184, R01 CA207371, and U01 CA206110. C. M.
   Ulrich is also funded by P30 CA042014. B. Gigic is funded by the Lackas
   Foundation, the ERA-NET on Translational Cancer Research (TRANSCAN)
   project 01KT1503 (Federal Ministry of Education and Research, Germany),
   the NCI project R01 CA189184, and the Stiftung Lebensblicke. W. M. Grady
   is funded by the Fred Hutchinson Cancer Research Center, the Seattle
   Translational Tumor Research Program, the Cottrell Family, and is
   supported by following grants: NIH grants P30CA015704, U01CA152756,
   R01CA194663, and R01CA220004. E. M. Siegel and ColoCare Moffitt were
   funded by the Florida Department of Health Bankhead Coley New
   Investigator Award (09BN-13) and the NCI projects R01 CA189184, R01
   CA207371, and U01 CA206110. ColoCare Moffitt has been supported in part
   by the Tissue Core Facility and the Survey Methods Core at the H. Lee
   Moffitt Cancer Center & Research Institute, an NCI designated
   Comprehensive Cancer Center (P30 CA076292). A. T. Toriola and G. A.
   Colditz are supported by U01 CA206110 and the Alvin J. Siteman Cancer
   Center, supported in part by the NCI Cancer Center Support Grant P30
   CA091842.
CR Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009
   Anderson G, 1998, CONTROL CLIN TRIALS, V19, P61
   Arem H, 2015, J CLIN ONCOL, V33, P180, DOI 10.1200/JCO.2014.58.1355
   Barrow TM, 2017, J PATHOL, V243, P366, DOI 10.1002/path.4955
   Benson AB, 2013, J NATL COMPR CANC NE, V11, P519, DOI 10.6004/jnccn.2013.0069
   Benson AB, 2013, J NATL COMPR CANC NE, V11, P141, DOI 10.6004/jnccn.2013.0022
   Bohm J, 2017, SURGERY, V161, P808, DOI 10.1016/j.surg.2016.08.025
   Boyko EJ, 2013, J DIABETES COMPLICAT, V27, P642, DOI 10.1016/j.jdiacomp.2013.07.007
   Chien C, 2005, CANCER, V104, P629, DOI 10.1002/cncr.21204
   Clark W, 2013, J AM COLL SURGEONS, V216, P1070, DOI 10.1016/j.jamcollsurg.2013.01.007
   Cleeland CS, 2000, CANCER-AM CANCER SOC, V89, P1634, DOI 10.1002/1097-0142(20001001)89:7<1634::AID-CNCR29>3.0.CO;2-V
   Elena JW, 2013, JNCI-J NATL CANCER I, V105, P85, DOI 10.1093/jnci/djs473
   Fayers P, 2002, EUR J CANCER, V38, pS125
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   FOLSOM AR, 1990, AM J EPIDEMIOL, V131, P794, DOI 10.1093/oxfordjournals.aje.a115570
   Gigic B, 2018, NUTR CANCER, V70, P51, DOI 10.1080/01635581.2018.1397707
   Hardikar S, 2015, CANCER EPIDEM BIOMAR, V24, P1130, DOI 10.1158/1055-9965.EPI-15-0039
   Himbert C, 2019, CANCER EPIDEM BIOMAR, V28, P76, DOI 10.1158/1055-9965.EPI-18-0654
   Irlbeck T, 2010, INT J OBESITY, V34, P781, DOI 10.1038/ijo.2009.279
   Lao VV, 2013, TRANSL ONCOL, V6, P458, DOI 10.1593/tlo.13238
   Lerner D, 2003, MED CARE, V41, P649, DOI 10.1097/00005650-200305000-00012
   Liesenfeld DB, 2015, AM J CLIN NUTR, V102, P433, DOI 10.3945/ajcn.114.103804
   Liu JJJ, 2014, J GERIATR ONCOL, V5, P40, DOI 10.1016/j.jgo.2013.11.004
   Luebeck GE, 2019, CANCER RES, V79, P495, DOI 10.1158/0008-5472.CAN-18-1682
   Luo Y, 2013, ONCOGENE, V32, P2037, DOI 10.1038/onc.2012.225
   Luo YX, 2014, GASTROENTEROLOGY, V147, P418, DOI 10.1053/j.gastro.2014.04.039
   Luo YX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003552
   Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349
   Nattenmueller J, 2016, EUR RADIOL, V26, P4131, DOI 10.1007/s00330-016-4231-8
   Newcomb PA, 2007, CANCER EPIDEM BIOMAR, V16, P2331, DOI 10.1158/1055-9965.EPI-07-0648
   Nothlings U, 2007, J NUTR, V137, P2781, DOI 10.1093/jn/137.12.2781
   Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40
   Ozoya OO, 2017, J GASTROINTEST SURG, V21, P534, DOI 10.1007/s11605-017-3362-9
   Park CL, 2009, J GEN INTERN MED, V24, P430, DOI 10.1007/s11606-009-0993-x
   Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030
   Patterson RE, 1999, ANN EPIDEMIOL, V9, P178, DOI 10.1016/S1047-2797(98)00055-6
   Postma TJ, 2005, EUR J CANCER, V41, P1135, DOI 10.1016/j.ejca.2005.02.012
   Ristau J, 2014, CANCER EPIDEM BIOMAR, V23, P2632, DOI 10.1158/1055-9965.EPI-14-0556
   Romaguera D, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0332-5
   Rosenthal EA, 2018, HUM GENET, V137, P795, DOI 10.1007/s00439-018-1938-4
   Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071
   Sherwood AM, 2013, CANCER IMMUNOL IMMUN, V62, P1453, DOI 10.1007/s00262-013-1446-2
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395
   Skender S, 2017, NUTR CANCER, V69, P229, DOI 10.1080/01635581.2017.1265131
   Skender Stephanie, 2015, BMC Res Notes, V8, P222, DOI 10.1186/s13104-015-1168-y
   Syrjala KL, 2016, PSYCHO-ONCOLOGY, V25, P529, DOI 10.1002/pon.3861
   Ulrich CM, 2013, J NUTR SCI, V2, DOI 10.1017/jns.2012.28
   Van Blarigan EL, 2015, J CLIN ONCOL, V33, P1825, DOI 10.1200/JCO.2014.59.7799
   Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003
   White E, 2004, AM J EPIDEMIOL, V159, P83, DOI 10.1093/aje/kwh010
   Yu M, 2015, EPIGENETICS-US, V10, P803, DOI 10.1080/15592294.2015.1068490
   Yuan ZX, 2017, BRIT J CANCER, V117, P1202, DOI 10.1038/bjc.2017.266
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhang W, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3141
NR 54
TC 33
Z9 33
U1 0
U2 2
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 1055-9965
EI 1538-7755
J9 CANCER EPIDEM BIOMAR
JI Cancer Epidemiol. Biomarkers Prev.
PD MAR
PY 2019
VL 28
IS 3
BP 591
EP 601
DI 10.1158/1055-9965.EPI-18-0773
PG 11
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA HU5NW
UT WOS:000465326400022
PM 30523039
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Allali, M
   Boukhatem, N
   Bouguenouch, L
   Hardin, H
   Boudouaya, HA
   Cadenas, MB
   Ouldim, K
   Amzazi, S
   Azcarate-Peril, MA
   Ghazal, H
AF Allali, Mane
   Boukhatem, Noureddine
   Bouguenouch, Leila
   Hardin, Hanaa
   Abir Boudouaya, H.
   Cadenas, M. Belen
   Ouldim, Karim
   Amzazi, Saaid
   Azcarate-Peril, M. Andrea
   Ghazal, Hassan
TI Gut microbiome of Moroccan colorectal cancer patients
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Gut microbiome composition; Colorectal cancer; Bacterial community; 16S
   rRNA sequencing; Moroccan population
ID BACTEROIDES-FRAGILIS; PERIODONTAL-DISEASE; INTESTINAL MICROBIOTA;
   BACTERIAL METABOLITES; MEDITERRANEAN DIET; FECAL MICROBIOTA; LIFE-STYLE;
   COLON; FUSOBACTERIUM; RISK
AB Although colorectal cancer is the third leading cause of death in Morocco, there are no studies of the microbiome changes associated with the disease in the Moroccan population. The aim of our study was to compare the stool microbiome of Moroccan cancer patients with healthy individuals. We analyzed the microbiome composition of samples from 11 CRC patients and 12 healthy individuals by 16S rRNA amplicon sequencing. Principal coordinate analysis of samples revealed defined cancer versus healthy clusters. Our findings showed that cancer samples had higher proportions of Firmicutes (T= 50.5%; N=28.4%; p = 0.04), specifically of Clostridia (T=48.3%; N= 19.0%; p = 0.002), and Fusobacteria (T=0.1%; N=0.0%; p= 0.02), especially of Fusobacteriia (T=0.1%; N=0.0%; p = 0.02), while Bacteroidetes were enriched in healthy samples (T=35.1%; N=62.8%; p = 0.06), particularly the class Bacteroidia (T=35.1%; N=62.6%; p = 0.06). Porphyromonas, Clostridium, Ruminococcus, Selenomonas, and Fusobacterium were significantly overrepresented in diseased patients, similarly to other studies. Predicted functional information showed that bacterial motility proteins, flagellar assembly, and fatty acid biosynthesis metabolism were significantly overrepresented in cancer patients, while amino acid metabolism and glycan biosynthesis were overrepresented in controls. This suggests that involvement of these functional metagenomes is similar and relevant in the carcinogenesis process, independent of the origin of the samples. Results from this study allowed identification of bacterial taxa relevant to the Moroccan population and encourages larger studies to facilitate population-directed therapeutic approaches.
C1 [Allali, Mane; Amzazi, Saaid] Mohammed V Univ Rabat, Fac Sci, Lab Biochem & Immunol, Rabat, Morocco.
   [Allali, Mane; Boukhatem, Noureddine; Hardin, Hanaa; Abir Boudouaya, H.; Ghazal, Hassan] Univ Mohammed Premier, Fac Sci Oujda, Lab Physiol Genet & Ethnopharmacol, Oujda, Morocco.
   [Ghazal, Hassan] Univ Mohammed Premier, Polydisciplinary Fac Nador, Nador, Morocco.
   [Bouguenouch, Leila; Ouldim, Karim] Univ Hosp Hassan II Fez, Dept Mol Genet, Fes, Morocco.
   [Allali, Mane; Cadenas, M. Belen; Azcarate-Peril, M. Andrea] Univ N Carolina, Sch Med, Dept Med, Chapel Hill, NC 27515 USA.
   [Allali, Mane; Cadenas, M. Belen; Azcarate-Peril, M. Andrea] Univ N Carolina, Sch Med, Microbiome Core Facil, Chapel Hill, NC 27515 USA.
   [Ghazal, Hassan] Natl Ctr Sci & Technolg Res, Rabat, Morocco.
C3 Mohammed V University in Rabat; Mohammed First University of Oujda;
   Mohammed First University of Oujda; Hassan II University Hospital Center
   of Fez; University of North Carolina; University of North Carolina
   Chapel Hill; University of North Carolina School of Medicine; University
   of North Carolina; University of North Carolina Chapel Hill; University
   of North Carolina School of Medicine
RP Ghazal, H (corresponding author), Univ Mohammed Premier, Fac Sci Oujda, Lab Physiol Genet & Ethnopharmacol, Oujda, Morocco.; Ghazal, H (corresponding author), Univ Mohammed Premier, Polydisciplinary Fac Nador, Nador, Morocco.; Ghazal, H (corresponding author), Natl Ctr Sci & Technolg Res, Rabat, Morocco.
EM hassan.ghazal@fulbrightmail.org
RI Core, UNC Microbiome/AAB-3304-2022; Azcarate-Peril, M.
   Andrea/AAA-9056-2022; Azcarate-Peril, M. Andrea/AFO-7157-2022;
   Azcarate-Peril, M. Andrea/ABH-5508-2020; Ghazal, Hassan/AAS-1090-2021
OI Azcarate-Peril, M. Andrea/0000-0003-0325-1289; Azcarate-Peril, M.
   Andrea/0000-0003-0325-1289; Azcarate-Peril, M.
   Andrea/0000-0003-0325-1289; 
FU NIH [U41HG006941]
FX IA is a Fulbright scholar. This work was also supported by a Grant from
   the NIH for H3ABioNet/H3Africa to H.G (grant number U41HG006941).
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Ahn J, 2012, CARCINOGENESIS, V33, P1055, DOI 10.1093/carcin/bgs112
   Allali I, 2015, GUT MICROBES, V6, P161, DOI 10.1080/19490976.2015.1039223
   Amato KR, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0120-7
   [Anonymous], 2004, GREATER CASABLANCA C
   Arnold JW, 2016, TRENDS MICROBIOL, V24, P887, DOI 10.1016/j.tim.2016.06.008
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Atanasova KR, 2014, MOL ORAL MICROBIOL, V29, P55, DOI 10.1111/omi.12047
   Avila-Campos MJ, 2007, J CLIN MICROBIOL, V45, P1336, DOI 10.1128/JCM.02108-06
   Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011
   Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006
   Benhammou S, 2016, APPETITE, V107, P521, DOI 10.1016/j.appet.2016.08.117
   Bi Y., 2015, INFECT DIS TRANSLAT, V1, P1
   Bingham SA, 2000, BIOCHEM SOC T, V28, P12, DOI 10.1042/bst0280012
   Boleij A, 2009, J CLIN MICROBIOL, V47, P516, DOI 10.1128/JCM.01755-08
   Bouchbika Z, 2013, PAN AFR MED J, V16, DOI 10.11604/pamj.2013.16.31.2791
   Brim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081352
   Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8
   Busolo DS, 2015, GLOB HEALTH PROMOT, V22, P31, DOI 10.1177/1757975914537094
   Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038
   Center MM, 2009, CANCER EPIDEM BIOMAR, V18, P1688, DOI 10.1158/1055-9965.EPI-09-0090
   Chen WHC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039039
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dulal S, 2014, CANCER J, V20, P225, DOI 10.1097/PPO.0000000000000050
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   EDWARDS U, 1989, NUCLEIC ACIDS RES, V17, P7843, DOI 10.1093/nar/17.19.7843
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3
   Ferlay J., 2012, IARC CANCERBASE
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105
   FINEGOLD SM, 1975, CANCER RES, V35, P3407
   Fitzpatrick SG, 2010, J DENT, V38, P83, DOI 10.1016/j.jdent.2009.10.007
   Flood DM, 2000, CANCER CAUSE CONTROL, V11, P403, DOI 10.1023/A:1008955722425
   Flynn KJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00102-16
   Frohlich EE, 2015, EUR J MICROBIOL IMMU, V5, P1, DOI [10.1556/EuJMI-D-14-00030, 10.1556/EUJMI-D-14-00030]
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gallimidi AB, 2015, ONCOTARGET, V6, P22613, DOI 10.18632/oncotarget.4209
   Geng JW, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-2
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gmur R, 2006, SYST APPL MICROBIOL, V29, P120, DOI 10.1016/j.syapm.2005.07.011
   Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110
   Hagland HR, 2015, CANCER LETT, V356, P273, DOI 10.1016/j.canlet.2014.02.026
   Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785
   Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006
   Hale VL, 2017, CANCER EPIDEM BIOMAR, V26, P85, DOI 10.1158/1055-9965.EPI-16-0337
   Harris JI, 2002, ORAL MICROBIOL IMMUN, V17, P224, DOI 10.1034/j.1399-302X.2002.170404.x
   Hope ME, 2005, FEMS MICROBIOL LETT, V244, P1, DOI 10.1016/j.femsle.2005.01.029
   Irabor DO, 2011, J CANCER EPIDEMIOL, V2011, DOI 10.1155/2011/675154
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20073, 10.3322/caac.20107]
   Keku TO, 2013, TRENDS MICROBIOL, V21, P506, DOI 10.1016/j.tim.2013.08.004
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   LeMarchand L, 1997, CANCER RES, V57, P4787
   Yang LY, 2006, WORLD J GASTROENTERO, V12, P6741, DOI 10.3748/wjg.v12.i42.6741
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371
   Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242
   Maccaferri S, 2011, DIGEST DIS, V29, P525, DOI 10.1159/000332966
   Mager DL, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-14
   Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   MCMICHAEL AJ, 1988, CANCER RES, V48, P751
   Michaud DS, 2013, GUT, V62, P1764, DOI 10.1136/gutjnl-2012-303006
   Nistal E, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00220
   Noah A, 2001, ASIA PAC J CLIN NUTR, V10, P2, DOI 10.1046/j.1440-6047.2001.00198.x
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Park CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25271
   Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Ray Katrina, 2011, Nat Rev Gastroenterol Hepatol, V8, P662, DOI 10.1038/nrgastro.2011.208
   Roberts Samantha, 2006, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09d05s02
   Rowland IR, 2009, CURR PHARM DESIGN, V15, P1524, DOI 10.2174/138161209788168191
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Sanapareddy N, 2012, ISME J, V6, P1858, DOI 10.1038/ismej.2012.43
   Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x
   Schippa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061176
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08
   Seder CW, 2009, J VASC SURG, V49, P1304, DOI 10.1016/j.jvs.2008.11.058
   Segal I, 2000, AM J GASTROENTEROL, V95, P859
   Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Sigusch BW, 2010, J PERIODONTOL, V81, P975, DOI 10.1902/jop.2010.090246
   Singh S, 2015, ADV EXP MED BIOL, V815, P281, DOI 10.1007/978-3-319-09614-8_16
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Suzuki TA, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.1037
   Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865
   Tazi MA, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.338
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Trichopoulou A, 2000, BRIT J NUTR, V84, pS205, DOI 10.1079/096582197388554
   Vargas AJ, 2012, NUTR CLIN PRACT, V27, P613, DOI 10.1177/0884533612454885
   Verma M, 2017, TECHNOL CANCER RES T, V16, P150, DOI 10.1177/1533034616645219
   Veronese N, 2017, CLIN NUTR, V36, P1609, DOI 10.1016/j.clnu.2016.09.035
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Waisberg Jaques, 2002, Arq. Gastroenterol., V39, P177, DOI 10.1590/S0004-28032002000300008
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Whitmore SE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003933
   Wick EC, 2014, INFLAMM BOWEL DIS, V20, P821, DOI 10.1097/MIB.0000000000000019
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yavari Parvin, 2006, Asian Pac J Cancer Prev, V7, P86
   Yilmaz O, 2010, CELL MICROBIOL, V12, P188, DOI 10.1111/j.1462-5822.2009.01390.x
   Yu HS, 2010, CHEM-BIOL INTERACT, V188, P367, DOI 10.1016/j.cbi.2010.08.005
   Yusof AS, 2012, ASIAN PAC J CANCER P, V13, P4713, DOI 10.7314/APJCP.2012.13.9.4713
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zeng H, 2006, AM J PHYSIOL-GASTR L, V290, pG96, DOI 10.1152/ajpgi.00273.2005
   Zhu QC, 2013, TUMOR BIOL, V34, P1285, DOI 10.1007/s13277-013-0684-4
NR 122
TC 38
Z9 41
U1 2
U2 17
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD AUG
PY 2018
VL 207
IS 3-4
BP 211
EP 225
DI 10.1007/s00430-018-0542-5
PG 15
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA GO9HA
UT WOS:000440415700006
PM 29687353
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Shi, W
   Shen, LJ
   Zou, W
   Wang, JW
   Yang, JN
   Wang, YZ
   Liu, BD
   Xie, LW
   Zhu, J
   Zhang, Z
AF Shi, Wei
   Shen, Lijun
   Zou, Wei
   Wang, Jingwen
   Yang, Jianing
   Wang, Yuezhu
   Liu, Bingdong
   Xie, Liwei
   Zhu, Ji
   Zhang, Zhen
TI The Gut Microbiome Is Associated With Therapeutic Responses and
   Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients-A
   Pilot Study
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE gut microbiome; rectal cancer; neoadjuvant chemoradiotherapy;
   therapeutic responses; toxicities
ID INTESTINAL MICROBIOTA; PROBIOTICS; RADIOTHERAPY; PREVENTION; BACTERIA;
   COLON
AB Responses to neoadjuvant chemoradiotherapy (nCRT) and therapy-related toxicities in rectal cancer vary among patients. To provide the individualized therapeutic option for each patient, predictive markers of therapeutic responses and toxicities are in critical need. We aimed to identify the association of gut microbiome with and its potential predictive value for therapeutic responses and toxicities. In the present study, we collected fecal microbiome samples from patients with rectal cancer at treatment initiation and just after nCRT. Taxonomic profiling via 16S ribosomal RNA gene sequencing was performed on all samples. Patients were classified as responders versus non-responders. Patients were grouped into no or mild diarrhea and severe diarrhea. STAMP and high-dimensional class comparisons via linear discriminant analysis of effect size (LEfSe) were used to compare the compositional differences between groups. Phylogenetic Investigation of Communities by Reconstruction of Unobserved States (PICRUSt) was utilized to predict differences in metabolic function between groups. Ten patients were classified as responders and 12 patients were classified as non-responders. Fourteen patients experienced no or mild diarrhea and 8 patients experienced severe diarrhea. Several bacteria taxa with significantly different relative abundances before and after nCRT were identified. Similarly, several baseline bacteria taxa and predicted pathways with significantly different relative abundances between responders and non-responders or between patients no or mild diarrhea and severe diarrhea were identified. Specifically, Shuttleworthia was identified as enriched in responders and several bacteria taxa in the Clostridiales order etc. were identified as enriched in non-responders. Pathways including fatty acid metabolism were predicted to be enriched in responders. In addition, Bifidobacterium, Clostridia, and Bacteroides etc. were identified as enriched in patients with no or mild diarrhea. Pathways including primary bile acid biosynthesis were predicted to be enriched in patients with no or mild diarrhea. Together, the microbiota and pathway markers identified in this study may be utilized to predict the therapeutic responses and therapy-related toxicities of nCRT in patients with rectal cancer. More patient data is needed to verify the current findings and the results of metagenomic, metatranscriptomic, and metabolomic analyses will further mine key biomarkers at the compositional and functional level.
C1 [Shi, Wei; Shen, Lijun; Zou, Wei; Wang, Jingwen; Yang, Jianing; Zhu, Ji; Zhang, Zhen] Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China.
   [Shi, Wei; Shen, Lijun; Zou, Wei; Wang, Jingwen; Yang, Jianing; Zhu, Ji; Zhang, Zhen] Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.
   [Wang, Yuezhu] Chinese Natl Human Genome Ctr Shanghai, Sequencing Dept, Shanghai, Peoples R China.
   [Liu, Bingdong; Xie, Liwei] Guangdong Acad Sci, Guangdong Open Lab Appl Microbiol, State Key Lab Appl Microbiol Southern China,Guang, Guangdong Prov Key Lab Microbial Culture Collect, Guangzhou, Peoples R China.
   [Xie, Liwei] Southern Med Univ, Zhujiang Hosp, Guangzhou, Peoples R China.
   [Xie, Liwei] Xinxiang Med Coll, Sch Publ Hlth, Xinxiang, Peoples R China.
C3 Fudan University; Guangdong Academy of Sciences; Southern Medical
   University - China; Xinxiang Medical University
RP Shi, W; Zhang, Z (corresponding author), Fudan Univ, Dept Radiat Oncol, Shanghai Canc Ctr, Shanghai, Peoples R China.; Shi, W; Zhang, Z (corresponding author), Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.
EM wei.shi118@foxmail.com; zhenzhang6@gmail.com
FU Shanghai Pujiang Talent Program [16PJ1402000]; National Natural Science
   Foundation of China [81773357]; Shanghai ACA Foundation [SACACY19B04];
   GDAS' Project of Science and Technology Development [2018GDASCX-0102]
FX 10.1080/19490976.2020.1712986 This work was supported by the Shanghai
   Pujiang Talent Program (Grant Number: 16PJ1402000), National Natural
   Science Foundation of China (No. 81773357), Shanghai ACA Foundation
   (SACACY19B04) and GDAS' Project of Science and Technology Development
   (No. 2018GDASCX-0102).
CR Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331
   Azcarate-Peril MA, 2011, AM J PHYSIOL-GASTR L, V301, pG401, DOI 10.1152/ajpgi.00110.2011
   Blacher E, 2017, J IMMUNOL, V198, P572, DOI 10.4049/jimmunol.1601247
   Burns MB, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0177-8
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Ciorba MA, 2015, CURR OPIN SUPPORT PA, V9, P157, DOI 10.1097/SPC.0000000000000134
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102
   Dayde D, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030573
   Delia P, 2007, WORLD J GASTROENTERO, V13, P912, DOI 10.3748/wjg.v13.i6.912
   Delia P, 2002, AM J GASTROENTEROL, V97, P2150
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Faith JJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008051
   Ferreira MR, 2014, LANCET ONCOL, V15, pE139, DOI 10.1016/S1470-2045(13)70504-7
   Ferreira MR, 2019, CLIN CANCER RES, V25, P6487, DOI 10.1158/1078-0432.CCR-19-0960
   Garrett WS, 2019, SCIENCE, V364, P1133, DOI 10.1126/science.aaw2367
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Greenhalgh TA, 2016, CLIN ONCOL-UK, V28, P116, DOI 10.1016/j.clon.2015.11.002
   Heshiki Y, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00811-2
   Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848
   Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143
   HUSEBYE E, 1995, GASTROENTEROLOGY, V109, P1078, DOI 10.1016/0016-5085(95)90565-0
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Jang BS, 2020, INT J RADIAT ONCOL, V107, P736, DOI 10.1016/j.ijrobp.2020.04.015
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20073, 10.3322/caac.20107]
   Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Mai V, 2013, CURR NUTR REP, V2, P10, DOI DOI 10.1007/S13668-012-0032-0
   Manichanh C, 2008, AM J GASTROENTEROL, V103, P1754, DOI 10.1111/j.1572-0241.2008.01868.x
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   Nam YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082659
   O'Mahony C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000112
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Pezzolo E, 2015, EUR J CLIN PHARMACOL, V71, P529, DOI 10.1007/s00228-015-1824-0
   Platten M, 2019, NAT REV DRUG DISCOV, V18, P379, DOI 10.1038/s41573-019-0016-5
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360
   Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846
   Ternes D, 2020, TRENDS MICROBIOL, V28, P698, DOI 10.1016/j.tim.2020.05.013
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67
   Touchefeu Y, 2014, ALIMENT PHARM THER, V40, P409, DOI 10.1111/apt.12878
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Wang AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126312
   Washington MK, 2009, ARCH PATHOL LAB MED, V133, P1539, DOI 10.1043/1543-2165-133.10.1539
   Wedlake L, 2008, EUR J CANCER, V44, P2212, DOI 10.1016/j.ejca.2008.07.018
   Wilkins T, 2017, AM FAM PHYSICIAN, V96, P170
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Yang J, 2020, GUT MICROBES, V11, P918, DOI 10.1080/19490976.2020.1712986
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
NR 65
TC 16
Z9 16
U1 3
U2 12
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD DEC 9
PY 2020
VL 10
AR 562463
DI 10.3389/fcimb.2020.562463
PG 12
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA PI2XW
UT WOS:000600960500001
PM 33363048
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Bhatt, AP
   Redinbo, MR
   Bultman, SJ
AF Bhatt, Aadra P.
   Redinbo, Matthew R.
   Bultman, Scott J.
TI The Role of the Microbiome in Cancer Development and Therapy
SO CA-A CANCER JOURNAL FOR CLINICIANS
LA English
DT Article
DE cancer; dysbiosis; microbiome; prebiotics; probiotics
ID HUMAN GUT MICROBIOME; CHAIN FATTY-ACIDS; FECAL MICROBIOTA;
   COLORECTAL-CANCER; HELICOBACTER-PYLORI; COMMENSAL BACTERIA; INTESTINAL
   MICROBIOTA; CHECKPOINT-BLOCKADE; METABOLIC SYNDROME; ESCHERICHIA-COLI
AB The human body harbors enormous numbers of microbiota that influence cancer susceptibility, in part through their prodigious metabolic capacity and their profound influence on immune cell function. Microbial pathogens drive tumorigenesis in 15% to 20% of cancer cases. Even larger numbers of malignancies are associated with an altered composition of commensal microbiota (dysbiosis) based on microbiome studies using metagenomic sequencing. Although association studies cannot distinguish whether changes in microbiota are causes or effects of cancer, a causative role is supported by rigorously controlled preclinical studies using gnotobiotic mouse models colonized with one or more specific bacteria. These studies demonstrate that microbiota can alter cancer susceptibility and progression by diverse mechanisms, such as modulating inflammation, inducing DNA damage, and producing metabolites involved in oncogenesis or tumor suppression. Evidence is emerging that microbiota can be manipulated for improving cancer treatment. By incorporating probiotics as adjuvants for checkpoint immunotherapy or by designing small molecules that target microbial enzymes, microbiota can be harnessed to improve cancer care. (C) 2017 American Cancer Society.
C1 [Bhatt, Aadra P.] Univ N Carolina, Dept Chem, Chapel Hill, NC USA.
   [Redinbo, Matthew R.] Univ N Carolina, Dept Chem Biochem & Biophys, Chem, Chapel Hill, NC USA.
   [Redinbo, Matthew R.] Univ N Carolina, Integrated Program Biol & Genome Sci, Chapel Hill, NC USA.
   [Redinbo, Matthew R.; Bultman, Scott J.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.
   [Bultman, Scott J.] Univ N Carolina, Dept Genet, 120 Mason Farm Rd,Genet Med Bldg,Rm 5060, Chapel Hill, NC 27599 USA.
C3 University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill;
   University of North Carolina; University of North Carolina Chapel Hill
RP Bultman, SJ (corresponding author), Univ N Carolina, Dept Genet, 120 Mason Farm Rd,Genet Med Bldg,Rm 5060, Chapel Hill, NC 27599 USA.
EM scott_bultman@med.unc.edu
RI ravegnini, gloria/K-1330-2016
OI ravegnini, gloria/0000-0002-7774-402X
FU National Institutes of Health [R01-0D-02057, CA098468, CA207416,
   T32DK007737]; US Department of Agriculture [055336]; NATIONAL CANCER
   INSTITUTE [R01CA207416, R01CA098468, R01CA125237] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASES [R01DK109559, T32DK007737] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126]
   Funding Source: NIH RePORTER
FX This work was supported by grant R01-0D-02057 from the National
   Institutes of Health (to Scott J. Bultman); grant 055336 from the US
   Department of Agriculture (to Scott J. Bultman); and grants CA098468 (to
   Matthew R. Redinbo), CA207416 (to Matthew R. Redinbo and Scott J.
   Bultman), and T32DK007737(to Aadra P. Bhatt) from the National
   Institutes of Health. Matthew R. Redinbo has inventions licensed to and
   equity ownership in Symberix, Inc. a pharmaceutical company creating
   microbiome-targeted therapeutics. Aadra P. Bhatt and Scott J. Bultman
   made no disclosures.
CR Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004
   Anand P, 2008, PHARM RES-DORDR, V25, P2097, DOI 10.1007/s11095-008-9661-9
   Araujo-Perez F, 2012, GUT MICROBES, V3, P530, DOI 10.4161/gmic.22157
   Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashford NA, 2015, SCIENCE, V347, P727, DOI 10.1126/science.aaa6246
   Attayek PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153795
   Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Bailey SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00276
   Benson AK, 2016, NAT GENET, V48, P1301, DOI 10.1038/ng.3707
   Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329
   Bhatt AP, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00401
   Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667
   Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663
   Brandi G, 2006, CLIN CANCER RES, V12, P1299, DOI 10.1158/1078-0432.CCR-05-0750
   Brim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081352
   Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Bultman SJ, 2016, SEMIN ONCOL, V43, P97, DOI 10.1053/j.seminoncol.2015.09.001
   Bultman SJ, 2014, CARCINOGENESIS, V35, P249, DOI 10.1093/carcin/bgt392
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061
   Chen HJ, 2016, NAT BIOTECHNOL, V34, P845, DOI 10.1038/nbt.3586
   Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   CLAESSON R, 1990, ORAL MICROBIOL IMMUN, V5, P137, DOI 10.1111/j.1399-302X.1990.tb00411.x
   Colangelo LA, 2002, CANCER EPIDEM BIOMAR, V11, P385
   Cole BF, 2009, J NATL CANCER I, V101, P256, DOI 10.1093/jnci/djn485
   Cox LM, 2015, NAT REV ENDOCRINOL, V11, P182, DOI 10.1038/nrendo.2014.210
   Cramer Peyton, 2017, Curr Gastroenterol Rep, V19, P3, DOI 10.1007/s11894-017-0540-6
   Cuzick J, 2009, LANCET ONCOL, V10, P501, DOI 10.1016/S1470-2045(09)70035-X
   Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009
   David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   de Jong FA, 2006, ONCOLOGIST, V11, P944, DOI 10.1634/theoncologist.11-8-944
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
   Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011
   Donohoe DR, 2014, CANCER DISCOV, V4, P1387, DOI 10.1158/2159-8290.CD-14-0501
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Eid A, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.111
   Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Fox JG, 2011, MUCOSAL IMMUNOL, V4, P22, DOI 10.1038/mi.2010.61
   Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003
   Fukamachi H, 2002, FEMS MICROBIOL LETT, V215, P75, DOI 10.1111/j.1574-6968.2002.tb11373.x
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Garrett WS, 2015, SCIENCE, V348, P80, DOI 10.1126/science.aaa4972
   Gill CIR, 2002, BRIT J NUTR, V88, pS73, DOI 10.1079/BJN2002632
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Goedert JJ, 2015, EBIOMEDICINE, V2, P597, DOI 10.1016/j.ebiom.2015.04.010
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262
   Hale VL, 2017, CANCER EPIDEM BIOMAR, V26, P85, DOI 10.1158/1055-9965.EPI-16-0337
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Harris CC, 2016, CARCINOGENESIS, V37, P1, DOI 10.1093/carcin/bgv246
   Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010
   Hullar MAJ, 2014, CANCER TREAT RES, V159, P377, DOI 10.1007/978-3-642-38007-5_22
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529
   IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Itzkowitz SH, 2004, GASTROENTEROLOGY, V126, P1634, DOI 10.1053/j.gastro.2004.03.025
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Jones RM, 2012, CURR MED CHEM, V19, P1519
   Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224
   Kaiko GE, 2016, CELL, V167, P1137, DOI 10.1016/j.cell.2016.10.034
   Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005
   Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Lakritz JR, 2015, ONCOTARGET, V6, P9387, DOI 10.18632/oncotarget.3328
   Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293
   Lee CH, 2016, JAMA-J AM MED ASSOC, V315, P142, DOI 10.1001/jama.2015.18098
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20
   Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495
   MARSHALL BJ, 1984, LANCET, V1, P1311
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Montassier E, 2015, ALIMENT PHARM THER, V42, P515, DOI 10.1111/apt.13302
   Montassier E, 2014, MICROB ECOL, V67, P690, DOI 10.1007/s00248-013-0355-4
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   Mueller NT, 2015, TRENDS MOL MED, V21, P109, DOI 10.1016/j.molmed.2014.12.002
   Nam YD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082659
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   Nugent JL, 2014, J PROTEOME RES, V13, P1921, DOI 10.1021/pr4009783
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Pitt JM, 2016, CANCER RES, V76, P4602, DOI 10.1158/0008-5472.CAN-16-0448
   Pitt JM, 2016, IMMUNITY, V44, P1255, DOI 10.1016/j.immuni.2016.06.001
   Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x
   Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09
   Repass J, 2016, ELIFE, V5
   Ridlon JM, 2016, GUT MICROBES, V7, P201, DOI 10.1080/19490976.2016.1150414
   Rigby RJ, 2016, GUT MICROBES, V7, P414, DOI 10.1080/19490976.2016.1215806
   Roberts AB, 2013, MOL PHARMACOL, V84, P208, DOI 10.1124/mol.113.085852
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009
   Sanapareddy N, 2012, ISME J, V6, P1858, DOI 10.1038/ismej.2012.43
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Selle K, 2015, P NATL ACAD SCI USA, V112, P8076, DOI 10.1073/pnas.1508525112
   Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360
   Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011
   Siegel RL, 2021, CA-CANCER J CLIN, V71, P7, DOI [10.3322/caac.21654, 10.3322/caac.21551]
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504
   Stringer AM, 2013, SUPPORT CARE CANCER, V21, P1843, DOI 10.1007/s00520-013-1741-7
   Taur Y, 2014, BLOOD, V124, P1174, DOI 10.1182/blood-2014-02-554725
   Thelestam M, 2004, Rev Physiol Biochem Pharmacol, V152, P111
   Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16
   Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026
   Uzunlulu M, 2016, ANN NUTR METAB, V68, P173, DOI 10.1159/000443743
   Vaezi MF, 2000, AM J GASTROENTEROL, V95, P2206, DOI 10.1111/j.1572-0241.2000.02305.x
   van Beurden YH, 2016, J GASTROINTEST LIVER, V25, P385, DOI 10.15403/jgld.2014.1121.253.cel
   van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Wallace BD, 2015, CHEM BIOL, V22, P1238, DOI 10.1016/j.chembiol.2015.08.005
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Wang FS, 2008, J BIOL CHEM, V283, P26714, DOI 10.1074/jbc.M800527200
   Wang J, 2016, NAT GENET, V48, P1396, DOI 10.1038/ng.3695
   Ward DV, 2016, CELL REP, V14, P2912, DOI 10.1016/j.celrep.2016.03.015
   Weeber F, 2015, P NATL ACAD SCI USA, V112, P13308, DOI 10.1073/pnas.1516689112
   Weinstock GM, 2012, NATURE, V489, P250, DOI 10.1038/nature11553
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Willett W C, 2000, Oncologist, V5, P393, DOI 10.1634/theoncologist.5-5-393
   Wolf D, 2015, J CELL PHYSIOL, V230, P2598, DOI 10.1002/jcp.25016
   Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720
   Wu SG, 1998, P NATL ACAD SCI USA, V95, P14979, DOI 10.1073/pnas.95.25.14979
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yuan M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030072
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zadra G, 2013, BBA-MOL CELL BIOL L, V1831, P1518, DOI 10.1016/j.bbalip.2013.03.010
   Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089
   Zolfo M, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw837
   Zoller V, 2015, DEUT MED WOCHENSCHR, V140, P1232, DOI 10.1055/s-0041-103798
NR 156
TC 280
Z9 297
U1 13
U2 161
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0007-9235
EI 1542-4863
J9 CA-CANCER J CLIN
JI CA-Cancer J. Clin.
PD JUL-AUG
PY 2017
VL 67
IS 4
BP 327
EP 344
DI 10.3322/caac.21398
PG 18
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA EZ8KD
UT WOS:000404973500008
PM 28481406
OA Green Accepted, gold
DA 2022-11-22
ER

PT J
AU Ma, YS
   Zhang, Y
   Xiang, JH
   Xiang, SX
   Zhao, YS
   Xiao, MT
   Du, FK
   Ji, HJ
   Kaboli, PJ
   Wu, X
   Li, MX
   Wen, QL
   Shen, J
   Yang, ZM
   Li, J
   Xiao, ZG
AF Ma, Yongshun
   Zhang, Yao
   Xiang, Jianghou
   Xiang, Shixin
   Zhao, Yueshui
   Xiao, Mintao
   Du, Fukuan
   Ji, Huijiao
   Kaboli, Parham Jabbarzadeh
   Wu, Xu
   Li, Mingxing
   Wen, Qinglian
   Shen, Jing
   Yang, Zhongmin
   Li, Jing
   Xiao, Zhangang
TI Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients
   With Inflammatory Bowel Disease and Colorectal Cancer
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE inflammatory bowel disease; colorectal cancer; intestinal bacteria;
   taxonomic biomarkers; metagenomics; fecal microbiota
AB Objectives: Several reports suggesting that the intestinal microbiome plays a key role in the development of inflammatory bowel disease (IBD) or colorectal cancer (CRC), but the changes of intestinal bacteria in healthy people, patients with IBD and CRC are not fully explained. The study aimed to investigate changes of intestinal bacteria in healthy subjects, patients with IBD, and patients with CRC.
   Materials: We collected data from the European Nucleotide Archive on healthy people and patients with colorectal cancer with the study accession number PRJEB6070, PRJEB7774, PRJEB27928, PRJEB12449, and PRJEB10878, collected IBD patient data from the Integrated Human Microbiome Project from the Human Microbiome Project Data Portal. We performed metagenome-wide association studies on the fecal samples from 290 healthy subjects, 512 IBD patients, and 285 CRC patients. We used the metagenomics dataset to study bacterial community structure, relative abundance, functional prediction, differentially abundant bacteria, and co-occurrence networks.
   Results: The bacterial community structure in both IBD and CRC was significantly different from healthy subjects. Our results showed that IBD patients had low intestinal bacterial diversity and CRC patients had high intestinal bacterial diversity compared to healthy subjects. At the phylum level, the relative abundance of Firmicutes in IBD decreased significantly, while the relative abundance of Bacteroidetes increased significantly. At the genus level, the relative abundance of Bacteroides in IBD was higher than in healthy people and CRC. Compared with healthy people and CRC, the main difference of intestinal bacteria in IBD patients was Bacteroidetes, and compared with healthy people and IBD, the main difference of intestinal bacteria in CRC patients was in Fusobacteria, Verrucomicrobia, and Proteobacteria. The main differences in the functional composition of intestinal bacteria in healthy people, IBD and CRC patients were L-homoserine and L-methionine biosynthesis, 5-aminoimidazole ribonucleotide biosynthesis II, L-methionine biosynthesis I, and superpathway of L-lysine, L-threonine, and L-methionine biosynthesis I. The results of stratified showed that the abundance of Firmicutes, Bacteroidetes, and Actinobacteria involved in metabolic pathways has significantly changed. Besides, the association network of intestinal bacteria in healthy people, IBD, and CRC patients has also changed.
   Conclusions: In conclusion, compared with healthy people, the taxonomic and functional composition of intestinal bacteria in IBD and CRC patients was significantly changed.
C1 [Ma, Yongshun; Zhang, Yao; Xiang, Shixin; Zhao, Yueshui; Xiao, Mintao; Du, Fukuan; Ji, Huijiao; Kaboli, Parham Jabbarzadeh; Wu, Xu; Li, Mingxing; Shen, Jing; Xiao, Zhangang] Southwest Med Univ, Dept Pharmacol, Lab Mol Pharmacol, Sch Pharm, Luzhou, Peoples R China.
   [Ma, Yongshun; Zhang, Yao; Xiang, Shixin; Zhao, Yueshui; Xiao, Mintao; Du, Fukuan; Ji, Huijiao; Kaboli, Parham Jabbarzadeh; Wu, Xu; Li, Mingxing; Shen, Jing] South Sichuan Inst Translat Med, Luzhou, Peoples R China.
   [Xiang, Jianghou] Wannan Med Coll, Yijishan Hosp, Wannan Med Coll, Affiliated Hosp 1, Wuhu, Peoples R China.
   [Wen, Qinglian] Southwest Med Univ, Affiliated Hosp, Dept Oncol, Luzhou, Peoples R China.
   [Yang, Zhongmin; Li, Jing] Southwest Med Univ, Hosp TCM, Dept Hematol & Oncol, Luzhou, Peoples R China.
   [Xiao, Zhangang] Southwest Med Univ, Affiliated Hosp, Dept Pharm, Luzhou, Peoples R China.
C3 Southwest Medical University; Wannan Medical College; Southwest Medical
   University; Southwest Medical University; Southwest Medical University
RP Xiao, ZG (corresponding author), Southwest Med Univ, Dept Pharmacol, Lab Mol Pharmacol, Sch Pharm, Luzhou, Peoples R China.; Yang, ZM; Li, J (corresponding author), Southwest Med Univ, Hosp TCM, Dept Hematol & Oncol, Luzhou, Peoples R China.; Xiao, ZG (corresponding author), Southwest Med Univ, Affiliated Hosp, Dept Pharm, Luzhou, Peoples R China.
EM brainyang@swmu.edu.cn; jing.li9@hotmail.com; xzg555898@hotmail.com
RI Kaboli, Parham/H-9623-2019
OI Kaboli, Parham/0000-0002-4157-7901; WU, XU/0000-0003-4555-0076; XIAO,
   Zhangang/0000-0003-3249-1118
FU National Natural Science Foundation of China; Sichuan Science and
   Technology Project
FX The authors thank the National Natural Science Foundation of China and
   Sichuan Science and Technology Project for funding supporting.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Clarke WT, 2019, WORLD J GASTROENTERO, V25, P4148, DOI 10.3748/wjg.v25.i30.4148
   Dahlhamer JM, 2016, MMWR-MORBID MORTAL W, V65, P1166, DOI 10.15585/mmwr.mm6542a3
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Gaulke CA, 2018, NAT MED, V24, P1495, DOI 10.1038/s41591-018-0210-8
   GILLEN CD, 1994, GUT, V35, P1590, DOI 10.1136/gut.35.11.1590
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06
   Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jackson DN, 2020, GUT MICROBES, V11, P285, DOI 10.1080/19490976.2019.1592421
   Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010
   Kolho KL, 2017, J CROHNS COLITIS, V11, P321, DOI 10.1093/ecco-jcc/jjw158
   Kwong TNY, 2018, GASTROENTEROLOGY, V155, P383, DOI 10.1053/j.gastro.2018.04.028
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lopez-Siles M, 2016, INFLAMM BOWEL DIS, V22, P28, DOI 10.1097/MIB.0000000000000590
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x
   Maccaferri S, 2011, DIGEST DIS, V29, P525, DOI 10.1159/000332966
   Manichanh C., 2006, GUT GUT, V55, P205, DOI [10.1136/gut.2005.073817, DOI 10.1136/gut.2005.073817]
   Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152
   Martinez-Medina Margarita, 2014, World J Gastrointest Pathophysiol, V5, P213, DOI 10.4291/wjgp.v5.i3.213
   Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4
   Mira-Pascual L, 2015, J GASTROENTEROL, V50, P167, DOI 10.1007/s00535-014-0963-x
   Mirsepasi-Lauridsen HC, 2019, CLIN MICROBIOL REV, V32, DOI [10.1128/CMR.00060-18, 10.1128/cmr.00060-18]
   Munkholm P, 2003, ALIMENT PHARM THER, V18, P1, DOI 10.1046/j.1365-2036.18.s2.2.x
   Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88
   Nishida A, 2018, CLIN J GASTROENTEROL, V11, P1, DOI 10.1007/s12328-017-0813-5
   Palmela C, 2018, GUT, V67, P574, DOI 10.1136/gutjnl-2017-314903
   Park CH, 2018, INTEST RES, V16, P338, DOI 10.5217/ir.2018.16.3.338
   Parker BJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00906
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quevrain E, 2016, GUT, V65, P415, DOI 10.1136/gutjnl-2014-307649
   Rutter M, 2004, GASTROENTEROLOGY, V126, P451, DOI 10.1053/j.gastro.2003.11.010
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Thomas AM, 2019, NAT MED, V25, P1948, DOI 10.1038/s41591-019-0663-4
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yu LCH, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0483-8
   Yusof HM, 2018, MALAYS J MED SCI, V25, P16, DOI 10.21315/mjms2018.25.5.3
   Zamani S, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00449
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhou LX, 2018, INFLAMM BOWEL DIS, V24, P1926, DOI 10.1093/ibd/izy182
NR 56
TC 7
Z9 8
U1 1
U2 13
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD FEB 26
PY 2021
VL 11
AR 599734
DI 10.3389/fcimb.2021.599734
PG 12
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA QX4HJ
UT WOS:000629305400001
PM 33738265
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Voigt, AY
   Zeller, G
   Bork, P
AF Voigt, Anita Y.
   Zeller, Georg
   Bork, Peer
TI Microbial Biomarkers for Early Cancer Detection
SO DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
LA German
DT Article
DE microbial biomarker; microbiome; metagenomics; colon cancer
ID HUMAN GUT MICROBIOME; SQUAMOUS-CELL CARCINOMA; FUSOBACTERIUM-NUCLEATUM;
   PORPHYROMONAS-GINGIVALIS; FECAL MICROBIOTA; ASSOCIATION; CARCINOGENESIS;
   TUMORIGENESIS; METAANALYSIS; METABOLISM
AB The human microbiome - the vast amount of microbes that colonize our body - play an important role in maintaining our health. Changes in microbiome composition have been linked to multiple diseases including cancer. Although mechanisms and causalities of these associations still have to be uncovered, microbiome alterations across various stages of disease can be utilized for novel diagnostic and prognostic tests. Research on biomarkers extracted from the gut microbiome has in particular focused on colorectal cancer, where clinical use is already on the horizon. For example, multiple microbial taxonomic markers such as Fusobacterium nucleatum and other oral pathogens have been identified in human feces with potential for non-invasive diagnostics and prognostics. The article summarizes the recent developments, but also limitations and challenges for the development of microbiome-based biomarkers for cancer early detection.
C1 [Voigt, Anita Y.; Zeller, Georg; Bork, Peer] EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.
C3 European Molecular Biology Laboratory (EMBL)
RP Bork, P (corresponding author), EMBL, Meyerhofstr 1, D-69117 Heidelberg, Germany.
EM Anita.voigt@embl.de; Georg.zeller@embl.de; bork@embl.de
RI Zeller, Georg/M-6484-2013; Bork, Peer/F-1813-2013
OI Zeller, Georg/0000-0003-1429-7485; Bork, Peer/0000-0002-2627-833X;
   Voigt, Anita Yvonne/0000-0002-6794-0385
CR Arthur JC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5724
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Gao SG, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0049-x
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Hua-Feng X, 2015, INDIAN J CANCER, V52, pE112, DOI 10.4103/0019-509X.172506
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Inaba H, 2014, CELL MICROBIOL, V16, P131, DOI 10.1111/cmi.12211
   Ito M, 2015, INT J CANCER, V137, P1258, DOI 10.1002/ijc.29488
   Jameson JL, 2015, NEW ENGL J MED, V372, P2229, DOI 10.1056/NEJMsb1503104
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kullander J, 2009, CANCER EPIDEM BIOMAR, V18, P472, DOI 10.1158/1055-9965.EPI-08-0905
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852
   Michaud DS, 2013, CARCINOGENESIS, V34, P2193, DOI 10.1093/carcin/bgt249
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Nagaraja V, 2014, ALIMENT PHARM THER, V39, P745, DOI 10.1111/apt.12655
   National Cancer Institute, HEL PYL CANC
   Noguera-Julian M, 2016, EBIOMEDICINE, V5, P135, DOI 10.1016/j.ebiom.2016.01.032
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Schloissnig S, 2013, NATURE, V493, P45, DOI 10.1038/nature11711
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Toprak NU, 2006, CLIN MICROBIOL INFEC, V12, P782, DOI 10.1111/j.1469-0691.2006.01494.x
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wroblewski LE, 2016, ADV EXP MED BIOL, V908, P393, DOI 10.1007/978-3-319-41388-4_19
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yu JH, 2016, INT J CANCER, V139, P1318, DOI 10.1002/ijc.30168
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 49
TC 4
Z9 4
U1 1
U2 37
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0012-0472
EI 1439-4413
J9 DEUT MED WOCHENSCHR
JI Dtsch. Med. Wochenschr.
PD FEB
PY 2017
VL 142
IS 4
BP 267
EP 274
DI 10.1055/s-0042-110193
PG 8
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA EQ5KO
UT WOS:000398121800016
PM 28235227
DA 2022-11-22
ER

PT J
AU Inamura, K
   Hamada, T
   Bullman, S
   Ugai, T
   Yachida, S
   Ogino, S
AF Inamura, Kentaro
   Hamada, Tsuyoshi
   Bullman, Susan
   Ugai, Tomotaka
   Yachida, Shinichi
   Ogino, Shuji
TI Cancer as microenvironmental, systemic and environmental diseases:
   opportunity for transdisciplinary microbiomics science
SO GUT
LA English
DT Article
DE CANCER EPIDEMIOLOGY; CANCER IMMUNOBIOLOGY; CANCER PREVENTION; INTESTINAL
   MICROBIOLOGY; MOLECULAR PATHOLOGY
ID FAMILIAL ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER;
   FUSOBACTERIUM-NUCLEATUM; GUT MICROBIOTA; DIETARY FIBER; VITAMIN-D;
   HELICOBACTER-PYLORI; ULCERATIVE-COLITIS; TUMOR MICROBIOME; EARLY-ONSET
AB Cancer is generally regarded as a localised disease, with the well-established role of the tumour microenvironment. However, the realm of cancer goes beyond the tumour microenvironment, and cancer should also be regarded as a systemic and environmental disease. The exposome (ie, the totality of exposures), which encompasses diets, supplements, smoking, alcohol, other lifestyle factors, medications, etc, likely alters the microbiome (inclusive of bacteria, viruses, archaea, fungi, parasites, etc) and immune system in various body sites and influences tumour phenotypes. The systemic metabolic/inflammatory status, which is likely influenced by exposures and intestinal physiological changes, may affect tissue microenvironment of colorectum and any other organs. Germline genomic factors can modify disease phenotypes via gene-by-environment interactions. Although challenges exist, it is crucial to advance not only basic experimental research that can analyse the effects of exposures, microorganisms and microenvironmental components on tumour evolution but also interdisciplinary human population research that can dissect the complex pathogenic roles of the exposome, microbiome and immunome. Metagenomic, metatranscriptomic and metabolomic analyses should be integrated into well-designed population research combined with advanced methodologies of artificial intelligence and molecular pathological epidemiology. Ideally, a prospective cohort study design that enables biospecimen (such as stool) collection before disease detection should be considered to address reverse causation and recall biases. Robust experimental and observational research together can provide insights into dynamic interactions between environmental exposures, microbiota, tumour and immunity during carcinogenesis processes, thereby helping us develop precision prevention and therapeutic strategies to ultimately reduce the cancer burden.
C1 [Inamura, Kentaro] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Tokyo 1358550, Japan.
   [Inamura, Kentaro] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Pathol, Tokyo, Japan.
   [Hamada, Tsuyoshi] Univ Tokyo, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan.
   [Hamada, Tsuyoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Hepatobiliary Pancreat Med, Tokyo, Japan.
   [Bullman, Susan] Fred Hutchinson Canc Ctr, Human Biol Div, Seattle, WA USA.
   [Ugai, Tomotaka; Ogino, Shuji] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.
   [Ugai, Tomotaka; Ogino, Shuji] Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, 75 Francis St, Boston, MA 02115 USA.
   [Ugai, Tomotaka; Ogino, Shuji] Harvard Med Sch, Boston, MA 02115 USA.
   [Yachida, Shinichi] Osaka Univ, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan.
   [Yachida, Shinichi] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Osaka, Japan.
   [Yachida, Shinichi] Natl Canc Ctr, Res Inst, Div Genom Med, Tokyo, Japan.
   [Ogino, Shuji] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Ogino, Shuji] Dana Farber Harvard Canc Ctr, Canc Immunol & Canc Epidemiol Programs, Boston, MA USA.
C3 Japanese Foundation for Cancer Research; Japanese Foundation for Cancer
   Research; University of Tokyo; Japanese Foundation for Cancer Research;
   Fred Hutchinson Cancer Center; Harvard University; Harvard T.H. Chan
   School of Public Health; Harvard University; Brigham & Women's Hospital;
   Harvard University; Harvard Medical School; Osaka University; Osaka
   University; National Cancer Center - Japan; Harvard University;
   Massachusetts Institute of Technology (MIT); Broad Institute; Harvard
   University; Dana-Farber Cancer Institute
RP Inamura, K (corresponding author), Japanese Fdn Canc Res, Canc Inst, Div Pathol, Tokyo 1358550, Japan.; Ogino, S (corresponding author), Brigham & Womens Hosp, Dept Pathol, Program MPE Mol Pathol Epidemiol, 75 Francis St, Boston, MA 02115 USA.
EM kentaro.inamura@jfcr.or.jp; sogino@bwh.harvard.edu
RI Inamura, Kentaro/G-4229-2018
OI Inamura, Kentaro/0000-0001-6444-3861; Ogino, Shuji/0000-0002-3909-2323;
   Yachida, Shinichi/0000-0001-5507-4566; Bullman,
   Susan/0000-0002-7713-0810
FU U.S. National Institutes of Health (NIH) [R35 CA197735, R01 CA248857];
   Cancer Research UK Grand Challenge Award (OPTIMISTICC) [C10674/A27140];
   JSPS KAKENHI [JP19K08362, JP22H02930, JP20H033620]; Takeda Science
   Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical
   Research; Ichiro Kanehara Foundation; Foundation for Promotion of Cancer
   Research in Japan; Yakult Bio-Science Foundation; Grant for Lung Cancer
   Research; Mishima Kaiun Memorial Foundation; Japan Society for the
   Promotion of Science [201960541]; Prevent Cancer Foundation; National
   Cancer Center Research and Development Fund [2020-A-4]; Practical
   Research for Innovative Cancer Control from the Japan Agency for Medical
   Research and Development (AMED) [JP21ck0106546]; Project for Cancer
   Research and Therapeutic Evolution (P-CREATE) from AMED [JP22cm0106477];
   Project for Promotion of Cancer Research and Therapeutic Evolution
   (P-PROMOTE) from AMED [JPama221404]; United States-Japan Cooperative
   Medical Science Program from AMED [JP20jk0210009]; AIP Accelerated
   Program from JST [21-191029679]; Integrated Frontier Research for
   Medical Science Division, Institute for Open and Transdisciplinary
   Research Initiatives, Osaka University; Joint Research Project of the
   Institute Medical Science, the University of Tokyo; Yasuda Medical
   Foundation; Mitsubishi Foundation; Princess Takamatsu Cancer Research
   Fund; Suzuki Foundation for Urological Medicine
FX This work was supported by U.S. National Institutes of Health (NIH)
   grants (R35 CA197735 to SO and R01 CA248857 to SO), and by Cancer
   Research UK Grand Challenge Award (OPTIMISTICC [C10674/A27140] to SO).
   KI was supported by grants from JSPS KAKENHI (JP22H02930), the Takeda
   Science Foundation, the Mochida Memorial Foundation for Medical and
   Pharmaceutical Research, the Ichiro Kanehara Foundation, Grant for Lung
   Cancer Research, Suzuki Foundation for Urological Medicine, Foundation
   for Promotion of Cancer Research in Japan, and the Yakult Bio-Science
   Foundation. TH was supported by grants from JSPS KAKENHI (JP19K08362)
   and the Takeda Science Foundation. TU was supported by grants from the
   Mishima Kaiun Memorial Foundation, Japan Society for the Promotion of
   Science (201960541), and Prevent Cancer Foundation. SY was supported by
   grants from the National Cancer Center Research and Development Fund
   (2020-A-4), JSPS KAKENHI (JP20H033620), Practical Research for
   Innovative Cancer Control from the Japan Agency for Medical Research and
   Development (AMED) (JP21ck0106546), Project for Cancer Research and
   Therapeutic Evolution (P-CREATE) from AMED (JP22cm0106477); Project for
   Promotion of Cancer Research and Therapeutic Evolution (P-PROMOTE) from
   AMED (JPama221404), United States-Japan Cooperative Medical Science
   Program from AMED (JP20jk0210009); AIP Accelerated Program from JST
   (21-191029679); Integrated Frontier Research for Medical Science
   Division, Institute for Open and Transdisciplinary Research Initiatives,
   Osaka University, Joint Research Project of the Institute Medical
   Science, the University of Tokyo, the Takeda Science Foundation, the
   Yasuda Medical Foundation, the Mitsubishi Foundation, and the Princess
   Takamatsu Cancer Research Fund. The funding source had no role in the
   decision to submit the manuscript to publication or preparation, review
   and approval of the manuscript.
CR Akimoto N, 2021, NAT REV CLIN ONCOL, V18, P230, DOI 10.1038/s41571-020-00445-1
   Alam A, 2022, CANCER CELL, V40, P153, DOI 10.1016/j.ccell.2022.01.003
   An YP, 2021, BBA-REV CANCER, V1876, DOI 10.1016/j.bbcan.2021.188626
   Andrews MC, 2021, NAT MED, V27, P1432, DOI 10.1038/s41591-021-01406-6
   Arima Kota, 2022, Gastroenterology, V163, P862, DOI 10.1053/j.gastro.2022.06.054
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Aykut B, 2019, NATURE, V574, P264, DOI 10.1038/s41586-019-1608-2
   Baghba R, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-0530-4
   Baj J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041055
   Bao Y, 2013, JNCI-J NATL CANCER I, V105, P95, DOI 10.1093/jnci/djs474
   Baruch EN, 2021, SCIENCE, V371, P602, DOI 10.1126/science.abb5920
   Beam A, 2021, NUTRIENTS, V13, DOI 10.3390/nu13082795
   Bernstein H, 2009, WORLD J GASTROENTERO, V15, P3329, DOI 10.3748/wjg.15.3329
   Bertocchi A, 2021, CANCER CELL, V39, P708, DOI 10.1016/j.ccell.2021.03.004
   Bolte LA, 2021, GUT, V70, P1287, DOI 10.1136/gutjnl-2020-322670
   Borozan I, 2022, CANCER EPIDEM BIOMAR, V31, P210, DOI 10.1158/1055-9965.EPI-21-0463
   Brennan CA, 2021, MBIO, V12, DOI 10.1128/mBio.00547-21
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Bullman S, 2021, NAT CANCER, V2, P1301, DOI 10.1038/s43018-021-00300-x
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Campbell PT, 2019, CANCER CAUSE CONTROL, V30, P799, DOI 10.1007/s10552-019-01177-z
   Canale FP, 2021, NATURE, V598, P662, DOI 10.1038/s41586-021-04003-2
   Cani PD, 2018, NAT REV GASTRO HEPAT, V15, P671, DOI 10.1038/s41575-018-0025-6
   Cao XY, 2022, NATURE, V604, P541, DOI 10.1038/s41586-022-04545-z
   Carlberg C, 2022, SEMIN CANCER BIOL, V79, P217, DOI 10.1016/j.semcancer.2020.05.018
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Chakladar J, 2020, CANCERS, V12, DOI 10.3390/cancers12061642
   Chang AE, 2021, TRENDS CANCER, V7, P583, DOI 10.1016/j.trecan.2021.02.005
   Cheng WY, 2020, GUT, V69, P1867, DOI 10.1136/gutjnl-2020-321153
   Coker OO, 2020, GASTROENTEROLOGY, V159, P1459, DOI 10.1053/j.gastro.2020.06.042
   Coker OO, 2019, GUT, V68, P654, DOI 10.1136/gutjnl-2018-317178
   Colom B, 2021, NATURE, V598, P510, DOI 10.1038/s41586-021-03965-7
   Costello SP, 2019, JAMA-J AM MED ASSOC, V321, P156, DOI 10.1001/jama.2018.20046
   Cullin N, 2021, CANCER CELL, V39, P1317, DOI 10.1016/j.ccell.2021.08.006
   Cunningham M, 2021, TRENDS MICROBIOL, V29, P667, DOI 10.1016/j.tim.2021.01.003
   Davar D, 2021, SCIENCE, V371, P595, DOI 10.1126/science.abf3363
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   de Martel C, 2020, LANCET GLOB HEALTH, V8, pE180, DOI 10.1016/S2214-109X(19)30488-7
   DeFilipp Z, 2019, NEW ENGL J MED, V381, P2043, DOI 10.1056/NEJMoa1910437
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Derosa L, 2018, ANN ONCOL, V29, P1437, DOI 10.1093/annonc/mdy103
   Derosa L, 2021, CANCER DISCOV, V11, P2396, DOI 10.1158/2159-8290.CD-21-0236
   Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043
   Domagala-Kulawik J, 2008, J PHYSIOL PHARMACOL, V59, P19
   Dong LQ, 2022, CANCER CELL, V40, P70, DOI 10.1016/j.ccell.2021.12.006
   Dou RX, 2016, BRIT J NUTR, V115, P1643, DOI 10.1017/S0007114516000696
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Eom BW, 2008, J SURG ONCOL, V98, P106, DOI 10.1002/jso.21027
   Erawijantari PP, 2020, GUT, V69, P1404, DOI 10.1136/gutjnl-2019-319188
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Finn OJ, 2018, NAT REV IMMUNOL, V18, P183, DOI 10.1038/nri.2017.140
   Ford AC, 2020, GUT, V69, P2113, DOI 10.1136/gutjnl-2020-320839
   Fujiyoshi K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025207118
   Fujiyoshi K, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkaa040
   Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043
   Gethings-Behncke C, 2020, CANCER EPIDEM BIOMAR, V29, P539, DOI 10.1158/1055-9965.EPI-18-1295
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Gough E, 2011, CLIN INFECT DIS, V53, P994, DOI 10.1093/cid/cir632
   Grando SA, 2014, NAT REV CANCER, V14, P419, DOI 10.1038/nrc3725
   Greathouse KL, 2020, CANCER CELL, V38, P158, DOI 10.1016/j.ccell.2020.06.017
   Guo Y, 2020, GUT, V69, P1598, DOI 10.1136/gutjnl-2019-319696
   Gupta S, 2020, JNCI-J NATL CANCER I, V112, P1105, DOI 10.1093/jnci/djaa007
   Gur C, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1581531
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Hamada T, 2019, J PATHOL, V247, P615, DOI 10.1002/path.5236
   Hamada T, 2019, JNCI-J NATL CANCER I, V111, P42, DOI 10.1093/jnci/djy137
   Hamada T, 2018, EUR J CANCER, V103, P98, DOI 10.1016/j.ejca.2018.07.130
   Hamada T, 2017, J CLIN ONCOL, V35, P1836, DOI 10.1200/JCO.2016.70.7547
   Hamada T, 2017, J GASTROENTEROL, V52, P265, DOI 10.1007/s00535-016-1272-3
   Hanahan D, 2022, CANCER DISCOV, V12, P31, DOI 10.1158/2159-8290.CD-21-1059
   Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18
   Harlid S, 2021, CANCERS, V13, DOI 10.3390/cancers13174406
   Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190
   Hiam-Galvez KJ, 2021, NAT REV CANCER, V21, P345, DOI 10.1038/s41568-021-00347-z
   HIBBERD AA, 2017, BMJ OPEN GASTROENTER, V4, DOI DOI 10.1136/BMJGAST-2017-000145
   Hullar MAJ, 2014, CANCER TREAT RES, V159, P377, DOI 10.1007/978-3-642-38007-5_22
   Iida N, 2021, NAT CANCER, V2, P1039, DOI 10.1038/s43018-021-00251-3
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Inamura K, 2021, SEMIN CANCER BIOL, V70, P11, DOI 10.1016/j.semcancer.2020.06.006
   Inamura K, 2020, SEMIN CANCER BIOL, V65, P164, DOI 10.1016/j.semcancer.2019.12.026
   Inamura K, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv363
   Ishikawa H, 2005, INT J CANCER, V116, P762, DOI 10.1002/ijc.21115
   Juul FE, 2018, NEW ENGL J MED, V378, P2535, DOI 10.1056/NEJMc1803103
   Kakiuchi N, 2021, NAT REV CANCER, V21, P239, DOI 10.1038/s41568-021-00335-3
   Kalaora S, 2021, NATURE, V592, P138, DOI 10.1038/s41586-021-03368-8
   Kartal E, 2022, GUT, V71, P1359, DOI 10.1136/gutjnl-2021-324755
   Kennedy EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01534
   Kiga K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16731-6
   Koh H, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky058
   Komiyama S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89963-1
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kosumi K, 2018, AM J PATHOL, V188, P2839, DOI 10.1016/j.ajpath.2018.08.015
   LaCourse KD, 2021, LANCET GASTROENTEROL, V6, P498, DOI 10.1016/S2468-1253(20)30362-9
   Lee B, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8091395
   Lee-Six H, 2019, NATURE, V574, P532, DOI 10.1038/s41586-019-1672-7
   Lega IC, 2020, ENDOCR REV, V41, P33, DOI 10.1210/endrev/bnz014
   Lida N, 2019, INT J CANCER, V145, P2701, DOI 10.1002/ijc.32339
   Lione L, 2021, ONCOIMMUNOLOGY, V10, DOI 10.1080/2162402X.2021.1898832
   Liou JM, 2020, GUT, V69, P2093, DOI 10.1136/gutjnl-2020-322368
   Liu JP, 2020, CELL, V182, P317, DOI 10.1016/j.cell.2020.05.038
   Liu L, 2018, EUR J EPIDEMIOL, V33, P381, DOI 10.1007/s10654-017-0346-8
   Liu L, 2018, CLIN GASTROENTEROL H, V16, P1622, DOI 10.1016/j.cgh.2018.04.030
   Liu NN, 2022, NAT MICROBIOL, V7, P238, DOI 10.1038/s41564-021-01030-7
   Liu WX, 2021, GASTROENTEROLOGY, V160, P2395, DOI 10.1053/j.gastro.2021.02.020
   Liu Y, 2021, BRIT J CANCER, V124, P963, DOI 10.1038/s41416-020-01198-5
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Maekawa T, 2018, BIOCHEM BIOPH RES CO, V506, P962, DOI 10.1016/j.bbrc.2018.10.169
   Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012
   MARSHALL BJ, 1984, LANCET, V1, P1311
   Matson V, 2021, GASTROENTEROLOGY, V160, P600, DOI 10.1053/j.gastro.2020.11.041
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   McAllister K, 2017, AM J EPIDEMIOL, V186, P753, DOI 10.1093/aje/kwx227
   McQuade JL, 2019, LANCET ONCOL, V20, pE77, DOI 10.1016/S1470-2045(18)30952-5
   Mehta RS, 2017, JAMA ONCOL, V3, P921, DOI 10.1001/jamaoncol.2016.6374
   Mehta RS, 2015, GASTROENTEROLOGY, V149, P614, DOI 10.1053/j.gastro.2015.05.038
   Mehta RS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju016
   Meng WB, 2015, DISCOV MED, V20, P285
   Merritt CR, 2020, NAT BIOTECHNOL, V38, P586, DOI 10.1038/s41587-020-0472-9
   Mima K, 2021, HUM GENET, V140, P725, DOI 10.1007/s00439-020-02235-2
   Mima K, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.53
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Mizutani S, 2020, CANCER SCI, V111, P766, DOI 10.1111/cas.14298
   Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001
   Morales E, 2019, METHODS MOL BIOL, V1928, P299, DOI 10.1007/978-1-4939-9027-6_16
   Nagata N, 2022, GASTROENTEROLOGY, V163, P222, DOI 10.1053/j.gastro.2022.03.054
   Nakatsu G, 2018, GASTROENTEROLOGY, V155, P529, DOI 10.1053/j.gastro.2018.04.018
   Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x
   Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189
   Nguyen LH, 2021, GASTROENTEROLOGY, V161, P1423, DOI 10.1053/j.gastro.2021.07.008
   Nguyen LH, 2020, GASTROENTEROLOGY, V158, P1313, DOI 10.1053/j.gastro.2019.12.029
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Ocvirk Soeren, 2019, Curr Gastroenterol Rep, V21, P62, DOI 10.1007/s11894-019-0725-2
   Ogino S, 2019, ANNU REV PATHOL-MECH, V14, P83, DOI 10.1146/annurev-pathmechdis-012418-012818
   Ogino S, 2018, GUT, V67, P1168, DOI 10.1136/gutjnl-2017-315537
   Oruc Z, 2019, WORLD J GASTRO ONCOL, V11, P348, DOI 10.4251/wjgo.v11.i5.348
   Pandolfi F, 2017, CLIN THER, V39, P884, DOI 10.1016/j.clinthera.2017.03.012
   Parida S, 2021, CANCER RES, V81, P790, DOI 10.1158/0008-5472.CAN-20-2629
   Park HE, 2017, VIRCHOWS ARCH, V471, P329, DOI 10.1007/s00428-017-2171-6
   Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703
   Pernigoni N, 2021, SCIENCE, V374, P216, DOI 10.1126/science.abf8403
   Pleguezuelos-Manzano C, 2020, NATURE, V580, P269, DOI 10.1038/s41586-020-2080-8
   Poore GD, 2020, NATURE, V579, P567, DOI 10.1038/s41586-020-2095-1
   Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI [10.1056/NEJMra1703481, 10.1056/NEJMc1801663]
   Pryor R, 2020, ANNU REV PHARMACOL, V60, P417, DOI 10.1146/annurev-pharmtox-010919-023612
   Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134
   Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488
   Ratner M, 2020, NAT BIOTECHNOL, V38, P1366, DOI 10.1038/s41587-020-00765-8
   Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084
   Renehan AG, 2015, NAT REV CANCER, V15, P484, DOI 10.1038/nrc3967
   Ridlon JM, 2016, GUT MICROBES, V7, P201, DOI 10.1080/19490976.2016.1150414
   Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Rubinstein MR, 2019, EMBO REP, V20, DOI 10.15252/embr.201847638
   Saito M, 2021, GASTRIC CANCER, V24, P983, DOI 10.1007/s10120-021-01215-3
   Schroeder BO, 2018, CELL HOST MICROBE, V23, P27, DOI 10.1016/j.chom.2017.11.004
   Sepich-Poore GD, 2021, SCIENCE, V371, P1331, DOI 10.1126/science.abc4552
   Serrano C, 2021, CURR OPIN PHYSIOL, V21, P57, DOI 10.1016/j.cophys.2021.04.003
   Shi YY, 2020, J EXP MED, V217, DOI 10.1084/jem.20192282
   Sieow BFL, 2021, TRENDS CANCER, V7, P447, DOI 10.1016/j.trecan.2020.11.004
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Soga T, 2009, ANAL CHEM, V81, P6165, DOI 10.1021/ac900675k
   Song MY, 2020, GASTROENTEROLOGY, V158, P322, DOI 10.1053/j.gastro.2019.06.048
   Song MY, 2016, CANCER PREV RES, V9, P27, DOI 10.1158/1940-6207.CAPR-15-0307
   Song MY, 2016, GUT, V65, P296, DOI 10.1136/gutjnl-2014-308852
   Spencer CN, 2021, SCIENCE, V374, P1632, DOI 10.1126/science.aaz7015
   Stewart OA, 2020, GUT MICROBES, V11, P1220, DOI 10.1080/19490976.2020.1762520
   Stringer AM, 2008, CANCER BIOL THER, V7, P1919, DOI 10.4161/cbt.7.12.6940
   Sullivan RJ, 2022, NAT REV DRUG DISCOV, V21, P495, DOI 10.1038/s41573-021-00259-5
   Tanoue T, 2019, NATURE, V565, P600, DOI 10.1038/s41586-019-0878-z
   Tarris G, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010104
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tomasetti C, 2015, SCIENCE, V347, P78, DOI 10.1126/science.1260825
   Tomkovich S, 2019, J CLIN INVEST, V129, P1699, DOI 10.1172/JCI124196
   Tomkovich S, 2017, CANCER RES, V77, P2620, DOI 10.1158/0008-5472.CAN-16-3472
   Trefflich I, 2021, NUTRIENTS, V13, DOI 10.3390/nu13061808
   Triner D, 2019, GASTROENTEROLOGY, V156, P1467, DOI 10.1053/j.gastro.2018.12.003
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Ugai T., 2021, JNCI-J NATL CANCER I
   Ugai T, 2022, MAYO CLIN PROC, V97, P124, DOI 10.1016/j.mayocp.2021.09.007
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087
   Wallace BD, 2010, SCIENCE, V330, P831, DOI 10.1126/science.1191175
   Wang J, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-28479-2
   Wang YH, 2018, NAT MED, V24, P1804, DOI 10.1038/s41591-018-0238-9
   Weersma RK, 2020, GUT, V69, P1510, DOI 10.1136/gutjnl-2019-320204
   Weir TL, 2021, SEMIN CANCER BIOL, V70, P53, DOI 10.1016/j.semcancer.2020.06.007
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wellenstein MD, 2019, NATURE, V572, P538, DOI 10.1038/s41586-019-1450-6
   Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271
   Wilkinson JE, 2021, NAT MED, V27, P766, DOI 10.1038/s41591-021-01258-0
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515
   Yamamoto T, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22158002
   Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y
   Yazici C, 2017, GUT, V66, P1983, DOI 10.1136/gutjnl-2016-313321
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Yuan L, 2018, BIOMED PHARMACOTHER, V108, P184, DOI 10.1016/j.biopha.2018.08.165
   Zamani S, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00449
   Zhang QF, 2021, CANCER DISCOV, V11, P1248, DOI 10.1158/2159-8290.CD-20-0304
   Zhang W, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02358
   Zhou CB, 2021, TRENDS CANCER, V7, P647, DOI 10.1016/j.trecan.2021.01.010
   Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3
   Zimmermann M, 2019, SCIENCE, V363, P600, DOI 10.1126/science.aat9931
   Zitvogel L, 2021, NAT REV CLIN ONCOL, V18, P591, DOI 10.1038/s41571-021-00508-x
   Zitvogel L, 2018, SCIENCE, V359, P1366, DOI 10.1126/science.aar6918
   Zitvogel L, 2017, NAT IMMUNOL, V18, P843, DOI 10.1038/ni.3754
   Zmora N, 2019, NAT REV GASTRO HEPAT, V16, P35, DOI 10.1038/s41575-018-0061-2
   Zuo T, 2019, GUT, V68, P1169, DOI 10.1136/gutjnl-2018-318131
NR 216
TC 2
Z9 2
U1 25
U2 25
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD OCT
PY 2022
VL 71
IS 10
BP 2107
EP 2122
DI 10.1136/gutjnl-2022-327209
EA JUL 2022
PG 16
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 4R1BC
UT WOS:000824633100001
PM 35820782
DA 2022-11-22
ER

PT J
AU Liu, YF
   Li, X
   Yang, YD
   Liu, Y
   Wang, SJ
   Ji, BY
   Wei, YJ
AF Liu, Yuanfeng
   Li, Xiang
   Yang, Yudie
   Liu, Ye
   Wang, Shijun
   Ji, Boyang
   Wei, Yongjun
TI Exploring Gut Microbiota in Patients with Colorectal Disease Based on
   16S rRNA Gene Amplicon and Shallow Metagenomic Sequencing
SO FRONTIERS IN MOLECULAR BIOSCIENCES
LA English
DT Article
DE gut microbiota; colorectal diseases; 16S amplicon; network analysis;
   shallow metagenomic sequencing
ID ESCHERICHIA-COLI; CANCER; ASSOCIATION; RISK
AB The gastrointestinal tract, the largest human microbial reservoir, is highly dynamic. The gut microbes play essential roles in causing colorectal diseases. In the present study, we explored potential keystone taxa during the development of colorectal diseases in central China. Fecal samples of some patients were collected and were allocated to the adenoma (Group A), colorectal cancer (Group C), and hemorrhoid (Group H) groups. The 16S rRNA amplicon and shallow metagenomic sequencing (SMS) strategies were used to recover the gut microbiota. Microbial diversities obtained from 16S rRNA amplicon and SMS data were similar. Group C had the highest diversity, although no significant difference in diversity was observed among the groups. The most dominant phyla in the gut microbiota of patients with colorectal diseases were Bacteroidetes, Firmicutes, and Proteobacteria, accounting for >95% of microbes in the samples. The most abundant genera in the samples were Bacteroides, Prevotella, and Escherichia/Shigella, and further species-level and network analyses identified certain potential keystone taxa in each group. Some of the dominant species, such as Prevotella copri, Bacteroides dorei, and Bacteroides vulgatus, could be responsible for causing colorectal diseases. The SMS data recovered diverse antibiotic resistance genes of tetracycline, macrolide, and beta-lactam, which could be a result of antibiotic overuse. This study explored the gut microbiota of patients with three different types of colorectal diseases, and the microbial diversity results obtained from 16S rRNA amplicon sequencing and SMS data were found to be similar. However, the findings of this study are based on a limited sample size, which warrants further large-scale studies. The recovery of gut microbiota profiles in patients with colorectal diseases could be beneficial for future diagnosis and treatment with modulation of the gut microbiota. Moreover, SMS data can provide accurate species- and gene-level information, and it is economical. It can therefore be widely applied in future clinical metagenomic studies.
C1 [Liu, Yuanfeng] Zhengzhou Univ, Affiliated Hosp 1, Dept Vasc & Endovasc Surg, Zhengzhou, Henan, Peoples R China.
   [Li, Xiang] Sci China Press, Beijing, Peoples R China.
   [Yang, Yudie; Wei, Yongjun] Zhengzhou Univ, Minist Educ, Sch Pharmaceut Sci, Key Lab Adv Drug Preparat Technol, Zhengzhou, Peoples R China.
   [Yang, Yudie; Wei, Yongjun] Zhengzhou Univ, Lab Synthet Biol, Zhengzhou, Peoples R China.
   [Liu, Ye; Wang, Shijun] Zhengzhou Univ, Affiliated Hosp 1, Colorectal & Anal Surg Dept, Oncol Dept, Zhengzhou, Henan, Peoples R China.
   [Ji, Boyang] Chalmers Univ Technol, Dept Biol & Biol Engn, Gothenburg, Sweden.
C3 Zhengzhou University; Zhengzhou University; Zhengzhou University;
   Zhengzhou University; Chalmers University of Technology
RP Wei, YJ (corresponding author), Zhengzhou Univ, Minist Educ, Sch Pharmaceut Sci, Key Lab Adv Drug Preparat Technol, Zhengzhou, Peoples R China.; Wei, YJ (corresponding author), Zhengzhou Univ, Lab Synthet Biol, Zhengzhou, Peoples R China.
EM yongjunwei@zzu.edu.cn
RI Wei, Yongjun/AAY-5100-2021
OI Wei, Yongjun/0000-0002-1554-1999; Ji, Boyang/0000-0002-7269-4342
FU Henan Provincial Key Laboratory of Children's Genetics and Metabolic
   Diseases Foundation [SS201909]; National Natural Science Foundation of
   China [31800079, 32111530179]
FX This work was supported by Henan Provincial Key Laboratory of Children's
   Genetics and Metabolic Diseases Foundation (NO. SS201909), the National
   Natural Science Foundation of China (No. 31800079 and 32111530179) and
   Clinical Laboratories, Shenyou Bio.
CR Bilen M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0485-5
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Brennan CA, 2019, NAT REV MICROBIOL, V17, P156, DOI 10.1038/s41579-018-0129-6
   Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Butt J, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1903825
   Cao Y, 2018, GUT, V67, P672, DOI 10.1136/gutjnl-2016-313413
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Click B, 2018, JAMA-J AM MED ASSOC, V319, P2021, DOI 10.1001/jama.2018.5809
   Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244
   Corley DA, 2014, NEW ENGL J MED, V370, P1298, DOI 10.1056/NEJMoa1309086
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   De Filippis F, 2019, CELL HOST MICROBE, V25, P444, DOI 10.1016/j.chom.2019.01.004
   Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1
   dos Reis SA, 2019, J MED MICROBIOL, V68, P1391, DOI 10.1099/jmm.0.001049
   Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448
   Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19
   Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814
   Flemer B, 2017, GUT, V66, P633, DOI 10.1136/gutjnl-2015-309595
   Gagniere J, 2016, WORLD J GASTROENTERO, V22, P501, DOI 10.3748/wjg.v22.i2.501
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Grazioso TP, 2019, ISCIENCE, V21, P168, DOI 10.1016/j.isci.2019.10.011
   Gu W, 2021, NAT MED, V27, P115, DOI 10.1038/s41591-020-1105-z
   Guan RB, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.588255
   Haghi F, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6115-1
   Haiminen N., 2021, OGUS ENABLE EFFECTIV, DOI [10.1101/2021.04.04.438427, DOI 10.1101/2021.04.04.438427]
   Hillmann B, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00069-18
   Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148
   Illiano P, 2020, FEBS J, V287, P833, DOI 10.1111/febs.15217
   Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787
   Jiang S, 2020, SCI TOTAL ENVIRON, V725, DOI 10.1016/j.scitotenv.2020.138220
   Klepac-Ceraj V., 2021, COMP ANAL 16S RRNA G, DOI [10.1101/2021.02.20.432118, DOI 10.1101/2021.02.20.432118]
   Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]
   Laudadio I, 2018, OMICS, V22, P248, DOI 10.1089/omi.2018.0013
   Li YH, 2021, BIOTECHNOL BIOTEC EQ, V35, P496, DOI 10.1080/13102818.2021.1896384
   Liang JW, 2021, J CLEAN PROD, V278, DOI 10.1016/j.jclepro.2020.123896
   Liang JW, 2019, CHEM ENG J, V360, P15, DOI 10.1016/j.cej.2018.11.167
   Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201
   Lopez LR, 2021, ANNU REV MED, V72, P243, DOI 10.1146/annurev-med-080719-091604
   Mai WN, 2020, J WATER PROCESS ENG, V37, DOI 10.1016/j.jwpe.2020.101515
   Nagpal S, 2020, NUCLEIC ACIDS RES, V48, pW572, DOI 10.1093/nar/gkaa254
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Peng MF, 2020, GUT MICROBES, V11, P433, DOI 10.1080/19490976.2019.1638724
   Pleguezuelos-Manzano C, 2020, NATURE, V580, P269, DOI 10.1038/s41586-020-2080-8
   Qiao SC, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01982-6
   Rajamaki K, 2021, GASTROENTEROLOGY, V161, P592, DOI 10.1053/j.gastro.2021.04.042
   Rausch P, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0743-1
   Rubinstein MR, 2019, EMBO REP, V20, DOI 10.15252/embr.201847638
   Russo E, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02699
   Saito K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212406
   Santiago-Rodriguez TM, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111380
   Schmitt M, 2021, NAT REV IMMUNOL, V21, P653, DOI 10.1038/s41577-021-00534-x
   Sears CL, 2014, J CLIN INVEST, V124, P4166, DOI 10.1172/JCI72334
   Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71
   Shi XJ, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00203
   Song MY, 2020, GASTROENTEROLOGY, V158, P322, DOI 10.1053/j.gastro.2019.06.048
   Song M, 2019, CLIN GASTROENTEROL H, V17, P275, DOI 10.1016/j.cgh.2018.07.012
   Tett A, 2019, CELL HOST MICROBE, V26, P666, DOI 10.1016/j.chom.2019.08.018
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   VERHAAR BJH, 2020, EUR HEART J, V41, P4259, DOI [DOI 10.1093/EURHEARTJ/EHAA704, 10.1093/eurheartj/ehaa704]
   Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008
   Wang MG, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.594081
   Wang WL, 2015, WORLD J GASTROENTERO, V21, P803, DOI 10.3748/wjg.v21.i3.803
   Wassenaar TM, 2018, CRIT REV MICROBIOL, V44, P619, DOI 10.1080/1040841X.2018.1481013
   Wei YJ, 2020, ENVIRON POLLUT, V265, DOI 10.1016/j.envpol.2020.114843
   Wei YJ, 2019, APPL MICROBIOL BIOT, V103, P3727, DOI 10.1007/s00253-019-09720-3
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Xing CS, 2021, CELL HOST MICROBE, V29, P959, DOI 10.1016/j.chom.2021.03.016
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yamashita Y, 2017, J ORAL SCI, V59, P201, DOI 10.2334/josnusd.16-0856
   Zhang, 2020, DIX SEQ INTEGRATED P, DOI [10.1101/2020.05.11.089748, DOI 10.1101/2020.05.11.089748]
NR 77
TC 5
Z9 5
U1 8
U2 19
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-889X
J9 FRONT MOL BIOSCI
JI Front. Mol. Biosci.
PD JUL 9
PY 2021
VL 8
AR 703638
DI 10.3389/fmolb.2021.703638
PG 12
WC Biochemistry & Molecular Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology
GA TP1XQ
UT WOS:000677391300001
PM 34307461
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Beura, S
   Kundu, P
   Das, AK
   Ghosh, A
AF Beura, Satyajit
   Kundu, Pritam
   Das, Amit Kumar
   Ghosh, Amit
TI Metagenome-scale community metabolic modelling for understanding the
   role of gut microbiota in human health
SO COMPUTERS IN BIOLOGY AND MEDICINE
LA English
DT Article
DE Microbial communities; Human gut microbiota; Metabolic disorders;
   Systems biology; Community metabolic model; Metagenome-scale community
   metabolic&nbsp; model
ID FLUX BALANCE ANALYSIS; IN-VITRO; FUSOBACTERIUM-NUCLEATUM;
   PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; DIETARY PATTERNS;
   RECONSTRUCTION; ECOSYSTEM; INTEGRATION; CONSORTIA
AB Metabolic activities of the microbial population are important to maintain the balance of almost all the eco-systems on earth. In the human gut environment, these microbial communities play essential roles in digestion and help to maintain biochemical homeostasis by synthesizing several vital metabolic compounds. Imbalance in the microbial abundance and community structure in the human gut microbiota leads to different diseases and metabolic disorders. Studying the metabolic interplay between the microbial consortia within the host envi-ronment is the key to exploring the cause behind the development of various diseases condition. However, mapping the entire biochemical characteristic of human gut microbiota may not be feasible only through experimental approaches. Therefore, the advanced systems biology approach, i.e., metagenome-scale community metabolic modelling, is introduced for understanding the metabolic role and interaction pattern of the entire microbiome. This in silico method directly uses the metagenomic information to model the microbial commu-nities, which mimic the metabolic behavior of the human gut microbiome. This review discusses the recent development of metagenome-scale community metabolic model reconstruction tools and their application in studying the inter-link between the human gut microbiome and health. The application of the community metabolic models to study the metabolic profile of the human gut microbiome has also been investigated. Alteration of the metabolic fluxes associated with different biochemical activities in type 1 diabetics, type 2 diabetics, inflammatory bowel diseases (IBD), gouty arthritis, colorectal cancer (CRC), etc., has also been assessed with the metagenome-scale models. Thus, modelling the microbial communities combined with advanced experimental design may lead to novel therapeutic approaches like personalized microbiome model-ling for treating human disease.
C1 [Beura, Satyajit; Das, Amit Kumar] IIT Kharagpur, Dept Biotechnol, Kharagpur 721302, West Bengal, India.
   [Kundu, Pritam; Ghosh, Amit] IIT Kharagpur, Sch Sch Energy Sci & Engn, Kharagpur 721302, West Bengal, India.
   [Ghosh, Amit] IIT Kharagpur, PK Sinha Ctr Bioenergy & Renewables, Kharagpur 721302, West Bengal, India.
   [Ghosh, Amit] IIT Kharagpur, Sch Energy Sci & Engn, Sir JC Bose Lab Complex, Kharagpur 721302, India.
C3 Indian Institute of Technology System (IIT System); Indian Institute of
   Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT
   System); Indian Institute of Technology (IIT) - Kharagpur; Indian
   Institute of Technology System (IIT System); Indian Institute of
   Technology (IIT) - Kharagpur; Indian Institute of Technology System (IIT
   System); Indian Institute of Technology (IIT) - Kharagpur
RP Ghosh, A (corresponding author), IIT Kharagpur, Sch Energy Sci & Engn, Sir JC Bose Lab Complex, Kharagpur 721302, India.
EM amitghosh@iikgp.ac.in
OI Ghosh, Amit/0000-0003-3514-885X; KUNDU, PRITAM/0000-0001-6129-4506;
   Beura, Satyajit/0000-0002-8052-2962
FU Department of Science and Technology-GoI [CRG/2020/002080]; Department
   of Biotechnology-GoI [BT/PR37958/GET/119/297/2020]; Scheme for
   Pro-motion of Academic and Research Collaboration (SPARC); MHRD-GoI
   [SPARC/2018-2019/P265/SL]; Tata Consultancy Services (TCS)
FX Authors are thankful to the Department of Science and Technology-GoI
   (Grant No. CRG/2020/002080) , Department of Biotechnology-GoI (Grant No.
   BT/PR37958/GET/119/297/2020) , and Scheme for Pro-motion of Academic and
   Research Collaboration (SPARC) , MHRD-GoI (Grant No.
   SPARC/2018-2019/P265/SL) . S.B thanks the support from Prime Minister's
   Research Fellows (PMRF) Scheme for the fellowship. P. K appreciates the
   support from Tata Consultancy Services (TCS) for the research
   fellowship.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980
   Aite M, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006146
   Aminian-Dehkordi J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55041-w
   Arakawa K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-168
   Arkin AP, 2018, NAT BIOTECHNOL, V36, P566, DOI 10.1038/nbt.4163
   Arora T, 2021, FRONT ENDOCRINOL, V12, DOI 10.3389/fendo.2021.761834
   Baldini F, 2019, BIOINFORMATICS, V35, P2332, DOI 10.1093/bioinformatics/bty941
   Barthelmes J, 2007, NUCLEIC ACIDS RES, V35, pD511, DOI 10.1093/nar/gkl972
   Bauer E, 2018, NPJ SYST BIOL APPL, V4, DOI 10.1038/s41540-018-0063-2
   Bauer E, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005544
   Baxter NT, 2019, MBIO, V10, DOI [10.1128/mBio.02566-18, 10.1128/mbio.02566-18]
   Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082
   Boele J., 2012, BMC SYST BIOL, V6
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004
   Brooks SP, 1998, STAT COMPUT, V8, P319, DOI 10.1023/A:1008820505350
   Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072
   Brunner JD, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007786
   Budinich M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171744
   Buchel F, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-116
   Cai JY, 2020, BIOINFORMATICS, V36, P5649, DOI 10.1093/bioinformatics/btaa1014
   Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]
   Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caspi R, 2008, NUCLEIC ACIDS RES, V36, pD623, DOI [10.1093/nar/gkt1103, 10.1093/nar/gkm900]
   Chan SHJ, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005539
   Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107
   Charubin K, 2019, METAB ENG, V52, P9, DOI 10.1016/j.ymben.2018.10.006
   Chevrette MG, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00175-19
   Chowdhury S, 2020, CURR OPIN BIOTECH, V66, P267, DOI 10.1016/j.copbio.2020.08.017
   Chowdhury S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8020197
   Christensen BB, 2002, APPL ENVIRON MICROB, V68, P2495, DOI 10.1128/AEM.68.5.2495-2502.2002
   Colijn C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000489
   Cook DJ, 2017, WIRES SYST BIOL MED, V9, DOI 10.1002/wsbm.1393
   Cuevas DA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00907
   DeLeon S, 2014, INFECT IMMUN, V82, P4718, DOI 10.1128/IAI.02198-14
   Di Filippo M, 2022, PLOS COMPUT BIOL, V18, DOI 10.1371/journal.pcbi.1009337
   Dias O, 2015, NUCLEIC ACIDS RES, V43, P3899, DOI 10.1093/nar/gkv294
   Diener C, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00606-19
   Dubey GP, 2011, CELL, V144, P590, DOI 10.1016/j.cell.2011.01.015
   Faria J.P., 2016, CONSTRUCTING ANAL ME, P247, DOI [10.1007/8623_2016_215, DOI 10.1007/8623_2016_215]
   Feng XY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-94
   Filkins LM, 2015, J BACTERIOL, V197, P2252, DOI 10.1128/JB.00059-15
   Fu JB, 2022, NAT PROTOC, V17, P129, DOI 10.1038/s41596-021-00636-9
   Fu JB, 2021, BRIEF BIOINFORM, V22, DOI 10.1093/bib/bbab138
   Garcia-Jimenez B, 2021, COMPUT STRUCT BIOTEC, V19, P226, DOI 10.1016/j.csbj.2020.12.003
   Geng J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019336118
   Glont M, 2018, NUCLEIC ACIDS RES, V46, pD1248, DOI 10.1093/nar/gkx1023
   Gomez JA, 2018, METHODS MOL BIOL, V1716, P353, DOI 10.1007/978-1-4939-7528-0_16
   Goncalves E, 2013, MOL BIOSYST, V9, P1576, DOI 10.1039/c3mb25489e
   Granata I, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2685-9
   Granger BR, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004875
   Grosskopf T, 2016, BMC EVOL BIOL, V16, DOI 10.1186/s12862-016-0733-x
   Guo Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep20602
   Gutierrez N, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00185-19
   Hanemaaijer M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173183
   Harcombe WR, 2014, CELL REP, V7, P1104, DOI 10.1016/j.celrep.2014.03.070
   Harishankar MK, 2013, 3 BIOTECH, V3, P137, DOI 10.1007/s13205-012-0078-0
   Hastings J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00002
   Hays SG, 2015, CURR OPIN BIOTECH, V36, P40, DOI 10.1016/j.copbio.2015.08.008
   Heinken A, 2021, NPJ SYST BIOL APPL, V7, DOI 10.1038/s41540-021-00178-6
   Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370
   Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2
   Heirendt L, 2017, BIOINFORMATICS, V33, P1421, DOI 10.1093/bioinformatics/btw838
   Henry CS, 2016, J CELL PHYSIOL, V231, P2339, DOI 10.1002/jcp.25428
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Henson MA, 2021, ENG LIFE SCI, V21, P489, DOI 10.1002/elsc.202100003
   Hertel J, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1915673
   Islam MM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02412
   Jenior ML, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007099
   Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102
   Karlsen E, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2472-z
   Karp Peter D, 2002, Bioinformatics, V18 Suppl 1, pS225
   Kato S, 2005, APPL ENVIRON MICROB, V71, P7099, DOI 10.1128/AEM.71.11.7099-7106.2005
   Khandelwal RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064567
   Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105
   Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002
   Koch S, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006759
   Koh HWL, 2019, NPJ SYST BIOL APPL, V5, DOI 10.1038/s41540-019-0099-y
   Kong WT, 2018, NAT CHEM BIOL, V14, P821, DOI 10.1038/s41589-018-0091-7
   Koren O, 2012, CELL, V150, P470, DOI 10.1016/j.cell.2012.07.008
   Kosina SM, 2016, ACS SYNTH BIOL, V5, P569, DOI 10.1021/acssynbio.5b00236
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kumar M, 2019, NAT MICROBIOL, V4, P1253, DOI 10.1038/s41564-019-0491-9
   Kumar M, 2018, METAB ENG, V49, P128, DOI 10.1016/j.ymben.2018.07.018
   Lagier JC, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00136
   Lavelle A, 2020, NAT REV GASTRO HEPAT, V17, P223, DOI 10.1038/s41575-019-0258-z
   Lee KWK, 2014, ISME J, V8, P894, DOI 10.1038/ismej.2013.194
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Li B, 2017, NUCLEIC ACIDS RES, V45, pW162, DOI 10.1093/nar/gkx449
   Li FC, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbac040
   Li FC, 2020, J MOL BIOL, V432, P3411, DOI 10.1016/j.jmb.2020.01.027
   Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9
   Louca S, 2015, ELIFE, V4, DOI 10.7554/eLife.08208
   Lozano GL, 2019, MBIO, V10, DOI 10.1128/mBio.02846-18
   Lu HZ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11581-3
   Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Machado D, 2018, NUCLEIC ACIDS RES, V46, P7542, DOI 10.1093/nar/gky537
   Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   Mazumdar V, 2009, J BACTERIOL, V191, P74, DOI 10.1128/JB.01123-08
   McCarty NS, 2019, TRENDS BIOTECHNOL, V37, P181, DOI 10.1016/j.tibtech.2018.11.002
   Mehta RS, 2017, JAMA ONCOL, V3, P921, DOI 10.1001/jamaoncol.2016.6374
   Mendes-Soares H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1230-3
   Mgpipe, TOOLB INV MET DAT PE
   Miller LD, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-149
   Mintz-Oron S, 2012, P NATL ACAD SCI USA, V109, P339, DOI 10.1073/pnas.1100358109
   Montagud A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-156
   Mori H, 2018, BMC SYST BIOL, V12, DOI 10.1186/s12918-018-0545-2
   Nanda P, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008860
   Nanda P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73253-3
   Navid A, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-150
   Noronha A, 2019, NUCLEIC ACIDS RES, V47, pD614, DOI 10.1093/nar/gky992
   Norsigian CJ, 2020, NUCLEIC ACIDS RES, V48, pD402, DOI 10.1093/nar/gkz1054
   Notebaart RA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-296
   Noureldein MH, 2020, J MOL ENDOCRINOL, V64, P29, DOI 10.1530/JME-19-0132
   O'Brien EJ, 2015, CELL, V161, P971, DOI 10.1016/j.cell.2015.05.019
   Oberhardt MA, 2015, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00527
   Pacheco AR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07946-9
   Palsson BO, 2015, SYSTEMS BIOLOGY: CONSTRAINT-BASED RECONSTRUCTION AND ANALYSIS, P1, DOI 10.1017/CBO9781139854610
   Patra P, 2021, BIOTECHNOL ADV, V47, DOI 10.1016/j.biotechadv.2021.107695
   Peterson JR, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3219-8
   Pitkanen E, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003465
   Ponomarova O, 2017, CELL SYST, V5, P345, DOI 10.1016/j.cels.2017.09.002
   Poolman MG, 2006, IEE P SYST BIOL, V153, P375, DOI 10.1049/ip-syb:20060010
   Popp D, 2020, FRONT BIOENG BIOTECH, V8, DOI 10.3389/fbioe.2020.00574
   Pusa T, 2020, BIOINFORMATICS, V36, P514, DOI 10.1093/bioinformatics/btz584
   Ren DW, 2014, MICROB ECOL, V68, P146, DOI 10.1007/s00248-013-0315-z
   Richelle A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006867
   Roume H, 2015, NPJ BIOFILMS MICROBI, V1, DOI 10.1038/npjbiofilms.2015.7
   Sabra W, 2010, ENG LIFE SCI, V10, P407, DOI 10.1002/elsc.201000111
   Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011
   Sanchez BJ, 2015, INTEGR BIOL-UK, V7, P846, DOI 10.1039/c5ib00083a
   Schmidt BJ, 2013, BIOINFORMATICS, V29, P2900, DOI 10.1093/bioinformatics/btt493
   Schroeder WL, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65457-4
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Sgobba E, 2020, CURR OPIN BIOTECH, V62, P72, DOI 10.1016/j.copbio.2019.09.011
   Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138
   Sheth RU, 2016, TRENDS GENET, V32, P189, DOI 10.1016/j.tig.2016.01.005
   Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532
   Song HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112524
   Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846
   Subramanian I, 2020, BIOINFORM BIOL INSIG, V14, DOI 10.1177/1177932219899051
   Succurro A, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00230-18
   Sun Y, 2008, WOUND REPAIR REGEN, V16, P805, DOI 10.1111/j.1524-475X.2008.00434.x
   Swainston N, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-186
   Tang Jing, 2021, Brief Bioinform, V22, DOI 10.1093/bib/bbaa105
   Tang J, 2019, MOL CELL PROTEOMICS, V18, P1683, DOI 10.1074/mcp.RA118.001169
   Tang J, 2020, BRIEF BIOINFORM, V21, P621, DOI 10.1093/bib/bby127
   Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Colarusso AV, 2021, CURR OPIN SYST BIOL, V26, P46, DOI 10.1016/j.coisb.2021.04.001
   Venturelli OS, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178157
   Vijayakumar S, 2018, METHODS MOL BIOL, V1716, P389, DOI 10.1007/978-1-4939-7528-0_18
   Villa F, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01251
   Vital M, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00130-17
   Wang ZN, 2018, PROTEIN CELL, V9, P416, DOI 10.1007/s13238-018-0549-0
   Wiback SJ, 2004, J THEOR BIOL, V228, P437, DOI 10.1016/j.jtbi.2004.02.006
   Wintermute EH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.66
   Wolfe BE, 2014, CELL, V158, P422, DOI 10.1016/j.cell.2014.05.041
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Yang QX, 2021, J PROTEOMICS, V232, DOI 10.1016/j.jprot.2020.104023
   Yang QX, 2020, NUCLEIC ACIDS RES, V48, pW436, DOI 10.1093/nar/gkaa258
   Ye C, 2014, J BIOTECHNOL, V182, P61, DOI 10.1016/j.jbiotec.2014.04.027
   Yizhak K, 2010, BIOINFORMATICS, V26, pi255, DOI 10.1093/bioinformatics/btq183
   Zelezniak A, 2015, P NATL ACAD SCI USA, V112, pE7156, DOI 10.1073/pnas.1522642113
   Zhou K, 2015, NAT BIOTECHNOL, V33, P377, DOI 10.1038/nbt.3095
   Zhou ZW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00371
   Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849
   Zhuang K, 2012, BIOTECHNOL BIOENG, V109, P2475, DOI 10.1002/bit.24528
   Zhuang K, 2011, ISME J, V5, P305, DOI 10.1038/ismej.2010.117
   Zomorrodi AR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01407-5
   Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363
   Zomorrodi AR, 2014, ACS SYNTH BIOL, V3, P247, DOI 10.1021/sb4001307
   Zuniga C, 2019, NAT MICROBIOL, V4, P2184, DOI 10.1038/s41564-019-0567-6
   Zur H, 2010, BIOINFORMATICS, V26, P3140, DOI 10.1093/bioinformatics/btq602
   Zuroff TR, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-59
NR 181
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0010-4825
EI 1879-0534
J9 COMPUT BIOL MED
JI Comput. Biol. Med.
PD OCT
PY 2022
VL 149
AR 105997
DI 10.1016/j.compbiomed.2022.105997
PG 16
WC Biology; Computer Science, Interdisciplinary Applications; Engineering,
   Biomedical; Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Life Sciences & Biomedicine - Other Topics; Computer Science;
   Engineering; Mathematical & Computational Biology
GA 5B0UM
UT WOS:000863292100007
PM 36055158
DA 2022-11-22
ER

PT J
AU Arvelo, F
   Sojo, F
   Cotte, C
AF Arvelo, Francisco
   Sojo, Felipe
   Cotte, Carlos
TI Cancer and Microbiota
SO INVESTIGACION CLINICA
LA Spanish
DT Review
DE cancer; microbiota; dysbiosis; genotoxins; microbiome
ID ENTEROTOXIGENIC BACTEROIDES-FRAGILIS; SQUAMOUS-CELL CARCINOMA; HUMAN GUT
   MICROBIOME; DNA-DAMAGE RESPONSE; HELICOBACTER-PYLORI; ORAL MICROBIOME;
   BREAST-CANCER; LUNG-CANCER; BACTERIAL GENOTOXINS; GASTRIC-CANCER
AB The human body is continuously exposed to both fixed and transient microorganisms, as well as their toxic metabolites, which can lead to the appearance and progression of cancer at sites distant from the particular habitat of each microbe. Various scientific studies have made it possible to understand the close relationship that exists between the microbiome and cancer, since the components of the first, having the ability to migrate to different areas of the body, can contribute to the development of various chronic diseases. Metagenomics studies suggest that dysbiosis, in the commensal microbiota, is associated with inflammatory disorders and various types of cancer, which can occur due to their effects on metabolism, cell proliferation, and immunity. The microbiota can cause cancer when predisposing conditions exist, such as in the initial stage of tumor progression (initiation), genetic instability, susceptibility to host immune response, progression, and response to therapy. The closest relationship between the microbiome and cancer, is through the dysregulation of the immune system. In this work, we review the current evidence on the association between the microbiota and some types of cancer such as gastric, colorectal, prostate, ovarian, oral, lung and breast cancer.
C1 [Arvelo, Francisco; Sojo, Felipe] Fdn Inst Estudios Avanzados IDEA, Ctr Biociencias, Caracas, Venezuela.
   [Arvelo, Francisco; Sojo, Felipe; Cotte, Carlos] Univ Cent Venezuela, Inst Biol Expt, Lab Cult Tejidos & Biol Tumores, Caracas, Venezuela.
C3 University of Central Venezuela
RP Arvelo, F (corresponding author), Univ Cent Venezuela, Fdn Inst Estudios Avanzados IDEA, Caracas, Venezuela.; Arvelo, F (corresponding author), Univ Cent Venezuela, Inst Biol Expt, Fac Ciencias, Caracas, Venezuela.
EM franarvelo@yahoo.com
CR Adar SD, 2016, ANN EPIDEMIOL, V26, P355, DOI 10.1016/j.annepidem.2016.03.010
   Ahn J, 2012, CANCER CAUSE CONTROL, V23, P399, DOI 10.1007/s10552-011-9892-7
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Artis D, 2008, NAT REV IMMUNOL, V8, P411, DOI 10.1038/nri2316
   Arvelo F, 2016, ECANCERMEDICALSCIENC, V10, DOI 10.3332/ecancer.2016.617
   Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741
   Atanasova KR, 2014, MOL ORAL MICROBIOL, V29, P55, DOI 10.1111/omi.12047
   Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058
   Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331
   Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126
   Bai YQ, 2019, J CELL BIOCHEM, V120, P105, DOI 10.1002/jcb.27130
   Banerjee S, 2017, ONCOTARGET, V8, P36225, DOI 10.18632/oncotarget.16717
   Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302
   Beck JM, 2012, TRANSL RES, V160, P258, DOI 10.1016/j.trsl.2012.02.005
   Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011
   Bergounioux J, 2012, CELL HOST MICROBE, V11, P240, DOI 10.1016/j.chom.2012.01.013
   Bhatt AP, 2017, CA-CANCER J CLIN, V67, P327, DOI 10.3322/caac.21398
   Bingula R, 2017, J ONCOL, V2017, DOI 10.1155/2017/5035371
   Bowers LW, 2015, BREAST CANCER RES TR, V149, P49, DOI 10.1007/s10549-014-3223-0
   Bronte-Tinkew DM, 2009, CANCER RES, V69, P632, DOI 10.1158/0008-5472.CAN-08-1191
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Buerfent BC, 2015, IMMUNOLOGY, V145, P150, DOI 10.1111/imm.12435
   Cani PD, 2018, GUT, V67, P1716, DOI 10.1136/gutjnl-2018-316723
   Caputi V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061689
   Carrega P, 2014, J IMMUNOL, V192, P3805, DOI 10.4049/jimmunol.1301889
   Chan AA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28061
   Chaturvedi R, 2011, GASTROENTEROLOGY, V141, P1696, DOI 10.1053/j.gastro.2011.07.045
   Chen RR, 2017, EJSO-EUR J SURG ONC, V43, P2308, DOI 10.1016/j.ejso.2017.09.011
   Churchward CP, 2017, MBIO, V8, DOI 10.1128/mBio.00534-17
   Clarke TB, 2014, INFECT IMMUN, V82, P4596, DOI 10.1128/IAI.02212-14
   Cuevas-Ramos G, 2010, P NATL ACAD SCI USA, V107, P11537, DOI 10.1073/pnas.1001261107
   Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x
   Dai ZJ, 2019, INT J CANCER, V145, P2032, DOI 10.1002/ijc.32017
   Daniel SG, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00065-17
   Darmawan R, 2015, J BIOREMED BIODEGRAD, V6, P283, DOI [DOI 10.4172/2155-6199.1000283, 10.4172/2155-6199.1000283]
   Davidsson S, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0074-9
   de Pedro M, 2015, BREAST CANCER RES TR, V149, P525, DOI 10.1007/s10549-015-3267-9
   Dias-Jacome E, 2016, REV ESP ENFERM DIG, V108, P530, DOI 10.17235/reed.2016.4261/2016
   Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0
   Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07
   Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179
   Fabich AJ, 2008, INFECT IMMUN, V76, P1143, DOI 10.1128/IAI.01386-07
   Feng QQ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00151
   Feng Y, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5457-z
   Fernandez MF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081747
   Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253
   Flores R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039745
   FORSYTHE SJ, 1987, J GEN MICROBIOL, V133, P1845
   Frisan T, 2016, BBA-BIOMEMBRANES, V1858, P567, DOI 10.1016/j.bbamem.2015.08.016
   Fuhrman BJ, 2014, J CLIN ENDOCR METAB, V99, P4632, DOI 10.1210/jc.2014-2222
   Fujio-Vejar S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01221
   Galvao-Moreira LV, 2016, ORAL ONCOL, V53, P17, DOI 10.1016/j.oraloncology.2015.11.013
   Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023
   Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378
   Ghoi DS, 2020, CLIN TRANSL GASTROEN, V11
   Gholizadeh P, 2016, BIOMED PHARMACOTHER, V84, P552, DOI 10.1016/j.biopha.2016.09.082
   Goedert JJ, 2018, BRIT J CANCER, V118, P471, DOI 10.1038/bjc.2017.435
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Grasso F, 2015, BIOMOLECULES, V5, P1762, DOI 10.3390/biom5031762
   Greathouse KL, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1501-6
   Guerra L, 2011, FEBS J, V278, P4577, DOI 10.1111/j.1742-4658.2011.08125.x
   Hatakeyama M, 2017, P JPN ACAD B-PHYS, V93, P196, DOI 10.2183/pjab.93.013
   Hayes RB, 2018, JAMA ONCOL, V4, P358, DOI 10.1001/jamaoncol.2017.4777
   He Y, 2017, CRIT REV MICROBIOL, V43, P81, DOI [10.1080/1040841X.2016.1176988, 10.1080/1040841x.2016.1176988]
   Heijink IH, 2012, EUR RESPIR J, V39, P419, DOI 10.1183/09031936.00193810
   Hernandez-Ramirez RU, 2009, INT J CANCER, V125, P1424, DOI 10.1002/ijc.24454
   Hieken TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep30751
   Hosgood HD, 2014, ENVIRON MOL MUTAGEN, V55, P643, DOI 10.1002/em.21878
   Huang GZ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01054
   Huycke MM, 2001, MOL MICROBIOL, V42, P729, DOI 10.1046/j.1365-2958.2001.02638.x
   Inaba H, 2014, CELL MICROBIOL, V16, P131, DOI 10.1111/cmi.12211
   Ito N, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113699
   Jena PK, 2018, J NUTR BIOCHEM, V57, P246, DOI 10.1016/j.jnutbio.2018.04.007
   Junier P, 2010, APPL MICROBIOL BIOT, V85, P425, DOI 10.1007/s00253-009-2228-9
   Kang J., 2017, New Microbes and New Infections, V19, P34, DOI 10.1016/j.nmni.2017.05.012
   Karpinski TM, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010020
   Kline KA, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.UTI-0012-2012
   Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412
   Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107
   Koroleva EA, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/484853
   Kosaka A, 2012, INT IMMUNOPHARMACOL, V14, P729, DOI 10.1016/j.intimp.2012.10.007
   Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345
   Landskron G, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/149185
   Lane ER, 2017, J INFLAMM RES, V10, P63, DOI 10.2147/JIR.S116088
   Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354
   Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760
   Lee JJ, 2012, KOREAN J PARASITOL, V50, P157, DOI 10.3347/kjp.2012.50.2.157
   Lee SH, 2016, LUNG CANCER, V102, P89, DOI 10.1016/j.lungcan.2016.10.016
   Lee WH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16418-x
   Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982
   Lertpiriyapong K, 2014, GUT, V63, P54, DOI 10.1136/gutjnl-2013-305178
   Liu F, 2019, INT J BIOL SCI, V15, P2381, DOI 10.7150/ijbs.35980
   Liu HX, 2018, INT J CANCER, V142, P769, DOI 10.1002/ijc.31098
   Otero LL, 2014, BEST PRACT RES CL GA, V28, P1017, DOI 10.1016/j.bpg.2014.09.003
   Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20
   Ma XW, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01664
   MACGREGOR I D M, 1989, Clinical Preventive Dentistry, V11, P3
   Mager DL, 2005, J TRANSL MED, V3, DOI 10.1186/1479-5876-3-27
   Mao S, 2007, CELL MICROBIOL, V9, P1997, DOI 10.1111/j.1462-5822.2007.00931.x
   Martin CR, 2018, CELL MOL GASTROENTER, V6, P133, DOI 10.1016/j.jcmgh.2018.04.003
   Marttila E, 2013, MOL ORAL MICROBIOL, V28, P281, DOI 10.1111/omi.12024
   Masood Umair, 2016, Case Rep Gastroenterol, V10, P769, DOI 10.1159/000452757
   Massari F, 2019, CANCERS, V11, DOI 10.3390/cancers11040459
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   Miftahussurur M, 2017, EXPERT REV MOL MED, V19, DOI 10.1017/erm.2017.4
   Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149
   Moss SF, 2017, CELL MOL GASTROENTER, V3, P183, DOI 10.1016/j.jcmgh.2016.12.001
   Nagy KN, 1998, ORAL ONCOL, V34, P304, DOI 10.1016/S1368-8375(98)00008-6
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Pabst O, 2012, NAT REV IMMUNOL, V12, P821, DOI 10.1038/nri3322
   Panebianco C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0483-7
   Pauly JL, 2011, J ONCOL, V2011, DOI 10.1155/2011/819129
   Pavlova SI, 2013, MICROBIOL-SGM, V159, P1437, DOI 10.1099/mic.0.066258-0
   Perera M, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.32762
   Perrone MG, 2020, CURR MED CHEM, V27, P5675, DOI 10.2174/0929867326666190816232330
   Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013
   Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003
   Purcell RV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11237-6
   Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09
   Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294
   Rea Domenica, 2018, Oncotarget, V9, P17915, DOI 10.18632/oncotarget.24681
   Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987
   Robles AI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001016
   Rosa MI, 2013, INT J GYNECOL CANCER, V23, P437, DOI 10.1097/IGC.0b013e318280f3e0
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Salim SY, 2011, INFLAMM BOWEL DIS, V17, P362, DOI 10.1002/ibd.21403
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Schwitalla S, 2013, CANCER CELL, V23, P93, DOI 10.1016/j.ccr.2012.11.014
   Sears CL, 2009, CLIN MICROBIOL REV, V22, P349, DOI 10.1128/CMR.00053-08
   Selber-Hnatiw S, 2017, FRONT MICROBIOL, V8, DOI [10.3389/fmicb.2017.017E5, 10.3389/fmicb.2017.01265]
   Shiels MS, 2011, CANCER EPIDEM BIOMAR, V20, P672, DOI 10.1158/1055-9965.EPI-10-1166
   Shrestha E, 2018, J UROLOGY, V199, P161, DOI 10.1016/j.juro.2017.08.001
   Siegel R. L., 2020, J CLIN, V70, P7, DOI DOI 10.3322/CAAC.21551
   Simons BW, 2015, J PATHOL, V235, P478, DOI 10.1002/path.4472
   Sobhani I, 2019, P NATL ACAD SCI USA, V116, P24285, DOI 10.1073/pnas.1912129116
   Souto R, 2014, BRAZ J MICROBIOL, V45, P495, DOI 10.1590/S1517-83822014000200017
   Spieck E, 2011, METHOD ENZYMOL, V486, P109, DOI [10.1016/B978-0-12-381294-0.00005-5, 10.1016/S0076-6879(11)86005-2]
   Szkaradkiewicz AK, 2013, J BIOL EARTH SCI, V3, pM14
   Thompson KJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188873
   To SQ, 2015, J STEROID BIOCHEM, V145, P179, DOI 10.1016/j.jsbmb.2014.05.004
   Toller IM, 2011, P NATL ACAD SCI USA, V108, P14944, DOI 10.1073/pnas.1100959108
   Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907
   Urbaniak C, 2016, APPL ENVIRON MICROB, V82, P5039, DOI 10.1128/AEM.01235-16
   Urbaniak C, 2014, APPL ENVIRON MICROB, V80, P3007, DOI 10.1128/AEM.00242-14
   Vacante M, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8110489
   Valenzuela MA, 2015, WORLD J GASTROENTERO, V21, P12742, DOI 10.3748/wjg.v21.i45.12742
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Wada Y, 2018, FEBS OPEN BIO, V8, P671, DOI 10.1002/2211-5463.12402
   Wang LL, 2014, WORLD J GASTROENTERO, V20, P4948, DOI 10.3748/wjg.v20.i17.4948
   Williams GD, 2015, J CLIN MICROBIOL, V53, P3077, DOI 10.1128/JCM.00438-15
   Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10
   Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022
   Wu J, 2016, ISME J, V10, P2435, DOI 10.1038/ismej.2016.37
   Wu SG, 2003, GASTROENTEROLOGY, V124, P392, DOI 10.1053/gast.2003.50047
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744
   Yan XM, 2015, AM J CANCER RES, V5, P3111
   Yang JQ, 2017, BREAST CANCER-TOKYO, V24, P220, DOI 10.1007/s12282-016-0734-z
   Yang QX, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/2082840
   Yao L, 2010, MOL ORAL MICROBIOL, V25, P89, DOI 10.1111/j.2041-1014.2010.00569.x
   Yao Yixin, 2014, J Carcinog Mutagen, V5
   Yilmaz O, 2004, INFECT IMMUN, V72, P3743, DOI 10.1128/IAI.72.7.3743-3751.2004
   Yu HN, 2015, ARCH MED SCI, V11, P385, DOI 10.5114/aoms.2015.50970
   Zhang H, 2018, AM J CANCER RES, V8, P1157
   Zhang WQ, 2018, AM J TRANSL RES, V10, P3171
NR 165
TC 0
Z9 0
U1 3
U2 12
PU INST INVESTIGACION CLINICA
PI MARACAIBO
PA APARTADO 23, MARACAIBO 4001-A, VENEZUELA
SN 0535-5133
EI 2477-9393
J9 INVEST CLIN
JI Invest. Clin.
PD DEC
PY 2021
VL 62
IS 4
BP 407
EP 440
DI 10.22209/IC.v62n4a09
PG 34
WC Medicine, Research & Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Research & Experimental Medicine
GA XK9IL
UT WOS:000727769600010
OA hybrid
DA 2022-11-22
ER

PT J
AU Amirian, ES
   Petrosino, JF
   Ajami, NJ
   Liu, YH
   Mims, MP
   Scheurer, ME
AF Amirian, E. Susan
   Petrosino, Joseph F.
   Ajami, Nadim J.
   Liu, Yanhong
   Mims, Martha P.
   Scheurer, Michael E.
TI Potential role of gastrointestinal microbiota composition in prostate
   cancer risk
SO INFECTIOUS AGENTS AND CANCER
LA English
DT Article
DE Human microbiome; Metagenome; Prostate cancer; Metabolic process
ID FOOD-BORNE CARCINOGEN; GUT MICROBIOTA; DAIRY-PRODUCTS;
   LACTOBACILLUS-ACIDOPHILUS; COLORECTAL-CANCER; MEAT INTAKE; LIFE-STYLE;
   RED MEAT; METABOLISM; CALCIUM
AB Background: Among men in the U. S., prostate cancer is the most common cancer and the second leading cause of cancer death. Despite its prevalence, there are few established risk factors for prostate cancer. Some studies have found that intake of certain foods/nutrients may be associated with prostate cancer risk, but few have accounted for how intake and metabolic factors may interact to influence bioavailable nutrient levels and subsequent disease risk.
   Presentation of the hypothesis: The composition of the gastrointestinal (GI) microbiome may influence metabolism of dietary compounds and nutrients (e. g., plant phenols, calcium, choline) that may be relevant to prostate cancer risk. We, therefore, propose the hypothesis that GI microbiota may have a markedly different composition among individuals with higher prostate cancer risk. These individuals could have microbial profiles that are conducive to intestinal inflammation and/or are less favorable for the metabolism and uptake of chemopreventive agents.
   Testing the hypothesis: Because very little preliminary data exist on this potential association, a case-control study may provide valuable information on this topic. Such a study could evaluate whether the GI microbial profile is markedly different between three groups of individuals: healthy men, those with latent prostate cancer, and those with invasive prostate cancer. Any findings could then be validated in a larger study, designed to collect a series of specimens over time.
   Implications of the hypothesis: Given the plethora of information emerging from the Human Microbiome Project, this is an opportune time to explore associations between the microbiome and complex human diseases. Identification of profiles that alter the host's risk for disease may clarify inconsistencies in the literature on dietary factors and cancer risk, and could provide valuable targets for novel cancer prevention strategies.
C1 [Amirian, E. Susan; Liu, Yanhong; Scheurer, Michael E.] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA.
   [Amirian, E. Susan; Liu, Yanhong; Scheurer, Michael E.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Petrosino, Joseph F.; Ajami, Nadim J.] Baylor Coll Med, Dept Molcular Virol & Microbiol, Houston, TX 77030 USA.
   [Petrosino, Joseph F.; Ajami, Nadim J.] Baylor Coll Med, Alkek Ctr Metagen & Microbiome Res, Houston, TX 77030 USA.
   [Mims, Martha P.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
C3 Baylor College of Medicine; Baylor College of Medicine; Baylor College
   of Medicine; Baylor College of Medicine; Baylor College of Medicine
RP Scheurer, ME (corresponding author), Baylor Coll Med, Dan L Duncan Canc Ctr, 1 Baylor Plaza MS BCM305, Houston, TX 77030 USA.
EM scheurer@bcm.edu
RI Petrosino, Joseph F./AAF-1621-2019; liu, yan/HCI-5542-2022
OI Scheurer, Michael/0000-0002-8379-6088
CR Akaza H, 2012, CANCER SCI, V103, P969, DOI 10.1111/j.1349-7006.2012.02257.x
   Alexander DD, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-50
   Amirian ES, 2011, PROSTATE, V71, P1382, DOI 10.1002/pros.21354
   Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08
   Aroniadis OC, 2013, CURR OPIN GASTROEN, V29, P79, DOI 10.1097/MOG.0b013e32835a4b3e
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Astorg P, 2004, CANCER CAUSE CONTROL, V15, P367, DOI 10.1023/B:CACO.0000027498.94238.a3
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Brenner AV, 2002, INT J CANCER, V99, P252, DOI 10.1002/ijc.10320
   Carruba G, 2007, J CELL BIOCHEM, V102, P899, DOI 10.1002/jcb.21529
   Cavalieri E, 2013, MOL ASPECTS MED, DOI [10.1016/j.mam.2013.08.002, DOI 10.1016/J.MAM.2013.08.002.[]
   Chan JM, 2001, EPIDEMIOL REV, V23, P87, DOI 10.1093/oxfordjournals.epirev.a000800
   Chan JM, 2001, AM J CLIN NUTR, V74, P549
   Commane D, 2005, MUTAT RES-FUND MOL M, V591, P276, DOI 10.1016/j.mrfmmm.2005.02.027
   Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075
   Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003
   Dennis LK, 2004, AM J EPIDEMIOL, V160, P436, DOI 10.1093/aje/kwh243
   Dutton RJ, 2012, CURR OPIN CLIN NUTR, V15, P448, DOI 10.1097/MCO.0b013e3283561133
   Flores R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-253
   Gao X, 2005, JNCI-J NATL CANCER I, V97, P1768, DOI 10.1093/jnci/dji402
   Goodman AL, 2010, CELL METAB, V12, P111, DOI 10.1016/j.cmet.2010.07.001
   Graessler J, 2012, PHARMACOGENOMICS J, DOI [10.1038/tpj.2012.43, DOI 10.1038/TPJ.2012.43.[]
   Haiser HJ, 2013, PHARMACOL RES, V69, P21, DOI 10.1016/j.phrs.2012.07.009
   Humblot C, 2005, APPL ENVIRON MICROB, V71, P5116, DOI 10.1128/AEM.71.9.5116-5123.2005
   Humblot C, 2007, CARCINOGENESIS, V28, P2419, DOI 10.1093/carcin/bgm170
   Hurst R, 2012, AM J CLIN NUTR, V96, P111, DOI 10.3945/ajcn.111.033373
   Huse SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034242
   Iebba V, 2012, INT J IMMUNOPATH PH, V25, P823, DOI 10.1177/039463201202500401
   Joshi AD, 2012, CARCINOGENESIS, V33, P2108, DOI 10.1093/carcin/bgs242
   Kasaikina MV, 2011, FASEB J, V25, P2492, DOI 10.1096/fj.11-181990
   Key TJ, 2007, AM J CLIN NUTR, V86, P672, DOI 10.1093/ajcn/86.3.672
   Khan AA, 1826, BIOCHIM BIOPHYS ACTA, V2012, P331
   Lampe JW, 2011, J AM COLL NUTR, V30, p464S, DOI 10.1080/07315724.2011.10719991
   Li K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032118
   Macdonald RS, 2012, J AGR FOOD CHEM
   Major JM, 2011, CANCER CAUSE CONTROL, V22, P1691, DOI 10.1007/s10552-011-9845-1
   Masood MI, 2011, CRIT REV MICROBIOL, V37, P91, DOI 10.3109/1040841X.2010.536522
   Montague JA, 2012, CANCER CAUSE CONTROL, V23, P1635, DOI 10.1007/s10552-012-0041-8
   MONTES RG, 1995, J DAIRY SCI, V78, P1657, DOI 10.3168/jds.S0022-0302(95)76790-X
   Morgan XC, 2013, TRENDS GENET, V29, P51, DOI 10.1016/j.tig.2012.09.005
   Musso G, 2011, ANNU REV MED, V62, P361, DOI 10.1146/annurev-med-012510-175505
   Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556
   Namasivayam N, 2011, ANN NY ACAD SCI, V1215, P60, DOI 10.1111/j.1749-6632.2010.05873.x
   Newmark HL, 2010, NUTR CANCER, V62, P297, DOI 10.1080/01635580903407221
   Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182
   Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031
   Ozten-Kandas Nur, 2011, J Carcinog, V10, P27, DOI 10.4103/1477-3163.90438
   Paasche S, 2013, JAAPA-J AM ACAD PHYS, V26, P46, DOI 10.1097/01.JAA.0000432570.98817.16
   Page WF, 1997, PROSTATE, V33, P240
   Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003
   Plowright RK, 2008, FRONT ECOL ENVIRON, V6, P420, DOI 10.1890/070086
   Punnen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027711
   Rafii F, 2007, COMPARATIVE MED, V57, P282
   Richman EL, 2012, AM J CLIN NUTR, V96, P855, DOI 10.3945/ajcn.112.039784
   Richman EL, 2011, CANCER PREV RES, V4, P2110, DOI 10.1158/1940-6207.CAPR-11-0354
   ROWLAND IR, 1980, ARCH ENVIRON HEALTH, V35, P155, DOI 10.1080/00039896.1980.10667485
   Russell SL, 2012, CURR OPIN GASTROEN, V28, P563, DOI 10.1097/MOG.0b013e3283573017
   Russell W, 2011, P NUTR SOC, V70, P389, DOI 10.1017/S0029665111000152
   Saad R, 2012, GUT PATHOG, V4, DOI 10.1186/1757-4749-4-16
   Sala-Vila A, 2011, CRIT REV FOOD SCI, V51, P855, DOI 10.1080/10408398.2010.483527
   Sanders ME, 2001, J DAIRY SCI, V84, P319, DOI 10.3168/jds.S0022-0302(01)74481-5
   Schwartz GG, 2012, CANCER EPIDEM BIOMAR, V21, P1768, DOI 10.1158/1055-9965.EPI-12-0585
   Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Sonn GA, 2005, PROSTATE CANCER P D, V8, P304, DOI 10.1038/sj.pcan.4500825
   Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170
   Teodoro AJ, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-36
   Tilg H, 2010, J CLIN GASTROENTEROL, V44, pS16, DOI 10.1097/MCG.0b013e3181dd8b64
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Travis RC, 2013, INT J CANCER, V132, P1901, DOI 10.1002/ijc.27836
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Vindigni SM, 2013, EXPERT REV GASTROENT, V7, P615, DOI 10.1586/17474124.2013.832501
   Wei MY, 2012, J ONCOL, V2012, DOI 10.1155/2012/271063
   Wilson KM, 2012, ASIAN J ANDROL, V14, P365, DOI 10.1038/aja.2011.142
   Wu KN, 2004, CANCER EPIDEM BIOMAR, V13, P260, DOI 10.1158/1055-9965.EPI-03-0012
   Xie B, 2012, ASIAN PAC J CANCER P, V13, P4677, DOI 10.7314/APJCP.2012.13.9.4677
NR 76
TC 33
Z9 37
U1 0
U2 39
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1750-9378
J9 INFECT AGENTS CANCER
JI Infect. Agents Cancer
PD NOV 4
PY 2013
VL 8
AR 42
DI 10.1186/1750-9378-8-42
PG 7
WC Oncology; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Immunology
GA 281HG
UT WOS:000329090100001
PM 24180596
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Wirbel, J
   Pyl, PT
   Kartal, E
   Zych, K
   Kashani, A
   Milanese, A
   Fleck, JS
   Voigt, AY
   Palleja, A
   Ponnudurai, R
   Sunagawa, S
   Coelho, LP
   Schrotz-King, P
   Vogtmann, E
   Habermann, N
   Nimeus, E
   Thomas, AM
   Manghi, P
   Gandini, S
   Serrano, D
   Mizutani, S
   Shiroma, H
   Shiba, S
   Shibata, T
   Yachida, S
   Yamada, T
   Waldron, L
   Naccarati, A
   Segata, N
   Sinha, R
   Ulrich, CM
   Brenner, H
   Arumugam, M
   Bork, P
   Zeller, G
AF Wirbel, Jakob
   Pyl, Paul Theodor
   Kartal, Ece
   Zych, Konrad
   Kashani, Alireza
   Milanese, Alessio
   Fleck, Jonas S.
   Voigt, Anita Y.
   Palleja, Albert
   Ponnudurai, Ruby
   Sunagawa, Shinichi
   Coelho, Luis Pedro
   Schrotz-King, Petra
   Vogtmann, Emily
   Habermann, Nina
   Nimeus, Emma
   Thomas, Andrew M.
   Manghi, Paolo
   Gandini, Sara
   Serrano, Davide
   Mizutani, Sayaka
   Shiroma, Hirotsugu
   Shiba, Satoshi
   Shibata, Tatsuhiro
   Yachida, Shinichi
   Yamada, Takuji
   Waldron, Levi
   Naccarati, Alessio
   Segata, Nicola
   Sinha, Rashmi
   Ulrich, Cornelia M.
   Brenner, Hermann
   Arumugam, Manimozhiyan
   Bork, Peer
   Zeller, Georg
TI Meta-analysis of fecal metagenomes reveals global microbial signatures
   that are specific for colorectal cancer
SO NATURE MEDICINE
LA English
DT Article
ID GUT METAGENOME; COLON; ASSOCIATION; TUMORIGENESIS; METABOLOMICS;
   INFORMATION; DISCOVERY; SELECTION; ALIGNMENT; ACCURATE
AB Association studies have linked microbiome alterations with many human diseases. However, they have not always reported consistent results, thereby necessitating cross-study comparisons. Here, a meta-analysis of eight geographically and technically diverse fecal shotgun metagenomic studies of colorectal cancer (CRC, n = 768), which was controlled for several confounders, identified a core set of 29 species significantly enriched in CRC metagenomes (false discovery rate (FDR) <1 x 10(-5)). CRC signatures derived from single studies maintained their accuracy in other studies. By training on multiple studies, we improved detection accuracy and disease specificity for CRC. Functional analysis of CRC metagenomes revealed enriched protein and mucin catabolism genes and depleted carbohydrate degradation genes. Moreover, we inferred elevated production of secondary bile acids from CRC metagenomes, suggesting a metabolic link between cancer-associated gut microbes and a fat-and meat-rich diet. Through extensive validations, this meta-analysis firmly establishes globally generalizable, predictive taxonomic and functional microbiome CRC signatures as a basis for future diagnostics.
C1 [Wirbel, Jakob; Kartal, Ece; Zych, Konrad; Milanese, Alessio; Fleck, Jonas S.; Voigt, Anita Y.; Ponnudurai, Ruby; Sunagawa, Shinichi; Coelho, Luis Pedro; Bork, Peer; Zeller, Georg] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.
   [Pyl, Paul Theodor; Kashani, Alireza; Palleja, Albert; Arumugam, Manimozhiyan] Univ Copenhagen, Fac Hlth & Med, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.
   [Pyl, Paul Theodor; Nimeus, Emma] Lund Univ, Dept Clin Sci Lund, Fac Med, Div Surg Oncol & Pathol, Lund, Sweden.
   [Kartal, Ece; Bork, Peer] Mol Med Partnership Unit, Heidelberg, Germany.
   [Voigt, Anita Y.] Jackson Lab Genom Med, Farmington, CT USA.
   [Sunagawa, Shinichi] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.
   [Schrotz-King, Petra; Brenner, Hermann] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany.
   [Schrotz-King, Petra; Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany.
   [Vogtmann, Emily; Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.
   [Habermann, Nina] European Mol Biol Lab, Genome Biol Unit, Heidelberg, Germany.
   [Nimeus, Emma] Skane Univ Hosp, Dept Clin Sci Lund, Fac Med, Div Surg, Lund, Sweden.
   [Thomas, Andrew M.; Manghi, Paolo; Segata, Nicola] Univ Trento, Dept CIBIO, Trento, Italy.
   [Thomas, Andrew M.] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
   [Gandini, Sara; Serrano, Davide] European Inst Oncol IRCCS, IEO, Milan, Italy.
   [Mizutani, Sayaka; Shiroma, Hirotsugu; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.
   [Mizutani, Sayaka] Japan Soc Promot Sci, Tokyo, Japan.
   [Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan.
   [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Lab Mol Med, Human Genome Ctr, Tokyo, Japan.
   [Yachida, Shinichi] Osaka Univ, Fac Med, Grad Sch Med, Dept Canc Genome Informat, Osaka, Japan.
   [Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.
   [Waldron, Levi] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.
   [Waldron, Levi] CUNY, Inst Implementat Sci Populat Hlth, New York, NY 10021 USA.
   [Naccarati, Alessio] Italian Inst Genom Med, Turin, Italy.
   [Naccarati, Alessio] Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic.
   [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.
   [Ulrich, Cornelia M.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA.
   [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany.
   [Arumugam, Manimozhiyan] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.
   [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Bork, Peer] Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany.
   [Coelho, Luis Pedro] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China.
C3 European Molecular Biology Laboratory (EMBL); Novo Nordisk Foundation;
   University of Copenhagen; Lund University; Jackson Laboratory; Swiss
   Federal Institutes of Technology Domain; ETH Zurich; Helmholtz
   Association; German Cancer Research Center (DKFZ); Ruprecht Karls
   University Heidelberg; Helmholtz Association; German Cancer Research
   Center (DKFZ); National Institutes of Health (NIH) - USA; NIH National
   Cancer Institute (NCI); European Molecular Biology Laboratory (EMBL);
   Lund University; Skane University Hospital; University of Trento;
   Universidade de Sao Paulo; IRCCS European Institute of Oncology (IEO);
   Tokyo Institute of Technology; Japan Society for the Promotion of
   Science; National Cancer Center - Japan; University of Tokyo; Osaka
   University; Japan Science & Technology Agency (JST); City University of
   New York (CUNY) System; City University of New York (CUNY) System;
   Italian Institute for Genomic Medicine (IIGM); Czech Academy of
   Sciences; Huntsman Cancer Institute; Utah System of Higher Education;
   University of Utah; Utah System of Higher Education; University of Utah;
   Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz
   Association; German Cancer Research Center (DKFZ); University of
   Southern Denmark; Helmholtz Association; Max Delbruck Center for
   Molecular Medicine; University of Wurzburg; Fudan University
RP Bork, P; Zeller, G (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.; Arumugam, M (corresponding author), Univ Copenhagen, Fac Hlth & Med, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.; Bork, P (corresponding author), Mol Med Partnership Unit, Heidelberg, Germany.; Arumugam, M (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.; Bork, P (corresponding author), Max Delbruck Ctr Mol Med, Berlin, Germany.; Bork, P (corresponding author), Univ Wurzburg, Dept Bioinformat, Bioctr, Wurzburg, Germany.
EM arumugam@sund.ku.dk; bork@embl.de; zeller@embl.de
RI Sunagawa, Shinichi/Q-5950-2019; Arumugam, Manimozhiyan/E-1211-2011;
   Waldron, Levi/H-2967-2019; Vogtmann, Emily/O-9125-2017; Coelho, Luis
   Pedro/D-1260-2009; Brenner, Hermann/B-4627-2017; Shibata,
   Tatsuhiro/AAO-1278-2021; Bork, Peer/F-1813-2013; shiba,
   satoshi/AAL-4953-2021; gandini, sara/J-4916-2018; Shibata,
   Tatsuhiro/ABA-8234-2020; Arumugam, Manimozhiyan/AAJ-2394-2020; Segata,
   Nicola/AAB-2980-2019; Brenner, Hermann/ABE-6383-2020; Shiba,
   Satoshi/AAJ-2157-2021; Pyl, Paul Theodor/K-5034-2015; Zeller,
   Georg/M-6484-2013
OI Sunagawa, Shinichi/0000-0003-3065-0314; Arumugam,
   Manimozhiyan/0000-0002-0886-9101; Waldron, Levi/0000-0003-2725-0694;
   Vogtmann, Emily/0000-0003-1355-5593; Coelho, Luis
   Pedro/0000-0002-9280-7885; Brenner, Hermann/0000-0002-6129-1572; Bork,
   Peer/0000-0002-2627-833X; gandini, sara/0000-0002-1348-4548; Arumugam,
   Manimozhiyan/0000-0002-0886-9101; Brenner, Hermann/0000-0002-6129-1572;
   Shiba, Satoshi/0000-0001-5159-5719; Manghi, Paolo/0000-0003-0846-6529;
   Kartal, Ece/0000-0002-7720-455X; Serrano, Davide/0000-0002-2945-4108;
   Palleja, Albert/0000-0001-5388-4063; Thomas, Andrew
   Maltez/0000-0001-5789-3354; Milanese, Alessio/0000-0002-7050-2239; Pyl,
   Paul Theodor/0000-0002-7651-883X; Wirbel, Jakob/0000-0002-4073-3562;
   Naccarati, Alessio/0000-0001-5774-0905; Nimeus,
   Emma/0000-0003-0262-9083; Zeller, Georg/0000-0003-1429-7485; Fleck,
   Jonas Simon/0000-0002-4686-7254
FU EMBL; German Cancer Research Center; Huntsman Cancer Foundation;
   Intramural Research Program of the National Cancer Institute; ETH
   Zurich; European Research Council [ERC-2010-AdG_20100317,
   ERC-AdG-669830, ERC-2016-STG-716575]; Novo Nordisk Foundation
   [NNF10CC1016515]; Danish Diabetes Academy - Novo Nordisk Foundation;
   TARGET Research Initiative (Danish Strategic Research Council)
   [0603-00484B]; Matthias-Lackas Foundation; National Cancer Institute
   [R01 CA189184, R01 CA207371, U01 CA206110, P30 CA042014]; Federal
   Ministry of Education and Research (BMBF) [031A537B, 01KT1503]; Helmut
   Horten Foundation; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   [16/23527-2]; Lega Italiana per La Lotta contro i Tumori; National
   Cancer Center Research and Development Fund [25-A-4, 28-A-4, 29-A-6];
   Practical Research Project for Rare/Intractable Diseases from the Japan
   Agency for Medical Research and Development [JP18ek0109187]; Japan
   Science and Technology Agency-PRESTO [JPMJPR1507]; Japan Society for the
   Promotion of Science KAKENHI [16J10135, 142558, 221S0002]; Joint
   Research Project of the Institute of Medical Science, University of
   Tokyo; Takeda Science Foundation; Suzuken Memorial Foundation; NATIONAL
   CANCER INSTITUTE [U01CA206110, ZIACP010198, R01CA207371, P30CA042014]
   Funding Source: NIH RePORTER
FX We are thankful to members of the Zeller, Bork, and Arumugam groups for
   inspiring discussions. Additionally, we thank Y.P. Yuan and the EMBL
   Information Technology Core Facility for support with high-performance
   computing, and the EMBL Genomics Core Facility for their sequencing
   support. We are also grateful for the advice provided by B. Klaus, EMBL
   Centre for Statistical Data Analysis. We acknowledge funding from EMBL,
   the German Cancer Research Center, the Huntsman Cancer Foundation, the
   Intramural Research Program of the National Cancer Institute, ETH
   Zurich, and the following external sources: the European Research
   Council (CancerBiome grant no. ERC-2010-AdG_20100317 to P.B., Microbios
   grant no. ERC-AdG-669830 to P.B., and Meta-PG grant no.
   ERC-2016-STG-716575 to N.S.); the Novo Nordisk Foundation (grant no.
   NNF10CC1016515 to M.A.); the Danish Diabetes Academy supported by the
   Novo Nordisk Foundation and TARGET Research Initiative (Danish Strategic
   Research Council grant no. 0603-00484B to M.A.); the Matthias-Lackas
   Foundation (to C.M.U.); the National Cancer Institute (grant nos. R01
   CA189184, R01 CA207371, U01 CA206110, and P30 CA042014 to C.M.U.); the
   Federal Ministry of Education and Research (BMBF; the de. NBI network
   no. 031A537B to P.B. and the ERA-NET TRANSCAN project no. 01KT1503 to
   C.M.U.); the Helmut Horten Foundation (to S. Sunagawa); and the Fundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (grant no. 16/23527-2 to
   A.M.T.). For the Italy validation cohorts, funding was provided by the
   Lega Italiana per La Lotta contro i Tumori. For the Japan validation
   cohort, funding was provided to T.Y. and S.Y. by the National Cancer
   Center Research and Development Fund (grant nos. 25-A-4,28-A-4, and
   29-A-6); Practical Research Project for Rare/Intractable Diseases from
   the Japan Agency for Medical Research and Development (grant no.
   JP18ek0109187); Japan Science and Technology Agency-PRESTO (grant no.
   JPMJPR1507); Japan Society for the Promotion of Science KAKENHI (grant
   nos. 16J10135, 142558, and 221S0002); Joint Research Project of the
   Institute of Medical Science, University of Tokyo; and the Takeda
   Science and Suzuken Memorial Foundations.
CR Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   [Anonymous], 2018, DIET NUTR PHYS ACT C
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   Aykan Nuri Faruk, 2015, Oncol Rev, V9, P288, DOI 10.4081/oncol.2015.288
   Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bohm J, 2017, SURGERY, V161, P808, DOI 10.1016/j.surg.2016.08.025
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Costea PI, 2014, NAT METHODS, V11, P359, DOI 10.1038/nmeth.2897
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72
   Dutilh BE, 2013, BEST PRACT RES CL GA, V27, P85, DOI 10.1016/j.bpg.2013.03.008
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Friedman JH, 2009, ELEMENTS STAT LEARNI
   Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Goedert JJ, 2014, CARCINOGENESIS, V35, P2089, DOI 10.1093/carcin/bgu131
   Green Tringe Susannah, 2005, Nature Reviews Genetics, V6, P805, DOI 10.1038/nrg1709
   Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18
   Hirayama A, 2009, CANCER RES, V69, P4918, DOI 10.1158/0008-5472.CAN-08-4806
   Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kultima JR, 2016, BIOINFORMATICS, V32, P2520, DOI 10.1093/bioinformatics/btw183
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Liesenfeld DB, 2015, AM J CLIN NUTR, V102, P433, DOI 10.3945/ajcn.114.103804
   Lozupone CA, 2013, GENOME RES, V23, P1704, DOI 10.1101/gr.151803.112
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979
   Mal M, 2012, ANAL BIOANAL CHEM, V403, P483, DOI 10.1007/s00216-012-5870-5
   MALLONEE DH, 1990, J BACTERIOL, V172, P7011, DOI 10.1128/jb.172.12.7011-7019.1990
   Mandal Siddhartha, 2015, Microbial Ecology in Health and Disease, V26, P27663, DOI 10.3402/mehd.v26.27663
   Mende DR, 2013, NAT METHODS, V10, P881, DOI [10.1038/nmeth.2575, 10.1038/NMETH.2575]
   Milanese A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08844-4
   Ocvirk Soren, 2017, Curr Nutr Rep, V6, P315, DOI 10.1007/s13668-017-0219-5
   Ogino S, 2018, GUT, V67, P1168, DOI 10.1136/gutjnl-2017-315537
   Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182
   Oksanen J., 2020, VEGAN COMMUNITY ECOL
   Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977
   Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159
   Pox CP, 2012, GASTROENTEROLOGY, V142, P1460, DOI 10.1053/j.gastro.2012.03.022
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   REDDY BS, 1981, CANCER RES, V41, P3766
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483
   Ridlon JM, 2010, ANAEROBE, V16, P137, DOI 10.1016/j.anaerobe.2009.05.004
   Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Shah MS, 2018, GUT, V67, P882, DOI 10.1136/gutjnl-2016-313189
   Shkoporov AN, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0446-z
   Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Vieira-Silva S, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.88, 10.1038/nmicrobiol.2016.88]
   Viennot S, 2009, GASTROEN CLIN BIOL, V33, pS190, DOI 10.1016/S0399-8320(09)73154-9
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   zur Hausen H, 2012, INT J CANCER, V130, P2475, DOI 10.1002/ijc.27413
NR 80
TC 355
Z9 370
U1 28
U2 191
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD APR
PY 2019
VL 25
IS 4
BP 679
EP +
DI 10.1038/s41591-019-0406-6
PG 24
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HR7OA
UT WOS:000463342800029
PM 30936547
OA Green Submitted, Green Accepted
DA 2022-11-22
ER

PT J
AU Jia, BL
   Park, D
   Hahn, Y
   Jeon, CO
AF Jia, Baolei
   Park, Dongbin
   Hahn, Yoonsoo
   Jeon, Che Ok
TI Metagenomic analysis of the human microbiome reveals the association
   between the abundance of gut bile salt hydrolases and host health
SO GUT MICROBES
LA English
DT Article
DE Gut microbiome; bile acids; bile salt hydrolase; metagenomic cohorts;
   human health
ID ACIDS; METABOLISM; OBESITY; CIRRHOSIS; RISK
AB Bile acid metabolism by the gut microbiome exerts both beneficial and harmful effects on host health. Microbial bile salt hydrolases (BSHs), which initiate bile acid metabolism, exhibit both positive and negative effects on host physiology. In this study, 5,790 BSH homologs were collected and classified into seven clusters based on a sequence similarity network. Next, the abundance and distribution of BSH in 380 metagenomes from healthy participants were analyzed. It was observed that different clusters occupied diverse ecological niches in the human microbiome and that the clusters with signal peptides were relatively abundant in the gut. Then, the association between BSH clusters and 12 human diseases was analyzed by comparing the abundances of BSH genes in patients (n = 1,605) and healthy controls (n = 1,540). The analysis identified a significant association between BSH gene abundance and 10 human diseases, including gastrointestinal diseases, obesity, type 2 diabetes, liver diseases, cardiovascular diseases, and neurological diseases. The associations were further validated by separate cohorts with inflammatory bowel diseases and colorectal cancer. These large-scale studies of enzyme sequences combined with metagenomic data provide a reproducible assessment of the association between gut BSHs and human diseases. This information can contribute to future diagnostic and therapeutic applications of BSH-active bacteria for improving human health.
C1 [Jia, Baolei] Qilu Univ Technol, Shandong Acad Sci, Sch Bioengn, State Key Lab Biobased Mat & Green Papermaking, Jinan, Peoples R China.
   [Jia, Baolei; Park, Dongbin; Hahn, Yoonsoo; Jeon, Che Ok] Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea.
C3 Qilu University of Technology; Chung Ang University
RP Jia, BL; Jeon, CO (corresponding author), Chung Ang Univ, Dept Life Sci, Seoul 06974, South Korea.
EM baoleijia@cau.ac.kr; cojeon@cau.ac.kr
RI Jia, Baolei/AIF-1053-2022
FU National Research Foundation of the Ministry of Science and ICT and
   Future Planning [2018R1A5A1025077]; Strategic Initiative for Microbiomes
   in the Ministry of Agriculture, Food, and Rural Afairs (as part of the
   multi-ministerial) Genome Technology to Business Translation Program,
   Republic of Korea; Shandong Provincial Key Research and Development 835
   Plan, China [2019JZZY011003]
FX This work was supported by the National Research Foundation
   [2018R1A5A1025077] of the Ministry of Science and ICT and Future
   Planning and the Strategic Initiative for Microbiomes in the Ministry of
   Agriculture, Food, and Rural Afairs (as part of the multi-ministerial)
   Genome Technology to Business Translation Program, Republic of Korea and
   the Shandong Provincial Key Research and Development 835 Plan
   [2019JZZY011003], China.
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Akiva E, 2017, P NATL ACAD SCI USA, V114, pE9549, DOI 10.1073/pnas.1706849114
   Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z
   Armstrong Laura E, 2017, Curr Pharmacol Rep, V3, P92, DOI 10.1007/s40495-017-0085-2
   Berini F, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx211
   Bernstein C, 1999, CANCER RES, V59, P2353
   Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z
   Cho CE, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600324
   Dong ZX, 2018, PROTEIN SCI, V27, P1742, DOI 10.1002/pro.3484
   Durack J, 2019, J EXP MED, V216, P20, DOI 10.1084/jem.20180448
   Foley MH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007581
   Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Huttenhower C, 2014, IMMUNITY, V40, P843, DOI 10.1016/j.immuni.2014.05.013
   Jia BL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007954
   Jia BL, 2019, FASEB J, V33, P7519, DOI 10.1096/fj.201802617R
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Jones ML, 2013, EXPERT OPIN BIOL TH, V13, P631, DOI 10.1517/14712598.2013.758706
   Joyce SA, 2014, GUT MICROBES, V5, P669, DOI 10.4161/19490976.2014.969986
   Joyce SA, 2014, P NATL ACAD SCI USA, V111, P7421, DOI 10.1073/pnas.1323599111
   Kakiyama G, 2013, J HEPATOL, V58, P949, DOI 10.1016/j.jhep.2013.01.003
   Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557
   Khurana S, 2011, CTS-CLIN TRANSL SCI, V4, P210, DOI 10.1111/j.1752-8062.2011.00272.x
   Knudsen BE, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00095-16
   Koppel N, 2016, CELL CHEM BIOL, V23, P18, DOI 10.1016/j.chembiol.2015.12.008
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kumar S, 2018, MOL BIOL EVOL, V35, P1, DOI 10.1093/molbev/msx313
   Levin BJ, 2017, SCIENCE, V355, DOI 10.1126/science.aai8386
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268
   McMillin M, 2016, FASEB J, V30, P3658, DOI 10.1096/fj.201600275R
   Mouzaki M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151829
   Musso G, 2010, DIABETES CARE, V33, P2277, DOI 10.2337/dc10-0556
   Nayfach S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0611-7
   Ogilvie LA, 2012, GUT, V61, P1642, DOI 10.1136/gutjnl-2012-302137
   Panek M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23296-4
   Pearson William R, 2013, Curr Protoc Bioinformatics, VChapter 3, DOI 10.1002/0471250953.bi0301s42
   Pereira-Fantini PM, 2014, J HEPATOL, V61, P1115, DOI 10.1016/j.jhep.2014.06.025
   Ratziu V, 2016, J HEPATOL, V65, P249, DOI 10.1016/j.jhep.2016.05.021
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Ridlon JM, 2013, GUT MICROBES, V4, P382, DOI 10.4161/gmic.25723
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shapiro H, 2018, J EXP MED, V215, P383, DOI 10.1084/jem.20171965
   Song ZW, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0628-3
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729
   Tomkin GH, 2016, J TRANSL INTERN MED, V4, P73, DOI 10.1515/jtim-2016-0018
   Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008
   Winston JA, 2020, GUT MICROBES, V11, P158, DOI 10.1080/19490976.2019.1674124
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Yao LN, 2018, ELIFE, V7, DOI 10.7554/eLife.37182
   Yu LX, 2017, NAT REV GASTRO HEPAT, V14, P527, DOI 10.1038/nrgastro.2017.72
   Zallot R, 2019, BIOCHEMISTRY-US, V58, P4169, DOI 10.1021/acs.biochem.9b00735
   Zhang LM, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00070-16
   Zhu J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0515-3
NR 57
TC 28
Z9 29
U1 6
U2 31
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PY 2020
VL 11
IS 5
BP 1300
EP 1313
DI 10.1080/19490976.2020.1748261
EA APR 2020
PG 14
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA OS5XC
UT WOS:000532250100001
PM 32329665
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Hester, CM
   Jala, VR
   Langille, MGI
   Umar, S
   Greiner, KA
   Haribabu, B
AF Hester, Christina M.
   Jala, Venkatakrishna R.
   Langille, Morgan G. I.
   Umar, Shahid
   Greiner, K. Allen
   Haribabu, Bodduluri
TI Fecal microbes, short chain fatty acids, and colorectal cancer across
   racial/ethnic groups
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Article
DE Colorectal cancer; Short chain fatty acids; Racial/ethnic disparities;
   Butyrate; Microbiota
ID BUTYRATE-PRODUCING BACTERIA; INTESTINAL MICROBIOTA; GUT MICROBIOTA;
   POLYPECTOMY; METABOLITES; HEALTH
AB AIM: To investigate differences in microbes and short chain fatty acid (SCFA) levels in stool samples from Hispanic and non-Hispanic African American, American Indian, and White participants.
   METHODS: Stool samples from twenty participants were subjected to analysis for relative levels of viable bacteria and for SCFA levels. Additionally, the samples were subjected to 16S rRNA gene pyrosequencing for identification of bacteria present in the stool. We used a metagenome functional prediction technique to analyze genome copy numbers and estimate the abundance of butyrate kinase in all samples.
   RESULTS: We found that African Americans had significantly lower levels of acetate, butyrate, and total SCFAs than all other racial/ethnic groups. We also found that participant microbial profiles differed by racial/ethnic group. African Americans had significantly more Firmicutes than Whites, with enriched Ruminococcaceae. The Firmicutes/Bacteroidetes ratio was also significantly higher for African Americans than for Whites (P = 0.049). We found Clostridium levels to be significantly and inversely related to total SCFA levels (P = 0.019) and we found Bacteroides to be positively associated (P = 0.027) and Clostridium to be negatively associated (P = 0.012) with levels of butyrate. We also identified a correlation between copy number for a butyrate kinase predicted from 16S rRNA gene abundance and levels of butyrate in stool.
   CONCLUSION: The identified differences in gut flora and SCFA levels may relate to colorectal cancer mortality differentials and may be useful as targets for future clinical and behavioral interventions.
C1 [Hester, Christina M.; Greiner, K. Allen] Univ Kansas, Med Ctr, Dept Family Med, Div Res, Kansas City, KS 66160 USA.
   [Hester, Christina M.; Umar, Shahid; Greiner, K. Allen] Univ Kansas, Med Ctr, Ctr Canc, Kansas City, KS 66160 USA.
   [Jala, Venkatakrishna R.; Haribabu, Bodduluri] Univ Louisville, James Graham Brown Canc Ctr, Louisville, KY 40202 USA.
   [Jala, Venkatakrishna R.; Haribabu, Bodduluri] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.
   [Langille, Morgan G. I.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada.
   [Umar, Shahid] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
C3 University of Kansas; University of Kansas Medical Center; University of
   Kansas; University of Kansas Medical Center; University of Louisville;
   University of Louisville; Dalhousie University; University of Kansas;
   University of Kansas Medical Center
RP Hester, CM (corresponding author), Univ Kansas, Med Ctr, Dept Family Med, Div Res, MS 3064,3901 Rainbow Blvd, Kansas City, KS 66160 USA.
EM chester@kumc.edu
RI Bodduluri, Haribabu/A-2584-2010; Jala, Venkatakrishna R/K-7255-2018
OI Bodduluri, Haribabu/0000-0002-8261-3294; Jala, Venkatakrishna
   R/0000-0002-4206-7305; Langille, Morgan/0000-0002-6604-3009
FU University of Kansas Cancer Center; National Cancer Institute at the NIH
   [U54CA154253]; University of Kansas Clinical Translational Science
   Program (Frontiers from the National Cancer Institute at NIH)
   [CA123245]; NCI at NIH [1R01CA138623]; James Graham Brown Cancer Center,
   University of Louisville; NATIONAL CANCER INSTITUTE [R01CA123245,
   U54CA154253, R01CA138623] Funding Source: NIH RePORTER
FX Supported by The University of Kansas Cancer Center, U54CA154253 from
   the National Cancer Institute at the NIH, the University of Kansas
   Clinical Translational Science Program (Frontiers, CA123245 from the
   National Cancer Institute at NIH), 1R01CA138623 from the NCI at NIH, and
   the James Graham Brown Cancer Center, University of Louisville.
CR Atkin WS, 1998, GUT, V42, P560, DOI 10.1136/gut.42.4.560
   Barcenilla A, 2000, APPL ENVIRON MICROB, V66, P1654, DOI 10.1128/AEM.66.4.1654-1661.2000
   Biddle A., 2013, DIVERSITY-BASEL, V5, P627, DOI [10.3390/d5030627, DOI 10.3390/d5030627]
   Bordonaro M, 2008, CELL CYCLE, V7, P1178, DOI 10.4161/cc.7.9.5818
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Corr SC, 2009, ADV FOOD NUTR RES, V56, P1, DOI 10.1016/S1043-4526(08)00601-3
   Dai ZL, 2011, FRONT BIOSCI-LANDMRK, V16, P1768, DOI 10.2741/3820
   Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002
   DuPont Andrew W, 2011, Nat Rev Gastroenterol Hepatol, V8, P523, DOI 10.1038/nrgastro.2011.133
   Ehrsam G, 2009, PUBLIC HEALTH REP, V124, P54, DOI 10.1177/003335490912400109
   Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Howlader N., SEER CANC STAT REV 1
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20073, 10.3322/caac.20107]
   Kim J, 2011, ANN SURG, V253, P647, DOI 10.1097/SLA.0b013e3182111102
   Kosiewicz MM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00180
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Lanier Anne P, 2008, Alaska Med, V49, P120
   Mandel JS, 2000, NEW ENGL J MED, V343, P1603, DOI 10.1056/NEJM200011303432203
   Mandel JS, 1999, J NATL CANCER I, V91, P434, DOI 10.1093/jnci/91.5.434
   Marchesi JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020447
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Mueller C, 2006, GUT, V55, P276, DOI 10.1136/gut.2004.054098
   MULLER AD, 1995, ANN INTERN MED, V123, P904, DOI 10.7326/0003-4819-123-12-199512150-00002
   O'Keefe SJD, 2008, CURR OPIN GASTROEN, V24, P51, DOI 10.1097/MOG.0b013e3282f323f3
   O'Keefe SJD, 2009, J NUTR, V139, P2044, DOI 10.3945/jn.109.104380
   Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8
   Remely M, 2013, J DIABETES METAB, V4, DOI 10.4172/2155-6156.1000253
   Roy Claude C, 2006, Nutr Clin Pract, V21, P351, DOI 10.1177/0115426506021004351
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Vipperla K, 2012, NUTR CLIN PRACT, V27, P624, DOI 10.1177/0884533612452012
   Wang TT, 2012, ISME J, V6, P320, DOI 10.1038/ismej.2011.109
   Winawer SJ, 1997, GASTROENTEROLOGY, V112, P594, DOI 10.1053/gast.1997.v112.agast970594
   Winawer SJ, 2001, GUT, V48, P753, DOI 10.1136/gut.48.6.753
   Yothers G, 2011, J NATL CANCER I, V103, P1498, DOI 10.1093/jnci/djr310
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
NR 40
TC 48
Z9 49
U1 0
U2 38
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 7041 Koll Center Parkway, Suite 160, PLEASANTON, CA, UNITED STATES
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAR 7
PY 2015
VL 21
IS 9
BP 2759
EP 2769
DI 10.3748/wjg.v21.i9.2759
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA CC9KJ
UT WOS:000350688400024
PM 25759547
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Gupta, A
   Dhakan, DB
   Maji, A
   Saxena, R
   Prasoodanan, PKV
   Mahajan, S
   Pulikkan, J
   Kurian, J
   Gomez, AM
   Scaria, J
   Amato, KR
   Sharma, AK
   Sharma, VK
AF Gupta, Ankit
   Dhakan, Darshan B.
   Maji, Abhijit
   Saxena, Rituja
   Prasoodanan, Vishnu P. K.
   Mahajan, Shruti
   Pulikkan, Joby
   Kurian, Jacob
   Gomez, Andres M.
   Scaria, Joy
   Amato, Katherine R.
   Sharma, Ashok K.
   Sharma, Vineet K.
TI Association of Flavonifractor plautii, a Flavonoid-Degrading Bacterium,
   with the Gut Microbiome of Colorectal Cancer Patients in India
SO MSYSTEMS
LA English
DT Article
DE colorectal cancer; gut microbiome; Flavonifractor plautii; biomarkers
ID FUSOBACTERIUM-NUCLEATUM; METAGENOME; IDENTIFICATION; CONVERSION;
   DYSBIOSIS; ALIGNMENT; CATALOG
AB Recently, dysbiosis in the human gut microbiome and shifts in the relative abundances of several bacterial species have been recognized as important factors in colorectal cancer (CRC). However, these studies have been carried out mainly in developed countries where CRC has a high incidence, and it is unclear whether the host-microbiome relationships deduced from these studies can be generalized to the global population. To test if the documented associations between the microbiome and CRC are conserved in a distinct context, we performed metagenomic and metabolomic association studies on fecal samples from 30 CRC patients and 30 healthy controls from two different locations in India, followed by a comparison of CRC data available from other populations. We confirmed the association of Bacteroides and other bacterial taxa with CRC that have been previously reported in other studies. However, the association of CRC with Flavonifractor plautii in Indian patients emerged as a novel finding. The plausible role of F. plautii appears to be linked with the degradation of beneficial anticarcinogenic flavonoids, which was also found to be significantly correlated with the enzymes and modules involved in flavonoid degradation within Indian CRC samples. Thus, we hypothesize that the degradation of beneficial flavonoids might be playing a role in cancer progression within this Indian cohort. We also identified 20 potential microbial taxonomic markers and 33 potential microbial gene markers that discriminate the Indian CRC from healthy microbiomes with high accuracy based on machine learning approaches.
   IMPORTANCE This study provides novel insights on the CRC-associated microbiome of a unique cohort in India, reveals the potential role of a new bacterium in CRC, and identifies cohort-specific biomarkers, which can potentially be used in noninvasive diagnosis of CRC. The study gains additional significance, as India is among the countries with a very low incidence of CRC, and the diet and lifestyle in India have been associated with a distinct gut microbiome in healthy Indians compared to other global populations. Thus, in this study, we hypothesize a unique relationship between CRC and the gut microbiome in an Indian population.
C1 [Gupta, Ankit; Dhakan, Darshan B.; Maji, Abhijit; Saxena, Rituja; Prasoodanan, Vishnu P. K.; Mahajan, Shruti; Sharma, Ashok K.; Sharma, Vineet K.] Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Metagenom & Syst Biol Grp, Bhopal, India.
   [Pulikkan, Joby] Cent Univ Kerala, Dept Genom Sci, Kasargod, India.
   [Kurian, Jacob] Amala Inst Med Sci, Dept Oncol, Trichur, India.
   [Gomez, Andres M.] Univ Minnesota, Dept Food Sci & Nutr, Dept Anim Sci, St Paul, MN 55108 USA.
   [Scaria, Joy] South Dakota State Univ, Anim Dis Res & Diagnost Lab, Brookings, SD 57007 USA.
   [Amato, Katherine R.] Northwestern Univ, Dept Anthropol, Evanston, IL 60208 USA.
C3 Indian Institute of Science Education & Research (IISER) - Bhopal;
   Central University of Kerala; University of Minnesota System; University
   of Minnesota Twin Cities; South Dakota State University; Northwestern
   University
RP Sharma, VK (corresponding author), Indian Inst Sci Educ & Res Bhopal, Dept Biol Sci, Metagenom & Syst Biol Grp, Bhopal, India.
EM vineetks@iiserb.ac.in
RI Sharma, Ashok Kumar/AAU-7623-2020; Dhakan, Darshan/AAE-6340-2022
OI Sharma, Ashok Kumar/0000-0002-2264-7628; K. Sharma,
   Vineet/0000-0002-2958-6215; Scaria, Joy/0000-0002-5299-8074
FU IISER Bhopal
FX This study was supported by intramural funding from IISER Bhopal.
CR Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   Arboleya S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01204
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Batra P, 2013, 3 BIOTECH, V3, P439, DOI 10.1007/s13205-013-0117-5
   Bonnet M, 2014, CLIN CANCER RES, V20, P859, DOI 10.1158/1078-0432.CCR-13-1343
   Braune A, 2016, GUT MICROBES, V7, P216, DOI 10.1080/19490976.2016.1158395
   Brenner H, 2014, NEW ENGL J MED, V371, P184, DOI 10.1056/NEJMc1405215
   Costea PI, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0072-8
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   DeGruttola AK, 2016, INFLAMM BOWEL DIS, V22, P1137, DOI 10.1097/MIB.0000000000000750
   DeSantis TZ, 2017, FUTURE MICROBIOL, V12, P1341, DOI 10.2217/fmb-2017-0185
   Dhakan DB, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz004
   Dingemanse C, 2015, CARCINOGENESIS, V36, P1388, DOI 10.1093/carcin/bgv120
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Fukiya S, 2009, FEMS MICROBIOL LETT, V293, P263, DOI 10.1111/j.1574-6968.2009.01531.x
   Gaci N, 2014, WORLD J GASTROENTERO, V20, P16062, DOI 10.3748/wjg.v20.i43.16062
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Han YPW, 2015, CURR OPIN MICROBIOL, V23, P141, DOI 10.1016/j.mib.2014.11.013
   Hisamuddin IM, 2006, CURR COLORECT CANC R, V2, P53, DOI 10.1007/s11888-006-0002-2
   Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005
   Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kutschera M, 2011, J APPL MICROBIOL, V111, P165, DOI 10.1111/j.1365-2672.2011.05025.x
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Laursen MF, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00448-17
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Le Gall Gwenaelle, 2018, Oncotarget, V9, P33278, DOI 10.18632/oncotarget.26022
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025
   Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336
   Maji A, 2018, ENVIRON MICROBIOL, V20, P402, DOI 10.1111/1462-2920.14015
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Nair S, 1998, J Assoc Physicians India, V46, P708
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Nobili V, 2018, ARCH MED SCI, V14, P81, DOI 10.5114/aoms.2016.62150
   Pandey KB, 2009, OXID MED CELL LONGEV, V2, P270, DOI 10.4161/oxim.2.5.9498
   Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619
   Pulikkan J, 2018, MICROB ECOL, V76, P1102, DOI 10.1007/s00248-018-1176-2
   Purcell RV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11237-6
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Raskov H, 2017, J CANCER, V8, P3378, DOI 10.7150/jca.20497
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Saxena R, 2015, MED HLTH GENOMICS, P107
   Scanlan PD, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-79
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71
   Shetty SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079353
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395
   Simons AL, 2005, J AGR FOOD CHEM, V53, P4258, DOI 10.1021/jf0500177
   Sinha R, 2003, J Postgrad Med, V49, P222
   Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Suzek BE, 2007, BIOINFORMATICS, V23, P1282, DOI 10.1093/bioinformatics/btm098
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08
   Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275
   Zou SM, 2018, GASTROENTEROL REP, V6, P1, DOI 10.1093/gastro/gox031
NR 63
TC 53
Z9 54
U1 0
U2 10
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD NOV-DEC
PY 2019
VL 4
IS 6
AR e00438-19
DI 10.1128/mSystems.00438-19
PG 20
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA JS7PG
UT WOS:000500495300005
PM 31719139
OA Green Published
DA 2022-11-22
ER

PT J
AU Holzl-Armstrong, L
   Kucab, JE
   Moody, S
   Zwart, EP
   Loutkotova, L
   Duffy, V
   Luijten, M
   da Costa, GG
   Stratton, MR
   Phillips, DH
   Arlt, VM
AF Holzl-Armstrong, Lisa
   Kucab, Jill E.
   Moody, Sarah
   Zwart, Edwin P.
   Loutkotova, Lucie
   Duffy, Veronica
   Luijten, Mirjam
   da Costa, Goncalo Gamboa
   Stratton, Michael R.
   Phillips, David H.
   Arlt, Volker M.
TI Mutagenicity of acrylamide and glycidamide in humanTP53knock-in (Hupki)
   mouse embryo fibroblasts
SO ARCHIVES OF TOXICOLOGY
LA English
DT Article
DE TP53; Mutation; Whole-genome sequencing; Dietary carcinogen; Acrylamide;
   DNA adducts
ID MUTATIONAL SIGNATURES; METABOLIC-ACTIVATION; TP53 MUTATIONS;
   DRINKING-WATER; WILD-TYPE; GENOTOXICITY; MICE; DNA; EXPOSURE; CELLS
AB Acrylamide is a suspected human carcinogen formed during high-temperature cooking of starch-rich foods. It is metabolised by cytochrome P450 2E1 to its reactive metabolite glycidamide, which forms pre-mutagenic DNA adducts. Using the humanTP53knock-in (Hupki) mouse embryo fibroblasts (HUFs) immortalisation assay (HIMA), acrylamide- and glycidamide-induced mutagenesis was studied in the tumour suppressor geneTP53. Selected immortalised HUF clones were also subjected to next-generation sequencing to determine mutations across the whole genome. TheTP53-mutant frequency after glycidamide exposure (1.1 mM for 24 h,n = 198) was 9% compared with 0% in cultures treated with acrylamide [1.5 (n = 24) or 3 mM (n = 6) for 48 h] and untreated vehicle (water) controls (n = 36). Most glycidamide-induced mutations occurred at adenines with A > T/T > A and A > G/T > C mutations being the most common types. Mutations induced by glycidamide occurred at specificTP53codons that have also been found to be mutated in human tumours (i.e., breast, ovary, colorectal, and lung) previously associated with acrylamide exposure. The spectrum ofTP53mutations was further reflected by the mutations detected by whole-genome sequencing (WGS) and a distinct WGS mutational signature was found in HUF clones treated with glycidamide that was again characterised by A > G/T > C and A > T/T > A mutations. The WGS mutational signature showed similarities with COSMIC mutational signatures SBS3 and 25 previously found in human tumours (e.g., breast and ovary), while the adenine component was similar to COSMIC SBS4 found mostly in smokers' lung cancer. In contrast, in acrylamide-treated HUF clones, only culture-related background WGS mutational signatures were observed. In summary, the results of the present study suggest that glycidamide may be involved in the development of breast, ovarian, and lung cancer.
C1 [Holzl-Armstrong, Lisa; Kucab, Jill E.; Duffy, Veronica; Phillips, David H.; Arlt, Volker M.] Kings Coll London, MRC PHE Ctr Environm & Hlth, Dept Analyt Environm & Forens Sci, London SE1 9NH, England.
   [Moody, Sarah; Stratton, Michael R.] Wellcome Trust Sanger Inst, Canc Ageing & Somat Mutat, Hinxton CB10 1SA, England.
   [Zwart, Edwin P.; Luijten, Mirjam] Natl Inst Publ Hlth & Environm RIVM, Ctr Hlth Protect, NL-3720 Bilthoven, Netherlands.
   [Loutkotova, Lucie; da Costa, Goncalo Gamboa] US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA.
   [Loutkotova, Lucie] Covance Inc, Salt Lake City, UT 84124 USA.
   [Arlt, Volker M.] GAB Consulting GmbH, Toxicol Dept, D-69126 Heidelberg, Germany.
C3 University of London; King's College London; Wellcome Trust Sanger
   Institute; Netherlands National Institute for Public Health & the
   Environment; US Food & Drug Administration (FDA); Covance
RP Arlt, VM (corresponding author), Kings Coll London, MRC PHE Ctr Environm & Hlth, Dept Analyt Environm & Forens Sci, London SE1 9NH, England.; Arlt, VM (corresponding author), GAB Consulting GmbH, Toxicol Dept, D-69126 Heidelberg, Germany.
EM volker.arlt@kcl.ac.uk
OI Luijten, Mirjam/0000-0002-5277-1443
FU MRC Centre for Environment and Health; Cancer Research UK Grand
   Challenge Award "Mutographs of Cancer" [C98/A24032]; Cancer Research UK
   [25041] Funding Source: researchfish
FX Lisa Holzl-Armstrong was supported by a PhD studentship from the MRC
   Centre for Environment and Health. Work at King's College London and the
   Wellcome Trust Sanger Institute was supported by the Cancer Research UK
   Grand Challenge Award "Mutographs of Cancer" (grant C98/A24032). The
   opinions expressed in this paper do not necessarily reflect those of the
   US Food and Drug Administration.
CR Alexandrov LB, 2020, NATURE, V578, P94, DOI 10.1038/s41586-020-1943-3
   Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477
   Arlt VM, 2002, CARCINOGENESIS, V23, P1937, DOI 10.1093/carcin/23.11.1937
   Baum M, 2005, MUTAT RES-GEN TOX EN, V580, P61, DOI 10.1016/j.mrgentox.2004.11.007
   Beland FA, 2015, FOOD CHEM TOXICOL, V86, P104, DOI 10.1016/j.fct.2015.09.017
   Benford D, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4002
   Besaratinia A, 2004, JNCI-J NATL CANCER I, V96, P1023, DOI 10.1093/jnci/djh186
   Besaratinia A, 2007, CARCINOGENESIS, V28, P519, DOI 10.1093/carcin/bgm006
   Blasiak J, 2004, CHEM-BIOL INTERACT, V149, P137, DOI 10.1016/j.cbi.2004.08.002
   Christenser S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12594-8
   da Costa GG, 2003, CHEM RES TOXICOL, V16, P1328, DOI 10.1021/tx034108e
   Friedman M, 2003, J AGR FOOD CHEM, V51, P4504, DOI 10.1021/jf030204+
   Ghanayem BI, 2005, BIOL REPROD, V72, P157, DOI 10.1095/biolreprod.104.033308
   Hainaut P, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026179
   Holzl-Armstrong L, 2019, METHOD PROTOCOL, V2, DOI 10.3390/mps2040085
   Hogervorst JG, 2007, CANCER EPIDEM BIOMAR, V16, P2304, DOI 10.1158/1055-9965.EPI-07-0581
   Huang MN, 2017, GENOME RES, V27, P1475, DOI 10.1101/gr.220038.116
   Jiang LP, 2007, TOXICOL IN VITRO, V21, P1486, DOI 10.1016/j.tiv.2007.06.011
   Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100
   Koskinen M, 2000, CHEM-BIOL INTERACT, V129, P209, DOI 10.1016/S0009-2797(00)00206-4
   Koyama N, 2006, MUTAT RES-GEN TOX EN, V603, P151, DOI 10.1016/j.mrgentox.2005.11.006
   Kucab JE, 2019, CELL, V177, P821, DOI 10.1016/j.cell.2019.03.001
   Kucab JE, 2017, INT J CANCER, V140, P877, DOI 10.1002/ijc.30504
   Kucab JE, 2016, DNA REPAIR, V39, P21, DOI 10.1016/j.dnarep.2015.11.004
   Kucab JE, 2015, MUTAT RES-FUND MOL M, V773, P48, DOI 10.1016/j.mrfmmm.2015.01.013
   Kucab JE, 2012, ENVIRON MOL MUTAGEN, V53, P207, DOI 10.1002/em.21679
   Kucab JE, 2010, FEBS J, V277, P2567, DOI [10.1111/j.1742-464X.2010.07676.x, 10.1111/j.1742-4658.2010.07676.x]
   Liu ZP, 2004, P NATL ACAD SCI USA, V101, P2963, DOI 10.1073/pnas.0308607101
   Mahabir AG, 2009, MUTAT RES-FUND MOL M, V666, P50, DOI 10.1016/j.mrfmmm.2009.04.005
   Manjanatha MG, 2006, ENVIRON MOL MUTAGEN, V47, P6, DOI 10.1002/em.20157
   Manjanatha MG, 2015, ENVIRON MOL MUTAGEN, V56, P446, DOI 10.1002/em.21939
   Marques MM, 2019, LANCET ONCOL, V20, P763, DOI 10.1016/S1470-2045(19)30246-3
   Martins C, 2007, TOXICOL SCI, V95, P383, DOI 10.1093/toxsci/kfl155
   Mei N, 2008, ENVIRON MOL MUTAGEN, V49, P741, DOI 10.1002/em.20429
   Mei N, 2008, FOOD CHEM TOXICOL, V46, P628, DOI 10.1016/j.fct.2007.09.093
   Mei N, 2010, TOXICOL SCI, V115, P412, DOI 10.1093/toxsci/kfq069
   Mojska H, 2016, ANN AGR ENV MED, V23, P456, DOI 10.5604/12321966.1219187
   Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073
   Olesen PT, 2008, INT J CANCER, V122, P2094, DOI 10.1002/ijc.23359
   Olivier M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04482
   Paulsson B, 2003, MUTAT RES-GEN TOX EN, V535, P15, DOI 10.1016/S1383-5718(02)00281-4
   Renaud HJ, 2011, TOXICOL SCI, V124, P261, DOI 10.1093/toxsci/kfr240
   SEGERBACK D, 1995, CARCINOGENESIS, V16, P1161, DOI 10.1093/carcin/16.5.1161
   Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P371, DOI 10.1016/S0278-6915(99)00156-8
   Sumner SCJ, 1999, CHEM RES TOXICOL, V12, P1110, DOI 10.1021/tx990040k
   SUMNER SCJ, 1992, CHEM RES TOXICOL, V5, P553, DOI 10.1021/tx00028a015
   Tomkova M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1509-y
   Whibley C, 2010, J BIOL CHEM, V285, P11326, DOI 10.1074/jbc.M109.064444
   WHO INT AGCY RES CANC, 1994, IARC MONOG EVAL CARC, V60, P389
   Wohak LE, 2016, ARCH TOXICOL, V90, P291, DOI 10.1007/s00204-014-1409-1
   Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394
   Zhivagui M, 2019, GENOME RES, V29, P521, DOI 10.1101/gr.242453.118
NR 52
TC 12
Z9 12
U1 0
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5761
EI 1432-0738
J9 ARCH TOXICOL
JI Arch. Toxicol.
PD DEC
PY 2020
VL 94
IS 12
BP 4173
EP 4196
DI 10.1007/s00204-020-02878-0
EA SEP 2020
PG 24
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA OP9QL
UT WOS:000566034600001
PM 32886187
OA hybrid, Green Published
DA 2022-11-22
ER

PT J
AU Farhana, L
   Sarkar, S
   Nangia-Makker, P
   Yu, YJ
   Khosla, P
   Levi, E
   Azmi, A
   Majumdar, APN
AF Farhana, Lulu
   Sarkar, Sarah
   Nangia-Makker, Pratima
   Yu, Yingjie
   Khosla, Pramod
   Levi, Edi
   Azmi, Asfar
   Majumdar, Adhip P. N.
TI Natural agents inhibit colon cancer cell proliferation and alter
   microbial diversity in mice
SO PLOS ONE
LA English
DT Article
ID GAMMA-TOCOTRIENOL; GUT MICROBIOTA; VITAMIN-E; SIGNALING PATHWAY; GOLDEN
   SPICE; CURCUMIN; BIOAVAILABILITY; POLYPHENOLS; METABOLITES; APOPTOSIS
AB The current study was undertaken to investigate the effect of differentially formulated polyphenolic compound Essential Turmeric Oil-Curcumin (ETO-Cur), and Tocotrienol-rich fraction (TRF) of vitamin E isomers on colorectal cancer (CRC) cells that produce aggressive tumors. Combinations of ETO-Cur and TRF were used to determine the combinatorial effects of ETO-Cur and TRF-mediated inhibition of growth of CRC cells in vitro and HCT116 cells xenograft in SCID mice. 16S rRNA gene sequence profiling was performed to determine the outcome of gut microbial communities in mice feces between control and ETO-Cur-TRF groups. Bacterial identifications were validated by performing SYBR-based Real Time (RT) PCR. For metagenomics analysis to characterize the microbial communities, multiple software/tools were used, including Quantitative Insights into Microbial Ecology (QIIME) processing tool. We found ETO-Cur and TRF to synergize and that the combination of ETO-Cur-TRF significantly inhibited growth of HCT-116 xenografts in SCID mice. This was associated with a marked alteration in microbial communities and increased microbial OTU (operation taxonomic unit) number. The relative abundance of taxa was increased and the level of microbial diversity after 34 days of combinatorial treatment was found to be 44% higher over the control. Shifting of microbial family composition was observed in ETO-Cur-TRF treated mice as evidenced by marked reductions in Bacteroidaceae, Ruminococcaceae, Clostridiales, Firmicutes and Parabacteroids families, compared to controls. Interestingly, during the inhibition of tumor growth in ETO-Cur treated mice, probiotic Lactobacillaceae and Bifidobacteriaceae were increased by 20-fold and 6-fold, respectively. The relative abundance of anti-inflammatory Clostridium XIVa was also increased in ETO-Cur-TRF treated mice when compared with the control. Our data suggest that ETO-Cur-TRF show synergistic effects in inhibiting colorectal cancer cell proliferation in vitro and in mouse xenografts in vivo, and might induce changes in microbial diversity in mice.
C1 [Farhana, Lulu; Sarkar, Sarah; Nangia-Makker, Pratima; Yu, Yingjie; Levi, Edi; Majumdar, Adhip P. N.] John Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA.
   [Farhana, Lulu; Nangia-Makker, Pratima; Yu, Yingjie; Azmi, Asfar; Majumdar, Adhip P. N.] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA.
   [Nangia-Makker, Pratima; Azmi, Asfar; Majumdar, Adhip P. N.] Karmanos Canc Inst, Detroit, MI 48201 USA.
   [Khosla, Pramod] Wayne State Univ, Dept Nutr & Food Sci, Detroit, MI USA.
   [Levi, Edi] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.
C3 Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne
   State University; Wayne State University
RP Majumdar, APN (corresponding author), John Dingell Vet Affairs Med Ctr, Detroit, MI 48201 USA.; Majumdar, APN (corresponding author), Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA.; Majumdar, APN (corresponding author), Karmanos Canc Inst, Detroit, MI 48201 USA.
EM majumdar@med.wayne.edu
OI Majumdar, Adhip/0000-0002-6413-5102
FU National Institute of Health, USA (NIH) [1R21CA175916]; Department of
   Veteran Affairs, USA [I101BX001927]; Metropolitan Detroit Research and
   Education Fund, Detroit, Michigan, USA (MDREF)
FX This study was funded by grants to Dr. Adhip Majumdar from the National
   Institute of Health, USA (NIH) (1R21CA175916), the Department of Veteran
   Affairs, USA (I101BX001927) and the Metropolitan Detroit Research and
   Education Fund, Detroit, Michigan, USA (MDREF). The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Abubakar IB, 2015, NAT PROD RES, V29, P2137, DOI 10.1080/14786419.2014.991927
   Aggarwal BB, 2010, BIOCHEM PHARMACOL, V80, P1613, DOI 10.1016/j.bcp.2010.07.043
   Ahn KS, 2007, J BIOL CHEM, V282, P809, DOI 10.1074/jbc.M610028200
   Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r
   Antony B, 2008, INDIAN J PHARM SCI, V70, P445, DOI 10.4103/0250-474X.44591
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Bachawal SV, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-84
   Baxter NT, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-20
   Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001
   Espin JC, 2017, BIOCHEM PHARMACOL, V139, P82, DOI 10.1016/j.bcp.2017.04.033
   Cerda B, 2005, J AGR FOOD CHEM, V53, P227, DOI 10.1021/jf049144d
   Dethlefsen L, 2006, TRENDS ECOL EVOL, V21, P517, DOI 10.1016/j.tree.2006.06.013
   Duineveld LAM, 2016, ANN FAM MED, V14, P215, DOI 10.1370/afm.1919
   Dulal S, 2014, CANCER J, V20, P225, DOI 10.1097/PPO.0000000000000050
   Evans HM, 1922, SCIENCE, V56, P650, DOI 10.1126/science.56.1458.650
   Farhana Lulu, 2018, World J Gastrointest Pathophysiol, V9, P47, DOI 10.4291/wjgp.v9.i2.47
   Farhana L, 2012, J ONCOL, V2012, DOI 10.1155/2012/796729
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Gross G, 2010, J AGR FOOD CHEM, V58, P10236, DOI 10.1021/jf101475m
   Gupta SC, 2012, CLIN EXP PHARMACOL P, V39, P283, DOI 10.1111/j.1440-1681.2011.05648.x
   Jeffery M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002200.pub2
   Kaileh M, 2010, J AM COLL NUTR, V29, p334S, DOI 10.1080/07315724.2010.10719848
   Keku TO, 2013, TRENDS MICROBIOL, V21, P506, DOI 10.1016/j.tim.2013.08.004
   Li H, 2019, BIOTECHNOLOGY ADV
   Lim SW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-469
   Lim SW, 2014, BIOMED PHARMACOTHER, V68, P1105, DOI 10.1016/j.biopha.2014.10.006
   Majumdar APN, 2009, NUTR CANCER, V61, P544, DOI 10.1080/01635580902752262
   Mantzorou M, 2018, PHYTOTHER RES, V32, P957, DOI 10.1002/ptr.6037
   McGarr SE, 2005, J CLIN GASTROENTEROL, V39, P98
   Mocchegiani E, 2014, AGEING RES REV, V14, P81, DOI 10.1016/j.arr.2014.01.001
   Nangia-Makker P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084369
   Nautiyal Jyoti, 2011, J Mol Signal, V6, P7, DOI 10.1186/1750-2187-6-7
   Ohno M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185999
   Prasad S, 2014, BIOTECHNOL ADV, V32, P1053, DOI 10.1016/j.biotechadv.2014.04.004
   Rajendran P, 2011, BRIT J PHARMACOL, V163, P283, DOI 10.1111/j.1476-5381.2010.01187.x
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112
   Sen CK, 2004, ANN NY ACAD SCI, V1031, P127, DOI 10.1196/annals.1331.013
   Sharma S, 2006, CLIN EXP PHARMACOL P, V33, P940, DOI 10.1111/j.1440-1681.2006.04468.x
   Shishu, 2008, AAPS PHARMSCITECH, V9, P810, DOI 10.1208/s12249-008-9096-y
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Toden S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00812-6
   van Gestel YRBM, 2014, CANCER EPIDEMIOL, V38, P448, DOI 10.1016/j.canep.2014.04.004
   Wang LL, 2018, EUR REV MED PHARMACO, V22, P7257, DOI 10.26355/eurrev_201811_16260
   Yan QL, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00381
   Yang ZH, 2010, INT J CANCER, V126, P852, DOI 10.1002/ijc.24766
   Yu YJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0372-7
   Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zam W, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/1367984
NR 50
TC 7
Z9 8
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 20
PY 2020
VL 15
IS 3
AR e0229823
DI 10.1371/journal.pone.0229823
PG 14
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA LQ9FU
UT WOS:000535303100014
PM 32196510
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Esteban-Torres, M
   Santamaria, L
   Cabrera-Rubio, R
   Plaza-Vinuesa, L
   Crispie, F
   de las Rivas, B
   Cotter, P
   Munoz, R
AF Esteban-Torres, Maria
   Santamaria, Laura
   Cabrera-Rubio, Raul
   Plaza-Vinuesa, Laura
   Crispie, Fiona
   de las Rivas, Blanca
   Cotter, Paul
   Munoz, Rosario
TI A Diverse Range of Human Gut Bacteria Have the Potential To Metabolize
   the Dietary Component Gallic Acid
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE HTS; antioxidant; human intestinal tract; microbiota; phenolic
   compounds; pyrogallol
ID CELL-FREE-EXTRACTS; COLORECTAL-CANCER; DEGRADATION; METAGENOMICS;
   LACTOBACILLI; GENERATION; ALIGNMENT; GALLATE; SEARCH
AB The human gut microbiota contains a broad variety of bacteria that possess functional genes, with resultant metabolites that affect human physiology and therefore health. Dietary gallates are phenolic components that are present in many foods and beverages and are regarded as having health-promoting attributes. However, the potential for metabolism of these phenolic compounds by the human microbiota remains largely unknown. The emergence of high-throughput sequencing (HIS) technologies allows this issue to be addressed. In this study, HTS was used to assess the incidence of gallate-decarboxylating bacteria within the gut microbiota of healthy individuals for whom bacterial diversity was previously determined to be high. This process was facilitated by the design and application of degenerate PCR primers to amplify a region encoding the catalytic C subunit of gallate decarboxylase (LpdC) from total metagenomic DNA extracted from human fecal samples. HIS resulted in the generation of a total of 3,261,967 sequence reads and revealed that the primary gallate-decarboxylating microbial phyla in the intestinal microbiota were Firrnicutes (74.6%), Proteobacteria (17.6%), and Actinobacteria (7.8%). These reads corresponded to 53 genera, i.e., 47% of the bacterial genera detected previously in these samples. Among these genera, Anaerostipes and Klebsiella accounted for the majority of reads (40%). The usefulness of the HTS-IpdC method was demonstrated by the production of pyrogallol from gallic acid, as expected for functional gallate decarboxylases, among representative strains belonging to species identified in the human gut microbiota by this method.
   IMPORTANCE Despite the increasing wealth of sequencing data, the health contributions of many bacteria found in the human gut microbiota have yet to be elucidated. This study applies a novel experimental approach to predict the ability of gut microbes to carry out a specific metabolic activity, i.e., gallate metabolism. The study showed that, while gallate-decarboxylating bacteria represented 47% of the bacterial genera detected previously in the same human fecal samples, no gallate decarboxylase homologs were identified from representatives of Bacteroidetes. The presence of functional gallate decarboxylases was demonstrated in representative Proteobacteria and Firrnicutes strains from the human microbiota, an observation that could be of considerable relevance to the in vivo production of pyrogallol, a physiologically important bioactive compound.
C1 [Esteban-Torres, Maria; Santamaria, Laura; Plaza-Vinuesa, Laura; de las Rivas, Blanca; Munoz, Rosario] CSIC, ICTAN, Lab Biotecnol Bacteriana, Madrid, Spain.
   [Esteban-Torres, Maria] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland.
   [Cabrera-Rubio, Raul; Crispie, Fiona; Cotter, Paul] Teagasc Food Res Ctr, Cork, Ireland.
C3 Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto
   de Ciencia y Tecnologia de Alimentos y Nutricion (ICTAN); University
   College Cork; Teagasc
RP Munoz, R (corresponding author), CSIC, ICTAN, Lab Biotecnol Bacteriana, Madrid, Spain.
EM rmunoz@ictan.csic.es
RI de las Rivas, Blanca/K-3899-2014; Muñoz, Rosario/H-8597-2012; Vinuesa,
   Laura Plaza/AAT-9600-2020; Esteban-Torres, Maria/AAA-8621-2020
OI de las Rivas, Blanca/0000-0002-8357-5226; Muñoz,
   Rosario/0000-0003-4170-9713; Vinuesa, Laura Plaza/0000-0001-7004-7064;
   Esteban-Torres, Maria/0000-0001-8433-5729
FU MINECO [AGL2014-52911-R]; FPI Fellowship from the MINECO; Irish Research
   Council postdoctoral grant [GOIPD/2017/1302]
FX This work was supported by MINECO grant AGL2014-52911-R (AEI/FEDER, UE).
   L.S. is a recipient of a FPI Fellowship from the MINECO, and M.E.-T. is
   a recipient of an Irish Research Council postdoctoral grant (grant
   GOIPD/2017/1302).
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Curiel JA, 2009, J AGR FOOD CHEM, V57, P6224, DOI 10.1021/jf901045s
   Chamkha M, 2002, INT J SYST EVOL MICR, V52, P939, DOI 10.1099/00207713-52-3-939
   Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Frantzen CA, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02199-17
   Ghaani M, 2016, ANAL METHODS-UK, V8, P1103, DOI 10.1039/c5ay02747k
   Haminiuk CWI, 2012, INT J FOOD SCI TECH, V47, P2023, DOI 10.1111/j.1365-2621.2012.03067.x
   Ji BY, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00219
   Jimenez N, 2014, MICROB CELL FACT, V13, DOI 10.1186/s12934-014-0154-8
   Jimenez N, 2014, APPL ENVIRON MICROB, V80, P2991, DOI 10.1128/AEM.00324-14
   Jimenez N, 2013, APPL ENVIRON MICROB, V79, P4253, DOI 10.1128/AEM.00840-13
   Joice R, 2014, CELL METAB, V20, P731, DOI 10.1016/j.cmet.2014.10.003
   Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0
   Knight R, 2012, NAT BIOTECHNOL, V30, P513, DOI 10.1038/nbt.2235
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   de Felipe FL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00684
   Lupa B, 2005, GENOMICS, V86, P342, DOI 10.1016/j.ygeno.2005.05.002
   NAKAJIMA H, 1992, J FOOD HYG SOC JPN, V33, P371
   Newsome AG, 2016, J AGR FOOD CHEM, V64, P1326, DOI 10.1021/acs.jafc.5b04966
   Nogales J, 2011, MOL MICROBIOL, V79, P359, DOI 10.1111/j.1365-2958.2010.07448.x
   O'Sullivan DJ, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0596-0
   Osawa R, 2000, APPL ENVIRON MICROB, V66, P3093, DOI 10.1128/AEM.66.7.3093-3097.2000
   OSAWA R, 1995, SYST APPL MICROBIOL, V18, P74, DOI 10.1016/S0723-2020(11)80451-0
   Ow YY, 2003, CURR DRUG METAB, V4, P241, DOI 10.2174/1389200033489479
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Riesenfeld CS, 2004, ANNU REV GENET, V38, P525, DOI 10.1146/annurev.genet.38.072902.091216
   Rodriguez H, 2008, FOOD CHEM, V107, P664, DOI 10.1016/j.foodchem.2007.08.063
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Shahidi F., 2004, Phenolics in food and nutraceuticals.
   Sun ZH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9322
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Vaquero I, 2004, INT J FOOD MICROBIOL, V96, P199, DOI 10.1016/j.ijfoodmicro.2004.04.004
   Zeida M, 1998, APPL ENVIRON MICROB, V64, P4743
NR 36
TC 10
Z9 10
U1 1
U2 38
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD OCT
PY 2018
VL 84
IS 19
AR e01558-18
DI 10.1128/AEM01558-18
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology
GA GV6FV
UT WOS:000446204500024
PM 30054365
DA 2022-11-22
ER

PT J
AU Paley, EL
AF Paley, Elena L.
TI Diet-Related Metabolic Perturbations of Gut Microbial Shikimate
   Pathway-Tryptamine-tRNA Aminoacylation-Protein Synthesis in Human Health
   and Disease
SO INTERNATIONAL JOURNAL OF TRYPTOPHAN RESEARCH
LA English
DT Article
DE human gut metabolomics; database sequence-analysis; shikimate pathway;
   aminoacyl-tRNA deficiency; dysbiosis; host-microbe interaction;
   cytotoxicity; tryptophan metabolism; diet; cell death diseases
ID INFLAMMATORY-BOWEL-DISEASE; MONOAMINE-OXIDASE INHIBITION; AROMATIC
   AMINO-ACID; ACTIVATED-CHARCOAL; CELL-DEATH; INDOLE-3-CARBOXYLIC ACID;
   ALZHEIMERS-DISEASE; FIBRINOID NECROSIS; PARKINSONS-DISEASE; FECAL
   METABOLOMICS
AB Human gut bacterial Na(+)-transporting NADH: ubiquinone reductase (NQR) sequence is associated with Alzheimer disease (AD). Here, Alzheimer disease-associated sequence (ADAS) is further characterized in cultured spore-forming Clostridium sp. Tryptophan and NQR substrate ubiquinone have common precursor chorismate in microbial shikimate pathway. Tryptophan-derived tryptamine presents in human diet and gut microbiome. Tryptamine inhibits tryptophanyl-tRNA synthetase (TrpRS) with consequent neurodegeneration in cell and animal models. Tryptophanyl-tRNA synthetase inhibition causes protein biosynthesis impairment similar to that revealed in AD. Tryptamine-induced TrpRS gene-dose reduction is associated with TrpRS protein deficiency and cell death. In animals, tryptamine treatment results in toxicity, weight gain, and prediabetes-related hypoglycemia. Sequence analysis of gut microbiome database reveals 89% to 100% ADAS nucleotide identity in American Indian (Cheyenne and Arapaho [C&A]) Oklahomans, of which similar to 93% being overweight or obese and 50% self-reporting type 2 diabetes (T2D). Alzheimer disease-associated sequence occurs in 10.8% of C&A vs 1.3% of healthy American population. This observation is of considerable interest because T2D links to AD and obesity. Alzheimer disease-associated sequence prevails in gut microbiome of colorectal cancer, which linked to AD. Metabolomics revealed that tryptamine, chorismate precursor quinate, and chorismate product 4-hydroxybenzoate (ubiquinone precursor) are significantly higher, while tryptophan-containing dipeptides are lower due to tRNA aminoacylation deficiency in C&A compared with non-native Oklahoman who showed no ADAS. Thus, gut microbial tryptamine overproduction correlates with ADAS occurrence. Antibiotic and diet additives induce ADAS and tryptamine. Mitogenic/cytotoxic tryptamine cause microbial and human cell death, gut dysbiosis, and consequent disruption of host-microbe homeostasis. Present analysis of 1246 participants from 17 human gut metagenomics studies revealed ADAS in cell death diseases.
C1 [Paley, Elena L.] Expert BioMed Inc, Miami Dade, FL USA.
   [Paley, Elena L.] Stop Alzheimers Corp, Miami Dade, FL USA.
   [Paley, Elena L.] Nova Southeastern Univ, Ft Lauderdale, FL 33314 USA.
C3 Nova Southeastern University
RP Paley, EL (corresponding author), Stop Alzheimers Corp, Expert BioMed Inc, 11933 SW 271st TER, Homestead, FL 33032 USA.
EM elena_paley@bellsouth.net
FU Art Medicus PLLC, Yonkers, NY, USA
FX This work was supported by Art Medicus PLLC, Yonkers, NY, USA.
CR ALABASTER VA, 1976, EUR J PHARMACOL, V35, P349, DOI 10.1016/0014-2999(76)90238-7
   Anwar MA, 2013, VASC PHARMACOL, V58, P140, DOI 10.1016/j.vph.2012.10.007
   Arakaki AK, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-57
   ASTROM A, 1957, BRIT J PHARM CHEMOTH, V12, P410, DOI 10.1111/j.1476-5381.1957.tb00157.x
   Atanassova MR, 2016, FOOD MICROBIOL, V53, P172, DOI 10.1016/j.fm.2015.09.012
   Babiloni C, 2013, J ALZHEIMERS DIS, V34, P707, DOI 10.3233/JAD-121807
   Backhed F, 2015, CELL HOST MICROBE, V17, P690, DOI [10.1016/j.chom.2015.04.004, 10.1016/j.chom.2015.05.012]
   Baker Glen B., 1992, Journal of Psychiatry and Neuroscience, V17, P206
   Balzano T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21399-6
   Barrett OJ, 2006, CHEMBIOCHEM, V7, P1882, DOI 10.1002/cbic.200600260
   Barry KA, 2010, J ANIM SCI, V88, P2978, DOI 10.2527/jas.2009-2464
   Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y
   Benemei S, 2008, J HEADACHE PAIN, V9, P401, DOI 10.1007/s10194-008-0066-2
   Beydoun MA, 2015, J ALZHEIMERS DIS, V48, P361, DOI 10.3233/JAD-150228
   Bhattarai Y, 2018, CELL HOST MICROBE, V23, P775, DOI 10.1016/j.chom.2018.05.004
   BIECK PR, 1989, CLIN PHARMACOL THER, V45, P260, DOI 10.1038/clpt.1989.26
   BIECK PR, 1982, EUR J CLIN PHARMACOL, V22, P301, DOI 10.1007/BF00548397
   Brandacher G, 2006, OBES SURG, V16, P541, DOI 10.1381/096089206776945066
   Brito JS, 2017, NEPHRON, V137, P1, DOI 10.1159/000476074
   Brown DG, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0151-y
   Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645
   Burke EA, 2018, CLIN GENET, V93, P712, DOI 10.1111/cge.13172
   Byrd D J, 1976, Proc Eur Dial Transplant Assoc, V12, P347
   Caini S, 2016, DIGEST LIVER DIS, V48, P1162, DOI 10.1016/j.dld.2016.07.008
   Callaway JC, 1996, LIFE SCI, V58, P1817, DOI 10.1016/0024-3205(96)00165-8
   CANDIA OA, 1983, BIOCHIM BIOPHYS ACTA, V762, P232, DOI 10.1016/0167-4889(83)90076-9
   Chow J, 2014, J PROTEOME RES, V13, P2534, DOI 10.1021/pr500011w
   Churro C, 2010, HYDROBIOLOGIA, V649, P195, DOI 10.1007/s10750-010-0245-4
   Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937
   Crawford C, 2007, J ANIM SCI, V85, P2949, DOI 10.2527/jas.2006-600
   D'Andrea G, 2017, NEUROL SCI, V38, pS37, DOI 10.1007/s10072-017-2862-4
   DAVIS PJ, 1976, J BACTERIOL, V126, P544, DOI 10.1128/JB.126.1.544-546.1976
   DeHaven CD, 2010, J CHEMINFORMATICS, V2, DOI 10.1186/1758-2946-2-9
   DENCKLA WD, 1967, J PHARMACOL EXP THER, V158, P128
   Desai BS, 2009, J NEURAL TRANSM, V116, P587, DOI 10.1007/s00702-009-0226-9
   Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442
   Dyson JK, 2012, WORLD J GASTROENTERO, V18, P3839, DOI 10.3748/wjg.v18.i29.3839
   Egashira T, 2003, TOXICOL LETT, V145, P161, DOI 10.1016/S0378-4274(03)00286-8
   Eguchi A, 2014, DIGEST DIS, V32, P579, DOI 10.1159/000360509
   Elias-Sonnenschein LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059676
   Elliott J, 2003, AM J VET RES, V64, P1124, DOI 10.2460/ajvr.2003.64.1124
   Eo J, 2016, GENE, V580, P177, DOI 10.1016/j.gene.2016.01.022
   Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600
   Felix C, 2018, MYCOLOGIA, V110, P642, DOI 10.1080/00275514.2018.1478597
   FRENCH S, 1985, P NATL ACAD SCI USA, V82, P4638, DOI 10.1073/pnas.82.14.4638
   FROMANT M, 1981, BIOCHIMIE, V63, P541, DOI 10.1016/S0300-9084(81)80087-9
   Gahr M, 2013, EUR NEUROPSYCHOPHARM, V23, P1364, DOI 10.1016/j.euroneuro.2013.05.009
   Gamir J, 2012, PLANT PHYSIOL BIOCH, V61, P169, DOI 10.1016/j.plaphy.2012.10.004
   Gevi F, 2016, MOL AUTISM, V7, DOI 10.1186/s13229-016-0109-5
   Ghanipour A, 2009, CANCER EPIDEM BIOMAR, V18, P2949, DOI 10.1158/1055-9965.EPI-09-0456
   Giau VV, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111765
   Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.24, 10.1038/NMICROBIOL.2016.24]
   GINZEL KH, 1953, Q J EXP PHYSIOL CMS, V38, P225, DOI 10.1113/expphysiol.1953.sp001033
   Goedert JJ, 2014, CARCINOGENESIS, V35, P2089, DOI 10.1093/carcin/bgu131
   Gondalia SV, 2013, INT J BIOTECHNOLOGY, V9, P245
   Gonzalez B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00670
   Gorsi U, 2018, CURR PROBL DIAGN RAD, V18, P30017
   GREEN H, 1960, P SOC EXP BIOL MED, V104, P153
   Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y
   Habibzadeh F, 2016, BIOCHEM MEDICA, V26, P297, DOI 10.11613/BM.2016.034
   Hamdani N, 2015, AUST NZ J PSYCHIAT, V49, P1221, DOI 10.1177/0004867415595873
   Heavin SB, 2009, LETT APPL MICROBIOL, V49, P179, DOI 10.1111/j.1472-765X.2009.02634.x
   Herrera F, 2006, ANAT REC PART A, V288A, P1026, DOI 10.1002/ar.a.20368
   Holmberg FEO, 2018, J TISSUE ENG REGEN M, V12, P923, DOI 10.1002/term.2506
   ISHIDA T, 1990, ARCH BIOCHEM BIOPHYS, V278, P217, DOI 10.1016/0003-9861(90)90251-S
   JACOB J, 1962, ARCH INT PHARMACOD T, V140, P92
   Jiang SJ, 2016, AM J PATHOL, V186, P2117, DOI 10.1016/j.ajpath.2016.04.009
   Joo CK, 1999, J CATARACT REFR SURG, V25, P652, DOI 10.1016/S0886-3350(99)00009-7
   Kalaria RN, 1999, ANN NY ACAD SCI, V893, P113, DOI 10.1111/j.1749-6632.1999.tb07821.x
   Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266
   Kennedy D, 2017, REPROD TOXICOL, V69, P146, DOI 10.1016/j.reprotox.2017.02.012
   KERENYI T, 1966, ACTA MORPHOL HUNG, V14, P175
   Kumar R, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-015-0622-2
   Lai SW, 2014, EUR J EPIDEMIOL, V29, P57, DOI [10.1007/s10654-014-9903-6, 10.1007/s10654-014-9878-3]
   Lankarani KB, 2013, WORLD J GASTROENTERO, V19, P8571, DOI 10.3748/wjg.v19.i46.8571
   Lee M, 2018, J AUTISM DEV DISORD, V48, P1523, DOI 10.1007/s10803-017-3409-5
   Li YT, 2018, J INT MED RES, V46, P1052, DOI 10.1177/0300060517745388
   Lin CH, 2018, BIOL PSYCHIAT, V84, P422, DOI 10.1016/j.biopsych.2017.12.006
   Liu SX, 2018, KIDNEY BLOOD PRESS R, V43, P755, DOI 10.1159/000489912
   Luan HM, 2015, J PROTEOME RES, V14, P467, DOI 10.1021/pr500807t
   Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018
   Luqman A, 2018, CELL REP, V22, P535, DOI 10.1016/j.celrep.2017.12.058
   MAXWELL DR, 1961, BRIT J PHARM CHEMOTH, V17, P310, DOI 10.1111/j.1476-5381.1961.tb01118.x
   Meyer EP, 2008, P NATL ACAD SCI USA, V105, P3587, DOI 10.1073/pnas.0709788105
   Mijajlovic MD, 2014, NEUROPSYCH DIS TREAT, V10, P2269, DOI 10.2147/NDT.S73491
   Moh C, 2011, RESULTS PROBL CELL D, V53, P565, DOI 10.1007/978-3-642-19065-0_23
   MOUSSEAU DD, 1994, J NEUROCHEM, V62, P621
   MOUSSEAU DD, 1993, METAB BRAIN DIS, V8, P1, DOI 10.1007/BF01000528
   Naka K, 2001, J VET MED SCI, V63, P281, DOI 10.1292/jvms.63.281
   NEMECEK GM, 1986, P NATL ACAD SCI USA, V83, P674, DOI 10.1073/pnas.83.3.674
   Nikolaus S, 2017, GASTROENTEROLOGY, V153, P1504, DOI 10.1053/j.gastro.2017.08.028
   Niyadurupola Nuwan, 2008, Community Eye Health, V21, P9
   O'Rourke L, 2018, J NUTR SCI, V7, DOI 10.1017/jns.2017.69
   Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505
   Ogawa M, 2017, MOL CLIN ONCOL, V6, P701, DOI 10.3892/mco.2017.1207
   Osnes-Ringen O, 2016, ACTA OPHTHALMOL, V94, P514, DOI 10.1111/aos.13009
   Ouellette SP, 2016, INFECT IMMUN, V84, P2703, DOI 10.1128/IAI.00377-16
   Paley EL, 1999, CANCER LETT, V137, P1, DOI 10.1016/S0304-3835(98)00342-5
   PALEY EL, 1991, EXP CELL RES, V195, P66, DOI 10.1016/0014-4827(91)90501-K
   Paley EL, 1996, CARCINOGENESIS, V17, P939, DOI 10.1093/carcin/17.5.939
   Paley EL, 1989, REN FAIL, V11, P223
   Paley EL, 2007, NEUROMOL MED, V9, P55, DOI 10.1385/NMM:9:1:55
   Paley EL, 2007, MOL IMMUNOL, V44, P541, DOI 10.1016/j.molimm.2006.02.006
   Paley EL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040410
   Paley EL, 2018, J ALZHEIMERS DIS, V61, P1531, DOI 10.3233/JAD-170764
   Paley EL, 2013, CURR ALZHEIMER RES, V10, P987
   Paley EL, 2011, PANCREAS, V40, P1043, DOI 10.1097/MPA.0b013e318222e635
   Paley EL, 2011, J ALZHEIMERS DIS, V26, P263, DOI 10.3233/JAD-2011-110176
   Palleja A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0312-1
   Papamichail M, 2018, EUR J PEDIATR, V177, P285, DOI 10.1007/s00431-017-3058-x
   Pfab R, 2017, TOXICOL REP, V4, P49, DOI 10.1016/j.toxrep.2016.12.007
   Pollheimer MJ, 2010, HUM PATHOL, V41, P1749, DOI 10.1016/j.humpath.2010.04.018
   Ponnusamy K, 2011, J MED MICROBIOL, V60, P817, DOI 10.1099/jmm.0.028126-0
   Ponziani FR, 2010, WORLD J GASTROENTERO, V16, P143, DOI 10.3748/wjg.v16.i2.143
   Profenno LA, 2010, BIOL PSYCHIAT, V67, P505, DOI 10.1016/j.biopsych.2009.02.013
   Pugin Benoit, 2017, Microbial Ecology in Health and Disease, V28, P1353881, DOI 10.1080/16512235.2017.1353881
   RADULOVACKI P, 1983, BRAIN RES BULL, V10, P43, DOI 10.1016/0361-9230(83)90072-2
   Raymond F, 2016, ISME J, V10, P707, DOI 10.1038/ismej.2015.148
   Reddy MV, 2002, ENVIRON MOL MUTAGEN, V40, P1, DOI 10.1002/em.10088
   Rocken C, 1996, ARCH PATHOL LAB MED, V120, P1044
   Rybaczyk LA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-134
   Sankaranarayanan K, 2015, CURR BIOL, V25, P3161, DOI 10.1016/j.cub.2015.10.060
   Santillo MF, 2014, TOXICOL IN VITRO, V28, P403, DOI 10.1016/j.tiv.2013.12.006
   Saraf MK, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0297-z
   Sarosiek K, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/3467403
   Saura J, 1996, LIFE SCI, V59, P1341, DOI 10.1016/0024-3205(96)00459-6
   Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189
   Shaala LA, 2015, MAR DRUGS, V13, P1698, DOI 10.3390/md13041698
   Sinha R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152126
   Skogvall S, 2014, RESP MED, V108, P905, DOI 10.1016/j.rmed.2014.03.001
   SULLIVAN JP, 1986, BIOCHEM PHARMACOL, V35, P3255, DOI 10.1016/0006-2952(86)90421-1
   SUSILO R, 1987, NEUROSCI LETT, V81, P325, DOI 10.1016/0304-3940(87)90404-6
   Swanson KS, 2002, J NUTR, V132, P3042, DOI 10.1093/jn/131.10.3042
   Sykora P, 2015, NUCLEIC ACIDS RES, V43, P943, DOI 10.1093/nar/gku1356
   TANIMUKAI H, 1970, BRIT J PSYCHIAT, V117, P421, DOI 10.1192/bjp.117.539.421
   Trushina E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063644
   Uppal N, 2014, J NEUROPATH EXP NEUR, V73, P891, DOI 10.1097/NEN.0000000000000108
   Valfre W, 2008, HEADACHE, V48, P109, DOI 10.1111/j.1526-4610.2007.00723.x
   van Langenberg DR, 2017, UNITED EUR GASTROENT, V5, P579, DOI 10.1177/2050640616663397
   Vasa RA, 2012, AUTISM RES TREAT, V2012
   Vaughn BP, 2016, INFLAMM BOWEL DIS, V22, P2182, DOI 10.1097/MIB.0000000000000893
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   VOIGT MN, 1974, J MILK FOOD TECHNOL, V37, P377, DOI 10.4315/0022-2747-37.7.377
   Wang Feng, 2003, Mol Cancer, V2, P4, DOI 10.1186/1476-4598-2-4
   Wen CP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1271-6
   White NC, 2008, J MED TOXICOL, V4, P238, DOI 10.1007/BF03161207
   WOLFGARTEN M, 1959, J PATHOL BACTERIOL, V77, P597, DOI 10.1002/path.1700770231
   Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059016, 10.1371/journal.pone.0059749]
   Wust N, 2017, FOOD ADDIT CONTAM A, V34, P404, DOI 10.1080/19440049.2016.1269207
   Yilmaz Y, 2009, HEPATOLOGY, V49, P698, DOI 10.1002/hep.22752
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
NR 152
TC 12
Z9 12
U1 3
U2 5
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1178-6469
J9 INT J TRYPTOPHAN RES
JI Int. J. Trypotophan Res.
PD MAR 28
PY 2019
VL 12
AR 1178646919834550
DI 10.1177/1178646919834550
PG 19
WC Neurosciences
WE Emerging Sources Citation Index (ESCI)
SC Neurosciences & Neurology
GA HX1SM
UT WOS:000467173400001
PM 30944520
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Paley, EL
AF Paley, Elena L.
TI Discovery of Gut Bacteria Specific to Alzheimer's Associated Diseases is
   a Clue to Understanding Disease Etiology: Meta-Analysis of
   Population-Based Data on Human Gut Metagenomics and Metabolomics
SO JOURNAL OF ALZHEIMERS DISEASE
LA English
DT Article
DE Alzheimer's human gut metagenome; angiogenesis; biogenic amines; food;
   gut metabolomics; protein biosynthesis
ID TRANSFER-RNA-SYNTHETASE; PORTAL-SYSTEMIC ENCEPHALOPATHY; INCREASED
   CEREBRAL MYOINOSITOL; MONOAMINE-OXIDASE INHIBITORS; AROMATIC AMINE
   DEHYDROGENASE; H-3 TRYPTAMINE BINDING; CHAIN FATTY-ACIDS;
   BIOGENIC-AMINES; ESCHERICHIA-COLI; ALCALIGENES-FAECALIS
AB Alzheimer's disease (AD)-associated sequence (ADAS) of cultured fecal bacteria was discovered in human gut targeted screening. This study provides important information to expand our current understanding of the structure/activity relationship of ADAS and putative inhibitors/activators that are potentially involved in ADAS appearance/disappearance. The NCBI database analysis revealed that ADAS presents at a large proportion in American Indian Oklahoman (C&A) with a high prevalence of obesity/diabetes and in colorectal cancer (CRC) patients from the US and China. An Oklahoman non-native group (NNI) showed no ADAS. Comparison of two large US populations reveals that ADAS is more frequent in individuals aged >= 66 and in females. Prevalence and levels of fecal metabolites are altered in the C&A and CRC groups versus controls. Biogenic amines (histamine, tryptamine, tyramine, phenylethylamine, cadaverine, putrescine, agmatine, spermidine) that present in food and are produced by gut microbiota are significantly higher in C&A (e.g., histamine/histidine 95-fold) versus NNI (histamine/histidine 16-fold). The majority of these bio-amines are cytotoxic at concentrations found in food. Inositol phosphate signaling implicated in AD is altered in C&A and CRC. Tryptamine stimulated accumulation of inositol phosphate. The seizure-eliciting tryptamine induced cytoplasmic vacuolization and vesiculation with cell fragmentation. Present additions of ADAS-carriers at different ages including infants led to an ADAS-comprising human sample size of 2,830 from 27 studies from four continents (North America, Australia, Asia, Europe). Levels of food-derived monoamine oxidase inhibitors and anti-bacterial compounds, the potential modulators of ADAS-bacteria growth and biogenic amine production, were altered in C&A versus NNI. ADAS is attributable to potentially modifiable risk factors of AD associated diseases.
C1 [Paley, Elena L.] Expert Biomed Inc, 11933 SW 271st TER Homestead, Miami, FL 33032 USA.
   [Paley, Elena L.] Stop Alzheimers Corp, Miami, FL USA.
RP Paley, EL (corresponding author), Expert Biomed Inc, 11933 SW 271st TER Homestead, Miami, FL 33032 USA.
EM elena_paley@bellsouth.net
FU Art Medicus PLLC, Yonkers, NY, U.S.A.; Benevity Fund
FX This work was supported partially by Art Medicus PLLC, Yonkers, NY,
   U.S.A. and by Benevity Fund (to nonprofit Stop Alzheimers Corp,
   http://www.stopalzheimerstest.com).
CR Abbass MA, 2013, JSLS-J SOC LAPAROEND, V17, P636, DOI 10.4293/108680813X13693422520512
   Abbott NJ, 2000, CELL MOL NEUROBIOL, V20, P131, DOI 10.1023/A:1007074420772
   Ames BN, 2002, AM J CLIN NUTR, V75, P616, DOI 10.1093/ajcn/75.4.616
   Andres N, 2001, J HISTOCHEM CYTOCHEM, V49, P209, DOI 10.1177/002215540104900208
   Anwar MA, 2012, BRIT J PHARMACOL, V165, P2191, DOI 10.1111/j.1476-5381.2011.01706.x
   Anwar MA, 2013, VASC PHARMACOL, V58, P140, DOI 10.1016/j.vph.2012.10.007
   ASADA T, 1993, JPN J PSYCHIAT NEUR, V47, P651
   Askelson TE, 2014, APPL ENVIRON MICROB, V80, P943, DOI 10.1128/AEM.03155-13
   Baffy G, 2018, DIGEST DIS SCI, V63, P563, DOI 10.1007/s10620-017-4903-5
   BALDRIDGE ET, 1962, NEW ENGL J MED, V267, P421, DOI 10.1056/NEJM196208302670901
   Barcik W, 2016, J ALLERGY CLIN IMMUN, V138, P1491, DOI 10.1016/j.jaci.2016.05.049
   Barton W, 2018, GUT, V67, P625, DOI 10.1136/gutjnl-2016-313627
   Baxter BA, 2018, NUTRIENTS, V11, pE28
   BENEDETTI MS, 1989, J NEURAL TRANSM, V77, P47, DOI 10.1007/BF01255818
   Benson C, 2015, MOD TR PHARMACOPSYCH, V30, P67, DOI 10.1159/000435933
   Bergander LV, 2012, MOL ENDOCRINOL, V26, P1542, DOI 10.1210/me.2011-1351
   Berman DE, 2008, NAT NEUROSCI, V11, P547, DOI 10.1038/nn.2100
   Bhushan A, 2018, EUR J EPIDEMIOL, V33, P223, DOI 10.1007/s10654-017-0330-3
   Bonczar G, 2018, CHEM PAP, V72, P2599, DOI 10.1007/s11696-018-0490-y
   Borges A, 2013, MICROB DRUG RESIST, V19, P256, DOI 10.1089/mdr.2012.0244
   Bramley Dale, 2004, N Z Med J, V117, pU1215
   Brawek B, 2014, CELL TISSUE RES, V357, P427, DOI 10.1007/s00441-014-1798-8
   BREVET A, 1995, J BIOL CHEM, V270, P14439, DOI 10.1074/jbc.270.24.14439
   Broadley KJ, 2010, PHARMACOL THERAPEUT, V125, P363, DOI 10.1016/j.pharmthera.2009.11.005
   Calzada J, 2013, J DAIRY SCI, V96, P4816, DOI 10.3168/jds.2012-6409
   Calzada J, 2013, APPL ENVIRON MICROB, V79, P1277, DOI 10.1128/AEM.03368-12
   Carod-Artal FJ, 2007, EPILEPSIA, V48, P886, DOI 10.1111/j.1528-1167.2007.01016.x
   CARSIOTIS M, 1974, J BACTERIOL, V119, P889, DOI 10.1128/JB.119.3.889-892.1974
   CHAR S, 1986, J BIOCHEM-TOKYO, V100, P349, DOI 10.1093/oxfordjournals.jbchem.a121721
   Chaudhary S, 2017, BIOMED PHARMACOTHER, V95, P37, DOI 10.1016/j.biopha.2017.07.156
   CHEN CC, 1980, BIOCHIM BIOPHYS ACTA, V613, P514, DOI 10.1016/0005-2744(80)90107-2
   Chen CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144589
   Chen HW, 2019, CELL, V177, P1217, DOI 10.1016/j.cell.2019.03.036
   Chen Q, 2015, J BIOCHEM MOL TOXIC, V29, P521, DOI 10.1002/jbt.21722
   Chen SH, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006843
   Chistoserdov AY, 2001, MICROBIOL-SGM, V147, P2195, DOI 10.1099/00221287-147-8-2195
   CLINESCHMIDT BV, 1974, BRIT J PHARMACOL, V50, P311, DOI 10.1111/j.1476-5381.1974.tb08577.x
   Curran CP, 2017, BIRTH DEFECTS RES, V109, P1640, DOI 10.1002/bdr2.1177
   Cuthbert CA, 2018, J CANCER SURVIV, V12, P733, DOI 10.1007/s11764-018-0710-z
   Cvetesic N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28631
   Dadhich S, 2014, ANN GASTROENTEROL, V27, P244
   de la Monte SM, 2014, ACTA NEUROPATHOL, V127, P71, DOI 10.1007/s00401-013-1233-3
   del Rio B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36239-w
   del Rio B, 2017, FOOD CHEM, V218, P249, DOI 10.1016/j.foodchem.2016.09.046
   Deng YL, 1997, J CHROMATOGR B, V689, P313, DOI 10.1016/S0378-4347(96)00359-3
   Denue BA, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.83.5814
   Devinsky O, 2016, NEUROLOGY, V86, P779, DOI 10.1212/WNL.0000000000002253
   Diaz-Santana A, 2015, INTEGR BIOL-UK, V7, P454, DOI 10.1039/c5ib00052a
   DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112
   Dinicola S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102187
   Drazic A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125823
   Dudzik D, 2017, J PHARMACEUT BIOMED, V144, P90, DOI 10.1016/j.jpba.2017.02.056
   Eapen AK, 2017, FOOD CHEM TOXICOL, V105, P448, DOI 10.1016/j.fct.2017.04.049
   ELGENDI MA, 1980, BRIT J CLIN PHARMACO, V10, P157, DOI 10.1111/j.1365-2125.1980.tb01733.x
   Elliott J, 2003, AM J VET RES, V64, P1124, DOI 10.2460/ajvr.2003.64.1124
   Elshorbagy AK, 2012, CURR OPIN CLIN NUTR, V15, P49, DOI 10.1097/MCO.0b013e32834d199f
   Fanos V, 2013, EARLY HUM DEV, V89, pS58, DOI 10.1016/S0378-3782(13)70017-3
   Ferrario C, 2014, CURR MICROBIOL, V68, P404, DOI 10.1007/s00284-013-0490-7
   FINLAYSON MH, 1981, BRAIN, V104, P79, DOI 10.1093/brain/104.1.79
   Fisar Z, 2010, NEUROENDOCRINOL LETT, V31, P645
   Fondell E, 2018, EUR J EPIDEMIOL, V33, P79, DOI 10.1007/s10654-017-0331-2
   Fong TG, 2009, NEUROLOGY, V72, P1570, DOI 10.1212/WNL.0b013e3181a4129a
   Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111
   Frej AD, 2016, MOL CELL BIOL, V36, P1464, DOI 10.1128/MCB.00039-16
   Fujita T, 2003, ANN NUTR METAB, V47, P165, DOI 10.1159/000070040
   Fusi E, 2004, SMALL RUMINANT RES, V53, P1, DOI 10.1016/j.smallrumres.2003.07.009
   Fusi E, 2008, ITAL J ANIM SCI, V7, P131
   Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883
   Gardini F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01218
   Garner MR, 2002, SYST APPL MICROBIOL, V25, P498, DOI 10.1078/07232020260517625
   Gaweska Helena, 2011, Biomol Concepts, V2, P365
   Goedert JJ, 2014, CARCINOGENESIS, V35, P2089, DOI 10.1093/carcin/bgu131
   Gong ZH, 2018, EUR J PEDIATR SURG, V28, P373, DOI 10.1055/s-0037-1603092
   Gonzalez-Dominguez R, 2014, ELECTROPHORESIS, V35, P3321, DOI 10.1002/elps.201400196
   GOVINDARAJ S, 1994, J BACTERIOL, V176, P2922, DOI 10.1128/JB.176.10.2922-2929.1994
   GRAVES PV, 1979, EUR J BIOCHEM, V96, P509, DOI 10.1111/j.1432-1033.1979.tb13064.x
   GREEN H, 1960, P SOC EXP BIOL MED, V104, P153
   Gretzmeier C, 2017, AUTOPHAGY, V13, P1064, DOI 10.1080/15548627.2016.1274485
   Guo K, 2017, INT J COLORECTAL DIS, V32, P635, DOI 10.1007/s00384-017-2751-6
   Gupta S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175686
   HAMLYN AN, 1974, LANCET, V2, P1531
   He Y, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.76
   Hedskog L, 2013, P NATL ACAD SCI USA, V110, P7916, DOI 10.1073/pnas.1300677110
   Heimer J, 2018, J FORENSIC LEG MED, V59, P16, DOI 10.1016/j.jflm.2018.07.009
   Hernandez-Ronquillo L, 2018, SEIZURE-EUR J EPILEP, V60, P8, DOI 10.1016/j.seizure.2018.05.018
   HIROSE A, 1990, JPN J PHARMACOL, V53, P321, DOI 10.1254/jjp.53.321
   Hoekstra E, 2016, ONCOTARGET, V7, P73525, DOI 10.18632/oncotarget.12321
   HOLLER E, 1973, BIOCHEMISTRY-US, V12, P1142, DOI 10.1021/bi00730a020
   HOMEIDA MMA, 1987, BRIT J CLIN PHARMACO, V24, P393, DOI 10.1111/j.1365-2125.1987.tb03187.x
   Hootman KC, 2017, P NATL ACAD SCI USA, V114, pE4233, DOI 10.1073/pnas.1620079114
   Hu Y, 2018, GASTROENTEROLOGY, V154, P916, DOI 10.1053/j.gastro.2017.11.010
   IGARASHI K, 1978, EUR J BIOCHEM, V90, P13, DOI 10.1111/j.1432-1033.1978.tb12569.x
   ISEKI K, 1993, BIOCHIM BIOPHYS ACTA, V1152, P9, DOI 10.1016/0005-2736(93)90225-O
   ISHII H, 1991, DIABETES RES CLIN PR, V14, P21, DOI 10.1016/0168-8227(91)90049-J
   Ishiyama Y, 2019, J CLIN HYPERTENS, V21, P421, DOI 10.1111/jch.13489
   Izquierdo-Casas J, 2019, CLIN NUTR, V38, P152, DOI 10.1016/j.clnu.2018.01.013
   JACOBS DM, 1980, DIS COLON RECTUM, V23, P567, DOI 10.1007/BF02988998
   Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200
   Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386
   Jeong CD, 2015, ASIAN AUSTRAL J ANIM, V28, P50, DOI 10.5713/ajas.14.0555
   Jimenez-Arellanes A, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-258
   Kallenberg K, 2009, RADIOLOGY, V253, P805, DOI 10.1148/radiol.2533071654
   KARASAWA A, 1987, J PHARMACOBIO-DYNAM, V10, P78, DOI 10.1248/bpb1978.10.78
   Kenez A, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1479-z
   KENNINGTON AS, 1990, NEW ENGL J MED, V323, P373, DOI 10.1056/NEJM199008093230603
   KEYSER JW, 1970, BIOCHEM J, V118, pP26
   Khodursky A, 2015, ANNU REV MICROBIOL, V69, P247, DOI 10.1146/annurev-micro-092412-155749
   Kim DH, 1999, BIOL PHARM BULL, V22, P422, DOI 10.1248/bpb.22.422
   Kim RR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41216-y
   Klingberg E, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1223-2
   Klingberg E, 2012, SCAND J GASTROENTERO, V47, P435, DOI 10.3109/00365521.2011.648953
   Kobayashi N, 2002, STEROIDS, V67, P827, DOI 10.1016/S0039-128X(02)00036-3
   KOCHERSPERGER LM, 1986, J NEUROSCI RES, V16, P601, DOI 10.1002/jnr.490160403
   Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055
   KOSAKOWSKI HM, 1973, EUR J BIOCHEM, V38, P274, DOI 10.1111/j.1432-1033.1973.tb03059.x
   Kruska N, 2011, NEUROBIOL DIS, V43, P465, DOI 10.1016/j.nbd.2011.04.020
   Kumar Ashish, 2008, Indian J Gastroenterol, V27, P74
   Kurrasch-Orbaugh DM, 2003, J PHARMACOL EXP THER, V304, P229, DOI 10.1124/jpet.102.042184
   Larit F, 2018, PHYTOMEDICINE, V40, P27, DOI 10.1016/j.phymed.2017.12.032
   Lavilla-Lerma L, 2013, INT J FOOD MICROBIOL, V163, P136, DOI 10.1016/j.ijfoodmicro.2013.02.015
   Leblhuber F, 2015, J NEURAL TRANSM, V122, P1319, DOI 10.1007/s00702-015-1381-9
   Lee CW, 2015, ONCOTARGET, V6, P21979, DOI 10.18632/oncotarget.4273
   Lee YC, 2016, J FOOD DRUG ANAL, V24, P157, DOI 10.1016/j.jfda.2015.02.002
   Lei XG, 2013, ANNU REV ANIM BIOSCI, V1, P283, DOI 10.1146/annurev-animal-031412-103717
   Levengood J, 2004, J BIOL CHEM, V279, P17707, DOI 10.1074/jbc.M313665200
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Li Y, 2016, NUTRIENTS, V8, DOI 10.3390/nu8030167
   Lim JW, 2018, EUR J MED CHEM, V157, P405, DOI 10.1016/j.ejmech.2018.07.071
   Linares DM, 2016, FOOD CHEM, V197, P658, DOI 10.1016/j.foodchem.2015.11.013
   Louie TM, 2002, J BIOL CHEM, V277, P39450, DOI 10.1074/jbc.M206339200
   Louis ED, 2014, NEUROTOXICOLOGY, V40, P52, DOI 10.1016/j.neuro.2013.11.005
   Louis ED, 2012, J TOXICOL ENV HEAL A, V75, P673, DOI 10.1080/15287394.2012.688485
   Lu Q, 2013, J CELL BIOCHEM, V114, P1009, DOI 10.1002/jcb.24440
   Luan HM, 2015, J PROTEOME RES, V14, P467, DOI 10.1021/pr500807t
   Lucas PM, 2005, APPL ENVIRON MICROB, V71, P1417, DOI 10.1128/AEM.71.3.1417-1424.2005
   Madeo F, 2018, SCIENCE, V359, P410, DOI 10.1126/science.aan2788
   Maldonado-Gomez MX, 2016, CELL HOST MICROBE, V20, P515, DOI 10.1016/j.chom.2016.09.001
   Manske C, 2016, APPL ENVIRON MICROB, V82, P5000, DOI 10.1128/AEM.01018-16
   Mao SY, 2016, ENVIRON MICROBIOL, V18, P525, DOI 10.1111/1462-2920.12724
   Marco-Ramell A, 2018, J PROTEOME RES, V17, P2307, DOI 10.1021/acs.jproteome.7b00855
   MARTIN WR, 1970, PSYCHOPHARMACOLOGIA, V18, P231, DOI 10.1007/BF00412669
   Martinez C, 2012, GUT LIVER, V6, P305, DOI 10.5009/gnl.2012.6.3.305
   Matsunaga I, 2012, BIOCHEM BIOPH RES CO, V419, P687, DOI 10.1016/j.bbrc.2012.02.079
   MATTSON MP, 1993, ANN NY ACAD SCI, V679, P1, DOI 10.1111/j.1749-6632.1993.tb18285.x
   MCEWEN CM, 1968, J BIOL CHEM, V243, P5217
   MCKENNA DJ, 1984, J ETHNOPHARMACOL, V10, P195, DOI 10.1016/0378-8741(84)90003-5
   McNamara BJ, 2011, PREV MED, V52, P3, DOI 10.1016/j.ypmed.2010.11.002
   Medda R, 1997, EUR J BIOCHEM, V250, P377, DOI 10.1111/j.1432-1033.1997.0377a.x
   Meng Q, 2016, APPL MICROBIOL BIOT, V100, P535, DOI 10.1007/s00253-015-7087-y
   Militsa N N, 2008, Klin Khir, P37
   MILLER BL, 1993, RADIOLOGY, V187, P433, DOI 10.1148/radiology.187.2.8475286
   Mindikoglu AL, 2018, TRANSL RES, V195, P25, DOI 10.1016/j.trsl.2017.12.002
   Mitchell AL, 2018, NUCLEIC ACIDS RES, V46, pD726, DOI 10.1093/nar/gkx967
   Miyanokoshi M, 2018, J BIOL CHEM, V293, P8428, DOI 10.1074/jbc.RA117.001247
   Miyata K, 2009, INTERNAL MED, V48, P321, DOI 10.2169/internalmedicine.48.1777
   Moezi L, 2015, EPILEPSY BEHAV, V44, P200, DOI 10.1016/j.yebeh.2015.01.013
   Molina-Hernandez A, 2008, J NEUROCHEM, V106, P706, DOI 10.1111/j.1471-4159.2008.05424.x
   Montano A, 1996, J FOOD PROTECT, V59, P657, DOI 10.4315/0362-028X-59.6.657
   MOUSSEAU DD, 1993, CELL MOL NEUROBIOL, V13, P3, DOI 10.1007/BF00712985
   MOUSSEAU DD, 1994, J NEUROCHEM, V62, P621
   MOUSSEAU DD, 1993, METAB BRAIN DIS, V8, P1, DOI 10.1007/BF01000528
   Muguruma Y, 2018, J CHROMATOGR B, V1091, P53, DOI 10.1016/j.jchromb.2018.05.031
   Nacev BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024793
   Nakanuma Y, 2001, PATHOL RES PRACT, V197, P65, DOI 10.1078/0344-0338-5710012
   Naoi M, 2004, NEUROTOXICOLOGY, V25, P193, DOI 10.1016/S0161-813X(03)00099-8
   Newell J, 1984, Nurse Pract, V9, P26
   Niaudet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137949
   Nishijima S, 2016, DNA RES, V23, P125, DOI 10.1093/dnares/dsw002
   Nishikawa T, 2014, NEUROPATH APPL NEURO, V40, P489, DOI 10.1111/nan.12056
   Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X
   Novotny JA, 2015, J NUTR, V145, P1185, DOI 10.3945/jn.114.203190
   Oberdoerster J, 2000, J PHARMACOL EXP THER, V295, P295
   Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505
   Ohara T, 2017, NEUROLOGY, V88, P1925, DOI 10.1212/WNL.0000000000003932
   Ohta H, 2017, BIOSCI BIOTECH BIOCH, V81, P1002, DOI 10.1080/09168451.2016.1274640
   Okuyama S, 1997, J PHARMACOL EXP THER, V282, P56
   OSBORNE NN, 1986, NEUROCHEM RES, V11, P1525, DOI 10.1007/BF00965771
   Oyama K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165831
   Pal SS, 2013, OCUL IMMUNOL INFLAMM, V21, P446, DOI 10.3109/09273948.2013.817592
   Paley EL, 1999, CANCER LETT, V137, P1, DOI 10.1016/S0304-3835(98)00342-5
   PALEY EL, 1991, EXP CELL RES, V195, P66, DOI 10.1016/0014-4827(91)90501-K
   Paley EL, 2007, NEUROMOL MED, V9, P55, DOI 10.1385/NMM:9:1:55
   Paley EL, 2007, MOL IMMUNOL, V44, P541, DOI 10.1016/j.molimm.2006.02.006
   Paley EL, 2019, INT J TRYPTOPHAN RES, V12, DOI 10.1177/1178646919834550
   Paley EL, 2018, NUTRIENTS, V10, DOI 10.3390/nu10040410
   Paley EL, 2018, J ALZHEIMERS DIS, V61, P1531, DOI 10.3233/JAD-170764
   Paley EL, 2011, TRANSL ONCOL, V4, P377, DOI 10.1593/tlo.11220
   Paley EL, 2011, PANCREAS, V40, P1043, DOI 10.1097/MPA.0b013e318222e635
   Paley EL, 2011, J ALZHEIMERS DIS, V26, P263, DOI 10.3233/JAD-2011-110176
   Papamichail M, 2018, EUR J PEDIATR, V177, P285, DOI 10.1007/s00431-017-3058-x
   Perez M, 2015, APPL MICROBIOL BIOT, V99, P3547, DOI 10.1007/s00253-014-6301-7
   Petersen LM, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0320-4
   Piccolo E, 2004, ONCOGENE, V23, P1754, DOI 10.1038/sj.onc.1207296
   Piert M, 2017, J NUCL MED, V58, P1216, DOI 10.2967/jnumed.116.173179
   Pons-Sanchez-Cascado S, 2005, J FOOD PROTECT, V68, P1683, DOI 10.4315/0362-028X-68.8.1683
   Price MN, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00297-18
   Procopet B, 2017, GASTROENTEROL REP, V5, P79, DOI 10.1093/gastro/gox012
   Pugin Benoit, 2017, Microbial Ecology in Health and Disease, V28, P1353881, DOI 10.1080/16512235.2017.1353881
   Qin XF, 2017, INFLAMM BOWEL DIS, V23, pE11, DOI 10.1097/MIB.0000000000001010
   Ray S, 2018, MICROBIOL RES, V207, P100, DOI 10.1016/j.micres.2017.11.011
   Ray S, 2016, PLANT PHYSIOL BIOCH, V109, P430, DOI 10.1016/j.plaphy.2016.10.019
   Rebholz CM, 2018, AM J CLIN NUTR, V108, P243, DOI 10.1093/ajcn/nqy099
   Rebholz CM, 2018, DIABETOLOGIA, V61, P1046, DOI 10.1007/s00125-018-4573-7
   Regnat K, 2018, APPL MICROBIOL BIOT, V102, P587, DOI 10.1007/s00253-017-8654-1
   REILLY MA, 1978, AGENTS ACTIONS, V8, P203, DOI 10.1007/BF01966604
   RICHARDSON PDI, 1981, GASTROENTEROLOGY, V81, P356
   Riley AM, 2014, CHEMBIOCHEM, V15, P57, DOI 10.1002/cbic.201300583
   Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003
   SABELLI HC, 1995, J NEUROPSYCH CLIN N, V7, P6
   Salter M, 2018, CARDIOVASC TOXICOL, V18, P583, DOI 10.1007/s12012-018-9476-9
   Sankaranarayanan K, 2015, CURR BIOL, V25, P3161, DOI 10.1016/j.cub.2015.10.060
   Schwarzinger M, 2018, LANCET PUBLIC HEALTH, V3, pE124, DOI 10.1016/S2468-2667(18)30022-7
   Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z
   Setchell KDR, 2006, ENVIRON HEALTH PERSP, V114, pA332, DOI 10.1289/ehp.114-a332
   Shalaby AR, 2000, NAHRUNG, V44, P23, DOI [10.1002/(SICI)1521-3803(20000101)44:1<23::AID-FOOD23>3.0.CO;2-B, 10.1002/(SICI)1521-3803(20000101)44:1&lt;23::AID-FOOD23&gt;3.0.CO;2-B]
   Shankar RR, 1998, METABOLISM, V47, P573, DOI 10.1016/S0026-0495(98)90242-6
   Sharma M, 2012, J CLIN EXP HEPATOL, V2, P338, DOI 10.1016/j.jceh.2012.08.001
   Shimohama S, 1998, NEUROSCIENCE, V82, P999
   Shimohama S, 1998, NEUROSCI LETT, V245, P159, DOI 10.1016/S0304-3940(98)00209-2
   SHONK T, 1995, MAGN RESON MED, V33, P858, DOI 10.1002/mrm.1910330619
   Sinha R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152126
   Song WS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29445-z
   SORENSEN MA, 1991, J MOL BIOL, V222, P265, DOI 10.1016/0022-2836(91)90211-N
   Spiller R, 2016, NAT REV GASTRO HEPAT, V13, P613, DOI 10.1038/nrgastro.2016.141
   Stygelbout V, 2014, BRAIN, V137, P537, DOI 10.1093/brain/awt344
   Su PP, 2018, PHYTOPATHOLOGY, V108, P542, DOI [10.1094/PHYTO-09-17-0332-R, 10.1094/phyto-09-17-0332-r]
   Sulpice E, 2009, BIOL CELL, V101, P525, DOI 10.1042/BC20080221
   SUSILO R, 1987, N-S ARCH PHARMACOL, V335, P70, DOI 10.1007/BF00165039
   TAKEDA Y, 1975, J BIOL CHEM, V250, P3878
   Takita T, 1996, J BIOCHEM-TOKYO, V119, P680
   Taylor DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093540
   TEDESCHI DH, 1959, J PHARMACOL EXP THER, V126, P223
   Tena D, 2015, JPN J INFECT DIS, V68, P128, DOI 10.7883/yoken.JJID.2014.164
   Thorpe LW, 1987, J HISTOCHEM CYTOCHEM, V35, P23, DOI 10.1177/35.1.3025289
   Tresaugues L, 2014, STRUCTURE, V22, P744, DOI 10.1016/j.str.2014.01.013
   Uebanso T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070756
   van den Brink DM, 2006, CELL MOL LIFE SCI, V63, P1752, DOI 10.1007/s00018-005-5463-y
   Vancamelbeke M, 2017, EXPERT REV GASTROENT, V11, P821, DOI 10.1080/17474124.2017.1343143
   Vantroys E, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0822-6
   Viala JPM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022397
   Vieira-Coelho MA, 2001, LIFE SCI, V69, P1957, DOI 10.1016/S0024-3205(01)01278-4
   Vitale AA, 2011, J NUCL MED, V52, P970, DOI 10.2967/jnumed.110.083246
   Vossel KA, 2017, LANCET NEUROL, V16, P311, DOI 10.1016/S1474-4422(17)30044-3
   Vossel KA, 2013, JAMA NEUROL, V70, P1158, DOI 10.1001/jamaneurol.2013.136
   Vrolijk MF, 2017, TOXICOL IN VITRO, V44, P206, DOI 10.1016/j.tiv.2017.07.009
   Vucenik I, 2006, NUTR CANCER, V55, P109, DOI 10.1207/s15327914nc5502_1
   Walter J, 2008, APPL ENVIRON MICROB, V74, P4985, DOI 10.1128/AEM.00753-08
   Wang G, 2014, J PROTEOME RES, V13, P2649, DOI 10.1021/pr5000895
   Wang XN, 2016, J PROTEOME RES, V15, P1126, DOI 10.1021/acs.jproteome.5b00217
   WARNER CK, 1976, CAN J BIOCHEM CELL B, V54, P650, DOI 10.1139/o76-094
   WARRINGTON RC, 1992, BIOCHEM CELL BIOL, V70, P365, DOI 10.1139/o92-056
   Watanabe T, 2018, INT J CLIN ONCOL, V23, P1, DOI 10.1007/s10147-017-1101-6
   WEINSHEL E, 1986, GASTROENTEROLOGY, V90, P744, DOI 10.1016/0016-5085(86)91132-7
   Widmann M, 2000, J BIOL CHEM, V275, P18619, DOI 10.1074/jbc.C000156200
   Williams JM, 2015, VET PATHOL, V52, P445, DOI 10.1177/0300985814559404
   WU HQ, 1995, EUR J PHARMACOL, V281, P55, DOI 10.1016/0014-2999(95)00224-9
   Wust J, 2016, FOOD FUNCT, V7, P2526, DOI [10.1039/C5FO01550B, 10.1039/c5fo01550b]
   Wust N, 2017, FOOD ADDIT CONTAM A, V34, P404, DOI 10.1080/19440049.2016.1269207
   Yang B, 2007, RENAL FAILURE, V29, P1025, DOI 10.1080/08860220701641272
   YAO JK, 1982, J NEUROL SCI, V55, P185, DOI 10.1016/0022-510X(82)90100-9
   Yemis GP, 2011, J FOOD PROTECT, V74, P2062, DOI 10.4315/0362-028X.JFP-11-230
   Yoshikawa T, 2014, J NUTR, V144, P1637, DOI 10.3945/jn.114.196105
   Youmans BP, 2015, GUT MICROBES, V6, P110, DOI 10.1080/19490976.2015.1019693
   Youmans BP, 2014, AM J TROP MED HYG, V90, P124, DOI 10.4269/ajtmh.13-0383
   Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431
   Zang XL, 2017, J PROTEOME RES, V16, P550, DOI 10.1021/acs.jproteome.6b00675
   Zarmouh NO, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/1423052
   ZEIDAN HM, 1988, BIOCHIM BIOPHYS ACTA, V955, P111, DOI 10.1016/0167-4838(88)90184-7
   Zhang S, 2015, DIABETES, V64, P1383, DOI 10.2337/db14-1188
   Zhang TL, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00176
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
   Zhao XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05852-6
   Zhou SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161627
   Zhu W, 2008, CLIN CHEM, V54, P705, DOI 10.1373/clinchem.2007.097725
   Zhu ZB, 2019, ATHEROSCLEROSIS, V287, P30, DOI 10.1016/j.atherosclerosis.2019.05.028
NR 277
TC 8
Z9 8
U1 1
U2 29
PU IOS PRESS
PI AMSTERDAM
PA NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS
SN 1387-2877
EI 1875-8908
J9 J ALZHEIMERS DIS
JI J. Alzheimers Dis.
PY 2019
VL 72
IS 1
BP 319
EP 355
DI 10.3233/JAD-190873
PG 37
WC Neurosciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Neurosciences & Neurology
GA JT1TQ
UT WOS:000500780700026
PM 31561379
DA 2022-11-22
ER

PT J
AU Greathouse, KL
   White, JR
   Padgett, RN
   Perrotta, BG
   Jenkins, GD
   Chia, N
   Chen, J
AF Greathouse, K. Leigh
   White, James Robert
   Padgett, R. Noah
   Perrotta, Brittany G.
   Jenkins, Gregory D.
   Chia, Nicholas
   Chen, Jun
TI Gut microbiome meta-analysis reveals dysbiosis is independent of body
   mass index in predicting risk of obesity-associated CRC
SO BMJ OPEN GASTROENTEROLOGY
LA English
DT Article
ID AKKERMANSIA-MUCINIPHILA; COLORECTAL-CANCER; INFLAMMATION; METABOLOME;
   CELLS; MICE
AB Objective Obesity is a risk factor for colorectal cancer (CRC), accounting for more than 14% of CRC incidence. Microbial dysbiosis and chronic inflammation are common characteristics in both obesity and CRC. Human and murine studies, together, demonstrate the significant impact of the microbiome in governing energy metabolism and CRC development; yet, little is understood about the contribution of the microbiome to development of obesity-associated CRC as compared to individuals who are not obese.
   Design In this study, we conducted a meta-analysis using five publicly available stool and tissue-based 16S rRNA and whole genome sequencing (WGS) data sets of CRC microbiome studies. High-resolution analysis was employed for 16S rRNA data, which allowed us to achieve species-level information to compare with WGS.
   Results Characterisation of the confounders between studies, 16S rRNA variable region and sequencing method did not reveal any significant effect on alpha diversity in CRC prediction. Both 16S rRNA and WGS were equally variable in their ability to predict CRC. Results from diversity analysis confirmed lower diversity in obese individuals without CRC; however, no universal differences were found in diversity between obese and non-obese individuals with CRC. When examining taxonomic differences, the probability of being classified as CRC did not change significantly in obese individuals for all taxa tested. However, random forest classification was able to distinguish CRC and non-CRC stool when body mass index was added to the model.
   Conclusion Overall, microbial dysbiosis was not a significant factor in explaining the higher risk of colon cancer among individuals with obesity.
C1 [Greathouse, K. Leigh] Baylor Univ, Robbins Coll Hlth & Human Sci, Nutr Sci Div, Waco, TX 76798 USA.
   [Greathouse, K. Leigh; Perrotta, Brittany G.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [White, James Robert] Resphera Biosci, Baltimore, MD USA.
   [Padgett, R. Noah] Baylor Univ, Dept Educ Psychol, Waco, TX 76798 USA.
   [Jenkins, Gregory D.; Chia, Nicholas] Mayo Clin, Dept Surg, Rochester, NY USA.
   [Jenkins, Gregory D.; Chia, Nicholas] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, NY USA.
   [Chia, Nicholas; Chen, Jun] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, NY USA.
C3 Baylor University; Baylor University; Baylor University; Mayo Clinic;
   Mayo Clinic; Mayo Clinic
RP Greathouse, KL (corresponding author), Baylor Univ, Robbins Coll Hlth & Human Sci, Nutr Sci Div, Waco, TX 76798 USA.; Greathouse, KL (corresponding author), Baylor Univ, Dept Biol, Waco, TX 76798 USA.
EM Leigh_Greathouse@baylor.edu
FU Baylor University Summer Sabbatical Grant; NCI [R01CA179243]; NATIONAL
   CANCER INSTITUTE [R01CA179243] Funding Source: NIH RePORTER
FX This work was supported by the Baylor University Summer Sabbatical Grant
   (PI-summer salary support). NC was supported by the NCI award
   R01CA179243.
CR Arnold M, 2015, LANCET ONCOL, V16, P36, DOI 10.1016/S1470-2045(14)71123-4
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Caer C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02660-w
   Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408
   Chehimi M, 2017, J CLIN MED, V6, DOI 10.3390/jcm6070068
   Chen J, 2018, BIOINFORMATICS, V34, P643, DOI 10.1093/bioinformatics/btx650
   Chen J, 2012, BIOINFORMATICS, V28, P2106, DOI 10.1093/bioinformatics/bts342
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Engeland A, 2005, CANCER CAUSE CONTROL, V16, P987, DOI 10.1007/s10552-005-3638-3
   Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Garidou L, 2015, CELL METAB, V22, P100, DOI 10.1016/j.cmet.2015.06.001
   GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002
   Greer RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13329
   Hanyuda A, 2017, EUR J EPIDEMIOL, V32, P393, DOI 10.1007/s10654-017-0254-y
   Hanyuda A, 2016, INT J CANCER, V139, P854, DOI 10.1002/ijc.30122
   Higashimura Y, 2016, AM J PHYSIOL-GASTR L, V310, pG367, DOI 10.1152/ajpgi.00324.2015
   Kellermayer R, 2011, FASEB J, V25, P1449, DOI 10.1096/fj.10-172205
   Koh GY, 2018, INT J CANC
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Liu L, 2018, CLIN GASTROENTEROL H, V16, P1622, DOI 10.1016/j.cgh.2018.04.030
   Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358
   Liu W, 2016, J CANCER, V7, P1780, DOI 10.7150/jca.15792
   Moya-Perez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126976
   Nakatsu G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9727
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Pfalzer AC, 2016, PHYSIOL GENOMICS, V48, P545, DOI 10.1152/physiolgenomics.00034.2016
   Pfalzer AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135758
   Purcell RV, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171602
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Schulz MD, 2014, NATURE, V514, P508, DOI 10.1038/nature13398
   Sinicrope FA, 2012, J CLIN ONCOL, V30, P406, DOI 10.1200/JCO.2011.39.2563
   Sze MA, 2018, MBIO, V9
   Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16
   Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Walters WA, 2014, FEBS LETT, V588, P4223, DOI 10.1016/j.febslet.2014.09.039
   Whiteman DC, 2016, CANCER EPIDEMIOL, V44, P203, DOI 10.1016/j.canep.2016.06.013
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yu DX, 2018, JNCI-J NATL CANCER I, V110, P831, DOI 10.1093/jnci/djx286
   Zackular JP, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00001-15
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zeng HW, 2016, J NUTR BIOCHEM, V35, P30, DOI 10.1016/j.jnutbio.2016.05.015
   Zhao SQ, 2017, J MOL ENDOCRINOL, V58, P1, DOI 10.1530/JME-16-0054
NR 51
TC 12
Z9 13
U1 0
U2 10
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2054-4774
J9 BMJ OPEN GASTROENTER
JI BMJ Open Gastroenterol.
PD JAN
PY 2019
VL 6
IS 1
AR e000247
DI 10.1136/bmjgast-2018-000247
PG 12
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA IC7DV
UT WOS:000471133700005
PM 30899534
OA Green Published, gold, Green Submitted
DA 2022-11-22
ER

PT J
AU Yadav, M
   Verma, MK
   Chauhan, NS
AF Yadav, Monika
   Verma, Manoj Kumar
   Chauhan, Nar Singh
TI A review of metabolic potential of human gut microbiome in human
   nutrition
SO ARCHIVES OF MICROBIOLOGY
LA English
DT Review
DE Gut microbiota; Microbiome; Microbiota
ID INTESTINAL MICROBIOTA; PRENATAL STRESS; HELICOBACTER-PYLORI; MOLECULAR
   ANALYSIS; METAGENOMIC ANALYSIS; COLONIC MICROBIOTA; ANAEROBIC-BACTERIA;
   PROFILING REVEALS; COLORECTAL-CANCER; LYMPHOID-TISSUES
AB The human gut contains a plethora of microbes, providing a platform for metabolic interaction between the host and microbiota. Metabolites produced by the gut microbiota act as a link between gut microbiota and its host. These metabolites act as messengers having the capacity to alter the gut microbiota. Recent advances in the characterization of the gut microbiota and its symbiotic relationship with the host have provided a platform to decode metabolic interactions. The human gut microbiota, a crucial component for dietary metabolism, is shaped by the genetic, epigenetic and dietary factors. The metabolic potential of gut microbiota explains its significance in host health and diseases. The knowledge of interactions between microbiota and host metabolism, as well as modification of microbial ecology, is really beneficial to have effective therapeutic treatments for many diet-related diseases in near future. This review cumulates the information to map the role of human gut microbiota in dietary component metabolism, the role of gut microbes derived metabolites in human health and host-microbe metabolic interactions in health and diseases.
C1 [Yadav, Monika; Verma, Manoj Kumar; Chauhan, Nar Singh] Maharshi Dayanand Univ, Dept Biochem, Rohtak 124001, Haryana, India.
C3 Maharshi Dayanand University
RP Chauhan, NS (corresponding author), Maharshi Dayanand Univ, Dept Biochem, Rohtak 124001, Haryana, India.
EM nschauhan@mdurohtak.ac.in
RI CHAUHAN, NAR SINGH/ABC-7379-2021
OI chauhan, Narsingh/0000-0003-4546-9358
FU Council of Scientific and Industrial Research (CSIR), Govt. of India
   [60(0099)/11/EMRII]; University grant Commission
FX Authors would like to thank Council of Scientific and Industrial
   Research (CSIR), Govt. of India for financial support under the scheme
   60(0099)/11/EMRII. Monika is thankful to University grant Commission for
   Junior research fellowship.
CR Acheson DWK, 2004, BEST PRACT RES CL GA, V18, P387, DOI 10.1016/j.bpg.2003.11.002
   Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836
   Barrett E, 2013, ARCH DIS CHILD-FETAL, V98, pF334, DOI 10.1136/archdischild-2012-303035
   Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006
   Bhute S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00660
   Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103
   Bingham SA, 1996, CARCINOGENESIS, V17, P515, DOI 10.1093/carcin/17.3.515
   Bjerrum JT, 2015, METABOLOMICS, V11, P122, DOI 10.1007/s11306-014-0677-3
   Boyd SD, 2013, CURR OPIN IMMUNOL, V25, P511, DOI 10.1016/j.coi.2013.07.007
   Braune A, 2016, GUT MICROBES, V7, P216, DOI 10.1080/19490976.2016.1158395
   Braune A, 2016, ENVIRON MICROBIOL, V18, P2117, DOI 10.1111/1462-2920.12864
   CARROLL BJ, 1971, CLIN PHARMACOL THER, V12, P743
   Chauhan NS, 2017, CURR TRENDS BIOMEDIC, V6, DOI [10.19080/CTBEB.2017.06.555680, DOI 10.19080/CTBEB.2017.06.555680]
   Chen Y, 2007, ARCH INTERN MED, V167, P821, DOI 10.1001/archinte.167.8.821
   CHRISTL SU, 1992, GASTROENTEROLOGY, V102, P1269
   CHRISTL SU, 1993, GASTROENTEROLOGY, V104, P392, DOI 10.1016/0016-5085(93)90406-3
   Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272
   Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037
   Coe CL, 2002, DEV PSYCHOBIOL, V41, P178, DOI 10.1002/dev.10063
   CORDRUWISCH R, 1988, ARCH MICROBIOL, V149, P350, DOI 10.1007/BF00411655
   CORRODI P, 1978, J INFECT DIS, V137, P1, DOI 10.1093/infdis/137.1.1
   Cummings JH, 1997, CLIN NUTR, V16, P3, DOI 10.1016/S0261-5614(97)80252-X
   CUMMINGS JH, 1987, AM J CLIN NUTR, V45, P1243, DOI 10.1093/ajcn/45.5.1243
   Dai ZL, 2010, AMINO ACIDS, V39, P1201, DOI 10.1007/s00726-010-0556-9
   Dayan J, 2006, PSYCHOSOM MED, V68, P938, DOI 10.1097/01.psy.0000244025.20549.bd
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Decroos K, 2005, ARCH MICROBIOL, V183, P45, DOI 10.1007/s00203-004-0747-4
   Derrien M, 2010, GUT MICROBES, V1, P254, DOI 10.4161/gmic.1.4.12778
   Dinakaran V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105221
   Dominguez-Bello MG, 2008, MICROBES INFECT, V10, P1072, DOI 10.1016/j.micinf.2008.07.036
   Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107
   Dominguez-Bello MG, 2011, GASTROENTEROLOGY, V140, P1713, DOI 10.1053/j.gastro.2011.02.011
   Dougherty DM, 2008, PSYCHOPHARMACOLOGY, V198, P431, DOI 10.1007/s00213-008-1163-2
   Duda-Chodak A, 2015, EUR J NUTR, V54, P325, DOI 10.1007/s00394-015-0852-y
   Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103
   Duncan SH, 2004, APPL ENVIRON MICROB, V70, P5810, DOI 10.1128/AEM.70.10.5810-5817.2004
   Dutton RJ, 2012, CURR OPIN CLIN NUTR, V15, P448, DOI 10.1097/MCO.0b013e3283561133
   Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Falony G, 2006, APPL ENVIRON MICROB, V72, P7835, DOI 10.1128/AEM.01296-06
   Fetissov SO, 2017, NAT REV ENDOCRINOL, V13, P11, DOI 10.1038/nrendo.2016.150
   Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Freeman DJ, 2004, HYPERTENSION, V44, P708, DOI 10.1161/01.HYP.0000143849.67254.ca
   FRICK PG, 1967, J APPL PHYSIOL, V23, P387, DOI 10.1152/jappl.1967.23.3.387
   Gao Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002719
   Garcia-Canaveras JC, 2012, J LIPID RES, V53, P2231, DOI 10.1194/jlr.D028803
   Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004
   GIBSON GR, 1990, J APPL BACTERIOL, V69, P769, DOI 10.1111/j.1365-2672.1990.tb01575.x
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Giurgescu C, 2009, JOGNN-J OBST GYN NEO, V38, P377, DOI 10.1111/j.1552-6909.2009.01034.x
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   GUSTAFSSON BE, 1977, J LIPID RES, V18, P717
   GUSTAFSSON BE, 1962, J NUTR, V78, P461, DOI 10.1093/jn/78.4.461
   LeBlanc JG, 2013, CURR OPIN BIOTECH, V24, P160, DOI 10.1016/j.copbio.2012.08.005
   HARRIS MA, 1976, APPL ENVIRON MICROB, V31, P907, DOI 10.1128/AEM.31.6.907-912.1976
   Hayashi H, 2005, J MED MICROBIOL, V54, P1093, DOI 10.1099/jmm.0.45935-0
   Hayashi H, 2003, MICROBIOL IMMUNOL, V47, P557, DOI 10.1111/j.1348-0421.2003.tb03418.x
   Hayashi H, 2002, MICROBIOL IMMUNOL, V46, P535, DOI 10.1111/j.1348-0421.2002.tb02731.x
   Heberling CA, 2013, MED HYPOTHESES, V80, P264, DOI 10.1016/j.mehy.2012.11.044
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   Hermanussen M, 2010, EUR J CLIN NUTR, V64, P88, DOI 10.1038/ejcn.2009.116
   Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009
   Hooper LV, 1998, BIOESSAYS, V20, P336, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;336::AID-BIES10&gt;3.0.CO;2-3
   Hope ME, 2005, FEMS MICROBIOL LETT, V244, P1, DOI 10.1016/j.femsle.2005.01.029
   Huizink AC, 2002, J AM ACAD CHILD PSY, V41, P1078, DOI 10.1097/00004583-200209000-00008
   Islami F, 2008, CANCER PREV RES, V1, P329, DOI 10.1158/1940-6207.CAPR-08-0109
   Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   JONES RSG, 1982, PROG NEUROBIOL, V19, P117, DOI 10.1016/0301-0082(82)90023-5
   Juge N, 2012, TRENDS MICROBIOL, V20, P30, DOI 10.1016/j.tim.2011.10.001
   Kamada N, 2013, NAT IMMUNOL, V14, P685, DOI 10.1038/ni.2608
   Kamada N, 2013, J IMMUNOL, V190, P1389, DOI 10.4049/jimmunol.1203100
   Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449
   Kanwar SS., 2016, MICROBES FOOD HLTH, P29, DOI DOI 10.1007/978-3-319-25277-3_2
   Kaplan JL, 2011, PEDIATR RES, V69, P465, DOI 10.1203/PDR.0b013e318217638a
   Keenan K, 2007, INFANT BEHAV DEV, V30, P134, DOI 10.1016/j.infbeh.2006.08.001
   Keenan K, 2013, AM J CLIN NUTR, V98, P396, DOI 10.3945/ajcn.112.040352
   KELLOGG TF, 1971, FED PROC, V30, P1808
   Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158
   Kim J, 2013, MICROBIOL-SGM, V159, P2616, DOI 10.1099/mic.0.070615-0
   Klein R E, 1976, Bull Pan Am Health Organ, V10, P301
   Koboziev I, 2014, FREE RADICAL BIO MED, V68, P122, DOI 10.1016/j.freeradbiomed.2013.11.008
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kordalewska M, 2015, J PHARMACEUT BIOMED, V113, P121, DOI 10.1016/j.jpba.2015.04.021
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kumar J, 2016, GENOM PROTEOM BIOINF, V14, P371, DOI 10.1016/j.gpb.2016.06.002
   Kunz C, 2009, ADV EXP MED BIOL, V639, P67, DOI 10.1007/978-1-4020-8749-3_6
   LAJOIE SF, 1988, APPL ENVIRON MICROB, V54, P2723, DOI 10.1128/AEM.54.11.2723-2727.1988
   Lampe JW, 2009, AM J CLIN NUTR, V89, pS1664, DOI 10.3945/ajcn.2009.26736T
   Landete J M, 2016, Crit Rev Food Sci Nutr, V56, P1826, DOI 10.1080/10408398.2013.789823
   Leloup J, 2009, ENVIRON MICROBIOL, V11, P1278, DOI 10.1111/j.1462-2920.2008.01855.x
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Lin L, 2017, BMC IMMUNOL, V18, DOI 10.1186/s12865-016-0187-3
   LOU HC, 1994, DEV MED CHILD NEUROL, V36, P826
   Loubinoux J, 2002, INT J SYST EVOL MICR, V52, P1305, DOI 10.1099/ijs.0.02175-0
   Louis P, 2004, J BACTERIOL, V186, P2099, DOI 10.1128/JB.186.7.2099-2106.2004
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lowe LP, 2010, J CLIN ENDOCR METAB, V95, P5427, DOI 10.1210/jc.2010-1662
   MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647
   Macfarlane S, 2006, APPL ENVIRON MICROB, V72, P6204, DOI 10.1128/AEM.00754-06
   Machiels K, 2014, GUT, V63, P1275, DOI 10.1136/gutjnl-2013-304833
   Magnusdottir S, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00148
   Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727
   Marin L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/905215
   Marteau P, 2001, APPL ENVIRON MICROB, V67, P4939, DOI 10.1128/AEM.67.10.4939-4942.2001
   Mondal AK, 2017, GENOME BIOL EVOL, V9, P1175, DOI 10.1093/gbe/evx076
   Moroni F, 1999, EUR J PHARMACOL, V375, P87, DOI 10.1016/S0014-2999(99)00196-X
   Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568
   Muir JG, 2004, AM J CLIN NUTR, V79, P1020
   Murri M, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-46
   Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892
   Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080
   Norris V, 2013, J BACTERIOL, V195, P411, DOI 10.1128/JB.01384-12
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   Ouwehand AC, 2005, CURR OPIN BIOTECH, V16, P212, DOI 10.1016/j.copbio.2005.01.007
   Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703
   Penders J, 2006, PEDIATRICS, V118, P511, DOI 10.1542/peds.2005-2824
   Perez-Jimenez J, 2011, AM J CLIN NUTR, V93, P1220, DOI 10.3945/ajcn.110.007096
   Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123
   Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823
   Praveen P, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0104-7
   PRENTISS PG, 1961, ARCH BIOCHEM BIOPHYS, V94, P424, DOI 10.1016/0003-9861(61)90069-8
   Principi N, 2016, J INFECTION, V73, P536, DOI 10.1016/j.jinf.2016.09.010
   Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quartieri A, 2016, MOL NUTR FOOD RES, V60, P1590, DOI 10.1002/mnfr.201500773
   Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022
   Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14
   Reinhardt C, 2012, NATURE, V483, P627, DOI 10.1038/nature10893
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Romano KA, 2015, MBIO, V6, DOI 10.1128/mBio.02481-14
   Rosenberg E, 2011, BIRTH DEFECTS RES C, V93, P56, DOI 10.1002/bdrc.20196
   Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005
   Ruma M, 2007, AM J OBSTET GYNECOL, V197, pS73, DOI 10.1016/j.ajog.2007.10.234
   Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594
   Said HM, 2013, AM J PHYSIOL-GASTR L, V305, pG601, DOI 10.1152/ajpgi.00231.2013
   SAKATA H, 1985, EUR J PEDIATR, V144, P186, DOI 10.1007/BF00451911
   Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103
   SANDYK R, 1992, INT J NEUROSCI, V67, P127, DOI 10.3109/00207459208994781
   Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55
   SAVAGE DC, 1970, AM J CLIN NUTR, V23, P1495
   Scanlan PD, 2009, FEMS MICROBIOL ECOL, V69, P213, DOI 10.1111/j.1574-6941.2009.00709.x
   Schloss PD, 2004, MICROBIOL MOL BIOL R, V68, P686, DOI 10.1128/MMBR.68.4.686-691.2004
   Schneider ML, 2002, PSYCHONEUROENDOCRINO, V27, P285, DOI 10.1016/S0306-4530(01)00050-6
   Scott KP, 2008, NUTR BULL, V33, P201, DOI 10.1111/j.1467-3010.2008.00706.x
   Scott KP, 2006, J BACTERIOL, V188, P4340, DOI 10.1128/JB.00137-06
   Seksik P, 2003, GUT, V52, P237, DOI 10.1136/gut.52.2.237
   Shanahan F, 2013, CURR OPIN GASTROEN, V29, P49, DOI 10.1097/MOG.0b013e32835a3493
   Sharma Renu, 2010, J Biomed Biotechnol, V2010, P305879, DOI 10.1155/2010/305879
   Sjogren K, 2012, BONE, V50, pS91, DOI [10.1016/j.bone.2012.02.272, 10.1002/jbmr.1588]
   Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x
   Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049
   Stappenbeck TS, 2002, P NATL ACAD SCI USA, V99, P15451, DOI 10.1073/pnas.202604299
   Suarez F, 1997, AM J PHYSIOL-GASTR L, V272, pG1028, DOI 10.1152/ajpgi.1997.272.5.G1028
   Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x
   THADEPALLI H, 1979, AM J SURG, V138, P845, DOI 10.1016/0002-9610(79)90309-X
   Tomas-Barberan F, 2014, MOL NUTR FOOD RES, V58, P1122, DOI 10.1002/mnfr.201300441
   Tomas-Barberan FA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500901
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turroni F, 2008, ANTON LEEUW INT J G, V94, P35, DOI 10.1007/s10482-008-9232-4
   Ubeda C, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.2
   Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622
   Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791
   Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14
   WADHWA PD, 1993, AM J OBSTET GYNECOL, V169, P858, DOI 10.1016/0002-9378(93)90016-C
   Wall R, 2009, CLIN MED INSIGHTS-PE, V3, P45
   Wang J, 2010, PHYTOMEDICINE, V17, P684, DOI 10.1016/j.phymed.2009.10.009
   Wang X, 2003, J APPL MICROBIOL, V95, P508, DOI 10.1046/j.1365-2672.2003.02005.x
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wauson EM, 2013, MOL ENDOCRINOL, V27, P1188, DOI 10.1210/me.2013-1100
   Weinstock M, 2005, BRAIN BEHAV IMMUN, V19, P296, DOI 10.1016/j.bbi.2004.09.006
   Weinstock M, 1997, NEUROSCI BIOBEHAV R, V21, P1, DOI 10.1016/S0149-7634(96)00014-0
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Wolf PG, 2016, GUT MICROBES, V7, P235, DOI 10.1080/19490976.2016.1182288
   Woollett LA, 2003, J LIPID RES, V44, P935, DOI 10.1194/jlr.M200478-JLR200
   Xu J, 2003, P NATL ACAD SCI USA, V100, P10452, DOI 10.1073/pnas.1734063100
   Yang EV, 2002, INT IMMUNOPHARMACOL, V2, P315, DOI 10.1016/S1567-5769(01)00182-5
   Yeoh N, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0314-y
   Yu Linda Chia-Hui, 2012, World J Gastrointest Pathophysiol, V3, P27, DOI 10.4291/wjgp.v3.i1.27
   Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003
   Zhang YJ, 2015, INT J MOL SCI, V16, P7493, DOI 10.3390/ijms16047493
   Zijlmans MAC, 2015, PSYCHONEUROENDOCRINO, V53, P233, DOI 10.1016/j.psyneuen.2015.01.006
NR 186
TC 95
Z9 97
U1 11
U2 132
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0302-8933
EI 1432-072X
J9 ARCH MICROBIOL
JI Arch. Microbiol.
PD MAR
PY 2018
VL 200
IS 2
BP 203
EP 217
DI 10.1007/s00203-017-1459-x
PG 15
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA FX3CZ
UT WOS:000425949100002
PM 29188341
DA 2022-11-22
ER

PT J
AU Wang, YQ
   Nguyen, LH
   Mehta, RS
   Song, MY
   Huttenhower, C
   Chan, AT
AF Wang, Yiqing
   Nguyen, Long H.
   Mehta, Raaj S.
   Song, Mingyang
   Huttenhower, Curtis
   Chan, Andrew T.
TI Association Between the Sulfur Microbial Diet and Risk of Colorectal
   Cancer
SO JAMA NETWORK OPEN
LA English
DT Article
ID PATTERNS; SULFIDE; ISOTHIOCYANATES; VALIDITY; DISEASE; COHORT; WOMEN;
   SEX; MEN
AB Importance Sulfur-metabolizing bacteria that reduce dietary sulfur to hydrogen sulfide have been associated with colorectal cancer (CRC). However, there are limited studies investigating the association between diet and sulfur-metabolizing bacteria in the development of CRC.
   Objective To develop a dietary score that correlates with gut sulfur-metabolizing bacteria and to examine its association with CRC risk.
   Design, Setting, and Participants This prospective cohort study included data from the Health Professionals Follow-up Study (1986-2014), Nurses' Health Study (1984-2016), and Nurses' Health Study II (1991-2017). Participants were US male health professionals and female registered nurses who were free of inflammatory bowel disease and cancer at baseline, with a subsample of participants who provided stool samples from 2012 to 2014. Statistical analysis was conducted from September 1, 2020, to June 1, 2021.
   Exposure A dietary pattern, assessed by a food-frequency questionnaire, that most correlated with 43 sulfur-metabolizing bacteria identified through taxonomic and functional profiling of gut metagenome data.
   Main Outcomes and Measures Incident CRC.
   Results Among 214 797 participants comprising 46 550 men (mean [SD] age at baseline, 54.3 [9.7] years) and 168 247 women (mean [SD] age at baseline, 43.0 [9.2] years), 3217 incident cases of CRC (1.5%) were documented during 5 278 048 person-years of follow-up. The sulfur microbial diet, developed in a subsample of 307 men (mean [SD] age, 70.5 [4.3] years) and 212 women (mean [SD] age, 61.0 [3.8] years), was characterized by high intakes of low-calorie beverages, french fries, red meats, and processed meats and low intakes of fruits, yellow vegetables, whole grains, legumes, leafy vegetables, and cruciferous vegetables. After adjustment for other risk factors, greater adherence to the sulfur microbial diet was associated with an increased risk of CRC, with a hazard ratio (HR) of 1.27 (95% CI, 1.12-1.44) comparing the highest vs the lowest quintile of the diet score (linear trend of diet score quintiles; P < .001 for trend). When assessed by anatomical subsites, greater adherence to the sulfur microbial diet was positively associated with distal CRC (HR, 1.25; 95% CI, 1.05-1.50; P = .02 for trend) but not proximal colon cancer (HR, 1.13; 95% CI, 0.93-1.39; P = .19 for trend).
   Conclusions and Relevance Adherence to the sulfur microbial diet was associated with an increased risk of CRC, suggesting a potential mediating role of sulfur-metabolizing bacteria in the associaton between diet and CRC. Further research is needed to confirm these findings and to determine the underlying mechanisms.
C1 [Wang, Yiqing; Nguyen, Long H.; Mehta, Raaj S.; Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.
   [Wang, Yiqing; Nguyen, Long H.; Mehta, Raaj S.; Song, Mingyang; Chan, Andrew T.] Harvard Med Sch, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.
   [Wang, Yiqing; Nguyen, Long H.; Mehta, Raaj S.; Song, Mingyang; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Wang, Yiqing; Nguyen, Long H.; Mehta, Raaj S.; Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Song, Mingyang] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Huttenhower, Curtis; Chan, Andrew T.] Broad Inst MIT & Harvard, Cambridge, MA USA.
   [Huttenhower, Curtis; Chan, Andrew T.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Chan, Andrew T.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
C3 Harvard University; Massachusetts General Hospital; Harvard University;
   Harvard Medical School; Harvard University; Massachusetts General
   Hospital; Harvard University; Harvard T.H. Chan School of Public Health;
   Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Harvard T.H. Chan School of Public Health; Harvard
   University; Massachusetts Institute of Technology (MIT); Broad
   Institute; Harvard University; Harvard T.H. Chan School of Public
   Health; Harvard University; Brigham & Women's Hospital
RP Chan, AT (corresponding author), Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.; Chan, AT (corresponding author), Harvard Med Sch, 55 Fruit St,GRJ-825C, Boston, MA 02114 USA.; Huttenhower, C (corresponding author), Broad Inst MIT & Harvard, Harvard TH Chan Sch Publ Hlth, Dept Biostat, 677 Huntington Ave, Boston, MA 02115 USA.
EM chuttenh@hsph.harvard.edu; achan@mgh.harvard.edu
FU National Institutes of Health [U01 CA167552, UM1 CA186107, P01 CA87969,
   U01 CA176726, K23 DK125838, R00 CA215314, R01 CA202704, R35 CA253185];
   American Gastroenterological Association; Crohn's and Colitis
   Foundation; American Cancer Society; Massachusetts General Hospital;
   Cancer Research UK
FX This work was supported by the National Institutes of Health (grant U01
   CA167552 to Health Professionals Follow-up Study, grants UM1 CA186107
   and P01 CA87969 to Nurses' Health Study, grant U01 CA176726 to Nurses'
   Health Study II, Loan Repayment Program and grant K23 DK125838 to Dr
   Nguyen, grant R00 CA215314 to Dr Song, grant R01 CA202704 to Drs
   Huttenhower and Chan, and grant R35 CA253185 to Dr Chan), American
   Gastroenterological Association (Research Scholars Award to Dr Nguyen),
   the Crohn's and Colitis Foundation (Research Fellowship Award and Career
   Development Award to Dr Nguyen and Senior Investigator Award to Dr
   Chan), American Cancer Society (Mentored Research Scholar Grant in
   Applied and Clinical Research to Dr Song), Massachusetts General
   Hospital (Stuart and Suzanne Steele Research Scholar Award to Dr Chan),
   and Cancer Research UK.
CR Abancens M, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.607909
   Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439
   Baran B, 2018, GASTROENTEROL RES, V11, P264, DOI 10.14740/gr1062w
   Benedix F, 2010, DIS COLON RECTUM, V53, P57, DOI 10.1007/DCR.0b013e3181c703a4
   Bertoia ML, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i17
   Bianchini F, 2004, DRUG METAB REV, V36, P655, DOI 10.1081/DMR-200033468
   Chen J, 2013, BIOSTATISTICS, V14, P244, DOI 10.1093/biostatistics/kxs038
   Daly CM, 2022, NUTR NEUROSCI, V25, P321, DOI 10.1080/1028415X.2020.1752996
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Dermadi D, 2017, CANCER RES, V77, P3352, DOI 10.1158/0008-5472.CAN-16-2860
   Din FVN, 2010, GUT, V59, P1670, DOI 10.1136/gut.2009.203000
   Franzosa EA, 2014, P NATL ACAD SCI USA, V111, pE2329, DOI 10.1073/pnas.1319284111
   Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797
   Guercio BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199244
   Hashem FA, 2012, PHYTOTHER RES, V26, P743, DOI 10.1002/ptr.3591
   Hu FB, 2000, AM J CLIN NUTR, V72, P912
   Hu FB, 1999, AM J CLIN NUTR, V69, P243
   Huang TY, 2019, CANCER CAUSE CONTROL, V30, P779, DOI 10.1007/s10552-019-01176-0
   Ijssennagger N, 2016, TRENDS MOL MED, V22, P190, DOI 10.1016/j.molmed.2016.01.002
   Jiang JJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20831
   Kesse E, 2006, AM J EPIDEMIOL, V164, P1085, DOI 10.1093/aje/kwj324
   Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167
   Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001
   Lieberman DA, 2014, GASTROENTEROLOGY, V147, P351, DOI 10.1053/j.gastro.2014.04.037
   London SJ, 2000, LANCET, V356, P724, DOI 10.1016/S0140-6736(00)02631-3
   Mach N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65444-9
   Magee EA, 2000, AM J CLIN NUTR, V72, P1488
   McIver LJ, 2018, BIOINFORMATICS, V34, P1235, DOI 10.1093/bioinformatics/btx754
   Mehta RS, 2018, NAT MICROBIOL, V3, P347, DOI 10.1038/s41564-017-0096-0
   Nguyen LH, 2020, GASTROENTEROLOGY, V158, P1313, DOI 10.1053/j.gastro.2019.12.029
   Palmisano BT, 2018, MOL METAB, V15, P45, DOI 10.1016/j.molmet.2018.05.008
   RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W
   Solomon CG, 1997, JAMA-J AM MED ASSOC, V278, P1078, DOI 10.1001/jama.278.13.1078
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Song SJ, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00021-16
   Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660
   Voigt AY, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0639-8
   Webster AD, 2019, GUT MICROBES, V10, P447, DOI 10.1080/19490976.2018.1559682
   Witten DM, 2009, BIOSTATISTICS, V10, P515, DOI 10.1093/biostatistics/kxp008
   Wu QJ, 2013, ANN ONCOL, V24, P1079, DOI 10.1093/annonc/mds601
   Yuan CZ, 2017, AM J EPIDEMIOL, V185, P570, DOI 10.1093/aje/kww104
   Zhang ZX, 2020, NUTRIENTS, V12, DOI 10.3390/nu12072088
   Zoltick ES, 2021, BRIT J CANCER, V125, P1016, DOI 10.1038/s41416-021-01487-7
NR 43
TC 4
Z9 4
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD NOV 12
PY 2021
VL 4
IS 11
AR e2134308
DI 10.1001/jamanetworkopen.2021.34308
PG 12
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA WW2CB
UT WOS:000717730400005
PM 34767023
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Wang, XY
   Sun, ZX
   Makale, EC
   Sun, ZK
   Wang, TC
   Hou, ZY
   Yu, XY
   Long, WF
   Du, GK
   Huang, HR
AF Wang, Xue-Yuan
   Sun, Zao-Xi
   Makale, Emmanuel Costantine
   Sun, Zheng-Ke
   Wang, Tai-Cheng
   Hou, Zhi-Ying
   Yu, Xing-Yue
   Long, Wenfang
   Du, Guan-Kui
   Huang, Hairong
TI Gut Microbial Profile in Patients with Pancreatic Cancer
SO JUNDISHAPUR JOURNAL OF MICROBIOLOGY
LA English
DT Article
DE Pancreatic Cancer; Gut Microbiota; Metagenomics; Tropical Area
ID EXPRESSION; BACTERIA; COLON
AB Background: Pancreatic cancer is a lethal tumor with a poor prognosis. The connection between pancreatic cancer and gut micro -biota is less reported. Objectives: This study analyzed microbial characteristics in patients with pancreatic cancer from the tropical area of China and explored the potential impact of the characteristic microflora on pancreatic cancer. Methods: Stool samples and blood test indices of participants were collected in Hainan, China. Metagenomic sequencing was used to analyze the gut microbiota characteristics. The R corrplot package was used to analyze the correlation between gut microbiota and blood test indices. Results: The microbial community in pancreatic cancer were clustered together and significantly separated from controls. The Simpson index was increased significantly in pancreatic cancer compared to controls. The abundances of butyrate-producing bac-teria (Anaerostipes hadrus, Lachnoclostridium phocaeense, and Romboutsia ilealis), Bifidobacteria, and [Eubacterium] eligens were sig-nificantly decreased, while Fusobacterium, Enterobacter, and Enterococcus were significantly increased in pancreatic cancer. Prevotella copri may have a vital role in the bacterial interaction network. Pathways connected to metabolism, environment (bacterial secre-tion system), genetic information (protein export and ribosome), and human diseases (infectious diseases and drug resistance) were increased in the pancreatic cancer group. Butyrate-producing bacteria (butyrate-producing bacterium SS3/4,A. hadrus, R. intestinalis, and Faecalibacterium prausnitzii) and Bifidobacteria were significantly negatively correlated with the neutrophil-to-lymphocyte ratio. Conclusions: The gut microbiome was distinct in patients with pancreatic cancer from the tropical area of China. Changes in intestinal flora abundance and metabolic pathways may play an essential role in the occurrence and development of pancreatic cancer.
C1 [Wang, Xue-Yuan; Yu, Xing-Yue; Long, Wenfang; Huang, Hairong] Hainan Med Univ, Int Sch Publ Hlth & One Hlth, Dept Epidemiol, Haikou, Hainan, Peoples R China.
   [Sun, Zao-Xi; Makale, Emmanuel Costantine; Sun, Zheng-Ke] Hainan Med Univ, Affiliated Hosp 1, Dept Gen Surg, Haikou, Hainan, Peoples R China.
   [Wang, Tai-Cheng] Hainan Med Univ, Affiliated Hosp 2, Dept Gen Surg, Haikou, Hainan, Peoples R China.
   [Hou, Zhi-Ying] Nanjing Med Univ, Kangda Coll, Dept Epidemiol, Nanjing, Peoples R China.
   [Du, Guan-Kui] Hainan Med Univ, Dept Biochem & Mol Biol, Haikou, Hainan, Peoples R China.
C3 Hainan Medical University; Hainan Medical University; Hainan Medical
   University; Nanjing Medical University; Hainan Medical University
RP Huang, HR (corresponding author), Hainan Med Univ, Int Sch Publ Hlth & One Hlth, Dept Epidemiol, Haikou, Hainan, Peoples R China.
EM jialidog1@163.com
FU Key Research Projects of Higher Education Institutions of Hainan
   Province [Hnky2019ZD-23]; Hainan Provincial Natural Science Foundation
   of China [821RC745]; innovative research projects for undergraduate
   students in Hainan Province [X201911810051, Qhys2021-375]
FX This work was supported by the Key Research Projects of Higher Education
   Institutions of Hainan Province (No. Hnky2019ZD-23) and supported by the
   Hainan Provincial Natural Science Foundation of China (821RC745) .) ,
   innovative research projects for graduate stu-dents in Hainan Province
   (Qhys2021-375) , and innovative research projects for undergraduate
   students in Hainan Province (X201911810051) .
CR Arvans DL, 2005, AM J PHYSIOL-GASTR L, V288, pG696, DOI 10.1152/ajpgi.00206.2004
   Battini S, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0810-z
   Bausch D, 2011, ANGIOGENESIS, V14, P235, DOI 10.1007/s10456-011-9207-3
   Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
   Cai J, 2021, Zhonghua Liu Xing Bing Xue Za Zhi, V42, P794, DOI 10.3760/cma.j.cn112338-20201115-01328
   Choy ATF, 2018, EXPERT REV MOL DIAGN, V18, P1005, DOI 10.1080/14737159.2018.1544495
   D'Argenio G, 2005, GUT, V54, P496, DOI 10.1136/gut.2004.049411
   Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033
   Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948
   Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043
   Half E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53041-4
   Kiehne K, 2006, WORLD J GASTROENTERO, V12, P1056, DOI 10.3748/wjg.v12.i7.1056
   Kim Y, 2008, ARCH PHARM RES, V31, P468, DOI 10.1007/s12272-001-1180-y
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Lee P, 2014, J DENT RES, V93, P162, DOI 10.1177/0022034513516346
   [邹彦 Zou Yan], 2020, [中华疾病控制杂志, Chinese Journal of Disease Control & Prevention], V24, P610
   Ni YQ, 2021, ISME J, V15, P3207, DOI 10.1038/s41396-021-00998-8
   Oh NS, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1785803
   Pancreatic Cancer Committee of Chinese Anticancer Association, 2021, Zhonghua Wai Ke Za Zhi, V59, P81, DOI 10.3760/cma.j.cn112139-20201113-00794
   Quah SY, 2014, INT ENDOD J, V47, P550, DOI 10.1111/iej.12185
   Rajagopala SV, 2017, CANCER PREV RES, V10, P226, DOI 10.1158/1940-6207.CAPR-16-0249
   Rattan P, 2020, LIVER TRANSPLANT, V26, P1316, DOI 10.1002/lt.25828
   Ren ZG, 2017, ONCOTARGET, V8, P95176, DOI 10.18632/oncotarget.18820
   Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Ruiz L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02345
   Sainz B, 2015, GUT, V64, P1921, DOI 10.1136/gutjnl-2014-308935
   Shen DC, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-020-00398-5
   Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI 10.3322/caac.21590
   Song MY, 2020, GASTROENTEROLOGY, V158, P322, DOI 10.1053/j.gastro.2019.06.048
   Szkandera J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078225
   Tan CC, 2015, PANCREAS, V44, P868, DOI 10.1097/MPA.0000000000000355
   Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124
   Tian H, 2017, BIOCELL, V41, P27
   Tripathi A, 2018, NAT REV GASTRO HEPAT, V15, P397, DOI 10.1038/s41575-018-0011-z
   Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009
   Wang AS, 2014, NMR BIOMED, V27, P1361, DOI 10.1002/nbm.3198
   Yang YX, 2008, WORLD J GASTROENTERO, V14, P6237, DOI 10.3748/wjg.14.6237
   Zeng HM, 2018, LANCET GLOB HEALTH, V6, pE555, DOI 10.1016/S2214-109X(18)30127-X
NR 39
TC 0
Z9 0
U1 0
U2 0
PU BRIEFLAND
PI Shertogenbosch
PA 25 Derde Morgen, Shertogenbosch, NETHERLANDS
SN 2008-3645
EI 2008-4161
J9 JUNDISHAPUR J MICROB
JI Jundishapur J. Microbiol.
PD APR
PY 2022
VL 15
IS 4
AR e122386
DI 10.5812/jjm-122386
PG 12
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 3M6OZ
UT WOS:000835580100004
OA gold
DA 2022-11-22
ER

PT J
AU Thomas, AM
   Manghi, P
   Asnicar, F
   Pasolli, E
   Armanini, F
   Zolfo, M
   Beghini, F
   Manara, S
   Karcher, N
   Pozzi, C
   Gandini, S
   Serrano, D
   Tarallo, S
   Francavilla, A
   Gallo, G
   Trompetto, M
   Ferrero, G
   Mizutani, S
   Shiroma, H
   Shiba, S
   Shibata, T
   Yachida, S
   Yamada, T
   Wirbel, J
   Schrotz-King, P
   Ulrich, CM
   Brenner, H
   Arumugam, M
   Bork, P
   Zeller, G
   Cordero, F
   Dias-Neto, E
   Setubal, JC
   Tett, A
   Pardini, B
   Rescigno, M
   Waldron, L
   Naccarati, A
   Segata, N
AF Thomas, Andrew Maltez
   Manghi, Paolo
   Asnicar, Francesco
   Pasolli, Edoardo
   Armanini, Federica
   Zolfo, Moreno
   Beghini, Francesco
   Manara, Serena
   Karcher, Nicolai
   Pozzi, Chiara
   Gandini, Sara
   Serrano, Davide
   Tarallo, Sonia
   Francavilla, Antonio
   Gallo, Gaetano
   Trompetto, Mario
   Ferrero, Giulio
   Mizutani, Sayaka
   Shiroma, Hirotsugu
   Shiba, Satoshi
   Shibata, Tatsuhiro
   Yachida, Shinichi
   Yamada, Takuji
   Wirbel, Jakob
   Schrotz-King, Petra
   Ulrich, Cornelia M.
   Brenner, Hermann
   Arumugam, Manimozhiyan
   Bork, Peer
   Zeller, Georg
   Cordero, Francesca
   Dias-Neto, Emmanuel
   Setubal, Joao Carlos
   Tett, Adrian
   Pardini, Barbara
   Rescigno, Maria
   Waldron, Levi
   Naccarati, Alessio
   Segata, Nicola
TI Metagenomic analysis of colorectal cancer datasets identifies
   cross-cohort microbial diagnostic signatures and a link with choline
   degradation
SO NATURE MEDICINE
LA English
DT Article
ID HUMAN GUT MICROBIOME; READ ALIGNMENT; RISK; DIVERSITY; TUMORIGENESIS;
   ASSOCIATION; SEARCH; HEALTH; TOOL
AB Several studies have investigated links between the gut microbiome and colorectal cancer (CRC), but questions remain about the replicability of biomarkers across cohorts and populations. We performed a meta-analysis of five publicly available datasets and two new cohorts and validated the findings on two additional cohorts, considering in total 969 fecal metagenomes. Unlike microbiome shifts associated with gastrointestinal syndromes, the gut microbiome in CRC showed reproducibly higher richness than controls (P < 0.01), partially due to expansions of species typically derived from the oral cavity. Meta-analysis of the microbiome functional potential identified gluconeogenesis and the putrefaction and fermentation pathways as being associated with CRC, whereas the stachyose and starch degradation pathways were associated with controls. Predictive microbiome signatures for CRC trained on multiple datasets showed consistently high accuracy in datasets not considered for model training and independent validation cohorts (average area under the curve, 0.84). Pooled analysis of raw metagenomes showed that the choline trimethylaminelyase gene was overabundant in CRC (P = 0.001), identifying a relationship between microbiome choline metabolism and CRC. The combined analysis of heterogeneous CRC cohorts thus identified reproducible microbiome biomarkers and accurate disease-predictive models that can form the basis for clinical prognostic tests and hypothesis-driven mechanistic studies.
C1 [Thomas, Andrew Maltez; Manghi, Paolo; Asnicar, Francesco; Pasolli, Edoardo; Armanini, Federica; Zolfo, Moreno; Beghini, Francesco; Manara, Serena; Karcher, Nicolai; Tett, Adrian; Segata, Nicola] Univ Trento, Dept CIBIO, Trento, Italy.
   [Thomas, Andrew Maltez; Setubal, Joao Carlos] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.
   [Thomas, Andrew Maltez; Manghi, Paolo; Dias-Neto, Emmanuel] CIPE AC Camargo Canc Ctr, Med Genom Lab, Sao Paulo, Brazil.
   [Pozzi, Chiara; Gandini, Sara; Serrano, Davide] European Inst Oncol, Milan, Italy.
   [Tarallo, Sonia; Francavilla, Antonio; Pardini, Barbara; Naccarati, Alessio] Italian Inst Genom Med, Turin, Italy.
   [Gallo, Gaetano] Univ Catanzaro, Dept Surg & Med Sci, Catanzaro, Italy.
   [Gallo, Gaetano; Trompetto, Mario] Clin S Rita, Dept Colorectal Surg, Vercelli, Italy.
   [Ferrero, Giulio; Cordero, Francesca] Univ Turin, Dept Comp Sci, Turin, Italy.
   [Mizutani, Sayaka; Shiroma, Hirotsugu; Yamada, Takuji] Tokyo Inst Technol, Sch Life Sci & Technol, Tokyo, Japan.
   [Mizutani, Sayaka] Japan Soc Promot Sci, Tokyo, Japan.
   [Shiba, Satoshi; Shibata, Tatsuhiro; Yachida, Shinichi] Natl Canc Ctr, Res Inst, Div Canc Genom, Tokyo, Japan.
   [Shibata, Tatsuhiro] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Tokyo, Japan.
   [Yachida, Shinichi] Osaka Univ, Dept Canc Genome Informat, Osaka, Japan.
   [Yamada, Takuji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.
   [Wirbel, Jakob; Bork, Peer; Zeller, Georg] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.
   [Schrotz-King, Petra; Brenner, Hermann] Natl Ctr Tumor Dis, Div Prevent Oncol, Heidelberg, Germany.
   [Schrotz-King, Petra; Brenner, Hermann] German Canc Res Ctr, Heidelberg, Germany.
   [Ulrich, Cornelia M.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA.
   [Ulrich, Cornelia M.] Univ Utah, Dept Populat Hlth Sci, Salt Lake City, UT USA.
   [Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany.
   [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium, Heidelberg, Germany.
   [Arumugam, Manimozhiyan] Univ Copenhagen, Fac Hlth & Med Sci, Novo Nordisk Fdn Ctr Basic Metab Res, Copenhagen, Denmark.
   [Arumugam, Manimozhiyan] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.
   [Bork, Peer] Mol Med Partnership Unit, Heidelberg, Germany.
   [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Bork, Peer] Univ Wurzburg, Bioctr, Dept Bioinformat, Wurzburg, Germany.
   [Dias-Neto, Emmanuel] Univ Sao Paulo, Inst Psychiat, Lab Neurosci, Sao Paulo, Brazil.
   [Setubal, Joao Carlos] Virginia Tech, Biocomplex Inst, Blacksburg, VA USA.
   [Pardini, Barbara] Univ Turin, Dept Med Sci, Turin, Italy.
   [Rescigno, Maria] Humanitas Res Hosp, Mucosal Immunol & Microbiota Unit, Milan, Italy.
   [Waldron, Levi] CUNY, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA.
   [Waldron, Levi] CUNY, Inst Implementat Sci Populat Hlth, New York, NY 10021 USA.
   [Naccarati, Alessio] Inst Expt Med, Dept Mol Biol Canc, Prague, Czech Republic.
C3 University of Trento; Universidade de Sao Paulo; A.C.Camargo Cancer
   Center; IRCCS European Institute of Oncology (IEO); Italian Institute
   for Genomic Medicine (IIGM); Magna Graecia University of Catanzaro;
   University of Turin; Tokyo Institute of Technology; Japan Society for
   the Promotion of Science; National Cancer Center - Japan; University of
   Tokyo; Osaka University; Japan Science & Technology Agency (JST);
   European Molecular Biology Laboratory (EMBL); Helmholtz Association;
   German Cancer Research Center (DKFZ); Ruprecht Karls University
   Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ);
   Huntsman Cancer Institute; Utah System of Higher Education; University
   of Utah; Utah System of Higher Education; University of Utah; Helmholtz
   Association; German Cancer Research Center (DKFZ); Helmholtz
   Association; German Cancer Research Center (DKFZ); Novo Nordisk
   Foundation; University of Copenhagen; University of Southern Denmark;
   Helmholtz Association; Max Delbruck Center for Molecular Medicine;
   University of Wurzburg; Universidade de Sao Paulo; Virginia Polytechnic
   Institute & State University; University of Turin; City University of
   New York (CUNY) System; City University of New York (CUNY) System; Czech
   Academy of Sciences
RP Segata, N (corresponding author), Univ Trento, Dept CIBIO, Trento, Italy.
EM nicola.segata@unitn.it
RI Brenner, Hermann/ABE-6383-2020; Tarallo, Sonia/AAB-8656-2022; Brenner,
   Hermann/B-4627-2017; Dias-Neto, Emmanuel/AAA-6701-2019; Asnicar,
   Francesco/AAB-9255-2020; Shiba, Satoshi/AAJ-2157-2021; Manara,
   Serena/AAQ-7771-2020; Arumugam, Manimozhiyan/AAJ-2394-2020; Pardini,
   Barbara/ABI-2295-2020; Bork, Peer/F-1813-2013; Shibata,
   Tatsuhiro/AAO-1278-2021; Dias-Neto, Emmanuel/AAE-9147-2020; francavilla,
   antonio/AAB-8783-2022; Cordero, Francesca/AAB-3655-2019; Beghini,
   Francesco/ABE-9981-2021; Dias-Neto, Emmanuel/A-5869-2008; Setubal, Joao
   Carlos/C-7305-2012; gandini, sara/J-4916-2018; Gallo,
   Gaetano/I-6917-2019; Ferrero, Giulio/K-9508-2019; Segata,
   Nicola/AAB-2980-2019; Arumugam, Manimozhiyan/E-1211-2011; Pozzi,
   Chiara/K-4481-2018; Shibata, Tatsuhiro/ABA-8234-2020; shiba,
   satoshi/AAL-4953-2021; Zolfo, Moreno/Y-4374-2019; Zolfo,
   Moreno/Q-4368-2016; Waldron, Levi/H-2967-2019; Pasolli,
   Edoardo/K-5156-2016; Zeller, Georg/M-6484-2013
OI Brenner, Hermann/0000-0002-6129-1572; Brenner,
   Hermann/0000-0002-6129-1572; Asnicar, Francesco/0000-0003-3732-1468;
   Shiba, Satoshi/0000-0001-5159-5719; Manara, Serena/0000-0001-6371-528X;
   Arumugam, Manimozhiyan/0000-0002-0886-9101; Pardini,
   Barbara/0000-0001-9571-4257; Bork, Peer/0000-0002-2627-833X; Cordero,
   Francesca/0000-0002-3143-3330; Beghini, Francesco/0000-0002-8105-9607;
   Dias-Neto, Emmanuel/0000-0001-5670-8559; Setubal, Joao
   Carlos/0000-0001-9174-2816; gandini, sara/0000-0002-1348-4548; Gallo,
   Gaetano/0000-0003-1066-4671; Ferrero, Giulio/0000-0002-4580-0680;
   Arumugam, Manimozhiyan/0000-0002-0886-9101; Pozzi,
   Chiara/0000-0003-2153-6130; Zolfo, Moreno/0000-0001-6661-4046; Zolfo,
   Moreno/0000-0001-6661-4046; Waldron, Levi/0000-0003-2725-0694; Tarallo,
   Sonia/0000-0003-0887-2607; Pasolli, Edoardo/0000-0003-0799-3490; Wirbel,
   Jakob/0000-0002-4073-3562; Serrano, Davide/0000-0002-2945-4108; Tett,
   Adrian/0000-0003-3141-3943; Manghi, Paolo/0000-0003-0846-6529;
   francavilla, antonio/0000-0003-1594-2837; Naccarati,
   Alessio/0000-0001-5774-0905; Thomas, Andrew Maltez/0000-0001-5789-3354;
   Zeller, Georg/0000-0003-1429-7485; Karcher, Nicolai/0000-0001-7894-8182
FU Lega Italiana per La Lotta contro i Tumori; Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [16/23527-2]; Conselho Nacional
   de Pesquisa e Desenvolvimento (CNPq, Brazil); FAPESP [14/26897-0];
   Associacao Beneficente Alzira Denise Hertzog Silva (ABADHS, Brazil);
   PRONON/SIPAR; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior -Brazil (CAPES) [001]; Italian Institute for Genomic Medicine
   (IIGM); Compagnia di San Paolo Torino; Fondazione Umberto Veronesi;
   Grant Agency of the Czech Republic [17-16857S]; Fondazione Umberto
   Veronesi [FUV-14-SG-GANDINI]; European Union [707345]; European Research
   Council (ERC-STG project MetaPG); MIUR 'Futuro in Ricerca'
   [RBFR13EWWI_001]; European Union; National Cancer Institute
   [U24CA180996, R01 CA189184, R01 CA207371, U01 CA206110, P30 CA042014];
   National Institute of Allergy and Infectious Diseases of the National
   Institutes of Health [1R21AI121784-01]; Fulbright Research Scholarship;
   EMBL; DKFZ; Huntsman Cancer Foundation; Intramural Research Program of
   the National Cancer Institute; ETH Zurich; European Research Council
   [ERC-2010-AdG_20100317, ERC-AdG-669830]; Novo Nordisk Foundation
   [NNF10CC1016515]; Danish Diabetes Academy - Novo Nordisk Foundation;
   TARGET research initiative (Danish Strategic Research Council)
   [0603-00484B]; Matthias-Lackas Foundation; BMBF [031A537B]; ERA-NET
   TRANSCAN project [01KT1503]; Helmut Horten Foundation; National Cancer
   Center Research and Development Fund [25-A-4, 28-A-4, 29-A-6]; Practical
   Research Project for Rare/Intractable Diseases from the Japan Agency for
   Medical Research and Development (AMED) [JP18ek0109187]; JST (Japan
   Science and Technology Agency)-PRESTO [JPMJPR1507]; Japan Society for
   the Promotion of Science KAKENHI [16J10135, 142558, 221S0002]; Joint
   Research Project of the Institute of Medical Science; University of
   Tokyo; Takeda Science Foundation; Suzuken Memorial Foundation; NATIONAL
   CANCER INSTITUTE [P30CA042014] Funding Source: NIH RePORTER
FX We thank the members of the Segata, Naccarati and Waldron groups for
   insightful discussions, all the volunteers enrolled in the study, the
   NGS facility at the University of Trento for performing the metagenomic
   sequencing, and the HPC facility at the University of Trento for
   supporting the computational experiments. This work was primarily
   supported by Lega Italiana per La Lotta contro i Tumori to N.S., F.C.
   and A.N., and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP, grant No. 16/23527-2) to A.M.T. This work was also partially
   supported by the Conselho Nacional de Pesquisa e Desenvolvimento (CNPq,
   Brazil) to J.C.S. and E.D.-N.; by FAPESP (grant No. 14/26897-0); by
   Associacao Beneficente Alzira Denise Hertzog Silva (ABADHS, Brazil) and
   PRONON/SIPAR to E.D.-N.; by Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior -Brazil (CAPES) (Finance Code No. 001 to J.C.S.; by the
   Italian Institute for Genomic Medicine (IIGM) and Compagnia di San Paolo
   Torino to A.N, A.F., B.P. and S.T.; by Fondazione Umberto Veronesi
   'Post-doctoral Fellowship Years 2014, 2015, 2016, 2017 and 2018' to B.P.
   and S.T.; by the Grant Agency of the Czech Republic (grant No.
   17-16857S) to A.N.; by Fondazione Umberto Veronesi (grant No.
   FUV-14-SG-GANDINI) to S.G.; by the European Union H2020 Marie Curie
   grant (No. 707345) to E.P.; by the European Research Council (ERC-STG
   project MetaPG) to N.S.; by MIUR 'Futuro in Ricerca' (grant No.
   RBFR13EWWI_001) to N.S.; by the People Programme (Marie Curie Actions)
   of the European Union FP7 and H2020 to N.S.; and by the National Cancer
   Institute (grant No. U24CA180996) and National Institute of Allergy and
   Infectious Diseases (grant No. 1R21AI121784-01) of the National
   Institutes of Health to L.W.B.P. is the recipient of a Fulbright
   Research Scholarship (year 2018). We acknowledge funding from EMBL,
   DKFZ, the Huntsman Cancer Foundation, the Intramural Research Program of
   the National Cancer Institute, ETH Zurich and the following external
   sources: the European Research Council (CancerBiome, grant No.
   ERC-2010-AdG_20100317) to P.B.; Microbios (No. ERC-AdG-669830) to P.B.;
   the Novo Nordisk Foundation (grant No. NNF10CC1016515) to M.A.; the
   Danish Diabetes Academy supported by the Novo Nordisk Foundation and
   TARGET research initiative (Danish Strategic Research Council, grant No.
   0603-00484B) to M.A.; the Matthias-Lackas Foundation (to C.M.U.); the
   National Cancer Institute (grant Nos. R01 CA189184, R01 CA207371, U01
   CA206110 and P30 CA042014 ll to C.M.U.); the BMBF (the de. NBI network,
   grant No. 031A537B) to P.B.; the ERA-NET TRANSCAN project (No. 01KT1503)
   to C.M.U.; and the Helmut Horten Foundation (to S.S.). For Validation
   Cohort2, funding was provided by grants from the National Cancer Center
   Research and Development Fund (grant Nos. 25-A-4, 28-A-4 and 29-A-6);
   Practical Research Project for Rare/Intractable Diseases from the Japan
   Agency for Medical Research and Development (AMED, grant No.
   JP18ek0109187); JST (Japan Science and Technology Agency)-PRESTO (grant
   No. JPMJPR1507); Japan Society for the Promotion of Science KAKENHI
   (grant Nos. 16J10135, 142558 and 221S0002); Joint Research Project of
   the Institute of Medical Science; the University of Tokyo; the Takeda
   Science Foundation; and the Suzuken Memorial Foundation.
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029
   Bae S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835
   Baxter NT, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0290-3
   Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609
   Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663
   BREIMAN L, 2001, MACH LEARN, V0045
   Brito IL, 2016, NATURE, V535, P435, DOI 10.1038/nature18927
   Chung L, 2018, CELL HOST MICROBE, V23, P203, DOI [10.1016/j.chom.2018.01.007, 10.1016/j.chom.2018.02.004]
   Costea PI, 2017, NAT BIOTECHNOL, V35, P1069, DOI 10.1038/nbt.3960
   Cougnoux A, 2014, GUT, V63, P1932, DOI 10.1136/gutjnl-2013-305257
   CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648
   Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210
   Fijan S, 2014, INT J ENV RES PUB HE, V11, P4745, DOI 10.3390/ijerph110504745
   Flemer B, 2018, GUT, V67, P1454, DOI 10.1136/gutjnl-2017-314814
   Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968
   Frank C, 2017, INT J CANCER, V140, P1510, DOI 10.1002/ijc.30583
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454
   Hannigan GD, 2018, MBIO, V9, DOI 10.1128/mBio.02248-18
   Hastie T., 2009, ELEMENTS STAT LEARNI
   Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430
   Human Microbiome Project Consortium, 2012, Nature, V486, P207, DOI 10.1038/nature11234
   Huxley RR, 2009, INT J CANCER, V125, P171, DOI 10.1002/ijc.24343
   Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1
   Johnson CM, 2013, CANCER CAUSE CONTROL, V24, P1207, DOI 10.1007/s10552-013-0201-5
   Kalnins G, 2015, J BIOL CHEM, V290, P21732, DOI 10.1074/jbc.M115.670471
   Kaminski J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004557
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010
   Klikauer T, 2016, TRIPLEC-COMMUN CAPIT, V14, P260
   Knight R, 2015, MICROB ECOL HEALTH D, V26, DOI DOI 10.3402/MEHD.V26.27663
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kummen M, 2017, UNITED EUR GASTROENT, V5, P532, DOI 10.1177/2050640616663453
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Oellgaard J, 2017, CURR PHARM DESIGN, V23, P3699, DOI 10.2174/1381612823666170622095324
   Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001
   Pasolli E, 2017, NAT METHODS, V14, P1023, DOI 10.1038/nmeth.4468
   Pasolli E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004977
   Pollock J, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02627-17
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Quince C, 2017, NAT BIOTECHNOL, V35, P833, DOI 10.1038/nbt.3935
   Rath S, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0271-9
   Riester M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju048
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Schmidt TSB, 2018, CELL, V172, P1198, DOI 10.1016/j.cell.2018.02.044
   Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153
   Segata N, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00190-17
   Segata N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3304
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Siegel R, 2014, CA-CANCER J CLIN, V64, P104, DOI 10.3322/caac.21220
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099
   Thomas AM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00179
   Thomas RM, 2015, TRENDS CANCER, V1, P24, DOI 10.1016/j.trecan.2015.07.005
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Xie YH, 2017, EBIOMEDICINE, V25, P32, DOI 10.1016/j.ebiom.2017.10.005
   Xu R, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S7-S4
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zackular JP, 2014, CANCER PREV RES, V7, P1112, DOI 10.1158/1940-6207.CAPR-14-0129
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 81
TC 287
Z9 293
U1 16
U2 114
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD APR
PY 2019
VL 25
IS 4
BP 667
EP +
DI 10.1038/s41591-019-0405-7
PG 25
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA HR7OA
UT WOS:000463342800028
PM 30936548
OA Green Submitted, Green Accepted
DA 2022-11-22
ER

PT S
AU Salonen, A
   de Vos, WM
AF Salonen, Anne
   de Vos, Willem M.
BE Doyle, MP
   Klaenhammer, TR
TI Impact of Diet on Human Intestinal Microbiota and Health
SO ANNUAL REVIEW OF FOOD SCIENCE AND TECHNOLOGY, VOL 5
SE Annual Review of Food Science and Technology
LA English
DT Review; Book Chapter
DE enterotypes; dietary intervention; short-chain fatty acids; bile acids;
   high-fat diet; Akkermansia muciniphila
ID HUMAN GUT MICROBIOME; HIGH-FAT DIET; COLON-CANCER RISK;
   LIPID-METABOLISM; CROHNS-DISEASE; BILE-ACIDS; METAGENOMIC ANALYSIS;
   INDUCED OBESITY; GASTROINTESTINAL SYMPTOMS; AKKERMANSIA-MUCINIPHILA
AB Our intestinal microbiota is involved in the breakdown and bioconversion of dietary and host components that are not degraded and taken up by our own digestive system. The end products generated by our microbiota fuel our enterocytes and support growth but also have signaling functions that generate systemic immune and metabolic responses. Due to the immense metabolic capacity of the intestinal microbiota and its relatively high plasticity, there is great interest in identifying dietary approaches that allow intentional and predictable modulation of the microbiota. In this article, we review the current insights on dietary influence on the human intestinal microbiota based on recent high-throughput molecular studies and interconnections with health. We focus especially on the emerging data that identify the amount and type of dietary fat as significant modulators of the colonic microbiota and its metabolic output.
C1 [Salonen, Anne; de Vos, Willem M.] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki 00014, Finland.
   [Salonen, Anne; de Vos, Willem M.] Univ Helsinki, Immunobiol Res Program, FIN-00014 Helsinki, Finland.
   [de Vos, Willem M.] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland.
   [de Vos, Willem M.] Wageningen Univ, Microbiol Lab, NL-6703 HB Wageningen, Netherlands.
C3 University of Helsinki; University of Helsinki; University of Helsinki;
   Wageningen University & Research
RP Salonen, A (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Helsinki 00014, Finland.
EM anne.salonen@helsinki.fi; willem.devos@wur.nl
RI Salonen, Anne/AAW-1858-2020
OI Salonen, Anne/0000-0002-6960-7447
CR Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Barnett AM, 2012, FOOD FUNCT, V3, P690, DOI 10.1039/c2fo30017f
   Bauman DE, 2003, 2003 CORNELL NUTRITION CONFERENCE FOR FEED MANUFACTURERS, PROCEEDINGS, P175
   Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003
   Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6
   Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001
   Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Carvalho FA, 2012, ANNU REV PHYSIOL, V74, P177, DOI 10.1146/annurev-physiol-020911-153330
   Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x
   Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63
   Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923
   CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x
   Day AS, 2013, DIGEST LIVER DIS, V45, P177, DOI 10.1016/j.dld.2012.07.014
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010
   De Palma G, 2009, BRIT J NUTR, V102, P1154, DOI 10.1017/S0007114509371767
   de Vos WM, 2013, MICROB BIOTECHNOL, V6, P316, DOI 10.1111/1751-7915.12047
   de Vos WM, 2013, NATURE, V498, P48, DOI 10.1038/nature12251
   de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x
   de Wit N, 2012, AM J PHYSIOL-GASTR L, V303, pG589, DOI 10.1152/ajpgi.00488.2011
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Derrien M, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00166
   Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225
   Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304
   Dodd D, 2011, MOL MICROBIOL, V79, P292, DOI 10.1111/j.1365-2958.2010.07473.x
   Duncan SH, 2007, APPL ENVIRON MICROB, V73, P1073, DOI 10.1128/AEM.02340-06
   Duncan SH, 2009, ENVIRON MICROBIOL, V11, P2112, DOI 10.1111/j.1462-2920.2009.01931.x
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025
   Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814
   Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33
   Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303
   Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897
   FLOCH MH, 1972, AM J CLIN NUTR, V25, P1418
   Gibson G. R., 1997, GASTROINTEST MICROBI, P269, DOI [DOI 10.1007/978-1-4615-4111-0_9, 10.1007/978-1-4615-4111-0_9]
   Gibson PR, 2010, J GASTROEN HEPATOL, V25, P252, DOI 10.1111/j.1440-1746.2009.06149.x
   Gibson PR, 2005, ALIMENT PHARM THER, V21, P1399, DOI 10.1111/j.1365-2036.2005.02506.x
   Gill CIR, 2002, BRIT J NUTR, V88, pS73, DOI 10.1079/BJN2002632
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gougoulias C, 2009, FOOD SCI TECHNOL B F, V5, P51
   HARFOOT C. G., 1988, RUMEN MICROBIAL ECOS, P382
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042
   Hippe B, 2011, FEMS MICROBIOL LETT, V316, P130, DOI 10.1111/j.1574-6968.2010.02197.x
   Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Islam KBMS, 2011, GASTROENTEROLOGY, V141, P1773, DOI 10.1053/j.gastro.2011.07.046
   Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035
   Jantchou P, 2010, AM J GASTROENTEROL, V105, P2195, DOI 10.1038/ajg.2010.192
   JENKINS TC, 1993, J DAIRY SCI, V76, P3851, DOI 10.3168/jds.S0022-0302(93)77727-9
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Kabeerdoss J, 2012, BRIT J NUTR, V108, P953, DOI 10.1017/S0007114511006362
   Karasov WH, 2011, ANNU REV PHYSIOL, V73, P69, DOI 10.1146/annurev-physiol-012110-142152
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266
   Kashyap PC, 2013, GASTROENTEROLOGY, V144, P967, DOI 10.1053/j.gastro.2013.01.047
   Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006
   Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kootte RS, 2012, DIABETES OBES METAB, V14, P112, DOI 10.1111/j.1463-1326.2011.01483.x
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116
   Kunkel D, 2011, DIGEST DIS SCI, V56, P1612, DOI 10.1007/s10620-011-1590-5
   Kurdi P, 2006, J BACTERIOL, V188, P1979, DOI 10.1128/JB.188.5.1979-1986.2006
   Kussmann Martin, 2011, Frontiers in Genetics, V2, P21, DOI 10.3389/fgene.2011.00021
   Lahti L, 2013, PEERJ, V1, DOI 10.7717/peerj.32
   Laparra JM, 2010, PHARMACOL RES, V61, P219, DOI 10.1016/j.phrs.2009.11.001
   Lappi J, 2013, J NUTR, V143, P648, DOI 10.3945/jn.112.172668
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Lin A, 2013, PLOS ONE, V8
   Liszt K, 2009, ANN NUTR METAB, V54, P253, DOI 10.1159/000229505
   Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x
   Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane
   Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe
   MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647
   Mai V, 2004, NUTR REV, V62, P235, DOI 10.1301/nr2004.jun235-242
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Marcobal A, 2012, CLIN MICROBIOL INFEC, V18, P12, DOI 10.1111/j.1469-0691.2012.03863.x
   Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221
   Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848
   Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153
   Martin V, 2012, J HUM LACT, V28, P36, DOI 10.1177/0890334411424729
   Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701
   Medani M, 2011, INFLAMM BOWEL DIS, V17, P1620, DOI 10.1002/ibd.21528
   Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Nakamura N, 2010, ANNU REV FOOD SCI T, V1, P363, DOI 10.1146/annurev.food.102308.124101
   Neyrinck AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020944
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d
   Ogilvie LA, 2012, GUT, V61, P1642, DOI 10.1136/gutjnl-2012-302137
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164
   Ouwehand AC, 2005, CURR OPIN BIOTECH, V16, P212, DOI 10.1016/j.copbio.2005.01.007
   Payne AN, 2012, OBES REV, V13, P799, DOI 10.1111/j.1467-789X.2012.01009.x
   Perry GH, 2007, NAT GENET, V39, P1256, DOI 10.1038/ng2123
   Png CW, 2010, AM J GASTROENTEROL, V105, P2420, DOI 10.1038/ajg.2010.281
   Possemiers S, 2011, FITOTERAPIA, V82, P53, DOI 10.1016/j.fitote.2010.07.012
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rajilic-Stojanovic M, 2013, BEST PRACT RES CL GA, V27, P5, DOI 10.1016/j.bpg.2013.03.006
   Rajilic-Stojanovic M, 2013, ENVIRON MICROBIOL, V15, P1146, DOI 10.1111/1462-2920.12023
   Rajilic-Stojanovic M, 2013, INFLAMM BOWEL DIS, V19, P481, DOI 10.1097/MIB.0b013e31827fec6d
   Rajilic-Stojanovic M, 2011, GASTROENTEROLOGY, V141, P1792, DOI 10.1053/j.gastro.2011.07.043
   Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x
   Ravussin Y, 2012, OBESITY, V20, P738, DOI 10.1038/oby.2011.111
   REDDY BS, 1981, CANCER RES, V41, P3766
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363
   Ross AB, 2011, BRIT J NUTR, V105, P1492, DOI 10.1017/S0007114510005209
   Russell WR, 2011, AM J CLIN NUTR, V93, P1062, DOI 10.3945/ajcn.110.002188
   Salonen A, 2012, CLIN MICROBIOL INFEC, V18, P16, DOI 10.1111/j.1469-0691.2012.03855.x
   Scholtens PAMJ, 2012, ANNU REV FOOD SCI T, V3, P425, DOI 10.1146/annurev-food-022811-101120
   Scott KP, 2011, BIOCHEM SOC T, V39, P1073, DOI 10.1042/BST0391073
   Scott KP, 2012, PHARM RES, V69, P52
   Shiga H, 2012, DIGEST LIVER DIS, V44, P736, DOI 10.1016/j.dld.2012.04.014
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Simoes CD, 2013, J NUTR, V143, P417, DOI 10.3945/jn.112.166322
   Staudacher HM, 2012, J NUTR, V142, P1510, DOI 10.3945/jn.112.159285
   Tap J, 2009, ENVIRON MICROBIOL, V11, P2574, DOI 10.1111/j.1462-2920.2009.01982.x
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Velagapudi VR, 2010, J LIPID RES, V51, P1101, DOI 10.1194/jlr.M002774
   Vipperla K, 2012, NUTR CLIN PRACT, V27, P624, DOI 10.1177/0884533612452012
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Walker AW, 2011, ISME J, V5, P220, DOI [10.1038/ismej.2010.118, 10.1038/ISMEJ.2010.118]
   Walter J, 2011, ANNU REV MICROBIOL, V65, P411, DOI 10.1146/annurev-micro-090110-102830
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Whelan K, 2009, AM J CLIN NUTR, V89, P240, DOI 10.3945/ajcn.2008.26219
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Windey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052387
   Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang CH, 2010, ISME J, V4, P232, DOI 10.1038/ismej.2009.112
   Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141
   Zoetendal EG, 1998, APPL ENVIRON MICROB, V64, P3854
NR 149
TC 146
Z9 153
U1 5
U2 183
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 1941-1413
EI 1941-1421
BN 978-0-8243-4905-9
J9 ANNU REV FOOD SCI T
JI Annu. Rev. Food Sci. Technol.
PY 2014
VL 5
BP 239
EP 262
DI 10.1146/annurev-food-030212-182554
PG 24
WC Food Science & Technology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA BA4YA
UT WOS:000336429000012
PM 24387608
DA 2022-11-22
ER

PT J
AU Shin, W
   Wu, A
   Massidda, MW
   Foster, C
   Thomas, N
   Lee, DW
   Koh, H
   Ju, Y
   Kim, J
   Kim, HJ
AF Shin, Woojung
   Wu, Alexander
   Massidda, Miles W.
   Foster, Charles
   Thomas, Newin
   Lee, Dong-Woo
   Koh, Hong
   Ju, Youngwon
   Kim, Joohoon
   Kim, Hyun Jung
TI A Robust Longitudinal Co-culture of Obligate Anaerobic Gut Microbiome
   With Human Intestinal Epithelium in an Anoxic-Oxic Interface-on-a-Chip
SO FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
LA English
DT Article
DE co-culture; gut microbiome; gut-on-a-chip; anoxic-oxic interface;
   host-microbiome interaction; microfluidics
ID CHAIN FATTY-ACIDS; HOST; NANOPARTICLES; MODEL; METAGENOMICS; PEROXIDASE;
   METABOLISM; DIFFUSION; DESIGN
AB The majority of human gut microbiome is comprised of obligate anaerobic bacteria that exert essential metabolic functions in the human colon. These anaerobic gut bacteria constantly crosstalk with the colonic epithelium in a mucosal anoxic-oxic interface (AOI). However, in vitro recreation of the metabolically mismatched colonic AOI has been technically challenging. Furthermore, stable co-culture of the obligate anaerobic commensal microbiome and epithelial cells in a mechanically dynamic condition is essential for demonstrating the host-gut microbiome crosstalk. Here, we developed an anoxic-oxic interface-on-a-chip (AOI Chip) by leveraging a modified human gut-on-a-chip to demonstrate a controlled oxygen gradient in the lumen-capillary transepithelial interface by flowing anoxic and oxic culture medium at various physiological milieus. Computational simulation and experimental results revealed that the presence of the epithelial cell layer and the flow-dependent conditioning in the lumen microchannel is necessary and sufficient to create the steady-state vertical oxygen gradient in the AOI Chip. We confirmed that the created AOI does not compromise the viability, barrier function, mucin production, and the expression and localization of tight junction proteins in the 3D intestinal epithelial layer. Two obligate anaerobic commensal gut microbiome, Bifidobacterium adolescentis and Eubacterium hallii, that exert metabolic cross-feeding in vivo, were independently co-cultured with epithelial cells in the AOI Chip for up to a week without compromising any cell viability. Our new protocol for creating an AOI in a microfluidic gut-on-a-chip may enable to demonstrate the key physiological interactions of obligate anaerobic gut microbiome with the host cells associated with intestinal metabolism, homeostasis, and immune regulation.
C1 [Shin, Woojung; Wu, Alexander; Massidda, Miles W.; Foster, Charles; Thomas, Newin; Kim, Hyun Jung] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.
   [Lee, Dong-Woo] Yonsei Univ, Coll Life Sci & Technol, Dept Biotechnol, Seoul, South Korea.
   [Koh, Hong] Yonsei Univ, Severance Fecal Microbiota Transplantat Ctr, Coll Med, Dept Pediat, Seoul, South Korea.
   [Ju, Youngwon; Kim, Joohoon] Kyung Hee Univ, Res Inst Basic Sci, Dept Chem, Seoul, South Korea.
   [Kim, Joohoon] Kyung Hee Univ, KHU KIST Dept Converging Sci & Technol, Seoul, South Korea.
   [Kim, Hyun Jung] Yonsei Univ, Coll Med, Dept Med Engn, Seoul, South Korea.
C3 University of Texas System; University of Texas Austin; Yonsei
   University; Yonsei University; Yonsei University Health System; Kyung
   Hee University; Kyung Hee University; Yonsei University; Yonsei
   University Health System
RP Kim, HJ (corresponding author), Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA.; Kim, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Med Engn, Seoul, South Korea.
EM hyunjung.kim@utexas.edu
RI Kim, Hyun Jung/GQP-3241-2022; Shin, Woojung/V-9900-2017; /S-2675-2017
OI Kim, Hyun Jung/0000-0001-5342-2870; Wu, Alexander/0000-0001-5106-132X;
   Shin, Woojung/0000-0002-1780-0317; /0000-0003-1481-2440; Massidda,
   Miles/0000-0001-7704-9273
FU Alternatives in Scientific Research of The International Foundation for
   Ethical Research Graduate Fellowship [UTA15-001318]; Bio & Medical
   Technology Development Program of the National Research Foundation (NRF)
   - Ministry of Science and ICT [2018M3A9H3025030]; Cancer Research
   Institute [UTA18-000889]; Alternative Research and Development
   Foundation [UTA18-001198]; National Research Foundation of Korea -
   Ministry of Science, ICT and Future Planning [NRF-2017R1A2B4004285]
FX This work was supported in part by the Alternatives in Scientific
   Research of The International Foundation for Ethical Research Graduate
   Fellowship (UTA15-001318 toWS), the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF) funded by the Ministry
   of Science and ICT (2018M3A9H3025030 to WS, D-WL, HK, and HJK), Cancer
   Research Institute (UTA18-000889 to HJK), Alternative Research and
   Development Foundation (UTA18-001198 to HJK), and the National Research
   Foundation of Korea funded by the Ministry of Science, ICT and Future
   Planning (NRF-2017R1A2B4004285 to YJ and JK).
CR Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020
   Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012
   Bein A, 2018, CELL MOL GASTROENTER, V5, P659, DOI 10.1016/j.jcmgh.2017.12.010
   Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006
   Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5
   Cho T, 2018, LANGMUIR, V34, P7436, DOI 10.1021/acs.langmuir.8b01169
   Chu HT, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0459-4
   COX ME, 1986, J POLYM SCI POL CHEM, V24, P621, DOI 10.1002/pola.1986.080240405
   Cremer J, 2017, P NATL ACAD SCI USA, V114, P6438, DOI 10.1073/pnas.1619598114
   Crooks RM, 2001, ACCOUNTS CHEM RES, V34, P181, DOI 10.1021/ar000110a
   Engels C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00713
   Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554
   Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x
   Giulitti S, 2013, LAB CHIP, V13, P4430, DOI 10.1039/c3lc50643f
   Huh D, 2013, NAT PROTOC, V8, P2135, DOI 10.1038/nprot.2013.137
   Ju Y, 2015, CHEM COMMUN, V51, P13752, DOI 10.1039/c5cc06055a
   Kelly CJ, 2015, CELL HOST MICROBE, V17, P662, DOI 10.1016/j.chom.2015.03.005
   Kim HJ, 2016, JOVE-J VIS EXP, DOI 10.3791/54344
   Kim HJ, 2016, P NATL ACAD SCI USA, V113, pE7, DOI 10.1073/pnas.1522193112
   Kim HJ, 2012, LAB CHIP, V12, P2165, DOI 10.1039/c2lc40074j
   Kim Y, 2014, ANAL CHEM, V86, P1654, DOI 10.1021/ac403415m
   KLAPPER MH, 1963, J BIOL CHEM, V238, P3736
   Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116
   Leslie JL, 2015, INFECT IMMUN, V83, P138, DOI 10.1128/IAI.02561-14
   Lim H, 2016, ANAL CHEM, V88, P4751, DOI 10.1021/acs.analchem.6b00073
   Lin CS, 2018, ONCOL REP, V39, P316, DOI 10.3892/or.2017.6087
   Luca F, 2018, TRENDS GENET, V34, P30, DOI 10.1016/j.tig.2017.10.001
   Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207
   Marzorati M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-133
   Mattei G, 2014, PROCESSES, V2, P548, DOI 10.3390/pr2030548
   Mehta K, 2006, BIOTECHNOL BIOENG, V94, P596, DOI 10.1002/bit.20857
   Merkel TC, 2000, J POLYM SCI POL PHYS, V38, P415, DOI 10.1002/(SICI)1099-0488(20000201)38:3<415::AID-POLB8>3.0.CO;2-Z
   Park GS, 2017, STEM CELL REV REP, V13, P321, DOI 10.1007/s12015-017-9739-z
   Sadabad MS, 2015, SCI REP-UK, V5, DOI 10.1038/srep17906
   SAVAGE DC, 1978, AM J CLIN NUTR, V31, pS131, DOI 10.1093/ajcn/31.10.S131
   Shah P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11535
   SHIMAMURA S, 1992, J DAIRY SCI, V75, P3296, DOI 10.3168/jds.S0022-0302(92)78105-3
   Shin W, 2018, P NATL ACAD SCI USA, V115, pE10539, DOI 10.1073/pnas.1810819115
   Shin W, 2018, METHOD CELL BIOL, V146, P135, DOI 10.1016/bs.mcb.2018.05.006
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Swanson HI, 2015, DRUG METAB DISPOS, V43, P1499, DOI 10.1124/dmd.115.065714
   Ulluwishewa D, 2015, CELL MICROBIOL, V17, P226, DOI 10.1111/cmi.12360
   von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001
   Walker AW, 2014, TRENDS MICROBIOL, V22, P267, DOI 10.1016/j.tim.2014.03.001
   Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035
   Wang T, 2017, TALANTA, V162, P143, DOI 10.1016/j.talanta.2016.10.006
   Zeitouni NE, 2015, HYPOXIA, V3, P53, DOI 10.2147/HP.S85625
   Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015
   Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369
NR 49
TC 65
Z9 65
U1 17
U2 62
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-4185
J9 FRONT BIOENG BIOTECH
JI Front. Bioeng. Biotechnol.
PD FEB 7
PY 2019
VL 7
AR 13
DI 10.3389/fbioe.2019.00013
PG 13
WC Biotechnology & Applied Microbiology; Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA HK9ZU
UT WOS:000458353900001
PM 30792981
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Ogino, S
   Campbell, PT
   Nishihara, R
   Phipps, AI
   Beck, AH
   Sherman, ME
   Chan, AT
   Troester, MA
   Bass, AJ
   Fitzgerald, KC
   Irizarry, RA
   Kelsey, KT
   Nan, H
   Peters, U
   Poole, EM
   Qian, ZR
   Tamimi, RM
   Tchetgen, EJT
   Tworoger, SS
   Zhang, XH
   Giovannucci, EL
   van den Brandt, PA
   Rosner, BA
   Wang, ML
   Chatterjee, N
   Begg, CB
AF Ogino, Shuji
   Campbell, Peter T.
   Nishihara, Reiko
   Phipps, Amanda I.
   Beck, Andrew H.
   Sherman, Mark E.
   Chan, Andrew T.
   Troester, Melissa A.
   Bass, Adam J.
   Fitzgerald, Kathryn C.
   Irizarry, Rafael A.
   Kelsey, Karl T.
   Nan, Hongmei
   Peters, Ulrike
   Poole, Elizabeth M.
   Qian, Zhi Rong
   Tamimi, Rulla M.
   Tchetgen, Eric J. Tchetgen
   Tworoger, Shelley S.
   Zhang, Xuehong
   Giovannucci, Edward L.
   van den Brandt, Piet A.
   Rosner, Bernard A.
   Wang, Molin
   Chatterjee, Nilanjan
   Begg, Colin B.
TI Proceedings of the second international molecular pathological
   epidemiology (MPE) meeting
SO CANCER CAUSES & CONTROL
LA English
DT Review
DE Epidemiologic method; Molecular pathologic epidemiology; Personalized
   medicine; Systems biology; Translational epidemiology; Unique disease
   principle
ID COLORECTAL-CANCER RISK; ISLAND METHYLATOR PHENOTYPE; LIFE-STYLE FACTORS;
   EPITHELIAL OVARIAN-CANCER; BODY-MASS INDEX; BREAST-CANCER;
   MICROSATELLITE INSTABILITY; ASPIRIN USE; CIGARETTE-SMOKING;
   FAMILY-HISTORY
AB Disease classification system increasingly incorporates information on pathogenic mechanisms to predict clinical outcomes and response to therapy and intervention. Technological advancements to interrogate omics (genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, interactomics, etc.) provide widely open opportunities in population-based research. Molecular pathological epidemiology (MPE) represents integrative science of molecular pathology and epidemiology. This unified paradigm requires multidisciplinary collaboration between pathology, epidemiology, biostatistics, bioinformatics, and computational biology. Integration of these fields enables better understanding of etiologic heterogeneity, disease continuum, causal inference, and the impact of environment, diet, lifestyle, host factors (including genetics and immunity), and their interactions on disease evolution. Hence, the Second International MPE Meeting was held in Boston in December 2014, with aims to: (1) develop conceptual and practical frameworks; (2) cultivate and expand opportunities; (3) address challenges; and (4) initiate the effort of specifying guidelines for MPE. The meeting mainly consisted of presentations of method developments and recent data in various malignant neoplasms and tumors (breast, prostate, ovarian and colorectal cancers, renal cell carcinoma, lymphoma, and leukemia), followed by open discussion sessions on challenges and future plans. In particular, we recognized need for efforts to further develop statistical methodologies. This meeting provided an unprecedented opportunity for interdisciplinary collaboration, consistent with the purposes of the Big Data to Knowledge, Genetic Associations and Mechanisms in Oncology, and Precision Medicine Initiative of the US National Institute of Health. The MPE meeting series can help advance transdisciplinary population science and optimize training and education systems for twenty-first century medicine and public health.
C1 [Ogino, Shuji] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02215 USA.
   [Ogino, Shuji; Nishihara, Reiko; Bass, Adam J.; Qian, Zhi Rong] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Med Oncol, Boston, MA 02215 USA.
   [Ogino, Shuji; Nishihara, Reiko; Fitzgerald, Kathryn C.; Tamimi, Rulla M.; Tchetgen, Eric J. Tchetgen; Tworoger, Shelley S.; Giovannucci, Edward L.; Wang, Molin] Harvard Univ, TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.
   [Campbell, Peter T.] Amer Canc Soc, Epidemiol Res Program, Atlanta, GA 30329 USA.
   [Nishihara, Reiko; Irizarry, Rafael A.; Tchetgen, Eric J. Tchetgen; Rosner, Bernard A.; Wang, Molin] Harvard Univ, TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA 02215 USA.
   [Nishihara, Reiko; Fitzgerald, Kathryn C.; Giovannucci, Edward L.] Harvard Univ, TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02215 USA.
   [Phipps, Amanda I.; Peters, Ulrike] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.
   [Phipps, Amanda I.; Peters, Ulrike] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA.
   [Beck, Andrew H.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Pathol, Boston, MA 02215 USA.
   [Beck, Andrew H.; Bass, Adam J.] Broad Inst, Cambridge, MA USA.
   [Sherman, Mark E.] NCI, Breast & Gynecol Canc Res Grp, Canc Prevent Div, Bethesda, MD 20892 USA.
   [Sherman, Mark E.; Chatterjee, Nilanjan] NCI, Div Canc Epidemiol & Genet, Rockville, MD USA.
   [Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Chan, Andrew T.; Poole, Elizabeth M.; Tamimi, Rulla M.; Tworoger, Shelley S.; Zhang, Xuehong; Giovannucci, Edward L.; Rosner, Bernard A.; Wang, Molin] Harvard Univ, Brigham & Womens Hosp, Sch Med, Channing Div Network Med,Dept Med, Boston, MA 02215 USA.
   [Troester, Melissa A.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA.
   [Irizarry, Rafael A.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Biostat & Computat Biol, Boston, MA 02215 USA.
   [Kelsey, Karl T.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.
   [Nan, Hongmei] Indiana Univ, Dept Epidemiol, Richard M Fairbanks Sch Publ Hlth, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA.
   [van den Brandt, Piet A.] Maastricht Univ, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.
   [Begg, Colin B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA.
C3 Harvard University; Brigham & Women's Hospital; Harvard Medical School;
   Harvard University; Dana-Farber Cancer Institute; Harvard Medical
   School; Harvard University; Harvard T.H. Chan School of Public Health;
   American Cancer Society; Harvard University; Harvard T.H. Chan School of
   Public Health; Harvard University; Harvard T.H. Chan School of Public
   Health; University of Washington; University of Washington Seattle; Fred
   Hutchinson Cancer Center; Harvard University; Beth Israel Deaconess
   Medical Center; Harvard Medical School; Harvard University;
   Massachusetts Institute of Technology (MIT); Broad Institute; National
   Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI);
   National Institutes of Health (NIH) - USA; NIH National Cancer Institute
   (NCI); Harvard University; Massachusetts General Hospital; Harvard
   University; Brigham & Women's Hospital; Harvard Medical School;
   University of North Carolina; University of North Carolina Chapel Hill;
   Harvard University; Dana-Farber Cancer Institute; Harvard Medical
   School; Brown University; Indiana University System; Indiana
   University-Purdue University Indianapolis; Maastricht University;
   Memorial Sloan Kettering Cancer Center
RP Ogino, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, 450 Brookline Ave,Room M422, Boston, MA 02215 USA.
EM shuji_ogino@dfci.harvard.edu
RI Tchetgen, Eric Tchetgen/AAF-6160-2021; Garcia-Closas,
   Montserrat/AAZ-6930-2021
OI Garcia-Closas, Montserrat/0000-0003-1033-2650; Ogino,
   Shuji/0000-0002-3909-2323; van den Brandt, Piet/0000-0001-8781-8099;
   Fitzgerald, Kathryn/0000-0003-3137-0322
FU US National Institute of Health (NIH) [R01 CA151993, K07 CA190673, R01
   CA137178, K24 DK098311, K07 CA172298]; Dana-Farber Cancer Institute;
   NATIONAL CANCER INSTITUTE [K07CA172298, K07CA190673, R01CA151993,
   R01CA137178, P30CA008748] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK098311]
   Funding Source: NIH RePORTER
FX We thank all of the members of the program committee, the speakers, the
   discussants, and the other participants of the Second International MPE
   Meeting on December 4-5, 2014 in Boston, MA, USA. We thank the
   Dana-Farber Cancer Institute (Edward J. Benz, Jr., President and CEO)
   for providing the meeting venue and the Department of Pathology, the
   Brigham and Women's Hospital (Jeffrey A. Golden, Chairperson), and
   Enzymatics, Inc., for providing meals and refreshments, respectively. We
   also thank the Department of Pathology, the Brigham and Women's Hospital
   (Jeffrey A. Golden, Chairperson); the Department of Epidemiology, the
   Harvard T.H. Chan School of Public Health (Michelle A. Williams,
   Chairperson); the Dana-Farber Harvard Cancer Center (Giovanni
   Parmigiani, Meir J. Stampfer, Lorelei A. Mucci, Deborah Schrag, and
   Charles S. Fuchs; Program Leaders); and the Channing Division of Network
   Medicine, the Department of Medicine, the Brigham and Women's Hospital
   (Edwin K. Silverman, Division Chief) for providing morale supports and
   helping in announcements. This work was supported in part by grants from
   the US National Institute of Health (NIH) [R01 CA151993 (to SO), K07
   CA190673 (to RN), R01 CA137178 (to ATC), K24 DK098311 (to ATC), and K07
   CA172298 (to AIP)], and the friends of the Dana-Farber Cancer Institute
   (to SO). ATC is Damon Runyon Clinical Investigator. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of NIH. The funders (including Enzymatics,
   Inc.) did not have any role in planning the meeting, the decision to
   submit the manuscript for publication, or the writing of the manuscript.
   Use of Human Genome Organisation (HUGO) Gene Nomenclature Committee
   (HGNC)-approved symbols for genes and gene products: We use symbols
   approved by HGNC and described at www.genenames.org; those include BRAF,
   CD274, ERBB2, ESR1, FASN, KRAS, MLH1, PDCD1LG2, PGR, PIK3CA, and VHL.
   Gene names are italicized, while names of gene products are
   non-italicized. Non-official names are described in parenthesis where
   helpful.
CR Abbenhardt C, 2013, INT J MOL EPIDEMIOL, V4, P140
   Aleman JO, 2014, GASTROENTEROLOGY, V146, P357, DOI 10.1053/j.gastro.2013.11.051
   Alvarez MC, 2013, WORLD J GASTROENTERO, V19, P3043, DOI 10.3748/wjg.v19.i20.3043
   Amirian ES, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-42
   Arain MA, 2010, AM J GASTROENTEROL, V105, P1189, DOI 10.1038/ajg.2009.699
   Araujo RF, 2013, PATHOL RES PRACT, V209, P753, DOI 10.1016/j.prp.2013.08.007
   Bae JM, 2013, BRIT J CANCER, V109, P1004, DOI 10.1038/bjc.2013.430
   Bardhan Kankana, 2013, Cancers (Basel), V5, P676, DOI 10.3390/cancers5020676
   Barrow TM, 2014, BIOCHEM BIOPH RES CO, V455, P70, DOI 10.1016/j.bbrc.2014.08.002
   Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480
   Bathe OF, 2014, GENES-BASEL, V5, P536, DOI 10.3390/genes5030536
   Beck AH, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002875
   Begg CB, 2013, STAT MED, V32, P5039, DOI 10.1002/sim.5902
   Begg CB, 2012, AM J EPIDEMIOL, V176, P512, DOI 10.1093/aje/kws128
   Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055
   Brandstedt J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-371
   Buchanan DD, 2013, CANCER EPIDEM BIOMAR, V22, P917, DOI 10.1158/1055-9965.EPI-12-1211
   Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462
   Caiazza F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00019
   Campbell PT, 2014, CANCER EPIDEM BIOMAR, V23, P2694, DOI 10.1158/1055-9965.EPI-14-0541
   Campbell PT, 2013, J CLIN ONCOL, V31, P876, DOI 10.1200/JCO.2012.45.9735
   Campbell PT, 2010, JNCI-J NATL CANCER I, V102, P391, DOI 10.1093/jnci/djq011
   Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208
   Chan AT, 2011, GASTROENTEROLOGY, V140, P799, DOI 10.1053/j.gastro.2010.11.041
   Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112
   Chatterjee N, 2004, J AM STAT ASSOC, V99, P127, DOI 10.1198/016214504000000124
   Chatterjee N, 2010, BIOMETRIKA, V97, P683, DOI 10.1093/biomet/asq036
   Chia VM, 2006, CANCER RES, V66, P6877, DOI 10.1158/0008-5472.CAN-06-1535
   Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137
   Cisyk AL, 2015, NEOPLASIA, V17, P306, DOI 10.1016/j.neo.2015.02.001
   Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365
   Coppede F, 2014, EXPERT REV GASTROENT, V8, P935, DOI 10.1586/17474124.2014.924397
   Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799
   Curtin Karen, 2011, Patholog Res Int, V2011, P902674, DOI 10.4061/2011/902674
   Curtin K, 2009, INT J CANCER, V125, P158, DOI 10.1002/ijc.24338
   DERSIMONIAN R, 1982, NEW ENGL J MED, V306, P1332, DOI 10.1056/NEJM198206033062204
   Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265
   Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322
   Esterhuyse MM, 2013, EXPERT REV MOL DIAGN, V13, P625, DOI 10.1586/14737159.2013.811897
   Faupel-Badger JM, 2013, JNCI-J NATL CANCER I, V105, P166, DOI 10.1093/jnci/djs505
   Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501
   Figueroa JD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju286
   Fini L, 2012, COLORECTAL CANC BIOL, P323
   Fink SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008481
   Gallo V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001117
   Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205
   Gao C, 2015, AUSTIN J GASTROENTER, V2, P1040
   Garcia-Closas M, 2013, NAT GENET, V45, P392, DOI 10.1038/ng.2561
   Gates MA, 2010, AM J EPIDEMIOL, V171, P45, DOI 10.1093/aje/kwp314
   Gaudet MM, 2012, LANCET ONCOL, V13, P862, DOI [10.1016/S1470-2045(12)70365-0, 10.1016/S1470-2045(12)70322-4]
   Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085
   Ghosh K, 2010, JNCI-J NATL CANCER I, V102, P1716, DOI 10.1093/jnci/djq414
   Ghosh K, 2010, J CLIN ONCOL, V28, P2207, DOI 10.1200/JCO.2009.23.4120
   Hagland HR, 2015, CANCER LETT, V356, P273, DOI 10.1016/j.canlet.2014.02.026
   Hagland HR, 2013, DIGEST SURG, V30, P12, DOI 10.1159/000347166
   Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310
   Haque TR, 2014, DIGEST DIS SCI, V59, P2874, DOI 10.1007/s10620-014-3277-1
   Herbert K, 2014, CURR COLORECT CANC R, V10, P363, DOI 10.1007/s11888-014-0247-0
   Hoffmeister M, 2013, CANCER EPIDEM BIOMAR, V22, P2303, DOI 10.1158/1055-9965.EPI-13-0239
   Houseman EA, 2015, CURR ENV HL IN PRESS
   Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306
   Hughes LAE, 2012, INT J EPIDEMIOL, V41, P1060, DOI 10.1093/ije/dys055
   Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005
   Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571
   Huser V, 2014, PHARMACOGN PERS MED, V7, P275, DOI 10.2147/PGPM.S49904
   Iwagami S, 2012, ANN SURG ONCOL, V19, P2726, DOI 10.1245/s10434-011-2176-3
   Jacobs RJ, 2012, CURR OPIN PHARMACOL, V12, P690, DOI 10.1016/j.coph.2012.07.010
   Jaffe AE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r31
   Jeon JY, 2012, J CLIN ONCOL, V30, P7, DOI 10.1200/JCO.2011.39.6374
   Jung S, 2013, JNCI-J NATL CANCER I, V105, P219, DOI 10.1093/jnci/djs635
   Koshiol J, 2012, ANN EPIDEMIOL, V22, P520, DOI 10.1016/j.annepidem.2012.03.001
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Kostic AD, 2011, NAT BIOTECHNOL, V29, P393, DOI 10.1038/nbt.1868
   Ku CS, 2012, MODERN PATHOL, V25, P1055, DOI 10.1038/modpathol.2012.62
   Kuchiba A, 2012, JNCI-J NATL CANCER I, V104, P415, DOI 10.1093/jnci/djr542
   Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173
   Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825
   Li PW, 2015, GUT, V64, P1419, DOI 10.1136/gutjnl-2014-308260
   Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756
   Limburg PJ, 2012, CANCER EPIDEM BIOMAR, V21, P681, DOI 10.1158/1055-9965.EPI-11-1168
   Limsui D, 2010, JNCI-J NATL CANCER I, V102, P1012, DOI 10.1093/jnci/djq201
   Lin JH, 2014, CURR COLORECT CANC R, V10, P94, DOI 10.1007/s11888-014-0208-7
   Lindor NM, 2010, MOL GENET METAB, V99, P157, DOI 10.1016/j.ymgme.2009.09.010
   Lochhead P, 2015, MODERN PATHOL, V28, P14, DOI 10.1038/modpathol.2014.81
   Lochhead P, 2014, AM J GASTROENTEROL, V109, P1205, DOI 10.1038/ajg.2014.153
   Markt SC, 2015, CANCER CAUSE CONTROL, V26, P25, DOI 10.1007/s10552-014-0478-z
   Mikeska T, 2014, GENES-BASEL, V5, P821, DOI 10.3390/genes5030821
   Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6
   Mima K, 2015, JAMA ONCOL IN PRESS
   Morton Lindsay M., 2014, Journal of the National Cancer Institute Monographs, P1, DOI 10.1093/jncimonographs/lgu005
   Nan H, 2013, JNCI-J NATL CANCER I, V105, P1852, DOI 10.1093/jnci/djt331
   Ng JMK, 2015, INT J MOL SCI, V16, P2472, DOI 10.3390/ijms16022472
   Nishi A, 2015, AM J PREV MED, V48, P116, DOI 10.1016/j.amepre.2014.09.031
   Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969
   Nishihara R, 2013, AM J EPIDEMIOL, V178, P84, DOI 10.1093/aje/kws431
   Nishihara R, 2013, JAMA-J AM MED ASSOC, V309, P2563, DOI 10.1001/jama.2013.6599
   Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244
   Ogino S, 2007, HUM PATHOL, V38, P842, DOI 10.1016/j.humpath.2006.11.018
   Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214
   Ogino S, 2012, AM J EPIDEMIOL, V176, P659, DOI 10.1093/aje/kws226
   Ogino S, 2012, INT J EPIDEMIOL, V41, P1072, DOI 10.1093/ije/dys076
   Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]
   Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182
   Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031
   Palmer JR, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju237
   Pettersson A, 2013, JNCI-J NATL CANCER I, V105, P1881, DOI 10.1093/jnci/djt332
   Phipps AI, 2011, BREAST CANCER RES TR, V126, P671, DOI 10.1007/s10549-010-1148-9
   Poole EM, 2013, CANCER EPIDEM BIOMAR, V22, P429, DOI 10.1158/1055-9965.EPI-12-1183-T
   Potter S, 2014, BODY MASS INDEX 112
   Poynter JN, 2009, CANCER EPIDEM BIOMAR, V18, P2745, DOI 10.1158/1055-9965.EPI-09-0517
   Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161
   Roman-Perez E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3152
   Rosner B, 2013, AM J EPIDEMIOL, V178, P296, DOI 10.1093/aje/kws457
   Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240
   Ryan BM, 2014, CANCER EPIDEMIOL, V38, P583, DOI 10.1016/j.canep.2014.07.003
   Samowitz WS, 2006, J NATL CANCER I, V98, P1731, DOI 10.1093/jnci/djj468
   Satia JA, 2005, CANCER EPIDEM BIOMAR, V14, P429, DOI 10.1158/1055-9965.EPI-04-0486
   Schulz KF, 2010, J PHARMACOL PHARMACO, V1, P100, DOI [10.4103/0976-500X.72352, 10.1016/j.jclinepi.2010.02.005, 10.1016/j.ijsu.2011.09.004, 10.1186/1741-7015-8-18]
   Shaheen NJ, 2014, AM J GASTROENTEROL, V109, P345, DOI 10.1038/ajg.2014.35
   Shanmuganathan R, 2013, J MOL DIAGN, V15, P17, DOI 10.1016/j.jmoldx.2012.06.007
   Sherman ME, 2012, CANCER PREV RES, V5, P528, DOI 10.1158/1940-6207.CAPR-11-0234
   Sherman ME, 2010, CANCER EPIDEM BIOMAR, V19, P966, DOI 10.1158/1055-9965.EPI-10-0056
   Simons CCJM, 2014, CANCER EPIDEM BIOMAR, V23, P1852, DOI 10.1158/1055-9965.EPI-13-1285
   Slattery ML, 2000, J NATL CANCER I, V92, P1831, DOI 10.1093/jnci/92.22.1831
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Spitz MR, 2012, CANCER DISCOV, V2, P1087, DOI 10.1158/2159-8290.CD-12-0424
   Sun XZ, 2014, CANCER EPIDEM BIOMAR, V23, P2810, DOI 10.1158/1055-9965.EPI-14-0507
   Szylberg L, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/573814
   Tahara T, 2014, CANCER RES, V74, P1311, DOI 10.1158/0008-5472.CAN-13-1865
   Tamimi RM, 2012, BREAST CANCER RES TR, V131, P159, DOI 10.1007/s10549-011-1702-0
   Terry MB, 2011, PREV MED, V53, P388, DOI 10.1016/j.ypmed.2011.10.006
   Tillmans LS, 2015, CANCER EPIDEM BIOMAR, V24, P713, DOI 10.1158/1055-9965.EPI-14-0756
   Tougeron D, 2014, CLIN CANCER RES, V20, P1087, DOI 10.1158/1078-0432.CCR-13-2563
   Vandenbroucke JP, 2007, PLOS MED, V4, P1628, DOI 10.1371/journal.pmed.0040297
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040297
   Wang M, 2015, AM J EPIDEM IN PRESS
   Weijenberg Matty P, 2013, Curr Nutr Rep, V2, P19
   Weisenberger DJ, 2015, CANCER EPIDEM BIOMAR, V24, P512, DOI 10.1158/1055-9965.EPI-14-1161
   Wennersten C, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0189-5
   Wild CP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju353
   Witvliet MI, 2014, AUSTIN J PUBLIC HLTH, V1
   Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014
   Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865
   Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806
   Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005
   Zhu Y, 2014, BRIT J CANCER, V110, P1359, DOI 10.1038/bjc.2014.6
   Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9
NR 148
TC 34
Z9 34
U1 0
U2 39
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0957-5243
EI 1573-7225
J9 CANCER CAUSE CONTROL
JI Cancer Causes Control
PD JUL
PY 2015
VL 26
IS 7
BP 959
EP 972
DI 10.1007/s10552-015-0596-2
PG 14
WC Oncology; Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology; Public, Environmental & Occupational Health
GA CK2DN
UT WOS:000356020900001
PM 25956270
OA Green Accepted, Green Submitted
DA 2022-11-22
ER

PT J
AU Liu, NN
   Jiao, N
   Tan, JC
   Wang, ZL
   Wu, DF
   Wang, AJ
   Chen, J
   Tao, LW
   Zhou, CF
   Fang, WJ
   Cheong, IH
   Pan, WH
   Liao, WQ
   Kozlakidis, Z
   Heeschen, C
   Moore, GG
   Zhu, LX
   Chen, XD
   Zhang, GQ
   Zhu, RX
   Wang, H
AF Liu, Ning-Ning
   Jiao, Na
   Tan, Jing-Cong
   Wang, Ziliang
   Wu, Dingfeng
   Wang, An-Jun
   Chen, Jie
   Tao, Liwen
   Zhou, Chenfen
   Fang, Wenjie
   Cheong, Io Hong
   Pan, Weihua
   Liao, Wanqing
   Kozlakidis, Zisis
   Heeschen, Christopher
   Moore, Geromy G.
   Zhu, Lixin
   Chen, Xingdong
   Zhang, Guoqing
   Zhu, Ruixin
   Wang, Hui
TI Multi-kingdom microbiota analyses identify bacterial-fungal interactions
   and biomarkers of colorectal cancer across cohorts
SO NATURE MICROBIOLOGY
LA English
DT Article
ID COMMENSAL FUNGI
AB Analysis of bacterial, archaeal, fungal and viral species in the gut microbiome of patients with colorectal cancer identified cross-kingdom interactions and multi-kingdom markers of disease.
   Despite recent progress in our understanding of the association between the gut microbiome and colorectal cancer (CRC), multi-kingdom gut microbiome dysbiosis in CRC across cohorts is unexplored. We investigated four-kingdom microbiota alterations using CRC metagenomic datasets of 1,368 samples from 8 distinct geographical cohorts. Integrated analysis identified 20 archaeal, 27 bacterial, 20 fungal and 21 viral species for each single-kingdom diagnostic model. However, our data revealed superior diagnostic accuracy for models constructed with multi-kingdom markers, in particular the addition of fungal species. Specifically, 16 multi-kingdom markers including 11 bacterial, 4 fungal and 1 archaeal feature, achieved good performance in diagnosing patients with CRC (area under the receiver operating characteristic curve (AUROC) = 0.83) and maintained accuracy across 3 independent cohorts. Coabundance analysis of the ecological network revealed associations between bacterial and fungal species, such as Talaromyces islandicus and Clostridium saccharobutylicum. Using metagenome shotgun sequencing data, the predictive power of the microbial functional potential was explored and elevated D-amino acid metabolism and butanoate metabolism were observed in CRC. Interestingly, the diagnostic model based on functional EggNOG genes achieved high accuracy (AUROC = 0.86). Collectively, our findings uncovered CRC-associated microbiota common across cohorts and demonstrate the applicability of multi-kingdom and functional markers as CRC diagnostic tools and, potentially, as therapeutic targets for the treatment of CRC.
C1 [Liu, Ning-Ning; Tan, Jing-Cong; Wang, An-Jun; Chen, Jie; Cheong, Io Hong; Heeschen, Christopher; Wang, Hui] Shanghai Jiao Tong Univ, Ctr Single Cell Omics, Sch Publ Hlth, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.
   [Jiao, Na] Zhejiang Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth, Sch Med, Hangzhou, Peoples R China.
   [Jiao, Na; Zhu, Lixin] Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Dept Colorectal Surg,Guangdong Inst Gastroenterol, Guangzhou, Peoples R China.
   [Jiao, Na; Zhu, Ruixin] GloriousMed Clin Lab Co Ltd, Res Inst, Shanghai, Peoples R China.
   [Wang, Ziliang] Shanghai Univ Tradit Chinese Med, Clin Med Transformat Ctr, Shanghai Hosp Tradit Chinese Med, Shanghai, Peoples R China.
   [Wang, Ziliang] Shanghai Univ Tradit Chinese Med, Off Acad Res, Shanghai Hosp Tradit Chinese Med, Shanghai, Peoples R China.
   [Wu, Dingfeng; Tao, Liwen; Zhu, Ruixin] Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Dept Gastroenterol,Shanghai Peoples Hosp 10, Shanghai, Peoples R China.
   [Wu, Dingfeng; Zhu, Ruixin] GloriousMed Clin Lab Co Ltd, Bioinformat Div, Shanghai, Peoples R China.
   [Zhou, Chenfen; Zhang, Guoqing] Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Univ Chinese Acad Sci, Key Lab Computat Biol,Biomed Big Data Ctr, Shanghai, Peoples R China.
   [Fang, Wenjie; Pan, Weihua; Liao, Wanqing] Second Mil Med Univ, Shanghai Changzheng Hosp, Dept Dermatol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.
   [Kozlakidis, Zisis] WHO, Lab Serv & Biobanking, Int Agcy Res Canc, Lyon, France.
   [Moore, Geromy G.] ARS, USDA, Southern Reg Res Ctr, New Orleans, LA USA.
   [Chen, Xingdong] Fudan Univ, Human Phenome Inst, State Key Lab Genet Engn, Shanghai, Peoples R China.
   [Chen, Xingdong] Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.
   [Chen, Xingdong] Fudan Univ, Taizhou Inst Hlth Sci, Taizhou, Peoples R China.
C3 Shanghai Jiao Tong University; Zhejiang University; Sun Yat Sen
   University; Shanghai University of Traditional Chinese Medicine;
   Shanghai University of Traditional Chinese Medicine; Tongji University;
   Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health,
   CAS; University of Chinese Academy of Sciences, CAS; Naval Medical
   University; World Health Organization; International Agency for Research
   on Cancer (IARC); United States Department of Agriculture (USDA); Fudan
   University; Fudan University; Fudan University
RP Wang, H (corresponding author), Shanghai Jiao Tong Univ, Ctr Single Cell Omics, Sch Publ Hlth, State Key Lab Oncogenes & Related Genes,Sch Med, Shanghai, Peoples R China.; Zhu, LX (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 6, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Dept Colorectal Surg,Guangdong Inst Gastroenterol, Guangzhou, Peoples R China.; Zhu, RX (corresponding author), GloriousMed Clin Lab Co Ltd, Res Inst, Shanghai, Peoples R China.; Zhu, RX (corresponding author), Tongji Univ, Sch Life Sci & Technol, Dept Bioinformat, Dept Gastroenterol,Shanghai Peoples Hosp 10, Shanghai, Peoples R China.; Zhu, RX (corresponding author), GloriousMed Clin Lab Co Ltd, Bioinformat Div, Shanghai, Peoples R China.; Zhang, GQ (corresponding author), Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Univ Chinese Acad Sci, Key Lab Computat Biol,Biomed Big Data Ctr, Shanghai, Peoples R China.; Chen, XD (corresponding author), Fudan Univ, Human Phenome Inst, State Key Lab Genet Engn, Shanghai, Peoples R China.; Chen, XD (corresponding author), Fudan Univ, Sch Life Sci, Shanghai, Peoples R China.; Chen, XD (corresponding author), Fudan Univ, Taizhou Inst Hlth Sci, Taizhou, Peoples R China.
EM zhulx6@mail.sysu.edu.cn; xingdongcheng@fudan.edu.cn; gqzhang@picb.ac.cn;
   rxzhu@tongji.edu.cn; huiwang@shsmu.edu.cn
RI Jiao, Na/GRE-8588-2022; Zhu, Ruixin/CAJ-1106-2022; , 金石为开/AFU-9737-2022
OI Zhu, Lixin/0000-0001-7904-1769; Zhang, Guoqing/0000-0001-8827-7546;
   Kozlakidis, Zisis/0000-0002-3836-7209; Fang, Wenjie/0000-0002-6406-5095
FU MOST Key R&D Program of China [2020YFA0907200, 2018YFC2000700,
   2017YFC0907500]; National Natural Science Foundation [82030099,
   81630086, 31900129, 82073637, 81774152, 81770571, 82000536]; Shanghai
   Public Health System Construction Three-Year Action Plan
   [GWV-10.1-XK15]; Program for Young Eastern Scholar at the Shanghai
   Institutions of Higher Learning program [QD2018016]; Innovative research
   team of high-level local universities in Shanghai, Medicine and
   Engineering Interdisciplinary Research Fund of Shanghai Jiao Tong
   University [YG2020YQ06, YG2020YQ19]; Innovative research team of
   high-level local universities in Shanghai [SSMU-ZLCX20180302]; Guangdong
   Province 'Pearl River Talent Plan' Innovation and Entrepreneurship Team
   Project [2019ZT08Y464]; Shanghai Municipal Science and Technology
   [2017SHZDZX01]; National Postdoctoral Program for Innovative Talents of
   China [BX20190393]; China Postdoctoral Science Foundation [2019M651568,
   2019M663252]
FX We thank all the enrolled participants who contributed specimens and
   data to this study. We thank G. Zhao for helpful comments and
   discussions. We acknowledge funding from the MOST Key R&D Program of
   China (no. 2020YFA0907200 to N.-N.L.; no. 2018YFC2000700 to H.W.; no.
   2017YFC0907500 to X.C.), National Natural Science Foundation (nos.
   82030099 and 81630086 to H.W.; no. 31900129 to N.-N.L.; no. 82073637 to
   X.C.; no. 81774152 to R.Z.; no. 81770571 to L.Z.; no. 82000536 to N.J.),
   Shanghai Public Health System Construction Three-Year Action Plan (no.
   GWV-10.1-XK15), the Program for Young Eastern Scholar at the Shanghai
   Institutions of Higher Learning program (no. QD2018016 to N.-N.L.),
   Innovative research team of high-level local universities in Shanghai,
   Medicine and Engineering Interdisciplinary Research Fund of Shanghai
   Jiao Tong University (no. YG2020YQ06 to H.W.; no. YG2020YQ19 to
   N.-N.L.), Innovative research team of high-level local universities in
   Shanghai (no. SSMU-ZLCX20180302 to H.W.),Guangdong Province 'Pearl River
   Talent Plan' Innovation and Entrepreneurship Team Project no.
   2019ZT08Y464 (to L.Z.), Shanghai Municipal Science and Technology Major
   Project no. 2017SHZDZX01 (to X.C.), National Postdoctoral Program for
   Innovative Talents of China no. BX20190393 (to N.J.) and China
   Postdoctoral Science Foundation (no. 2019M651568 to D.W.; no.
   2019M663252 to N.J.). Where authors are identified as personnel of the
   International Agency for Research on Cancer/WHO, the authors alone are
   responsible for the views expressed in this article and they do not
   necessarily represent the decisions, policy or views of the
   International Agency for Research on Cancer/WHO.
CR Bond A, 2019, ALIMENT PHARM THER, V49, P1005, DOI 10.1111/apt.15140
   Borrel G, 2017, ISME J, V11, P2059, DOI 10.1038/ismej.2017.72
   Chen HD, 2019, GUT, V68, P1450, DOI 10.1136/gutjnl-2018-317124
   Coker OO, 2020, GASTROENTEROLOGY, V159, P1459, DOI 10.1053/j.gastro.2020.06.042
   Coker OO, 2019, GUT, V68, P654, DOI 10.1136/gutjnl-2018-317178
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0
   Dickson Iain, 2019, Nat Rev Gastroenterol Hepatol, V16, P76, DOI 10.1038/s41575-019-0105-2
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Fong WN, 2020, ONCOGENE, V39, P4925, DOI 10.1038/s41388-020-1341-1
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Gmeiner WH, 2008, ONCOL REP, V19, P245
   Heintz-Buschart A, 2018, TRENDS MICROBIOL, V26, P563, DOI 10.1016/j.tim.2017.11.002
   Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55
   Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789
   Janney A, 2020, NATURE, V585, P509, DOI 10.1038/s41586-020-2729-3
   Jiang TT, 2017, CELL HOST MICROBE, V22, P809, DOI 10.1016/j.chom.2017.10.013
   Jiang YF, 2021, ALZHEIMERS DEMENT, V17, P18, DOI 10.1002/alz.12171
   Jiao N, 2018, GUT, V67, P1881, DOI 10.1136/gutjnl-2017-314307
   Kaminski MF, 2020, GASTROENTEROLOGY, V158, P404, DOI 10.1053/j.gastro.2019.11.026
   Keum N, 2019, NAT REV GASTRO HEPAT, V16, P713, DOI 10.1038/s41575-019-0189-8
   Ladabaum U, 2020, GASTROENTEROLOGY, V158, P418, DOI 10.1053/j.gastro.2019.06.043
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36893-0
   Lieberman D, 2016, JAMA-J AM MED ASSOC, V316, P2135, DOI 10.1001/jama.2016.17418
   Lloyd-Price J, 2019, NATURE, V569, P655, DOI 10.1038/s41586-019-1237-9
   Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104
   Ma S., 2020, POPULATION STRUCTURE, DOI [10.1101/2020.08.31.261214, DOI 10.1101/2020.08.31.261214]
   Mallick H, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009442
   Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495
   Najumudeen AK, 2021, NAT GENET, V53, DOI 10.1038/s41588-020-00753-3
   Nakatsu G, 2018, GASTROENTEROLOGY, V155, P529, DOI 10.1053/j.gastro.2018.04.018
   Pierce EC, 2021, NAT MICROBIOL, V6, P87, DOI 10.1038/s41564-020-00800-z
   Porto-Figueira P, 2018, ANAL CHIM ACTA, V1023, P53, DOI 10.1016/j.aca.2018.04.027
   Rao CT, 2021, NATURE, V591, P633, DOI 10.1038/s41586-021-03241-8
   Rowan-Nash AD, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00044-18
   Senore C, 2019, GUT, V68, P1232, DOI 10.1136/gutjnl-2018-317293
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tierney BT, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23029-8
   Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819
   Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wong SH, 2019, NAT REV GASTRO HEPAT, V16, P690, DOI 10.1038/s41575-019-0209-8
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Wu YQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23265-y
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
NR 50
TC 9
Z9 11
U1 19
U2 42
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD FEB
PY 2022
VL 7
IS 2
BP 238
EP +
DI 10.1038/s41564-021-01030-7
EA JAN 2022
PG 26
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA YU3NV
UT WOS:000749088800002
PM 35087227
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU McDonald, JAK
AF McDonald, Julie A. K.
TI In vitro models of the human microbiota and microbiome
SO EMERGING TOPICS IN LIFE SCIENCES
LA English
DT Review
AB Gut microbiome studies have been gaining popularity over the years, especially with the development of new technologies (e.g. metataxonomics, metagenomics, metatranscriptomics, and metabonomics) that makes it easier for researchers to characterize the composition and functionality of these complex microbial communities. The goal of these studies is to identify a microorganism, group of microbes, or microbial metabolite which correlates with a disease state (e.g. inflammatory bowel disease, colorectal cancer, and obesity). Many of these are cross-sectional studies, where fecal samples from a group of diseased individuals are compared with those from a group of healthy individuals at a single time point. However, there are a wide range of variables that can affect the gut microbiota of humans which make mechanistic studies challenging. Longitudinal studies are required for research to more reliably correlate interventions or disease status to microbiota composition and functionality. However, longitudinal studies in humans and animals are difficult, expensive, and time-consuming. This review will discuss in vitro gut fermentation models and how they can be used to perform longitudinal studies that complement in vivo microbiome studies. Gut fermentation models support the growth of stable, reproducible, and diverse microbial communities in a tightly controlled environment set to mimic the conditions microbes encounter in the gastrointestinal tract. Gut fermentation models will make it easier for researchers to perform mechanistic studies and aid in the development of novel treatments that are both targeted and maintained over time.
C1 [McDonald, Julie A. K.] Imperial Coll London, Ctr Digest & Gut Hlth, London W2 1NY, England.
C3 Imperial College London
RP McDonald, JAK (corresponding author), Imperial Coll London, Ctr Digest & Gut Hlth, London W2 1NY, England.
EM julie.mcdonald@imperial.ac.uk
CR Aguirre M, 2017, BENEF MICROBES, V8, P31, DOI 10.3920/BM2016.0113
   Allison SD, 2008, P NATL ACAD SCI USA, V105, P11512, DOI 10.1073/pnas.0801925105
   Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08
   Arrieta MC, 2016, CELL HOST MICROBE, V19, P575, DOI 10.1016/j.chom.2016.04.014
   Auchtung JM, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0106-5
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Backhed F, 2012, CELL HOST MICROBE, V12, P611, DOI 10.1016/j.chom.2012.10.012
   Begley CG, 2012, NATURE, V483, P531, DOI 10.1038/483531a
   Blanquet-Diot S, 2009, J NUTR, V139, P876, DOI 10.3945/jn.108.103655
   Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380
   Bucci V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0980-6
   Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50
   Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037
   Cinquin C, 2004, MICROB ECOL, V48, P128, DOI 10.1007/s00248-003-2022-7
   Cinquin C, 2006, FEMS MICROBIOL ECOL, V57, P324, DOI 10.1111/j.1574-6941.2006.00117.x
   COHEN SM, 1995, REGUL TOXICOL PHARM, V21, P75, DOI 10.1006/rtph.1995.1012
   Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a
   Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203
   Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486
   Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003
   De Boever Patrick, 2001, Microbial Ecology in Health and Disease, V13, P111, DOI 10.1080/089106001300136183
   Denning TL, 2011, J IMMUNOL, V187, P733, DOI 10.4049/jimmunol.1002701
   Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107
   Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280
   DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133
   Ericsson AC, 2015, ILAR J, V56, P205, DOI 10.1093/ilar/ilv021
   Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704
   Fite A, 2013, J CLIN MICROBIOL, V51, P849, DOI 10.1128/JCM.02574-12
   Gagnon M, 2011, PROBIOTIC BACTERIA AND ENTERIC INFECTIONS: CYTOPROTECTION BY PROBIOTIC BACTERIA, P65, DOI 10.1007/978-94-007-0386-5_3
   Gerard P, 2004, FEMS MICROBIOL ECOL, V47, P337, DOI 10.1016/S0168-6496(03)00285-X
   HEGSTED DM, 1975, CANCER RES, V35, P3537
   Hufeldt MR, 2010, COMPARATIVE MED, V60, P336
   Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2011.34, 10.1038/nrclinonc.2010.204]
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Kheadr E, 2010, J APPL MICROBIOL, V109, P54, DOI 10.1111/j.1365-2672.2009.04644.x
   Koppel N, 2017, SCIENCE, V356, DOI 10.1126/science.aag2770
   Le Blay G, 2009, FEMS MICROBIOL ECOL, V67, P198, DOI 10.1111/j.1574-6941.2008.00625.x
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011
   Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072
   MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb04882.x
   Macfarlane S, 2005, APPL ENVIRON MICROB, V71, P7483, DOI 10.1128/AEM.71.11.7483-7492.2005
   Marzorati M, 2014, ADV M C M, P107, DOI 10.1079/9781780640495.0107
   McDonald JAK, 2015, J MICROBIOL METH, V108, P36, DOI 10.1016/j.mimet.2014.11.007
   McDonald JAK, 2013, J MICROBIOL METH, V95, P167, DOI 10.1016/j.mimet.2013.08.008
   Meurens F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000677
   MINEKUS M, 1995, ATLA-ALTERN LAB ANIM, V23, P197
   Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622
   MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615
   Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011
   Perrin S, 2014, NATURE, V507, P423, DOI 10.1038/507423a
   Petersen C, 2014, CELL MICROBIOL, V16, P1024, DOI 10.1111/cmi.12308
   Pimm S.L., 1991, BALANCE NATURE ECOLO
   Prinz F, 2011, NAT REV DRUG DISCOV, V10, P712, DOI 10.1038/nrd3439-c1
   Rajilic-Stojanovic M, 2010, MICROBIOL-SGM, V156, P3270, DOI 10.1099/mic.0.042044-0
   Rawls JF, 2004, P NATL ACAD SCI USA, V101, P4596, DOI 10.1073/pnas.0400706101
   Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Robinson CD, 2014, INFECT IMMUN, V82, P2815, DOI 10.1128/IAI.01524-14
   RUMNEY CJ, 1992, CRIT REV FOOD SCI, V31, P299, DOI 10.1080/10408399209527575
   Salzman NH, 2008, ADV EXP MED BIOL, V635, P67, DOI 10.1007/978-0-387-09550-9_6
   Scanlan PD, 2008, ISME J, V2, P1183, DOI 10.1038/ismej.2008.76
   Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009
   Sghir A, 1998, J APPL MICROBIOL, V85, P769, DOI 10.1111/j.1365-2672.1998.00590.x
   Shultz LD, 2012, NAT REV IMMUNOL, V12, P786, DOI 10.1038/nri3311
   Souliman S, 2006, EUR J PHARM SCI, V27, P72, DOI 10.1016/j.ejps.2005.08.006
   Souliman S, 2007, DRUG DEV IND PHARM, V33, P475, DOI 10.1080/03639040601128654
   SOUSA WP, 1984, ANNU REV ECOL SYST, V15, P353, DOI 10.1146/annurev.es.15.110184.002033
   Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540
   Stein RR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003388
   Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580
   Nguyen TLA, 2015, DIS MODEL MECH, V8, P1, DOI 10.1242/dmm.017400
   Trosvik P, 2010, ENVIRON MICROBIOL, V12, P2677, DOI 10.1111/j.1462-2920.2010.02236.x
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Van den Abbeele P, 2013, ISME J, V7, P949, DOI 10.1038/ismej.2012.158
   Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10
   Venema K, 2013, BEST PRACT RES CL GA, V27, P115, DOI 10.1016/j.bpg.2013.03.002
   von Martels JZH, 2017, ANAEROBE, V44, P3, DOI 10.1016/j.anaerobe.2017.01.001
   Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Walker AW, 2011, ISME J, V5, P220, DOI [10.1038/ismej.2010.118, 10.1038/ISMEJ.2010.118]
   Zihler A, 2010, MICROBIOL-SGM, V156, P3342, DOI 10.1099/mic.0.042036-0
NR 82
TC 5
Z9 5
U1 1
U2 11
PU PORTLAND PRESS LTD
PI LONDON
PA 5TH FLR, 90 HIGH HOLBORN, LONDON WC1V 6LJ, ENGLAND
SN 2397-8554
EI 2397-8562
J9 EMERG TOP LIFE SCI
JI Emerg. Top. Life Sci.
PD NOV
PY 2017
VL 1
IS 4
BP 373
EP 384
DI 10.1042/ETLS20170045
PG 12
WC Biochemistry & Molecular Biology; Biology
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA VJ3CQ
UT WOS:000575351500008
PM 33525770
DA 2022-11-22
ER

PT J
AU Dalal, N
   Jalandra, R
   Bayal, N
   Yadav, AK
   Harshulika
   Sharma, M
   Makharia, GK
   Kumar, P
   Singh, R
   Solanki, PR
   Kumar, A
AF Dalal, Nishu
   Jalandra, Rekha
   Bayal, Nitin
   Yadav, Amit K.
   Harshulika
   Sharma, Minakshi
   Makharia, Govind K.
   Kumar, Pramod
   Singh, Rajeev
   Solanki, Pratima R.
   Kumar, Anil
TI Gut microbiota-derived metabolites in CRC progression and causation
SO JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
LA English
DT Review
DE Colorectal cancer; CRC inflammation; Gastrointestinal diseases; Gut
   microbiota; Microbial metabolites
ID CHAIN FATTY-ACIDS; HELICOBACTER-PYLORI INFECTION; COLORECTAL-CANCER
   RISK; TRIMETHYLAMINE-N-OXIDE; FUSOBACTERIUM-NUCLEATUM; INTESTINAL
   MICROBIOTA; CLOSTRIDIUM-SEPTICUM; ESCHERICHIA-COLI;
   ENTEROCOCCUS-FAECALIS; DIETARY FIBER
AB Background Based on recent research reports, dysbiosis and improper concentrations of microbial metabolites in the gut may result into the carcinogenesis of colorectal cancer. Recent advancement also highlights the involvement of bacteria and their secreted metabolites in the cancer causation. Gut microbial metabolites are functional output of the host-microbiota interactions and produced by anaerobic fermentation of food components in the diet. They contribute to influence variety of biological mechanisms including inflammation, cell signaling, cell-cycle disruption which are majorly disrupted in carcinogenic activities. Purpose In this review, we intend to discuss recent updates and possible molecular mechanisms to provide the role of bacterial metabolites, gut bacteria and diet in the colorectal carcinogenesis. Recent evidences have proposed the role of bacteria, such as Fusobacterium nucleaturm, Streptococcus bovis, Helicobacter pylori, Bacteroides fragilis and Clostridium septicum, in the carcinogenesis of CRC. Metagenomic study confirmed that these bacteria are in increased abundance in CRC patient as compared to healthy individuals and can cause inflammation and DNA damage which can lead to development of cancer. These bacteria produce metabolites, such as secondary bile salts from primary bile salts, hydrogen sulfide, trimethylamine-N-oxide (TMAO), which are likely to promote inflammation and subsequently cancer development. Conclusion Recent studies suggest that gut microbiota-derived metabolites have a role in CRC progression and causation and hence, could be implicated in CRC diagnosis, prognosis and therapy.
C1 [Dalal, Nishu; Jalandra, Rekha; Bayal, Nitin; Kumar, Anil] Natl Inst Immunol, Gene Regulat Lab, New Delhi 110067, India.
   [Dalal, Nishu; Singh, Rajeev] Delhi Univ, Satyawati Coll, Dept Environm Sci, Delhi 110052, India.
   [Jalandra, Rekha; Sharma, Minakshi] Maharshi Dayanand Univ, Dept Zool, Rohtak 124001, Haryana, India.
   [Yadav, Amit K.; Solanki, Pratima R.] Jawaharlal Nehru Univ, Special Ctr Nanosci, New Delhi 110067, India.
   [Harshulika] Minist Environm Forest & Climate Change, New Delhi 110003, India.
   [Makharia, Govind K.] AIIMS, Dept Gastroenterol & Human Nutr, New Delhi 110029, India.
   [Kumar, Pramod] Delhi Univ, Sri Aurobindo Coll, New Delhi 110067, India.
C3 Department of Biotechnology (DBT) India; National Institute of
   Immunology (NII); University of Delhi; Maharshi Dayanand University;
   Jawaharlal Nehru University, New Delhi; All India Institute of Medical
   Sciences (AIIMS) New Delhi; University of Delhi
RP Kumar, A (corresponding author), Natl Inst Immunol, Gene Regulat Lab, New Delhi 110067, India.; Solanki, PR (corresponding author), Jawaharlal Nehru Univ, Special Ctr Nanosci, New Delhi 110067, India.
EM partima@mail.jnu.ac.in; anilk@nii.ac.in
RI YADAV, AMIT K./ABH-4068-2020; Bayal, Nitin/GZL-4718-2022; Kumar,
   Anil/L-3294-2016; Solanki, Pratima R./N-1041-2013
OI YADAV, AMIT K./0000-0002-2347-3746; Kumar, Anil/0000-0002-8785-6033; 
FU National Institute of Immunology, New Delhi; SERB-DST [CRG/2018/002957]
FX This review was financially supported by the Core grant of the National
   Institute of Immunology, New Delhi, and SERB-DST (Grant no.
   CRG/2018/002957).
CR Abdulamir AS, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-11
   Abdulamir AS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-249
   Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Ai DM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00826
   Al Hinai EA, 2019, GUT MICROBES, V10, P398, DOI 10.1080/19490976.2018.1534514
   Alhinai EA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215295
   Amarnani R, 2017, J INFECT PUBLIC HEAL, V10, P681, DOI 10.1016/j.jiph.2016.09.009
   Andriamihaja M, 2015, FREE RADICAL BIO MED, V85, P219, DOI 10.1016/j.freeradbiomed.2015.04.004
   [Anonymous], 2020, CANCER DISCOV, V10, P635, DOI 10.1158/2159-8290.CD-RW2020-037
   Armaghany Tannaz, 2012, Gastrointest Cancer Res, V5, P19
   Bae S, 2014, CANCER RES, V74, P7442, DOI 10.1158/0008-5472.CAN-14-1835
   Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x
   Beaumont M, 2018, FASEB J, V32, P6681, DOI 10.1096/fj.201800544
   Biarc J, 2004, CARCINOGENESIS, V25, P1477, DOI 10.1093/carcin/bgh091
   Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Boleij A, 2011, CLIN INFECT DIS, V53, P870, DOI 10.1093/cid/cir609
   Buc E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056964
   Capaldo CT, 2017, J MOL MED, V95, P927, DOI 10.1007/s00109-017-1557-x
   Cassidy A, 2017, AM J CLIN NUTR, V105, P10, DOI 10.3945/ajcn.116.136051
   Chakravorty A, 2015, TOXINS, V7, P516, DOI 10.3390/toxins7020516
   Chan CWH, 2019, J CANCER, V10, P5874, DOI 10.7150/jca.31737
   Chang H, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070950
   Chen HM, 2013, AM J CLIN NUTR, V97, P1044, DOI 10.3945/ajcn.112.046607
   Chen J, 2017, SEMIN IMMUNOL, V32, P43, DOI 10.1016/j.smim.2017.09.006
   Chen ML, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006347
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Chew SSB, 2001, ANZ J SURG, V71, P647, DOI 10.1046/j.1445-1433.2001.02231.x
   Cipe G, 2015, WORLD J GASTRO ONCOL, V7, P233, DOI 10.4251/wjgo.v7.i10.233
   Cohen LJ, 2015, P NATL ACAD SCI USA, V112, pE4825, DOI 10.1073/pnas.1508737112
   Cook JW, 1940, NATURE, V145, P627, DOI 10.1038/145627a0
   Corredoira J, 2017, EUR J INTERN MED, V41, P68, DOI 10.1016/j.ejim.2017.02.009
   Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799
   Dahmus JD, 2018, J GASTROINTEST ONCOL, V9, P769, DOI 10.21037/jgo.2018.04.07
   Dai ZJ, 2019, INT J CANCER, V145, P2032, DOI 10.1002/ijc.32017
   Dalal N, 2020, BIOMED PHARMACOTHER, V131, DOI 10.1016/j.biopha.2020.110648
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Devlin AS, 2016, CELL HOST MICROBE, V20, P709, DOI 10.1016/j.chom.2016.10.021
   Dieterich W., 2018, MED SCI BASEL, DOI 10.3390/medsci6040116
   Diether NE, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7010019
   Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018
   Dziubanska-Kusibab PJ, 2020, NAT MED, V26, P1063, DOI 10.1038/s41591-020-0908-2
   Elliott TR, 2013, INFLAMM BOWEL DIS, V19, P2326, DOI 10.1097/MIB.0b013e3182a38a92
   Fan PX, 2015, CURR PROTEIN PEPT SC, V16, P646, DOI 10.2174/1389203716666150630133657
   Fang H, 2017, MICROB CELL FACT, V16, DOI 10.1186/s12934-017-0631-y
   Feng QQ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00151
   Fischbach MA, 2011, CELL HOST MICROBE, V10, P336, DOI 10.1016/j.chom.2011.10.002
   Forgie AJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01802
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Gausachs M, 2017, CLIN CANCER RES, V23, P5936, DOI 10.1158/1078-0432.CCR-17-0821
   Georgescauld F, 2009, FEBS LETT, V583, P820, DOI 10.1016/j.febslet.2009.01.043
   Gil-Cardoso K, 2016, NUTR RES REV, V29, P234, DOI 10.1017/S0954422416000159
   Giovannucci E, 2004, J NUTR, V134, p2475S, DOI 10.1093/jn/134.9.2475S
   Goodwin AC, 2011, P NATL ACAD SCI USA, V108, P15354, DOI 10.1073/pnas.1010203108
   Guertin KA, 2017, CANCER EPIDEM BIOMAR, V26, P945, DOI 10.1158/1055-9965.EPI-16-0948
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Hartwich A, 2001, INT J COLORECTAL DIS, V16, P202, DOI 10.1007/s003840100288
   Howarth NC, 2008, AM J CLIN NUTR, V88, P1074, DOI 10.1093/ajcn/88.4.1074
   Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529
   Jahani-Sherafat Somayeh, 2018, Gastroenterol Hepatol Bed Bench, V11, P101
   Jakobsson HE, 2015, EMBO REP, V16, P164, DOI 10.15252/embr.201439263
   Johnson CH, 2015, CELL METAB, V21, P891, DOI 10.1016/j.cmet.2015.04.011
   Kantor ED, 2014, NUTR CANCER, V66, P716, DOI 10.1080/01635581.2013.804101
   Kasai C, 2016, ONCOL REP, V35, P325, DOI 10.3892/or.2015.4398
   KASPER S, 2020, SCI REP-UK
   Kato I, 2013, NUTR CANCER, V65, P169, DOI 10.1080/01635581.2013.748922
   Kennedy CL, 2005, MOL MICROBIOL, V57, P1357, DOI 10.1111/j.1365-2958.2005.04774.x
   Kim EK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181183
   Kim KB, 2010, J TOXICOL ENV HEAL A, V73, P1420, DOI 10.1080/15287394.2010.511545
   Kim TJ, 2017, HELICOBACTER, V22, DOI 10.1111/hel.12377
   Kim YH, 2019, J GASTROEN HEPATOL, V34, P544, DOI 10.1111/jgh.14526
   King M, 2020, IMMUNE NETW, V20, DOI 10.4110/in.2020.20.e30
   Kishino S, 2013, P NATL ACAD SCI USA, V110, P17808, DOI 10.1073/pnas.1312937110
   Klampfer L, 2003, MOL CANCER RES, V1, P855
   Knip M, 2016, NAT REV ENDOCRINOL, V12, P154, DOI 10.1038/nrendo.2015.218
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kostic AD, 2012, GENOME RES, V22, P292, DOI 10.1101/gr.126573.111
   Lee DW, 2018, ANN SURG ONCOL, V25, P3389, DOI 10.1245/s10434-018-6681-5
   Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048
   LICHTENSTERN C, 2020, CELLS-BASEL
   Liu TY, 2020, INT J CANCER, V146, P1780, DOI 10.1002/ijc.32563
   Liu XM, 2017, BIOMARK MED, V11, P443, DOI 10.2217/bmm-2016-0262
   Long XH, 2019, NAT MICROBIOL, V4, P2319, DOI 10.1038/s41564-019-0541-3
   Lu R, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.20
   Lu R, 2016, NEOPLASIA, V18, P307, DOI 10.1016/j.neo.2016.04.001
   Lucas C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061310
   Luhrs H, 2002, SCAND J GASTROENTERO, V37, P458, DOI 10.1080/003655202317316105
   Lunn JC, 2007, CARCINOGENESIS, V28, P685, DOI 10.1093/carcin/bgl192
   Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421
   Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054
   Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530
   McCoy AN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053653
   McNabney SM., 2017, OBES INSULIN RESIST, DOI 10.3390/nu9121348
   Meijnikman AS, 2018, ENDOCR REV, V39, P133, DOI 10.1210/er.2017-00192
   Nam JH, 2017, CANCER CAUSE CONTROL, V28, P107, DOI 10.1007/s10552-016-0839-x
   NEOPTOLEMOS JP, 1988, BRIT J CANCER, V58, P575, DOI 10.1038/bjc.1988.262
   Nougayrede JP, 2006, SCIENCE, V313, P848, DOI 10.1126/science.1127059
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ocvirk S, 2020, AM J CLIN NUTR, V111, P406, DOI 10.1093/ajcn/nqz301
   Ocvirk Soren, 2017, Curr Nutr Rep, V6, P315, DOI 10.1007/s13668-017-0219-5
   Ohira H, 2017, J ATHEROSCLER THROMB, V24, P660, DOI 10.5551/jat.RV17006
   Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8
   Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277
   Payne CM, 2007, CARCINOGENESIS, V28, P215, DOI 10.1093/carcin/bgl139
   Powolny A, 2001, INT J BIOCHEM CELL B, V33, P193, DOI 10.1016/S1357-2725(00)00080-7
   Prasad K. N., 2019, BIOACTIVE CARBOHYDRA, V17, DOI [DOI 10.1016/J.BCDF.2018.09.001, 10.1016/j.bcdf.2018.09.001]
   Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
   Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x
   Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106
   Rowland I, 2018, EUR J NUTR, V57, P1, DOI 10.1007/s00394-017-1445-8
   Rubinstein MR, 2019, EMBO REP, V20, DOI 10.15252/embr.201847638
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018
   Sears CL, 2001, TOXICON, V39, P1737, DOI 10.1016/S0041-0101(01)00160-X
   Seesaha PK, 2020, FUTURE ONCOL, V16, P293, DOI 10.2217/fon-2019-0552
   Shmuely H, 2001, AM J GASTROENTEROL, V96, P3406
   Sivaprakasam S, 2016, PHARMACOL THERAPEUT, V164, P144, DOI 10.1016/j.pharmthera.2016.04.007
   Slattery ML, 1997, INT J CANCER, V73, P670, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;670::AID-IJC10&gt;3.0.CO;2-A
   Sole C, 2021, GASTROENTEROLOGY, V160, P206, DOI 10.1053/j.gastro.2020.08.054
   Sun J, 2016, GENES DIS, V3, P130, DOI 10.1016/j.gendis.2016.03.004
   Tatishchev SF, 2012, J GASTROINTEST ONCOL, V3, P380, DOI 10.3978/j.issn.2078-6891.2012.058
   Theodoratou E, 2007, CANCER EPIDEM BIOMAR, V16, P684, DOI 10.1158/1055-9965.EPI-06-0785
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tsoi H, 2017, GASTROENTEROLOGY, V152, P1419, DOI 10.1053/j.gastro.2017.01.009
   Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237
   Vernocchi P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103688
   Vieytes CAM, 2019, CURR NUTR REP, V8, P230, DOI 10.1007/s13668-019-0264-3
   Viljoen KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119462
   Vipperla K, 2016, FOOD FUNCT, V7, P1731, DOI [10.1039/c5fo01276g, 10.1039/C5FO01276G]
   Wang C, 2017, ONCOTARGET, V8, P1092, DOI 10.18632/oncotarget.13582
   Wang G, 2019, J CELL PHYSIOL, V234, P17023, DOI 10.1002/jcp.28436
   Wang ZN, 2018, PROTEIN CELL, V9, P416, DOI 10.1007/s13238-018-0549-0
   Weng Z, 2015, J ALLERGY CLIN IMMUN, V135, P1044, DOI 10.1016/j.jaci.2014.10.032
   Wessler S, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0171-4
   Wilson AJ, 2010, CANCER RES, V70, P609, DOI 10.1158/0008-5472.CAN-09-2327
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yan SJ, 2016, SCI BULL, V61, P1151, DOI 10.1007/s11434-016-1142-7
   Yang Y, 2017, GASTROENTEROLOGY
   Yao LN, 2018, ELIFE, V7, DOI 10.7554/eLife.37182
   Ye XC, 2017, CANCER PREV RES, V10, P398, DOI 10.1158/1940-6207.CAPR-16-0178
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zamani S, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00449
   Zeng HW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051214
   Zhang HL, 2019, RSC ADV, V9, P3072, DOI 10.1039/c8ra08520j
   Zhou YL, 2016, ONCOTARGET, V7, P80794, DOI 10.18632/oncotarget.13094
NR 148
TC 16
Z9 17
U1 3
U2 11
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0171-5216
EI 1432-1335
J9 J CANCER RES CLIN
JI J. Cancer Res. Clin. Oncol.
PD NOV
PY 2021
VL 147
IS 11
BP 3141
EP 3155
DI 10.1007/s00432-021-03729-w
EA JUL 2021
PG 15
WC Oncology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Oncology
GA UZ8PE
UT WOS:000673675000001
PM 34273006
DA 2022-11-22
ER

PT J
AU Boursi, B
   Werner, TJ
   Gholami, S
   Houshmand, S
   Mamtani, R
   Lewis, JD
   Wu, GD
   Alavi, A
   Yang, YX
AF Boursi, Ben
   Werner, Thomas J.
   Gholami, Saeid
   Houshmand, Sina
   Mamtani, Ronac
   Lewis, James D.
   Wu, Gary D.
   Alavi, Abass
   Yang, Yu-Xiao
TI Functional imaging of the interaction between gut microbiota and the
   human host: A proof-of-concept clinical study evaluating novel use for
   18F-FDG PET-CT
SO PLOS ONE
LA English
DT Article
ID INTESTINAL F-18-FDG UPTAKE; METFORMIN; ANTIBIOTICS; METAGENOME; COLON
AB Recent data comparing germ-free to conventionally-raised mice demonstrated that energy homeostasis of colonocytes is dependent on gut microbiota through regulation of short chain fatty acids (SCFA) production and glucose utilization. We sought to evaluate 18F-FDG PET-CT as a novel technique for functional imaging of alterations in glucose metabolism as a result of the interaction between the gut microbiota and the human host. We conducted a prospective study in healthy humans that underwent 18F-FDG PET-CT and sampling of the gut microbiota before and after orally administered broad-spectrum antibiotics. The primary outcomes were total and regional physiologic colonic 18F-FDG uptake (measured as the mean and max standardized uptake values [SUVmean and SUVmax]). The study demonstrated significant increases in physiologic colonic 18F-FDG uptake in all study participants following antibiotic treatment and a 4-5log reduction of gut bacterial load. The mean increase in SUVmax was 0.63 +/- 0.37 SD (p = 0.004) and the median increase was 0.42 with an IQR of 0.40-0.81. The mean increase in SUVmean was 0.31 +/- 0.24 SD (p = 0.01) and the median increase was 0.41 with an IQR of 0.06-0.55. A likely explanation for this phenomenon is a shift in colonocyte metabolism to glycolysis due to a shortage of SCFA.
C1 [Boursi, Ben; Lewis, James D.; Wu, Gary D.; Yang, Yu-Xiao] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.
   [Boursi, Ben; Mamtani, Ronac; Lewis, James D.; Yang, Yu-Xiao] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.
   [Boursi, Ben; Mamtani, Ronac] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.
   [Boursi, Ben] Tel Aviv Univ, Tel Aviv, Israel.
   [Boursi, Ben] Sheba Med Ctr, Dept Oncol, Ramat Gan, Israel.
   [Werner, Thomas J.; Gholami, Saeid; Houshmand, Sina; Alavi, Abass] Univ Penn, Perelman Sch Med, Dept Nucl Med, Philadelphia, PA 19104 USA.
C3 University of Pennsylvania; Pennsylvania Medicine; University of
   Pennsylvania; Pennsylvania Medicine; University of Pennsylvania;
   Pennsylvania Medicine; Tel Aviv University; Chaim Sheba Medical Center;
   University of Pennsylvania; Pennsylvania Medicine
RP Boursi, B (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA.; Boursi, B (corresponding author), Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA.; Boursi, B (corresponding author), Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA.; Boursi, B (corresponding author), Tel Aviv Univ, Tel Aviv, Israel.; Boursi, B (corresponding author), Sheba Med Ctr, Dept Oncol, Ramat Gan, Israel.
EM ben.boursi@sheba.health.gov.il
RI yang, yx/GZM-0464-2022
FU NATIONAL CANCER INSTITUTE [K23CA187185] Funding Source: NIH RePORTER;
   NCI NIH HHS [K23 CA187185] Funding Source: Medline
CR Abreu MT, 2014, GASTROENTEROLOGY, V146, P1534, DOI 10.1053/j.gastro.2014.01.001
   Bahler L, 2016, DIABETES RES CLIN PR, V114, P55, DOI 10.1016/j.diabres.2016.02.009
   BENDER JF, 1979, ANTIMICROB AGENTS CH, V15, P455, DOI 10.1128/AAC.15.3.455
   Brader P, 2008, CLIN CANCER RES, V14, P2295, DOI 10.1158/1078-0432.CCR-07-4254
   Capitanio S, 2015, WORLD J RADIOL, V7, P57, DOI 10.4329/wjr.v7.i3.57
   Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400
   Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052
   Dejea CM, 2014, P NATL ACAD SCI USA, V111, P18321, DOI 10.1073/pnas.1406199111
   Donohoe DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046589
   Franquet E, 2014, NUCL MED COMMUN, V35, P1026, DOI 10.1097/MNM.0000000000000170
   Ghosh SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108577
   Gontier E, 2008, EUR J NUCL MED MOL I, V35, P95, DOI 10.1007/s00259-007-0563-6
   Hevia A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147809
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Ling ZX, 2014, APPL ENVIRON MICROB, V80, P2546, DOI 10.1128/AEM.00003-14
   Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208
   Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990
   Massollo M, 2013, J NUCL MED, V54, P259, DOI 10.2967/jnumed.112.106666
   Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329
   Ni J, 2017, SCI TRANSL MED, V9, P416
   Nylund L, 2015, ALLERGY, V70, P241, DOI 10.1111/all.12549
   Oh JR, 2010, AM J ROENTGENOL, V195, P1404, DOI 10.2214/AJR.10.4663
   Ozulker T, 2010, EUR J NUCL MED MOL I, V37, P1011, DOI 10.1007/s00259-009-1330-7
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   REDDY BS, 1975, CANCER RES, V35, P287
   ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424
   ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Steenkamp DW, 2014, ENDOCR PRACT, V20, P1079, DOI 10.4158/EP14127.RA
   Tatlidil R, 2002, RADIOLOGY, V224, P783, DOI 10.1148/radiol.2243011214
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
NR 32
TC 12
Z9 12
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 15
PY 2018
VL 13
IS 2
AR e0192747
DI 10.1371/journal.pone.0192747
PG 9
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA FW4LB
UT WOS:000425283900051
PM 29447210
OA Green Published, gold, Green Submitted
DA 2022-11-22
ER

PT J
AU Lee, SJ
   Rho, M
AF Lee, Seung Jae
   Rho, Mina
TI Multimodal deep learning applied to classify healthy and disease states
   of human microbiome
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GUT MICROBIOTA; DIVERSITY; ANNOTATION; ALIGNMENT; PROJECT; GENOMES; KEGG
AB Metagenomic sequencing methods provide considerable genomic information regarding human microbiomes, enabling us to discover and understand microbial diseases. Compositional differences have been reported between patients and healthy people, which could be used in the diagnosis of patients. Despite significant progress in this regard, the accuracy of these tools needs to be improved for applications in diagnostics and therapeutics. MDL4Microbiome, the method developed herein, demonstrated high accuracy in predicting disease status by using various features from metagenome sequences and a multimodal deep learning model. We propose combining three different features, i.e., conventional taxonomic profiles, genome-level relative abundance, and metabolic functional characteristics, to enhance classification accuracy. This deep learning model enabled the construction of a classifier that combines these various modalities encoded in the human microbiome. We achieved accuracies of 0.98, 0.76, 0.84, and 0.97 for predicting patients with inflammatory bowel disease, type 2 diabetes, liver cirrhosis, and colorectal cancer, respectively; these are comparable or higher than classical machine learning methods. A deeper analysis was also performed on the resulting sets of selected features to understand the contribution of their different characteristics. MDL4Microbiome is a classifier with higher or comparable accuracy compared with other machine learning methods, which offers perspectives on feature generation with metagenome sequences in deep learning models and their advantages in the classification of host disease status.
C1 [Lee, Seung Jae; Rho, Mina] Hanyang Univ, Dept Comp Sci, Seoul, South Korea.
   [Rho, Mina] Hanyang Univ, Dept Biomed Informat, Seoul, South Korea.
C3 Hanyang University; Hanyang University
RP Rho, M (corresponding author), Hanyang Univ, Dept Comp Sci, Seoul, South Korea.; Rho, M (corresponding author), Hanyang Univ, Dept Biomed Informat, Seoul, South Korea.
EM minarho@hanyang.ac.kr
OI Lee, Seungjae/0000-0001-9081-2835
FU Bio & Medical Technology Development Program of the National Research
   Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning
   [2017M3A9F3041232]; Institute of Information & Communications Technology
   Planning & Evaluation (IITP) - Korea Government (MSIT) [2020-0-01373]
FX This work was supported by Bio & Medical Technology Development Program
   of the National Research Foundation of Korea (NRF), funded by the
   Ministry of Science, ICT & Future Planning (2017M3A9F3041232), Institute
   of Information & Communications Technology Planning & Evaluation (IITP)
   grant funded by the Korea Government (MSIT) [No. 2020-0-01373,
   Artificial Intelligence Graduate School Program (Hanyang University)].
CR Asgari E, 2018, BIOINFORMATICS, V34, P32, DOI 10.1093/bioinformatics/bty296
   Breiman Leo, 2001, MACH LEARN, V45, P5
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Chen T, 2016, KDD16 P 22 ACM, P785, DOI DOI 10.1145/2939672.2939785
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Feng Changyong, 2014, Shanghai Arch Psychiatry, V26, P105, DOI 10.3969/j.issn.1002-0829.2014.02.009
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Halfvarson J, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.4
   Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Joshi NA., 2011, SICKLE SLIDING WINDO
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070
   Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165
   Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Li B, 2015, ENVIRON SCI TECHNOL, V49, P10492, DOI 10.1021/acs.est.5b02345
   Lo C, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2833-2
   LOEB LA, 1974, CANCER RES, V34, P2311
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Marx V, 2016, NAT METHODS, V13, P401, DOI 10.1038/nmeth.3837
   Matsuoka K, 2015, SEMIN IMMUNOPATHOL, V37, P47, DOI 10.1007/s00281-014-0454-4
   Ounit R, 2016, BIOINFORMATICS, V32, P3823, DOI 10.1093/bioinformatics/btw542
   Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866
   Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226
   Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Shen Y, 2018, SCHIZOPHR RES, V197, P470, DOI 10.1016/j.schres.2018.01.002
   Talseth-Palmer Bente A, 2011, Int J Biomed Sci, V7, P158
   Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33
   Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x
   Tilg H, 2016, GUT, V65, P2035, DOI 10.1136/gutjnl-2016-312729
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   von Meijenfeldt FAB, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1817-x
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Xu Xilin, 2016, Biophys Rep, V2, P106, DOI 10.1007/s41048-016-0033-4
   Zhou YH, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00579
   Zielezinski A, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1319-7
NR 44
TC 0
Z9 0
U1 7
U2 11
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JAN 17
PY 2022
VL 12
IS 1
AR 824
DI 10.1038/s41598-022-04773-3
PG 11
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA YI1XP
UT WOS:000743649400062
PM 35039534
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Li, M
   Wang, CH
   Guo, Q
   Xu, CM
   Xie, ZJ
   Tan, J
   Wu, SF
   Wang, PH
   Guo, JY
   Fang, ZC
   Zhu, SW
   Duan, LP
   Jiang, XQ
   Zhu, HQ
AF Li, Mo
   Wang, Chunhui
   Guo, Qian
   Xu, Congmin
   Xie, Zhongjie
   Tan, Jie
   Wu, Shufang
   Wang, Peihong
   Guo, Jinyuan
   Fang, Zhencheng
   Zhu, Shiwei
   Duan, Liping
   Jiang, Xiaoqing
   Zhu, Huaiqiu
TI More Positive or More Negative? Metagenomic Analysis Reveals Roles of
   Virome in Human Disease-Related Gut Microbiome
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE virus; gut microbiome; health and disease; microbial community; viral
   database
ID IRRITABLE-BOWEL-SYNDROME; BACTERIOPHAGE; CLASSIFICATION; INFLAMMATION;
   DYSBIOSIS; DATABASE; GENOME; ACLAME; DIET
AB Viruses are increasingly viewed as vital components of the human gut microbiota, while their roles in health and diseases remain incompletely understood. Here, we first sequenced and analyzed the 37 metagenomic and 18 host metabolomic samples related to irritable bowel syndrome (IBS) and found that some shifted viruses between IBS and controls covaried with shifted bacteria and metabolites. Especially, phages that infect beneficial lactic acid bacteria depleted in IBS covaried with their hosts. We also retrieved public whole-genome metagenomic datasets of another four diseases (type 2 diabetes, Crohn's disease, colorectal cancer, and liver cirrhosis), totaling 438 samples including IBS, and performed uniform analysis of the gut viruses in diseases. By constructing disease-specific co-occurrence networks, we found viruses actively interacting with bacteria, negatively correlated with possible dysbiosis-related and inflammation-mediating bacteria, increasing the connectivity between bacteria modules, and contributing to the robustness of the networks. Functional enrichment analysis showed that phages interact with bacteria through predation or expressing genes involved in the transporter and secretion system, metabolic enzymes, etc. We further built a viral database to facilitate systematic functional classification and explored the functions of viral genes on interacting with bacteria. Our analyses provided a systematic view of the gut virome in the disease-related microbial community and suggested possible positive roles of viruses concerning gut health.
C1 [Li, Mo; Wang, Chunhui; Zhu, Huaiqiu] Peking Univ, Tsinghua Univ, Sch Life Sci, Natl Inst Biol Sci PTN Joint Ph D Program, Beijing, Peoples R China.
   [Li, Mo; Wang, Chunhui; Guo, Qian; Xu, Congmin; Xie, Zhongjie; Tan, Jie; Wu, Shufang; Wang, Peihong; Guo, Jinyuan; Fang, Zhencheng; Jiang, Xiaoqing; Zhu, Huaiqiu] Peking Univ, Coll Future Technol, Dept Biomed Engn, Beijing, Peoples R China.
   [Guo, Qian; Tan, Jie; Wu, Shufang; Fang, Zhencheng; Jiang, Xiaoqing; Zhu, Huaiqiu] Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China.
   [Zhu, Shiwei; Duan, Liping] Peking Univ Third Hosp, Dept Gastroenterol, Beijing, Peoples R China.
   [Zhu, Huaiqiu] Peking Univ, Inst Med Technol, Hlth Sci Ctr, Beijing, Peoples R China.
C3 Peking University; Tsinghua University; Peking University; Peking
   University; Peking University; Peking University
RP Zhu, HQ (corresponding author), Peking Univ, Tsinghua Univ, Sch Life Sci, Natl Inst Biol Sci PTN Joint Ph D Program, Beijing, Peoples R China.; Jiang, XQ; Zhu, HQ (corresponding author), Peking Univ, Coll Future Technol, Dept Biomed Engn, Beijing, Peoples R China.; Jiang, XQ; Zhu, HQ (corresponding author), Peking Univ, Ctr Quantitat Biol, Beijing, Peoples R China.; Zhu, HQ (corresponding author), Peking Univ, Inst Med Technol, Hlth Sci Ctr, Beijing, Peoples R China.
EM jiangxiaoqing357@126.com; hqzhu@pku.edu.cn
RI xu, congmin/GYJ-5547-2022; Fang, Zhencheng/HCG-9557-2022
FU National Key Research and Development Program of China [2021YFC2300300,
   2017YFC1200205]; National Natural Science Foundation of China [32070667,
   31671366]
FX This work was supported by the National Key Research and Development
   Program of China (2021YFC2300300, 2017YFC1200205) and the National
   Natural Science Foundation of China (32070667, 31671366).
CR Almand EA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030058
   Baldassano SN, 2016, SCI REP-UK, V6, DOI 10.1038/srep26087
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Barr JJ, 2015, P NATL ACAD SCI USA, V112, P13675, DOI 10.1073/pnas.1508355112
   Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110
   Berger AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010019
   Brennan CA, 2016, ANNU REV MICROBIOL, V70, P395, DOI 10.1146/annurev-micro-102215-095513
   Brenner DA, 2015, J CLIN GASTROENTEROL, V49, pS25, DOI 10.1097/MCG.0000000000000391
   Chen LM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17840-y
   Chey WD, 2015, JAMA-J AM MED ASSOC, V313, P949, DOI 10.1001/jama.2015.0954
   Clooney AG, 2019, CELL HOST MICROBE, V26, P764, DOI 10.1016/j.chom.2019.10.009
   Coughlan S, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1887719
   Csardi G., 2006, INTERJOURNAL COMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191
   Fang ZC, 2020, BIOINFORMATICS, V36, P3239, DOI 10.1093/bioinformatics/btaa103
   Fang ZC, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz066
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Febvre HP, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030666
   Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Gao RY, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.657867
   Garmaeva S, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0704-y
   Grazziotin AL, 2017, NUCLEIC ACIDS RES, V45, pD491, DOI 10.1093/nar/gkw975
   Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109
   Gregory AC, 2020, CELL HOST MICROBE, V28, P724, DOI 10.1016/j.chom.2020.08.003
   Hatti-Kaul R, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fny213
   Heinken A, 2021, NPJ SYST BIOL APPL, V7, DOI 10.1038/s41540-021-00178-6
   Hsu BB, 2019, CELL HOST MICROBE, V25, P803, DOI 10.1016/j.chom.2019.05.001
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11
   Kreimer A, 2008, P NATL ACAD SCI USA, V105, P6976, DOI 10.1073/pnas.0712149105
   Kurtz ZD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004226
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leplae R, 2004, NUCLEIC ACIDS RES, V32, pD45, DOI 10.1093/nar/gkh084
   Leplae R, 2010, NUCLEIC ACIDS RES, V38, pD57, DOI 10.1093/nar/gkp938
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Liu YX, 2016, CLIN GASTROENTEROL H, V14, P1602, DOI 10.1016/j.cgh.2016.05.033
   Ma YF, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0410-y
   Manrique P, 2016, P NATL ACAD SCI USA, V113, P10400, DOI 10.1073/pnas.1601060113
   Menzel P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11257
   Mihindukulasuriya KA, 2021, GASTROENTEROLOGY, V161, P1194, DOI 10.1053/j.gastro.2021.06.077
   Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111
   Moreno-Gallego JL, 2019, CELL HOST MICROBE, V25, P261, DOI 10.1016/j.chom.2019.01.019
   Mukhopadhy I, 2019, THER ADV GASTROENTER, V12, DOI 10.1177/1756284819836620
   Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189
   Paez-Espino D, 2016, NATURE, V536, P425, DOI 10.1038/nature19094
   Perez-Brocal V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2013.9
   Pimentel M, 2020, DIGEST DIS SCI, V65, P829, DOI 10.1007/s10620-020-06109-5
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Reyesa A, 2015, P NATL ACAD SCI USA, V112, P11941, DOI 10.1073/pnas.1514285112
   Sharma S, 2019, J NUTR BIOCHEM, V63, P101, DOI 10.1016/j.jnutbio.2018.10.003
   Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011
   Shkoporov AN, 2019, CELL HOST MICROBE, V26, P527, DOI 10.1016/j.chom.2019.09.009
   Shkoporov AN, 2019, CELL HOST MICROBE, V25, P195, DOI 10.1016/j.chom.2019.01.017
   Silveira CB, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.10
   Sutton TDS, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00784
   Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33
   Toussaint A, 2017, CURR OPIN MICROBIOL, V38, P88, DOI 10.1016/j.mib.2017.04.009
   Vitkup D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r39
   Wang XQ, 2015, SCI BULL, V60, P348, DOI 10.1007/s11434-014-0658-y
   Wang Z, 2019, CHINESE MED J-PEKING, V132, P889, DOI 10.1097/CM9.0000000000000192
   Wassenaar TM, 2018, EUR J MICROBIOL IMMU, V8, P63, DOI 10.1556/1886.2018.00017
   Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918
   Xu CM, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.580980
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zhai P, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1849-8
   Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275
   Zuo T, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02247
NR 70
TC 0
Z9 0
U1 14
U2 18
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD APR 12
PY 2022
VL 12
AR 846063
DI 10.3389/fcimb.2022.846063
PG 16
WC Immunology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA 1A7LW
UT WOS:000791934500001
PM 35493727
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Jeraldo, P
   Hernandez, A
   Nielsen, HB
   Chen, XF
   White, BA
   Goldenfeld, N
   Nelson, H
   Alhquist, D
   Boardman, L
   Chia, N
AF Jeraldo, Patricio
   Hernandez, Alvaro
   Nielsen, Henrik B.
   Chen, Xianfeng
   White, Bryan A.
   Goldenfeld, Nigel
   Nelson, Heidi
   Alhquist, David
   Boardman, Lisa
   Chia, Nicholas
TI Capturing One of the Human Gut Microbiome's Most Wanted: Reconstructing
   the Genome of a Novel Butyrate-Producing, Clostridia! Scavenger from
   Metagenomic Sequence Data
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE microbiome; metagenomics; Butyticicoccus; binning; genome assembly
ID EUBACTERIUM-DESMOLANS; BACTERIA; DIVERSITY; ALIGNMENT; ACCURATE; TOOLS;
   GENE; MICROORGANISMS; SAMPLES; SEARCH
AB The role of the microbiome in health and disease is attracting great attention, yet we still know little about some of the most prevalent microorganisms inside our bodies. Several years ago, Human Microbiome Project (HMP) researchers generated a list of "most wanted" taxa: bacteria both prevalent among healthy volunteers and distantly related to any sequenced organisms. Unfortunately, the challenge of assembling high quality genomes from a tangle of metagenomic reads has slowed progress in learning about these uncultured bacteria. Here, we describe how recent advances in sequencing and analysis allowed us to assemble "most wanted" genomes from metagenomic data collected from four stool samples. Using a combination of both de novo and guided assembly methods, we assembled and binned over 100 genomes from an initial data set of over 1,300 Gbp. One of these genome bins, which met HMP's criteria for a "most wanted" taxa, contained three essentially complete genomes belonging to a previously uncultivated species. This species is most closely related to Eubacterium desmolans and the clostridial cluster IVICIostridium leptum subgroup species Butyncicoccus pullicaecorum (71-76% average nucleotide identity). Gene function analysis indicates that the species is an obligate anaerobe, forms spores, and produces the antiinflammatory short -chain fatty acids acetate and butyrate. It also appears to take up metabolically costly molecules such as cobalamin, methionine, and branch-chained amino acids from the environment, and to lack virulence genes. Thus, the evidence is consistent with a secondary degrader that occupies a host-dependent, nutrient scavenging niche within the gut; its ability to produce butyrate, which is thought to play an anti-inflammatory role, makes it intriguing for the study of diseases such as colon cancer and inflammatory bowel disease. In conclusion, we have assembled essentially complete genomes from stool metagenomic data, yielding valuable information about uncultured organisms' metabolic and ecologic niches, factors that may be required to successfully culture these bacteria, and their role in maintaining health and causing disease.
C1 [Jeraldo, Patricio; Nelson, Heidi; Chia, Nicholas] Mayo Clin, Ctr Individualized Med, Microbiome Program, Rochester, MN USA.
   [Jeraldo, Patricio; Nelson, Heidi; Chia, Nicholas] Mayo Clin, Dept Surg, Rochester, MN USA.
   [Jeraldo, Patricio; White, Bryan A.; Goldenfeld, Nigel] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA.
   [Hernandez, Alvaro] Univ Illinois, Roy J Carver Biotechnol Ctr, Urbana, IL USA.
   [Nielsen, Henrik B.] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.
   [Chen, Xianfeng] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA.
   [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL USA.
   [Goldenfeld, Nigel] Univ Illinois, Dept Phys, Urbana, IL USA.
   [Alhquist, David; Boardman, Lisa] Mayo Clin, Div Gastroenterol & Hepatol, Rochester, MN USA.
   [Chia, Nicholas] Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA.
C3 Mayo Clinic; Mayo Clinic; University of Illinois System; University of
   Illinois Urbana-Champaign; University of Illinois System; University of
   Illinois Urbana-Champaign; Technical University of Denmark; Mayo Clinic;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   Mayo Clinic; Mayo Clinic
RP Chia, N (corresponding author), Mayo Clin, Ctr Individualized Med, Microbiome Program, Rochester, MN USA.; Chia, N (corresponding author), Mayo Clin, Dept Surg, Rochester, MN USA.; Chia, N (corresponding author), Mayo Clin, Dept Physiol & Biomed Engn, Rochester, MN USA.
EM chia.nicholas@mayo.edu
RI Jeraldo, Patricio/H-8178-2019; Chen, Xianfeng/ABG-8256-2021; Nielsen,
   Henrik Bjorn/B-8961-2019
OI Jeraldo, Patricio/0000-0003-0282-4217; Chia,
   Nicholas/0000-0001-9652-691X; Nielsen, Henrik Bjorn/0000-0003-2281-5713
FU National Cancer Institute [R01CA179243]; Center for Individualized
   Medicine at Mayo Clinic; Mayo Illinois Strategic Alliance for Technology
   based Healthcare; NATIONAL CANCER INSTITUTE [R01CA179243] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND
   KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER
FX We acknowledge funding from the National Cancer Institute under grant
   number R01CA179243, the Center for Individualized Medicine at Mayo
   Clinic, and the Mayo Illinois Strategic Alliance for Technology based
   Healthcare.
CR Al-Hinai MA, 2015, MICROBIOL MOL BIOL R, V79, P19, DOI 10.1128/MMBR.00025-14
   Albertsen M, 2013, NAT BIOTECHNOL, V31, P533, DOI 10.1038/nbt.2579
   Alneberg, 2013, ARXIV13124038
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406
   Boisvert S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r122
   BOKKENHEUSER VD, 1986, APPL ENVIRON MICROB, V52, P1153, DOI 10.1128/AEM.52.5.1153-1156.1986
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Chen J, 2016, PEERJ, V4, DOI 10.7717/peerj.1514
   Chu J, 2014, BIOINFORMATICS, V30, P3402, DOI 10.1093/bioinformatics/btu558
   Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879
   Crusoe Michael R, 2015, F1000Res, V4, P900, DOI 10.12688/f1000research.6924.1
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   Di Rienzi SC, 2013, ELIFE, V2, DOI 10.7554/eLife.01102
   Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Eren AM, 2015, PEERJ, V3, DOI 10.7717/peerj.1319
   Fierer N, 2008, P NATL ACAD SCI USA, V105, P17994, DOI 10.1073/pnas.0807920105
   Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041294
   Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800
   Geirnaert A, 2014, ANAEROBE, V30, P70, DOI 10.1016/j.anaerobe.2014.08.010
   Gevers D, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001377
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Hyatt D, 2012, BIOINFORMATICS, V28, P2223, DOI 10.1093/bioinformatics/bts429
   Jeraldo P, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00526-15
   Kuleshov V, 2016, NAT BIOTECHNOL, V34, P64, DOI 10.1038/nbt.3416
   Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lok C, 2015, NATURE, V522, P270, DOI 10.1038/522270a
   Marakeby H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089142
   Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938
   Meyer F, 2009, NUCLEIC ACIDS RES, V37, P6643, DOI 10.1093/nar/gkp698
   MORRIS GN, 1986, INT J SYST BACTERIOL, V36, P183, DOI 10.1099/00207713-36-2-183
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Petkau A, 2010, BIOINFORMATICS, V26, P3125, DOI 10.1093/bioinformatics/btq588
   Pignatelli M., 2014, BLAST2LCA
   Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47
   Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950
   Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106
   Rossello-Mora R, 2015, SYST APPL MICROBIOL, V38, P209, DOI 10.1016/j.syapm.2015.02.001
   Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967
   Schwiertz A, 2000, APPL ENVIRON MICROB, V66, P375, DOI 10.1128/AEM.66.1.375-382.2000
   Sharon I, 2015, GENOME RES, V25, P534, DOI 10.1101/gr.183012.114
   Sharon I, 2013, SCIENCE, V342, P1057, DOI 10.1126/science.1247023
   Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111
   Snyder EE, 2007, NUCLEIC ACIDS RES, V35, pD401, DOI 10.1093/nar/gkl858
   Soo RM, 2014, GENOME BIOL EVOL, V6, P1031, DOI 10.1093/gbe/evu073
   Stewart EJ, 2012, J BACTERIOL, V194, P4151, DOI 10.1128/JB.00345-12
   Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x
   Tennessen K, 2016, ISME J, V10, P269, DOI 10.1038/ismej.2015.100
   TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990
   Van Immerseel F, 2010, J MED MICROBIOL, V59, P141, DOI 10.1099/jmm.0.017541-0
   Vinolo MAR, 2011, NUTRIENTS, V3, P858, DOI 10.3390/nu3100858
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107
NR 67
TC 19
Z9 20
U1 2
U2 18
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015,
   SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 26
PY 2016
VL 7
AR 783
DI 10.3389/fmicb.2016.00783
PG 13
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA DM6TO
UT WOS:000376485500005
PM 27303377
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Amaretti, A
   Gozzoli, C
   Simone, M
   Raimondi, S
   Righini, L
   Perez-Brocal, V
   Garcia-Lopez, R
   Moya, A
   Rossi, M
AF Amaretti, Alberto
   Gozzoli, Caterina
   Simone, Marta
   Raimondi, Stefano
   Righini, Lucia
   Perez-Brocal, Vicente
   Garcia-Lopez, Rodrigo
   Moya, Andres
   Rossi, Maddalena
TI Profiling of Protein Degraders in Cultures of Human Gut Microbiota
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE gut microbiota; proteolysis; metagenomics; enrichment culture;
   Enterobacteriaceae
ID DIETARY-PROTEIN; SP-NOV; BACTEROIDES; FERMENTATION; METABOLISM;
   BACTERIA; PH; CONSEQUENCES; DEGRADATION; ENUMERATION
AB Unabsorbed proteins reach the colon and are fermented by the microbiota, yielding a variety of harmful metabolites. In the present study, a 16S rRNA gene survey identified the bacterial taxa flourishing in 11 batch fermentations with proteins and peptones as the sole fermentable substrates, inoculated with the feces of six healthy adults. Organic acids, ammonia, and indole resulting from protein breakdown and fermentation accumulated in all of the cultures. Analysis of differential abundances among time-points identified Enterobacteriaceae, Burkholderiaceae, and Desulfovibrionaceae (including Esherichia-Shigella, Sutterella, Parasutterella, and Bilophila) among the bacteria that especially in the cultures with low inoculation load. Lachnospiraceae and Ruminococcaceae also encompassed many taxa that significantly expanded, mainly in cultures inoculated with high inoculation load, and showed the strongest correlation with the production of ammonium, indole, and p-cresol. Anaerotruncus, Dorea, Oscillibacter, Eubacterium oxidoreducens, Lachnoclostridium, Paeniclostridium, and Rombutsia were among them. Other Firmicutes (e.g., Roseburia, Ruminococcus, Lachnospira, Dialister, Erysipelotrichaceae, and Streptococcaceae) and many Bacteroidetes (e.g., Barnesiellaceae, Prevotellaceae, and Rickenelliaceae) decreased. Sequences attributed to Bacteroides, unresolved at the level of species, presented opposite contributions, resulting in no significant changes in the genus. This study sheds light on the multitude of bacterial taxa putatively participating in protein catabolism in the colon. Protein fermentation was confirmed as unfavorable to health, due to both the production of toxic metabolites and the blooming of opportunistic pathogens and pro-inflammatory bacteria.
C1 [Amaretti, Alberto; Gozzoli, Caterina; Simone, Marta; Raimondi, Stefano; Righini, Lucia; Rossi, Maddalena] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.
   [Amaretti, Alberto; Rossi, Maddalena] Univ Modena & Reggio Emilia, BIOGEST SITEIA, Modena, Italy.
   [Perez-Brocal, Vicente; Garcia-Lopez, Rodrigo; Moya, Andres] Fdn Promot Sanit & Biomed Res Valencian Community, Area Genom & Hlth, Valencia, Spain.
   [Perez-Brocal, Vicente; Garcia-Lopez, Rodrigo; Moya, Andres] CIBER Epidemiol & Publ Hlth CIBERESP, Madrid, Spain.
   [Moya, Andres] Univ Valencia, Inst Integrat Syst Biol I2SysBio, Spanish Natl Res Council CSIC UVEG, Valencia, Spain.
C3 Universita di Modena e Reggio Emilia; Universita di Modena e Reggio
   Emilia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP;
   University of Valencia
RP Rossi, M (corresponding author), Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.; Rossi, M (corresponding author), Univ Modena & Reggio Emilia, BIOGEST SITEIA, Modena, Italy.
EM maddalena.rossi@unimore.it
RI Garcia-Lopez, Rodrigo/K-6479-2014; Perez Brocal, Vicente/K-3627-2014
OI Garcia-Lopez, Rodrigo/0000-0002-6713-8085; Perez Brocal,
   Vicente/0000-0002-1927-9676
FU FAR 2014 (Fondo di Ateneo per la Ricerca, University of Modena and
   Reggio Emilia); Spanish Ministry of Economy and Competitiveness
   [SAF2015-65878-R]; Generalitat Valenciana [Prometeo/2018/A/133];
   Asociacion Espanola Contra el Cancer [AECC 2017-1485]; European Regional
   Development Fund (ERDF)
FX This work was funded by FAR 2014 (Fondo di Ateneo per la Ricerca,
   University of Modena and Reggio Emilia) in the framework of a project
   entitled "Caratterizzazione della Componente Proteolitica del Microbiota
   Intestinale Umano" "Characterization of the Proteolytic Component of the
   Human Gut Microbiota." This work was also supported by grants to AM from
   the Spanish Ministry of Economy and Competitiveness (project
   SAF2015-65878-R), Generalitat Valenciana (project Prometeo/2018/A/133),
   and Asociacion Espanola Contra el Cancer (project AECC 2017-1485), and
   was co-financed by the European Regional Development Fund (ERDF).
CR Amaretti A, 2013, APPL MICROBIOL BIOT, V97, P3109, DOI 10.1007/s00253-012-4509-y
   BARKER HA, 1981, ANNU REV BIOCHEM, V50, P23, DOI 10.1146/annurev.bi.50.070181.000323
   Barrios C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134311
   Blachier F, 2010, AMINO ACIDS, V39, P335, DOI 10.1007/s00726-009-0445-2
   Bolyen Evan, 2018, J Open Source Educ, V1, DOI 10.21105/jose.00027
   Bottari B, 2017, INT J FOOD MICROBIOL, V255, P32, DOI 10.1016/j.ijfoodmicro.2017.05.015
   Cani PD, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01765
   CUMMINGS JH, 1991, J APPL BACTERIOL, V70, P443, DOI 10.1111/j.1365-2672.1991.tb02739.x
   D'Auria G, 2011, J BACTERIOL, V193, P7008, DOI 10.1128/JB.06301-11
   da Silva SM, 2008, ANTON LEEUW INT J G, V93, P381, DOI 10.1007/s10482-007-9215-x
   Dai ZL, 2011, FRONT BIOSCI-LANDMRK, V16, P1768, DOI 10.2741/3820
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Davila AM, 2013, PHARMACOL RES, V68, P95, DOI 10.1016/j.phrs.2012.11.005
   Ganzle MG, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00340
   Ju TT, 2019, ISME J, V13, P1520, DOI 10.1038/s41396-019-0364-5
   Kim J, 2004, FEMS MICROBIOL REV, V28, P455, DOI 10.1016/j.femsre.2004.03.001
   Kobayashi J, 2018, NITRIC OXIDE-BIOL CH, V73, P66, DOI 10.1016/j.niox.2017.06.001
   La Reau AJ, 2018, J MICROBIOL, V56, P199, DOI 10.1007/s12275-018-8024-4
   Lee JH, 2010, FEMS MICROBIOL REV, V34, P426, DOI 10.1111/j.1574-6976.2009.00204.x
   Ma N, 2017, CURR PROTEIN PEPT SC, V18, P795, DOI 10.2174/1389203718666170216153505
   MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647
   Macfarlane S, 1997, J MED MICROBIOL, V46, P547, DOI 10.1099/00222615-46-7-547
   Moore-Connors JM, 2016, INFLAMM BOWEL DIS, V22, P709, DOI 10.1097/MIB.0000000000000717
   Raimondi S, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080251
   Riedel T, 2017, INT J MED MICROBIOL, V307, P311, DOI 10.1016/j.ijmm.2017.05.007
   RIEPE SP, 1980, J CLIN INVEST, V66, P314, DOI 10.1172/JCI109859
   Rist VTS, 2014, ANAEROBE, V25, P72, DOI 10.1016/j.anaerobe.2013.10.003
   Russell WR, 2013, CURR OPIN MICROBIOL, V16, P246, DOI 10.1016/j.mib.2013.07.002
   Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sivaprakasam S, 2016, PHARMACOL THERAPEUT, V164, P144, DOI 10.1016/j.pharmthera.2016.04.007
   Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x
   Smith EA, 1998, FEMS MICROBIOL ECOL, V25, P355, DOI 10.1016/S0168-6496(98)00004-X
   Song YL, 2004, J CLIN MICROBIOL, V42, P5565, DOI 10.1128/JCM.42.12.5565-5570.2004
   Taras D, 2002, INT J SYST EVOL MICR, V52, P423, DOI 10.1099/00207713-52-2-423
   Veziant J, 2016, WORLD J CLIN ONCOL, V7, P293, DOI 10.5306/wjco.v7.i3.293
   Walker AW, 2005, APPL ENVIRON MICROB, V71, P3692, DOI 10.1128/AEM.71.7.3692-3700.2005
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07
   Wexler HM, 1996, INT J SYST BACTERIOL, V46, P252, DOI 10.1099/00207713-46-1-252
   Wilson B, 2017, J GASTROEN HEPATOL, V32, P64, DOI 10.1111/jgh.13700
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
NR 43
TC 40
Z9 41
U1 2
U2 22
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD NOV 15
PY 2019
VL 10
AR 2614
DI 10.3389/fmicb.2019.02614
PG 13
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA JW7LO
UT WOS:000503229700001
PM 31803157
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Jiang, PZ
   Wu, SC
   Luo, QB
   Zhao, XM
   Chen, WH
AF Jiang, Puzi
   Wu, Sicheng
   Luo, Qibin
   Zhao, Xing-ming
   Chen, Wei-Hua
TI Metagenomic Analysis of Common Intestinal Diseases Reveals Relationships
   among Microbial Signatures and Powers Multidisease Diagnostic Models
SO MSYSTEMS
LA English
DT Article
DE gut dysbiosis; human microbiome; intestinal disease; machine
   learning-based disease classification; noninvasive disease diagnosis
ID INFLAMMATORY-BOWEL-DISEASE; GUT MICROBIOME; COLORECTAL-CANCER;
   RISK-FACTORS; METABOLITES; SUSCEPTIBILITY; EPIDEMIOLOGY; PATHOGENESIS;
   METAANALYSIS; COMMUNITY
AB Common intestinal diseases such as Crohn's disease (CD), ulcerative colitis (UC), and colorectal cancer (CRC) share clinical symptoms and altered gut microbes, necessitating cross-disease comparisons and the use of multidisease models. Here, we performed meta-analyses on 13 fecal metagenome data sets of the three diseases. We identified 87 species and 65 pathway markers that were consistently changed in multiple data sets of the same diseases. According to their overall trends, we grouped the disease-enriched marker species into disease-specific and disease-common clusters and revealed their distinct phylogenetic relationships; species in the CD-specific cluster were phylogenetically related, while those in the CRC-specific cluster were more distant. Strikingly, UC-specific species were phylogenetically closer to CRC, likely because UC patients have higher risk of CRC. Consistent with their phylogenetic relationships, marker species had similar within-cluster and different between-cluster metabolic preferences. A portion of marker species and pathways correlated with an indicator of leaky gut, suggesting a link between gut dysbiosis and human-derived contents. Marker species showed more coordinated changes and tighter inner-connections in cases than the controls, suggesting that the diseased gut may represent a stressed environment and pose stronger selection on gut microbes. With the marker species and pathways, we constructed four high-performance (including multidisease) models with an area under the receiver operating characteristic curve (AUROC) of 0.87 and true-positive rates up to 90%, and explained their putative clinical applications. We identified consistent microbial alterations in common intestinal diseases, revealed metabolic capacities and the relationships among marker bacteria in distinct states, and supported the feasibility of metagenome-derived multidisease diagnosis.
   IMPORTANCE Gut microbes have been identified as potential markers in distinguishing patients from controls in colorectal cancer, ulcerative colitis, and Crohn's disease individually, whereas there lacks a systematic analysis to investigate the exclusive microbial shifts of these enteropathies with similar clinical symptoms. Our meta-analysis and cross-disease comparisons identified consistent microbial alterations in each enteropathy, revealed microbial ecosystems among marker bacteria in distinct states, and demonstrated the necessity and feasibility of metagenome-based multidisease classifications. To the best of our knowledge, this is the first study to construct multi-class models for these common intestinal diseases.
C1 [Jiang, Puzi; Wu, Sicheng; Chen, Wei-Hua] Huazhong Univ Sci & Technol, Hubei Key Lab Bioinformat & Mol Imaging, Ctr Artificial Intelligence Biol,Coll Life Sci &, Key Lab Mol Biophys,Minist Educ,Dept Bioinformat, Wuhan, Hubei, Peoples R China.
   [Luo, Qibin] Tech Univ Munich, Dept Genome Oriented Bioinformat, Wissenschaftszentrum Weihenstephan, Freising Weihenstephan, Germany.
   [Zhao, Xing-ming] Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China.
   [Zhao, Xing-ming] Minist Educ, Key Lab Computat Neurosci & Brain Inspired Intell, Beijing, Peoples R China.
   [Chen, Wei-Hua] HeNan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.
C3 Huazhong University of Science & Technology; Technical University of
   Munich; Fudan University; Henan Normal University
RP Chen, WH (corresponding author), Huazhong Univ Sci & Technol, Hubei Key Lab Bioinformat & Mol Imaging, Ctr Artificial Intelligence Biol,Coll Life Sci &, Key Lab Mol Biophys,Minist Educ,Dept Bioinformat, Wuhan, Hubei, Peoples R China.; Zhao, XM (corresponding author), Fudan Univ, Inst Sci & Technol Brain Inspired Intelligence, Shanghai, Peoples R China.; Zhao, XM (corresponding author), Minist Educ, Key Lab Computat Neurosci & Brain Inspired Intell, Beijing, Peoples R China.; Chen, WH (corresponding author), HeNan Normal Univ, Coll Life Sci, Xinxiang, Henan, Peoples R China.
EM xmzhao@fudan.edu.cn; weihuachen@hust.edu.cn
RI Chen, Weihua/GRS-9256-2022
OI Chen, Wei-Hua/0000-0003-2168-6147; Chen, Weihua/0000-0001-5160-4398
FU National Key Research and Development Program of China [2019YFA0905600,
   2018YFC0910500]; National Natural Science Foundation of China [61932008,
   61772368, 61572363]; Natural Science Foundation of Shanghai
   [17ZR1445600]; Shanghai Municipal Science and Technology Major Project
   [2018SHZDZX01]; ZJLab
FX This work was partly supported by the National Key Research and
   Development Program of China (2019YFA0905600 to W.-H.C.), the National
   Natural Science Foundation of China (61932008, 61772368, and 61572363 to
   X.-m.Z.), the National Key Research and Development Program of China
   (2018YFC0910500 to X.-m.Z.), the Natural Science Foundation of Shanghai
   (17ZR1445600 to X.-m.Z.), a Shanghai Municipal Science and Technology
   Major Project (2018SHZDZX01 to X.-m.Z.), and ZJLab. The funders had no
   role in study design, data collection and interpretation, or the
   decision to submit the work for publication.
CR Abdalla M, 2018, J CROHNS COLITIS, V12, P757, DOI 10.1093/ecco-jcc/jjy073
   Alipour M, 2016, J CROHNS COLITIS, V10, P462, DOI 10.1093/ecco-jcc/jjv223
   Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136
   Ananthakrishnan AN, 2015, NAT REV GASTRO HEPAT, V12, P205, DOI 10.1038/nrgastro.2015.34
   Araghi M, 2019, LANCET GASTROENTEROL, V4, P511, DOI 10.1016/S2468-1253(19)30147-5
   Bengoechea JA, 2019, FEMS MICROBIOL REV, V43, P123, DOI 10.1093/femsre/fuy043
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12
   Bowen WH, 2018, TRENDS MICROBIOL, V26, P229, DOI 10.1016/j.tim.2017.09.008
   Caspi R, 2020, NUCLEIC ACIDS RES, V48, pD445, DOI 10.1093/nar/gkz862
   Colvin H, 2016, SCI REP-UK, V6, DOI 10.1038/srep36289
   Cong J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01008
   Crittenden S, 2018, IMMUNOL CELL BIOL, V96, P1049, DOI 10.1111/imcb.12167
   Dam B., 2019, OXIDATIVE STRESS MIC, P43, DOI DOI 10.1007/978-981-13-8763-0_4
   Dickinson BT, 2015, GUT, V64, P1485, DOI 10.1136/gutjnl-2014-308075
   Dinakaran V, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03220
   Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3
   Duvallet C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01973-8
   Farraye FA, 2010, GASTROENTEROLOGY, V138, P746, DOI [10.1053/j.gastro.2009.12.035, 10.1053/j.gastro.2009.12.037]
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968
   Frank C, 2017, INT J CANCER, V140, P1510, DOI 10.1002/ijc.30583
   Franzosa EA, 2019, NAT MICROBIOL, V4, P293, DOI 10.1038/s41564-018-0306-4
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Han J, 2018, P NATL ACAD SCI USA, V115, P1057, DOI 10.1073/pnas.1712625115
   Harrison PW, 2021, NUCLEIC ACIDS RES, V49, pD82, DOI 10.1093/nar/gkaa1028
   Horiuchi A, 2020, ANAEROBE, V62, DOI 10.1016/j.anaerobe.2019.102100
   Hu Z, 2019, NAT GENET, V51, P1113, DOI 10.1038/s41588-019-0423-x
   HUNTER JE, 1990, J APPL PSYCHOL, V75, P334, DOI 10.1037/0021-9010.75.3.334
   Jiang PZ, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6749-z
   Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209
   Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006
   Knights D, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0107-1
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   La Vecchia S, 2020, SEMIN CELL DEV BIOL, V98, P63, DOI 10.1016/j.semcdb.2019.05.018
   Lane ER, 2017, J INFLAMM RES, V10, P63, DOI 10.2147/JIR.S116088
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359
   Louis P, 2017, ENVIRON MICROBIOL, V19, P29, DOI 10.1111/1462-2920.13589
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   M'Koma AE, 2013, CLIN MED INSIGHTS-GA, V6, P33, DOI 10.4137/CGast.S12731
   Ma XY, 2014, GUT, V63, P326, DOI 10.1136/gutjnl-2012-304121
   Mars RAT, 2020, CELL, V183, P1137, DOI 10.1016/j.cell.2020.10.040
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0
   Ni J, 2017, NAT REV GASTRO HEPAT, V14, P573, DOI 10.1038/nrgastro.2017.88
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8
   Otasek D, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1758-4
   Palmer RJ, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.00407-17
   Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42
   Sayers EW, 2020
   Schirmer M, 2019, NAT REV MICROBIOL, V17, P497, DOI 10.1038/s41579-019-0213-6
   Schirmer M, 2018, NAT MICROBIOL, V3, P337, DOI 10.1038/s41564-017-0089-z
   Sebastian S, 2014, J CROHNS COLITIS, V8, P5, DOI 10.1016/j.crohns.2013.04.008
   Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]
   Sontag RL, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00032-15
   Stapley SA, 2017, BRIT J GEN PRACT, V67, pE336, DOI 10.3399/bjgp17X690425
   Subramanian B, 2019, NUCLEIC ACIDS RES, V47, pW270, DOI 10.1093/nar/gkz357
   Takahashi K, 2016, DIGESTION, V93, P59, DOI 10.1159/000441768
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Vila AV, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14177-z
   Vila AV, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8914
   Vincent C, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/246203
   Vogtmann E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155362
   Vuik FER, 2019, GUT, V68, P1820, DOI 10.1136/gutjnl-2018-317592
   Welch JLM, 2020, CELL HOST MICROBE, V28, P160, DOI 10.1016/j.chom.2020.07.009
   Williams RJ, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00358
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wu SC, 2020, NUCLEIC ACIDS RES, V48, pD545, DOI 10.1093/nar/gkz764
   Ye YL, 2015, INT J CLIN EXP MED, V8, P22529
   Yilmaz B, 2019, NAT MED, V25, P701, DOI 10.1038/s41591-019-0411-9
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zeng MY, 2017, MUCOSAL IMMUNOL, V10, P18, DOI 10.1038/mi.2016.75
   Zhang YZ, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1232-6
   Zhu JZ, 2017, DIGEST DIS SCI, V62, P235, DOI 10.1007/s10620-016-4362-4
NR 80
TC 6
Z9 6
U1 2
U2 16
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD MAY-JUN
PY 2021
VL 6
IS 3
AR e00112-21
DI 10.1128/mSystems.00112-21
PG 18
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA RZ6FV
UT WOS:000648693300006
PM 33947803
OA Green Published, gold, Green Submitted
DA 2022-11-22
ER

PT J
AU Lee, JW
   Cowley, ES
   Wolf, PG
   Doden, HL
   Murai, T
   Caicedo, KYO
   Ly, LK
   Sun, FR
   Takei, H
   Nittono, H
   Daniel, SL
   Cann, I
   Gaskins, HR
   Anantharaman, K
   Alves, JMP
   Ridlon, JM
AF Lee, Jae Won
   Cowley, Elise S.
   Wolf, Patricia G.
   Doden, Heidi L.
   Murai, Tsuyoshi
   Caicedo, Kelly Yovani Olivos
   Ly, Lindsey K.
   Sun, Furong
   Takei, Hajime
   Nittono, Hiroshi
   Daniel, Steven L.
   Cann, Isaac
   Gaskins, H. Rex
   Anantharaman, Karthik
   Alves, Joao M. P.
   Ridlon, Jason M.
TI Formation of secondary allo-bile acids by novel enzymes from gut
   Firmicutes
SO GUT MICROBES
LA English
DT Article
DE Secondary allo-bile acids; bile acid dehydroxylation; bile acid 5
   alpha-reductases; Firmicutes; colorectal cancer
ID DEOXYCHOLIC-ACID; CLOSTRIDIUM-SCINDENS; CHOLIC-ACID;
   FUNCTIONAL-CHARACTERIZATION; SALT BIOTRANSFORMATIONS; METABOLISM;
   7-ALPHA-DEHYDROXYLATION; IDENTIFICATION; BACTERIA; SERUM
AB The gut microbiome of vertebrates is capable of numerous biotransformations of bile acids, which are responsible for intestinal lipid digestion and function as key nutrient-signaling molecules. The human liver produces bile acids from cholesterol predominantly in the A/B-cis orientation in which the sterol rings are "kinked", as well as small quantities of A/B-trans oriented "flat" stereoisomers known as "primary alto-bile acids'. While the complex multi-step bile acid 7 alpha-dehydroxylation pathway has been well-studied for conversion of "kinked" primary bile acids such as cholic acid (CA) and chenodeoxycholic acid (CDCA) to deoxycholic acid (DCA) and lithocholic acid (LCA), respectively, the enzymatic basis for the formation of "flat" stereoisomers allo-deoxycholic acid (allo-DCA) and allo-lithocholic acid (allo-LCA) by Firmicutes has remained unsolved for three decades. Here, we present a novel mechanism by which Firmicutes generate the "flat" bile acids a llo-DCA and allo-LCA. The BaiAl was shown to catalyze the final reduction from 3-oxo-allo-DCA to a llo-DCA and 3-oxo-allo-LCA to allo-LCA. Phylogenetic and metagenomic analyses of human stool samples indicate that BaiP and BaiJ are encoded only in Firmicutes and differ from membrane-associated bile acid 5 alpha-reductases recently reported in Bacteroidetes that indirectly generate allo-LCA from 3-oxo-Delta(4)-LCA. We further map the distribution of baiP and baiJ among Firmicutes in human metagenomes, demonstrating an increased abundance of the two genes in colorectal cancer (CRC) patients relative to healthy individuals.
C1 [Lee, Jae Won; Wolf, Patricia G.; Doden, Heidi L.; Ly, Lindsey K.; Cann, Isaac; Gaskins, H. Rex; Ridlon, Jason M.] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
   [Lee, Jae Won; Wolf, Patricia G.; Doden, Heidi L.; Cann, Isaac; Gaskins, H. Rex; Ridlon, Jason M.] Univ Illinois, Dept Anim Sci, Urbana, IL USA.
   [Cowley, Elise S.; Anantharaman, Karthik] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.
   [Cowley, Elise S.] Univ Wisconsin, Microbiol Doctoral Training Program, Madison, WI USA.
   [Wolf, Patricia G.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA.
   [Wolf, Patricia G.] Univ Illinois, Canc Ctr, Chicago, IL USA.
   [Murai, Tsuyoshi] Hlth Sci Univ Hokkaido, Sch Pharmaceut Sci, Tobetsu, Hokkaido, Japan.
   [Caicedo, Kelly Yovani Olivos; Alves, Joao M. P.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   [Ly, Lindsey K.; Cann, Isaac; Gaskins, H. Rex; Ridlon, Jason M.] Univ Illinois, Div Nutr Sci, Urbana, IL USA.
   [Sun, Furong] Univ Illinois, Sch Chem Sci, Mass Spectrometry Lab, Urbana, IL USA.
   [Takei, Hajime; Nittono, Hiroshi] Junshin Clin Bile Acid Inst, Tokyo, Japan.
   [Daniel, Steven L.] Eastern Illinois Univ, Dept Biol Sci, Charleston, IL 61920 USA.
   [Cann, Isaac] Univ Illinois, Dept Microbiol, Urbana, IL USA.
   [Gaskins, H. Rex; Ridlon, Jason M.] Canc Ctr Illinois, Urbana, IL USA.
   [Ridlon, Jason M.] Univ Illinois, Ctr Adv Study, Urbana, IL USA.
   [Ridlon, Jason M.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.
   [Wolf, Patricia G.] Purdue Univ, Dept Nutr Sci, W Lafayette, IL USA.
C3 University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Wisconsin System; University of Wisconsin Madison;
   University of Illinois System; University of Illinois Chicago;
   University of Illinois Chicago Hospital; University of Illinois System;
   University of Illinois Chicago; University of Illinois Chicago Hospital;
   Health Sciences University of Hokkaido; Universidade de Sao Paulo;
   University of Illinois System; University of Illinois Urbana-Champaign;
   University of Illinois System; University of Illinois Urbana-Champaign;
   Eastern Illinois University; University of Illinois System; University
   of Illinois Urbana-Champaign; University of Illinois System; University
   of Illinois Urbana-Champaign; Virginia Commonwealth University; Purdue
   University System; Purdue University
RP Ridlon, JM (corresponding author), Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL 61801 USA.
EM jmridlon@illinois.edu
FU National Library of Medicine training grant [NLM 5T15LM007359]; MSTP
   [T32 GM140935]; Cancer Education and Career Development Program
   [T32CA057699]; NSF [GRFP 2017224867]; David H. and Norraine A. Baker
   Graduate Fellowship in Animal Sciences at Illinois
FX E.S.C. is a Medical Scientist Training Program (MSTP) student and was
   supported by a National Library of Medicine training grant to the
   Computation and Informatics in Biology and Medicine Training Program
   (NLM 5T15LM007359) at UW-Madison, and in part by MSTP grant T32
   GM140935. P.G.W. was supported at UI-Chicago by the Cancer Education and
   Career Development Program grant T32CA057699. L.K.L. was supported by
   NSF GRFP 2017224867. H.L.D. was supported by the David H. and Norraine
   A. Baker Graduate Fellowship in Animal Sciences at Illinois.
CR BAYERDORFFER E, 1995, GUT, V36, P268, DOI 10.1136/gut.36.2.268
   BAYERDORFFER E, 1993, GASTROENTEROLOGY, V104, P145, DOI 10.1016/0016-5085(93)90846-5
   Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0
   Bhowmik S, 2016, PROTEINS, V84, P316, DOI 10.1002/prot.24971
   Bhowmik S, 2014, PROTEINS, V82, P216, DOI 10.1002/prot.24353
   BJORKHEM I, 1989, J LIPID RES, V30, P1033
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Chaudhari SN, 2021, NAT CHEM BIOL, V17, P20, DOI 10.1038/s41589-020-0604-z
   Chen XJ, 2020, INT J SYST EVOL MICR, V70, P2988, DOI 10.1099/ijsem.0.003925
   Chiang JYL, 2022, MOL CELL ENDOCRINOL, V548, DOI 10.1016/j.mce.2022.111618
   Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189
   Dawson JA, 1996, J LIPID RES, V37, P1258
   Devendran S, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00052-19
   Devendran S, 2018, J LIPID RES, V59, P1005, DOI 10.1194/jlr.M083949
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Fiorucci S, 2021, DIGEST DIS SCI, V66, P674, DOI 10.1007/s10620-020-06715-3
   Funabashi M, 2020, NATURE, V582, P566, DOI 10.1038/s41586-020-2396-4
   GUSTAFSSON BG, 1968, ACTA PATHOL MIC SC, V72, P433
   Hale VL, 2017, CANCER EPIDEM BIOMAR, V26, P85, DOI 10.1158/1055-9965.EPI-16-0337
   Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z
   Harris SC, 2018, BBA-MOL CELL BIOL L, V1863, P276, DOI 10.1016/j.bbalip.2017.12.001
   Heinken A, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0689-3
   Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647
   Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062
   HYLEMON PB, 1991, J LIPID RES, V32, P89
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Kang DJ, 2008, BBA-MOL CELL BIOL L, V1781, P16, DOI 10.1016/j.bbalip.2007.10.008
   Kim KH, 2022, MSYSTEMS, V7, DOI [10.1128/spectrum.02775-22, 10.1128/msystems.00455-22]
   Lan K, 2016, ANAL CHEM, V88, P7041, DOI 10.1021/acs.analchem.6b00573
   LEPPIK RA, 1983, STEROIDS, V41, P475, DOI 10.1016/0039-128X(83)90087-9
   Li W, 2021, CELL HOST MICROBE, V29, P1366, DOI 10.1016/j.chom.2021.07.013
   Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931
   MahmoudianDehkordi S, 2019, ALZHEIMERS DEMENT, V15, P76, DOI 10.1016/j.jalz.2018.07.217
   MALLONEE DH, 1995, CURR MICROBIOL, V30, P259, DOI 10.1007/BF00295498
   Marksteiner J, 2018, METABOLOMICS, V14, DOI 10.1007/s11306-017-1297-5
   MIDTVEDT T, 1974, AM J CLIN NUTR, V27, P1341, DOI 10.1093/ajcn/27.11.1341
   Narushima S, 2006, LIPIDS, V41, P835, DOI 10.1007/s11745-006-5038-1
   Ochsenkuhn T, 1999, CANCER, V85, P1664, DOI 10.1002/(SICI)1097-0142(19990415)85:8<1664::AID-CNCR4>3.3.CO;2-F
   Ocvirk S, 2020, AM J CLIN NUTR, V111, P406, DOI 10.1093/ajcn/nqz301
   Ocvirk Soren, 2017, Curr Nutr Rep, V6, P315, DOI 10.1007/s13668-017-0219-5
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001
   Porez G, 2012, J LIPID RES, V53, P1723, DOI 10.1194/jlr.R024794
   Quinn RA, 2020, NATURE, V579, P123, DOI 10.1038/s41586-020-2047-9
   Ridlon JM, 2020, GUT MICROBES, V11, P381, DOI 10.1080/19490976.2019.1618173
   Ridlon JM, 2016, GUT MICROBES, V7, P22, DOI 10.1080/19490976.2015.1127483
   Ridlon JM, 2013, J LIPID RES, V54, P2437, DOI 10.1194/jlr.M038869
   Ridlon JM, 2012, J LIPID RES, V53, P66, DOI 10.1194/jlr.M020313
   Ridlon JM, 2010, ANAEROBE, V16, P137, DOI 10.1016/j.anaerobe.2009.05.004
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Sato Y, 2021, NATURE, V599, P458, DOI 10.1038/s41586-021-03832-5
   Shiffka SJ, 2017, BBA-BIOMEMBRANES, V1859, P2269, DOI 10.1016/j.bbamem.2017.08.019
   Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7
   Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107
   Tadano Tomoaki, 2006, Rinsho Byori, V54, P103
   Tadano Tomoaki, 2007, Rinsho Byori, V55, P417
   vanFaassen A, 1997, CANCER LETT, V114, P293, DOI 10.1016/S0304-3835(97)04683-1
   Vital M, 2019, COMPUT STRUCT BIOTEC, V17, P1016, DOI 10.1016/j.csbj.2019.07.012
   Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000
   Wells JE, 2000, J HEPATOL, V32, P4, DOI 10.1016/S0168-8278(00)80183-X
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wolf PG, 2022, MICROBIOME, V10, DOI 10.1186/s40168-022-01242-x
   Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347
   Zhou HP, 2014, STEROIDS, V86, P62, DOI 10.1016/j.steroids.2014.04.016
NR 67
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PD DEC 31
PY 2022
VL 14
IS 1
AR e2132903
DI 10.1080/19490976.2022.2132903
PG 19
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA 5Y9GH
UT WOS:000879587700001
PM 36343662
OA Green Published, Green Submitted, gold
DA 2022-11-22
ER

PT J
AU Zitvogel, L
   Ma, YT
   Raoult, D
   Kroemer, G
   Gajewski, TF
AF Zitvogel, Laurence
   Ma, Yuting
   Raoult, Didier
   Kroemer, Guido
   Gajewski, Thomas F.
TI The microbiome in cancer immunotherapy: Diagnostic tools and therapeutic
   strategies
SO SCIENCE
LA English
DT Review
ID FUSOBACTERIUM-NUCLEATUM; COLORECTAL-CANCER; GUT MICROBIOTA; INTESTINAL
   MICROBIOTA; ENTEROCOCCUS-HIRAE; RESISTANCE; ANTITUMOR; IMMUNITY;
   BACTERIA; DISEASE
AB The fine line between human health and disease can be driven by the interplay between host and microbial factors. This "metagenome" regulates cancer initiation, progression, and response to therapies. Besides the capacity of distinct microbial species to modulate the pharmacodynamics of chemotherapeutic drugs, symbiosis between epithelial barriers and their microbial ecosystems has a major impact on the local and distant immune system, markedly influencing clinical outcome in cancer patients. Efficacy of cancer immunotherapy with immune checkpoint antibodies can be diminished with administration of antibiotics, and superior efficacy is observed with the presence of specific gut microbes. Future strategies of precision medicine will likely rely on novel diagnostic and therapeutic tools with which to identify and correct defects in the microbiome that compromise therapeutic efficacy.
C1 [Zitvogel, Laurence] GRCC, Equipe Labellisee Ligue Natl Canc, Villejuif, France.
   [Zitvogel, Laurence] INSERM, U1015, Villejuif, France.
   [Zitvogel, Laurence] Univ Paris Sud, Univ Paris Saclay, Gustave Roussy, Villejuif, France.
   [Zitvogel, Laurence] Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France.
   [Ma, Yuting] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Ma, Yuting] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Ma, Yuting] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Raoult, Didier] Aix Marseille Univ, Unite Rech Malad Infect & Trop Emergentes, Inst Hosp Univ IHU Mediterranee Infect, UM63,CNRS 7278,IRD 198,INSERM 1095, 19-21 Blvd Jean Moulin, F-13005 Marseille, France.
   [Kroemer, Guido] Univ Paris 05, Univ Pierre & Marie Curie, Ctr Rech Cordeliers, Sorbonne Paris Cite, Paris, France.
   [Kroemer, Guido] GRCC, Metabol & Cell Biol Platforms, Villejuif, France.
   [Kroemer, Guido] Equipe 11 Labellisee Ligue Natl Canc, UMRS 1138, Paris, France.
   [Gajewski, Thomas F.] Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60615 USA.
   [Gajewski, Thomas F.] Univ Chicago, Ben May Dept Canc, Chicago, IL 60615 USA.
C3 Institut National de la Sante et de la Recherche Medicale (Inserm);
   UDICE-French Research Universities; Universite Paris Saclay;
   UDICE-French Research Universities; Universite Paris Saclay; UNICANCER;
   Gustave Roussy; Chinese Academy of Medical Sciences - Peking Union
   Medical College; Institute of Basic Medical Sciences - CAMS; Chinese
   Academy of Medical Sciences - Peking Union Medical College; Peking Union
   Medical College; UDICE-French Research Universities; Aix-Marseille
   Universite; Centre National de la Recherche Scientifique (CNRS);
   Institut National de la Sante et de la Recherche Medicale (Inserm);
   Institut de Recherche pour le Developpement (IRD); Institut National de
   la Sante et de la Recherche Medicale (Inserm); UDICE-French Research
   Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French
   Research Universities; Sorbonne Universite; Universite Paris Cite;
   University of Chicago; University of Chicago
RP Zitvogel, L (corresponding author), GRCC, Equipe Labellisee Ligue Natl Canc, Villejuif, France.; Zitvogel, L (corresponding author), INSERM, U1015, Villejuif, France.; Zitvogel, L (corresponding author), Univ Paris Sud, Univ Paris Saclay, Gustave Roussy, Villejuif, France.; Zitvogel, L (corresponding author), Ctr Clin Invest Biotherapies Canc CICBT 1428, Villejuif, France.; Gajewski, TF (corresponding author), Univ Chicago, Dept Med, Dept Pathol, Chicago, IL 60615 USA.; Gajewski, TF (corresponding author), Univ Chicago, Ben May Dept Canc, Chicago, IL 60615 USA.
EM laurence.zitvogel@gustaveroussy.fr; tgajewsk@medicine.bsd.uchicago.edu
RI KROEMER, Guido/B-4263-2013; RAOULT, Didier/A-8434-2008; Kroemer,
   Guido/AAY-9859-2020
OI KROEMER, Guido/0000-0002-9334-4405; RAOULT, Didier/0000-0002-0633-5974;
   ZITVOGEL, laurence/0000-0003-1596-0998
FU Ligue Contre le Cancer (Equipe Labelisee); Agence Nationale de la
   Recherche (ANR)-Projets blancs; ANR under the frame of E-Rare-2, the
   ERA-Net for Research on Rare Diseases; Association pour la Recherche sur
   le Cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer
   (INCa); Institut Universitaire de France; Fondation pour la Recherche
   Medicale (FRM); European Commission (ArtForce); European Research
   Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; Site de
   Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA
   Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and
   Personalized Medicine (CARPEM); Recherche
   Hospitalo-Universitaire-LUMIERE; Seerave Foundation; Institut Suisse de
   Recherche Experimentale sur le Cancer (ISREC) Foundation; Swiss
   Foundation; Paris Alliance of Cancer Research Institutes (PACRI);
   Natural Science Foundation of China (NSFC) [81722037, 81671630]; China
   Ministry of Science and Technology (National key research and
   development program) [2017YFA0506200]; Natural Science Foundation of
   Jiangsu Province [BK20170006, BK20160379]; Chinese National Thousand
   Talents Program; Chinese Academy of Medical Sciences (CAMS) Initiative
   for Innovative Medicine [CAMS-I2M, 2016-I2M-1-005]; Non-profit Central
   Research Institute Fund of CAMS [2016ZX310194, 2017NL31004,
   2017RC31008]; French Ministery/IHU Mediterranee Infections; Team Science
   Award from the Melanoma Research Alliance [R35 CA210098]; American
   Cancer Society-Jules L. Plangere Jr. Family Foundation Professorship in
   Cancer Immunotherapy; University of Chicago Medicine Comprehensive
   Cancer Center; Institutional Training Grant [T32 CA009594]; Center for
   Research Informatics of The University of Chicago Biological Science
   Division; Roche-Genentech; BMS; Merck; Incyte; Seattle Genetics; Ono
FX L.Z. and G.K. were supported by the Ligue Contre le Cancer (Equipe
   Labelisee); Agence Nationale de la Recherche (ANR)-Projets blancs; ANR
   under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases;
   Association pour la Recherche sur le Cancer (ARC); Canceropole
   Ile-de-France; Institut National du Cancer (INCa); Institut
   Universitaire de France; Fondation pour la Recherche Medicale (FRM); the
   European Commission (ArtForce); the European Research Council (ERC); the
   LeDucq Foundation; the LabEx Immuno-Oncology; the Site de Recherche
   Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and
   Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and
   Personalized Medicine (CARPEM); Recherche
   Hospitalo-Universitaire-LUMIERE; the Seerave Foundation; Institut Suisse
   de Recherche Experimentale sur le Cancer (ISREC) Foundation; Swiss
   Foundation; the Paris Alliance of Cancer Research Institutes (PACRI);
   and philanthropy (from E. Badinter and N. Meyer). L.Z. is inventor on
   patent EP17305206 and European license 16306779.6 held by Institut
   Gustave Roussy that covers use of microbial modulators for
   anti-PD1/PD-L1/PD-L2 antibody-based treatments. Y.M. is supported by the
   Natural Science Foundation of China (NSFC, grants 81722037 and
   81671630), China Ministry of Science and Technology (National key
   research and development program, grant 2017YFA0506200), Natural Science
   Foundation of Jiangsu Province (grants BK20170006 and BK20160379),
   Chinese National Thousand Talents Program, Chinese Academy of Medical
   Sciences (CAMS) Initiative for Innovative Medicine (grants CAMS-I2M and
   2016-I2M-1-005), and the Non-profit Central Research Institute Fund of
   CAMS (grants 2016ZX310194, 2017NL31004, and 2017RC31008). D.R. is
   supported by the French Ministery/IHU Mediterranee Infections. T.G. was
   supported by Team Science Award R35 CA210098 from the Melanoma Research
   Alliance, the American Cancer Society-Jules L. Plangere Jr. Family
   Foundation Professorship in Cancer Immunotherapy, and funds from the
   University of Chicago Medicine Comprehensive Cancer Center; by
   Institutional Training Grant T32 CA009594, and from The Center for
   Research Informatics of The University of Chicago Biological Science
   Division. T.F.G. is an advisory board member for Roche-Genentech, Merck,
   Abbvie, Bayer, Aduro, and Fog Pharma. T.F.G. receives research support
   from Roche-Genentech, BMS, Merck, Incyte, Seattle Genetics, and Ono.
   T.F.G. is a shareholder/cofounder of Jounce Therapeutics. L.Z., D.R.,
   and G.K. are shareholders/founders of everImmune. The University of
   Chicago holds a licensing arrangement with Evelo. T.F.G. is an inventor
   on patent 15/170,284 submitted by the University of Chicago that covers
   the use of microbiota to improve cancer immunotherapy.
CR Alang N, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv004
   Arthur JC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02868
   Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462
   Banna GL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00603
   Belkaid Y, 2013, NAT IMMUNOL, V14, P646, DOI 10.1038/ni.2604
   Bindels LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131009
   Blanton LV, 2016, SCIENCE, V351, DOI 10.1126/science.aad3311
   Bullman S, 2017, SCIENCE, V358, P1443, DOI 10.1126/science.aal5240
   Bultman SJ, 2016, SEMIN ONCOL, V43, P97, DOI 10.1053/j.seminoncol.2015.09.001
   Caballero S, 2017, CELL HOST MICROBE, V21, P592, DOI 10.1016/j.chom.2017.04.002
   Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108
   Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349
   Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009
   de Vos WM, 2012, NUTR REV, V70, pS45, DOI 10.1111/j.1753-4887.2012.00505.x
   Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391
   Dzutsev A, 2017, ANNU REV IMMUNOL, V35, P199, DOI 10.1146/annurev-immunol-051116-052133
   Enache-Angoulvant A, 2005, CLIN INFECT DIS, V41, P1559, DOI 10.1086/497832
   Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020
   Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043
   Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022
   Gopalakrishnan V., 2017, SCIENCE, V358
   Gur C, 2015, IMMUNITY, V42, P344, DOI 10.1016/j.immuni.2015.01.010
   Hanninen A, 2018, GUT, V67, P1445, DOI 10.1136/gutjnl-2017-314508
   Huang HC, 2011, ARCH DERMATOL RES, V303, P527, DOI 10.1007/s00403-011-1135-y
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033
   Jenq RR, 2015, BIOL BLOOD MARROW TR, V21, P1373, DOI 10.1016/j.bbmt.2015.04.016
   Joglekar P, 2017, CELL, V169, P378, DOI 10.1016/j.cell.2017.04.009
   Kang CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076520
   Lagier JC, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.203, 10.1038/nmicrobiol.2016.203]
   Lee SM, 2013, NATURE, V501, P426, DOI 10.1038/nature12447
   LI J, 2016, P NATL ACAD SCI USA, V1306, pE130
   Liang XJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04985
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Moayyedi P, 2017, MED J AUSTRALIA, V207, P166, DOI 10.5694/mja17.00295
   Nanjundappa RH, 2017, CELL, V171, P655, DOI 10.1016/j.cell.2017.09.022
   Odamaki T, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/567809
   Ottman N, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01014-17
   Pahle J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3123-x
   Paulos CM, 2007, J CLIN INVEST, V117, P2197, DOI 10.1172/JCI32205
   Peled JU, 2017, J CLIN ONCOL, V35, P1650, DOI 10.1200/JCO.2016.70.3348
   Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016
   PLOVIER H, 2017, NAT MED, V107, pU113
   Pluzanska A, 1985, Pol Arch Med Wewn, V73, P351
   Pustelny C, 2015, INFECT IMMUN, V83, P417, DOI 10.1128/IAI.02234-14
   Roberts NJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008982
   Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016
   ROSZKOWSKI K, 1985, J CANCER RES CLIN, V109, P72, DOI 10.1007/BF01884258
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Sato J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12535-9
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017
   Shen Y, 2012, CELL HOST MICROBE, V12, P509, DOI 10.1016/j.chom.2012.08.004
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Stappenbeck TS, 2016, NATURE, V534, P191, DOI 10.1038/nature18285
   Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336
   TAKADA H, 1995, INFECT IMMUN, V63, P57, DOI 10.1128/IAI.63.1.57-65.1995
   Takagi A, 2001, CARCINOGENESIS, V22, P599, DOI 10.1093/carcin/22.4.599
   Takahashi T, 2001, J UROLOGY, V166, P2506, DOI 10.1016/S0022-5347(05)65625-X
   Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003
   Thiemann S, 2017, CELL HOST MICROBE, V21, P682, DOI 10.1016/j.chom.2017.05.005
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Venugopalan V, 2010, EMERG INFECT DIS, V16, P1661, DOI 10.3201/eid1611.100574
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Wang Y, 2014, GUT MICROBES, V5, P552, DOI 10.4161/gmic.29797
   Wong SH, 2017, GASTROENTEROLOGY, V153, P1621, DOI 10.1053/j.gastro.2017.08.022
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zhang JY, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00521-14
   Zitvogel L, 2017, NAT REV MICROBIOL, V15, P465, DOI 10.1038/nrmicro.2017.44
NR 73
TC 336
Z9 356
U1 11
U2 272
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD MAR 23
PY 2018
VL 359
IS 6382
SI SI
BP 1366
EP 1370
DI 10.1126/science.aar6918
PG 5
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA GA0ZG
UT WOS:000428043600039
PM 29567708
OA Green Submitted
DA 2022-11-22
ER

PT J
AU Oliver, A
   Chase, AB
   Weihe, C
   Orchanian, SB
   Riedel, SF
   Hendrickson, CL
   Lay, M
   Sewall, JM
   Martiny, JBH
   Whiteson, K
AF Oliver, Andrew
   Chase, Alexander B.
   Weihe, Claudia
   Orchanian, Stephanie B.
   Riedel, Stefan F.
   Hendrickson, Clark L.
   Lay, Mi
   Sewall, Julia Massimelli
   Martiny, Jennifer B. H.
   Whiteson, Katrine
TI High-Fiber, Whole-Food Dietary Intervention Alters the Human Gut
   Microbiome but Not Fecal Short-Chain Fatty Acids
SO MSYSTEMS
LA English
DT Article
DE diet intervention; fiber; GroEL; microbiome; metagenomics
ID CARBOHYDRATE-ACTIVE ENZYMES; BREAKFAST CEREAL; HEALTHY-MEN; CONSUMPTION;
   ALIGNMENT; DATABASE; REVEALS; IMPACT
AB Dietary shifts can have a direct impact on the gut microbiome by preferentially selecting for microbes capable of utilizing the various dietary nutrients. The intake of dietary fiber has decreased precipitously in the last century, while consumption of processed foods has increased. Fiber, or microbiota-accessible carbohydrates (MACs), persist in the digestive tract and can be metabolized by specific bacteria encoding fiber-degrading enzymes. The digestion of MACs results in the accumulation of short-chain fatty acids (SCFAs) and other metabolic by-products that are critical to human health. Here, we implemented a 2-week dietary fiber intervention aiming for 40 to 50 g of fiber per day within the context of a course-based undergraduate research experience (CURE) (n = 20). By coupling shotgun metagenomic sequencing and targeted gas chromatography-mass spectrometry (GC-MS), we found that the dietary intervention significantly altered the composition of individual gut microbiomes, accounting for 8.3% of the longitudinal variability within subjects. Notably, microbial taxa that increased in relative abundance as a result of the diet change included known MAC degraders (i.e., Bifidobacterium and Lactobacillus). We further assessed the genetic diversity within Bifidobacterium, assayed by amplification of the groEL gene. Concomitant with microbial composition changes, we show an increase in the abundance of genes involved in inositol degradation. Despite these changes in gut microbiome composition, we did not detect a consistent shift in SCFA abundance. Collectively, our results demonstrate that on a short-term timescale of 2 weeks, increased fiber intake can induce compositional changes of the gut microbiome, including an increase in MAC-degrading bacteria.
   IMPORTANCE A profound decrease in the consumption of dietary fiber in many parts of the world in the last century may be associated with the increasing prevalence of type II diabetes, colon cancer, and other health problems. A typical U.S. diet includes about similar to 15 g of fiber per day, far less fiber than the daily recommended allowance. Changes in dietary fiber intake affect human health not only through the uptake of nutrients directly but also indirectly through changes in the microbial community and their associated metabolism. Here, we conducted a 2-week diet intervention in healthy young adults to investigate the impact of fiber consumption on the gut microbiome. Participants increased their average fiber consumption by 25 g/day on average for 2 weeks. The high -fiber diet intervention altered the gut microbiome of the study participants, including increases in known fiber-degrading microbes, such as Bifidobacterium and Lactobacillus.
C1 [Oliver, Andrew; Orchanian, Stephanie B.; Riedel, Stefan F.; Hendrickson, Clark L.; Lay, Mi; Sewall, Julia Massimelli; Whiteson, Katrine] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.
   [Chase, Alexander B.] Scripps Inst Oceanog, Ctr Marine Biotechnol & Biomed, La Jolla, CA USA.
   [Weihe, Claudia; Martiny, Jennifer B. H.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.
   [Sewall, Julia Massimelli] Maastricht Univ, Fac Sci & Engn, Maastricht, Netherlands.
C3 University of California System; University of California Irvine;
   University of California System; University of California San Diego;
   Scripps Institution of Oceanography; University of California System;
   University of California Irvine; Maastricht University
RP Whiteson, K (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92717 USA.
EM katrine@uci.edu
RI Chase, Alexander/AAV-3955-2021
OI Chase, Alexander/0000-0003-1984-6279; Massimelli Sewall,
   Julia/0000-0003-4126-2501; Whiteson, Katrine/0000-0002-5423-6014;
   Orchanian, Stephanie/0000-0002-2491-1074; Martiny,
   Jennifer/0000-0002-2415-1247
FU T32 training grant from UC Irvine's training program in microbiology and
   infectious diseases [1T32AI14134601A1]; UCI Microbiome Initiative
FX We acknowledge the T32 training grant, which supported Andrew Oliver
   (1T32AI14134601A1) , from UC Irvine's training program in microbiology
   and infectious diseases.; We also acknowledge the UCI Microbiome
   Initiative for supporting the study, Thistle for supporting our
   provision of high fiber meals, and Heather Maughan for thoughtful edits
   to the manuscript. We especially thank the students from the course
   M130L at UC Irvine Spring in 2018.
CR American Association for the Advancement of Science, 2009, NO TITL IS CHANG UND
   Ampatzoglou A, 2015, J NUTR, V145, P215, DOI 10.3945/jn.114.202176
   Baxter NT, 2019, MBIO, V10, DOI [10.1128/mBio.02566-18, 10.1128/mbio.02566-18]
   Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036
   Belenguer A, 2006, APPL ENVIRON MICROB, V72, P3593, DOI 10.1128/AEM.72.5.3593-3599.2006
   Bushnell B., 2015, BBMAP SHORT READ ALI
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742
   Carvalho-Wells AL, 2010, BRIT J NUTR, V104, P1353, DOI 10.1017/S0007114510002084
   Caspi R, 2018, NUCLEIC ACIDS RES, V46, pD633, DOI 10.1093/nar/gkx935
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Clemente JC, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500183
   Cooper DN, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020173
   Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923
   CUMMINGS JH, 1981, GUT, V22, P763, DOI 10.1136/gut.22.9.763
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   de la Cuesta-Zuluaga J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010051
   Dinicola S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18102187
   Truong DT, 2017, GENOME RES, V27, P626, DOI 10.1101/gr.216242.116
   Eddy Sean R, 2009, Genome Inform, V23, P205
   El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050
   Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]
   Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   GRAF E, 1985, CANCER-AM CANCER SOC, V56, P717, DOI 10.1002/1097-0142(19850815)56:4<717::AID-CNCR2820560402>3.0.CO;2-4
   Grasten SM, 2007, NUTR RES, V27, P454, DOI 10.1016/j.nutres.2007.05.010
   Herman DR, 2020, J ACAD NUTR DIET, V120, P517, DOI 10.1016/j.jand.2019.07.024
   Hooda S, 2012, J NUTR, V142, P1259, DOI 10.3945/jn.112.158766
   Hryckowian AJ, 2018, NAT MICROBIOL, V3, P662, DOI 10.1038/s41564-018-0150-6
   Hu LJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8110336
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   Jenkins DJA, 1999, METABOLISM, V48, P264, DOI 10.1016/S0026-0495(99)90045-8
   Jones JM, 2014, NUTR J, V13, DOI [10.1007/s11047-013-9401-x, 10.1186/1475-2891-13-34]
   Junick J, 2012, APPL ENVIRON MICROB, V78, P2613, DOI 10.1128/AEM.07749-11
   Karl JP, 2017, AM J CLIN NUTR, V105, P589, DOI 10.3945/ajcn.116.139683
   Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202. Article published online before March 2002
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Kuhn M, 2020, **DATA OBJECT**
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178
   Maier TV, 2017, MBIO, V8, DOI [10.1128/mBio.01343-17, 10.1128/mbio.01343-17]
   Makki K, 2018, CELL HOST MICROBE, V23, P705, DOI 10.1016/j.chom.2018.05.012
   Martinez I, 2013, ISME J, V7, P269, DOI 10.1038/ismej.2012.104
   Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538
   McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18
   Merkel S, 2012, J MICROBIOL BIOL EDU, V13, P32, DOI 10.1128/jmbe.v13i1.363
   National Research Council, 2003, PROT PART FAC SOC BE
   Nayfach S, 2019, NATURE, V568, P505, DOI 10.1038/s41586-019-1058-x
   Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115
   Nemoto H, 2011, J MED INVESTIG, V58, P235, DOI 10.2152/jmi.58.235
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009
   Oksanen J., 2019, **DATA OBJECT**
   Pallav K, 2014, GUT MICROBES, V5, P458, DOI 10.4161/gmic.29558
   Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880
   Reynolds A, 2019, LANCET, V393, P434, DOI 10.1016/S0140-6736(18)31809-9
   Riviere A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00979
   Rodriguez CI, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6435-1
   ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424
   Ross AB, 2011, BRIT J NUTR, V105, P1492, DOI 10.1017/S0007114510005209
   Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005
   Sawicki CM, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020125
   Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026
   Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Sewall JM, 2020, J MICROBIOL BIOL EDU, V21, DOI 10.1128/jmbe.v21i1.1991
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Smith SC, 2006, EUR J NUTR, V45, P335, DOI 10.1007/s00394-006-0603-1
   So D, 2018, AM J CLIN NUTR, V107, P965, DOI 10.1093/ajcn/nqy041
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Sze MA, 2019, MBIO, V10, DOI 10.1128/mBio.01454-19
   Tap J, 2015, ENVIRON MICROBIOL, V17, P4954, DOI 10.1111/1462-2920.13006
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022
   Ueyama J, 2020, ANAL BIOCHEM, V589, DOI 10.1016/j.ab.2019.113508
   US Department of Agriculture Agricultural Research Service, 2012, NUTR INT FOOD MEAN A
   Utzschneider KM, 2016, J CLIN ENDOCR METAB, V101, P2622, DOI 10.1210/jc.2015-4251
   Velazquez M, 2000, ANAEROBE, V6, P87, DOI 10.1006/anae.1999.0318
   Venkataraman A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0178-x
   Vogt JA, 2003, J NUTR, V133, P3145, DOI 10.1093/jn/133.10.3145
   Wastyk HC, 2020, GUT MICROBIOTA TARGE, DOI [10.1101/2020.09.30.321448, DOI 10.1101/2020.09.30.321448]
   Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   [曾瑶池 Zeng Yaochi], 2015, [中华临床营养杂志, Chinese Journal of Clinical Nutrition], V23, P27
   Zhao GH, 2006, BIOMED CHROMATOGR, V20, P674, DOI 10.1002/bmc.580
   Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774
   Zhen Zhang, 2014, 2014 IEEE International Conference on Acoustics, Speech and Signal Processing (ICASSP), P564, DOI 10.1109/ICASSP.2014.6853659
NR 89
TC 23
Z9 24
U1 3
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5077
J9 MSYSTEMS
JI mSystems
PD APR
PY 2021
VL 6
IS 2
AR e00115-21
DI 10.1128/mSystems.00115-21
PG 16
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA TC5DH
UT WOS:000668658500008
PM 33727392
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Romick-Rosendale, LE
   Legomarcino, A
   Patel, NB
   Morrow, AL
   Kennedy, MA
AF Romick-Rosendale, Lindsey E.
   Legomarcino, Anne
   Patel, Neil B.
   Morrow, Ardythe L.
   Kennedy, Michael A.
TI Prolonged antibiotic use induces intestinal injury in mice that is
   repaired after removing antibiotic pressure: implications for empiric
   antibiotic therapy
SO METABOLOMICS
LA English
DT Article
DE Antibiotic; Metabolomics; Mouse model; Necrotizing enterocolitis; NMR;
   PCA
ID EARLY-ONSET SEPSIS; PROPIONATE FORMATION; NECROTIZING ENTEROCOLITIS;
   URINARY HYDROXYPROLINE; HIPPURATE SYNTHESIS; ANAEROBIC-BACTERIA; GUT
   MICROBIOTA; COLONIC-MUCOSA; BIRTH; ACID
AB Metabolic profiling of urine and fecal extracts, histological investigation of intestinal ilea, and fecal metagenomics analyses were used to investigate effects of prolonged antibiotic use in mice. The study provides insight into the effects of extended empiric antibiotic therapy in humans. Mice were administered a broad-spectrum antibiotic for four consecutive days followed by oral gavage with Clostridium butyricum, an opportunistic gram-positive pathogenic bacteria commonly isolated in fecal and blood cultures of necrotizing enterocolitis patients. Metagenomics data indicated loss of bacterial diversity after 4 days on antibiotics that was restored after removing antibiotic pressure. Histological analyses indicated damage to ileal villi after antibiotic treatment that underwent repair after lifting antibiotic pressure. Metabolic profiling confirmed intestinal injury in antibiotic-treated mice indicated by increased urinary trans-4-hydroxy-l-proline, a breakdown product of collagen present in connective tissue of ileal villi that may serve as a biomarker for antibiotic-induced injury in at risk populations.
C1 [Romick-Rosendale, Lindsey E.; Patel, Neil B.; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA.
   [Legomarcino, Anne; Morrow, Ardythe L.] Univ Cincinnati, Coll Med, Dept Pediat, Perinatal Inst,Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45218 USA.
   [Morrow, Ardythe L.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45218 USA.
C3 University System of Ohio; Miami University; Cincinnati Children's
   Hospital Medical Center; University System of Ohio; University of
   Cincinnati; University System of Ohio; University of Cincinnati
RP Kennedy, MA (corresponding author), Miami Univ, Dept Chem & Biochem, 701 East High St, Oxford, OH 45056 USA.
EM kennedm4@miamioh.edu
RI Morrow, Ardythe/GQO-8482-2022; Kennedy, Michael/M-2578-2019; Kennedy,
   Michael/ABE-6002-2021; Lagomarcino, Anne J/Q-6060-2018
OI Romick-Rosendale, Lindsey/0000-0002-7252-1193; Lagomarcino, Anne
   J/0000-0002-3893-5771
FU Miami University; Ohio Board of Regents; NIH/NCI [1R15CA152985];  [R01
   HD 059140/HD/NICHD]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD
   HEALTH & HUMAN DEVELOPMENT [R01HD059140] Funding Source: NIH RePORTER;
   NATIONAL CANCER INSTITUTE [R15CA152985] Funding Source: NIH RePORTER
FX The authors would like to acknowledge support of Miami University and
   the Ohio Board of Regents for funding to establish the Ohio Eminent
   Scholar Laboratory where the work was performed. MAK acknowledges Miami
   University start-up funds that, in part, supported this study. The
   authors would also like to acknowledge support from Bruker Biospin, Inc
   that enabled development of the statistical significance analysis
   software used in the analysis of the data reported in this paper. ALM
   was supported by R01 HD 059140/HD/NICHD. MAK was supported by a grant
   from the NIH/NCI (1R15CA152985).
CR ANASUYA A, 1970, BRIT J NUTR, V24, P97, DOI 10.1079/BJN19700013
   Aypak C, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-27
   BELIVEAU GP, 1987, J NUTR, V117, P36, DOI 10.1093/jn/117.1.36
   Bruckner R, 2002, FEMS MICROBIOL LETT, V209, P141
   Bundy JG, 2007, GENOME RES, V17, P510, DOI 10.1101/gr.5662207
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   CHAMBERS S, 1985, J INFECT DIS, V152, P1308, DOI 10.1093/infdis/152.6.1308
   CHEN XB, 1992, J NUTR, V122, P2226, DOI 10.1093/jn/122.11.2226
   Clark RH, 2006, PEDIATRICS, V117, P67, DOI 10.1542/peds.2005-0179
   CONDON RJ, 1970, J ANIM SCI, V31, P1037
   Cordero L, 2003, INFECT CONT HOSP EP, V24, P662, DOI 10.1086/502270
   Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423
   Craig SAS, 2004, AM J CLIN NUTR, V80, P539
   CSELOVSZKY J, 1992, APPL MICROBIOL BIOT, V37, P94, DOI 10.1007/BF00174210
   DELAHUERGA J, 1952, J CLIN INVEST, V31, P598, DOI 10.1172/JCI102646
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280
   Doron SI, 2008, J CLIN GASTROENTEROL, V42, pS58, DOI 10.1097/MCG.0b013e3181618ab7
   Faris B, 2010, TECH COLOPROCTOL, V14, P97, DOI 10.1007/s10151-010-0574-3
   Fjellstedt E, 2003, UROL RES, V31, P417, DOI 10.1007/s00240-003-0366-6
   FREUNDLICH M, 1962, P NATL ACAD SCI USA, V48, P1804, DOI 10.1073/pnas.48.10.1804
   Gewolb IH, 1999, ARCH DIS CHILD-FETAL, V80, pF167, DOI 10.1136/fn.80.3.F167
   Gojkovic Z, 2001, GENETICS, V158, P999
   Goodpaster AM, 2011, CHEMOMETR INTELL LAB, V109, P162, DOI 10.1016/j.chemolab.2011.08.009
   Goodpaster AM, 2010, ANAL BIOCHEM, V401, P134, DOI 10.1016/j.ab.2010.02.005
   Hamandi B, 2009, AM J TRANSPLANT, V9, P1657, DOI 10.1111/j.1600-6143.2009.02664.x
   Hammer HF, 2011, DIGEST DIS, V29, P550, DOI 10.1159/000332981
   HARTMANN F, 1989, METABOLISM, V38, P18, DOI 10.1016/0026-0495(89)90134-0
   Hempel S, 2012, JAMA-J AM MED ASSOC, V307, P1959, DOI 10.1001/jama.2012.3507
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   HOWARD FM, 1977, LANCET, V2, P1099
   Iapichino G, 2008, J MED MICROBIOL, V57, P1007, DOI 10.1099/jmm.0.47387-0
   Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836
   Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3
   Kerai MDJ, 2001, ALCOHOL ALCOHOLISM, V36, P29, DOI 10.1093/alcalc/36.1.29
   Kern WV, 2013, J CLIN ONCOL, V31, P1149, DOI 10.1200/JCO.2012.45.8109
   King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594
   Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202
   Kollef MH, 2008, CLIN INFECT DIS, V47, pS3, DOI 10.1086/590061
   Kosaka T, 2008, GENOME RES, V18, P442, DOI 10.1101/gr.7136508
   Koser SA, 1933, J BACTERIOL, V26, P475, DOI 10.1128/JB.26.5.475-488.1933
   KOSLOSKE A, 1994, ACTA PAEDIATR, V83, P2, DOI 10.1111/j.1651-2227.1994.tb13232.x
   Kuppala VS, 2011, J PEDIATR-US, V159, P720, DOI 10.1016/j.jpeds.2011.05.033
   LAWRENCE G, 1982, LANCET, V1, P137
   Liu GM, 2011, METABOLOMICS, V7, P536, DOI 10.1007/s11306-010-0271-2
   LUFT FC, 1978, J INFECT DIS, V138, P541, DOI 10.1093/infdis/138.4.541
   MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442
   MACY JM, 1978, J BACTERIOL, V134, P84, DOI 10.1128/JB.134.1.84-91.1978
   Marques A, 2008, INFECT DIS CLIN N AM, V22, P341, DOI 10.1016/j.idc.2007.12.011
   Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190
   McGuire W, 2004, BRIT MED J, V329, P1277, DOI 10.1136/bmj.329.7477.1277
   Merheb M, 2007, DIABETES CARE, V30, P2652, DOI 10.2337/dc07-0872
   Miller TL, 1996, APPL ENVIRON MICROB, V62, P1589, DOI 10.1128/AEM.62.5.1589-1592.1996
   MOSSER JL, 1970, J BIOL CHEM, V245, P287
   NANTOSALONEN K, 1984, J INHERIT METAB DIS, V7, P117, DOI 10.1007/BF01801767
   Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080
   PAXTON R, 1986, BIOCHEM J, V234, P295, DOI 10.1042/bj2340295
   Perencevich M, 2006, INFLAMM BOWEL DIS, V12, P651, DOI 10.1097/01.MIB.0000225330.38119.c7
   Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072
   PROCKOP DJ, 1961, J CLIN INVEST, V40, P843, DOI 10.1172/JCI104318
   PULLAN RD, 1994, GUT, V35, P353, DOI 10.1136/gut.35.3.353
   R CoreTeam, 2022, R LANG ENV STAT COMP
   Ravot G, 1996, APPL ENVIRON MICROB, V62, P2657, DOI 10.1128/AEM.62.7.2657-2659.1996
   ROEDIGER WEW, 1980, GUT, V21, P793, DOI 10.1136/gut.21.9.793
   Romick-Rosendale L. E., 2011, USE NMR BASED METABO
   Romick-Rosendale LE, 2009, MAGN RESON CHEM, V47, pS36, DOI 10.1002/mrc.2511
   SALEM AR, 1972, BIOCHEM J, V127, P845, DOI 10.1042/bj1270845
   SALTER DN, 1974, BRIT J NUTR, V32, P625, DOI 10.1079/BJN19740115
   Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024
   SCHAUB J, 1973, Z KINDERHEILKD, V115, P141, DOI 10.1007/BF00440539
   SCHEIFINGER CC, 1973, APPL MICROBIOL, V26, P789, DOI 10.1128/AEM.26.5.789-795.1973
   Shanahan F, 2004, INFLAMM BOWEL DIS, V10, P324, DOI 10.1097/00054725-200405000-00023
   SHAPIRO SK, 1964, J BIOL CHEM, V239, P1551
   Siddiqui S., 2012, COCHRANE LIB, V5, P1
   Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020
   SPARNINS VL, 1976, J BACTERIOL, V127, P362, DOI 10.1128/JB.127.1.362-366.1976
   STAMS AJM, 1984, ARCH MICROBIOL, V139, P167, DOI 10.1007/BF00401994
   Stoll BJ, 2005, PEDIATR INFECT DIS J, V24, P635, DOI 10.1097/01.inf.0000168749.82105.64
   Stoll BJ, 2002, NEW ENGL J MED, V347, P240, DOI 10.1056/NEJMoa012657
   STURM R, 1980, PEDIATRICS, V66, P928
   Sun Y, 2011, METHODS MOL BIOL, V733, P129, DOI 10.1007/978-1-61779-089-8_9
   Tripathi N, 2012, CLIN PERINATOL, V39, P61, DOI 10.1016/j.clp.2011.12.003
   Tzialla C, 2012, J MATERN-FETAL NEO M, V25, P35, DOI 10.3109/14767058.2012.714987
   UDENFRIEND S, 1966, SCIENCE, V152, P1335, DOI 10.1126/science.152.3727.1335
   Watanabe M., 2011, INT J PEPT RES THER, V17, P1
   West T. P., 2011, RES J MICROBIOLOGY, V6, P172
   Williams HRT, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-108
   Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536
   Wright WF, 2012, AM FAM PHYSICIAN, V85, P1086
   Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107
   Xie C, 2012, INTERN MED J, V42, pE157, DOI 10.1111/j.1445-5994.2011.02436.x
   Zgoda-Pols JR, 2011, TOXICOL APPL PHARM, V255, P48, DOI 10.1016/j.taap.2011.05.015
NR 92
TC 11
Z9 11
U1 3
U2 38
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1573-3882
EI 1573-3890
J9 METABOLOMICS
JI Metabolomics
PD FEB
PY 2014
VL 10
IS 1
BP 8
EP 20
DI 10.1007/s11306-013-0546-5
PG 13
WC Endocrinology & Metabolism
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism
GA 302RK
UT WOS:000330622400003
PM 26273236
OA Green Accepted
DA 2022-11-22
ER

PT J
AU McHardy, IH
   Goudarzi, M
   Tong, M
   Ruegger, PM
   Schwager, E
   Weger, JR
   Graeber, TG
   Sonnenburg, JL
   Horvath, S
   Huttenhower, C
   McGovern, DPB
   Fornace, AJ
   Borneman, J
   Braun, J
AF McHardy, Ian H.
   Goudarzi, Maryam
   Tong, Maomeng
   Ruegger, Paul M.
   Schwager, Emma
   Weger, John R.
   Graeber, Thomas G.
   Sonnenburg, Justin L.
   Horvath, Steve
   Huttenhower, Curtis
   McGovern, Dermot P. B.
   Fornace, Albert J., Jr.
   Borneman, James
   Braun, Jonathan
TI Integrative analysis of the microbiome and metabolome of the human
   intestinal mucosal surface reveals exquisite inter-relationships
SO MICROBIOME
LA English
DT Article
DE Microbiome; Metabolome; Inter-omic analysis
ID INFLAMMATORY-BOWEL-DISEASE; CHAIN FATTY-ACIDS; GUT MICROBIOTA; BUTYRATE;
   FERMENTATION; DIVERSITY; PATTERNS; BACTERIA; OBESITY; HEALTH
AB Background: Consistent compositional shifts in the gut microbiota are observed in IBD and other chronic intestinal disorders and may contribute to pathogenesis. The identities of microbial biomolecular mechanisms and metabolic products responsible for disease phenotypes remain to be determined, as do the means by which such microbial functions may be therapeutically modified.
   Results: The composition of the microbiota and metabolites in gut microbiome samples in 47 subjects were determined. Samples were obtained by endoscopic mucosal lavage from the cecum and sigmoid colon regions, and each sample was sequenced using the 16S rRNA gene V4 region (Illumina-HiSeq 2000 platform) and assessed by UPLC mass spectroscopy. Spearman correlations were used to identify widespread, statistically significant microbial-metabolite relationships. Metagenomes for identified microbial OTUs were imputed using PICRUSt, and KEGG metabolic pathway modules for imputed genes were assigned using HUMAnN. The resulting metabolic pathway abundances were mostly concordant with metabolite data. Analysis of the metabolome-driven distribution of OTU phylogeny and function revealed clusters of clades that were both metabolically and metagenomically similar.
   Conclusions: The results suggest that microbes are syntropic with mucosal metabolome composition and therefore may be the source of and/or dependent upon gut epithelial metabolites. The consistent relationship between inferred metagenomic function and assayed metabolites suggests that metagenomic composition is predictive to a reasonable degree of microbial community metabolite pools. The finding that certain metabolites strongly correlate with microbial community structure raises the possibility of targeting metabolites for monitoring and/or therapeutically manipulating microbial community function in IBD and other chronic diseases.
C1 [McHardy, Ian H.; Braun, Jonathan] Univ Calif Los Angeles, Pathol & Lab Med, Los Angeles, CA 90095 USA.
   [McGovern, Dermot P. B.] Cedars Sinai Med Ctr, Widjaja Family Fdn, Inflammatory Bowel & Immunobiol Res Inst, Los Angeles, CA 90048 USA.
   [Goudarzi, Maryam; Fornace, Albert J., Jr.] Georgetown Univ, Biochem & Mol & Cellular Biol, Washington, DC USA.
   [Ruegger, Paul M.; Weger, John R.; Borneman, James] UC Riverside, Plant Pathol, Riverside, CA USA.
   [Horvath, Steve] Univ Calif Los Angeles, Biostat, Los Angeles, CA USA.
   [Sonnenburg, Justin L.] Stanford Univ, Microbiol & Immunol, Palo Alto, CA 94304 USA.
   [Schwager, Emma; Huttenhower, Curtis] Harvard Univ, Biostat, Boston, MA 02115 USA.
   [Tong, Maomeng; Graeber, Thomas G.] Univ Calif Los Angeles, Mol & Med Pharmacol, Los Angeles, CA USA.
C3 University of California System; University of California Los Angeles;
   Cedars Sinai Medical Center; Georgetown University; University of
   California System; University of California Riverside; University of
   California System; University of California Los Angeles; Stanford
   University; Harvard University; University of California System;
   University of California Los Angeles
RP Braun, J (corresponding author), Univ Calif Los Angeles, Pathol & Lab Med, Los Angeles, CA 90095 USA.
EM JBraun@mednet.ucla.edu
RI Goudarzi, Maryam/O-9472-2015; Fornace, Albert/A-7407-2008
OI Goudarzi, Maryam/0000-0003-4961-3935; McHardy, Ian/0000-0002-2121-5460;
   Graeber, Thomas/0000-0001-8574-9181; Fornace,
   Albert/0000-0001-9695-085X; Huttenhower, Curtis/0000-0002-1110-0096;
   Braun, Jonathan/0000-0003-1646-2974
FU NIH [DK46763, AI078885, DK062413, DK084554]; NCRR and NCATS
   [UL1TR000124]; Crohn's and Colitis Foundation of America [3153];
   Burroughs Wellcome Fund Inter-school Program in Metabolic Diseases
   Fellowship; Cedars-Sinai F Widjaja Family Foundation Inflammatory Bowel
   and Immunobiology Research Institute Research Funds; Helmsley
   Foundation; NIH/NCI [P30-CA051008]; NATIONAL INSTITUTE OF DIABETES AND
   DIGESTIVE AND KIDNEY DISEASES [P01DK046763] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM074897]
   Funding Source: NIH RePORTER
FX This work was supported by NIH DK46763 (DPBM, JB), AI078885 (JB),
   DK062413 (DPBM), DK084554 (D.P.B.M.), NCRR and NCATS UL1TR000124 (JB),
   the Crohn's and Colitis Foundation of America 3153 (JB and DPBM), the
   Burroughs Wellcome Fund Inter-school Program in Metabolic Diseases
   Fellowship (MT), Cedars-Sinai F Widjaja Family Foundation Inflammatory
   Bowel and Immunobiology Research Institute Research Funds (DPBM), and
   the Helmsley Foundation (DPBM). The authors would like to acknowledge
   Georgetown University's Proteomics and Metabolomics shared resource
   partially supported by NIH/NCI grant P30-CA051008. They also recognize
   the efforts of Sebastian Anizan (affiliated with Lombardi Comprehensive
   Cancer Center, Georgetown University) for contributing to metabolite
   processing.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951
   Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9
   Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958
   Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]
   Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   CLAUSEN MR, 1995, GUT, V37, P684, DOI 10.1136/gut.37.5.684
   Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486
   Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245
   Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x
   Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04
   Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]
   DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523, DOI 10.1038/nrgastro.2011.133
   Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004
   Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109
   Hamer HM, 2012, AM J PHYSIOL-GASTR L, V302, pG1, DOI 10.1152/ajpgi.00048.2011
   Harrell L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032545
   Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937
   Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108
   Hennig C, 2013, BOOK FPC FLEXIBLE PR
   Hong PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025042
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386
   Jay JJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S7
   Khoruts A, 2010, J CLIN GASTROENTEROL, V44, P354, DOI 10.1097/MCG.0b013e3181c87e02
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542
   Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5
   Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x
   Lundin A, 2008, CELL MICROBIOL, V10, P1093, DOI 10.1111/j.1462-5822.2007.01108.x
   Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Nugent R, 2010, METHODS MOL BIOL, V620, P369, DOI 10.1007/978-1-60761-580-4_12
   Oksanen J, 2012, BOOK VEGAN COMMUNITY
   Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613
   Presley LL, 2012, INFLAMM BOWEL DIS, V18, P409, DOI 10.1002/ibd.21793
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038
   Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499
   Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397
   Smirnova GV, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1199, DOI 10.1007/s10541-005-0248-3
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170
   Tannock GW, 2001, AM J CLIN NUTR, V73, p410S, DOI 10.1093/ajcn/73.2.410s
   Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826
   Tibshirani R, 2005, J COMPUT GRAPH STAT, V14, P511, DOI 10.1198/106186005X59243
   Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108
   Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S10
   Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049
   Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
NR 64
TC 175
Z9 179
U1 5
U2 75
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PY 2013
VL 1
AR 17
DI 10.1186/2049-2618-1-17
PG 19
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA V40VZ
UT WOS:000209507400017
PM 24450808
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Verbeke, KA
   Boobis, AR
   Chiodini, A
   Edwards, CA
   Franck, A
   Kleerebezem, M
   Nauta, A
   Raes, J
   van Tol, EAF
   Tuohy, KM
AF Verbeke, Kristin A.
   Boobis, Alan R.
   Chiodini, Alessandro
   Edwards, Christine A.
   Franck, Anne
   Kleerebezem, Michiel
   Nauta, Arjen
   Raes, Jeroen
   van Tol, Eric A. F.
   Tuohy, Kieran M.
CA ILSI Europe Prebiotics Task Force
TI Towards microbial fermentation metabolites as markers for health
   benefits of prebiotics
SO NUTRITION RESEARCH REVIEWS
LA English
DT Review
DE Microbial metabolites; Prebiotic health benefits; Metagenome;
   Nutrikinetics
ID CHAIN FATTY-ACIDS; IN-VITRO FERMENTATION; MICROFLORA-ASSOCIATED
   CHARACTERISTICS; RANDOMIZED CONTROLLED-TRIAL;
   INFLAMMATORY-BOWEL-DISEASE; COLON-CANCER RISK; HUMAN FECAL WATER;
   OLIGOFRUCTOSE-ENRICHED INULIN; INTESTINAL EPITHELIAL-CELLS; HUMAN GUT
   MICROBIOME
AB Available evidence on the bioactive, nutritional and putative detrimental properties of gut microbial metabolites has been evaluated to support a more integrated view of how prebiotics might affect host health throughout life. The present literature inventory targeted evidence for the physiological and nutritional effects of metabolites, for example, SCFA, the potential toxicity of other metabolites and attempted to determine normal concentration ranges. Furthermore, the biological relevance of more holistic approaches like faecal water toxicity assays and metabolomics and the limitations of faecal measurements were addressed. Existing literature indicates that protein fermentation metabolites (phenol, p-cresol, indole, ammonia), typically considered as potentially harmful, occur at concentration ranges in the colon such that no toxic effects are expected either locally or following systemic absorption. The endproducts of saccharolytic fermentation, SCFA, may have effects on colonic health, host physiology, immunity, lipid and protein metabolism and appetite control. However, measuring SCFA concentrations in faeces is insufficient to assess the dynamic processes of their nutrikinetics. Existing literature on the usefulness of faecal water toxicity measures as indicators of cancer risk seems limited. In conclusion, at present there is insufficient evidence to use changes in faecal bacterial metabolite concentrations as markers of prebiotic effectiveness. Integration of results from metabolomics and metagenomics holds promise for understanding the health implications of prebiotic microbiome modulation but adequate tools for data integration and interpretation are currently lacking. Similarly, studies measuring metabolite fluxes in different body compartments to provide a more accurate picture of their nutrikinetics are needed.
C1 [Verbeke, Kristin A.] Katholieke Univ Leuven, Translat Res Gastrointestinal Disorders TARGID, Leuven, Belgium.
   [Verbeke, Kristin A.] Leuven Food Sci & Nutr Res Ctr LFoRCe, Leuven, Belgium.
   [Boobis, Alan R.] Univ London Imperial Coll Sci Technol & Med, Dept Med, London, England.
   [Chiodini, Alessandro] ILSI Europe, BE-1200 Brussels, Belgium.
   [Edwards, Christine A.] Univ Glasgow, Human Nutr Sch Med, Coll MVLS, Glasgow, Lanark, Scotland.
   [Franck, Anne] Cargill, Vilvoorde, Belgium.
   [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact, NL-6700 AP Wageningen, Netherlands.
   [Nauta, Arjen] FrieslandCampina, Amersfoort, Netherlands.
   [Raes, Jeroen] Katholieke Univ Leuven, Rega Inst, Microbiol & Immunol, Leuven, Belgium.
   [Raes, Jeroen] VIB, Leuven, Belgium.
   [Raes, Jeroen] Vrije Univ Brussel, DBIT, Brussels, Belgium.
   [van Tol, Eric A. F.] Mead Johnson Nutr, Nijmegen, Netherlands.
   [Tuohy, Kieran M.] Fdn Edmund Mach, Res & Innovat Ctr, Nutr & Nutrigen, Trento, Italy.
C3 KU Leuven; Imperial College London; University of Glasgow; Cargill;
   Wageningen University & Research; KU Leuven; Flanders Institute for
   Biotechnology (VIB); Vrije Universiteit Brussel; Fondazione Edmund Mach
RP Chiodini, A (corresponding author), ILSI Europe Aisbl, Ave E Mounier 83,Box 6, B-1200 Brussels, Belgium.
EM publications@ilsieurope.be
RI Edwards, christine/AGQ-4192-2022; Kleerebezem, Michiel/AAT-2078-2021;
   Tuohy, Kieran M/G-9142-2011; Boobis, Alan/E-1536-2018; raes,
   jeroen/D-7835-2018
OI Tuohy, Kieran M/0000-0001-6882-7192; Boobis, Alan/0000-0003-3371-386X;
   raes, jeroen/0000-0002-1337-041X; Kleerebezem,
   Michiel/0000-0001-8552-2235; Verbeke, Kristin/0000-0002-5352-7565;
   Edwards, Christine/0000-0003-0406-918X; Chiodini,
   Alessandro/0000-0003-0971-7860
FU ILSI Europe Prebiotics Task Force
FX The expert group received funding from the ILSI Europe Prebiotics Task
   Force. Industry members of this task force are listed on the ILSI Europe
   website (www.ilsi.eu). For further information about ILSI Europe, please
   email info@ilsieurope.be or call +32 2 771 00 14. The opinions expressed
   and the conclusions of this publication are those of the authors and do
   not necessarily represent the views of ILSI Europe or those of its
   member companies.
CR ADAMS RF, 1985, LANCET, V2, P1313
   Al-Lahham S, 2012, EUR J CLIN INVEST, V42, P357, DOI 10.1111/j.1365-2362.2011.02590.x
   Alakomi HL, 2007, J AGR FOOD CHEM, V55, P3905, DOI 10.1021/jf070190y
   Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058
   Alles MS, 1997, AM J CLIN NUTR, V66, P1286, DOI 10.1093/ajcn/66.5.1286
   Andrieux C, 2002, SCAND J GASTROENTERO, V37, P792, DOI 10.1080/713786532
   Ariake Koichiro, 2000, Journal of Medical and Dental Sciences, V47, P233
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Asano Y, 2012, AM J PHYSIOL-GASTR L, V303, pG1288, DOI 10.1152/ajpgi.00341.2012
   Attene-Ramos MS, 2007, MOL CANCER RES, V5, P455, DOI 10.1158/1541-7786.MCR-06-0439
   Attene-Ramos MS, 2010, ENVIRON MOL MUTAGEN, V51, P304, DOI 10.1002/em.20546
   Attene-Ramos MS, 2006, MOL CANCER RES, V4, P9, DOI 10.1158/1541-7786.MCR-05-0126
   Bakker-Zierikzee AM, 2005, BRIT J NUTR, V94, P783, DOI 10.1079/BJN20051451
   Bazzocco S, 2008, EUR J NUTR, V47, P442, DOI 10.1007/s00394-008-0747-2
   Benassi-Evans B, 2010, MUTAT RES-GEN TOX EN, V703, P130, DOI 10.1016/j.mrgentox.2010.08.009
   Bianchi MA, 2010, BRIT J NUTR, V104, P1500, DOI 10.1017/S0007114510002424
   Birkett A, 1996, AM J CLIN NUTR, V63, P766, DOI 10.1093/ajcn/63.5.766
   Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9
   Blachier F, 2010, AMINO ACIDS, V39, P335, DOI 10.1007/s00726-009-0445-2
   Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S
   Bolca S, 2013, CURR OPIN BIOTECH, V24, P220, DOI 10.1016/j.copbio.2012.09.009
   Boler BMV, 2011, BRIT J NUTR, V106, P1864, DOI 10.1017/S0007114511002388
   Borthakur A, 2012, AM J PHYSIOL-GASTR L, V303, pG1126, DOI 10.1152/ajpgi.00308.2012
   BOSWORTH D, 1986, MUTAGENESIS, V1, P143, DOI 10.1093/mutage/1.2.143
   Bottcher MF, 2000, CLIN EXP ALLERGY, V30, P1590, DOI 10.1046/j.1365-2222.2000.00982.x
   Brinkworth GD, 2009, BRIT J NUTR, V101, P1493, DOI 10.1017/S0007114508094658
   Bron PA, 2012, NAT REV MICROBIOL, V10, P66, DOI 10.1038/nrmicro2690
   Calvani R, 2010, INT J OBESITY, V34, P1095, DOI 10.1038/ijo.2010.44
   Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886
   Cervantes-Laurean D, 2006, J NUTR BIOCHEM, V17, P531, DOI 10.1016/j.jnutbio.2005.10.002
   Cheng Y, 2012, J PROTEOME RES, V11, P1354, DOI 10.1021/pr201001a
   Cherbut C, 2003, P NUTR SOC, V62, P95, DOI 10.1079/PNS2002213
   Clarke JM, 2011, AM J CLIN NUTR, V94, P1276, DOI 10.3945/ajcn.111.017228
   Cloetens L, 2008, J AM COLL NUTR, V27, P512, DOI 10.1080/07315724.2008.10719733
   Cloetens L, 2010, BRIT J NUTR, V103, P703, DOI 10.1017/S0007114509992248
   Collino S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056564
   Connolly ML, 2010, ANAEROBE, V16, P483, DOI 10.1016/j.anaerobe.2010.07.001
   Cook SI, 1998, ALIMENT PHARM THER, V12, P499, DOI 10.1046/j.1365-2036.1998.00337.x
   Costabile A, 2008, BRIT J NUTR, V99, P110, DOI 10.1017/S0007114507793923
   Costabile A, 2012, BRIT J NUTR, V108, P471, DOI 10.1017/S0007114511005782
   Cuervo A, 2013, NUTR RES, V33, P811, DOI 10.1016/j.nutres.2013.05.016
   CUMMINGS JH, 1979, AM J CLIN NUTR, V32, P2094, DOI 10.1093/ajcn/32.10.2094
   Dall'Asta M, 2012, NUTRITION, V28, P197, DOI 10.1016/j.nut.2011.06.005
   Damen B, 2012, J NUTR, V142, P470, DOI 10.3945/jn.111.146464
   Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   de Goffau MC, 2014, DIABETOLOGIA, V57, P1569, DOI 10.1007/s00125-014-3274-0
   de Goffau MC, 2013, DIABETES, V62, P1238, DOI 10.2337/db12-0526
   de Graaf AA, 2007, ADV MICROBIAL PHYSL, V53, P313
   de Graaf' AA, 2008, ADV MICROB PHYSIOL, V53, P73, DOI 10.1016/S0065-2911(07)53002-X
   de Kok TMCM, 2000, MUTAT RES-REV MUTAT, V463, P53, DOI 10.1016/S1383-5742(00)00003-X
   De Preter V, 2004, BRIT J NUTR, V92, P439, DOI 10.1079/BJN20041228
   De Preter V, 2006, J AM COLL NUTR, V25, P541, DOI 10.1080/07315724.2006.10719570
   De Preter V, 2007, AM J PHYSIOL-GASTR L, V292, pG358, DOI 10.1152/ajpgi.00052.2006
   De Preter V, 2013, CLIN TRANSL GASTROEN, V4, DOI 10.1038/ctg.2012.24
   De Preter V, 2012, INFLAMM BOWEL DIS, V18, P2371, DOI 10.1002/ibd.22949
   De Preter V, 2011, MOL NUTR FOOD RES, V55, P714, DOI 10.1002/mnfr.201000442
   De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016
   Del Rio D, 2013, ANTIOXID REDOX SIGN, V18, P1818, DOI 10.1089/ars.2012.4581
   Del Rio D, 2010, BRIT J NUTR, V104, pS67, DOI 10.1017/S0007114510003958
   Dell'Agli M, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-208
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Deplancke B, 2003, FASEB J, V17, P1310, DOI 10.1096/fj.02-0883fje
   Dougal K, 2012, FEMS MICROBIOL ECOL, V82, P642, DOI 10.1111/j.1574-6941.2012.01441.x
   Duzgun AP, 2007, HEPATO-GASTROENTEROL, V54, P1483
   EDWARDS CA, 1994, ACTA PAEDIATR, V83, P459, DOI 10.1111/j.1651-2227.1994.tb13059.x
   El Oufir L, 2000, EUR J CLIN NUTR, V54, P603, DOI 10.1038/sj.ejcn.1600687
   Faber TA, 2011, J ANIM SCI, V89, P103, DOI 10.2527/jas.2010-3028
   Fallani M, 2011, MICROBIOL-SGM, V157, P1385, DOI 10.1099/mic.0.042143-0
   Faust K, 2012, NAT REV MICROBIOL, V10, P538, DOI 10.1038/nrmicro2832
   Fava F, 2013, INT J OBESITY, V37, P216, DOI 10.1038/ijo.2012.33
   Fernando WMU, 2010, BENEF MICROBES, V1, P197, DOI 10.3920/BM2009.0027
   Fleissner CK, 2010, BRIT J NUTR, V104, P919, DOI 10.1017/S0007114510001303
   FLORIN T, 1991, GUT, V32, P766, DOI 10.1136/gut.32.7.766
   Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005
   Freeland KR, 2010, BRIT J NUTR, V103, P82, DOI 10.1017/S0007114509991462
   Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611
   Fung KYC, 2012, BRIT J NUTR, V108, P820, DOI 10.1017/S0007114512001948
   Fung KYC, 2011, J PROTEOME RES, V10, P1860, DOI 10.1021/pr1011125
   Geurts L, 2014, BENEF MICROBES, V5, P3, DOI 10.3920/BM2012.0065
   Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149
   GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401
   Gill CIR, 2007, NUTR CANCER, V57, P59, DOI 10.1080/01635580701268220
   Gill CIR, 2010, J AGR FOOD CHEM, V58, P10389, DOI 10.1021/jf1017143
   Gin H, 1999, METABOLISM, V48, P1179, DOI 10.1016/S0026-0495(99)90135-X
   Glei M, 2005, BIOMARKERS, V10, P203, DOI 10.1080/13547500500138963
   Glinghammar B, 1999, CARCINOGENESIS, V20, P969, DOI 10.1093/carcin/20.6.969
   Glinghammar B, 2001, GASTROENTEROLOGY, V120, P401, DOI 10.1053/gast.2001.21188
   Goncalves P, 2012, J CELL BIOCHEM, V113, P2937, DOI 10.1002/jcb.24172
   Gostner A, 2006, BRIT J NUTR, V95, P40, DOI 10.1079/BJN20051589
   Govers MJAP, 1999, GUT, V45, P840, DOI 10.1136/gut.45.6.840
   Gratz SW, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00004
   GuerinDanan C, 1997, J PEDIATR GASTR NUTR, V25, P281, DOI 10.1097/00005176-199709000-00007
   Halperin ML, 1996, KIDNEY INT, V49, P1, DOI 10.1038/ki.1996.1
   Haza AI, 2000, NUTR CANCER, V36, P79, DOI 10.1207/S15327914NC3601_12
   Heavey PM, 2003, BRIT J NUTR, V89, P509, DOI 10.1079/BJN2002814
   Henry CJK, 2008, INT J FOOD SCI NUTR, V59, P61, DOI 10.1080/09637480701664183
   Hobden MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077128
   Holodniy M, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0014764, 10.1371/journal.pone.0025792]
   Holscher HD, 2012, JPEN-PARENTER ENTER, V36, p95S, DOI 10.1177/0148607111430087
   Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490
   HOVE H, 1995, DIS COLON RECTUM, V38, P519, DOI 10.1007/BF02148853
   HOVE H, 1995, DIGEST DIS SCI, V40, P1372, DOI 10.1007/BF02065554
   Huda-Faujan N, 2010, Open Biochem J, V4, P53, DOI 10.2174/1874091X01004010053
   Hughes R, 2008, NUTR CANCER, V60, P259, DOI 10.1080/01635580701649644
   Hughes SA, 2008, FEMS MICROBIOL ECOL, V64, P482, DOI 10.1111/j.1574-6941.2008.00478.x
   Hylla S, 1998, AM J CLIN NUTR, V67, P136, DOI 10.1093/ajcn/67.1.136
   Ishimi Y, 2009, FORUM NUTR, V61, P104, DOI 10.1159/000212743
   Jackman KA, 2007, CURR MED CHEM, V14, P2824, DOI 10.2174/092986707782360178
   Jaganath IB, 2009, FREE RADICAL BIO MED, V47, P1180, DOI 10.1016/j.freeradbiomed.2009.07.031
   Jouet P, 2013, NEUROGASTROENT MOTIL, V25, P943, DOI 10.1111/nmo.12212
   JOVOV B, 1991, AM J PHYSIOL, V261, pC1196, DOI 10.1152/ajpcell.1991.261.6.C1196
   Jowett SL, 2004, GUT, V53, P1479, DOI 10.1136/gut.2003.024828
   KAMATH PS, 1990, GUT, V31, P443, DOI 10.1136/gut.31.4.443
   Karlsson PC, 2005, J NUTR, V135, P2343
   Kedia G, 2009, CURR MICROBIOL, V58, P338, DOI 10.1007/s00284-008-9335-1
   Kim E, 2013, NUTR RES, V33, P983, DOI 10.1016/j.nutres.2013.07.018
   Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108
   Klinder A, 2004, NUTR CANCER, V49, P144, DOI 10.1207/s15327914nc4902_5
   Klinder A, 2007, NUTR CANCER, V57, P158, DOI 10.1080/01635580701274848
   Knol J, 2005, J PEDIATR GASTR NUTR, V40, P36, DOI 10.1097/00005176-200501000-00007
   Ko HS, 2009, CURR MICROBIOL, V59, P608, DOI 10.1007/s00284-009-9481-0
   Koehne CH, 2004, SEMIN ONCOL, V31, P12, DOI 10.1053/j.seminoncol.2004.03.041
   Ktsoyan ZA, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00148
   LAPRE JA, 1992, CARCINOGENESIS, V13, P41, DOI 10.1093/carcin/13.1.41
   Larrosa M, 2006, J AGR FOOD CHEM, V54, P1611, DOI 10.1021/jf0527403
   Laurentin A, 2004, EUR J NUTR, V43, P183, DOI 10.1007/s00394-004-0457-3
   Layden BT, 2012, DIABET METAB SYND OB, V5, P49, DOI 10.2147/DMSO.S29244
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598
   Lecerf JM, 2012, BRIT J NUTR, V108, P1847, DOI 10.1017/S0007114511007252
   Leschelle X, 2005, BBA-GEN SUBJECTS, V1725, P201, DOI 10.1016/j.bbagen.2005.06.002
   Levine J, 1998, AM J GASTROENTEROL, V93, P83, DOI 10.1111/j.1572-0241.1998.083_c.x
   Lewis SJ, 1997, GUT, V41, P245, DOI 10.1136/gut.41.2.245
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240
   LING WH, 1992, J NUTR, V122, P924, DOI 10.1093/jn/122.4.924
   Lyra A, 2010, BENEF MICROBES, V1, P407, DOI 10.3920/BM2010.0030
   Macfarlane GT, 2011, J CLIN GASTROENTEROL, V45, pS120, DOI 10.1097/MCG.0b013e31822fecfe
   MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb04882.x
   Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207
   Machiels Kathleen, 2014, Gut, V63, P1275, DOI 10.1136/gutjnl-2013-304833
   Magee EA, 2000, AM J CLIN NUTR, V72, P1488
   Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
   Makelainen HS, 2007, J FOOD SCI, V72, pM153, DOI 10.1111/j.1750-3841.2007.00350.x
   Marchesi J, 2007, CURR OPIN INFECT DIS, V20, P508, DOI 10.1097/QCO.0b013e3282a56a99
   Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123
   Marquet P, 2009, FEMS MICROBIOL LETT, V299, P128, DOI 10.1111/j.1574-6968.2009.01750.x
   Martin FPJ, 2011, MAGN RESON CHEM, V49, pS47, DOI 10.1002/mrc.2810
   Martin FPJ, 2010, J PROTEOME RES, V9, P5284, DOI 10.1021/pr100554m
   Martin FPJ, 2009, J PROTEOME RES, V8, P5568, DOI 10.1021/pr900607v
   Martin FPJ, 2009, J PROTEOME RES, V8, P2090, DOI 10.1021/pr801068x
   McCall IC, 2009, TOXICOL APPL PHARM, V241, P61, DOI 10.1016/j.taap.2009.08.002
   McOrist AL, 2008, BRIT J NUTR, V100, P138, DOI 10.1017/S0007114507886351
   McOrist AL, 2011, J NUTR, V141, P883, DOI 10.3945/jn.110.128504
   Medani M, 2011, INFLAMM BOWEL DIS, V17, P1620, DOI 10.1002/ibd.21528
   Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022
   MIDTVEDT AC, 1992, J PEDIATR GASTR NUTR, V15, P395, DOI 10.1097/00005176-199211000-00005
   Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008
   Moco S, 2012, J PROTEOME RES, V11, P4781, DOI 10.1021/pr300581s
   Moore J, 1998, DIGEST DIS SCI, V43, P162, DOI 10.1023/A:1018848709769
   Morita T, 1999, J NUTR, V129, P2081, DOI 10.1093/jn/129.11.2081
   Morrison DJ, 2006, BRIT J NUTR, V96, P570, DOI 10.1079/BJN20061853
   Morrow D, 1996, BRIT J CANCER, V74, pPO68
   Mortensen PB, 1996, SCAND J GASTROENTERO, V31, P132, DOI 10.3109/00365529609094568
   MURRAY MJ, 1994, AM J SURG, V167, P575, DOI 10.1016/0002-9610(94)90101-5
   Ndagijimana M, 2009, INT J FOOD MICROBIOL, V134, P147, DOI 10.1016/j.ijfoodmicro.2009.04.016
   Nemoto H, 2012, DIGEST DIS SCI, V57, P2955, DOI 10.1007/s10620-012-2236-y
   Ni NT, 2008, BIOORG MED CHEM LETT, V18, P1567, DOI 10.1016/j.bmcl.2008.01.081
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Nilsson A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059985
   Noack J, 2013, NUTRIENTS, V5, P1500, DOI 10.3390/nu5051500
   Nordling MM, 2003, SCAND J GASTROENTERO, V38, P549, DOI 10.1080/00365520310002913
   Nordlund E, 2012, J AGR FOOD CHEM, V60, P8134, DOI 10.1021/jf3008037
   Norin Elisabeth, 2004, Microbial Ecology in Health and Disease, V16, P8, DOI 10.1080/08910600410026364
   Nyangale EP, 2012, J PROTEOME RES, V11, P5573, DOI 10.1021/pr300637d
   Okello EJ, 2012, FOOD FUNCT, V3, P651, DOI 10.1039/c2fo10174b
   Osswald K, 2000, MUTAT RES-GEN TOX EN, V472, P59, DOI 10.1016/S1383-5718(00)00113-3
   Ou JH, 2012, NUTR CANCER, V64, P34, DOI 10.1080/01635581.2012.630164
   Parrett AM, 1997, AM J CLIN NUTR, V65, P927, DOI 10.1093/ajcn/65.4.927
   Parrett AM, 1997, ARCH DIS CHILD, V76, P249, DOI 10.1136/adc.76.3.249
   Patel KP, 2012, CLIN J AM SOC NEPHRO, V7, P982, DOI 10.2215/CJN.12491211
   Patney N L, 1977, J Indian Med Assoc, V68, P94
   Patney N L, 1976, J Assoc Physicians India, V24, P291
   Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8
   Pedersen G, 2002, SCAND J GASTROENTERO, V37, P74, DOI 10.1080/003655202753387392
   Petry N, 2012, AM J CLIN NUTR, V96, P325, DOI 10.3945/ajcn.112.035717
   Pitcher MCL, 2000, GUT, V46, P64, DOI 10.1136/gut.46.1.64
   Ploger S, 2012, ANN NY ACAD SCI, V1258, P52, DOI 10.1111/j.1749-6632.2012.06553.x
   Ponnusamy K, 2011, J MED MICROBIOL, V60, P817, DOI 10.1099/jmm.0.028126-0
   Pool-Zobel BL, 2005, BRIT J NUTR, V93, pS73, DOI 10.1079/BJN20041349
   Pylkas AM, 2005, J MED FOOD, V8, P113, DOI 10.1089/jmf.2005.8.113
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Qiu YP, 2010, J PROTEOME RES, V9, P1627, DOI 10.1021/pr901081y
   Qiu YP, 2009, J PROTEOME RES, V8, P4844, DOI 10.1021/pr9004162
   Ramakers JD, 2007, MOL NUTR FOOD RES, V51, P211, DOI 10.1002/mnfr.200600149
   Reimer RA, 2012, J HUM NUTR DIET, V25, P373, DOI 10.1111/j.1365-277X.2012.01230.x
   RENWICK AG, 1988, HUM TOXICOL, V7, P267, DOI 10.1177/096032718800700307
   Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35
   Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363
   ROE DA, 1971, J NUTR, V101, P645, DOI 10.1093/jn/101.5.645
   Roediger WEW, 1997, GUT, V41, P731, DOI 10.1136/gut.41.6.731
   ROEDIGER WEW, 1982, GASTROENTEROLOGY, V83, P424
   Roowi S, 2010, J AGR FOOD CHEM, V58, P1296, DOI 10.1021/jf9032975
   Sakurazawa T, 2005, J GASTROENTEROL, V40, P600, DOI 10.1007/s00535-005-1594-z
   Samuelsson U, 2004, DIABETIC MED, V21, P64, DOI 10.1046/j.1464-5491.2003.01066.x
   Sarbini SR, 2013, BRIT J NUTR, V109, P1980, DOI 10.1017/S0007114512004205
   Sauer J, 2007, J NUTR BIOCHEM, V18, P736, DOI 10.1016/j.jnutbio.2006.12.012
   SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020
   Seiber JN, 2014, J AGR FOOD CHEM, V62, P22, DOI 10.1021/jf4046254
   Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d
   Shao YF, 2004, P NATL ACAD SCI USA, V101, P18030, DOI 10.1073/pnas.0408345102
   Shinohara K, 2010, ANAEROBE, V16, P510, DOI 10.1016/j.anaerobe.2010.03.005
   Shiomi Y, 2011, INFLAMM BOWEL DIS, V17, P2261, DOI 10.1002/ibd.21616
   SIIGUR U, 1993, ACTA PAEDIATR, V82, P536, DOI 10.1111/j.1651-2227.1993.tb12747.x
   Slavin J, 2011, FOOD FUNCT, V2, P72, DOI 10.1039/c0fo00101e
   Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x
   Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121
   Song WB, 2009, WORLD J GASTROENTERO, V15, P3916, DOI 10.3748/wjg.15.3916
   STEPHEN AM, 1987, GUT, V28, P601, DOI 10.1136/gut.28.5.601
   Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953
   Swanson KS, 2002, J NUTR, V132, P3042, DOI 10.1093/jn/131.10.3042
   Taguri T, 2006, BIOL PHARM BULL, V29, P2226, DOI 10.1248/bpb.29.2226
   Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986
   Theil PK, 2011, BRIT J NUTR, V105, P373, DOI 10.1017/S0007114510003715
   Tiihonen K, 2010, BRIT J NUTR, V103, P1070, DOI 10.1017/S0007114509992807
   Timm DA, 2010, J MED FOOD, V13, P961, DOI 10.1089/jmf.2009.0135
   Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146
   Tjellstrom B, 2005, AM J GASTROENTEROL, V100, P2784, DOI 10.1111/j.1572-0241.2005.00313.x
   Tjellstrom Bo, 2013, Microbial Ecology in Health and Disease, V24, P20905, DOI 10.3402/mehd.v24i0.20905
   Tjellstrom B, 2012, SCAND J GASTROENTERO, V47, P1454, DOI 10.3109/00365521.2012.703234
   Tjellstrom B, 2010, SCAND J GASTROENTERO, V45, P1059, DOI 10.3109/00365521.2010.483738
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   TREEM WR, 1994, J PEDIATR GASTR NUTR, V18, P159, DOI 10.1097/00005176-199402000-00007
   Tulipani S, 2011, J PROTEOME RES, V10, P5047, DOI 10.1021/pr200514h
   Tuohy KM, 2012, J AGR FOOD CHEM, V60, P8776, DOI 10.1021/jf2053959
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075
   Van den Abbeele P, 2013, J AGR FOOD CHEM, V61, P9819, DOI 10.1021/jf4021784
   Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045
   Verbeke K, 2010, EUR J CLIN NUTR, V64, P678, DOI 10.1038/ejcn.2010.92
   VERNIA P, 1988, GASTROENTEROLOGY, V95, P1564, DOI 10.1016/S0016-5085(88)80078-7
   VISEK WJ, 1978, AM J CLIN NUTR, V31, pS216, DOI 10.1093/ajcn/31.10.S216
   Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4
   Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697
   Wang L, 2012, DIGEST DIS SCI, V57, P2096, DOI 10.1007/s10620-012-2167-7
   Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13
   WANG X, 1993, J APPL BACTERIOL, V75, P373, DOI 10.1111/j.1365-2672.1993.tb02790.x
   Washington N, 1998, AM J CLIN NUTR, V67, P317, DOI 10.1093/ajcn/67.2.237
   Whelan K, 2005, J NUTR, V135, P1896, DOI 10.1093/jn/135.8.1896
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Windey K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052387
   Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542
   Wolever TMS, 1997, METABOLISM, V46, P805, DOI 10.1016/S0026-0495(97)90127-X
   Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015
   Worthley DL, 2009, AM J CLIN NUTR, V90, P578, DOI 10.3945/ajcn.2009.28106
   Wu WT, 2011, BRIT J NUTR, V105, P593, DOI 10.1017/S0007114510004009
   Wutzke KD, 2010, EUR J CLIN NUTR, V64, P1215, DOI 10.1038/ejcn.2010.120
   Yap IKS, 2010, J PROTEOME RES, V9, P6647, DOI 10.1021/pr100798r
   Zeng HW, 2003, J NUTR, V133, P2682, DOI 10.1093/jn/133.8.2682
   Zhao Y, 2013, J PROTEOME RES, V12, P2987, DOI 10.1021/pr400263n
   Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603
   Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212
NR 266
TC 174
Z9 189
U1 13
U2 136
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0954-4224
EI 1475-2700
J9 NUTR RES REV
JI Nutr. Res. Rev.
PD JUN
PY 2015
VL 28
IS 1
BP 42
EP 66
DI 10.1017/S0954422415000037
PG 25
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA CR0UI
UT WOS:000361038300003
PM 26156216
OA Green Published, Green Accepted, hybrid
DA 2022-11-22
ER

PT J
AU Wang, JC
   Tang, LL
   Zhou, HY
   Zhou, J
   Glenn, TC
   Shen, CL
   Wang, JS
AF Wang, Jincheng
   Tang, Lili
   Zhou, Hongyuan
   Zhou, Jun
   Glenn, Travis C.
   Shen, Chwan-Li
   Wang, Jia-Sheng
TI Long-term treatment with green tea polyphenols modifies the gut
   microbiome of female sprague-dawley rats
SO JOURNAL OF NUTRITIONAL BIOCHEMISTRY
LA English
DT Article
DE Green Tea Polyphenol; Catechin; Gut microbiome; Metagenomics; 16S gene
   survey; Next generation sequencing
ID INTESTINAL MICROBIOTA; HUMAN HEALTH; METABOLISM; ABSORPTION; DIVERSITY;
   EXCRETION; BENEFITS; OBESITY; IDENTIFICATION; CONSERVATION
AB Green tea polyphenols (GTP) have been shown to exert a spectrum of health benefits to animals and humans. It is plausible that the beneficial effects of GTP are a result of its interaction with the gut microbiota. This study evaluated the effect of long-term treatment with GTP on the gut microbiota of experimental rats and the potential linkage between changes of the gut microbiota with the beneficial effects of GTP. Six-month-old Sprague-Dawley rats were randomly allocated into three dosing regimens (0, 0.5%, and 1.5% of GTP) and followed for 6 months. At the end of month 3 or month 6, half of the animals from each group were sacrificed and their colon contents were collected for microbiome analysis using 16S ribosomal RNA and shotgun metagenomic community sequencing. GTP treatment significantly decreased the biodiversity and modified the microbial community in a dose-dependent manner; similar patterns were observed at both sampling times. Multiple operational taxonomic units and phylotypes were modified: the phylotypes Bacteroidetes and Oscillospira, previously linked to the lean phenotype in human and animal studies, were enriched; and Peptostreptococcaceae previously linked to colorectal cancer phenotype was depleted in GTP treated groups in a dose-dependent manner. Several microbial gene orthologs were modified, among which genes related to energy production and conversion were consistently enriched in samples from month 6 in a dose-dependent manner. This study showed that long-term treatment with GTP induced a dose-dependent modification of the gut microbiome in experimental rats, which might be linked to beneficial effects of GTP. (C) 2018 Elsevier Inc. All rights reserved.
C1 [Wang, Jincheng; Tang, Lili; Zhou, Jun; Glenn, Travis C.; Wang, Jia-Sheng] Univ Georgia, Interdisciplinary Toxicol Program, Athens, GA 30602 USA.
   [Wang, Jincheng; Tang, Lili; Zhou, Hongyuan; Zhou, Jun; Glenn, Travis C.; Wang, Jia-Sheng] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA.
   [Zhou, Hongyuan] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Peoples R China.
   [Shen, Chwan-Li] Texas Tech Univ, Sch Med, Dept Pathol, Hlth Sci Ctr, Lubbock, TX 79430 USA.
C3 University System of Georgia; University of Georgia; University System
   of Georgia; University of Georgia; Jiangnan University; Texas Tech
   University System; Texas Tech University; Texas Tech University Health
   Science Center
RP Wang, JS (corresponding author), Univ Georgia, 206A Environm Hlth Sci Bldg, Athens, GA 30602 USA.
EM jswang@uga.edu
RI Glenn, Travis C/A-2390-2008
OI Glenn, Travis C/0000-0001-7725-3637; , jun/0000-0002-0688-544X
FU USAID via Peanut CRSP at University of Georgia [ECG-A-00-07-00001-00];
   NIH Fogarty International Center [1R24TW009489]; NCCIH, NIH
   [U01AT006691]; FOGARTY INTERNATIONAL CENTER [R24TW009489] Funding
   Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE
   MEDICINE [U01AT006691] Funding Source: NIH RePORTER
FX ECG-A-00-07-00001-00, from USAID via Peanut CRSP at University of
   Georgia; 1R24TW009489, from NIH Fogarty International Center; and
   U01AT006691 from NCCIH, NIH.
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x
   [Anonymous], 2016, ADAPTERAMA UNIVERSAL, DOI DOI 10.1101/049114
   Auger C, 2008, J NUTR, V138, P1535
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Cardona F, 2013, J NUTR BIOCHEM, V24, P1415, DOI 10.1016/j.jnutbio.2013.05.001
   Chen LS, 1997, DRUG METAB DISPOS, V25, P1045
   Cheng M, 2017, FOOD RES INT, V92, P9, DOI 10.1016/j.foodres.2016.12.008
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Clifford MN, 2013, AM J CLIN NUTR, V98, p1619S, DOI 10.3945/ajcn.113.058958
   Cox-York KA, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12488
   del Campo R, 2014, J CYST FIBROS, V13, P716, DOI 10.1016/j.jcf.2014.02.007
   Del Rio D, 2010, NUTR METAB CARDIOVAS, V20, P1, DOI 10.1016/j.numecd.2009.05.015
   Eloe-Fadrosh EA, 2015, MBIO, V6, DOI 10.1128/mBio.00231-15
   Escobar JS, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0311-6
   Everard A, 2014, ISME J, V8, P2116, DOI 10.1038/ismej.2014.45
   FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3
   Garrett R., 2010, BIOCHEMISTRY
   Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053
   Higdon JV, 2003, CRIT REV FOOD SCI, V43, P89, DOI 10.1080/10408690390826464
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248
   Huttenhower C, 2014, CELL, V159, P227, DOI 10.1016/j.cell.2014.09.022
   Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119
   International Conference on Harmonisation, 1998, DURATION CHRONIC TOX, pS4
   Janssens PLHR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153134
   Jumpstart Consortium Human Microbiome Project Data Generation Working Group. Evaluation of 16S rDNA-Based Community Profiling for Human Microbiome Research, 2012, PLOS ONE, V7, DOI [10.1371/joumal.pone.0039315, DOI 10.1371/JOUMAL.PONE.0039315]
   Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006
   Kida K, 2000, J AGR FOOD CHEM, V48, P4151, DOI 10.1021/jf000386x
   Konikoff T, 2016, TRENDS MICROBIOL, V24, P523, DOI 10.1016/j.tim.2016.02.015
   Kuczynski J, 2010, NAT METHODS, V7, P813, DOI [10.1038/NMETH.1499, 10.1038/nmeth.1499]
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   LEE MJ, 1995, CANCER EPIDEM BIOMAR, V4, P393
   Leser TD, 2009, ENVIRON MICROBIOL, V11, P2194, DOI 10.1111/j.1462-2920.2009.01941.x
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li DH, 2016, METHODS, V102, P3, DOI 10.1016/j.ymeth.2016.02.020
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Liao ZL, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00042
   Lozupone CA, 2008, FEMS MICROBIOL REV, V32, P557, DOI 10.1111/j.1574-6976.2008.00111.x
   Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06
   Luo HT, 2006, CARCINOGENESIS, V27, P262, DOI 10.1093/carcin/bgi147
   Manach C, 2005, AM J CLIN NUTR, V81, p230S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]
   Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190
   McNulty NP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002701
   Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Nocker A, 2007, MICROB ECOL, V54, P276, DOI 10.1007/s00248-006-9199-5
   Qian GQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048090
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rahnavard G., HIGH SENSITIVI UNPUB
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096
   Scholz-Ahrens K. E., 2016, NFS Journal, V3, P41, DOI 10.1016/j.nfs.2016.03.001
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Shen CL, 2017, J FOOD SCI, V82, P2192, DOI 10.1111/1750-3841.13745
   Shen CL, 2013, AM J CLIN NUTR, V98, p1694S, DOI 10.3945/ajcn.113.058255
   Shen CL, 2012, NUTR RES, V32, P448, DOI 10.1016/j.nutres.2012.05.001
   Sinha R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0841-8
   Sohail MU, 2015, AVIAN PATHOL, V44, P67, DOI 10.1080/03079457.2015.1004622
   Stalmach A, 2010, MOL NUTR FOOD RES, V54, P323, DOI 10.1002/mnfr.200900194
   Tang LL, 2008, CARCINOGENESIS, V29, P411, DOI 10.1093/carcin/bgn008
   Thomas F, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00093
   Tilg H, 2010, J CLIN GASTROENTEROL, V44, pS16, DOI 10.1097/MCG.0b013e3181dd8b64
   Tims S, 2013, ISME J, V7, P707, DOI 10.1038/ismej.2012.146
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Uronis JM, 2011, INFLAMM BOWEL DIS, V17, P289, DOI 10.1002/ibd.21366
   Verdam FJ, 2013, OBESITY, V21, pE607, DOI 10.1002/oby.20466
   Visioli F, 2011, CRIT REV FOOD SCI, V51, P524, DOI 10.1080/10408391003698677
   Wang JC, 2016, TOXICOL SCI, V150, P54, DOI 10.1093/toxsci/kfv259
   Wang JC, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/732302
   Zhang ZG, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101146
NR 73
TC 52
Z9 52
U1 2
U2 63
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0955-2863
EI 1873-4847
J9 J NUTR BIOCHEM
JI J. Nutr. Biochem.
PD JUN
PY 2018
VL 56
BP 55
EP 64
DI 10.1016/j.jnutbio.2018.01.005
PG 10
WC Biochemistry & Molecular Biology; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Nutrition & Dietetics
GA GJ9TL
UT WOS:000435747700006
PM 29454999
OA Green Accepted, Bronze
DA 2022-11-22
ER

PT J
AU Park, JM
   Han, NY
   Han, YM
   Chung, MK
   Lee, HK
   Ko, KH
   Kim, EH
   Hahm, KB
AF Park, Jong-Min
   Han, Na Young
   Han, Young-Min
   Chung, Mi Kyung
   Lee, Hoo Keun
   Ko, Kwang Hyun
   Kim, Eun-Hee
   Hahm, Ki Baik
TI Predictive proteomic biomarkers for inflammatory bowel
   disease-associated cancer: Where are we now in the era of the next
   generation proteomics?
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE Inflammatory bowel disease; Biomarker; Proteomics; Tailored medicine;
   Colitic cancer
ID UDP-GLUCOSE DEHYDROGENASE; COLORECTAL NEOPLASIA RISK; FLIGHT
   MASS-SPECTROMETRY; INTESTINAL INFLAMMATION; NONNEOPLASTIC EPITHELIUM;
   INCREASED EXPRESSION; FECAL LACTOFERRIN; CARCINOGENESIS; IDENTIFICATION;
   MARKERS
AB Recent advances in genomic medicine have opened up the possibility of tailored medicine that may eventually replace traditional "one-size-fits all" approaches to the treatment of inflammatory bowel disease (IBD). In addition to exploring the interactions between hosts and microbes, referred to as the microbiome, a variety of strategies that can be tailored to an individual in the coming era of personalized medicine in the treatment of IBD are being investigated. These include prompt genomic screening of patients at risk of developing IBD, the utility of molecular discrimination of IBD subtypes among patients diagnosed with IBD, and the discovery of proteome biomarkers to diagnose or predict cancer risks. Host genetic factors influence the etiology of IBD, as do microbial ecosystems in the human bowel, which are not uniform, but instead represent many different microhabitats that can be influenced by diet and might affect processes essential to bowel metabolism. Further advances in basic research regarding intestinal inflammation may reveal new insights into the role of inflammatory mediators, referred to as the inflammasome, and the macromolecular complex of metabolites formed by intestinal bacteria. Collectively, knowledge of the inflammasome and metagenomics will lead to the development of biomarkers for IBD that target specific pathogenic mechanisms involved in the spontaneous progress of IBD. In this review article, our recent results regarding the discovery of potential proteomic biomarkers using a label-free quantification technique are introduced and on-going projects contributing to either the discrimination of IBD subtypes or to the prediction of cancer risks are accompanied by updated information from IBD biomarker research. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
C1 [Park, Jong-Min; Han, Young-Min; Chung, Mi Kyung; Kim, Eun-Hee] CHA Univ, CHA Canc Prevent Res Ctr, Seoul 135081, South Korea.
   [Han, Na Young; Lee, Hoo Keun] Gachon Univ, Coll Pharm, Inchon 406799, South Korea.
   [Ko, Kwang Hyun; Hahm, Ki Baik] CHA Univ, Bundang Med Ctr, Ctr Digest Dis, Songnam 463838, South Korea.
C3 Pochon Cha University; Gachon University; Pochon Cha University
RP Hahm, KB (corresponding author), CHA Univ, CHA Canc Prevent Res Ctr, 605 Yeoksam 1 Dong, Seoul 135081, South Korea.
EM hahmkb@cha.ac.kr
OI Lee, Hookeun/0000-0002-0696-8421
FU Ministry of Education and Science Technology, Korea [2010-0002052]; JSPS
   Asian CORE Program, Japan
FX Supported by Grant from the Ministry of Education and Science
   Technology, 2010-0002052, Korea and JSPS Asian CORE Program, Japan
CR Abraham BP, 2012, GASTROENTEROL CLIN N, V41, P483, DOI 10.1016/j.gtc.2012.01.007
   Ahmadi A, 2009, WORLD J GASTROENTERO, V15, P61, DOI 10.3748/wjg.15.61
   Alex P, 2009, INFLAMM BOWEL DIS, V15, P616, DOI 10.1002/ibd.20652
   Alex P, 2009, INFLAMM BOWEL DIS, V15, P341, DOI 10.1002/ibd.20753
   Araki K, 2009, BRIT J CANCER, V101, P492, DOI 10.1038/sj.bjc.6605163
   Brewis IA, 2010, ADV PROTEIN CHEM STR, V80, P1, DOI [10.1016/S1876-1623(10)80001-X, 10.1016/B978-0-12-381264-3.00001-1]
   Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340
   Chooi WH, 2013, MOL BIOTECHNOL, V54, P623, DOI 10.1007/s12033-012-9604-x
   Colliver DW, 2006, EXP MOL PATHOL, V80, P1, DOI 10.1016/j.yexmp.2005.09.008
   Demir IE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060529
   Dyson JK, 2012, WORLD J GASTROENTERO, V18, P3839, DOI 10.3748/wjg.v18.i29.3839
   Egger S, 2010, BIOCHEM SOC T, V38, P1378, DOI 10.1042/BST0381378
   Fan HZ, 2009, J CANCER RES CLIN, V135, P591, DOI 10.1007/s00432-008-0493-0
   Fassan M, 2013, BEST PRACT RES CL GA, V27, P159, DOI 10.1016/j.bpg.2013.03.009
   Feagins LA, 2009, NAT REV GASTRO HEPAT, V6, P297, DOI 10.1038/nrgastro.2009.44
   Fromm-Dornieden C, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-9
   Fujii S, 2005, GUT, V54, P1287, DOI 10.1136/gut.2004.062059
   Fujii S, 2010, DIGESTION, V82, P179, DOI 10.1159/000311064
   Fujiwara I, 2008, DIS COLON RECTUM, V51, P1387, DOI 10.1007/s10350-008-9212-9
   Garrity-Park MM, 2009, GUT, V58, P1226, DOI 10.1136/gut.2008.166686
   Gemoll Timo, 2010, Archives of Physiology and Biochemistry, V116, P188, DOI 10.3109/13813455.2010.495130
   Gerich ME, 2014, NAT REV GASTRO HEPAT, V11, P287, DOI 10.1038/nrgastro.2013.242
   Gisbert Javier P, 2007, Gastroenterol Hepatol, V30, P117, DOI 10.1157/13100073
   Goel GA, 2011, AM J GASTROENTEROL, V106, P719, DOI 10.1038/ajg.2011.51
   Graham DB, 2013, TRENDS IMMUNOL, V34, P371, DOI 10.1016/j.it.2013.04.001
   Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6
   Guo ZH, 2013, J CLIN GASTROENTEROL, V47, P69, DOI 10.1097/MCG.0b013e3182601752
   Gushima M, 2011, HISTOPATHOLOGY, V59, P460, DOI 10.1111/j.1365-2559.2011.03965.x
   Gushima M, 2009, J PATHOL, V219, P77, DOI 10.1002/path.2570
   Hagihara A, 2004, ONCOGENE, V23, P8705, DOI 10.1038/sj.onc.1207783
   Han NY, 2013, J DIGEST DIS, V14, P166, DOI 10.1111/1751-2980.12035
   Han NY, 2012, J DIGEST DIS, V13, P497, DOI 10.1111/j.1751-2980.2012.00625.x
   Hartnett L, 2012, CARCINOGENESIS, V33, P723, DOI 10.1093/carcin/bgs006
   Hashimoto K, 2013, ONCOL LETT, V6, P1271, DOI 10.3892/ol.2013.1528
   Herszenyi L, 2007, DIGEST DIS, V25, P267, DOI 10.1159/000103898
   Hortin GL, 2006, CLIN CHEM, V52, P1223, DOI 10.1373/clinchem.2006.069252
   Hua Z, 2011, SURGERY, V149, P783, DOI 10.1016/j.surg.2010.12.007
   Huang DL, 2010, INT J CANCER, V126, P315, DOI 10.1002/ijc.24820
   Huh JW, 2005, BIOTECHNOL LETT, V27, P1229, DOI 10.1007/s10529-005-0022-z
   Iskandar HN, 2012, TRANSL RES, V159, P313, DOI 10.1016/j.trsl.2012.01.001
   Itzkowitz SH, 2004, AM J PHYSIOL-GASTR L, V287, pG7, DOI 10.1152/ajpgi.00079.2004
   Jawad N, 2011, RECENT RESULTS CANC, V185, P99, DOI 10.1007/978-3-642-03503-6_6
   Kilanczyk E, 2012, CELL CALCIUM, V51, P470, DOI 10.1016/j.ceca.2012.04.005
   Kim YJ, 2010, CANCER PREV RES, V3, P1314, DOI 10.1158/1940-6207.CAPR-09-0272
   Kim YJ, 2010, CANCER PREV RES, V3, P963, DOI 10.1158/1940-6207.CAPR-10-0033
   Ko KH, 2013, CLIN ENDOSC, V46, P611, DOI 10.5946/ce.2013.46.6.611
   Kraus S, 2009, CURR OPIN PHARMACOL, V9, P405, DOI 10.1016/j.coph.2009.06.006
   Langhorst J, 2012, DRUG TODAY, V48, P149, DOI 10.1358/dot.2012.48.2.1732555
   Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x
   Lewis JD, 2011, GASTROENTEROLOGY, V140, P1817, DOI 10.1053/j.gastro.2010.11.058
   Li ZQ, 2014, J MOL MED, V92, P291, DOI 10.1007/s00109-013-1104-3
   Liu XP, 2006, CANCER INVEST, V24, P747, DOI 10.1080/07357900601063873
   Maier SK, 2013, MOL CELL PROTEOMICS, V12, P2901, DOI 10.1074/mcp.M113.027599
   Mangerich A, 2013, FREE RADICAL RES, V47, P958, DOI 10.3109/10715762.2013.832239
   Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152
   Marvin LF, 2003, CLIN CHIM ACTA, V337, P11, DOI 10.1016/j.cccn.2003.08.008
   McKiernan E, 2011, TUMOR BIOL, V32, P441, DOI 10.1007/s13277-010-0137-2
   Mendoza JL, 2009, GASTROEN CLIN BIOL, V33, pS158, DOI 10.1016/S0399-8320(09)73151-3
   Meyer TE, 2012, PROSTATE, V72, P65, DOI 10.1002/pros.21407
   Nanni P, 2007, RAPID COMMUN MASS SP, V21, P4142, DOI 10.1002/rcm.3323
   Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001
   Nowotny M, 2000, J BIOL CHEM, V275, P31178, DOI 10.1074/jbc.M001622200
   Ock CY, 2012, WORLD J GASTROENTERO, V18, P302, DOI 10.3748/wjg.v18.i4.302
   Papp M, 2007, WORLD J GASTROENTERO, V13, P2028, DOI 10.3748/wjg.v13.i14.2028
   Rubin DT, 2007, GASTROINTEST ENDOSC, V66, P108, DOI 10.1016/j.gie.2006.12.056
   Rubin DC, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00107
   Saigusa S, 2013, J CLIN GASTROENTEROL, V47, pE80, DOI 10.1097/MCG.0b013e31828f51e1
   Schwamborn K, 2010, NAT REV CANCER, V10, P639, DOI 10.1038/nrc2917
   Strober W, 2007, J CLIN INVEST, V117, P514, DOI 10.1172/JCI30587
   Tamai H, 2011, Blood Cancer J, V1, pe38, DOI 10.1038/bcj.2011.37
   Tatsurni N, 2006, VIRCHOWS ARCH, V448, P756, DOI 10.1007/s00428-006-0188-3
   Thorsteinsdottir S, 2011, NAT REV GASTRO HEPAT, V8, P395, DOI 10.1038/nrgastro.2011.96
   Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057
   Vaiopoulou A, 2012, DIGEST DIS SCI, V57, P2755, DOI 10.1007/s10620-012-2291-4
   Viennot S, 2009, GASTROEN CLIN BIOL, V33, pS190, DOI 10.1016/S0399-8320(09)73154-9
   Vucelic B, 2009, DIGEST DIS, V27, P269, DOI 10.1159/000228560
   Walkiewicz D, 2008, INFLAMM BOWEL DIS, V14, P669, DOI 10.1002/ibd.20376
   Wang TP, 2010, EXP CELL RES, V316, P2893, DOI 10.1016/j.yexcr.2010.07.017
   Watanabe T, 2011, CLIN COLORECTAL CANC, V10, P134, DOI 10.1016/j.clcc.2011.03.011
   Wei Q, 2009, CANCER RES, V69, P2332, DOI 10.1158/0008-5472.CAN-08-3083
   Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005
   Yeo M, 2006, PROTEOMICS, V6, P1158, DOI 10.1002/pmic.200500390
   Yoo SH, 2008, GUT LIVER, V2, P113, DOI 10.5009/gnl.2008.2.2.113
NR 83
TC 5
Z9 5
U1 1
U2 16
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD OCT 7
PY 2014
VL 20
IS 37
BP 13466
EP 13476
DI 10.3748/wjg.v20.i37.13466
PG 11
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA AR9GN
UT WOS:000343881200021
PM 25309077
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Chang, HB
   Mishra, R
   Cen, CP
   Tang, YQ
   Ma, CC
   Wasti, S
   Wang, YY
   Ou, QY
   Chen, KN
   Zhang, JC
AF Chang, Haibo
   Mishra, Rajeev
   Cen, Chaoping
   Tang, Yunqing
   Ma, Chenchen
   Wasti, Sanjeev
   Wang, Yuanyuan
   Ou, Qianying
   Chen, Kaining
   Zhang, Jiachao
TI Metagenomic Analyses Expand Bacterial and Functional Profiling
   Biomarkers for Colorectal Cancer in a Hainan Cohort, China
SO CURRENT MICROBIOLOGY
LA English
DT Article
ID FUSOBACTERIUM-NUCLEATUM; MICROBIOTA; ASSOCIATION; METABOLITES; GENE
AB This study was conducted for the metagenomic analysis of stool samples from CRC affected individuals to identify biomarkers for CRC in Hainan, the only tropical island province of China. The gut microbiota of CRC patients differed significantly from that of healthy and reference database cohorts based on Aitchison distance and Bray-Cutis distance but there was no significant difference in alpha diversity. Furthermore, at the species level, 68 species were significantly altered including 37 CRC-enriched, such as, Fusobacterium nucleatum, Parvimonas micra, Gemella morbillorum, Citrobacter portucalensis, Alloprevotella sp., Shigella sonnei, Coriobacteriaceae bacterium, etc. Sixty-seven different metabolic pathways were acquired, and pathways involved in the synthesis of many amino acids were significantly declined. Besides, 2 identified antibiotic resistance genes performed well (area under the receive-operation curve AUC = 0.833, 95% CI 58.51-100%) compared with virulence factor genes. The results of the present study provide region-specific bacterial and functional biomarkers of gut microbiota for CRC patients in Hainan. Microbiota is considered as a non-invasive biomarker for the detection of CRC. Gut microbiota of different geographic regions should be further studied to expand the understanding of markers, especially for the China cohort due to diverse nationalities and lifestyles.
C1 [Chang, Haibo; Ma, Chenchen; Wang, Yuanyuan; Zhang, Jiachao] Hainan Univ, Coll Food Sci & Engn, Haikou 570228, Hainan, Peoples R China.
   [Tang, Yunqing] Haikou Peoples Hosp, Haikou 570228, Hainan, Peoples R China.
   [Mishra, Rajeev; Wasti, Sanjeev] Univ Hawaii Manoa, Coll Trop Agr & Human Resources, Dept Human Nutr Food & Anim Sci, Honolulu, HI 96822 USA.
   [Cen, Chaoping; Ou, Qianying; Chen, Kaining] Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Haikou 570228, Hainan, Peoples R China.
C3 Hainan University; University of Hawaii System; University of Hawaii
   Manoa; Hainan Medical University
RP Zhang, JC (corresponding author), Hainan Univ, Coll Food Sci & Engn, Haikou 570228, Hainan, Peoples R China.; Chen, KN (corresponding author), Hainan Med Univ, Hainan Affiliated Hosp, Hainan Gen Hosp, Haikou 570228, Hainan, Peoples R China.
EM kainch@sina.com; zhjch321123@163.com
RI Wang, Yu/GZL-9655-2022; Wasti, Sanjeev/AAY-3787-2021
OI Wasti, Sanjeev/0000-0003-0393-6229; Mishra, rajeev/0000-0003-1404-3477;
   Zhang, Jiachao/0000-0001-8099-6749
FU Key R&D programs in Hainan [ZDYF2019150]; Scientific Research Foundation
   of Hainan University [KYQD1548]
FX This work was supported by Key R&D programs in Hainan (Grant No.
   ZDYF2019150), the Scientific Research Foundation of Hainan University
   (Grant No. KYQD1548).
CR Boleij A, 2015, CLIN INFECT DIS, V60, P208, DOI 10.1093/cid/ciu787
   Butt J, 2016, INT J CANCER, V138, P1670, DOI 10.1002/ijc.29914
   Dai ZW, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0451-2
   Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1
   Duan YJ, 2020, SCI TOTAL ENVIRON, V705, DOI 10.1016/j.scitotenv.2019.135674
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Hasan MS, 2019, J GLOB ANTIMICROB RE, V18, P126, DOI 10.1016/j.jgar.2019.05.031
   Igbinosa EO, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00123-18
   Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004
   Kashani N, 2020, NEW MICROB NEW INFEC, V34, DOI 10.1016/j.nmni.2020.100651
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kwong TNY, 2018, GASTROENTEROLOGY, V155, P383, DOI 10.1053/j.gastro.2018.04.028
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002
   Liang QY, 2017, CLIN CANCER RES, V23, P2061, DOI 10.1158/1078-0432.CCR-16-1599
   Liu B, 2019, NUCLEIC ACIDS RES, V47, pD687, DOI 10.1093/nar/gky1080
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lu J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.104
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Martin-Fernandez JA, 2015, STAT MODEL, V15, DOI 10.1177/1471082X14535524
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Mizutani S, 2020, CANCER SCI, V111, P766, DOI 10.1111/cas.14298
   Murphy N, 2019, MOL ASPECTS MED, V69, P2, DOI 10.1016/j.mam.2019.06.005
   Nosho K, 2016, WORLD J GASTROENTERO, V22, P557, DOI 10.3748/wjg.v22.i2.557
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Pleguezuelos-Manzano C, 2020, NATURE, V580, P269, DOI 10.1038/s41586-020-2080-8
   Queen J, 2020, GUT MICROBES, V11, DOI 10.1080/19490976.2019.1706425
   Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177
   Selgrad M, 2008, J CELL PHYSIOL, V216, P378, DOI 10.1002/jcp.21427
   Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186
   Song MY, 2020, GASTROENTEROLOGY, V158, P322, DOI 10.1053/j.gastro.2019.06.048
   Stary L, 2017, BIOMED PAP, V161, P333, DOI 10.5507/bp.2017.051
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46
   Xie YH, 2017, EBIOMEDICINE, V25, P32, DOI 10.1016/j.ebiom.2017.10.005
   Yang J, 2020, GUT MICROBES, V11, P918, DOI 10.1080/19490976.2020.1712986
   Zapala MA, 2006, P NATL ACAD SCI USA, V103, P19430, DOI 10.1073/pnas.0609333103
   Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11
NR 41
TC 6
Z9 6
U1 4
U2 15
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0343-8651
EI 1432-0991
J9 CURR MICROBIOL
JI Curr. Microbiol.
PD FEB
PY 2021
VL 78
IS 2
BP 705
EP 712
DI 10.1007/s00284-020-02299-3
EA JAN 2021
PG 8
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA QD2EX
UT WOS:000605905300002
PM 33410957
DA 2022-11-22
ER

PT J
AU Fan, L
   Zhu, XZ
   Sun, S
   Yu, C
   Huang, X
   Ness, R
   Dugan, LL
   Shu, LH
   Seidner, DL
   Murff, HJ
   Fodor, AA
   Azcarate-Peril, MA
   Shrubsole, MJ
   Dai, Q
AF Fan, Lei
   Zhu, Xiangzhu
   Sun, Shan
   Yu, Chang
   Huang, Xiang
   Ness, Reid
   Dugan, Laura L.
   Shu, Lihua
   Seidner, Douglas L.
   Murff, Harvey J.
   Fodor, Anthony A.
   Azcarate-Peril, M. Andrea
   Shrubsole, Martha J.
   Dai, Qi
TI Ca:Mg ratio, medium-chain fatty acids, and the gut microbiome
SO CLINICAL NUTRITION
LA English
DT Article
DE Ca:Mg intake ratio; Medium-chain fatty acids; Sucrose consumption;
   Microbial alpha diversity; Ketone body; Randomized controlled trial
ID ESCHERICHIA-COLI; URINARY SUCROSE; KETOGENIC DIET; HEXANOIC ACID;
   MAGNESIUM; FRUCTOSE; CALCIUM; METABOLISM; RISK; FERMENTATION
AB Background & aims: Ketogenic medium-chain fatty acids (MCFAs) with profound health benefits are commonly found in dairy products, palm kernel oil and coconut oil. We hypothesize that magnesium (Mg) supplementation leads to enhanced gut microbial production of MCFAs and, in turn, increased circulating MCFAs levels. Methods: We tested this hypothesis in the Personalized Prevention of Colorectal Cancer Trial (PPCCT) (NCT01105169), a double-blind 2 X 2 factorial randomized controlled trial enrolling 240 participants. Six 24-h dietary recalls were performed for all participants at the baseline and during the intervention period. Based on the baseline 24-h dietary recalls, the Mg treatment used a personalized dose of Mg supplementation that would reduce the calcium (Ca): Mg intake ratio to around 2.3. We measured plasma MCFAs, sugars, ketone bodies and tricarboxylic acid cycle (TCA cycle) metabolites using the Metabolon's global Precision Metabolomics (TM) LC-MS platform. Whole-genome shotgun metagenomics (WGS) sequencing was performed to assess microbiota in stool samples, rectal swabs, and rectal biopsies. Results: Personalized Mg treatment (mean dose 205.58 mg/day with a range from 77.25 to 389.55 mg/ day) significantly increased the plasma levels of C7:0, C8:0, and combined C7:0 and C8:0 by 18.45%, 25.28%, and 24.20%, respectively, compared to 14.15%, 10.12%, and 12.62% decreases in the placebo arm. The effects remain significant after adjusting for age, sex, race and baseline level (P = 0.0126, P = 0.0162, and P = 0.0031, respectively) and FDR correction at 0.05 (q = 0.0324 for both C7:0 and C8:0). Mg treatment significantly reduced the plasma level of sucrose compared to the placebo arm (P = 0.0036 for multivariable-adjusted and P = 0.0216 for additional FDR correction model) whereas alterations in daily intakes of sucrose, fructose, glucose, maltose and C8:0 from baseline to the end of trial did not differ between two arms. Mediation analysis showed that combined C7:0 and C8:0 partially mediated the effects of Mg treatment on total and individual ketone bodies (P for indirect effect = 0.0045, 0.0043, and 0.03, respectively). The changes in plasma levels of C7:0 and C8:0 were significantly and positively correlated with the alterations in stool microbiome a diversity (r = 0.51, p = 0.0023 and r = 0.34, p = 0.0497, respectively) as well as in stool abundance for the signatures of MCFAs-related microbiota with acyl-ACP thioesterase gene producing C7:0 (r = 0.46, p = 0.0067) and C8:0 (r = 0.49, p = 0.003), respectively, following Mg treatment. Conclusions: Optimizing Ca:Mg intake ratios to around 2.3 through 12-week personalized Mg supplementation leads to increased circulating levels of MCFAs (i.e. C7:0 and C8:0), which is attributed to enhanced production from gut microbial fermentation and, maybe, sucrose consumption. (c) 2022 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.
C1 [Fan, Lei; Zhu, Xiangzhu; Huang, Xiang; Shrubsole, Martha J.; Dai, Qi] Vanderbilt Univ, Dept Med, Div Epidemiol, Vanderbilt Ingram Canc Ctr,Sch Med,Med Ctr, Nashville, TN USA.
   [Sun, Shan; Fodor, Anthony A.] Univ North Carolina Charlotte, Dept Bioinformat & Gen, Charlotte, NC USA.
   [Yu, Chang] Vanderbilt Univ, Sch Med, Dept Biostat, Nashville, TN USA.
   [Ness, Reid] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol, Nashville, TN USA.
   [Dugan, Laura L.; Murff, Harvey J.] Vanderbilt Univ, Vet Hlth Adm Valley Healthcare Syst, Geriatr Res Educ Clin Ctr GRECC, HSR&D Ctr,Med Ctr, Nashville, TN USA.
   [Dugan, Laura L.] Vanderbilt Univ, Vanderbilt Brain Inst, Nashville, TN USA.
   [Dugan, Laura L.; Murff, Harvey J.] Vanderbilt Univ, Div Geriatr Med, Dept Med, Med Ctr, Nashville, TN USA.
   [Shu, Lihua] Vanderbilt Univ, Sch Med, Nashville, TN USA.
   [Seidner, Douglas L.] Cleveland Clin, Ctr Human Nutr, Dept Gastroenterol Hepatol & Nutr, Digest Dis & Surg Inst, Cleveland, OH USA.
   [Azcarate-Peril, M. Andrea] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA.
   [Azcarate-Peril, M. Andrea] Univ N Carolina, UNC Microbiome Core, Ctr Gastrointestinal Biol & Dis, Sch Med, Chapel Hill, NC USA.
C3 Vanderbilt University; University of North Carolina; University of North
   Carolina Charlotte; Vanderbilt University; Vanderbilt University;
   Geriatric Research Education & Clinical Center; US Department of
   Veterans Affairs; Veterans Health Administration (VHA); Vanderbilt
   University; Vanderbilt University; Vanderbilt University; Vanderbilt
   University; Cleveland Clinic Foundation; University of North Carolina;
   University of North Carolina Chapel Hill; University of North Carolina;
   University of North Carolina Chapel Hill; University of North Carolina
   School of Medicine
RP Dai, Q (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, 2525 West End Ave,Suite 800, Nashville, TN 37203 USA.
EM qi.dai@vanderbilt.edu
OI Huang, Xiang/0000-0003-0180-103X; ness, reid/0000-0002-1645-7393
FU National Cancer Institute, Department of Health and Human Services [R01
   CA149633, R01 CA202936, R01 DK110166]; Ingram Cancer Center Endowment
   Fund; NCRR/NIH [UL1 RR024975]; Vanderbilt Institute for Clinical and
   Translational Research [UL1TR000445]; Center for Gastrointestinal
   Biology and Disease [CGIBD P30 DK034987]; UNC Nutrition Obesity Research
   Center [NORC P30 DK056350];  [P30CA68485]
FX Part of the study was supported by R01 CA149633, R01 CA202936 and R01
   DK110166 from the National Cancer Institute, Department of Health and
   Human Services as well as the Ingram Cancer Center Endowment Fund. Data
   collection, sample storage and processing for this study were partially
   conducted by the Survey and Biospecimen Shared Resource, which is
   supported in part by P30CA68485. Clinical visits to the Vanderbilt
   Clinical Research Center were supported in part by the Vanderbilt CTSA
   grant UL1 RR024975 from NCRR/NIH. The parent study data were stored in
   Research Electronic Data Capture (REDCap) and data analyses (VR12960)
   were supported in part by the Vanderbilt Institute for Clinical and
   Translational Research (UL1TR000445). The UNC Microbiome Core is funded
   in part by the Center for Gastrointestinal Biology and Disease (CGIBD
   P30 DK034987) and the UNC Nutrition Obesity Research Center (NORC P30
   DK056350). The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health.
CR Abdelwahab MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036197
   Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020
   Augustin K, 2018, LANCET NEUROL, V17, P84, DOI 10.1016/S1474-4422(17)30408-8
   Barker HA, 1942, J BACTERIOL, V43, P347, DOI 10.1128/JB.43.3.347-363.1942
   Beld J, 2014, J APPL PHYCOL, V26, P1619, DOI 10.1007/s10811-013-0203-4
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Cantu DC, 2010, PROTEIN SCI, V19, P1281, DOI 10.1002/pro.417
   Chatterjee P, 2020, MECH AGEING DEV, V186, DOI 10.1016/j.mad.2020.111209
   Chiuve SE, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000114
   Choi K, 2013, APPL BIOCHEM BIOTECH, V171, P1094, DOI 10.1007/s12010-013-0310-3
   Crowley EK, 2018, MAR DRUGS, V16, DOI 10.3390/md16060216
   Dai Q, 2013, BMJ OPEN, V3, DOI [10.1136/bmjopen-2012-002111corr1, 10.1136/bmjopen-2012-002111]
   Dai Q, 2007, AM J CLIN NUTR, V86, P743, DOI 10.1093/ajcn/86.3.743
   Dai Q, 2018, AM J CLIN NUTR, V108, P1249, DOI 10.1093/ajcn/nqy274
   Dai Q, 2016, BRIT J NUTR, V115, P342, DOI 10.1017/S0007114515004444
   Dai Q, 2012, EPIDEMIOLOGY, V23, P504, DOI 10.1097/EDE.0b013e31824deb09
   Dong JY, 2011, DIABETES CARE, V34, P2116, DOI 10.2337/dc11-0518
   Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554
   Fan L, 2021, CLIN NUTR ESPEN, V41, P436, DOI 10.1016/j.clnesp.2020.12.011
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Geng SS, 2016, EUR J NUTR, V55, P931, DOI 10.1007/s00394-015-0907-0
   Goncalves MD, 2019, SCIENCE, V363, P1345, DOI 10.1126/science.aat8515
   Guyenet S, SUGAR CONSUMPTION US
   Holdeman LV, 1977, ANAEROBE LAB MANUAL, V4th
   Jackman JA, 2020, J ANIM SCI BIOTECHNO, V11, DOI 10.1186/s40104-020-00446-1
   Jang C, 2018, CELL METAB, V27, P351, DOI 10.1016/j.cmet.2017.12.016
   Jang YS, 2013, APPL MICROBIOL BIOT, V97, P9355, DOI 10.1007/s00253-013-5161-x
   Jansen N, 2016, ONCOL LETT, V11, P584, DOI 10.3892/ol.2015.3923
   Jegatheesan P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030230
   Jenkins B, 2015, MOLECULES, V20, P2425, DOI 10.3390/molecules20022425
   Jenkins BJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44845
   Jeon BS, 2010, APPL MICROBIOL BIOT, V88, P1161, DOI 10.1007/s00253-010-2827-5
   Jiang L, 2010, APPL BIOCHEM BIOTECH, V160, P350, DOI 10.1007/s12010-008-8305-1
   Johnson RJ, 2017, ADV NUTR, V8, P412, DOI 10.3945/an.116.014654
   Jones RB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22408-4
   Joosen AMCP, 2008, INT J OBESITY, V32, P1736, DOI 10.1038/ijo.2008.145
   Khan TA, 2016, EUR J NUTR, V55, pS25, DOI 10.1007/s00394-016-1345-3
   Kieboom BCT, 2017, NEUROLOGY, V89, P1716, DOI 10.1212/WNL.0000000000004517
   Lennen RM, 2010, BIOTECHNOL BIOENG, V106, P193, DOI 10.1002/bit.22660
   Levy RG, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001903.pub2, 10.1002/14651858.CD001903.pub3]
   Li WS, 2018, PUBLIC HEALTH NUTR, V21, P2088, DOI 10.1017/S1368980018000642
   LIBERTINI LJ, 1978, J BIOL CHEM, V253, P1393
   MacKinnon DP., 2012, INTRO STAT MEDIATION
   Marten B, 2006, INT DAIRY J, V16, P1374, DOI 10.1016/j.idairyj.2006.06.015
   Mumme K, 2015, J ACAD NUTR DIET, V115, P249, DOI 10.1016/j.jand.2014.10.022
   Ozawa M, 2012, J AM GERIATR SOC, V60, P1515, DOI 10.1111/j.1532-5415.2012.04061.x
   Pachikian BD, 2010, J NUTR, V140, P509, DOI 10.3945/jn.109.117374
   Park YK, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1154-4
   Pase MP, 2017, ALZHEIMERS DEMENT, V13, P955, DOI 10.1016/j.jalz.2017.01.024
   Restrepo S, 2019, AM J ENOL VITICULT, V70, P169, DOI 10.5344/ajev.2018.18030
   Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629
   Sherkhanov S, 2014, METAB ENG, V25, P1, DOI 10.1016/j.ymben.2014.06.003
   Sneed NM, 2022, CURR DEV NUTR, V6, P778
   Sonnenburg JL, 2004, NAT IMMUNOL, V5, P569, DOI 10.1038/ni1079
   St-Pierre V, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00046
   Sun S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-94205-5
   Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009
   Tasevska N, 2021, AM J CLIN NUTR, V114, P721, DOI 10.1093/ajcn/nqab158
   Taylor MK, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081910
   Te Morenga L, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.637267
   Townsend GE, 2019, P NATL ACAD SCI USA, V116, P233, DOI 10.1073/pnas.1813780115
   Udeh HO, 2014, INT J BIOL BIOMOL AG, V8, P1208, DOI [10.5281/zenodo.1096815, DOI 10.5281/ZENODO.1096815]
   VIEGAS CA, 1989, APPL ENVIRON MICROB, V55, P21, DOI 10.1128/AEM.55.1.21-28.1989
   Volker AR, 2014, MICROBIOL-SGM, V160, P1513, DOI 10.1099/mic.0.078329-0
   WALKER GM, 1990, FERMENTATION TECHNOLOGIES : INDUSTRIAL APPLICATIONS, P233
   Walker GM, 2004, ADV APPL MICROBIOL, V54, P197, DOI 10.1016/S0065-2164(04)54008-X
   Walker GM, 1996, J AM SOC BREW CHEM, V54, P13
   Wang BG, 2016, J FOOD SCI, V81, pH794, DOI 10.1111/1750-3841.13210
   Wood DE, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1891-0
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Wu LJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18076-5
   Ye F, 2015, J CLIN NEUROL, V11, P26, DOI 10.3988/jcn.2015.11.1.26
   Yin H, 2019, J AGR FOOD CHEM, V67, P5607, DOI 10.1021/acs.jafc.9b00128
   YOUSEFI-MASHOUF R, 1992, Microbial Ecology in Health and Disease, V5, P31
   Zhu XZ, 2020, J ALZHEIMERS DIS, V75, P85, DOI 10.3233/JAD-191223
NR 75
TC 0
Z9 0
U1 0
U2 0
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 0261-5614
EI 1532-1983
J9 CLIN NUTR
JI Clin. Nutr.
PD NOV
PY 2022
VL 41
IS 11
BP 2490
EP 2499
DI 10.1016/j.clnu.2022.08.031
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA 6F5NT
UT WOS:000884108000007
PM 36223712
DA 2022-11-22
ER

PT J
AU Rosenstiel, P
AF Rosenstiel, P.
TI Molecular diagnostic workup of the gutmicrobiome. Insight into our other
   genome
SO GASTROENTEROLOGE
LA German
DT Article
DE Microbiome; Internalmedicine; Inflammatory bowel disease;
   Microbiological techniques; Metagenomics
ID FECAL MICROBIOTA TRANSPLANTATION; HUMAN GUT MICROBIOME;
   INFLAMMATORY-BOWEL-DISEASE; DUAL RNA-SEQ; ULCERATIVE-COLITIS;
   MASS-SPECTROMETRY; CELL-CULTURE; AMINO-ACIDS; DIVERSITY; PATHOGEN
AB Recent advances in high-throughput sequencing enabled a novel view at the gut microbiome and its diverse functions for normal human physiology. While the composition of the intestinal microbiota is highly variable between individuals, distinct organizational principles (e.g. enterogradients, core gut microbiome) have been identified. It has thus been suggested that the gut microbiome can be understood as an additional organ system with genetic information content 100-times higher than the genome size of its human host. It is perceived that disturbed host-microbial interactions and related inflammatory signaling play important roles in the etiology of a number of human diseases including metabolic disorders (e.g. obesity, types 1 and 2 diabetes, non-alcoholic fatty liver disease), chronic inflammatory disorders (e. g. inflammatory bowel diseases, psoriasis), but also in certain forms of cancer affecting the gastrointestinal tract (e. g. colonic or hepatocellular cancer). In this review we will thus critically describe methods which have been developed to exploit the diagnostic potential of the gut microbiota. As a perspective, we will discuss the therapeutic potential of targeted bacteriotherapy/ecobiotics for selected fields of internalmedicine.
C1 [Rosenstiel, P.] Christian Albrechts Univ Kiel, Inst Klin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany.
C3 University of Kiel
RP Rosenstiel, P (corresponding author), Christian Albrechts Univ Kiel, Inst Klin Mol Biol, Rosalind Franklin Str 12, D-24105 Kiel, Germany.
EM p.rosenstiel@mucosa.de
RI Rosenstiel, Philip/A-5137-2009
OI Rosenstiel, Philip/0000-0002-9692-8828
CR Adolph TE, 2013, NATURE, V503, P272, DOI 10.1038/nature12599
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517
   Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725
   Borody TJ, 2012, NAT REV GASTRO HEPAT, V9, P88, DOI 10.1038/nrgastro.2011.244
   Cario E, 2006, J IMMUNOL, V176, P4258, DOI 10.4049/jimmunol.176.7.4258
   Collins DA, 2015, PATHOLOGY, V47, P211, DOI 10.1097/PAT.0000000000000238
   Colman RJ, 2014, J CROHNS COLITIS, V8, P1569, DOI 10.1016/j.crohns.2014.08.006
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236
   Desmet S, 2016, J CLIN MICROBIOL, V54, P2513, DOI 10.1128/JCM.01066-16
   Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107
   Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280
   Dierkes C, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-126
   Dominguez-Bello MG, 2016, NAT MED, V22, P250, DOI 10.1038/nm.4039
   EISEMAN B, 1958, SURGERY, V44, P854
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Gevers D, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002779
   Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550
   Glass Elizabeth M, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5368
   Greenblum S, 2012, P NATL ACAD SCI USA, V109, P594, DOI 10.1073/pnas.1116053109
   Haas CT, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0583-9
   Hasler R, 2017, GUT, V66, P2087, DOI 10.1136/gutjnl-2016-311651
   Hagel S, 2016, DTSCH ARZTEBL INT, V113, P583, DOI 10.3238/arztebl.2016.0583
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Hashimoto T, 2012, NATURE, V487, P477, DOI 10.1038/nature11228
   Hildebrand F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r4
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Johansson MEV, 2011, SCIENCE, V334, P182, DOI 10.1126/science.1213909
   Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107
   Jordana-Lluch E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140865
   Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225
   Kelly CR, 2016, ANN INTERN MED, V165, P609, DOI 10.7326/M16-0271
   Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009
   Lax S, 2014, SCIENCE, V345, P1048, DOI 10.1126/science.1254529
   Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Lindner C, 2015, NAT IMMUNOL, V16, P880, DOI 10.1038/ni.3213
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Maccaferri S, 2011, DIGEST DIS, V29, P525, DOI 10.1159/000332966
   Marotz C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.169, 10.1038/nmicrobiol.2016.169]
   Maurer JJ, 2011, ANNU REV FOOD SCI T, V2, P259, DOI 10.1146/annurev.food.080708.100730
   McLoughlin KS, 2011, BRIEF FUNCT GENOMICS, V10, P342, DOI 10.1093/bfgp/elr027
   Metzgar D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158186
   Millar BC, 2007, CURR ISSUES MOL BIOL, V9, P21
   Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001
   Moore AM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00188
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Ott SJ, 2004, GUT, V53, P685, DOI 10.1136/gut.2003.025403
   Ott SJ, 2004, J CLIN MICROBIOL, V42, P2566, DOI 10.1128/JCM.42.6.2566-2572.2004
   Ott SJ, 2008, J CLIN MICROBIOL, V46, P3510, DOI 10.1128/JCM.01512-08
   Ott SJ, 2017, GASTROENTEROLOGY, V152, P799, DOI 10.1053/j.gastro.2016.11.010
   Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940
   Prokhorova TA, 2009, MOL CELL PROTEOMICS, V8, P959, DOI 10.1074/mcp.M800287-MCP200
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341
   Relman DA, 2012, NUTR REV, V70, pS2, DOI 10.1111/j.1753-4887.2012.00489.x
   Rescigno Maria, 2009, F1000 Biol Rep, V1, P9, DOI 10.3410/B1-9
   Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000
   Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607
   Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058
   Sokol H, 2006, INFLAMM BOWEL DIS, V12, P106, DOI 10.1097/01.MIB.0000200323.38139.c6
   Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974
   Stralin K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159694
   Su GM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127195
   Swiatczak B, 2012, SEMIN IMMUNOL, V24, P43, DOI 10.1016/j.smim.2011.11.004
   Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294
   Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037
   Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108
   Wang J, 2014, P NATL ACAD SCI USA, V111, pE2703, DOI 10.1073/pnas.1402342111
   Wang WW, 2015, INFLAMM BOWEL DIS, V21, P1419, DOI 10.1097/MIB.0000000000000344
   Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547
   Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852
   Whittaker RW, 1991, J BIOGEOGR, V28, P453
   WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987
   Wolk DM, 2012, J MOL DIAGN, V14, P295, DOI 10.1016/j.jmoldx.2012.02.005
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang HW, 2015, CLIN LAB MED, V35, P461, DOI 10.1016/j.cll.2015.02.006
NR 89
TC 0
Z9 0
U1 0
U2 7
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1861-9681
EI 1861-969X
J9 GASTROENTEROLOGE
JI Gastroenterologe
PD FEB
PY 2017
VL 12
IS 1
BP 49
EP +
DI 10.1007/s11377-016-0129-x
PG 11
WC Gastroenterology & Hepatology
WE Emerging Sources Citation Index (ESCI)
SC Gastroenterology & Hepatology
GA FM6IB
UT WOS:000415152900007
DA 2022-11-22
ER

PT J
AU Ferguson, LR
   Laing, B
   Marlow, G
   Bishop, K
AF Ferguson, Lynnette R.
   Laing, Bobbi
   Marlow, Gareth
   Bishop, Karen
TI The role of vitamin D in reducing gastrointestinal disease risk and
   assessment of individual dietary intake needs: Focus on genetic and
   genomic technologies
SO MOLECULAR NUTRITION & FOOD RESEARCH
LA English
DT Review
ID CIRCULATING 25-HYDROXYVITAMIN D; INFLAMMATORY-BOWEL-DISEASE; ALL-CAUSE
   MORTALITY; COLORECTAL-CANCER; D-RECEPTOR; ULCERATIVE-COLITIS; GUT
   MICROBIOTA; NEW-ZEALAND; D LEVEL; HEALTH
AB With the endogenous formation of vitamin D being significantly curtailed because of public awareness of skin cancer dangers, attention is turning to dietary sources. Cumulative evidence has implicated vitamin D deficiency in increasing susceptibility to various gastrointestinal disorders, including colorectal cancer, inflammatory bowel diseases, diverticulitis, and irritable bowel syndrome. There is also reason to suggest adjunct vitamin D therapy for such diseases. Although there is justification for increasing vitamin D intake overall, optimal intakes will vary among individuals. Genomic technologies have revealed several hundreds of genes associated with vitamin D actions. The nature of these genes emphasizes the potentially negative implications of modulating vitamin D intakes in the absence of complementary human genetic and genomic data, including information on the gut microbiome. However, we are not yet in a position to apply this information. Genomic data (transcriptomics, metabolomics, proteomics, and metagenomics) could provide evidence that vitamin D sufficiency has been achieved. We suggest that there is an increasingly strong case for considering the more widespread use of vitamin D fortified foods and/or dietary supplements to benefit gastrointestinal health. However, intake levelsmight beneficially be informed by personalized genetic and genomic information, for optimal disease prevention and maintenance of remission.
C1 [Ferguson, Lynnette R.; Bishop, Karen] Univ Auckland, Auckland Canc Soc Res Ctr, FMHS, Auckland 1, New Zealand.
   [Ferguson, Lynnette R.; Laing, Bobbi; Marlow, Gareth] Univ Auckland, Discipline Nutr & Dietet, FMHS, Auckland 1, New Zealand.
C3 University of Auckland; University of Auckland
RP Ferguson, LR (corresponding author), Univ Auckland, Auckland Canc Soc Res Ctr, FMHS, Auckland 1, New Zealand.
EM l.ferguson@auckland.ac.nz
RI Bishop, Karen/G-7073-2015
OI Bishop, Karen/0000-0003-4935-7708; Marlow, Gareth/0000-0002-7608-9086;
   Laing, Bobbi Brennan/0000-0003-3064-1717
FU Auckland Division, Cancer Society of New Zealand; Ministry of Business,
   Innovation and employment, as part of the Nutrigenomics New Zealand
   consortium; Valrae Collins PhD Fellowship
FX Prof Lynnette Ferguson and Dr Karen Bishop acknowledge financial support
   from the Auckland Division, Cancer Society of New Zealand. Funding for
   Dr Gareth Marlow was from the Ministry of Business, Innovation and
   employment, as part of the Nutrigenomics New Zealand consortium. Ms
   Bobbi Laing is funded through the Valrae Collins PhD Fellowship.
CR Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164
   Al-Daghri NM, 2014, BIOANALYSIS, V6, P721, DOI 10.4155/bio.14.5
   Ames BN, 2007, AM J CLIN NUTR, V86, P522, DOI 10.1093/ajcn/86.2.522
   Ananthakrishnan AN, 2014, CLIN GASTROENTEROL H, V12, P821, DOI 10.1016/j.cgh.2013.10.011
   [Anonymous], NUTR REF VAL AUSTR N
   Baghurst K., 2002, REANALYSIS 1995 NAT
   Basson A, 2014, JPEN-PARENTER ENTER, V38, P438, DOI 10.1177/0148607113506013
   Batelle Technology Partnership Practice for United for Medical Research, 2013, IMP GEN US EC
   Bischoff-Ferrari HA, 2014, LANCET DIABETES ENDO, V2, P363, DOI 10.1016/S2213-8587(14)70096-8
   Bishop KS, 2015, NUTRIENTS, V7, P922, DOI 10.3390/nu7020922
   Blakely T, 2015, MED CARE, V53, P302, DOI 10.1097/MLR.0000000000000330
   Camilleri M, 2000, PHARMACOECONOMICS, V17, P331, DOI 10.2165/00019053-200017040-00003
   Canavan C, 2014, CLIN EPIDEMIOL, V6, P71, DOI 10.2147/CLEP.S40245
   Cantorna MT, 2014, EXP BIOL MED, V239, P1524, DOI 10.1177/1535370214523890
   Carlberg C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00167
   Carvalho AYOM, 2013, NUTRIENTS, V5, P3898, DOI 10.3390/nu5103898
   Cheng J, 2014, J LIPID RES, V55, P455, DOI 10.1194/jlr.M044420
   Cleynen I., LANCET
   Crowe FL, 2011, PUBLIC HEALTH NUTR, V14, P340, DOI 10.1017/S1368980010002454
   Day AS, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/703890
   Dekker Evelien, 2005, Cancer Imaging, V5 Spec No A, pS127, DOI 10.1102/1470-7330.2005.0036
   Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176
   Elnenaei MO, 2011, BRIT J NUTR, V105, P71, DOI 10.1017/S0007114510003065
   Ensrud KE, 2011, J AM GERIATR SOC, V59, P101, DOI 10.1111/j.1532-5415.2010.03201.x
   Ensrud KE, 2010, J CLIN ENDOCR METAB, V95, P5266, DOI 10.1210/jc.2010-2317
   Feldman D, 2014, NAT REV CANCER, V14, P342, DOI 10.1038/nrc3691
   Ferguson LR, 2015, CURR CANCER DRUG TAR, V15, P173, DOI 10.2174/156800961503150505120604
   Ferguson LR, 2013, EXPERT REV CLIN IMMU, V9, P717, DOI 10.1586/1744666X.2013.824245
   Ferguson LR, 2012, NAT REV GASTRO HEPAT, V9, P260, DOI 10.1038/nrgastro.2012.41
   Fodor A, 2014, ADV EXP MED BIOL, V817, P25, DOI 10.1007/978-1-4939-0897-4_2
   Fraser WD, 2013, CALCIFIED TISSUE INT, V92, P118, DOI 10.1007/s00223-012-9693-3
   Freedman BI, 2010, J CLIN ENDOCR METAB, V95, P1076, DOI 10.1210/jc.2009-1797
   Garland CF, 2014, AM J PUBLIC HEALTH, V104, pE43, DOI 10.2105/AJPH.2014.302034
   Gearry RB, 2013, J GASTROEN HEPATOL, V28, P899, DOI 10.1111/jgh.12218
   Gentschew L, 2012, MOL NUTR FOOD RES, V56, P524, DOI 10.1002/mnfr.201100630
   Ghaly S, 2014, EXPERT REV GASTROENT, V8, P909, DOI 10.1586/17474124.2014.925796
   Gibson PR, 2014, J CROHNS COLITIS, V8, P598, DOI 10.1016/j.crohns.2013.11.017
   GODCHAUX W, 1984, J BIOL CHEM, V259, P2982
   Goldsmith JR, 2014, J GASTROENTEROL, V49, P785, DOI 10.1007/s00535-014-0953-z
   Grant WB, 2015, ANTICANCER RES, V35, P1154
   Grant WB, 2014, LANCET DIABETES ENDO, V2, P364, DOI 10.1016/S2213-8587(14)70098-1
   Grant WB, 2012, DERM-ENDOCRINOL, V4, P85, DOI 10.4161/derm.19667
   Grant WB, 2010, J AM MED DIR ASSOC, V11, P617, DOI 10.1016/j.jamda.2010.03.013
   Green TJ, 2010, ASIA PAC J CLIN NUTR, V19, P195
   Guo CX, 2014, ENDOCR METAB IMMUNE, V14, P255, DOI 10.2174/1871530314666140709085159
   Guo CX, 2014, MOL NUTR FOOD RES, V58, P528, DOI 10.1002/mnfr.201300266
   HARDING WR, 1986, ECOL FOOD NUTR, V19, P83, DOI 10.1080/03670244.1986.9990951
   Hayden E. C., 2014, IS 1000 GENOME REAL
   He Q, 2013, J STEROID BIOCHEM, V135, P7, DOI 10.1016/j.jsbmb.2012.11.002
   Heaney RP, 2014, NUTR REV, V72, P48, DOI 10.1111/nure.12090
   Herszenyi L, 2015, DIGEST DIS, V33, P52, DOI 10.1159/000368447
   Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553
   Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1
   Hollis BW, 2008, CURR OPIN ENDOCRINOL, V15, P489, DOI 10.1097/MED.0b013e328317ca6c
   Hood L., 2013, GENOME MED, V5, P1, DOI DOI 10.1186/GM514
   Hossein-nezhad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058725
   Hossein-nezhad A, 2012, CURR OPIN CLIN NUTR, V15, P567, DOI 10.1097/MCO.0b013e3283594978
   Houghton LA, 2011, J NUTR, V141, P1840, DOI 10.3945/jn.111.145052
   Jablonski NG, 2012, J ROY COLL PHYS EDIN, V42, P58, DOI 10.4997/JRCPE.2012.114
   Jablonski NG, 2012, P AM PHILOS SOC, V156, P45
   Jones ML, 2013, J CLIN ENDOCR METAB, V98, P2944, DOI 10.1210/jc.2012-4262
   Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582
   Kim Y, 2015, METHODS, V79-80, P52, DOI 10.1016/j.ymeth.2014.10.022
   Kini GP, 2014, NEW ZEAL MED J, V127, P51
   Kosmowska-Miskow A, 2014, ADV CLIN EXP MED, V23, P497, DOI 10.17219/acem/37208
   Kotze MJ, 2015, CRIT REV CL LAB SCI, V52, P120, DOI 10.3109/10408363.2014.997930
   Kussmann Martin, 2011, Frontiers in Genetics, V2, P21, DOI 10.3389/fgene.2011.00021
   Lai KK, 2015, INFLAMM BOWEL DIS, V21, P378, DOI 10.1097/MIB.0000000000000286
   Lehrer RI, 2002, CURR OPIN HEMATOL, V9, P18, DOI 10.1097/00062752-200201000-00004
   Lemberg DA, 2015, J PAEDIATR CHILD H, V51, P266, DOI 10.1111/jpc.12685
   Li MA, 2014, J CLIN ENDOCR METAB, V99, P2327, DOI 10.1210/jc.2013-4320
   Lips P, 2010, J STEROID BIOCHEM, V121, P297, DOI 10.1016/j.jsbmb.2010.02.021
   Liu PT, 2012, NAT MED, V18, P267, DOI 10.1038/nm.2584
   Ly NP, 2011, J ALLERGY CLIN IMMUN, V127, P1087, DOI 10.1016/j.jaci.2011.02.015
   Maccaferri S, 2011, DIGEST DIS, V29, P525, DOI 10.1159/000332966
   Maguire LH, 2015, JAMA SURG, V150, P74, DOI 10.1001/jamasurg.2014.2049
   Maguire LH, 2013, CLIN GASTROENTEROL H, V11, P1631, DOI 10.1016/j.cgh.2013.07.035
   Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49
   Maier CJ, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-18
   Makishima M, 2002, SCIENCE, V296, P1313, DOI 10.1126/science.1070477
   Marshall T. G, 2007, METAGENOMICS 2007
   Meeker S, 2014, CANCER RES, V74, P4398, DOI 10.1158/0008-5472.CAN-13-2820
   Ministry of Health New Zealand, BOW CANC PROGR
   Mohr SB, 2015, J STEROID BIOCHEM, V148, P239, DOI 10.1016/j.jsbmb.2014.12.010
   Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001
   Neovius M, 2013, GASTROENTEROLOGY, V144, P536, DOI 10.1053/j.gastro.2012.12.004
   Ng K. M., PROLONGED SURVIVAL M
   Nguyen GC, 2011, WORLD J GASTROENTERO, V17, P1600, DOI 10.3748/wjg.v17.i12.1600
   NIH Office of Dietary Supplements, VIT D FACT SHEET HLT
   Nowson CA, 2013, MED J AUSTRALIA, V199, P394, DOI [10.5694/mja13.10432, 10.5694/mja12.11635]
   O'Donovan CB, 2015, MOL NUTR FOOD RES, V59, P377, DOI 10.1002/mnfr.201400591
   O'Sullivan A, 2011, MOL NUTR FOOD RES, V55, P679, DOI 10.1002/mnfr.201000458
   Ooi JH, 2013, J NUTR, V143, P1679, DOI 10.3945/jn.113.180794
   Ovesen L, 2003, ANN NUTR METAB, V47, P107, DOI 10.1159/000070031
   Pludowski P, 2013, AUTOIMMUN REV, V12, P976, DOI 10.1016/j.autrev.2013.02.004
   Podd D, 2015, JAAPA-J AM ACAD PHYS, V28, P20, DOI 10.1097/01.JAA.0000459810.95512.14
   Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357
   Rheem DS, 2010, SCAND J GASTROENTERO, V45, P775, DOI 10.3109/00365521003734125
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35
   Roy S, 1999, J INFECT DIS, V179, P187, DOI 10.1086/314536
   Saccone D, 2015, GENE, V561, P171, DOI 10.1016/j.gene.2015.02.024
   Salazar JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000444
   Schottker B, 2013, AM J CLIN NUTR, V97, P782, DOI 10.3945/ajcn.112.047712
   Shah AB, 2012, ANZ J SURG, V82, P258, DOI 10.1111/j.1445-2197.2011.05995.x
   Shelling AN, 2007, MUTAT RES-FUND MOL M, V622, P33, DOI 10.1016/j.mrfmmm.2007.04.011
   Simon Tripp, 2011, EC IMPACT HUMAN GENO
   So JY, 2015, J STEROID BIOCHEM, V148, P79, DOI 10.1016/j.jsbmb.2014.10.007
   Song MY, 2016, GUT, V65, P296, DOI 10.1136/gutjnl-2014-308852
   Song MY, 2015, GASTROENTEROLOGY, V148, P1244, DOI 10.1053/j.gastro.2014.12.035
   Spedding S, 2013, NUTRIENTS, V5, P5127, DOI 10.3390/nu5125127
   Sprake Eleanor F, 2012, BMJ Case Rep, V2012, DOI 10.1136/bcr-2012-007223
   Tang H, 2014, CANCER BIOMARK, V14, P313, DOI 10.3233/CBM-140409
   Tarroni P, 2012, J CELL BIOCHEM, V113, P640, DOI 10.1002/jcb.23392
   Tomasello G, 2014, WORLD J GASTROENTERO, V20, P18121, DOI 10.3748/wjg.v20.i48.18121
   Toriola AT, 2014, CANCER EPIDEM BIOMAR, V23, P917, DOI 10.1158/1055-9965.EPI-14-0053
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Vitamin D External Quality Assessment Scheme, VIT D EXT QUAL ASS S
   Wang B, 2014, EUR J CANCER, V50, P2173, DOI 10.1016/j.ejca.2014.05.004
   Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0
   Wang WL, 2015, WORLD J GASTROENTERO, V21, P803, DOI 10.3748/wjg.v21.i3.803
   Wesa KM, 2015, NUTR CANCER, V67, P424, DOI 10.1080/01635581.2015.998838
   Winkels RM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-374
   Wu SP, 2015, GUT, V64, P1082, DOI 10.1136/gutjnl-2014-307436
   Wu SP, 2010, AM J PATHOL, V177, P686, DOI 10.2353/ajpath.2010.090998
   Xu YZ, 2003, CHINESE MED J-PEKING, V116, P1070
   Yenamandra S. P., 2009, Experimental Oncology, V31, P92
   Yu SH, 2008, P NATL ACAD SCI USA, V105, P20834, DOI 10.1073/pnas.0808700106
   Zgaga L, 2014, J CLIN ONCOL, V32, P2430, DOI 10.1200/JCO.2013.54.5947
   Zhiqin W, 2014, INTEST RES, V12, P194, DOI 10.5217/ir.2014.12.3.194
NR 130
TC 12
Z9 13
U1 1
U2 31
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1613-4125
EI 1613-4133
J9 MOL NUTR FOOD RES
JI Mol. Nutr. Food Res.
PD JAN
PY 2016
VL 60
IS 1
SI SI
BP 119
EP 133
DI 10.1002/mnfr.201500243
PG 15
WC Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Food Science & Technology
GA DA3WK
UT WOS:000367730800012
PM 26251177
DA 2022-11-22
ER

PT J
AU Butto, LF
   Haller, D
AF Butto, Ludovica F.
   Haller, Dirk
TI Functional relevance of microbiome signatures: The correlation era
   requires tools for consolidation
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Article
DE Microbiome; metagenomics; inflammatory bowel diseases; allergy;
   colorectal cancer; diabetes; fecal microbiota transplantation;
   gnotobiology; synthetic bacterial consortia
ID HUMAN GUT MICROBIOME; DIET-INDUCED OBESITY; INTESTINAL MICROBIOTA; FECAL
   MICROBIOTA; MICE; ASSOCIATION; DYSBIOSIS; BACTERIAL; COLITIS; FAT
AB Compelling research over the past decade identified a fundamental role of the intestinal microbiome on human health. Compositional and functional changes of this microbial ecosystem are correlated with a variety of human pathologies. Metagenomic resolution and bioinformatic tools considerably improved, allowing even strain-level analysis. However, the search for microbial risk patterns in human cohorts is often confounded by environmental factors (eg, medication) and host status (eg, disease relapse), questioning the prognostic and therapeutic value of the currently available information. In addition to a better stratification of human phenotypes, the implementation of standardized protocols for sampling and analysis is needed to improve the reproducibility and comparability of microbiome signatures at a meaningful taxonomic resolution. At the level of mechanistic understanding, the molecular integration of pleiotropic signals coming from this complex and dynamically changing ecosystem is one of the biggest challenges in this field. The first successful attempts to apply reverse genetics based on the available metagenomic information yielded identification of small molecules and metabolites with functional relevance for microbe-host interactions. Further expansion on the isolation of bacteria from the "unculturable biomass" will help characterize microbiome signatures in model systems, finally aiming at the development of clinically relevant synthetic consortia with safe and functionally well-defined strains. In conclusion and beyond reasonable enthusiasm, the mechanistic implementation and clinical relevance of microbiome alterations on disease susceptibility is still in its infancy, but the integration of all the above-mentioned strategies will help overcome the correlation era in microbiome research and lead to a rational evaluation of clinical strategies relevant for targeted microbial intervention.
C1 [Butto, Ludovica F.; Haller, Dirk] Univ Munich, Chair Nutr & Immunol, Freising Weihenstephan, Germany.
C3 University of Munich
RP Haller, D (corresponding author), Gregor Mendel Str 2, D-85354 Freising Weihenstephan, Germany.
EM dirk.haller@tum.de
RI Butto, Ludovica/P-1882-2019
OI Haller, Dirk/0000-0002-6977-4085
FU Topfer; Helmsley Charitable Trust
FX D. Haller serves as a consultant for Gnubiotics, Clasado Bimuno, and
   Avito; receives grant support from Topfer and the Helmsley Charitable
   Trust; holds a patent with Lactocepin; and receives royalties from
   Thieme Verlag. L. F. Butto declares no relevant conflicts of interest.
CR [Anonymous], GUT
   Arrieta MC, 2016, GUT MICROBES, V7, P342, DOI 10.1080/19490976.2016.1182293
   Arrieta MC, 2016, CELL HOST MICROBE, V19, P575, DOI 10.1016/j.chom.2016.04.014
   Arrieta MC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab2271
   Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487
   Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Bashan A, 2016, NATURE, V534, P259, DOI 10.1038/nature18301
   Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554
   Bokulich NA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7121
   Browne HP, 2016, NATURE, V533, P543, DOI 10.1038/nature17645
   Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215
   Busquets D, 2015, J CROHNS COLITIS, V9, P899, DOI 10.1093/ecco-jcc/jjv119
   Butto LF, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00555
   Cammarota G, 2017, GUT
   Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484
   Chen YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep34055
   Chung HC, 2012, CELL, V149, P1578, DOI 10.1016/j.cell.2012.04.037
   Couturier-Maillard A, 2013, J CLIN INVEST, V123, P700, DOI 10.1172/JCI62236
   Crouzet L, 2013, NEUROGASTROENT MOTIL, V25, pe272, DOI 10.1111/nmo.12103
   Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993
   de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2015.186, 10.1038/nrgastro.2016.186]
   Devlin AS, 2015, NAT CHEM BIOL, V11, P685, DOI [10.1038/NCHEMBIO.1864, 10.1038/nchembio.1864]
   Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552
   Donia MS, 2015, SCIENCE, V349, DOI 10.1126/science.1254766
   Du ZY, 2015, GUT PATHOG, V7, DOI 10.1186/s13099-015-0080-2
   Escalona M, 2016, NAT REV GENET, V17, P459, DOI 10.1038/nrg.2016.57
   Eun CS, 2014, INFECT IMMUN, V82, P2239, DOI 10.1128/IAI.01513-13
   Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176
   Fujimura KE, 2015, CELL HOST MICROBE, V17, P592, DOI 10.1016/j.chom.2015.04.007
   Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004
   Gevers D, 2014, CELL HOST MICROBE, V15, P382, DOI 10.1016/j.chom.2014.02.005
   Gronbach K, 2014, GASTROENTEROLOGY, V146, P765, DOI 10.1053/j.gastro.2013.11.033
   Guo CJ, 2017, CELL, V168, P517, DOI 10.1016/j.cell.2016.12.021
   Haberman Y, 2014, J CLIN INVEST, V124, P3617, DOI 10.1172/JCI75436
   Hanage WP, 2014, NATURE, V512, P247, DOI 10.1038/512247a
   Hiergeist A, 2016, INT J MED MICROBIOL, V306, P334, DOI 10.1016/j.ijmm.2016.03.005
   Hormannsperger G, 2015, ILAR J, V56, P179, DOI 10.1093/ilar/ilv019
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Jalanka-Tuovinen J, 2014, GUT, V63, P1737, DOI 10.1136/gutjnl-2013-305994
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501
   Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88
   Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263
   Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582
   Kang DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068322
   Karlsson F, 2013, DIABETES, V62, P3341, DOI 10.2337/db13-0844
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Kostic AD, 2015, CELL HOST MICROBE, V17, P260, DOI 10.1016/j.chom.2015.01.001
   Kubeck R, 2016, MOL METAB, V5, P1162, DOI 10.1016/j.molmet.2016.10.001
   Lagkouvardos I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.131, 10.1038/nmicrobiol.2016.131]
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee T., 2016, GUT
   Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292
   Li SS, 2016, SCIENCE, V352, P586, DOI 10.1126/science.aad8852
   Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550
   Marcobal A, 2013, ISME J, V7, P1933, DOI 10.1038/ismej.2013.89
   Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008
   Moayyedi P, 2015, GASTROENTEROLOGY, V149, P102, DOI 10.1053/j.gastro.2015.04.001
   Nagao-Kitamoto H, 2016, CELL MOL GASTROENTER, V2, P468, DOI 10.1016/j.jcmgh.2016.02.003
   Nielsen HB, 2014, NAT BIOTECHNOL, V32, P822, DOI 10.1038/nbt.2939
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ott SJ, 2016, GASTROENTEROLOGY
   Paramsothy S, 2017, LANCET
   Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
   Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   Rabot S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32484
   Rausch P, 2016, INT J MED MICROBIOL, V306, P343, DOI 10.1016/j.ijmm.2016.03.004
   Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043
   Rehman A, 2016, GUT, V65, P238, DOI 10.1136/gutjnl-2014-308341
   Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214
   Rossen NG, 2015, GASTROENTEROLOGY, V149, P110, DOI 10.1053/j.gastro.2015.03.045
   Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333
   Schwerd T, 2016, J ALLERGY CLIN IMMUN, V138, P592, DOI 10.1016/j.jaci.2015.12.1331
   Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007
   Sender R, 2016, CELL, V164, P337, DOI 10.1016/j.cell.2016.01.013
   Serino M, 2014, CURR CARDIOL REP, V16, DOI 10.1007/s11886-014-0540-1
   Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Steck N, 2011, GASTROENTEROLOGY, V141, P959, DOI 10.1053/j.gastro.2011.05.035
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Turpin W, 2016, NAT GENET, V48, P1413, DOI 10.1038/ng.3693
   Tyler AD, 2014, AM J GASTROENTEROL, V109, P983, DOI 10.1038/ajg.2014.73
   Van de Wiele T, 2016, NAT REV RHEUMATOL, V12, P398, DOI 10.1038/nrrheum.2016.85
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721
   von Schillde MA, 2012, CELL HOST MICROBE, V11, P387, DOI 10.1016/j.chom.2012.02.006
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Wang L, 2013, MOL AUTISM, V4, DOI 10.1186/2040-2392-4-42
   Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336
   Xiao L, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.161, 10.1038/nmicrobiol.2016.161]
   Xiao L, 2015, NAT BIOTECHNOL, V33, P1103, DOI 10.1038/nbt.3353
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
NR 108
TC 16
Z9 17
U1 0
U2 23
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
EI 1097-6825
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD APR
PY 2017
VL 139
IS 4
BP 1092
EP 1098
DI 10.1016/j.jaci.2017.02.010
PG 7
WC Allergy; Immunology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Allergy; Immunology
GA ER4LR
UT WOS:000398771800003
PM 28390576
OA Bronze
DA 2022-11-22
ER

PT J
AU Dubinkina, VB
   Tyakht, AV
   Odintsova, VY
   Yarygin, KS
   Kovarsky, BA
   Pavlenko, AV
   Ischenko, DS
   Popenko, AS
   Alexeev, DG
   Taraskina, AY
   Nasyrova, RF
   Krupitsky, EM
   Shalikiani, NV
   Bakulin, IG
   Shcherbakov, PL
   Skorodumova, LO
   Larin, AK
   Kostryukova, ES
   Abdulkhakov, RA
   Abdulkhakov, SR
   Malanin, SY
   Ismagilova, RK
   Grigoryeva, TV
   Ilina, EN
   Govorun, VM
AF Dubinkina, Veronika B.
   Tyakht, Alexander V.
   Odintsova, Vera Y.
   Yarygin, Konstantin S.
   Kovarsky, Boris A.
   Pavlenko, Alexander V.
   Ischenko, Dmitry S.
   Popenko, Anna S.
   Alexeev, Dmitry G.
   Taraskina, Anastasiya Y.
   Nasyrova, Regina F.
   Krupitsky, Evgeny M.
   Shalikiani, Nino V.
   Bakulin, Igor G.
   Shcherbakov, Petr L.
   Skorodumova, Lyubov O.
   Larin, Andrei K.
   Kostryukova, Elena S.
   Abdulkhakov, Rustam A.
   Abdulkhakov, Sayar R.
   Malanin, Sergey Y.
   Ismagilova, Ruzilya K.
   Grigoryeva, Tatiana V.
   Ilina, Elena N.
   Govorun, Vadim M.
TI Links of gut microbiota composition with alcohol dependence syndrome and
   alcoholic liver disease
SO MICROBIOME
LA English
DT Article
DE Metagenome; Human gut microbiota; Alcoholic dependence syndrome;
   Alcoholic liver cirrhosis; Bifidobacterium; Lactobacillus; Gut-brain
   axis; Virulence factors; Acetaldehyde
ID INTESTINAL MICROBIOTA; CIRRHOSIS; BACTERIA; ETHANOL; DIVERSITY;
   MORTALITY; CATALOG; RUSSIA; COLON; DIET
AB Background: Alcohol abuse has deleterious effects on human health by disrupting the functions of many organs and systems. Gut microbiota has been implicated in the pathogenesis of alcohol-related liver diseases, with its composition manifesting expressed dysbiosis in patients suffering from alcoholic dependence. Due to its inherent plasticity, gut microbiota is an important target for prevention and treatment of these diseases. Identification of the impact of alcohol abuse with associated psychiatric symptoms on the gut community structure is confounded by the liver dysfunction. In order to differentiate the effects of these two factors, we conducted a comparative "shotgun" metagenomic survey of 99 patients with the alcohol dependence syndrome represented by two cohorts-with and without liver cirrhosis. The taxonomic and functional composition of the gut microbiota was subjected to a multifactor analysis including comparison with the external control group.
   Results: Alcoholic dependence and liver cirrhosis were associated with profound shifts in gut community structures and metabolic potential across the patients. The specific effects on species-level community composition were remarkably different between cohorts with and without liver cirrhosis. In both cases, the commensal microbiota was found to be depleted. Alcoholic dependence was inversely associated with the levels of butyrate-producing species from the Clostridiales order, while the cirrhosis-with multiple members of the Bacteroidales order. The opportunist pathogens linked to alcoholic dependence included pro-inflammatory Enterobacteriaceae, while the hallmarks of cirrhosis included an increase of oral microbes in the gut and more frequent occurrence of abnormal community structures. Interestingly, each of the two factors was associated with the expressed enrichment in many Bifidobacterium and Lactobacillus-but the exact set of the species was different between alcoholic dependence and liver cirrhosis. At the level of functional potential, the patients showed different patterns of increase in functions related to alcohol metabolism and virulence factors, as well as pathways related to inflammation.
   Conclusions: Multiple shifts in the community structure and metabolic potential suggest strong negative influence of alcohol dependence and associated liver dysfunction on gut microbiota. The identified differences in patterns of impact between these two factors are important for planning of personalized treatment and prevention of these pathologies via microbiota modulation. Particularly, the expansion of Bifidobacterium and Lactobacillus suggests that probiotic interventions for patients with alcohol-related disorders using representatives of the same taxa should be considered with caution. Taxonomic and functional analysis shows an increased propensity of the gut microbiota to synthesis of the toxic acetaldehyde, suggesting higher risk of colorectal cancer and other pathologies in alcoholics.
C1 [Dubinkina, Veronika B.; Yarygin, Konstantin S.; Pavlenko, Alexander V.; Ischenko, Dmitry S.; Alexeev, Dmitry G.; Kostryukova, Elena S.; Govorun, Vadim M.] Moscow Inst Phys & Technol, Inst Skiy Per 9, Dolgoprudnyi 141700, Moscow Region, Russia.
   [Dubinkina, Veronika B.; Tyakht, Alexander V.; Odintsova, Vera Y.; Yarygin, Konstantin S.; Kovarsky, Boris A.; Pavlenko, Alexander V.; Ischenko, Dmitry S.; Popenko, Anna S.; Alexeev, Dmitry G.; Skorodumova, Lyubov O.; Larin, Andrei K.; Kostryukova, Elena S.; Ilina, Elena N.; Govorun, Vadim M.] Fed Res & Clin Ctr Phys Chem Med, Malaya Pirogovskaya 1a, Moscow 119435, Russia.
   [Dubinkina, Veronika B.] Univ Illinois, Dept Bioengn, 1304 W Springfield Ave Urbana, Champaign, IL 61801 USA.
   [Dubinkina, Veronika B.] Carl R Woese Inst Genom Biol, 1206 West Gregory Dr, Urbana, IL 61801 USA.
   [Tyakht, Alexander V.] ITMO Univ, Kronverkskiy Pr 49, St Petersburg 197101, Russia.
   [Taraskina, Anastasiya Y.; Nasyrova, Regina F.; Krupitsky, Evgeny M.] St Petersburg Bekhterev Psychoneurol Res Inst, Bekhtereva 3, St Petersburg 192019, Russia.
   [Shalikiani, Nino V.; Bakulin, Igor G.; Shcherbakov, Petr L.] Moscow Clin Sci Ctr, Shosse Entuziastov 86, Moscow 111123, Russia.
   [Abdulkhakov, Rustam A.; Abdulkhakov, Sayar R.] Kazan State Med Univ, Butlerova 49, Kazan 420012, Russia.
   [Abdulkhakov, Sayar R.; Malanin, Sergey Y.; Ismagilova, Ruzilya K.; Grigoryeva, Tatiana V.] Kazan Fed Univ, Kremlyovskaya 18, Kazan 420008, Russia.
C3 Moscow Institute of Physics & Technology; Federal Research & Clinical
   Center of Physical-Chemical Medicine; University of Illinois System;
   University of Illinois Urbana-Champaign; ITMO University; V.M. Bekhterev
   National Research Medical Center Psychiatry & Neurology; Kazan State
   Medical University; Kazan Federal University
RP Tyakht, AV (corresponding author), Fed Res & Clin Ctr Phys Chem Med, Malaya Pirogovskaya 1a, Moscow 119435, Russia.; Tyakht, AV (corresponding author), ITMO Univ, Kronverkskiy Pr 49, St Petersburg 197101, Russia.
EM a.tyakht@gmail.com
RI Ilina, Elena N/N-8190-2015; Ismagilova, Ruzilya/K-2587-2017; Nasyrova,
   Regina F/B-1259-2014; Skorodumova, Liubov Olegovna/B-1528-2017; Ilina,
   Elena/ABI-1172-2020; Grigoryeva, Tatiana/H-8611-2014; Tyakht,
   Alexander/O-1327-2015; Govorun, Vadim M/A-9043-2018; Dubinkina,
   Veronika/O-2628-2015; Malanin, Sergey/R-4831-2016; Abdulkhakov, Sayar
   R./H-6812-2014; Krupitsky, Evgeny/M-5935-2016; Odintsova,
   Vera/N-5010-2015; Alexeev, Dmitry/A-6167-2013
OI Ilina, Elena N/0000-0003-0130-5079; Skorodumova, Liubov
   Olegovna/0000-0002-7747-2730; Ilina, Elena/0000-0003-0130-5079;
   Grigoryeva, Tatiana/0000-0001-5314-7012; Dubinkina,
   Veronika/0000-0002-4844-6795; Malanin, Sergey/0000-0002-3343-4441;
   Abdulkhakov, Sayar/0000-0001-9542-3580; Krupitsky,
   Evgeny/0000-0002-0529-4525; Odintsova, Vera/0000-0003-1897-4033;
   Alexeev, Dmitry/0000-0003-0783-1176
FU Ministry of Education and Science of the Russian Federation
   [RFMEFI60414X0119]
FX This work was financially supported by the Ministry of Education and
   Science of the Russian Federation (unique project identifier
   RFMEFI60414X0119).
CR Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172
   Bajaj JS, 2015, NATURE, V525, pE1, DOI 10.1038/nature14851
   Bajaj JS, 2014, J HEPATOL, V60, P940, DOI 10.1016/j.jhep.2013.12.019
   Bull-Otterson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053028
   Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989
   Chen YF, 2011, HEPATOLOGY, V54, P562, DOI 10.1002/hep.24423
   Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001
   Dubinkina VB, 2016, BIOCHEM MOSC-SUPPL S, V10, P184, DOI 10.1134/S1990750816020037
   Dubinkina VB, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0875-7
   Fukui H, 2015, WORLD J HEPATOL, V7, P425, DOI 10.4254/wjh.v7.i3.425
   Gorky J, 2016, PROG NEURO-PSYCHOPH, V65, DOI 10.1016/j.pnpbp.2015.06.013
   Gramenzi A, 2006, ALIMENT PHARM THER, V24, P1151, DOI 10.1111/j.1365-2036.2006.03110.x
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847
   Kortman GAM, 2014, FEMS MICROBIOL REV, V38, P1202, DOI 10.1111/1574-6976.12086
   Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Leclercq S, 2014, P NATL ACAD SCI USA, V111, pE4485, DOI 10.1073/pnas.1415174111
   Leon DA, 2007, LANCET, V369, P2001, DOI 10.1016/S0140-6736(07)60941-6
   Lewis JD, 2015, CELL HOST MICROBE, V18, P489, DOI 10.1016/j.chom.2015.09.008
   Li JH, 2014, NAT BIOTECHNOL, V32, P834, DOI 10.1038/nbt.2942
   Llopis M, 2016, GUT, V65, P830, DOI 10.1136/gutjnl-2015-310585
   Lovinger DM, 1997, ALCOHOL HEALTH RES W, V21, P114
   Masip L, 2006, ANTIOXID REDOX SIGN, V8, P753, DOI 10.1089/ars.2006.8.753
   McKee M, 2005, ALCOHOL CLIN EXP RES, V29, P1884, DOI 10.1097/01.alc.0000183012.93303.90
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Mutlu EA, 2012, AM J PHYSIOL-GASTR L, V302, pG966, DOI 10.1152/ajpgi.00380.2011
   Nosova T, 1998, ALCOHOL ALCOHOLISM, V33, P273
   Peng Y, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-15
   Pokusaeva K, 2017, NEUROGASTROENT MOTIL, V29, DOI 10.1111/nmo.12904
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Qin N, 2014, NATURE
   Quigley EMM, 2013, J HEPATOL, V58, P1020, DOI 10.1016/j.jhep.2012.11.023
   R Development Core Team RFFSC, 2008, R LANG ENV STAT COMP, P2673
   Ridlon JM, 2015, DIGEST DIS, V33, P338, DOI 10.1159/000371678
   Rossen NG, 2015, WORLD J GASTROENTERO, V21, P5359, DOI 10.3748/wjg.v21.i17.5359
   Shalikiani NV, 2015, TERAPEVT ARKH, V87, P59, DOI 10.17116/terarkh2015871259-65
   Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846
   Szabo G, 2010, DIGEST DIS, V28, P737, DOI 10.1159/000324281
   Taur Y, 2012, CLIN INFECT DIS, V55, P905, DOI 10.1093/cid/cis580
   Tilg H, 2016, GUT, V65, P728, DOI 10.1136/gutjnl-2015-311014
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Tsuruya A, 2016, ALCOHOL ALCOHOLISM, V51, P395, DOI 10.1093/alcalc/agv135
   Tsuruya A, 2016, SCI REP-UK, V6, DOI 10.1038/srep27923
   Tuomisto S, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-40
   Tyakht AV, 2017, DATA BRIEF, V11, P98, DOI 10.1016/j.dib.2017.01.008
   Tyakht AV, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3469
   Ulyantsev VI, 2016, BIOINFORMATICS, V32, P2760, DOI 10.1093/bioinformatics/btw312
   Varemo L, 2013, NUCLEIC ACIDS RES, V41, P4378, DOI 10.1093/nar/gkt111
   Vassallo G, 2015, ALIMENT PHARM THER, V41, P917, DOI 10.1111/apt.13164
   Veiga P, 2014, SCI REP-UK, V4, DOI 10.1038/srep06328
   Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Wang W, 2014, J CLIN MICROBIOL, V52, P398, DOI 10.1128/JCM.01500-13
   Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047
   Yarygin K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176154
   Zaridze D, 2014, LANCET, V383, P1465, DOI 10.1016/S0140-6736(13)62247-3
NR 57
TC 184
Z9 189
U1 6
U2 74
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2049-2618
J9 MICROBIOME
JI Microbiome
PD OCT 17
PY 2017
VL 5
AR 141
DI 10.1186/s40168-017-0359-2
PG 14
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA FJ9LY
UT WOS:000413099900001
PM 29041989
OA gold, Green Published
DA 2022-11-22
ER

PT S
AU Blaut, M
AF Blaut, Michael
BE Dobrindt, U
   Hacker, JH
   Svanborg, C
TI Ecology and Physiology of the Intestinal Tract
SO BETWEEN PATHOGENICITY AND COMMENSALISM
SE Current Topics in Microbiology and Immunology
LA English
DT Review; Book Chapter
ID OUTER-MEMBRANE PROTEINS; 16S RIBOSOMAL-RNA; BACTERIUM
   OXALOBACTER-FORMIGENES; BACTEROIDES-THETAIOTAOMICRON;
   GASTROINTESTINAL-TRACT; HUMAN-COLON; HUMAN FECES;
   AKKERMANSIA-MUCINIPHILA; STARCH UTILIZATION; MUCIN DEGRADATION
AB The number of microorganisms inhabiting the human digestive tract exceeds the number of body cells by a factor of ten. This microbial community affects host physiology and host health. The metabolic potential of the gut microbiota is immense affording the extraction of energy from otherwise indigestible carbohydrates (dietary fiber) and the conversion of host-derived substances, non-nutritive dietary components and drugs. Recognized functions of the gut microbiota include provision of colonization resistance against pathogens and priming of both the innate and the acquired immune systems. However, the intestinal microbiota may also contribute to the development of diseases such as ulcerative colitis and colorectal cancer. Culture-dependent studies provided basic knowledge on the gut microbiota, but only the advent of culture-independent molecular methods led to a better understanding of host-microbe interactions. The application of metagenomics to the gut microbial ecosystem revealed truly remarkable correlations between certain diseases and the gut microbiome. It also led to the suggestion of the existence of a 'core microbiome' that encompasses key functions shared by each individual. However, the mechanisms underlying host-microbe interactions have not yet been unraveled.
C1 German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Gastrointestinal Microbiol, D-14558 Nuthetal, Germany.
C3 Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)
RP Blaut, M (corresponding author), German Inst Human Nutr Potsdam Rehbruecke DIfE, Dept Gastrointestinal Microbiol, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.
EM blaut@dife.de
OI Blaut, Michael/0000-0002-6628-2907
CR Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696
   ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731
   Alpert C, 2009, ENVIRON MICROBIOL, V11, P751, DOI 10.1111/j.1462-2920.2008.01798.x
   AMANN R, 1991, NATURE, V351, P161, DOI 10.1038/351161a0
   Arts ICW, 2005, AM J CLIN NUTR, V81, p317S, DOI 10.1093/ajcn/81.1.317S
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Atkinson C, 2004, J NUTR, V134, P596, DOI 10.1093/jn/134.3.596
   AXELSON M, 1982, NATURE, V298, P659, DOI 10.1038/298659a0
   Baughn AD, 2004, NATURE, V427, P441, DOI 10.1038/nature02285
   Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103
   Blaut M, 2002, BRIT J NUTR, V87, pS203, DOI 10.1079/BJN/2002539
   Blaut M, 2006, FOOD CHEM TOXICOL, V44, P1940, DOI 10.1016/j.fct.2006.06.015
   BOKKENHEUSER VD, 1979, APPL ENVIRON MICROB, V37, P1001, DOI 10.1128/AEM.37.5.1001-1006.1979
   Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380
   CHENG Q, 1992, J BACTERIOL, V174, P7185, DOI 10.1128/jb.174.22.7185-7193.1992
   CHENG QO, 1995, J BACTERIOL, V177, P3721, DOI 10.1128/jb.177.13.3721-3727.1995
   Chiang YC, 2008, MOL CELL PROBE, V22, P262, DOI 10.1016/j.mcp.2008.05.004
   Cho KH, 2001, J BACTERIOL, V183, P7198, DOI 10.1128/JB.183.24.7198-7205.2001
   Clavel T, 2006, FEMS MICROBIOL ECOL, V55, P471, DOI 10.1111/j.1574-6941.2005.00057.x
   Clavel T, 2005, APPL ENVIRON MICROB, V71, P6077, DOI 10.1128/AEM.71.10.6077-6085.2005
   Clavel T, 2007, SYST APPL MICROBIOL, V30, P16, DOI 10.1016/j.syapm.2006.02.003
   Clavel T, 2006, ANAEROBE, V12, P140, DOI 10.1016/j.anaerobe.2005.11.002
   Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07
   CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   Cummings JH, 1995, HUMAN COLONIC BACTER, P101
   Cummings JH, 1994, ILSI WORKSH COL MICR
   Deisinger PJ, 1996, J TOXICOL ENV HEALTH, V47, P31, DOI 10.1080/009841096161915
   Derrien M, 2004, INT J SYST EVOL MICR, V54, P1469, DOI 10.1099/ijs.0.02873-0
   Dore J, 1998, SYST APPL MICROBIOL, V21, P65, DOI 10.1016/S0723-2020(98)80009-X
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998
   FILIPE MI, 1979, INVEST CELL PATHOL, V2, P195
   Finegold S.M., 1983, HUMAN INTESTINAL MIC, P3, DOI DOI 10.1016/B978-0-12-341280-5.50007-0
   FINEGOLD SM, 1974, AM J CLIN NUTR, V27, P1456, DOI 10.1093/ajcn/27.12.1456
   Franks AH, 1998, APPL ENVIRON MICROB, V64, P3336
   Gibson GR, 1999, J NUTR, V129, p1438S, DOI 10.1093/jn/129.7.1438S
   GIBSON GR, 1995, GASTROENTEROLOGY, V108, P975, DOI 10.1016/0016-5085(95)90192-2
   GIBSON SAW, 1989, APPL ENVIRON MICROB, V55, P679, DOI 10.1128/AEM.55.3.679-683.1989
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gniechwitz D, 2007, J AGR FOOD CHEM, V55, P11027, DOI 10.1021/jf072389g
   Hansson GC, 2010, GUT MICROBES, V1, P51, DOI 10.4161/gmic.1.1.10470
   Hentges DJ, 1983, HUMAN INTESTINAL MIC, P19
   Hespell R. B., 1983, HUMAN INTESTINAL MIC, P21
   HILLMAN K, 1993, LETT APPL MICROBIOL, V16, P299, DOI 10.1111/j.1472-765X.1993.tb00362.x
   HOLDEMAN LV, 1972, AM J CLIN NUTR, V25, P1314
   Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833
   Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51
   HUNGATE RE, 1950, BACTERIOL REV, V14, P1
   HWA V, 1992, J BACTERIOL, V174, P342, DOI 10.1128/jb.174.1.342-344.1992
   Joshi S, 1995, PLANT FOOD HUM NUTR, V48, P39, DOI 10.1007/BF01089198
   Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011
   KOTARSKI SF, 1985, J BACTERIOL, V163, P1080, DOI 10.1128/JB.163.3.1080-1086.1985
   Kumar R, 2002, EUR UROL, V41, P318, DOI 10.1016/S0302-2838(02)00040-4
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   LINN S, 1983, J BACTERIOL, V156, P859, DOI 10.1128/JB.156.2.859-866.1983
   MACDONALD IA, 1979, APPL ENVIRON MICROB, V37, P992, DOI 10.1128/AEM.37.5.992-1000.1979
   MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647
   Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007
   Maruo T, 2008, INT J SYST EVOL MICR, V58, P1221, DOI 10.1099/ijs.0.65404-0
   Matthies A, 2009, APPL ENVIRON MICROB, V75, P1740, DOI 10.1128/AEM.01795-08
   McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234
   Mittal RD, 2003, MED PRIN PRACT, V12, P208, DOI 10.1159/000072285
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x
   Reeves AR, 1997, J BACTERIOL, V179, P643, DOI 10.1128/jb.179.3.643-649.1997
   Reichardt N, 2009, MOL NUTR FOOD RES, V53, P287, DOI 10.1002/mnfr.200700509
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Sajilata MG, 2006, COMPR REV FOOD SCI F, V5, P1, DOI 10.1111/j.1541-4337.2006.tb00076.x
   SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977
   SALYERS AA, 1989, APPL ENVIRON MICROB, V55, P2572, DOI 10.1128/AEM.55.10.2572-2578.1989
   SALYERS AA, 1980, J BACTERIOL, V143, P781, DOI 10.1128/JB.143.2.781-788.1980
   SALYERS AA, 1980, J BACTERIOL, V143, P772, DOI 10.1128/JB.143.2.772-780.1980
   Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528
   Schoefer L, 2002, FEMS MICROBIOL LETT, V208, P197, DOI 10.1111/j.1574-6968.2002.tb11081.x
   Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776
   Shipman JA, 1999, J BACTERIOL, V181, P7206, DOI 10.1128/JB.181.23.7206-7211.1999
   Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000
   Sidhu H, 1999, J AM SOC NEPHROL, V10, pS334
   SLAVIN JL, 1981, J NUTR, V111, P287, DOI 10.1093/jn/111.2.287
   Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Suau A, 2001, SYST APPL MICROBIOL, V24, P139, DOI 10.1078/0723-2020-00015
   Suau A, 1999, APPL ENVIRON MICROB, V65, P4799
   Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   VANSOEST PJ, 1984, P NUTR SOC, V43, P25, DOI 10.1079/PNS19840024
   VARIYAM EP, 1981, GASTROENTEROLOGY, V81, P751
   VERVAEKE IJ, 1973, J APPL BACTERIOL, V36, P397, DOI 10.1111/j.1365-2672.1973.tb04121.x
   Wells JM, 2011, P NATL ACAD SCI USA, V108, P4607, DOI 10.1073/pnas.1000092107
   WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987
   Woting A, 2010, FEMS MICROBIOL ECOL, V72, P507, DOI 10.1111/j.1574-6941.2010.00863.x
   Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029
NR 97
TC 26
Z9 26
U1 2
U2 37
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0070-217X
EI 2196-9965
BN 978-3-642-36560-7; 978-3-642-36559-1
J9 CURR TOP MICROBIOL
JI Curr.Top.Microbiol.Immunol.
PY 2013
VL 358
BP 247
EP 272
DI 10.1007/82_2011_192
D2 10.1007/978-3-642-36560-7
PG 26
WC Immunology; Microbiology
WE Book Citation Index – Science (BKCI-S); Science Citation Index Expanded (SCI-EXPANDED)
SC Immunology; Microbiology
GA BJT96
UT WOS:000330362000008
PM 22120885
DA 2022-11-22
ER

PT J
AU Wang, ZK
   Yang, YS
AF Wang, Zi-Kai
   Yang, Yun-Sheng
TI Upper gastrointestinal microbiota and digestive diseases
SO WORLD JOURNAL OF GASTROENTEROLOGY
LA English
DT Review
DE Microbiota; Upper gastrointestinal tract; Digestive diseases; 16S rDNA;
   Metagenomics
ID IRRITABLE-BOWEL-SYNDROME; HELICOBACTER-PYLORI INFECTION;
   HERPES-SIMPLEX-VIRUS; GUT MICROBIOTA; FECAL MICROBIOTA; BACTERIAL
   OVERGROWTH; INTESTINAL MICROBIOTA; MONGOLIAN GERBILS; TEMPORAL
   STABILITY; MOLECULAR ANALYSIS
AB Metagenomics which combines the power of genomics, bioinformatics, and systems biology, provide new access to the microbial world. Metagenomics permit the genetic analysis of complex microbial populations without requiring prior cultivation. Through the conceptual innovations in metagenomics and the improvements in DNA high-throughput sequencing and bioinformatics analysis technology, gastrointestinal microbiology has entered the metagenomics era and become a hot topic worldwide. Human microbiome research is underway, however, most studies in this area have focused on the composition and function of the intestinal microbiota and the relationship between intestinal microbiota and metabolic diseases (obesity, diabetes, metabolic syndrome, etc.) and intestinal disorders [inflammatory bowel disease, colorectal cancer, irritable bowel syndrome (IBS), etc.]. Few investigations on microbiota have been conducted within the upper gastrointestinal tract (esophagus, stomach and duodenum). The upper gastrointestinal microbiota is essential for several gastrointestinal illnesses, including esophagitis, Barrett's esophagus, and esophageal carcinoma, gastritis and gastric cancer, small intestinal bacterial overgrowth, IBS and celiac disease. However, the constitution and diversity of the microbiota in different sections of the upper gastrointestinal tract under health and various disease states, as well as the function of microbiota in the pathogenesis of various digestive diseases are still undefined. The current article provides an overview of the recent findings regarding the relationship between upper gastrointestinal microbiota and gastrointestinal diseases; and discusses the study limitations and future directions of upper gastrointestinal microbiota research. (C) 2013 Baishideng. All rights reserved.
C1 [Wang, Zi-Kai; Yang, Yun-Sheng] Chinese PLA Med Acad, Chinese PLA Gen Hosp, Dept Gastroenterol & Hepatol, Beijing 100853, Peoples R China.
C3 Chinese People's Liberation Army General Hospital
RP Yang, YS (corresponding author), Chinese PLA Med Acad, Chinese PLA Gen Hosp, Dept Gastroenterol & Hepatol, Beijing 100853, Peoples R China.
EM sunny301ddc@126.com
RI Wang, Zikai/GQZ-6788-2022
CR Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005
   Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836
   [Anonymous], 1981, LANCET, V2, P906
   Aron-Wisnewsky J, 2012, NAT REV GASTRO HEPAT, V9, P590, DOI 10.1038/nrgastro.2012.161
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Belda-Ferre P, 2012, ISME J, V6, P46, DOI 10.1038/ismej.2011.85
   Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103
   Cassone A, 2012, AIDS, V26, P1457, DOI 10.1097/QAD.0b013e3283536ba8
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Collado MC, 2009, J CLIN PATHOL, V62, P264, DOI 10.1136/jcp.2008.061366
   Collins D, 2011, LANCET ONCOL, V12, P504, DOI 10.1016/S1470-2045(10)70186-8
   Cotter PD, 2011, CURR OPIN GASTROEN, V27, P99, DOI 10.1097/MOG.0b013e328341dc67
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219
   Dicksved J, 2009, J MED MICROBIOL, V58, P509, DOI 10.1099/jmm.0.007302-0
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Fillon SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042938
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Ford AC, 2009, DIS COLON RECTUM, V52, P1805, DOI 10.1007/DCR.0b013e3181ae0ab8
   Ford AC, 2009, CLIN GASTROENTEROL H, V7, P1279, DOI 10.1016/j.cgh.2009.06.031
   Franks Isobel, 2013, Nat Rev Gastroenterol Hepatol, V10, P3, DOI 10.1038/nrgastro.2012.227
   FRIED M, 1994, GUT, V35, P23, DOI 10.1136/gut.35.1.23
   Gagliardi D, 1998, Dis Esophagus, V11, P248
   Gao Ying-lan, 2008, Chinese Medical Sciences Journal, V23, P126
   Garcia A, 2009, REV MED CHILE, V137, P369, DOI /S0034-98872009000300007
   GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0
   Gotteland M, 2003, J ANTIMICROB CHEMOTH, V51, P1317, DOI 10.1093/jac/dkg227
   Greer JB, 2011, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00168
   Grusell EN, 2013, DIS ESOPHAGUS, V26, P84, DOI 10.1111/j.1442-2050.2012.01328.x
   Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9
   Harmsen HJM, 2002, APPL ENVIRON MICROB, V68, P2982, DOI 10.1128/AEM.68.6.2982-2990.2002
   Hu Y, 2012, WORLD J GASTROENTERO, V18, P1257, DOI 10.3748/wjg.v18.i11.1257
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789
   Jakobsson HE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009836
   Jazeron JF, 2012, J CLIN MICROBIOL, V50, P948, DOI 10.1128/JCM.05748-11
   Jeffery IB, 2012, GUT, V61, P997, DOI 10.1136/gutjnl-2011-301501
   Kado S, 2001, CANCER RES, V61, P2395
   Kassinen A, 2007, GASTROENTEROLOGY, V133, P24, DOI 10.1053/j.gastro.2007.04.005
   Kerckhoffs APM, 2011, J MED MICROBIOL, V60, P236, DOI 10.1099/jmm.0.022848-0
   Kerckhoffs APM, 2009, WORLD J GASTROENTERO, V15, P2887, DOI 10.3748/wjg.15.2887
   Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107
   Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287
   Li F, 2007, J MICROBIOL METH, V68, P303, DOI 10.1016/j.mimet.2006.09.006
   Li XX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007985
   Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061
   Lyra A, 2009, WORLD J GASTROENTERO, V15, P5936, DOI 10.3748/wjg.15.5936
   Macfarlane S, 2007, CLIN INFECT DIS, V45, P29, DOI 10.1086/518578
   Makhani M, 2011, J CLIN GASTROENTEROL, V45, P40, DOI 10.1097/MCG.0b013e3181f423ea
   Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7
   Malinen E, 2005, AM J GASTROENTEROL, V100, P373, DOI 10.1111/j.1572-0241.2005.40312.x
   MARSHALL BJ, 1984, LANCET, V1, P1311
   Matto J, 2005, FEMS IMMUNOL MED MIC, V43, P213, DOI 10.1016/j.femsim.2004.08.009
   McColl KEL, 2010, NEW ENGL J MED, V362, P1597, DOI 10.1056/NEJMcp1001110
   Michail S, 2012, INFLAMM BOWEL DIS, V18, P1799, DOI 10.1002/ibd.22860
   Moayyedi P, 2010, GUT, V59, P325, DOI 10.1136/gut.2008.167270
   Monstein HJ, 2000, J MED MICROBIOL, V49, P817, DOI 10.1099/0022-1317-49-9-817
   Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0
   Nakagawa S, 2005, CLIN DIAGN LAB IMMUN, V12, P347, DOI 10.1128/CDLI.12.2.347-353.2005
   Nistal E, 2012, INFLAMM BOWEL DIS, V18, P649, DOI 10.1002/ibd.21830
   Pajecki D, 2002, J GASTROINTEST SURG, V6, P723, DOI 10.1016/S1091-255X(02)00028-8
   Palmer C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj007
   Pei ZH, 2004, P NATL ACAD SCI USA, V101, P4250, DOI 10.1073/pnas.0306398101
   Pei ZH, 2005, WORLD J GASTROENTERO, V11, P7277, DOI 10.3748/wjg.v11.i46.7277
   Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109
   Pimentel M, 2003, AM J GASTROENTEROL, V98, P412, DOI 10.1016/S0002-9270(02)05902-6
   Pimentel M, 2011, GASTROENTEROL CLIN N, V40, P69, DOI 10.1016/j.gtc.2010.12.010
   Pimentel M, 2011, NEW ENGL J MED, V364, P22, DOI 10.1056/NEJMoa1004409
   Posserud I, 2007, GUT, V56, P802, DOI 10.1136/gut.2006.108712
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095
   Sanduleanu S, 2001, ALIMENT PHARM THERAP, V15, P1163, DOI 10.1046/j.1365-2036.2001.01029.x
   Sanz Y, 2007, FEMS IMMUNOL MED MIC, V51, P562, DOI 10.1111/j.1574-695X.2007.00337.x
   Sartor RB, 2012, NAT REV GASTRO HEPAT, V9, P561, DOI 10.1038/nrgastro.2012.157
   Saulnier DM, 2011, GASTROENTEROLOGY, V141, P1782, DOI 10.1053/j.gastro.2011.06.072
   Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x
   Shen XJ, 2010, GUT MICROBES, V1, P138, DOI 10.4161/gmic.1.3.12360
   Shibuya K, 2001, Int J Infect Dis, V5, P78, DOI 10.1016/S1201-9712(01)90030-X
   Simren M, 2006, GUT, V55, P297, DOI 10.1136/gut.2005.075127
   Smith NR, 2008, APPL ENVIRON MICROB, V74, P216, DOI 10.1128/AEM.01355-07
   Spiegel BMR, 2011, CLIN GASTROENTEROL H, V9, P461, DOI 10.1016/j.cgh.2011.02.030
   Spiegel BMR, 2008, AM J GASTROENTEROL, V103, P2972, DOI 10.1111/j.1572-0241.2008.01992.x
   Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074
   Stearns JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00170
   Suerbaum S, 2009, GASTROENTEROLOGY, V137, P419, DOI 10.1053/j.gastro.2009.06.017
   Sun YQ, 2003, HELICOBACTER, V8, P149, DOI 10.1046/j.1523-5378.2003.00136.x
   Tana C, 2010, NEUROGASTROENT MOTIL, V22, P512, DOI 10.1111/j.1365-2982.2009.01427.x
   Tjellstrom B, 2005, AM J GASTROENTEROL, V100, P2784, DOI 10.1111/j.1572-0241.2005.00313.x
   Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Vaishampayan PA, 2010, GENOME BIOL EVOL, V2, P53, DOI 10.1093/gbe/evp057
   Vesper BJ, 2009, CURR DRUG METAB, V10, P84, DOI 10.2174/138920009787048392
   Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336
   Woodmansey EJ, 2007, J APPL MICROBIOL, V102, P1178, DOI 10.1111/j.1365-2672.2007.03400.x
   Yang LY, 2012, CLIN CANCER RES, V18, P2138, DOI 10.1158/1078-0432.CCR-11-0934
   Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046
   Yin YN, 2011, HELICOBACTER, V16, P389, DOI 10.1111/j.1523-5378.2011.00862.x
   Yu D, 2011, GUT, V60, P334, DOI 10.1136/gut.2009.205476
   Zaman C, 2010, J GASTROEN HEPATOL, V25, pS11, DOI 10.1111/j.1440-1746.2009.06215.x
   Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002
NR 103
TC 51
Z9 57
U1 2
U2 128
PU BAISHIDENG PUBLISHING GROUP INC
PI PLEASANTON
PA 8226 REGENCY DR, PLEASANTON, CA 94588 USA
SN 1007-9327
EI 2219-2840
J9 WORLD J GASTROENTERO
JI World J. Gastroenterol.
PD MAR 14
PY 2013
VL 19
IS 10
BP 1541
EP 1550
DI 10.3748/wjg.v19.i10.1541
PG 10
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 105IK
UT WOS:000316060500007
PM 23539678
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Singh, R
   Chandrashekharappa, S
   Bodduluri, SR
   Baby, BV
   Hegde, B
   Kotla, NG
   Hiwale, AA
   Saiyed, T
   Patel, P
   Vijay-Kumar, M
   Langille, MGI
   Douglas, GM
   Cheng, X
   Rouchka, EC
   Waigel, SJ
   Dryden, GW
   Alatassi, H
   Zhang, HG
   Haribabu, B
   Vemula, PK
   Jala, VR
AF Singh, Rajbir
   Chandrashekharappa, Sandeep
   Bodduluri, Sobha R.
   Baby, Becca, V
   Hegde, Bindu
   Kotla, Niranjan G.
   Hiwale, Ankita A.
   Saiyed, Taslimarif
   Patel, Paresh
   Vijay-Kumar, Matam
   Langille, Morgan G., I
   Douglas, Gavin M.
   Cheng, Xi
   Rouchka, Eric C.
   Waigel, Sabine J.
   Dryden, Gerald W.
   Alatassi, Houda
   Zhang, Huang-Ge
   Haribabu, Bodduluri
   Vemula, Praveen K.
   Jala, Venkatakrishna R.
TI Enhancement of the gut barrier integrity by a microbial metabolite
   through the Nrf2 pathway
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ARYL-HYDROCARBON RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; TIGHT JUNCTIONS;
   CROSS-TALK; INTESTINAL INFLAMMATION; STRESS-RESPONSE; ELLAGIC ACID;
   GENE; HEALTH; UROLITHIN
AB The importance of gut microbiota in human health and pathophysiology is undisputable. Despite the abundance of metagenomics data, the functional dynamics of gut microbiota in human health and disease remain elusive. Urolithin A (UroA), a major microbial metabolite derived from polyphenolics of berries and pomegranate fruits displays anti-inflammatory, anti-oxidative, and anti-ageing activities. Here, we show that UroA and its potent synthetic analogue (UAS03) significantly enhance gut barrier function and inhibit unwarranted inflammation. We demonstrate that UroA and UAS03 exert their barrier functions through activation of aryl hydrocarbon receptor (AhR)-nuclear factor erythroid 2-related factor 2 (Nrf2)-dependent pathways to upregulate epithelial tight junction proteins. Importantly, treatment with these compounds attenuated colitis in pre-clinical models by remedying barrier dysfunction in addition to anti-inflammatory activities. Cumulatively, the results highlight how microbial metabolites provide two-pronged beneficial activities at gut epithelium by enhancing barrier functions and reducing inflammation to protect from colonic diseases.
C1 [Singh, Rajbir; Bodduluri, Sobha R.; Baby, Becca, V; Hegde, Bindu; Zhang, Huang-Ge; Haribabu, Bodduluri; Jala, Venkatakrishna R.] Univ Louisville, James Graham Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40202 USA.
   [Chandrashekharappa, Sandeep; Kotla, Niranjan G.; Hiwale, Ankita A.; Vemula, Praveen K.] Inst Stem Cell Biol & Regenerat Med inStem, GKVK Campus, Bangalore 560065, Karnataka, India.
   [Saiyed, Taslimarif; Patel, Paresh] Ctr Cellular & Mol Platforms C CAMP, GKVK Campus, Bangalore 560065, Karnataka, India.
   [Vijay-Kumar, Matam; Cheng, Xi] Univ Toledo, Dept Physiol & Pharmacol, Coll Med & Life Sci, Toledo, OH 43614 USA.
   [Langille, Morgan G., I; Douglas, Gavin M.] Dalhousie Univ, Dept Pharmacol, Halifax, NS B3H 4R2, Canada.
   [Rouchka, Eric C.] Univ Louisville, Kentucky Biomed Res Infrastruct Network, Comp Engn & Comp Sci, Louisville, KY 40202 USA.
   [Waigel, Sabine J.; Dryden, Gerald W.] Univ Louisville, Dept Med, Louisville, KY 40202 USA.
   [Alatassi, Houda] Univ Louisville, Dept Pathol, Louisville, KY 40202 USA.
C3 University of Louisville; Department of Biotechnology (DBT) India;
   Institute for Stem Cell Biology & Regenerative Medicine - inStem;
   University System of Ohio; University of Toledo; Dalhousie University;
   University of Louisville; University of Louisville; University of
   Louisville
RP Jala, VR (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Dept Microbiol & Immunol, Louisville, KY 40202 USA.; Vemula, PK (corresponding author), Inst Stem Cell Biol & Regenerat Med inStem, GKVK Campus, Bangalore 560065, Karnataka, India.
EM praveenv@instem.res.in; jvrao001@louisville.edu
RI Hegde, Bindu/AAK-2421-2020; Bodduluri, Haribabu/A-2584-2010; Singh,
   Rajbir/AAT-4666-2020; Vijay-Kumar, Matam/Q-8988-2019;
   Chandrashekharappa, Dr. Sandeep/V-8205-2018; Kotla,
   Niranjan/AGR-6113-2022; Cheng, Xi/AAV-6176-2020
OI Hegde, Bindu/0000-0001-5213-0606; Bodduluri,
   Haribabu/0000-0002-8261-3294; Singh, Rajbir/0000-0002-2307-2360;
   Chandrashekharappa, Dr. Sandeep/0000-0003-2475-7270; Kotla,
   Niranjan/0000-0003-0396-5871; Cheng, Xi/0000-0002-0838-5094; Langille,
   Morgan/0000-0002-6604-3009
FU NIH/NCI [R21CA216090, CA191683]; NIH/NIGMS CoBRE grant [P20GM125504-01];
   Microbiology and Immunology (U of L); Rounsavall Foundation; The Jewish
   Heritage Fund for Excellence Research Enhancement Grant; JGBCC; NIH
   [P20GM103436, P30GM106396]; J. G. Brown Foundation; Department of
   Biotechnology (DBT) [BT/PR12490/AAQ/3/716/2015]; Institute for Stem Cell
   Biology and Regenerative Medicine (inStem); Ramalingaswami ReEntry
   Fellowship (DBT), India; Department of Science and Technology (DST)
   under the Scheme for Young Scientists and Technologies program
   [SP/YO/078/2017]; Council of Scientific & Industrial Research (CSIR);
   NATIONAL CANCER INSTITUTE [R21CA216090] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM125504,
   P30GM106396, P20GM103436] Funding Source: NIH RePORTER
FX This work is financially supported by NIH/NCI (R21CA216090), NIH/NIGMS
   CoBRE grant (P20GM125504-01) and pilot grants from Microbiology and
   Immunology (U of L), Rounsavall Foundation and The Jewish Heritage Fund
   for Excellence Research Enhancement Grant and JGBCC to V.R.J.; V.R.J.
   and R.S. are partially supported by funds from NIH/NCI (CA191683). Part
   of RNA-Seq experiment was performed with assistance of the U of L
   Genomics Facility, which is supported by NIH P20GM103436 (KY IDeA
   Networks of Biomedical Research Excellence), NIH P30GM106396 (UofL J.G.
   Brown Cancer Center Phase III CoBRE), the J. G. Brown Foundation, and
   user fees. We thank JGBCC imaging core facilites at U of L. This work is
   financially supported by Department of Biotechnology (DBT)
   (BT/PR12490/AAQ/3/716/2015) to P.K.V., and core-funds from the Institute
   for Stem Cell Biology and Regenerative Medicine (inStem). P.K.V. is
   supported by Ramalingaswami ReEntry Fellowship (DBT), India. S.C. is
   supported by Department of Science and Technology (DST) under the Scheme
   for Young Scientists and Technologies program (SP/YO/078/2017). A.A.H.
   is supported by Senior Research Fellowship by Council of Scientific &
   Industrial Research (CSIR). We thank animal house facility/members and
   Central Imaging & Flow Cytometry, NMR facilities at inStem and NCBS.
CR Al-Sawaf O, 2015, CLIN SCI, V129, P989, DOI 10.1042/CS20150436
   Andrews S., 2014, FASTQC QUALITY CONTR
   Antoniou E, 2016, ANN MED SURG, V11, P9, DOI 10.1016/j.amsu.2016.07.019
   Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373
   Bain CC, 2014, IMMUNOL REV, V260, P102, DOI 10.1111/imr.12192
   Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20
   Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011
   Benson JM, 2011, TOXICOL SCI, V120, P68, DOI 10.1093/toxsci/kfq360
   Capaldo CT, 2009, BBA-BIOMEMBRANES, V1788, P864, DOI 10.1016/j.bbamem.2008.08.027
   Espin JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418
   Cerda B, 2005, J AGR FOOD CHEM, V53, P5571, DOI 10.1021/jf050384i
   DELPRE G, 1989, AM J GASTROENTEROL, V84, P1038
   Derosa G, 2016, ADV EXP MED BIOL, V928, P473, DOI 10.1007/978-3-319-41334-1_20
   Dzutsev A, 2017, ANNU REV IMMUNOL, V35, P199, DOI 10.1146/annurev-immunol-051116-052133
   Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557
   Esser C, 2015, PHARMACOL REV, V67, P259, DOI 10.1124/pr.114.009001
   Flicek P, 2014, NUCLEIC ACIDS RES, V42, pD749, DOI 10.1093/nar/gkt1196
   Forster C, 2008, HISTOCHEM CELL BIOL, V130, P55, DOI 10.1007/s00418-008-0424-9
   Fukumoto S, 2014, IMMUNOL CELL BIOL, V92, P460, DOI 10.1038/icb.2014.2
   Furumatsu K, 2011, DIGEST DIS SCI, V56, P2532, DOI 10.1007/s10620-011-1643-9
   Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027
   Gaya P, 2018, J FUNCT FOODS, V45, P95, DOI 10.1016/j.jff.2018.03.040
   Gbinigie OA, 2017, NUTR RES, V46, P38, DOI 10.1016/j.nutres.2017.07.007
   Gimenez-Bastida JA, 2012, MOL NUTR FOOD RES, V56, P784, DOI 10.1002/mnfr.201100677
   Goettel JA, 2016, CELL REP, V17, P1318, DOI 10.1016/j.celrep.2016.09.082
   Gopalakrishnan V, 2018, CANCER CELL, V33, P570, DOI 10.1016/j.ccell.2018.03.015
   Habauzit V, 2012, THER ADV CHRONIC DIS, V3, P87, DOI 10.1177/2040622311430006
   Hayes JD, 2009, TOXICOL SCI, V111, P199, DOI 10.1093/toxsci/kfp168
   Heber D, 2008, CANCER LETT, V269, P262, DOI 10.1016/j.canlet.2008.03.043
   Khor TO, 2006, CANCER RES, V66, P11580, DOI 10.1158/0008-5472.CAN-06-3562
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678
   Kobayashi EH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11624
   Konig J, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2016.54
   Kowapradit J, 2010, AAPS PHARMSCITECH, V11, P497, DOI 10.1208/s12249-010-9399-7
   Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575
   Landy J, 2016, WORLD J GASTROENTERO, V22, P3117, DOI 10.3748/wjg.v22.i11.3117
   Larrosa M, 2010, J NUTR BIOCHEM, V21, P717, DOI 10.1016/j.jnutbio.2009.04.012
   Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7
   Loboda A, 2016, CELL MOL LIFE SCI, V73, P3221, DOI 10.1007/s00018-016-2223-0
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Metidji A, 2018, IMMUNITY, V49, P353, DOI 10.1016/j.immuni.2018.07.010
   Miao WM, 2005, J BIOL CHEM, V280, P20340, DOI 10.1074/jbc.M412081200
   Mitsuishi Y, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00200
   Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007
   MURTHY SNS, 1993, DIGEST DIS SCI, V38, P1722, DOI 10.1007/BF01303184
   Novak EA, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00062
   Razani Z, 2017, PHYTOTHER RES, V31, P1731, DOI 10.1002/ptr.5901
   Rodenburg W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-144
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Saha P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156811
   Sak Katrin, 2014, Pharmacogn Rev, V8, P122, DOI 10.4103/0973-7847.134247
   Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080
   Schulzke JD, 2009, ANN NY ACAD SCI, V1165, P294, DOI 10.1111/j.1749-6632.2009.04062.x
   Sekine H, 2009, MOL CELL BIOL, V29, P6391, DOI 10.1128/MCB.00337-09
   Selma MV, 2014, FOOD FUNCT, V5, P1779, DOI [10.1039/c4fo00092g, 10.1039/C4FO00092G]
   Shin S, 2007, MOL CELL BIOL, V27, P7188, DOI 10.1128/MCB.00915-07
   Singh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072517
   Smith PD, 2011, MUCOSAL IMMUNOL, V4, P31, DOI 10.1038/mi.2010.66
   Sonnenburg JL, 2016, NATURE, V535, P56, DOI 10.1038/nature18846
   Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245
   Stockton A, 2017, J NUTR SCI, V6, DOI 10.1017/jns.2017.36
   Tamboli CP, 2004, GUT, V53, P1, DOI 10.1136/gut.53.1.1
   Tomas-Barberan FA, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201500901
   Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   Tsukita S, 2002, CURR OPIN CELL BIOL, V14, P531, DOI 10.1016/S0955-0674(02)00362-9
   Vindigni SM, 2016, THER ADV GASTROENTER, V9, P606, DOI 10.1177/1756283X16644242
   Wardyn JD, 2015, BIOCHEM SOC T, V43, P621, DOI 10.1042/BST20150014
   Yeager RL, 2009, TOXICOL SCI, V111, P238, DOI 10.1093/toxsci/kfp115
NR 70
TC 262
Z9 272
U1 28
U2 158
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JAN 9
PY 2019
VL 10
AR 89
DI 10.1038/s41467-018-07859-7
PG 18
WC Multidisciplinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Science & Technology - Other Topics
GA HG8PB
UT WOS:000455264100001
PM 30626868
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Stevenson, LJ
   Bracegirdle, J
   Liu, LW
   Sharrock, AV
   Ackerley, DF
   Keyzers, RA
   Owen, JG
AF Stevenson, Luke J.
   Bracegirdle, Joe
   Liu, Liwei
   Sharrock, Abigail, V
   Ackerley, David F.
   Keyzers, Robert A.
   Owen, Jeremy G.
TI Metathramycin, a new bioactive aureolic acid discovered by heterologous
   expression of a metagenome derived biosynthetic pathway
SO RSC CHEMICAL BIOLOGY
LA English
DT Article
ID ANTITUMOR DRUG; COMBINATORIAL BIOSYNTHESIS; TARGETED DISCOVERY;
   NATURAL-PRODUCTS; ABC TRANSPORTER; GENE-CLUSTER; MITHRAMYCIN;
   STREPTOMYCES; ORGANISM; GENOMES
AB Bacterial natural products have been a rich source of bioactive compounds for drug development, and advances in DNA sequencing, informatics and molecular biology have opened new avenues for their discovery. Here, we describe the isolation of an aureolic acid biosynthetic gene cluster from a metagenome library derived from a New Zealand soil sample. Heterologous expression of this pathway in Streptomyces albus resulted in the production and isolation of two new aureolic acid compounds, one of which (metathramycin, 6) possesses potent bioactivity against a human colon carcinoma cell line (HCT-116, IC50 = 14.6 nM). As metathramycin was a minor constituent of the fermentation extract, its discovery relied on a combination of approaches including bioactivity guided fractionation, MS/MS characterisation and pathway engineering. This study not only demonstrates the presence of previously uncharacterised aureolic acids in the environment, but also the value of an integrated natural product discovery approach which may be generally applicable to low abundance bioactive metabolites.
C1 [Stevenson, Luke J.; Liu, Liwei; Sharrock, Abigail, V; Ackerley, David F.; Owen, Jeremy G.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.
   [Stevenson, Luke J.; Bracegirdle, Joe; Sharrock, Abigail, V; Ackerley, David F.; Keyzers, Robert A.; Owen, Jeremy G.] Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.
   [Stevenson, Luke J.; Bracegirdle, Joe; Sharrock, Abigail, V; Ackerley, David F.; Keyzers, Robert A.; Owen, Jeremy G.] Victoria Univ Wellington, Ctr Biodiscovery, Sch Biol Sci, Wellington, New Zealand.
   [Bracegirdle, Joe; Keyzers, Robert A.] Victoria Univ Wellington, Sch Chem & Phys Sci, Wellington, New Zealand.
C3 Victoria University Wellington; University of Auckland; Victoria
   University Wellington; Victoria University Wellington
RP Owen, JG (corresponding author), Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand.; Owen, JG (corresponding author), Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.; Owen, JG (corresponding author), Victoria Univ Wellington, Ctr Biodiscovery, Sch Biol Sci, Wellington, New Zealand.
EM jeremy.owen@vuw.ac.nz
RI Sharrock, Abigail/GWC-8967-2022; Keyzers, Rob/K-2144-2015
OI Liu, Li-Wei/0000-0002-0578-1091; Keyzers, Rob/0000-0002-7658-7421;
   Stevenson, Luke/0000-0002-1130-2747; Sharrock,
   Abigail/0000-0003-2837-9481; Bracegirdle, Joe/0000-0001-7725-3477;
   Ackerley, David/0000-0002-6188-9902
CR Baig I, 2008, J NAT PROD, V71, P199, DOI 10.1021/np0705763
   Berlin Y. A., 1973, CHEM NAT COMPD, V9, P504
   Berlin Y. A., 1975, CHEM NAT COMPD, V9, P492
   BERLIN YA, 1968, CHEM COMMUN, P762, DOI 10.1039/c19680000762
   Bhushan A, 2019, NAT CHEM, V11, P931, DOI 10.1038/s41557-019-0323-9
   Blin K, 2017, NUCLEIC ACIDS RES, V45, pW36, DOI 10.1093/nar/gkx319
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brady SF, 2007, NAT PROTOC, V2, P1297, DOI 10.1038/nprot.2007.195
   BRAZHNIKOVA M G, 1962, Antibiotiki, V7, P39
   Copp JN, 2014, PROTEIN ENG DES SEL, V27, P399, DOI 10.1093/protein/gzu025
   Feng ZY, 2011, P NATL ACAD SCI USA, V108, P12629, DOI 10.1073/pnas.1103921108
   Fernandez E, 1996, MOL GEN GENET, V251, P692, DOI 10.1007/BF02174118
   Fulmer GR, 2010, ORGANOMETALLICS, V29, P2176, DOI 10.1021/om100106e
   Garcia-Bernardo J, 2000, FEMS MICROBIOL LETT, V186, P61, DOI 10.1111/j.1574-6968.2000.tb09082.x
   Gibson M, 2005, J AM CHEM SOC, V127, P17594, DOI 10.1021/ja055750t
   Herai S, 2004, P NATL ACAD SCI USA, V101, P14031, DOI 10.1073/pnas.0406058101
   Hover BM, 2018, NAT MICROBIOL, V3, P415, DOI 10.1038/s41564-018-0110-1
   Jayasuriya H, 2002, J NAT PROD, V65, P1091, DOI 10.1021/np010642f
   Kallifidas D, 2012, METHOD ENZYMOL, V517, P225, DOI 10.1016/B978-0-12-404634-4.00011-5
   Kang HS, 2017, J IND MICROBIOL BIOT, V44, P285, DOI 10.1007/s10295-016-1874-z
   Kang HS, 2016, ACS SYNTH BIOL, V5, P1002, DOI 10.1021/acssynbio.6b00080
   Kang HS, 2014, J AM CHEM SOC, V136, P18111, DOI 10.1021/ja510606j
   Kang HS, 2013, ANGEW CHEM INT EDIT, V52, P11063, DOI 10.1002/anie.201305109
   Katz M, 2016, J IND MICROBIOL BIOT, V43, P129, DOI 10.1007/s10295-015-1706-6
   Kim JH, 2010, BIOPOLYMERS, V93, P833, DOI 10.1002/bip.21450
   Kim MC, 2018, J AM CHEM SOC, V140, P10775, DOI 10.1021/jacs.8b04848
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leem SH, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng029
   Lombo F, 1999, J BACTERIOL, V181, P642
   Lombo F., 2006, APPL MICROBIOL BIOT, V73, P1
   Mendez C, 2015, PLANTA MED, V81, P1326, DOI [10.1055/s0035-1557876, 10.1055/s-0035-1557876]
   Menendez N, 2004, CHEM BIOL, V11, P21, DOI 10.1016/j.chembiol.2003.12.011
   Menendez N, 2007, MICROBIOL-SGM, V153, P3061, DOI 10.1099/mic.0.2007/007922-0
   Metsa-Ketela M, 1999, FEMS MICROBIOL LETT, V180, P1
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Nunez LE, 2012, J MED CHEM, V55, P5813, DOI 10.1021/jm300234t
   Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084
   Ogawa H, 1998, J ANTIBIOT, V51, P261, DOI 10.7164/antibiotics.51.261
   Owen JG, 2015, P NATL ACAD SCI USA, V112, P4221, DOI 10.1073/pnas.1501124112
   Prado L, 1999, CHEM BIOL, V6, P19, DOI 10.1016/S1074-5521(99)80017-9
   Remsing LL, 2003, J AM CHEM SOC, V125, P5745, DOI 10.1021/ja034162h
   Rodriguez D, 2003, J BACTERIOL, V185, P3962, DOI 10.1128/JB.185.13.3962-3965.2003
   Sabin J.G., 2013, BIOCHEM PHARMACOL, V2, P1
   STAJNER K, 1974, FOLIA MICROBIOL, V19, P498, DOI 10.1007/BF02872916
   Stevenson LJ, 2019, ACS CHEM BIOL, V14, P2115, DOI 10.1021/acschembio.9b00618
   Sugimoto Y, 2019, SCIENCE, V366, P1332, DOI 10.1126/science.aax9176
   Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521
   Winn R., 2010, TECHNIQUES AQUATIC T, V2
   Wohlert SE, 1999, J NAT PROD, V62, P119, DOI 10.1021/np980355k
   Zhang JJ, 2019, NAT PROD REP, V36, P1313, DOI 10.1039/c9np00025a
NR 50
TC 6
Z9 7
U1 0
U2 7
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2633-0679
J9 RSC CHEM BIOL
JI RSC Chem. Biol.
PD APR 1
PY 2021
VL 2
IS 2
BP 556
EP 567
DI 10.1039/d0cb00228c
PG 12
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Emerging Sources Citation Index (ESCI)
SC Biochemistry & Molecular Biology; Chemistry
GA RP5QZ
UT WOS:000641784900016
PM 34458799
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Sogodogo, E
   Drancourt, M
   Grine, G
AF Sogodogo, E.
   Drancourt, M.
   Grine, Ghiles
TI Methanogens as emerging pathogens in anaerobic abscesses
SO EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
LA English
DT Review
ID 16S RIBOSOMAL-RNA; METHANOBREVIBACTER-SMITHII; SP-NOV; ARCHAEA;
   IDENTIFICATION; BACTERIA
AB Methanogens are strictly anaerobic archaea metabolising by-products of bacterial fermentation into methane by using three known metabolic pathways, i.e. the reduction of carbon dioxide, the fermentation of acetate or the dismutation of methanol or methylamines. Methanogens described in human microbiota include only Euryarchaeota, i.e. Methanobrevibacter smithii, Methanobrevibacter oralis, Methanobrevibacter arbophilus, Methanobrevibacter massiliensis, Methanomassiliicoccus luminyensis, Methanosphaera stadtmanae and Ca. Methanomethylophilus alvus and Ca. Methanomassiliicoccus intestinalis. Methanogens are emerging pathogens associated with brain and muscular abscesses. They have been implicated in dysbiosis of the oral microbiota, periodontitis and peri-implantitis. They have also been associated with dysbiosis of the digestive tract microbiota linked to metabolic disorders (anorexia, malnutrition and obesity) and with lesions of the digestive tract (colon cancer). Their detection in anaerobic pus specimens and oral and digestive tract specimens relies on microscopic examination by fluorescence in situ hybridisation, specific DNA extraction followed by polymerase chain reaction (PCR)-based amplification of the 16S rRNA and mcrA gene fragments and isolation and culture in the supporting presence of hydrogen-producing bacteria. Diagnostic identification can be performed by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) and can be further completed by genotyping through multi-spacer sequencing and, ultimately, whole genome sequencing (WGS). Ornidazole derivatives, fusidic acid and rifampicin are the compounds to be included in in vitro susceptibility testing to complete the clinical workflow. Clinical microbiology laboratories should work toward developing cheap and easy protocols for the routine detection and identification of methanogens in selected specimens in order to refine the diagnosis of infections, as well as to expand the knowledge about this group of intriguing microorganisms.
C1 [Sogodogo, E.; Drancourt, M.; Grine, Ghiles] IHU Mediterranee Infect, UMR MEPHI, 19-21 Bd Jean Moulin, F-13005 Marseille, France.
   [Sogodogo, E.; Drancourt, M.; Grine, Ghiles] Aix Marseille Univ, MEPHI, IRD, IHU Mediterranee Infect, Marseille, France.
C3 UDICE-French Research Universities; Aix-Marseille Universite; Institut
   de Recherche pour le Developpement (IRD); UDICE-French Research
   Universities; Aix-Marseille Universite
RP Grine, G (corresponding author), IHU Mediterranee Infect, UMR MEPHI, 19-21 Bd Jean Moulin, F-13005 Marseille, France.; Grine, G (corresponding author), Aix Marseille Univ, MEPHI, IRD, IHU Mediterranee Infect, Marseille, France.
EM grineghiles@gmail.com
CR Allen KD, 2018, METHOD ENZYMOL, V606, P461, DOI 10.1016/bs.mie.2018.04.015
   Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125
   Bang C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185919
   BELAY N, 1988, APPL ENVIRON MICROB, V54, P600, DOI 10.1128/AEM.54.2.600-603.1988
   Belkacemi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27862-8
   Drancourt M, 2017, CLIN INFECT DIS, V65, P1, DOI 10.1093/cid/cix286
   Dridi B, 2012, CLIN MICROBIOL INFEC, V18, P825, DOI 10.1111/j.1469-0691.2012.03952.x
   Dridi B, 2012, INT J SYST EVOL MICR, V62, P1902, DOI 10.1099/ijs.0.033712-0
   Dridi B, 2012, APMIS, V120, P85, DOI 10.1111/j.1600-0463.2011.02833.x
   Dridi B, 2011, J ANTIMICROB CHEMOTH, V66, P2038, DOI 10.1093/jac/dkr251
   Dridi B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007063
   Grine G, 2017, EUR J CLIN MICROBIOL, V36, P2449, DOI 10.1007/s10096-017-3084-7
   Grine G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27372-7
   Huynh HTT, 2015, EUR J CLIN MICROBIOL, V34, P1097, DOI 10.1007/s10096-015-2325-x
   Huynh HTT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121565
   Kern Tobias, 2016, Int J Syst Evol Microbiol, V66, P1533, DOI 10.1099/ijsem.0.000894
   Kern T, 2015, INT J SYST EVOL MICR, V65, P1975, DOI 10.1099/ijs.0.000210
   Khelaifia S, 2016, EUR J CLIN MICROBIOL, V35, P985, DOI 10.1007/s10096-016-2627-7
   Khelaifia S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061563
   Khelaifia Saber, 2013, BMC Res Notes, V6, P186, DOI 10.1186/1756-0500-6-186
   Khelaifia S, 2013, INT J ANTIMICROB AG, V41, P544, DOI 10.1016/j.ijantimicag.2013.02.013
   Koskinen K, 2017, MBIO, V8, DOI 10.1128/mBio.00824-17
   KURR M, 1991, ARCH MICROBIOL, V156, P239, DOI 10.1007/BF00262992
   Lurie-Weinberger MN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004833
   Luton PE, 2002, MICROBIOL-SGM, V148, P3521, DOI 10.1099/00221287-148-11-3521
   Lyu Z, 2018, CURR BIOL, V28, pR727, DOI 10.1016/j.cub.2018.05.021
   MILLER TL, 1982, APPL ENVIRON MICROB, V43, P227, DOI 10.1128/AEM.43.1.227-232.1982
   Million M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26051
   Moissl-Eichinger C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04197-4
   Neu J, 2011, CLIN PERINATOL, V38, P321, DOI 10.1016/j.clp.2011.03.008
   Nkamga VD, 2018, CLIN MICROBIOL INFEC, V24, P207, DOI 10.1016/j.cmi.2017.08.021
   Nkamga VD, 2016, CLIN MICROBIOL INFEC, V22, P1008, DOI 10.1016/j.cmi.2016.09.007
   Nkamga VD, 2015, CURR MICROBIOL, V70, P810, DOI 10.1007/s00284-015-0787-9
   Nkamga VD, 2017, HUM MICROBIOME J, V3, P1, DOI [10.1016/j.humic.2016.11.005, DOI 10.1016/J.HUMIC.2016.11.005]
   Nkamga VD, 2016, BERGEYS MANUAL SYSTE
   Ollivier B, 1997, FEMS MICROBIOL LETT, V147, P51, DOI 10.1016/S0378-1097(96)00501-0
   Probst AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065388
   RASKIN L, 1994, APPL ENVIRON MICROB, V60, P1232, DOI 10.1128/AEM.60.4.1232-1240.1994
   Samuel BS, 2007, P NATL ACAD SCI USA, V104, P10643, DOI 10.1073/pnas.0704189104
   Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885
   Triantafyllou K, 2014, J NEUROGASTROENTEROL, V20, P31, DOI 10.5056/jnm.2014.20.1.31
   Tung NH, 2013, APMIS, V121, P467, DOI 10.1111/apm.12015
   Vanwonterghem I, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.170, 10.1038/nmicrobiol.2016.170]
   Vianna ME, 2006, J CLIN MICROBIOL, V44, P1274, DOI 10.1128/JCM.44.4.1274-1282.2006
   Wampach L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00738
   WEAVER GA, 1986, GUT, V27, P698, DOI 10.1136/gut.27.6.698
   Wolfe RS, 2011, METHOD ENZYMOL, V494, P1, DOI 10.1016/B978-0-12-385112-3.00001-9
   Yazici C, 2016, DIGEST DIS SCI, V61, P2648, DOI 10.1007/s10620-016-4174-6
   ZEIKUS JG, 1975, A VAN LEEUW J MICROB, V41, P543, DOI 10.1007/BF02565096
NR 49
TC 12
Z9 12
U1 1
U2 17
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0934-9723
EI 1435-4373
J9 EUR J CLIN MICROBIOL
JI Eur. J. Clin. Microbiol. Infect. Dis.
PD MAY
PY 2019
VL 38
IS 5
BP 811
EP 818
DI 10.1007/s10096-019-03510-5
PG 8
WC Infectious Diseases; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Infectious Diseases; Microbiology
GA HT9EM
UT WOS:000464869000001
PM 30796545
DA 2022-11-22
ER

PT J
AU Zhang, JB
   Lacroix, C
   Wortmann, E
   Ruscheweyh, HJ
   Sunagawa, S
   Sturla, SJ
   Schwab, C
AF Zhang, Jianbo
   Lacroix, Christophe
   Wortmann, Esther
   Ruscheweyh, Hans-Joachim
   Sunagawa, Shinichi
   Sturla, Shana J.
   Schwab, Clarissa
TI Gut microbial beta-glucuronidase and glycerol/diol dehydratase activity
   contribute to dietary heterocyclic amine biotransformation
SO BMC MICROBIOLOGY
LA English
DT Article
DE Heterocyclic amines (HCA); Glycerol; diol dehydratase; Reuterin;
   -Glucuronidase; Faecalibacterium prausnitzii; Eubacterium hallii
ID N-HYDROXY-PHIP; METABOLIC-ACTIVATION; ESCHERICHIA-COLI; AROMATIC-AMINES;
   CARCINOGEN; BACTERIA; 2-AMINO-1-METHYL-6-PHENYLIMIDAZO<4,5-B>PYRIDINE;
   1,3-PROPANEDIOL; TRANSFORMATION; FERMENTATION
AB BackgroundConsuming red and processed meat has been associated with an increased risk of colorectal cancer (CRC), which is partly attributed to exposure to carcinogens such as heterocyclic amines (HCA) formed during cooking and preservation processes. The interaction of gut microbes and HCA can result in altered bioactivities and it has been shown previously that human gut microbiota can transform mutagenic HCA to a glycerol conjugate with reduced mutagenic potential. However, the major form of HCA in the colon are glucuronides(HCA-G) and it is not known whether these metabolites, via stepwise microbial hydrolysis and acrolein conjugation, are viable precursors for glycerol conjugated metabolites. We hypothesized that such a process could be concurrently catalyzed by bacterial beta-glucuronidase (B-GUS) and glycerol/diol dehydratase (GDH) activity. We therefore investigated how the HCA-G PhIP-N2--D-glucuronide (PhIP-G), a representative liver metabolite of PhIP(2-Amino-1-methyl-6-phenylimidazo [4,5-b] pyridine), which is the most abundant carcinogenic HCA in well-cooked meat,is transformedby enzymatic activity of human gut microbial representatives of the phyla Firmicutes, Bacteroidetes, and Proteobacteria.ResultsWe employed a combination of growth and enzymatic assays, and a bioanalysis approach combined with metagenomics. B-GUS of Faecalibacterium prausnitzii converted PhIP-G to PhIP and GDH of Flavonifractor plautii, Blautia obeum, Eubacterium hallii, and Lactobacillus reuteri converted PhIP to PhIP-M1 in the presence of glycerol. In addition, B-GUS- and GDH-positive bacteria cooperatively converted PhIP-G to PhIP-M1. A screen of genes encoding B-GUS and GDH was performed for fecal microbiome data from healthy individuals (n=103) and fromCRCpatients (n = 53), which revealed a decrease in abundance of taxa with confirmed GDH and HCA transformation activity in CRC patients.ConclusionsThis study for the first time demonstrates that gut microbes mediate the stepwise transformation of PhIP-G to PhIP-M1 via the intermediate production of PhIP. Findings from this study suggest that targeted manipulation with gut microbes bearing specific functions, or dietary glycerol supplementation might modify gut microbial activity to reduce HCA-induced CRC risk.
C1 [Zhang, Jianbo; Lacroix, Christophe; Wortmann, Esther; Sturla, Shana J.; Schwab, Clarissa] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.
   [Ruscheweyh, Hans-Joachim; Sunagawa, Shinichi] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland.
   [Zhang, Jianbo] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
C3 Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal
   Institutes of Technology Domain; ETH Zurich; Massachusetts Institute of
   Technology (MIT)
RP Schwab, C (corresponding author), Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland.
EM jianbo.zhang@hest.ethz.ch; clarissa.schwab@hest.ethz.ch
RI Sunagawa, Shinichi/Q-5950-2019; Schwab, Clarissa/AGL-7943-2022; ZHANG,
   JIANBO/L-5453-2013; Zhang, Jianbo/AAV-8023-2020; Lacroix,
   Christophe/B-5139-2016; schwab, clarissa/AAZ-4537-2020
OI Sunagawa, Shinichi/0000-0003-3065-0314; ZHANG,
   JIANBO/0000-0003-3526-4586; Zhang, Jianbo/0000-0003-3526-4586; Lacroix,
   Christophe/0000-0003-4360-2020; Schwab, Clarissa/0000-0002-5443-1602;
   Ruscheweyh, Hans-Joachim/0000-0001-7473-6086
FU ETH Zurich [ETH-41 16-1]; Chinese Scholarship Council [201406320209]
FX This work was supported by ETH Zurich (grant ETH-41 16-1 to SJS) and the
   Chinese Scholarship Council (grant 201406320209 to JZ). The funding
   bodies were not involved in the study design, data collection, analysis,
   and interpretation, decision to publish, and preparation of the
   manuscript.
CR ALEXANDER J, 1991, CARCINOGENESIS, V12, P2239, DOI 10.1093/carcin/12.12.2239
   Augustsson K, 1997, CARCINOGENESIS, V18, P1931, DOI 10.1093/carcin/18.10.1931
   Barbirato F, 1996, APPL ENVIRON MICROB, V62, P1448, DOI 10.1128/AEM.62.4.1448-1451.1996
   Bircher L, 2018, MICROB BIOTECHNOL, V11, P163, DOI 10.1111/1751-7915.12844
   BORONAT A, 1981, J BACTERIOL, V147, P181, DOI 10.1128/JB.147.1.181-185.1981
   Bouvard V, 2015, LANCET ONCOL, V16, P1599, DOI 10.1016/S1470-2045(15)00444-1
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176
   Dabek M, 2008, FEMS MICROBIOL ECOL, V66, P487, DOI 10.1111/j.1574-6941.2008.00520.x
   DRAGSTED LO, 1995, CARCINOGENESIS, V16, P2785, DOI 10.1093/carcin/16.11.2785
   Engels C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36246
   Engels C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00713
   Fekry MI, 2016, ENV MICROBIOL REP, V8, P201, DOI 10.1111/1758-2229.12369
   Ganzle MG, 2015, CURR OPIN FOOD SCI, V2, P106, DOI 10.1016/j.cofs.2015.03.001
   Gloux K, 2011, P NATL ACAD SCI USA, V108, P4539, DOI 10.1073/pnas.1000066107
   Gu D, 2011, ANAL CHEM, V83, P1093, DOI 10.1021/ac102918b
   HASEGAWA R, 1993, CARCINOGENESIS, V14, P2553, DOI 10.1093/carcin/14.12.2553
   HEIN DW, 1994, ARCH TOXICOL, V68, P129, DOI 10.1007/s002040050045
   Helmus DS, 2013, NUTR CANCER, V65, P1141, DOI 10.1080/01635581.2013.834945
   Humblot C, 2007, CARCINOGENESIS, V28, P2419, DOI 10.1093/carcin/bgm170
   KADERLIK KR, 1994, CARCINOGENESIS, V15, P1703, DOI 10.1093/carcin/15.8.1703
   Kim DH, 2001, ARCH PHARM RES, V24, P564, DOI 10.1007/BF02975166
   Lopez-Siles M, 2015, APPL ENVIRON MICROB, V81, P7582, DOI 10.1128/AEM.02006-15
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Malfatti MA, 2004, CHEM RES TOXICOL, V17, P1137, DOI 10.1021/tx049898m
   Malfatti MA, 2001, CARCINOGENESIS, V22, P1087, DOI 10.1093/carcin/22.7.1087
   MALFATTI MA, 1994, CHEM RES TOXICOL, V7, P139, DOI 10.1021/tx00038a005
   McIntosh FM, 2012, ENVIRON MICROBIOL, V14, P1876, DOI 10.1111/j.1462-2920.2012.02711.x
   Moghe A, 2015, TOXICOL SCI, V143, P242, DOI 10.1093/toxsci/kfu233
   Nicken P, 2015, TOXICOL LETT, V234, P92, DOI 10.1016/j.toxlet.2015.02.015
   O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189
   Pellock SJ, 2018, ACS CENTRAL SCI, V4, P868, DOI 10.1021/acscentsci.8b00239
   Pellock SJ, 2017, J BIOL CHEM, V292, P8569, DOI 10.1074/jbc.R116.767434
   Pollet RM, 2017, STRUCTURE, V25, P967, DOI 10.1016/j.str.2017.05.003
   Pritchard SE, 2014, NEUROGASTROENT MOTIL, V26, P124, DOI 10.1111/nmo.12243
   Seo MY, 2009, APPL MICROBIOL BIOT, V84, P527, DOI 10.1007/s00253-009-1980-1
   STYCZYNSKI PB, 1993, CHEM RES TOXICOL, V6, P846, DOI 10.1021/tx00036a014
   Sunagawa S, 2013, NAT METHODS, V10, P1196, DOI [10.1038/NMETH.2693, 10.1038/nmeth.2693]
   TAKADA H, 1982, CANCER RES, V42, P331
   Takasuna K, 1998, CANCER CHEMOTH PHARM, V42, P280, DOI 10.1007/s002800050818
   Turesky RJ, 2002, MUTAT RES-FUND MOL M, V506, P187, DOI 10.1016/S0027-5107(02)00165-3
   Turesky RJ, 2011, CHEM RES TOXICOL, V24, P1169, DOI 10.1021/tx200135s
   Vanhaecke L, 2008, FOOD CHEM TOXICOL, V46, P140, DOI 10.1016/j.fct.2007.07.008
   Vanhaecke L, 2008, TOXICOL LETT, V178, P61, DOI 10.1016/j.toxlet.2008.02.004
   Vanhaecke L, 2008, APPL ENVIRON MICROB, V74, P1469, DOI 10.1128/AEM.02064-07
   Vanhaecke L, 2006, J AGR FOOD CHEM, V54, P3454, DOI 10.1021/jf053170+
   Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803
   Yoon SH, 2017, INT J SYST EVOL MICR, V67, P1613, DOI 10.1099/ijsem.0.001755
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zenser TV, 1999, DRUG METAB DISPOS, V27, P1064
   Zhang JB, 2019, TOXICOL IN VITRO, V59, P238, DOI 10.1016/j.tiv.2019.04.004
   Zhang JB, 2018, MBIO, V9, DOI 10.1128/mBio.01947-17
   Zhang JB, 2017, TOXICOL SCI, V159, P266, DOI 10.1093/toxsci/kfx132
NR 53
TC 16
Z9 17
U1 0
U2 19
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2180
J9 BMC MICROBIOL
JI BMC Microbiol.
PD MAY 16
PY 2019
VL 19
AR 99
DI 10.1186/s12866-019-1483-x
PG 14
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA HY8VD
UT WOS:000468417600002
PM 31096909
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU El-Semman, IE
   Karlsson, FH
   Shoaie, S
   Nookaew, I
   Soliman, TH
   Nielsen, J
AF El-Semman, Ibrahim E.
   Karlsson, Fredrik H.
   Shoaie, Saeed
   Nookaew, Intawat
   Soliman, Taysir H.
   Nielsen, Jens
TI Genome-scale metabolic reconstructions of Bifidobacterium adolescentis
   L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction
SO BMC SYSTEMS BIOLOGY
LA English
DT Article
DE Bifidobacterium adolescentis L2-32; Faecalibacterium prausnitzii A2-165;
   Genome-scale metabolic model; Metabolic modeling of gut microbiota
ID SYSTEMS BIOLOGY; GUT MICROBIOTA; BACTEROIDES-THETAIOTAOMICRON; FLUX
   ANALYSIS; DATABASE; MODELS; CONSTRAINT; BUTYRATE; BACTERIA; GROWTH
AB Background: The gut microbiota plays an important role in human health and disease by acting as a metabolic organ. Metagenomic sequencing has shown how dysbiosis in the gut microbiota is associated with human metabolic diseases such as obesity and diabetes. Modeling may assist to gain insight into the metabolic implication of an altered microbiota. Fast and accurate reconstruction of metabolic models for members of the gut microbiota, as well as methods to simulate a community of microorganisms, are therefore needed. The Integrated Microbial Genomes (IMG) database contains functional annotation for nearly 4,650 bacterial genomes. This tremendous new genomic information adds new opportunities for systems biology to reconstruct accurate genome scale metabolic models (GEMs).
   Results: Here we assembled a reaction data set containing 2,340 reactions obtained from existing genome-scale metabolic models, where each reaction is assigned with KEGG Orthology. The reaction data set was then used to reconstruct two genome scale metabolic models for gut microorganisms available in the IMG database Bifidobacterium adolescentis L2-32, which produces acetate during fermentation, and Faecalibacterium prausnitzii A2-165, which consumes acetate and produces butyrate. F. prausnitzii is less abundant in patients with Crohn's disease and has been suggested to play an anti-inflammatory role in the gut ecosystem. The B. adolescentis model, iBif452, comprises 699 reactions and 611 unique metabolites. The F. prausnitzii model, iFap484, comprises 713 reactions and 621 unique metabolites. Each model was validated with in vivo data. We used OptCom and Flux Balance Analysis to simulate how both organisms interact.
   Conclusions: The consortium of iBif452 and iFap484 was applied to predict F. prausnitzii's demand for acetate and production of butyrate which plays an essential role in colonic homeostasis and cancer prevention. The assembled reaction set is a useful tool to generate bacterial draft models from KEGG Orthology.
C1 [El-Semman, Ibrahim E.; Karlsson, Fredrik H.; Shoaie, Saeed; Nookaew, Intawat; Nielsen, Jens] Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
   [El-Semman, Ibrahim E.] Assiut Univ, Fac Sci, Dept Math, Assiut, Egypt.
   [Soliman, Taysir H.] Assiut Univ, Fac Comp & Informat, Dept Informat Syst, Assiut, Egypt.
C3 Chalmers University of Technology; Egyptian Knowledge Bank (EKB); Assiut
   University; Egyptian Knowledge Bank (EKB); Assiut University
RP Nielsen, J (corresponding author), Chalmers Univ Technol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden.
EM nielsenj@chalmers.se
RI Nielsen, Jens/Q-1347-2017
OI Nielsen, Jens/0000-0002-9955-6003; Shoaie, Saeed/0000-0001-5834-4533;
   Karlsson, Fredrik/0000-0003-4377-6514
FU Egyptian Cultural Affairs and Missions Sector; Knut and Alice Wallenberg
   Foundation; Chalmers Library
FX We thank Ali Zomorrodi and Prof. Costas Maranas for providing us with
   OptCom implementation. Ibrahim E. El-Semman appreciates the Egyptian
   Cultural Affairs and Missions Sector for their financial support. We
   acknowledge funding from the Knut and Alice Wallenberg Foundation. We
   thank Chalmers Library for funding the open access charge.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Agren R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002980
   Alcantara R, 2012, NUCLEIC ACIDS RES, V40, pD754, DOI 10.1093/nar/gkr1126
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Becker SA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-8
   Boele J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-8
   Borenstein E, 2012, BRIEF BIOINFORM, V13, P769, DOI 10.1093/bib/bbs022
   Bornstein BJ, 2008, BIOINFORMATICS, V24, P880, DOI 10.1093/bioinformatics/btn051
   Caspeta L, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-24
   Caspi R, 2012, NUCLEIC ACIDS RES, V40, pD742, DOI 10.1093/nar/gkr1014
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Czyzyk J, 1998, IEEE COMPUT SCI ENG, V5, P68, DOI 10.1109/99.714603
   DEGNAN BA, 1994, APPL MICROBIOL BIOT, V40, P800, DOI 10.1007/s002530050070
   DEVRIES W, 1968, J BACTERIOL, V96, P472, DOI 10.1128/JB.96.2.472-478.1968
   Duncan SH, 2004, BRIT J NUTR, V91, P915, DOI 10.1079/BJN20041150
   Duncan SH, 2002, INT J SYST EVOL MICR, V52, P2141, DOI [10.1099/ijs.0.02241-0, 10.1099/00207713-52-6-2141]
   Duncan SH, 2002, APPL ENVIRON MICROB, V68, P5186, DOI 10.1128/AEM.68.10.5186-5190.2002
   Eddy Sean R, 2009, Genome Inform, V23, P205
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Falony G, 2009, APPL ENVIRON MICROB, V75, P2312, DOI 10.1128/AEM.02649-08
   Fandi KG, 2001, LETT APPL MICROBIOL, V32, P235, DOI 10.1046/j.1472-765X.2001.00895.x
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Feng XY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-94
   Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Flint HJ, 2011, J CLIN GASTROENTEROL, V45, pS128, DOI 10.1097/MCG.0b013e31821f44c4
   Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646
   Gonnerman MC, 2013, BIOTECHNOL J, V8, P1070, DOI 10.1002/biot.201200266
   Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672
   Jamshidi N, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-26
   Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063
   Karlsson FH, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2266
   Karlsson FH, 2011, TRENDS BIOTECHNOL, V29, P251, DOI 10.1016/j.tibtech.2011.01.009
   Klitgord N, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001002
   Lee JH, 2010, MICROBIOL MOL BIOL R, V74, P378, DOI 10.1128/MMBR.00004-10
   Liu LM, 2010, FEBS LETT, V584, P2556, DOI 10.1016/j.febslet.2010.04.052
   Lopez-Siles M, 2012, APPL ENVIRON MICROB, V78, P420, DOI 10.1128/AEM.06858-11
   Mahadevan R, 2003, METAB ENG, V5, P264, DOI 10.1016/j.ymben.2003.09.002
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044
   Neidhardt F.C., 1990, PHYSL BACTERIAL CELL
   Nicholson JK, 2012, SCIENCE
   Oliveira AP, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-39
   Osterlund T, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-36
   Park JM, 2009, BIOTECHNOL ADV, V27, P979, DOI 10.1016/j.biotechadv.2009.05.019
   Price ND, 2003, TRENDS BIOTECHNOL, V21, P162, DOI 10.1016/S0167-7799(03)00030-1
   Price NP, 2006, BIOCATAL BIOTRANSFOR, V24, P95, DOI 10.1080/10242420500533325
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862
   Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308
   Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532
   Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Stephanopoulos GN, 1998, METAB ENG, P21
   Stolyar S, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100131
   Teusink B, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S11
   Teusink B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000410
   Teusink B, 2006, J BIOL CHEM, V281, P40041, DOI 10.1074/jbc.M606263200
   Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P5204, DOI 10.1128/AEM.00146-06
   van Hoek MJA, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-22
   Vazquez A, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-7
   Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667
   Wrzodek C, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-15
   Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61
   Ze XL, 2012, ISME J, V6, P1535, DOI 10.1038/ismej.2012.4
   Zengler K, 2012, NAT REV MICROBIOL, V10, P366, DOI 10.1038/nrmicro2763
   Zomorrodi AR, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002363
NR 74
TC 63
Z9 65
U1 1
U2 48
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1752-0509
J9 BMC SYST BIOL
JI BMC Syst. Biol.
PD APR 3
PY 2014
VL 8
AR 41
DI 10.1186/1752-0509-8-41
PG 11
WC Mathematical & Computational Biology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Mathematical & Computational Biology
GA AF6DJ
UT WOS:000334804300001
PM 24708835
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Zhang, Y
AF Zhang, Yong
TI Probiotic effects of Lactobacillus casei Zhang: From single strain omics
   to metagenomics
SO CHINESE SCIENCE BULLETIN-CHINESE
LA Chinese
DT Review
DE Lactobacillus casei Zhang; probiotic effect; omics
ID FERMENTATION CHARACTERISTICS; TRANSIT TOLERANCE; KOUMISS; METABOLISM;
   EXPRESSION; MICROBIOTA; RESPONSES; STRESS; MILK; RATS
AB Lactobacillus casei Zhang (LCZ) is a well-studied probiotic bacterium that was inspired by traditional Mongolian medicine and isolated from naturally fermented koumiss in Inner Mongolia. There are three major stages of LCZ research and development. It contains single strain omics and in vitro evaluation stage (Stage 1), gut dominated microbes and in vivo evaluation stage (Stage 2) as well as metagenomics and clinical evaluation stage (Stage 3). LCZ was screened out from acid resistance, bile salt tolerance and processed favorable effects of in vitro cell adhesion characteristics and regulation of macrophage activity. And then, the whole genome of LCZ was determined and analyzed, which is the first identified Lactobacillus genome in China at 2008. Antibiotics resistance experiments showed a strong stability of LCZ genome under amoxicillin or gentamycin exposure through 2000 generations of laboratory evolution. A set of functional proteins such as NagA and NagB were identified from LCZ proteomics of growth process, acid stress or bile salt tolerance. Furthermore in vivo tests, LCZ has been demonstrated to process several beneficial effects including regulating microbiota abundance and ratios, lipid peroxidation inhibition and increasing antioxidant enzymes activities, regulating cellular and humoral immunity and tumor associated immune function, hepatoprotective effect and inhibition of liver transplanted tumor growth. Researchers have long appreciated the benefits of the gut microbiota to health. Moreover, LCZ was confirmed to promote the intestinal Bacteroides abundance and thereby alleviating impaired glucose tolerance and preventing type 2 diabetes mellitus by Q-PCR methods. Using the third generation PacBio sequencing technology, LCZ could delay the colon cancer progression in mice via altered gut microbiota composition and microbial acetic acid production. Detailedly, Alloprevotella rava and Parabacteroides merdae are the precise potential health-promoting species increased by LCZ intake. In addition to modulate gut microbiota composition, probiotic LCZ also manipulate bile acids, affects its conversation and induced tissue influx of chloride ion, which can impact the expression of chloride ion related proteins (eg.CLCN3 and CFTR). Small-scale human trial indicated that LCZ could maintain the abundance of gut microbiota, increase the number of beneficial bacteria and reduce potential harmful bacteria via 454 pyrosequencing. In 2018, a large-scale, randomized, double-blind and placebo-controlled study was conducted by LCZ administration in Malaysian population. In adult subjects, it confirmed that LCZ could prevent upper respiratory tract infection including reducing the number of days for pharyngeal and general flu symptoms as well as nasal symptoms. In elderly populations, LCZ not only reduced nasal symptoms but also alleviated aged index including improving the mean corpuscular hemoglobin concentration and erythrocyte sedimentation rate. These are attributing to microbiota modulation and its mediated immunity such as increased anti-inflammatory IL-4. It is suggested that LCZ will exert more benefits in microbiota regulation and became a promising health food / special medical food for preventive or therapeutic effects.
C1 [Zhang, Yong] Univ Sci & Technol Beijing, Biol & Agr Res Ctr, Beijing 100024, Peoples R China.
C3 University of Science & Technology Beijing
RP Zhang, Y (corresponding author), Univ Sci & Technol Beijing, Biol & Agr Res Ctr, Beijing 100024, Peoples R China.
EM zhy-545@163.com
CR Alcantara C, 2012, MICROBIOL-SGM, V158, P1206, DOI 10.1099/mic.0.055657-0
   Ashraf R, 2014, CRIT REV FOOD SCI, V54, P938, DOI 10.1080/10408398.2011.619671
   Cani PD, 2011, PHARMACOL THERAPEUT, V130, P202, DOI 10.1016/j.pharmthera.2011.01.012
   Chen Y, 2010, J DAIRY SCI, V93, P884, DOI 10.3168/jds.2009-2672
   DEL PIANO M, 2006, Digestive and Liver Disease, V38, P248
   Dong J, 2015, BENEFICIAL MICROORGA
   dos Reis SA, 2017, NUTR RES, V37, P1, DOI 10.1016/j.nutres.2016.11.009
   Guo HL, 2017, J FOOD SCI, V82, P724, DOI 10.1111/1750-3841.13645
   Guo Z, 2009, LWT-FOOD SCI TECHNOL, V42, P1640, DOI 10.1016/j.lwt.2009.05.025
   Hamon E, 2012, J PROTEOME RES, V11, P109, DOI 10.1021/pr200828t
   Hor YY, 2018, J FUNCT FOODS, V44, P235, DOI 10.1016/j.jff.2018.03.017
   Karimi G, 2015, FOOD NUTR RES, V59, DOI 10.3402/fnr.v59.29273
   Koskenniemi K, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002741
   Kozhakhmetov Samat, 2014, Cent Asian J Glob Health, V3, P163, DOI 10.5195/cajgh.2014.163
   Kwok LY, 2014, BENEF MICROBES, V5, P295, DOI 10.3920/BM2013.0047
   Larsen B, 2001, CLIN INFECT DIS, V32, pE69, DOI 10.1086/318710
   Panwar H, 2014, EUR J NUTR, V53, P1465, DOI 10.1007/s00394-013-0649-9
   Sivananthan K, 2018, IMMUNOPHARM IMMUNOT, V40, P465, DOI 10.1080/08923973.2018.1469143
   Wang HK, 2010, FOOD TECHNOL BIOTECH, V48, P62
   Wang J, 2009, J DAIRY SCI, V92, P2468, DOI 10.3168/jds.2008-1849
   Wang YZ, 2013, MICROBIOL IMMUNOL, V57, P54, DOI 10.1111/j.1348-0421.516.x
   Wang YZ, 2013, INT IMMUNOPHARMACOL, V15, P30, DOI 10.1016/j.intimp.2012.10.026
   Wu R, 2010, J DAIRY SCI, V93, P3858, DOI 10.3168/jds.2009-2967
   Wu RN, 2011, INT J FOOD MICROBIOL, V147, P181, DOI 10.1016/j.ijfoodmicro.2011.04.003
   Wu R, 2009, MOL CELL PROTEOMICS, V8, P2321, DOI 10.1074/mcp.M800483-MCP200
   Wu R, 2009, J BASIC MICROB, V49, P318, DOI 10.1002/jobm.200800047
   Ya T, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-68
   Yao GQ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00165
   Zhang HePing, 2006, China Dairy Industry, V34, P4
   Zhang JC, 2014, FEMS MICROBIOL ECOL, V88, P612, DOI 10.1111/1574-6941.12328
   Zhang WY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02316
   Zhang WY, 2010, J BACTERIOL, V192, P5268, DOI 10.1128/JB.00802-10
   Zhang Y, 2017, ONCOTARGET, V8, P24719, DOI 10.18632/oncotarget.15791
   Zhang Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05654
   Zhang Y, 2014, EUR J NUTR, V53, P221, DOI 10.1007/s00394-013-0519-5
   Zhang Yong, 2012, Scientia Agricultura Sinica, V45, P943
   Zhang Y, 2010, EUR FOOD RES TECHNOL, V231, P151, DOI 10.1007/s00217-010-1255-1
   Zhong Z, 2012, EUR J LIPID SCI TECH, V114, P244, DOI 10.1002/ejlt.201100118
   Zhou Q, 2009, INT J DAIRY TECHNOL, V62, P249, DOI 10.1111/j.1471-0307.2009.00470.x
   托娅, 2010, [肿瘤防治研究, Cancer Research on Prevention and Treatment], V37, P463
NR 40
TC 2
Z9 3
U1 6
U2 23
PU SCIENCE PRESS
PI EPHRATA
PA 300 WEST CHESNUT ST, EPHRATA, PA 17522 USA
SN 0023-074X
EI 2095-9419
J9 CHIN SCI B-CHIN
JI Chin. Sci. Bull.-Chin.
PY 2019
VL 64
IS 3
BP 307
EP 314
DI 10.1360/N972018-00591
PG 8
WC Multidisciplinary Sciences
WE Emerging Sources Citation Index (ESCI)
SC Science & Technology - Other Topics
GA JM8DZ
UT WOS:000496440100008
OA Bronze
DA 2022-11-22
ER

PT J
AU Wang, YQ
   Wang, HJ
   Howard, AG
   Meyer, KA
   Tsilimigras, MCB
   Avery, CL
   Sha, W
   Sun, S
   Zhang, JG
   Su, C
   Wang, ZH
   Zhang, B
   Fodor, AA
   Gordon-Larsen, P
AF Wang, Yiqing
   Wang, Huijun
   Howard, Annie Green
   Meyer, Katie A.
   Tsilimigras, Matthew C. B.
   Avery, Christy L.
   Sha, Wei
   Sun, Shan
   Zhang, Jiguo
   Su, Chang
   Wang, Zhihong
   Zhang, Bing
   Fodor, Anthony A.
   Gordon-Larsen, Penny
TI Circulating Short-Chain Fatty Acids Are Positively Associated with
   Adiposity Measures in Chinese Adults
SO NUTRIENTS
LA English
DT Article
DE short-chain fatty acids; BMI; waist-to-height ratio; fiber; gut
   metagenome
ID APPETITE REGULATION; GUT MICROBIOTA; WEIGHT-LOSS; OVERWEIGHT; OBESITY;
   DIET; QUANTIFICATION; PROPIONATE; BUTYRATE; ACETATE
AB Epidemiological studies suggest a positive association between obesity and fecal short-chain fatty acids (SCFAs) produced by microbial fermentation of dietary carbohydrates, while animal models suggest increased energy harvest through colonic SCFA production in obesity. However, there is a lack of human population-based studies with dietary intake data, plasma SCFAs, gut microbial, and anthropometric data. In 490 Chinese adults aged 30-68 years, we examined the associations between key plasma SCFAs (butyrate/isobutyrate, isovalerate, and valerate measured by non-targeted plasma metabolomics) with body mass index (BMI) using multivariable-adjusted linear regression. We then assessed whether overweight (BMI >= 24 kg/m(2)) modified the association between dietary-precursors of SCFAs (insoluble fiber, total carbohydrates, and high-fiber foods) with plasma SCFAs. In a sub-sample (n= 209) with gut metagenome data, we examined the association between gut microbial SCFA-producers with BMI. We found positive associations between butyrate/isobutyrate and BMI (p-value < 0.05). The associations between insoluble fiber and butyrate/isobutyrate differed by overweight (p-value < 0.10). There was no statistical evidence for an association between microbial SCFA-producers and BMI. In sum, plasma SCFAs were positively associated with BMI and that the colonic fermentation of fiber may differ for adults with versus without overweight.
C1 [Wang, Yiqing; Meyer, Katie A.; Tsilimigras, Matthew C. B.; Gordon-Larsen, Penny] Univ North Carolina Chapel Hill UNC Chapel Hill, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
   [Wang, Yiqing; Meyer, Katie A.; Tsilimigras, Matthew C. B.; Gordon-Larsen, Penny] Univ North Carolina Chapel Hill UNC Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA.
   [Wang, Huijun; Zhang, Jiguo; Su, Chang; Wang, Zhihong; Zhang, Bing] Chinese Ctr Dis Control & Prevent, Natl Inst Nutr & Hlth, Beijing 102206, Peoples R China.
   [Howard, Annie Green] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
   [Howard, Annie Green; Tsilimigras, Matthew C. B.; Avery, Christy L.; Gordon-Larsen, Penny] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.
   [Meyer, Katie A.] Univ N Carolina, Nutr Res Inst, Kannapolis, NC 28081 USA.
   [Tsilimigras, Matthew C. B.; Avery, Christy L.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.
   [Sha, Wei] Atrium Hlth, Dept Canc Biostat, Levine Canc Inst, Charlotte, NC 28204 USA.
   [Sha, Wei; Sun, Shan; Fodor, Anthony A.] Univ North Carolina Charlotte, Dept Bioinformat & Genom, Charlotte, NC 28223 USA.
C3 Chinese Center for Disease Control & Prevention; University of North
   Carolina; University of North Carolina Chapel Hill; University of North
   Carolina; University of North Carolina Chapel Hill; University of North
   Carolina; University of North Carolina; University of North Carolina
   Chapel Hill; University of North Carolina; University of North Carolina
   Charlotte
RP Gordon-Larsen, P (corresponding author), Univ North Carolina Chapel Hill UNC Chapel Hill, Dept Nutr, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27599 USA.; Gordon-Larsen, P (corresponding author), Univ North Carolina Chapel Hill UNC Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA.; Gordon-Larsen, P (corresponding author), Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC 27516 USA.
EM yiqing@live.unc.edu; wanghj@ninh.chinacdc.cn; aghoward@email.unc.edu;
   ktmeyer@email.unc.edu; matthew_tsilimigras@unc.edu;
   Christy_avery@unc.edu; wei.sha@atriumhealth.org; ssun5@uncc.edu;
   zhangjg@ninh.chinacdc.cn; suchang@ninh.chinacdc.cn;
   wangzh@ninh.chinacdc.cn; zhangbing@chinacdc.cn; afodor@uncc.edu;
   pglarsen@unc.edu
OI Howard, Annie Green/0000-0003-0837-8166; Avery,
   Christy/0000-0002-1044-8162
FU NIH; National Institute of Diabetes and Digestive and Kidney Diseases
   [R01-DK104371]; Eunice Kennedy Shriver National Institute of Child
   Health and Human Development (NICHD) [R01 HD30880]; NIH Fogarty grant
   [D43 TW009077]; NICHD (NIH grant) [P2C HD050924]; Sanofi
   [29230-50347-466001]; Ruth L. Kirschstein National Research Service
   Awards (NRSA) Genetic Epidemiology of Heart, Lung, and Blood (HLB)
   Traits Training Grant (GenHLB) [T32HL129982]
FX This research was funded by the NIH and National Institute of Diabetes
   and Digestive and Kidney Diseases (R01-DK104371). We are grateful to the
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development (NICHD) for R01 HD30880 and the NIH Fogarty grant D43
   TW009077 for financial support for the CHNS data collection and analysis
   files from 1989 to 2015 and future surveys. We are also grateful for
   funding from the NICHD to CPC at the UNC-CH (NIH grant P2C HD050924).
   Y.W. is grateful to the Sanofi funding award 29230-50347-466001 for
   educational support. M.C.B.T. is supported by Ruth L. Kirschstein
   National Research Service Awards (NRSA) Genetic Epidemiology of Heart,
   Lung, and Blood (HLB) Traits Training Grant (GenHLB, T32HL129982).
CR Anderson M.J., 2017, WILEY STATSREF STAT, DOI [10.1002/9781118445112.stat07841, DOI 10.1002/9781118445112.STAT07841]
   Ashwell M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010159
   Aune D., 2018, BODY MASS INDEX ABDO
   Baxter NT, 2019, MBIO, V10, DOI [10.1128/mBio.02566-18, 10.1128/mbio.02566-18]
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Boets E, 2015, NUTRIENTS, V7, P8916, DOI 10.3390/nu7115440
   Brahe LK, 2013, OBES REV, V14, P950, DOI 10.1111/obr.12068
   Brooks AW, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006842
   Byrne CS, 2015, INT J OBESITY, V39, P1331, DOI 10.1038/ijo.2015.84
   Chambers Edward S, 2018, Curr Nutr Rep, V7, P198, DOI 10.1007/s13668-018-0248-8
   Chambers ES, 2018, DIABETES OBES METAB, V20, P1034, DOI 10.1111/dom.13159
   Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913
   CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221
   De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957
   de la Cuesta-Zuluaga J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010051
   Ding M, 2019, AM J EPIDEMIOL, V188, P1932, DOI 10.1093/aje/kwz171
   Du SF, 2014, AM J CLIN NUTR, V99, P334, DOI 10.3945/ajcn.113.059121
   Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031
   Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h
   Goffredo M, 2016, J CLIN ENDOCR METAB, V101, P4367, DOI 10.1210/jc.2016-1797
   Heimann E, 2016, ADIPOCYTE, V5, P359, DOI 10.1080/21623945.2016.1252011
   Hu XJ, 2013, MOL NUTR FOOD RES, V57, P2147, DOI 10.1002/mnfr.201300159
   Inoue Y, 2018, J EPIDEMIOL COMMUN H, V72, P484, DOI 10.1136/jech-2017-210258
   Isken F, 2010, J NUTR BIOCHEM, V21, P278, DOI 10.1016/j.jnutbio.2008.12.012
   Jones RB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22408-4
   Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027
   Kim KN, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102512
   Layden BT, 2012, DIABET METAB SYND OB, V5, P49, DOI 10.2147/DMSO.S29244
   Long T, 2017, NAT GENET, V49, P568, DOI 10.1038/ng.3809
   Miranda VPN, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/7346863
   Mueller NT, 2020, AM J CLIN NUTR, V111, P545, DOI 10.1093/ajcn/nqz322
   Oliphant K, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0704-8
   Peng YG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144539
   Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322
   Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x
   Rahat-Rozenbloom S, 2014, INT J OBESITY, V38, P1525, DOI 10.1038/ijo.2014.46
   Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185
   Salazar N, 2015, CLIN NUTR, V34, P501, DOI 10.1016/j.clnu.2014.06.001
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Sun S., 2020, GEOGRAPHIC VAR UNPUB
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Vogt JA, 2003, J NUTR, V133, P3145, DOI 10.1093/jn/133.10.3145
   Winglee K, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0338-7
   Yan RH, 2017, J AM HEART ASSOC, V6, DOI [10.1161/jaha.116.004445, 10.1161/JAHA.116.004445]
   Yang JY, 2013, J MED FOOD, V16, P862, DOI [10.1089/jmf.2012.0292, 10.1100/jmf.2012.0292]
   Yeh TL, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081228
   Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P83
   Zou J, 2018, CELL HOST MICROBE, V23, P41, DOI 10.1016/j.chom.2017.11.003
NR 49
TC 8
Z9 8
U1 1
U2 13
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6643
J9 NUTRIENTS
JI Nutrients
PD JUL
PY 2020
VL 12
IS 7
AR 2127
DI 10.3390/nu12072127
PG 15
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA MS4FZ
UT WOS:000554235400001
PM 32708978
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Zaramela, LS
   Martino, C
   Alisson-Silva, F
   Rees, SD
   Diaz, SL
   Chuzel, L
   Ganatra, MB
   Taron, CH
   Secrest, P
   Zuniga, C
   Huang, JB
   Siegel, D
   Chang, G
   Varki, A
   Zengler, K
AF Zaramela, Livia S.
   Martino, Cameron
   Alisson-Silva, Frederico
   Rees, Steven D.
   Diaz, Sandra L.
   Chuzel, Lea
   Ganatra, Mehul B.
   Taron, Christopher H.
   Secrest, Patrick
   Zuniga, Cristal
   Huang, Jianbo
   Siegel, Dionicio
   Chang, Geoffrey
   Varki, Ajit
   Zengler, Karsten
TI Gut bacteria responding to dietary change encode sialidases that exhibit
   preference for red meat-associated carbohydrates
SO NATURE MICROBIOLOGY
LA English
DT Article
ID VERTEBRATE AMINO-SUGARS; METABOLISM; SPECIFICITY; PREDICTION; SEQUENCE
AB Dietary habits have been associated with alterations of the human gut resident microorganisms contributing to obesity, diabetes and cancer(1). In Western diets, red meat is a frequently eaten foods(2), but long-term consumption has been associated with increased risk of diseases(3,4). Red meat is enriched in N-glycolylneuraminic acid (Neu5Gc) that cannot be synthesized by humanss. However, consumption can cause Neu5Gc incorporation into cell surface glycans(6), especially in carcinomaess(4,7). As a consequence, an inflammatory response is triggered when Neu5Gc-containing glycans encounter circulating anti-Neu5Gc antibodies(8,9). Although bacteria can use free sialic acids as a nutrient source(10-12), it is currently unknown if gut microorganisms contribute to releasing Neu5Gc from food. We found that a Neu5Gc-rich diet induces changes in the gut microbiota, with Bacteroidales and Clostridiales responding the most. Genome assembling of mouse and human shotgun metagenomic sequencing identified bacterial sialidases with previously unobserved substrate preference for Neu5Gc-containing glycans. X-ray crystallography revealed key amino acids potentially contributing to substrate preference. Additionally, we verified that mouse and human sialidases were able to release Neu5Gc from red meat. The release of Neu5Gc from red meat using bacterial sialidases could reduce the risk of inflammatory diseases associated with red meat consumption, including colorectal cancers and atherosclerosis(13).
C1 [Zaramela, Livia S.; Martino, Cameron; Zuniga, Cristal; Zengler, Karsten] Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.
   [Martino, Cameron] Univ Calif San Diego, Bioinformat & Syst Biol Program, San Diego, CA 92103 USA.
   [Alisson-Silva, Frederico; Diaz, Sandra L.; Secrest, Patrick; Varki, Ajit] Univ Calif San Diego, Dept Med & Cellular & Mol Med, San Diego, CA 92103 USA.
   [Alisson-Silva, Frederico; Diaz, Sandra L.; Secrest, Patrick; Varki, Ajit] Glycobiol Res & Training Ctr, San Diego, CA USA.
   [Rees, Steven D.; Huang, Jianbo; Siegel, Dionicio; Chang, Geoffrey] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92103 USA.
   [Chuzel, Lea; Ganatra, Mehul B.; Taron, Christopher H.] New England Biolabs Inc, Ipswich, MA USA.
   [Zengler, Karsten] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.
   [Zengler, Karsten] Univ Calif San Diego, Ctr Microbiome Innovat, San Diego, CA 92103 USA.
   [Alisson-Silva, Frederico] Univ Fed Rio de Janeiro, Paulo de Goes Inst Microbiol, Rio De Janeiro, Brazil.
C3 University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego;
   University of California System; University of California San Diego; New
   England Biolabs; University of California System; University of
   California San Diego; University of California System; University of
   California San Diego; Universidade Federal do Rio de Janeiro
RP Zengler, K (corresponding author), Univ Calif San Diego, Dept Pediat, San Diego, CA 92103 USA.; Zengler, K (corresponding author), Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA.; Zengler, K (corresponding author), Univ Calif San Diego, Ctr Microbiome Innovat, San Diego, CA 92103 USA.
EM kzengler@ucsd.edu
RI Rees, Steven/AAM-4932-2020; Zuniga, Cristal/CAA-0015-2022; da Silva,
   Frederico/AAY-4758-2021; Zaramela, Lívia Soares/AAD-2687-2022
OI da Silva, Frederico/0000-0001-6717-2518; Zaramela, Lívia
   Soares/0000-0002-1065-3799; Taron, Christopher/0000-0001-8149-4556;
   Rees, Steven/0000-0002-2258-7469; Martino, Cameron/0000-0001-9334-1258;
   Chuzel, Lea/0000-0001-7185-5872; Zuniga, Cristal/0000-0002-0135-7429
FU National Institutes of Health [R01GM32373]; National Science Foundation
   [IOS-1444435]; National Institutes of Health, USA (NIH) [T32GM8806];
   Chancellor's Research Excellence Scholarship (UCSD); Program Science
   Without Borders-Capes Brazil [Bex 9254-13-7]; NATIONAL INSTITUTE OF
   BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009380] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032373,
   T32GM008806] Funding Source: NIH RePORTER
FX We thank all Zengler, Varki and Chang-lab members for helpful
   discussions. Research was supported in part by the National Institutes
   of Health under award no.R01GM32373 (to A.V.) and by the National
   Science Foundation under award no. IOS-1444435 (to G.C.). C.M. was
   supported by grants from the National Institutes of Health, USA (NIH
   grant no. T32GM8806) and by a Chancellor's Research Excellence
   Scholarship (UCSD). F.A.-S. was partly supported by the Program Science
   Without Borders Bex 9254-13-7-Capes Brazil.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Alisson-Silva F, 2016, MOL ASPECTS MED, V51, P16, DOI 10.1016/j.mam.2016.07.002
   Almagro-Moreno S, 2010, GUT MICROBES, V1, P45, DOI 10.4161/gmic.1.1.10386
   Almagro-Moreno S, 2009, INFECT IMMUN, V77, P3807, DOI 10.1128/IAI.00279-09
   Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118
   Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75
   Banda K, 2012, J BIOL CHEM, V287, P28852, DOI 10.1074/jbc.M112.364182
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cai TB, 2004, ORG LETT, V6, P4203, DOI 10.1021/ol048397p
   Chokhawala HA, 2007, CHEMBIOCHEM, V8, P194, DOI 10.1002/cbic.200600410
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Davies LRL, 2012, J BIOL CHEM, V287, P28917, DOI 10.1074/jbc.M112.365056
   Dhar C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00807
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   ERCEGOVIC T, 1995, J ORG CHEM, V60, P3378, DOI 10.1021/jo00116a022
   Etemadi A., 2017, BMJ-BRIT MED J, V357, P1
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Flint HJ, 2012, GUT MICROBES, V3, P289, DOI 10.4161/gmic.19897
   Hall AB, 2017, NAT REV GENET, V18, DOI 10.1038/nrg.2017.63
   Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07
   Huang L, 2018, NUCLEIC ACIDS RES, V46, pD516, DOI 10.1093/nar/gkx894
   Huang YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9141
   Inoue S, 2001, BIOCHEM BIOPH RES CO, V280, P104, DOI 10.1006/bbrc.2000.4084
   Juge N, 2016, BIOCHEM SOC T, V44, P166, DOI 10.1042/BST20150226
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Kang DWD, 2015, PEERJ, V3, DOI 10.7717/peerj.1165
   Kawanishi K, 2019, P NATL ACAD SCI USA, V116, P16036, DOI 10.1073/pnas.1902902116
   Kim S, 2011, APPL MICROBIOL BIOT, V91, P1, DOI 10.1007/s00253-011-3307-2
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x
   Li JH, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00547-17
   Li YH, 2011, MOL BIOSYST, V7, P1060, DOI 10.1039/c0mb00244e
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507
   Mann N, 2000, EUR J NUTR, V39, P71, DOI 10.1007/s003940050005
   McDonald ND, 2016, MBIO, V7, DOI 10.1128/mBio.02237-15
   Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436
   NUMATA M, 1988, CARBOHYD RES, V174, P73, DOI 10.1016/0008-6215(88)85082-1
   Nurk S, 2017, GENOME RES, V27, P824, DOI 10.1101/gr.213959.116
   Owen CD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02109-8
   Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114
   Samraj AN, 2015, P NATL ACAD SCI USA, V112, P542, DOI 10.1073/pnas.1417508112
   Samraj AN, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00033
   Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308
   Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654
   Smits SA, 2017, SCIENCE, V357, P802, DOI 10.1126/science.aan4834
   Tailford LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8624
   Tan J, 2015, J MICROBIOL, V53, P295, DOI 10.1007/s12275-015-5060-1
   Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100
   Varki A, 2010, P NATL ACAD SCI USA, V107, P8939, DOI 10.1073/pnas.0914634107
   Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749
   Wood PL, 2006, J CHROMATOGR B, V831, P313, DOI 10.1016/j.jchromb.2005.12.031
   Zengler K, 2018, NAT REV MICROBIOL, V16, P383, DOI 10.1038/s41579-018-0004-5
   Zuniga C, 2017, MICROB BIOTECHNOL, V10, P1500, DOI 10.1111/1751-7915.12855
NR 56
TC 34
Z9 36
U1 0
U2 48
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD DEC
PY 2019
VL 4
IS 12
BP 2082
EP 2089
DI 10.1038/s41564-019-0564-9
PG 8
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA JQ6RV
UT WOS:000499071100011
PM 31548686
OA Green Accepted, Green Submitted
DA 2022-11-22
ER

PT J
AU Bhar, S
   Singh, R
   Pinna, NK
   Bose, T
   Dutta, A
   Mande, SS
AF Bhar, Subhrajit
   Singh, Rashmi
   Pinna, Nishal Kumar
   Bose, Tungadri
   Dutta, Anirban
   Mande, Sharmila S.
TI Sensing Host Health: Insights from Sensory Protein Signature of the
   Metagenome
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE sensory protein; metagenome; biomarker; machine learning; disease
   diagnostics
ID GUT MICROBIOTA; TRANSDUCTION; DYSBIOSIS; EVOLUTION; SYSTEMS
AB The human microbiota, which comprises an ensemble of taxonomically and functionally diverse but often mutually cooperating microorganisms, benefits its host by shaping the host immunity, energy harvesting, and digestion of complex carbohydrates as well as production of essential nutrients. Dysbiosis in the human microbiota, especially the gut microbiota, has been reported to be linked to several diseases and metabolic disorders. Recent studies have further indicated that tracking these dysbiotic variations could potentially be exploited as biomarkers of disease states. However, the human microbiota is not geography agnostic, and hence a taxonomy-based (microbiome) biomarker for disease diagnostics has certain limitations. In comparison, (microbiome) function-based biomarkers are expected to have a wider applicability. Given that (i) the host physiology undergoes certain changes in the course of a disease and (ii) host-associated microbial communities need to adapt to this changing microenvironment of their host, we hypothesized that signatures emanating from the abundance of bacterial proteins associated with the signal transduction system (herein referred to as sensory proteins [SPs]) might be able to distinguish between healthy and diseased states. To test this hypothesis, publicly available metagenomic data sets corresponding to three diverse health conditions, namely, colorectal cancer, type 2 diabetes mellitus, and schizophrenia, were analyzed. Results demonstrated that SP signatures (derived from host-associated metagenomic samples) indeed differentiated among healthy individual and patients suffering from diseases of various severities. Our finding was suggestive of the prospect of using SP signatures as early biomarkers for diagnosing the onset and progression of multiple diseases and metabolic disorders. IMPORTANCE The composition of the human microbiota, a collection of host-associated microbes, has been shown to differ among healthy and diseased individuals. Recent studies have investigated whether tracking these variations could be exploited for disease diagnostics. It has been noted that compared to microbial taxonomies, the ensemble of functional proteins encoded by microbial genes are less likely to be affected by changes in ethnicity and dietary preferences. These functions are expected to help the microbe adapt to changing environmental conditions. Thus, healthy individuals might harbor a different set of genes than diseased individuals. To test this hypothesis, we analyzed metagenomes from healthy and diseased individuals for signatures of a particular group of proteins called sensory proteins (SP), which enable the bacteria to sense and react to changes in their microenvironment. Results demonstrated that SP signatures indeed differentiate among healthy individuals and those suffering from diseases of various severities.
   The composition of the human microbiota, a collection of host-associated microbes, has been shown to differ among healthy and diseased individuals. Recent studies have investigated whether tracking these variations could be exploited for disease diagnostics.
C1 [Bhar, Subhrajit; Singh, Rashmi; Pinna, Nishal Kumar; Bose, Tungadri; Dutta, Anirban; Mande, Sharmila S.] Tata Consultancy Serv Ltd, TCS Res, Pune, Maharashtra, India.
C3 Tata Sons; Tata Consultancy Services Limited (TCS)
RP Bose, T; Dutta, A; Mande, SS (corresponding author), Tata Consultancy Serv Ltd, TCS Res, Pune, Maharashtra, India.
EM tungadri.bose@tcs.com; anirban.dutt@tcs.com; sharmila.mande@tcs.com
RI Dutta, Anirban/B-1519-2010
OI Dutta, Anirban/0000-0002-8209-026X
CR Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anand S, 2021, FEBS LETT, V595, P1825, DOI 10.1002/1873-3468.14107
   Ananthakrishnan AN, 2020, INFLAMM BOWEL DIS, V26, P1463, DOI 10.1093/ibd/izaa071
   Barrett JF, 1998, ANTIMICROB AGENTS CH, V42, P1529, DOI 10.1128/AAC.42.7.1529
   Bhar S, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00478-20
   Bose T, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-6398-2
   Bose T, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4947-8
   Bose T, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00128
   Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421
   Capra EJ, 2012, ANNU REV MICROBIOL, V66, P325, DOI 10.1146/annurev-micro-092611-150039
   Carding Simon, 2015, Microbial Ecology in Health and Disease, V26, P26191, DOI 10.3402/mehd.v26.26191
   Castro-Nallar E, 2015, PEERJ, V3, DOI 10.7717/peerj.1140
   Chenard T, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01724-8
   Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016
   Dalby MJ, 2017, CELL REP, V21, P1521, DOI 10.1016/j.celrep.2017.10.056
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Francke C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-385
   Gozd-Barszczewska A, 2017, ANN AGR ENV MED, V24, P416, DOI 10.26444/aaem/75456
   Haque MM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16352-y
   Hiippala K, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.575455
   Huang XL, 2015, J BACTERIOL, V197, P2517, DOI 10.1128/JB.00176-15
   Jacobi S, 2004, J BACTERIOL, V186, P2540, DOI 10.1128/JB.186.9.2540-2547.2004
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kaur H, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01365
   Kaur H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02166
   La Rosa SL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08812-y
   Lardi M, 2015, APPL ENVIRON MICROB, V81, P4077, DOI 10.1128/AEM.00694-15
   Lee H, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-1793-3
   Liang DC, 2018, GUT PATHOG, V10, DOI 10.1186/s13099-018-0230-4
   Manor O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18871-1
   Mirzaei R, 2022, BIOMED PHARMACOTHER, V145, DOI 10.1016/j.biopha.2021.112352
   Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913
   Mohajeri MH, 2018, EUR J NUTR, V57, pS1, DOI 10.1007/s00394-018-1703-4
   Nguyen TT, 2019, SCHIZOPHR RES, V204, P23, DOI 10.1016/j.schres.2018.09.014
   Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277
   Pinna NK, 2021, GENOME MED, V13, DOI 10.1186/s13073-021-00851-9
   Porras AM, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109457
   Qiao YA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19982-y
   Rajeev L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r99
   Rizvi A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02417
   Shi FY, 2021, GUT, V70, pA17, DOI 10.1136/gutjnl-2021-IDDF.24
   Szeligowski T, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00156
   Thaiss CA, 2016, NATURE, V535, P65, DOI 10.1038/nature18847
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Thomas S, 2017, CANCER RES, V77, P1783, DOI 10.1158/0008-5472.CAN-16-2929
   Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006
   Valdes Ana M, 2018, BMJ, V361, pk2179, DOI 10.1136/bmj.k2179
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13
   Zhang H, 2021, J ADV RES, V27, P19, DOI 10.1016/j.jare.2020.02.013
NR 51
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD AUG 9
PY 2022
VL 88
IS 15
DI 10.1128/aem.00596-22
EA JUL 2022
PG 12
WC Biotechnology & Applied Microbiology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biotechnology & Applied Microbiology; Microbiology
GA 3R7JB
UT WOS:000825367900001
PM 35862686
DA 2022-11-22
ER

PT J
AU Bastos, RMC
   Simplicio, A
   Savio-Silva, C
   Oliveira, LFV
   Cruz, GNF
   Sousa, EH
   Noronha, IL
   Mangueira, CLP
   Quaglierini-Ribeiro, H
   Josefi-Rocha, GR
   Rangel, EB
AF Bastos, Rosana M. C.
   Simplicio-Filho, Antonio
   Savio-Silva, Christian
   Oliveira, Luiz Felipe, V
   Cruz, Giuliano N. F.
   Sousa, Eliza H.
   Noronha, Irene L.
   Mangueira, Cristovao L. P.
   Quaglierini-Ribeiro, Heloisa
   Josefi-Rocha, Gleice R.
   Rangel, Erika B.
TI Fecal Microbiota Transplant in a Pre-Clinical Model of Type 2 Diabetes
   Mellitus, Obesity and Diabetic Kidney Disease
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE diabetes mellitus; diabetic kidney disease; gut microbiota; fecal
   transplant; obesity
ID GUT MICROBIOTA; INSULIN-RESISTANCE; HYDROGEN-SULFIDE; MICE; LEPTIN;
   GLUCOSE; INFLAMMATION; ASSOCIATION; METAGENOME; SUCCINATE
AB Diabetes mellitus (DM) burden encompasses diabetic kidney disease (DKD), the leading cause of end-stage renal disease worldwide. Despite compelling evidence indicating that pharmacological intervention curtails DKD progression, the search for non-pharmacological strategies can identify novel targets for drug development against metabolic diseases. One of those emergent strategies comprises the modulation of the intestinal microbiota through fecal transplant from healthy donors. This study sought to investigate the benefits of fecal microbiota transplant (FMT) on functional and morphological parameters in a preclinical model of type 2 DM, obesity, and DKD using BTBRob/ob mice. These animals develop hyperglycemia and albuminuria in a time-dependent manner, mimicking DKD in humans. Our main findings unveiled that FMT prevented body weight gain, reduced albuminuria and tumor necrosis factor-alpha (TNF-alpha) levels within the ileum and ascending colon, and potentially ameliorated insulin resistance in BTBRob/ob mice. Intestinal structural integrity was maintained. Notably, FMT was associated with the abundance of the succinate-consuming Odoribacteraceae bacteria family throughout the intestine. Collectively, our data pointed out the safety and efficacy of FMT in a preclinical model of type 2 DM, obesity, and DKD. These findings provide a basis for translational research on intestinal microbiota modulation and testing its therapeutic potential combined with current treatment for DM.
C1 [Bastos, Rosana M. C.; Simplicio-Filho, Antonio; Savio-Silva, Christian; Sousa, Eliza H.; Mangueira, Cristovao L. P.; Quaglierini-Ribeiro, Heloisa; Josefi-Rocha, Gleice R.; Rangel, Erika B.] Hosp Israelita Albert Einstein, BR-05652900 Sao Paulo, SP, Brazil.
   [Oliveira, Luiz Felipe, V; Cruz, Giuliano N. F.] BiomeHub, BR-88040900 Florianopolis, SC, Brazil.
   [Noronha, Irene L.] Univ Sao Paulo, Sch Med, Div Nephrol, BR-01246903 Sao Paulo, SP, Brazil.
   [Rangel, Erika B.] Univ Fed Sao Paulo, Nephrol Div, BR-04023900 Sao Paulo, SP, Brazil.
C3 Hospital Israelita Albert Einstein; Universidade de Sao Paulo;
   Universidade Federal de Sao Paulo (UNIFESP)
RP Rangel, EB (corresponding author), Hosp Israelita Albert Einstein, BR-05652900 Sao Paulo, SP, Brazil.; Rangel, EB (corresponding author), Univ Fed Sao Paulo, Nephrol Div, BR-04023900 Sao Paulo, SP, Brazil.
EM rmcbastos22@gmail.com; antonio.simplicio@einstein.br;
   christian.silvio@einstein.br; felipe@biome-hub.com;
   giuliano.netto@biome-hub.com; eliza.higuti@einstein.br; irenenor@usp.br;
   cristovao.mangueira@einstein.br; heloisa.quaglierini@gmail.com;
   gjosefi@gmail.com; erikabr@uol.com.br
RI Rangel, Erika/H-3066-2013; Simplicio da Silva Filho,
   Antonio/GVR-7744-2022
OI Rangel, Erika/0000-0003-0982-2484; Simplicio da Silva Filho,
   Antonio/0000-0002-6405-234X; Josefi Rocha, Gleice
   Regina/0000-0002-3319-760X
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/Sao Paulo
   Research Foundation) [2013/19560-6, 2017/23195-2, 20165/423320,
   2017/18072-9]; EFSD (European Foundation for the Study of
   Diabetes)/Sanofi; CNPq (Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico/National Council for Scientific and Technological
   Development)
FX This work was supported by grants from FAPESP (Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo/Sao Paulo Research Foundation; no.
   2013/19560-6 and 2017/23195-2) and EFSD (European Foundation for the
   Study of Diabetes)/Sanofi to E.B.R. This work was supported by a master
   research fellowship grant (no. 2017/18072-9) from FAPESP (Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo/Sao Paulo Research Foundation)
   to C.S.S., a post-doctoral fellowship grant (no. 2016/26263-6) from
   FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo/Sao Paulo
   Research Foundation) to E.H.S., and a scientific initiation research
   fellowship grant (no. 20165/423320) from CNPq (Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico/National Council for Scientific
   and Technological Development) to H.Q.-R.
CR Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116
   Anders HJ, 2018, NAT REV NEPHROL, V14, P361, DOI 10.1038/s41581-018-0001-y
   Anini Y, 2003, DIABETES, V52, P252, DOI 10.2337/diabetes.52.2.252
   Araujo TG, 2012, ENDOCRINOLOGY, V153, P5760, DOI 10.1210/en.2012-1496
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Beltowski J, 2006, ATHEROSCLEROSIS, V189, P47, DOI 10.1016/j.atherosclerosis.2006.03.003
   Beserra BTS, 2015, CLIN NUTR, V34, P845, DOI 10.1016/j.clnu.2014.10.004
   Camilleri M, 2019, CURR OPIN ENDOCRINOL, V26, P3, DOI 10.1097/MED.0000000000000448
   Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625
   Chakaroun RM, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041082
   Chen XP, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1104-3
   COHEN AJ, 1989, AM J PHYSIOL, V257, pF580, DOI 10.1152/ajprenal.1989.257.4.F580
   Ellekilde M, 2014, RES VET SCI, V96, P241, DOI 10.1016/j.rvsc.2014.01.007
   Ellekilde M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05922
   Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227
   Fan Y, 2021, NAT REV MICROBIOL, V19, P55, DOI 10.1038/s41579-020-0433-9
   Fournel A, 2016, AM J PHYSIOL-GASTR L, V310, pG645, DOI 10.1152/ajpgi.00015.2016
   Fraulob JC, 2010, J CLIN BIOCHEM NUTR, V46, P212, DOI 10.3164/jcbn.09-83
   Grazioli S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00832
   Han SJ, 2017, FREE RADICAL BIO MED, V112, P423, DOI 10.1016/j.freeradbiomed.2017.08.017
   Hawrelak Jason A, 2004, Altern Med Rev, V9, P180
   Herat LY, 2020, WORLD J GASTROENTERO, V26, DOI 10.3748/wjg.v26.i23.3225
   Holst JJ, 2020, J CLIN ENDOCR METAB, V105, pE2710, DOI 10.1210/clinem/dgaa327
   Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290
   Jia LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07335-0
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kashani A, 2019, ANIM MICROBIOME, V1, DOI 10.1186/s42523-019-0007-1
   Kim J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01947
   Kim MH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76474-8
   Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1
   Kushkevych I, 2021, J ADV RES, V27, P71, DOI 10.1016/j.jare.2020.03.007
   Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085
   Lee DM, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0708-x
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Lindstrom P, 2007, THESCIENTIFICWORLDJO, V7, P666, DOI 10.1100/tsw.2007.117
   Loubinoux J, 2002, FEMS MICROBIOL ECOL, V40, P107, DOI 10.1111/j.1574-6941.2002.tb00942.x
   Madsen MSA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52103-x
   Magne F, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051474
   Napolitano M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.590370
   O'Brien PD, 2015, NEUROBIOL DIS, V73, P348, DOI 10.1016/j.nbd.2014.10.015
   Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016
   Perez-Perez A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165887
   Procaccini C, 2012, MOL ASPECTS MED, V33, P35, DOI 10.1016/j.mam.2011.10.012
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Sadagopan N, 2007, AM J HYPERTENS, V20, P1209, DOI 10.1016/j.amjhyper.2007.05.010
   Savio-Silva C, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22041546
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Serena C, 2018, ISME J, V12, P1642, DOI 10.1038/s41396-018-0068-2
   Shimazu-Kuwahara S, 2017, MOL METAB, V6, P288, DOI 10.1016/j.molmet.2017.01.006
   Thaiss CA, 2018, SCIENCE, V359, P1376, DOI 10.1126/science.aar3318
   Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18
   TUCKER BJ, 1992, KIDNEY INT, V42, P1160, DOI 10.1038/ki.1992.400
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Vallianou NG, 2019, HORM-INT J ENDOCRINO, V18, P141, DOI 10.1007/s42000-019-00093-w
   van Diepen JA, 2017, DIABETOLOGIA, V60, P1304, DOI 10.1007/s00125-017-4261-z
   Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031
   Wang H, 2020, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00455
   Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011
   Wolters M, 2019, CLIN NUTR, V38, P2504, DOI 10.1016/j.clnu.2018.12.024
   Yang MS, 2019, INT J ENDOCRINOL, V2019, DOI 10.1155/2019/1394097
   Yu F, 2019, AGING-US, V11, P10454, DOI 10.18632/aging.102469
   Zhang Q, 2020, DIABET METAB SYND OB, V13, P5003, DOI 10.2147/DMSO.S286430
   Zhao CH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230200
   Zhao L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00233
   Zhao M, 2017, WORLD J DIABETES, V8, P249, DOI 10.4239/wjd.v8.i6.249
NR 67
TC 3
Z9 3
U1 8
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2022
VL 23
IS 7
AR 3842
DI 10.3390/ijms23073842
PG 20
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Chemistry
GA 0L4FN
UT WOS:000781431600001
PM 35409202
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Chun, JL
   Ji, SY
   Lee, SD
   Lee, YK
   Kim, B
   Kim, KH
AF Chun, Ju Lan
   Ji, Sang Yun
   Lee, Sung Dae
   Lee, Yoo Kyung
   Kim, Byeonghyeon
   Kim, Ki Hyun
TI Difference of gut microbiota composition based on he body condition
   scores in dogs
SO JOURNAL OF ANIMAL SCIENCE AND TECHNOLOGY
LA English
DT Article
DE Dog; Fusobacteria; Gut microbiota; Metagenomic analysis; Overweight;
   Taxonomic profile
ID OBESITY; FUSOBACTERIA
AB Microorganism residing in the gut has been known to have important roles in the animal body. Microbes and host microenvironment are highly related with host's health including energy metabolism and immune system. Moreover, it reported that gut microbiome is correlated with diseases like obesity in human and dogs. There have been many studies to identify and characterize microbes and their genes in human body. However, there was little information of microbiome in companion animals. Here, we investigated microbiota communities in feaces from twenty - four Beagles (aged 2 years old) and analyzed the taxonomy profile using metagenomics to study the difference among gut microbiome based on body condition score (BCS). gDNA was isolated from feaces, sequenced and clustered. Taxonomy profiling was performed based on the NCBI database. BCS was evaluated once a week according to the description provided by World Small Animal Veterinary Association. Firmicutes phylum was the most abundant followed by Bacteroidetes, Fusobacteria, Proteobacteria and Actinobacteria. That main microbiota in gut were differently distributed based on the BCS. Fusobacteria has been known to be associated with colon cancer in human. Interestingly, Fusobacteria was in the third level from the top in healthy dog's gut microbiome. In addition, Fusobacteria was especially higher in overweight dogs which had 6 scales of BCS. Species Fusobacterium perfoetens was also more abundant when dogs were in BCS 6. It implied that F perfoetens would be positively related with overweight in dogs. These finding would contribute to further studies of gut microbiome and their functions to improve dog's diets and health condition.
C1 [Chun, Ju Lan; Ji, Sang Yun; Lee, Sung Dae; Lee, Yoo Kyung; Kim, Byeonghyeon; Kim, Ki Hyun] Natl Inst Anim Sci, Rural Dev Adm, Wonju 55365, South Korea.
C3 National Institute of Animal Science, Republic of Korea; Rural
   Development Administration (RDA), Republic of Korea
RP Kim, KH (corresponding author), Natl Inst Anim Sci, Rural Dev Adm, Wonju 55365, South Korea.
EM kihyun@korea.kr
OI Kim, Kihyun/0000-0002-9834-2126; Chun, Ju-Lan/0000-0002-4618-586X; Lee,
   yookyung/0000-0002-9896-4152; Ji, Sang Yun/0000-0001-7235-3655
FU National Institute of Animal Science [PJ013984012019]; 2019 RDA
   Fellowship Program of the National Institute of Animal Science, Rural
   Development Administration, Korea
FX This research was supported by a grant "Cooperative Research Program of
   Center for Companion Animal Research (Project No. PJ013984012019)" from
   the National Institute of Animal Science, Acknowledgements Authors
   acknowledge the 2019 RDA Fellowship Program of the National Institute of
   Animal Science, Rural Development Administration, Korea.
CR Arane K, 2016, CAN FAM PHYSICIAN, V62, P812
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   Coelho LP, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0450-3
   Conrads G, 2002, INT J SYST EVOL MICR, V52, P493, DOI 10.1099/00207713-52-2-493
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Deng P, 2015, BRIT J NUTR, V113, pS6, DOI 10.1017/S0007114514002943
   Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611
   Gao R, 2017, EUR J CLIN MICROBIOL, V36, P757, DOI 10.1007/s10096-016-2881-8
   German AJ, 2003, J VET INTERN MED, V17, P33, DOI 10.1111/j.1939-1676.2003.tb01321.x
   HAMPP EG, 1960, J BACTERIOL, V79, P716, DOI 10.1128/JB.79.5.716-728.1960
   Hu HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134333
   Hullar MAJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197686
   Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Li QH, 2017, MBIO, V8, DOI [10.1128/mBio.01703-16, 10.1128/mbio.01703-16]
   Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358
   MACDONALD ML, 1984, ANNU REV NUTR, V4, P521, DOI 10.1146/annurev.nu.04.070184.002513
   Mentula S, 2005, APPL ENVIRON MICROB, V71, P4169, DOI 10.1128/AEM.71.8.4169-4175.2005
   Moon CD, 2018, MICROBIOLOGYOPEN, V7, DOI 10.1002/mbo3.677
   ROBRISH SA, 1991, INFECT IMMUN, V59, P4547, DOI 10.1128/IAI.59.12.4547-4554.1991
   Roy S, 2017, NAT REV CANCER, V17, P271, DOI 10.1038/nrc.2017.13
   Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Sheehan D, 2017, GASTROENTEROL CLIN N, V46, P143, DOI 10.1016/j.gtc.2016.09.011
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837
NR 29
TC 12
Z9 12
U1 1
U2 5
PU KOREAN SOCIETY ANIMAL SCIENCE & TECHNOLOGY
PI SEOUL
PA ROOM 1618, 8-13 GWANGPYEONG-RO 56 GIL, GANGNAM, SEOUL, 06367, SOUTH
   KOREA
SN 2672-0191
EI 2055-0391
J9 J ANIM SCI TECHNOL
JI J. Anim. Sci. Technol.
PY 2020
VL 62
IS 2
BP 239
EP 246
DI 10.5187/jast.2020.62.2.239
PG 8
WC Agriculture, Dairy & Animal Science; Biotechnology & Applied
   Microbiology; Veterinary Sciences
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Agriculture; Biotechnology & Applied Microbiology; Veterinary Sciences
GA LD0JQ
UT WOS:000525719800012
PM 32292931
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Hertel, J
   Heinken, A
   Martinelli, F
   Thiele, I
AF Hertel, Johannes
   Heinken, Almut
   Martinelli, Filippo
   Thiele, Ines
TI Integration of constraint-based modeling with fecal metabolomics reveals
   large deleterious effects of Fusobacterium spp. on community butyrate
   production
SO GUT MICROBES
LA English
DT Article
DE Metabolic modeling; microbiome; fusiobacteria; metagenomic data; flux
   balance analysis
ID COLORECTAL-CANCER; GUT MICROBIOTA; INTESTINAL MICROBIOTA; NUCLEATUM;
   METABOLISM; HEALTH; NUTRITION
AB Characterizing the metabolic functions of the gut microbiome in health and disease is pivotal for translating alterations in microbial composition into clinical insights. Two major analysis paradigms have been used to explore the metabolic functions of the microbiome but not systematically integrated with each other: statistical screening approaches, such as metabolome-microbiome association studies, and computational approaches, such as constraint-based metabolic modeling. To combine the strengths of the two analysis paradigms, we herein introduce a set of theoretical concepts allowing for the population statistical treatment of constraint-based microbial community models. To demonstrate the utility of the theoretical framework, we applied it to a public metagenomic dataset consisting of 365 colorectal cancer (CRC) cases and 251 healthy controls, shining a light on the metabolic role of Fusobacterium spp. in CRC. We found that (1) glutarate production capability was significantly enriched in CRC microbiomes and mechanistically linked to lysine fermentation in Fusobacterium spp., (2) acetate and butyrate production potentials were lowered in CRC, and (3) Fusobacterium spp. presence had large negative ecological effects on community butyrate production in CRC cases and healthy controls. Validating the model predictions against fecal metabolomics, the in silico frameworks correctly predicted in vivo species metabolite correlations with high accuracy. In conclusion, highlighting the value of combining statistical association studies with in silico modeling, this study provides insights into the metabolic role of Fusobacterium spp. in the gut, while providing a proof of concept for the validity of constraint-based microbial community modeling.
C1 [Hertel, Johannes; Heinken, Almut; Martinelli, Filippo; Thiele, Ines] Natl Univ Galway, Sch Med, Galway, Ireland.
   [Hertel, Johannes] Univ Med, Dept Psychiat & Psychotherapy, Greifswald, Germany.
   [Heinken, Almut; Martinelli, Filippo; Thiele, Ines] Natl Univ Galway, Ryan Inst, Galway, Ireland.
   [Thiele, Ines] Natl Univ Galway, Discipline Microbiol, Galway, Ireland.
   [Thiele, Ines] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland.
C3 Ollscoil na Gaillimhe-University of Galway; Ollscoil na
   Gaillimhe-University of Galway; Ollscoil na Gaillimhe-University of
   Galway; University College Cork
RP Thiele, I (corresponding author), Natl Univ Galway, Sch Med, Galway, Ireland.
EM ines.thiele@nuigalway.ie
FU H2020 European Research Council [757922]; National Institute on Aging
   [1U19AG063744-01, 1RF1AG058942-01]
FX This work was supported by the H2020 European Research Council [757922];
   National Institute on Aging [1U19AG063744-01]; National Institute on
   Aging [1RF1AG058942-01].
CR Baldini F, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00775-7
   Baldini F, 2019, BIOINFORMATICS, V35, P2332, DOI 10.1093/bioinformatics/bty941
   Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x
   Buckel W, 2001, APPL MICROBIOL BIOT, V57, P263, DOI 10.1007/s002530100773
   Carr A, 2019, ISME J, V13, P2647, DOI 10.1038/s41396-019-0459-z
   Chang CJ, 2019, J FOOD DRUG ANAL, V27, P615, DOI 10.1016/j.jfda.2018.12.011
   Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111
   Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035
   Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S
   Douglas AE, 2019, NAT REV MICROBIOL, V17, P764, DOI 10.1038/s41579-019-0242-1
   Flanagan L, 2014, EUR J CLIN MICROBIOL, V33, P1381, DOI 10.1007/s10096-014-2081-3
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Flynn KJ, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00102-16
   Garza DR, 2020, CANCER METAB, V8, DOI 10.1186/s40170-020-0208-9
   Guo SH, 2018, CLIN CHEM, V64, P1327, DOI 10.1373/clinchem.2018.289728
   Harrell F.E., 2001, REGRESSION MODELING, P87, DOI DOI 10.1007/978-3-319-19425-7
   Heinken A, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0689-3
   Heinken A, 2013, GUT MICROBES, V4, P28, DOI 10.4161/gmic.22370
   Heirendt L, 2019, NAT PROTOC, V14, P639, DOI 10.1038/s41596-018-0098-2
   Henson MA, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00026-19
   Hertel J, 2019, CELL REP, V29, P1767, DOI 10.1016/j.celrep.2019.10.035
   Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772
   Kim M, 2020, MBIO, V11, DOI 10.1128/mBio.03186-19
   Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167
   Koeth RA, 2013, NAT MED, V19, P576, DOI 10.1038/nm.3145
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   Kumar M, 2019, NAT MICROBIOL, V4, P1253, DOI 10.1038/s41564-019-0491-9
   Kumar M, 2018, METAB ENG, V49, P128, DOI 10.1016/j.ymben.2018.07.018
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   Magnusdottir S, 2017, NAT BIOTECHNOL, V35, P81, DOI 10.1038/nbt.3703
   Mehta RS, 2017, JAMA ONCOL, V3, P921, DOI 10.1001/jamaoncol.2016.6374
   Mima K, 2016, GUT, V65, P1973, DOI 10.1136/gutjnl-2015-310101
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Ng C, 2019, J GASTROINTEST ONCOL, V10, P1164, DOI 10.21037/jgo.2019.06.04
   Noecker C, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00579-19
   Noronha A, 2019, NUCLEIC ACIDS RES, V47, pD614, DOI 10.1093/nar/gky992
   Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614
   Pearl J, 2009, STAT SURV, V3, P96, DOI 10.1214/09-SS057
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Shaffer M, 2017, TRANSL RES, V189, P51, DOI 10.1016/j.trsl.2017.07.001
   Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011
   Shashkova T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148386
   Smith EA, 1997, ANAEROBE, V3, P327, DOI 10.1006/anae.1997.0121
   Thiele I, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20198982
   Thiele Ines, 2017, Curr Opin Syst Biol, V4, P43, DOI 10.1016/j.coisb.2017.06.001
   Thiele I, 2013, CURR OPIN BIOTECH, V24, P4, DOI 10.1016/j.copbio.2012.10.001
   Tilg H, 2018, CANCER CELL, V33, P954, DOI 10.1016/j.ccell.2018.03.004
   Tokudome S, 2001, EUR J CLIN NUTR, V55, P735, DOI 10.1038/sj.ejcn.1601215
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Van Wey AS, 2014, INT J FOOD MICROBIOL, V191, P172, DOI 10.1016/j.ijfoodmicro.2014.09.006
   Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14
   White A, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4786-7
   Wilson ID, 2017, TRANSL RES, V179, P204, DOI 10.1016/j.trsl.2016.08.002
   Wirbel J, 2019, NAT MED, V25, P679, DOI 10.1038/s41591-019-0406-6
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Xu SY, 2020, CANCERS, V12, DOI 10.3390/cancers12020372
   Yachida S, 2019, NAT MED, V25, P968, DOI 10.1038/s41591-019-0458-7
   Yang G, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01434
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Yuan J, 2019, CELL METAB, V30, P675, DOI 10.1016/j.cmet.2019.08.018
   Zhou ZW, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00371
   Zhu QC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090849
   Zierer J, 2018, NAT GENET, V50, P790, DOI 10.1038/s41588-018-0135-7
NR 65
TC 11
Z9 11
U1 3
U2 5
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1949-0976
EI 1949-0984
J9 GUT MICROBES
JI Gut Microbes
PD JAN 1
PY 2021
VL 13
IS 1
DI 10.1080/19490976.2021.1915673
PG 22
WC Gastroenterology & Hepatology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology; Microbiology
GA WK6WU
UT WOS:000709866600001
PM 34057024
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Tong, M
   McHardy, I
   Ruegger, P
   Goudarzi, M
   Kashyap, PC
   Haritunians, T
   Li, X
   Graeber, TG
   Schwager, E
   Huttenhower, C
   Fornace, AJ
   Sonnenburg, JL
   McGovern, DPB
   Borneman, J
   Braun, J
AF Tong, Maomeng
   McHardy, Ian
   Ruegger, Paul
   Goudarzi, Maryam
   Kashyap, Purna C.
   Haritunians, Talin
   Li, Xiaoxiao
   Graeber, Thomas G.
   Schwager, Emma
   Huttenhower, Curtis
   Fornace, Albert J., Jr.
   Sonnenburg, Justin L.
   McGovern, Dermot P. B.
   Borneman, James
   Braun, Jonathan
TI Reprograming of gut microbiome energy metabolism by the FUT2 Crohn's
   disease risk polymorphism
SO ISME JOURNAL
LA English
DT Article
DE glycan foraging; intestinal microbiome; microbial ecology; multi'omic
   analysis
ID FECAL MICROBIOTA; MUCOSA; DIET; DIVERSITY; GENOTYPE; HEALTH; MUCINS;
   CELLS; ACIDS; TWIN
AB Fucosyltransferase 2 (FUT2) is an enzyme that is responsible for the synthesis of the H antigen in body fluids and on the intestinal mucosa. The H antigen is an oligosaccharide moiety that acts as both an attachment site and carbon source for intestinal bacteria. Non-secretors, who are homozygous for the loss-of-function alleles of FUT2 gene (sese), have increased susceptibility to Crohn's disease (CD). To characterize the effect of FUT2 polymorphism on the mucosal ecosystem, we profiled the microbiome, meta-proteome and meta-metabolome of 75 endoscopic lavage samples from the cecum and sigmoid of 39 healthy subjects (12 SeSe, 18 Sese and 9 sese). Imputed metagenomic analysis revealed perturbations of energy metabolism in the microbiome of non-secretor and heterozygote individuals, notably the enrichment of carbohydrate and lipid metabolism, cofactor and vitamin metabolism and glycan biosynthesis and metabolism-related pathways, and the depletion of amino-acid biosynthesis and metabolism. Similar changes were observed in mice bearing the FUT2(-/-) genotype. Metabolomic analysis of human specimens revealed concordant as well as novel changes in the levels of several metabolites. Human metaproteomic analysis indicated that these functional changes were accompanied by sub-clinical levels of inflammation in the local intestinal mucosa. Therefore, the colonic microbiota of non-secretors is altered at both the compositional and functional levels, affecting the host mucosal state and potentially explaining the association of FUT2 genotype and CD susceptibility.
C1 [Tong, Maomeng; Graeber, Thomas G.; Braun, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [McHardy, Ian; Braun, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.
   [Ruegger, Paul; Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA.
   [Goudarzi, Maryam; Fornace, Albert J., Jr.] Georgetown Univ, Dept Biochem & Mol & Cellular Biol, Washington, DC USA.
   [Kashyap, Purna C.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.
   [Haritunians, Talin; Li, Xiaoxiao; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Inflammatory Bowel & Immunobiol Res Ins, Los Angeles, CA 90048 USA.
   [Schwager, Emma; Huttenhower, Curtis] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
C3 University of California System; University of California Los Angeles;
   University of California Los Angeles Medical Center; David Geffen School
   of Medicine at UCLA; University of California System; University of
   California Los Angeles; University of California Los Angeles Medical
   Center; David Geffen School of Medicine at UCLA; University of
   California System; University of California Riverside; Georgetown
   University; Stanford University; Cedars Sinai Medical Center; Harvard
   University; Harvard T.H. Chan School of Public Health
RP Braun, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, CHS 13-222, Los Angeles, CA 90095 USA.
EM JBraun@mednet.ucla.edu
RI Goudarzi, Maryam/O-9472-2015; Fornace, Albert/A-7407-2008
OI Goudarzi, Maryam/0000-0003-4961-3935; McHardy, Ian/0000-0002-2121-5460;
   Fornace, Albert/0000-0001-9695-085X; McGovern,
   Dermot/0000-0001-5621-759X; Braun, Jonathan/0000-0003-1646-2974;
   Graeber, Thomas/0000-0001-8574-9181
FU NIH [DK046763, DK08569, AI078885, DK062413]; NCRR; NCATS [UL1TR000124];
   Crohn's and Colitis Foundation of America [3153]; Burroughs Wellcome
   Fund Inter-school Program in Metabolic Diseases Fellowship; Cedars-Sinai
   F. Widjaja Family Foundation Inflammatory Bowel; Immunobiology Research
   Institute Research Funds; Helmsley Foundation; NIH/NCI [P30-CA051008];
   NATIONAL CANCER INSTITUTE [P30CA051008, P30CA016042] Funding Source: NIH
   RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
   [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH
   RESOURCES [UL1RR033176] Funding Source: NIH RePORTER; NATIONAL INSTITUTE
   OF ALLERGY AND INFECTIOUS DISEASES [R01AI078885] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH
   [U54DE023798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085691, P01DK046763,
   U01DK062413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCES [T32GM074897] Funding Source: NIH RePORTER
FX This work was supported by NIH DK046763 (to JB, DPBM), DK08569 (to JB),
   AI078885 (to JB, DK062413 (to DPBM), NCRR and NCATS UL1TR000124 (to JB),
   the Crohn's and Colitis Foundation of America 3153 (to JB), the
   Burroughs Wellcome Fund Inter-school Program in Metabolic Diseases
   Fellowship (to MT), Cedars-Sinai F. Widjaja Family Foundation
   Inflammatory Bowel and Immunobiology Research Institute Research Funds
   (to DPBM) and the Helmsley Foundation (DPBM). We thank Georgetown
   University's Proteomics and Metabolomics shared resource partially
   supported by the NIH/NCI Grant P30-CA051008.
CR Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358
   Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Perez-Cobas AE, 2013, GUT, V62, P1591, DOI 10.1136/gutjnl-2012-303184
   Erickson AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049138
   Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606
   Ferrer-Admetlla A, 2009, MOL BIOL EVOL, V26, P1993, DOI 10.1093/molbev/msp108
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339
   Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687
   Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Hurd EA, 2005, GLYCOBIOLOGY, V15, P1002, DOI 10.1093/glycob/cwi089
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009
   Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105
   Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582
   Kashyap PC, 2013, P NATL ACAD SCI USA, V110, P17059, DOI 10.1073/pnas.1306070110
   Katayama T, 2004, J BACTERIOL, V186, P4885, DOI 10.1128/JB.186.15.4885-4893.2004
   Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863
   Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746
   Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568
   Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542
   Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5
   Magalhaes A, 2009, GLYCOBIOLOGY, V19, P1525, DOI 10.1093/glycob/cwp131
   Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817
   Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521
   Martens EC, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001221
   McGovern DPB, 2010, HUM MOL GENET, V19, P3468, DOI 10.1093/hmg/ddq248
   McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538
   McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17
   Metges CC, 2000, J NUTR, V130, p1857S, DOI 10.1093/jn/130.7.1857S
   Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79
   Mueller S, 2006, APPL ENVIRON MICROB, V72, P1027, DOI 10.1128/AEM.72.2.1027-1033.2006
   Ng KM, 2013, NATURE, V502, P96, DOI 10.1038/nature12503
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Pacheco AR, 2012, NATURE, V492, P113, DOI 10.1038/nature11623
   Petnicki-Ocwieja T, 2009, P NATL ACAD SCI USA, V106, P15813, DOI 10.1073/pnas.0907722106
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935
   Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108
   Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825
   SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35
   Smith MI, 2013, SCIENCE, V339, P548, DOI 10.1126/science.1229000
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Sokol H, 2010, CURR OPIN GASTROEN, V26, P327, DOI 10.1097/MOG.0b013e328339536b
   Sonnenburg ED, 2010, CELL, V141, P1241, DOI 10.1016/j.cell.2010.05.005
   Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051
   Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540
   Stewart JA, 2005, J MED MICROBIOL, V54, P1239, DOI 10.1099/jmm.0.46189-0
   Tattoli I, 2012, CELL HOST MICROBE, V11, P563, DOI 10.1016/j.chom.2012.04.012
   Tong MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080702
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Van der Sluis M, 2006, GASTROENTEROLOGY, V131, P117, DOI 10.1053/j.gastro.2006.04.020
   Wacklin P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020113
   Willing BP, 2010, GUT MICROBES, V1, P213, DOI 10.4161/gmic.1.4.12520
   Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
   Zoetendal Erwin G., 2001, Microbial Ecology in Health and Disease, V13, P129, DOI 10.1080/089106001750462669
NR 74
TC 136
Z9 138
U1 1
U2 48
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1751-7362
EI 1751-7370
J9 ISME J
JI ISME J.
PD NOV
PY 2014
VL 8
IS 11
BP 2193
EP 2206
DI 10.1038/ismej.2014.64
PG 14
WC Ecology; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Microbiology
GA AS7SB
UT WOS:000344454000004
PM 24781901
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Kang, S
   You, HJ
   Ju, Y
   Kim, HJ
   Jeong, YJ
   Johnston, TV
   Ji, GE
   Ku, S
   Park, MS
AF Kang, Sini
   You, Hyun Ju
   Ju, Ying
   Kim, Hee Jung
   Jeong, Yun Ju
   Johnston, Tony V.
   Ji, Geun Eog
   Ku, Seockmo
   Park, Myeong Soo
TI Butyl-fructooligosaccharides modulate gut microbiota in healthy mice and
   ameliorate ulcerative colitis in a DSS-induced model
SO FOOD & FUNCTION
LA English
DT Article
ID CHAIN FATTY-ACIDS; AMYLOSE MAIZE STARCH; BUTYRATE ENEMAS;
   COLONIC-MUCOSA; INTESTINAL MICROBIOTA; BUTYRYLATED STARCH;
   ENERGY-METABOLISM; INFLAMMATION; DIET; PERMEABILITY
AB Butyl-fructooligosaccharides (B-FOSs) are newly synthesized prebiotics composed of short-chain FOS (GF2, 1-kestose; GF3, nystose; GF4, fructofuranosyl-nystose; GF5, 1-F-(1-b-d-fructofuranosyl)-2-nystose) bound with one or two butyric groups by ester bonds. Previous in vitro studies have shown that B-FOS treatment increases butyrate production and protects the growth of butyrate-producing bacteria during fermentation. The aim of this study was to further test B-FOS as a novel prebiotic compound by evaluating the effect of B-FOS on gut microbiota via 16S rRNA metagenomic analysis in an Institute of Cancer Research (ICR) mouse model and examining its anti-inflammatory efficacy in a mouse model of colitis induced by dextran sodium sulphate (DSS). In the healthy ICR mouse study, linear discriminant analysis effect size results revealed that Bifidobacterium was the representative phylotype in the B-FOS treatment compared to the control group. Furthermore, the cecal butyrate concentration of the B-FOS group was significantly higher than that of the control (P < 0.05). The high concentration of butyrate in the B-FOS treatment was probably associated with the high relative abundance of clusters of orthologous group (COG) 4770 (acetyl/propionyl-CoA carboxylase). In the DSS-induced infection study, B-FOS significantly ameliorated the symptoms of DSS-induced colitis, increased the mRNA expression of occludin, decreased tumor necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and interleukin (IL-8) in the colon tissues, and significantly increased cecal butyrate concentrations. These findings suggest that B-FOS ameliorated DSS-induced colitis by maintaining the epithelial barrier and reducing the secretion of inflammation related cytokines.
C1 [Kang, Sini] Hubei Univ Technol, Hubei Res Ctr Food Fermentat Engn & Technol, Natl Ctr Cellular Regulat & Mol Pharmaceut 111, Key Lab Fermentat Engn,Minist Educ,Hubei Key Lab, Wuhan 430068, Peoples R China.
   [Kang, Sini; Ju, Ying; Kim, Hee Jung; Jeong, Yun Ju; Ji, Geun Eog] Seoul Natl Univ, Res Inst Human Ecol, Dept Food & Nutr, Seoul 08826, South Korea.
   [You, Hyun Ju] Seoul Natl Univ, Grad Sch Publ Hlth, Inst Hlth & Environm, Seoul 08826, South Korea.
   [Johnston, Tony V.; Ku, Seockmo] Middle Tennessee State Univ, Coll Basic & Appl Sci, Sch Agr, Fermentat Sci Program, Murfreesboro, TN 37132 USA.
   [Ji, Geun Eog; Park, Myeong Soo] BIFIDO Co Ltd, Res Ctr, Hongcheon 25117, South Korea.
C3 Hubei University of Technology; Seoul National University (SNU); Seoul
   National University (SNU); Middle Tennessee State University; BIFIDO Co.
   Ltd.
RP Ku, S (corresponding author), Middle Tennessee State Univ, Coll Basic & Appl Sci, Sch Agr, Fermentat Sci Program, Murfreesboro, TN 37132 USA.; Park, MS (corresponding author), BIFIDO Co Ltd, Res Ctr, Hongcheon 25117, South Korea.
EM dhlover1@snu.ac.kr; seockmo.ku@mtsu.edu
RI Jeong, Yunju/GRS-0008-2022
OI Ku, Seockmo/0000-0003-2661-5073
FU Ministry of Small and Medium-sized Enterprises (SMEs) and Startups
   (MSS), Korea [S2848321]; Faculty Research and Creative Activity
   Committee (FRCAC) - Middle Tennessee State University in U.S [221745];
   HBUT National "111" Center for Cellular Regulation and Molecular
   Pharmaceutics in China [XBTK-2021004]
FX This work was carried out with the support of the Ministry of Small and
   Medium-sized Enterprises (SMEs) and Startups (MSS), Korea, under the
   "Regional Specialized Industry Development Program (R&D, Project number
   S2848321)" supervised by the Korea Institute for Advancement of
   Technology (KIAT). This work was also supported by a Faculty Research
   and Creative Activity Committee (FRCAC) grant (No. 221745) funded by
   Middle Tennessee State University in U.S., and the Collaborative
   Grant-in-Aid of the HBUT National "111" Center for Cellular Regulation
   and Molecular Pharmaceutics (XBTK-2021004) in China. Seockmo Ku and Tony
   V. Johnston participated this work based on a non-disclosure research
   agreement between Middle Tennessee State University and BIFIDO Co., Ltd.
CR Andoh A, 1999, JPEN-PARENTER ENTER, V23, pS70, DOI 10.1177/014860719902300518
   Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523
   Bajka BH, 2008, CARCINOGENESIS, V29, P2169, DOI 10.1093/carcin/bgn173
   Bajka BH, 2006, BRIT J NUTR, V96, P276, DOI 10.1079/BJN20061807
   Bolnick DI, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5500
   Bornet F. R. J., 2002, Bioscience and Microflora, V21, P55
   Breuer RI, 1997, GUT, V40, P485, DOI 10.1136/gut.40.4.485
   Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403
   Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111
   Chen GX, 2018, EBIOMEDICINE, V30, P317, DOI 10.1016/j.ebiom.2018.03.030
   Chen HL, 2000, NUTR RES, V20, P1725, DOI 10.1016/S0271-5317(00)00274-8
   Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340
   Clark JM, 2007, AM J CLIN NUTR, V86, P1146, DOI 10.1093/ajcn/86.4.1146
   Clarke JM, 2008, CARCINOGENESIS, V29, P2190, DOI 10.1093/carcin/bgn192
   Clarke JM, 2011, AM J CLIN NUTR, V94, P1276, DOI 10.3945/ajcn.111.017228
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   De Preter V, 2012, INFLAMM BOWEL DIS, V18, P1127, DOI 10.1002/ibd.21894
   Deusch S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01605
   Fava F, 2011, WORLD J GASTROENTERO, V17, P557, DOI 10.3748/wjg.v17.i5.557
   Ferrer-Picon E, 2020, INFLAMM BOWEL DIS, V26, P43, DOI 10.1093/ibd/izz119
   Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339
   FU XD, 2018, CRITICAL REV FOOD SC, V59, P1, DOI DOI 10.1080/10408398.2018.1542587
   Fu XD, 2019, CRIT REV FOOD SCI, V59, pS130, DOI 10.1080/10408398.2018.1542587
   Geier MS, 2007, DIS COLON RECTUM, V50, P1061, DOI 10.1007/s10350-007-0213-x
   Geuking MB, 2014, GUT MICROBES, V5, P411, DOI 10.4161/gmic.29330
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Hamer HM, 2010, CLIN NUTR, V29, P738, DOI 10.1016/j.clnu.2010.04.002
   Hirayama K., 1994, Bifidobacteria and Microflora, V13, P1
   Hsu CK, 2004, J NUTR, V134, P1523, DOI 10.1093/jn/134.6.1523
   Kang S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020445
   Karimi G., 2014, BUTYRIC ACID, P597
   Kim H, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050788
   Kitajima S, 1999, EXP ANIM TOKYO, V48, P137, DOI 10.1538/expanim.48.137
   Lam KL, 2019, J AGR FOOD CHEM, V67, P12335, DOI 10.1021/acs.jafc.9b04811
   Lama A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41295-x
   Le Blay G, 1999, J NUTR, V129, P2231, DOI 10.1093/jn/129.12.2231
   Lee C, 2017, INT IMMUNOPHARMACOL, V51, P47, DOI 10.1016/j.intimp.2017.07.023
   Lee YK., 2009, HDB PROBIOTICS PREBI, V2, DOI DOI 10.1002/9780470432624
   Leonel AJ, 2012, CURR OPIN CLIN NUTR, V15, P474, DOI 10.1097/MCO.0b013e32835665fa
   Liao MJ, 2021, FOOD FUNCT, V12, P9844, DOI [10.1039/d1fo01147b, 10.1039/D1FO01147B]
   Liu FT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10722-2
   Mao BY, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081105
   Mao BY, 2015, J AGR FOOD CHEM, V63, P856, DOI 10.1021/jf505156h
   McBrearty N., 2019, SHORT CHAIN FATTY AC
   McDermott AJ, 2014, IMMUNOLOGY, V142, P24, DOI 10.1111/imm.12231
   Mishiro T, 2013, LAB INVEST, V93, P834, DOI 10.1038/labinvest.2013.70
   Osman N, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-31
   Paineau D, 2014, J NUTR SCI VITAMINOL, V60, P167, DOI 10.3177/jnsv.60.167
   Pan XD, 2009, J ZHEJIANG UNIV-SC B, V10, P258, DOI 10.1631/jzus.B0820261
   Peng LY, 2009, J NUTR, V139, P1619, DOI 10.3945/jn.109.104638
   Peng R., LANCET, DOI [10.2139/ssrn.3697999, DOI 10.2139/SSRN.3697999]
   Polansky O, 2016, APPL ENVIRON MICROB, V82, P1569, DOI 10.1128/AEM.03473-15
   Poritz LS, 2007, J SURG RES, V140, P12, DOI 10.1016/j.jss.2006.07.050
   Ren YL, 2018, J NUTR BIOCHEM, V57, P67, DOI 10.1016/j.jnutbio.2018.03.005
   Sabater-Molina M, 2009, J PHYSIOL BIOCHEM, V65, P315, DOI 10.1007/BF03180584
   SCHEPPACH W, 1992, GASTROENTEROLOGY, V103, P51, DOI 10.1016/0016-5085(92)91094-K
   Schonfeld P, 2016, J LIPID RES, V57, P943, DOI 10.1194/jlr.R067629
   Segain JP, 2000, GUT, V47, P397, DOI 10.1136/gut.47.3.397
   Simeoli R, 2017, BRIT J PHARMACOL, V174, P1484, DOI 10.1111/bph.13637
   Solomon L., 2010, COMP CLIN PATHOL, V19, P235, DOI [DOI 10.1007/S00580-010-0979-4, 10.1007/s00580-010-0979-4]
   Srinivas SR, 2007, AM J PHYSIOL-GASTR L, V293, pG1046, DOI 10.1152/ajpgi.00233.2007
   Srutkova D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134050
   Steinhart AH, 1996, ALIMENT PHARM THER, V10, P729, DOI 10.1046/j.1365-2036.1996.d01-509.x
   Szilagyi A, 2005, CAN J GASTROENTEROL, V19, P505, DOI 10.1155/2005/415698
   Thibault R, 2010, INFLAMM BOWEL DIS, V16, P684, DOI 10.1002/ibd.21108
   Thursby E, 2017, BIOCHEM J, V474, P1823, DOI 10.1042/BCJ20160510
   Venkatraman A, 2000, SCAND J GASTROENTERO, V35, P1053
   Vernia P, 2003, EUR J CLIN INVEST, V33, P244, DOI 10.1046/j.1365-2362.2003.01130.x
   Vieira ELM, 2012, J NUTR BIOCHEM, V23, P430, DOI 10.1016/j.jnutbio.2011.01.007
   Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99
   Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y
   Yang B, 2018, J FUNCT FOODS, V49, P61, DOI 10.1016/j.jff.2018.08.014
   YOUNES H, 1995, J NUTR, V125, P1010
   Zha ZQ, 2020, INT J BIOL MACROMOL, V156, P1217, DOI 10.1016/j.ijbiomac.2019.11.159
   Zhai R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00239
   Zhang L, 2021, TRENDS ENDOCRIN MET, V32, P159, DOI 10.1016/j.tem.2020.12.003
NR 76
TC 2
Z9 2
U1 13
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD FEB 21
PY 2022
VL 13
IS 4
BP 1834
EP 1845
DI 10.1039/d1fo03337a
EA JAN 2022
PG 12
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA ZD5YN
UT WOS:000749719200001
PM 35084011
DA 2022-11-22
ER

PT J
AU Singh, H
   Torralba, MG
   Moncera, KJ
   DiLello, L
   Parini, J
   Nelson, KE
   Pieper, R
AF Singh, Harinder
   Torralba, Manolito G.
   Moncera, Kelvin J.
   DiLello, Lauren
   Parini, Joann
   Nelson, Karen E.
   Pieper, Rembert
TI Gastro-intestinal and oral microbiome signatures associated with healthy
   aging
SO GEROSCIENCE
LA English
DT Article
DE Oral microbiome; Gut microbiome; 16S rRNA; Metagenomic analysis; Healthy
   aging; Chronic disease; Longevity; Akkermansia; Streptococcus
ID CHAIN FATTY-ACIDS; GUT MICROBIOTA; AKKERMANSIA-MUCINIPHILA; LIFE-SPAN;
   FUSOBACTERIUM-NUCLEATUM; INTESTINAL MICROBIOTA; INFLAMMATION; DIVERSITY;
   GENE; MITOCHONDRIA
AB The human oral and gut microbiomes influence health via competition for a distinct niche in the body with pathogens, via metabolic capabilities that increase host digestive capacity and generate compounds engaged in signaling pathways and modulation of immune system functions. Old age alters our metabolic and regenerative capacity. Following recruitment of 65 human subjects in the age range of 70 to 82, we discerned healthy aging (HA) and non-healthy aging (NHA) cohorts discordant in the occurrence of one or more major diseases: (1) cancer, (2) acute or chronic cardiovascular diseases, (3) acute or chronic pulmonary diseases, (4) diabetes, and (5) stroke or neurodegenerative disorders. We analyzed these cohorts' oral microbiomes (saliva) and gut microbiomes (stool) to assess diversity and identify microbial biomarkers for HA. In contrast to the gut microbiome where no change was observed, we found that the saliva microbiome had higher alpha-diversity in the HA compared with the NHA group. We observed the genus Akkermansia to be significantly more abundant in the gut microbiota of the HA group. Akkermansia muciniphila is a colonic mucin-degrading bacterium believed to have beneficial effects on gastrointestinal health, particularly in the context of diabetes and obesity. Erysipelotrichaceae UCG-003 was a taxon increased in abundance in the HA cohort. Streptococcus was the only genus observed to be significantly decreased in abundance in both the gut and oral microbiomes of the HA cohort compared with the NHA cohort. Our data support the notion that these microbes are potential probiotics to decrease the risks of non-healthy aging.
C1 [Singh, Harinder; Nelson, Karen E.; Pieper, Rembert] J Craig Venter Inst, 9605 Med Ctr Dr, Rockville, MD 20850 USA.
   [Torralba, Manolito G.; Moncera, Kelvin J.; Nelson, Karen E.] J Craig Venter Inst, 4120 Capricorn Lane, La Jolla, CA 92037 USA.
   [DiLello, Lauren; Parini, Joann] Western Connecticut Hlth Network, 24 Hosp Ave, Danbury, CT 06810 USA.
C3 J. Craig Venter Institute; J. Craig Venter Institute
RP Singh, H; Pieper, R (corresponding author), J Craig Venter Inst, 9605 Med Ctr Dr, Rockville, MD 20850 USA.
EM hsingh@jcvi.org; rembertpieper2@gmail.com
OI Moncera, Kelvin Jens/0000-0002-9907-0687
FU Ruggles Family Foundation
FX This work was generously funded by the Ruggles Family Foundation,
   Moline, IL, and Mr. and Mrs. Rudy Ruggles.
CR Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005
   AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Belzer C, 2012, ISME J, V6, P1449, DOI 10.1038/ismej.2012.6
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125
   BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268
   Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035
   Carmona-Gutierrez D, 2016, AGEING RES REV, V32, P2, DOI 10.1016/j.arr.2016.04.009
   Chen WG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039743
   Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14
   Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   Collado MC, 2007, APPL ENVIRON MICROB, V73, P7767, DOI 10.1128/AEM.01477-07
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   Derrien M, 2008, APPL ENVIRON MICROB, V74, P1646, DOI 10.1128/AEM.01226-07
   Desai MS, 2016, CELL, V167, P1339, DOI 10.1016/j.cell.2016.10.043
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057
   Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960
   Gans KM, 2003, J NUTR, V133, p556S, DOI 10.1093/jn/133.2.556S
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Gomez A, 2017, CELL HOST MICROBE, V22, P269, DOI 10.1016/j.chom.2017.08.013
   Greer RL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13329
   Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104
   HARMAN D, 1972, J AM GERIATR SOC, V20, P145, DOI 10.1111/j.1532-5415.1972.tb00787.x
   Heintz C, 2014, CELL, V156, P408, DOI 10.1016/j.cell.2014.01.025
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jiang Q, 2019, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00442
   Kaakoush NO, 2015, FRONT CELL INFECT MI, V5, DOI [10.3389/fcimb.2015.00084, 10.3309/fcimb.2015.00004]
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kilian M, 2014, MBIO, V5, DOI 10.1128/mBio.01490-14
   Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707
   Krajmalnik-Brown R, 2012, NUTR CLIN PRACT, V27, P201, DOI 10.1177/0884533611436116
   Kumar Manish, 2016, Nutr Healthy Aging, V4, P3, DOI 10.3233/NHA-150002
   Leishman Shaneen J, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5781
   Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319
   Liu GY, 2015, MICROBIOL-SGM, V161, P1297, DOI 10.1099/mic.0.000086
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   McMurdie PJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003531
   McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217
   Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102
   Parmentier-Decrucq E, 2009, INFLAMM BOWEL DIS, V15, P1476, DOI 10.1002/ibd.20931
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rajagopala SV, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2965-y
   Rajaram S, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-45
   Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14
   Reunanen J, 2015, APPL ENVIRON MICROB, V81, P3655, DOI 10.1128/AEM.04050-14
   Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185
   Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Salminen A, 2010, CELL SIGNAL, V22, P573, DOI 10.1016/j.cellsig.2009.10.006
   Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333
   Schippa S, 2014, NUTRIENTS, V6, P5786, DOI 10.3390/nu6125786
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848
   Sebastiani Paola, 2010, Science, V2010, DOI 10.1126/science.1190532
   Shang FM, 2018, WORLD J GASTRO ONCOL, V10, P71, DOI 10.4251/wjgo.v10.i3.71
   Shen EZ, 2014, NATURE, V508, P128, DOI 10.1038/nature13012
   Sun J, 2016, GENES DIS, V3, P130, DOI 10.1016/j.gendis.2016.03.004
   Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9
   Team RC, 2015, R LANG ENV STAT COMP
   Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638
   Tsuzukibashi O, 2017, J MICROBIOL METH, V134, P21, DOI 10.1016/j.mimet.2017.01.005
   Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019
   van den Bogert B, 2013, FEMS MICROBIOL ECOL, V85, P376, DOI 10.1111/1574-6941.12127
   Velarde Michael C, 2014, Longev Healthspan, V3, P2, DOI 10.1186/2046-2395-3-2
   Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07
   Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105
   Woods JA, 2012, AGING DIS, V3, P130
   Yamamura K, 2016, CLIN CANCER RES, V22, P5574, DOI 10.1158/1078-0432.CCR-16-1786
   Yang LY, 2009, GASTROENTEROLOGY, V137, P588, DOI 10.1053/j.gastro.2009.04.046
NR 74
TC 41
Z9 44
U1 6
U2 51
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 2509-2715
EI 2509-2723
J9 GEROSCIENCE
JI GeroScience
PD DEC
PY 2019
VL 41
IS 6
SI SI
BP 907
EP 921
DI 10.1007/s11357-019-00098-8
EA OCT 2019
PG 15
WC Geriatrics & Gerontology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Geriatrics & Gerontology
GA KI9NS
UT WOS:000490630400001
PM 31620923
OA Green Published
DA 2022-11-22
ER

PT J
AU Tarallo, S
   Ferrero, G
   De Filippis, F
   Francavilla, A
   Pasolli, E
   Panero, V
   Cordero, F
   Segata, N
   Grioni, S
   Pensa, RG
   Pardini, B
   Ercolini, D
   Naccarati, A
AF Tarallo, Sonia
   Ferrero, Giulio
   De Filippis, Francesca
   Francavilla, Antonio
   Pasolli, Edoardo
   Panero, Valentina
   Cordero, Francesca
   Segata, Nicola
   Grioni, Sara
   Pensa, Ruggero Gaetano
   Pardini, Barbara
   Ercolini, Danilo
   Naccarati, Alessio
TI Stool microRNA profiles reflect different dietary and gut microbiome
   patterns in healthy individuals
SO GUT
LA English
DT Article
DE diet; molecular genetics; colonic microflora
ID EXPRESSION; MIR-143/145; OBESITY; CANCER
AB Objectives MicroRNA (miRNA) profiles have been evaluated in several biospecimens in relation to common diseases for which diet may have a considerable impact. We aimed at characterising how specific diets are associated with the miRNome in stool of vegans, vegetarians and omnivores and how this is reflected in the gut microbial composition, as this is still poorly explored. Design We performed small RNA and shotgun metagenomic sequencing in faecal samples and dietary recording from 120 healthy volunteers, equally distributed for the different diets and matched for sex and age. Results We found 49 miRNAs differentially expressed among vegans, vegetarians and omnivores (adj. p <0.05) and confirmed trends of expression levels of such miRNAs in vegans and vegetarians compared with an independent cohort of 45 omnivores. Two miRNAs related to lipid metabolism, miR-636 and miR-4739, were inversely correlated to the non-omnivorous diet duration, independently of subject age. Seventeen miRNAs correlated (|rho|>0.22, adj. p <0.05) with the estimated intake of nutrients, particularly animal proteins, phosphorus and, interestingly, lipids. In omnivores, higher Prevotella and Roseburia and lower Bacteroides abundances than in vegans and vegetarians were observed. Lipid metabolism-related miR-425-3p and miR-638 expression levels were associated with increased abundances of microbial species, such as Roseburia sp. CAG 182 and Akkermansia muciniphila, specific of different diets. An integrated analysis identified 25 miRNAs, 25 taxa and 7 dietary nutrients that clearly discriminated (area under the receiver operating characteristic curve=0.89) the three diets. Conclusion Stool miRNA profiles are associated with specific diets and support the role of lipids as a driver of epigenetic changes and host-microbial molecular interactions in the gut.
C1 [Tarallo, Sonia; Francavilla, Antonio; Panero, Valentina; Pardini, Barbara; Naccarati, Alessio] Italian Inst Genom Med IIGM, IRCCS Candiolo, Turin, Italy.
   [Tarallo, Sonia; Francavilla, Antonio; Pardini, Barbara; Naccarati, Alessio] Candiolo Canc Inst FPO IRCCS, Turin, Italy.
   [Ferrero, Giulio; Cordero, Francesca; Pensa, Ruggero Gaetano] Univ Torino, Dept Comp Sci, Turin, Italy.
   [Ferrero, Giulio] Univ Torino, Dept Clin & Biol Sci, Turin, Italy.
   [De Filippis, Francesca; Pasolli, Edoardo; Ercolini, Danilo] Univ Naples Federico II, Dept Agr Sci, Naples, Italy.
   [De Filippis, Francesca; Pasolli, Edoardo; Ercolini, Danilo] Univ Naples Federico II, Task Force Microbiome Studies, Naples, Italy.
   [Segata, Nicola] Univ Trento, Ctr Integrat Biol, Trento, Italy.
   [Grioni, Sara] Fdn IRCCS Ist Nazl Tumori, Epidemiol & Prevent Unit, Milan, Italy.
C3 IRCCS Fondazione del Piemonte per l'Oncologia; Italian Institute for
   Genomic Medicine (IIGM); IRCCS Fondazione del Piemonte per l'Oncologia;
   University of Turin; University of Turin; University of Naples Federico
   II; University of Naples Federico II; University of Trento; Fondazione
   IRCCS Istituto Nazionale Tumori Milan
RP Ercolini, D (corresponding author), Univ Naples Federico II, Dept Agr Sci, Naples, Italy.; Ercolini, D (corresponding author), Univ Naples Federico II, Task Force Microbiome Studies, Naples, Italy.; Naccarati, A (corresponding author), IIGM, Mol Epidemiol & Expos Unit, Turin, Italy.
EM ercolini@unina.it; alessio.naccarati@iigm.it
RI De Filippis, Francesca/K-3816-2016; francavilla, antonio/AAB-8783-2022;
   Ferrero, Giulio/K-9508-2019; Tarallo, Sonia/AAB-8656-2022; Segata,
   Nicola/K-7240-2016; Pasolli, Edoardo/K-5156-2016
OI De Filippis, Francesca/0000-0002-3474-2884; Ferrero,
   Giulio/0000-0002-4580-0680; Cordero, Francesca/0000-0002-3143-3330;
   Segata, Nicola/0000-0002-1583-5794; Pasolli,
   Edoardo/0000-0003-0799-3490; Tarallo, Sonia/0000-0003-0887-2607
FU Fondazione Umberto Veronesi; Compagnia di San Paolo Torino, Italy; Lega
   Italiana per La Lotta contro i Tumori; Fondazione CRT [2019-0450];
   European H2020 research project Oncobiome [825410]; COST action
   TRANSCOLONCAN [CA17118]; JPI HDHL-INTIMIC-Knowledge Platform of Food,
   Diet, Intestinal Microbiomics and Human Health [790]; PRIN2017 grant by
   the Italian Ministry of University and Research [20174FHBWR_005]
FX This work was supported by Fondazione Umberto Veronesi postdoctoral
   fellowships 2017 and 2018 (recipients, ST and BP), Compagnia di San
   Paolo Torino, Italy (to BP, AN, ST), Lega Italiana per La Lotta contro i
   Tumori (to FC, BP and AN), Fondazione CRT (grant number 2019-0450 to
   RGP) the European H2020 research project Oncobiome (Grant number
   825410), and the COST action TRANSCOLONCAN (CA17118). DE laboratory
   received funding from the JPI HDHL-INTIMIC-Knowledge Platform of Food,
   Diet, Intestinal Microbiomics and Human Health (ID 790) grant and the
   PRIN2017 (20174FHBWR_005) grant by the Italian Ministry of University
   and Research.
CR Appleby PN, 2016, P NUTR SOC, V75, P287, DOI 10.1017/S0029665115004334
   Beckett EL, 2017, CLIN CHIM ACTA, V474, P60, DOI 10.1016/j.cca.2017.09.001
   Ruiz-Roso MB, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00707
   Bi KF, 2020, GENES-BASEL, V11, DOI 10.3390/genes11091075
   Can U, 2016, PEDIATR OBES, V11, P228, DOI 10.1111/ijpo.12050
   Carpi S, 2019, NUTRIENTS, V11, DOI 10.3390/nu11122855
   Chadaideh KS, 2021, CELL METAB, V33, P857, DOI 10.1016/j.cmet.2021.04.011
   Chivukula RR, 2014, CELL, V157, P1104, DOI 10.1016/j.cell.2014.03.055
   Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485
   Craig WJ, 2009, AM J CLIN NUTR, V89, pS1627, DOI 10.3945/ajcn.2009.26736N
   Dai ZW, 2020, NAT REV GENET, V21, P737, DOI 10.1038/s41576-020-0270-8
   De Angelis M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61192-y
   De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957
   Dinu M, 2017, CRIT REV FOOD SCI, V57, P3640, DOI 10.1080/10408398.2016.1138447
   Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009
   Elsafadi M, 2017, STEM CELL RES, V20, P94, DOI 10.1016/j.scr.2017.03.001
   Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200
   Ferrero G, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.619200
   Ferrero G, 2018, ONCOTARGET, V9, P3097, DOI 10.18632/oncotarget.23203
   Francavilla A, 2020, MUTAGENESIS, V35, P243, DOI 10.1093/mutage/gez038
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Garcia-Lacarte M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201217
   Garcia-Segura L, 2013, J NUTRIGENET NUTRIGE, V6, P16, DOI 10.1159/000345826
   Gavrilas LI, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100590
   Gil-Zamorano J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75751-w
   Gonzalez-Becerra K, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1120-6
   Gross M, 2013, CURR BIOL, V23, pR359, DOI 10.1016/j.cub.2013.04.047
   Huang S, 2019, J CELL PHYSIOL, V234, P11200, DOI 10.1002/jcp.27770
   Huang Z, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1811-3
   Huang ZH, 2020, CARDIOL RES PRACT, V2020, DOI 10.1155/2020/1481937
   Hullings AG, 2020, AM J CLIN NUTR, V112, P603, DOI 10.1093/ajcn/nqaa161
   Katz DL, 2014, ANNU REV PUBL HEALTH, V35, P83, DOI 10.1146/annurev-publhealth-032013-182351
   Kent OA, 2014, NUCLEIC ACIDS RES, V42, P7528, DOI 10.1093/nar/gku461
   Kilic ID, 2015, GENE, V560, P140, DOI 10.1016/j.gene.2015.01.048
   Kim NH, 2020, CLIN NUTR, V39, P910, DOI 10.1016/j.clnu.2019.03.033
   Koukos G, 2013, GASTROENTEROLOGY, V145, P842, DOI 10.1053/j.gastro.2013.07.001
   Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141
   Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025
   Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248
   Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]
   Li ZQ, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0305-8
   Linna-Kuosmanen S, 2021, CARDIOVASC RES, V117, P1339, DOI 10.1093/cvr/cvaa219
   Liu SR, 2019, CELL HOST MICROBE, V26, P779, DOI 10.1016/j.chom.2019.10.008
   Liu SR, 2016, CELL HOST MICROBE, V19, P32, DOI 10.1016/j.chom.2015.12.005
   Lopez S, 2018, J NUTR BIOCHEM, V57, P45, DOI 10.1016/j.jnutbio.2018.03.010
   LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8
   Ludwig N, 2016, NUCLEIC ACIDS RES, V44, P3865, DOI 10.1093/nar/gkw116
   Macchione IG, 2019, EUR REV MED PHARMACO, V23, P8075, DOI 10.26355/eurrev_201909_19024
   Malmuthuge N, 2021, TRENDS MICROBIOL, V29, P713, DOI 10.1016/j.tim.2020.12.003
   Mantilla-Escalante DC, 2019, NUTRIENTS, V11, DOI 10.3390/nu11061326
   Medawar E, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0552-0
   Merrett JE, 2020, BIOCHEM J, V477, P2735, DOI 10.1042/BCJ20200433
   Meslier V, 2020, GUT, V69, P1258, DOI 10.1136/gutjnl-2019-320438
   Peng Y, 2016, SIGNAL TRANSDUCT TAR, V1, DOI 10.1038/sigtrans.2015.4
   Piotrowska M, 2021, PHARMACOL RES, V163, DOI 10.1016/j.phrs.2020.105243
   Poli V, 2020, CANCERS, V12, DOI 10.3390/cancers12030708
   Qi RL, 2019, BBA-MOL CELL BIOL L, V1864, P744, DOI 10.1016/j.bbalip.2019.02.007
   Rashid H, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00181
   Riboli E, 2002, PUBLIC HEALTH NUTR, V5, P1113, DOI 10.1079/PHN2002394
   Rodriguez-Nogales A, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700144
   Sabo AA, 2020, CANCERS, V12, DOI 10.3390/cancers12061507
   Saliba W, 2019, EUR J CANCER PREV, V28, P287, DOI 10.1097/CEJ.0000000000000451
   Salvini S., 1998, BANCA DATI COMPOSIZI
   Scholz M, 2016, NAT METHODS, V13, P435, DOI [10.1038/NMETH.3802, 10.1038/nmeth.3802]
   Segner H, 2009, COMP BIOCHEM PHYS C, V149, P187, DOI 10.1016/j.cbpc.2008.10.099
   Sharma Salil, 2018, J Alzheimers Dis Parkinsonism, V8, DOI 10.4172/2161-0460.1000420
   Singh A, 2019, BIOINFORMATICS, V35, P3055, DOI 10.1093/bioinformatics/bty1054
   Sokol H, 2009, INFLAMM BOWEL DIS, V15, P1183, DOI 10.1002/ibd.20903
   Tarallo S, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00289-19
   Tarallo S, 2014, MUTAGENESIS, V29, P385, DOI 10.1093/mutage/geu028
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Tili E, 2017, CURR OPIN PHARMACOL, V37, P142, DOI 10.1016/j.coph.2017.10.010
   Tomova A, 2019, FRONT NUTR, V6, DOI 10.3389/fnut.2019.00047
   Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Udayasuryan B, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101878
   Virtue AT, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav1892
   Wang LP, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3513179
   Wang R, 2015, EUR J ENDOCRINOL, V172, P291, DOI 10.1530/EJE-14-0867
   Wu GD, 2016, GUT, V65, P63, DOI 10.1136/gutjnl-2014-308209
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Xiao YT, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.426
   Xie XQ, 2020, MOL THER-ONCOLYTICS, V17, P320, DOI 10.1016/j.omto.2020.04.003
   Xu ST, 2019, JAMA OPHTHALMOL, V137, P537, DOI 10.1001/jamaophthalmol.2019.0238
   Zhang J, 2018, PEERJ, V6, DOI 10.7717/peerj.4262
NR 85
TC 15
Z9 15
U1 8
U2 19
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
PD JUL
PY 2022
VL 71
IS 7
BP 1302
EP 1314
DI 10.1136/gutjnl-2021-325168
EA JUL 2021
PG 13
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 2B2BX
UT WOS:000728888300001
PM 34315772
OA hybrid, Green Published
DA 2022-11-22
ER

PT J
AU Han, J
   Antunes, LCM
   Finlay, BB
   Borcherst, CH
AF Han, Jun
   Antunes, L. Caetano M.
   Finlay, B. Brett
   Borcherst, Christoph H.
TI Metabolomics: towards understanding host-microbe interactions
SO FUTURE MICROBIOLOGY
LA English
DT Article
DE gut microbiota; host-microbe interaction; mass spectrometry;
   metabolomics; metagenomics; microbial profiling; nuclear magnetic
   resonance spectroscopy
ID GUT MICROBIOTA; SYSTEMS BIOLOGY; MASS-SPECTROMETRY; INTESTINAL
   MICROBIOTA; CLOSTRIDIUM-DIFFICILE; METAGENOMIC ANALYSIS; SYMBIOTIC
   BACTERIA; COLORECTAL-CANCER; IDENTIFICATION; HEALTH
AB Metabolomics employs an array of analytical techniques, including high-resolution nuclear magnetic resonance spectroscopy and mass spectrometry, to simultaneously analyze hundreds to thousands of small-molecule metabolites in biological samples. In conjunction with chemoinformatics and bioinformatics tools, metabolomics enables comprehensive characterization of the metabolic phenotypes (metabotypes) of the human, and other mammalian, hosts that have co-evolved with a large number of diverse commensal microbes, especially in the intestinal tract. Correlation of the metabotypes with the microbial profiles derived from culture-independent molecular techniques is increasingly helping to decipher inherent and intimate host-microbe relationships. This integrated, systems biology approach is improving our understanding of the molecular mechanisms underlying multilevel host-microbe interactions, and promises to elucidate the etiologies of human disorders resulting from unfavorable human-microbial associations, including enteric infections.
C1 [Han, Jun; Borcherst, Christoph H.] Univ Victoria, Genome BC Prote Ctr, Victoria, BC V8Z 7X8, Canada.
   [Antunes, L. Caetano M.; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V6T 1Z4, Canada.
   [Finlay, B. Brett] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z4, Canada.
C3 University of Victoria; University of British Columbia; University of
   British Columbia
RP Borcherst, CH (corresponding author), Univ Victoria, Genome BC Prote Ctr, 3101-4464 Markham St, Victoria, BC V8Z 7X8, Canada.
EM hanjun@proteincentre.com; antunes@msl.ubc.ca;
   bfinlay@interchange.ubc.ca; christoph@proteincentre.com
RI Antunes, Luis Caetano Martha/P-4988-2019; Martha Antunes, Luis
   Caetano/B-6864-2012
OI Martha Antunes, Luis Caetano/0000-0002-4933-2570; Martha Antunes, Luis
   Caetano/0000-0003-1686-0788
FU Canadian Institutes of Health Research; Crohn and Colitis Foundations of
   Canada; Department of Foreign Affairs and International Trade Canada
FX The authors would like to acknowledge Genome Canada and Genome British
   Columbia for platform Anding and support as well as the Canadian
   Institutes of Health Research and Crohn and Colitis Foundations of
   Canada for operating grants. L Caetano MA ntunes is supported by a
   postdoctoral followship from the Department of Foreign Affairs and
   International Trade Canada. The authors have no other relevant
   affiliations or financial involvement with any organization or entity
   with a financial interest in or financial conflict with the subject
   matter or materials discussed in the manuscript apart from those
   disclosed.
CR AMANN R, 1991, NATURE, V351, P161, DOI 10.1038/351161a0
   Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101
   Blachier F, 2007, AMINO ACIDS, V33, P547, DOI 10.1007/s00726-006-0477-9
   Bonen DK, 2003, GASTROENTEROLOGY, V124, P521, DOI 10.1053/gast.2003.50045
   Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0
   Cani PD, 2007, CURR OPIN CLIN NUTR, V10, P729, DOI 10.1097/MCO.0b013e3282efdebb
   Chu FF, 2004, CANCER RES, V64, P962, DOI 10.1158/0008-5472.CAN-03-2272
   Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56
   Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106
   Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001
   Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591
   Elia M, 2007, EUR J CLIN NUTR, V61, pS40, DOI 10.1038/sj.ejcn.1602938
   Fava F, 2006, CURR MED CHEM, V13, P3005, DOI 10.2174/092986706778521814
   Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   GO EP, 2009, J NEUROIMMUNE PHARM, DOI DOI 10.1007/511481-009-9157-3
   Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0
   Hadley C, 2006, EMBO REP, V7, P470, DOI 10.1038/sj.embor.7400699
   Han J, 2008, METABOLOMICS, V4, P128, DOI 10.1007/s11306-008-0104-8
   Hill MJ, 1997, EUR J CANCER PREV, V6, pS43, DOI 10.1097/00008469-199703001-00009
   Huycke MM, 2004, EXP BIOL MED, V229, P586, DOI 10.1177/153537020422900702
   Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386
   Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505
   Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105
   Katajamaa M, 2007, J CHROMATOGR A, V1158, P318, DOI 10.1016/j.chroma.2007.04.021
   Katz JA, 1999, CURR OPIN GASTROEN, V15, P291, DOI 10.1097/00001574-199907000-00003
   Kawakami K, 2007, EXP ANIM TOKYO, V56, P301, DOI 10.1538/expanim.56.301
   KELLY CP, 1994, NEW ENGL J MED, V330, P257, DOI 10.1056/NEJM199401273300406
   Kelly D, 2007, MUTAT RES-FUND MOL M, V622, P58, DOI 10.1016/j.mrfmmm.2007.03.011
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751
   Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105
   Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010
   Mahida YR, 2004, CLIN SCI, V107, P331, DOI 10.1042/CS20040136
   Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.40
   Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190
   Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   Monleon D, 2009, NMR BIOMED, V22, P342, DOI 10.1002/nbm.1345
   Murdoch TB, 2008, ANAL CHEM, V80, P5524, DOI 10.1021/ac8005236
   MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993
   Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095
   Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728
   Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152
   Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001
   Plumb R, 2004, RAPID COMMUN MASS SP, V18, P2331, DOI 10.1002/rcm.1627
   Rajilic-Stojanovic M, 2007, ENVIRON MICROBIOL, V9, P2125, DOI 10.1111/j.1462-2920.2007.01369.x
   Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x
   Rezzi S, 2008, J CHROMATOGR B, V871, P271, DOI 10.1016/j.jchromb.2008.04.001
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000
   Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515
   Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105
   Saric J, 2008, J PROTEOME RES, V7, P352, DOI 10.1021/pr070340k
   SAVAGE DC, 1977, ANNU REV MICROBIOL, V31, P107, DOI 10.1146/annurev.mi.31.100177.000543
   Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x
   Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3
   Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08
   SIVSAMMYE G, 1990, J CLIN MICROBIOL, V28, P1851, DOI 10.1128/JCM.28.8.1851-1853.1990
   Slupsky CM, 2009, J PROTEOME RES, V8, P3029, DOI 10.1021/pr900103y
   Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020
   Sousa T, 2008, INT J PHARMACEUT, V363, P1, DOI 10.1016/j.ijpharm.2008.07.009
   Swann J, 2009, MOL BIOSYST, V5, P351, DOI 10.1039/b811468d
   Tohge T, 2009, PHYTOCHEMISTRY, V70, P450, DOI 10.1016/j.phytochem.2009.02.004
   Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q
   Tuohy KM, 2009, CURR PHARM DESIGN, V15, P1415, DOI 10.2174/138161209788168182
   Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Waldram A, 2009, J PROTEOME RES, V8, P2361, DOI 10.1021/pr8009885
   Waters NJ, 2000, ANAL BIOCHEM, V282, P16, DOI 10.1006/abio.2000.4574
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   WILSON DS, 1989, J THEOR BIOL, V136, P337, DOI 10.1016/S0022-5193(89)80169-9
   Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015
   Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156
   Yap IKS, 2008, J PROTEOME RES, V7, P3718, DOI 10.1021/pr700864x
   Young Yuki, 2006, Curr Gastroenterol Rep, V8, P470, DOI 10.1007/s11894-006-0037-1
   Zrostlikova J, 2003, J CHROMATOGR A, V1019, P173, DOI 10.1016/S0021-9673(03)01302-5
NR 79
TC 34
Z9 35
U1 1
U2 31
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0913
EI 1746-0921
J9 FUTURE MICROBIOL
JI Future Microbiol.
PD FEB
PY 2010
VL 5
IS 2
SI SI
BP 153
EP 161
DI 10.2217/FMB.09.132
PG 9
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 559EI
UT WOS:000274804400009
PM 20143941
DA 2022-11-22
ER

PT J
AU Moschen, AR
   Wieser, V
   Tilg, H
AF Moschen, Alexander R.
   Wieser, Verena
   Tilg, Herbert
TI Dietary Factors: Major Regulators of the Gut's Microbiota
SO GUT AND LIVER
LA English
DT Review
DE Nutrition; Inflammation; Intestinal immunity; Microflora
ID HIGH-FAT-DIET; INTESTINAL MICROBIOTA; FECAL MICROBIOTA; OBESITY;
   ENDOTOXEMIA; MICE; METAGENOMICS; RESISTANCE; CAPACITY; DISEASE
AB Dietary factors and the associated lifestyle play a major role in the pathophysiology of many diseases. Several diets, especially a Western lifestyle with a high consumption of meat and carbohydrates and a low consumption of vegetables, have been linked to common diseases, such as metabolic syndrome, atherosclerosis, inflammatory bowel diseases, and colon cancer. The gastrointestinal tract harbors a complex and yet mainly molecularly defined microbiota, which contains an enormous number of different species. Recent advances in sequencing technologies have allowed the characterization of the human microbiome and opened the possibility to study the effect of "environmental" factors on this microbiome. The most important environmental factor is probably "what we eat," and the initial studies have revealed fascinating results on the interaction of nutrients with our microbiota. Whereas short-term changes in dietary patterns may not have major influences, long-term diets can affect the microbiota in a substantial manner. This issue may potentially have major relevance for human gastrointestinal health and disease because our microbiota has features to regulate many immune and metabolic functions. Increasing our knowledge on the interaction between nutrients and microbiota may have tremendous consequences and result in a better understanding of diseases, even beyond the gastrointestinal tract, and finally lead to better preventive and therapeutic strategies. (Gut Liver 2012;6:411-416)
C1 [Moschen, Alexander R.; Wieser, Verena; Tilg, Herbert] Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria.
C3 Medical University of Innsbruck
RP Tilg, H (corresponding author), Med Univ Innsbruck, Christian Doppler Res Lab Gut Inflammat, Anichstr 35, A-6020 Innsbruck, Austria.
EM herbert.tilg@i-med.ac.at
RI Moschen, Alexander/ABF-2267-2021
OI Moschen, Alexander R/0000-0003-3598-7848
FU Christian Doppler Research Society
FX This study was supported by the Christian Doppler Research Society.
CR Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Ashida H, 2012, NAT CHEM BIOL, V8, P36, DOI 10.1038/nchembio.741
   Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104
   Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0
   Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491
   Claesson MJ, 2011, P NATL ACAD SCI USA, V108, P4586, DOI 10.1073/pnas.1000097107
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   DuPont AW, 2011, NAT REV GASTRO HEPAT, V8, P523
   Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042
   Jalanka-Tuovinen J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023035
   Kabeerdoss J, 2011, BR J NUTR
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018
   Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011
   Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111
   Muegge BD, 2011, SCIENCE, V332, P970, DOI 10.1126/science.1198719
   Murphy EF, 2010, GUT, V59, P1635, DOI 10.1136/gut.2010.215665
   Pendyala S, 2012, GASTROENTEROLOGY, V142, P1100, DOI 10.1053/j.gastro.2012.01.034
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199
   Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110
   Thomas LV, 2012, BRIT J NUTR, V107, pS1, DOI 10.1017/S0007114511006970
   Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540
   Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141
NR 31
TC 112
Z9 132
U1 0
U2 108
PU EDITORIAL OFFICE GUT & LIVER
PI SEOUL
PA 305 LOTTE GOLD ROSE II, 890-59, DAECHI 4-DONG, GANGNAM-GU, SEOUL,
   135-839, SOUTH KOREA
SN 1976-2283
J9 GUT LIVER
JI Gut Liver
PD OCT 15
PY 2012
VL 6
IS 4
BP 411
EP 416
DI 10.5009/gnl.2012.6.4.411
PG 6
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 025FG
UT WOS:000310170600002
PM 23170142
OA Green Published, Green Submitted
DA 2022-11-22
ER

PT J
AU Torres-Maravilla, E
   Reyes-Pavon, D
   Benitez-Cabello, A
   Gonzalez-Vazquez, R
   Ramirez-Chamorro, LM
   Langella, P
   Bermudez-Humaran, LG
AF Torres-Maravilla, Edgar
   Reyes-Pavon, Diana
   Benitez-Cabello, Antonio
   Gonzalez-Vazquez, Raquel
   Ramirez-Chamorro, Luis M.
   Langella, Philippe
   Bermudez-Humaran, Luis G.
TI Strategies for the Identification and Assessment of Bacterial Strains
   with Specific Probiotic Traits
SO MICROORGANISMS
LA English
DT Review
DE probiotics; strain-identification; isolation approach; in vitro
   screening
ID LACTIC-ACID BACTERIA; CHAIN FATTY-ACIDS; PROTEIN-COUPLED RECEPTOR; GUT
   MICROBIOTA; FOOD ALLERGY; DENDRITIC CELLS; MOLECULAR-IDENTIFICATION;
   CECT 8145; T-CELLS; INTERLEUKIN-10
AB Early in the 1900s, it was proposed that health could be improved and senility delayed by manipulating gut microbiota with the host-friendly bacteria found in yogurt. Later, in 1990, the medical community reconsidered this idea and today probiotics represent a developed area of research with a billion-dollar global industry. As a result, in recent decades, increased attention has been paid to the isolation and characterization of novel probiotic bacteria from fermented foods and dairy products. Most of the identified probiotic strains belong to the lactic acid bacteria group and the genus Bifidobacterium. However, current molecular-based knowledge has allowed the identification and culture of obligatory anaerobic commensal bacteria from the human gut, such as Akkermansia spp. and Faecalibacterium spp., among other human symbionts. We are aware that the identification of new strains of these species does not guarantee their probiotic effects and that each effect must be proved through in vitro and in vivo preclinical studies before clinical trials (before even considering it as a probiotic strain). In most cases, the identification and characterization of new probiotic strain candidates may lack the appropriate set of in vitro experiments allowing the next assessment steps. Here, we address some innovative strategies reported in the literature as alternatives to classical characterization: (i) identification of alternatives using whole-metagenome shotgun sequencing, metabolomics, and multi-omics analysis; and (ii) probiotic characterization based on molecular effectors and/or traits to target specific diseases (i.e., inflammatory bowel diseases, colorectal cancer, allergies, among others).
C1 [Torres-Maravilla, Edgar; Ramirez-Chamorro, Luis M.; Langella, Philippe; Bermudez-Humaran, Luis G.] Univ Paris Saclay, AgroParisTech, Micalis Inst, INRAE, F-78350 Jouy En Josas, France.
   [Reyes-Pavon, Diana] Univ Autonoma Baja California, Fac Med, Mexicali 21000, Baja California, Mexico.
   [Benitez-Cabello, Antonio] Inst Grasa CSIC, Food Biotechnol Dept, Ctra Utrera Km 1,Bldg 46, Seville 41013, Spain.
   [Gonzalez-Vazquez, Raquel] Univ Autonoma Metropolitana Xochimilco, Lab Biotecnol, Dept Sistemas Biol, CONACYT, Mexico City 04960, DF, Mexico.
C3 AgroParisTech; INRAE; UDICE-French Research Universities; Universite
   Paris Saclay; Universidad Autonoma de Baja California; Consejo Superior
   de Investigaciones Cientificas (CSIC); CSIC - Instituto de la Grasa
   (IG); Universidad Autonoma Metropolitana - Mexico
RP Bermudez-Humaran, LG (corresponding author), Univ Paris Saclay, AgroParisTech, Micalis Inst, INRAE, F-78350 Jouy En Josas, France.
EM edgar.torres-maravilla@inrae.fr; diana.reyes.pavon@uabc.edu.mx;
   abenitez@ig.csic.es; rgonzalezv@correo.xoc.uam.mx;
   luis-maria.ramirez-chamorro@inrae.fr; philippe.langella@inrae.fr;
   luis.bermudez@inrae.fr
OI Benitez-Cabello, Antonio/0000-0001-9978-1617; Torres-Maravilla,
   Edgar/0000-0002-3359-4517
CR Aoki R, 2017, SCI REP-UK, V7, DOI 10.1038/srep43522
   Arboleya S., 2019, FASEB J, V33, P13546, DOI [10.1096/fj.201901433R, DOI 10.1096/fj.201901433R]
   Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726
   Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016
   Benitez-Cabello A, 2020, FOOD MICROBIOL, V91, DOI 10.1016/j.fm.2020.103497
   Benitez-Cabello A, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00836
   Bersanelli M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-015-0857-9
   Bhattarai Y, 2018, CELL HOST MICROBE, V23, P775, DOI 10.1016/j.chom.2018.05.004
   Bhushan B, 2021, PROBIOTICS ANTIMICRO, V13, P453, DOI 10.1007/s12602-020-09696-x
   Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9
   Calderon-Perez L, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63475-w
   Campbell LM, 2013, PHARMACEUTICALS, V6, P929, DOI 10.3390/ph6080929
   Cao S, 2014, FEBS LETT, V588, P4258, DOI 10.1016/j.febslet.2014.04.026
   Caselli M, 2013, WORLD J GASTROENTERO, V19, P1527, DOI 10.3748/wjg.v19.i10.1527
   Chamignon C, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8071053
   Chand D, 2017, BBA-GEN SUBJECTS, V1861, P2981, DOI 10.1016/j.bbagen.2016.09.024
   Chen HQ, 2017, MOL MED REP, V16, P5979, DOI 10.3892/mmr.2017.7351
   Chinthrajah RS, 2016, J ALLERGY CLIN IMMUN, V137, P984, DOI 10.1016/j.jaci.2016.02.004
   Choi SS, 2021, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.597553
   Comeau AM, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00127-16
   Cuffaro B, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9092104
   de Castro A, 2022, FOOD CONTROL, V136, DOI 10.1016/j.foodcont.2022.108868
   de Paiva LB, 2013, BRAZ J PHARM SCI, V49, P395, DOI 10.1590/S1984-82502013000300002
   de Simone C, 2019, CLIN GASTROENTEROL H, V17, P809, DOI 10.1016/j.cgh.2018.01.018
   Deleu S, 2021, EBIOMEDICINE, V66, DOI 10.1016/j.ebiom.2021.103293
   Deng ZX, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.538077
   Dixon A, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01080-y
   dos Santos SC, 2020, ALLERGOL IMMUNOPATH, V48, P95, DOI 10.1016/j.aller.2019.04.009
   Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6
   Douillard FP, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.03.008
   Engevik MA, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.14719
   Erlich TH, 2018, ALLERGY, V73, P2160, DOI 10.1111/all.13467
   Fabersani E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00266
   Feng YH, 2018, CELL PHYSIOL BIOCHEM, V49, P190, DOI 10.1159/000492853
   Fu LL, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01536
   Fukumoto S, 2014, IMMUNOL CELL BIOL, V92, P460, DOI 10.1038/icb.2014.2
   Gad M, 2011, FEMS IMMUNOL MED MIC, V63, P93, DOI 10.1111/j.1574-695X.2011.00835.x
   GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x
   Gevers D, 2001, FEMS MICROBIOL LETT, V205, P31, DOI 10.1016/S0378-1097(01)00439-6
   Ghavami SB, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176266
   Gonsalkorale WM, 2003, GUT, V52, P91, DOI 10.1136/gut.52.1.91
   Gonzalez-Vazquez R, 2015, PROBIOTICS ANTIMICRO, V7, P242, DOI 10.1007/s12602-015-9202-x
   Guantario B, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00595
   Guarcello R, 2016, APPL ENVIRON MICROB, V82, P6870, DOI 10.1128/AEM.01051-16
   Hernandez-Delgado NC, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9051063
   Hernandez-Gomez JG, 2021, FOODS, V10, DOI 10.3390/foods10030674
   Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66
   Hong SH, 2016, APPL ENVIRON MICROB, V82, P3940, DOI 10.1128/AEM.00848-16
   Hu RJ, 2020, BMC MICROBIOL, V20, DOI 10.1186/s12866-020-01953-x
   Huo YX, 2020, MOLECULES, V25, DOI 10.3390/molecules25071490
   Queipo-Ortuno MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065465
   Jangid A, 2022, SCI REP-UK, V12, DOI 10.1038/s41598-022-10762-3
   Jaswal R, 2019, GENES-BASEL, V10, DOI 10.3390/genes10050325
   Jiang LM, 2021, ARCH MICROBIOL, V203, P4141, DOI 10.1007/s00203-021-02404-5
   Jin BY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.741371
   Kanehisa M, 2016, J MOL BIOL, V428, P726, DOI 10.1016/j.jmb.2015.11.006
   Kechaou N, 2013, APPL ENVIRON MICROB, V79, P1491, DOI 10.1128/AEM.03075-12
   Kim CS, 2021, J GERONTOL A-BIOL, V76, P32, DOI 10.1093/gerona/glaa090
   Kim JA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218922
   Kim JH, 2016, J ALLERGY CLIN IMMUN, V137, P507, DOI 10.1016/j.jaci.2015.08.016
   Kim W, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1793514
   Kimura I, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00085
   Kiousi DE, 2021, ADV NUTR, V12, P1802, DOI 10.1093/advances/nmab014
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Konieczna P, 2012, GUT, V61, P354, DOI 10.1136/gutjnl-2011-300936
   Konings WN, 2000, CURR OPIN MICROBIOL, V3, P276, DOI 10.1016/S1369-5274(00)00089-8
   Krawiec P, 2021, J INFLAMM-LOND, V18, DOI 10.1186/s12950-021-00279-3
   Kropp C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-90885-1
   Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107
   Lacy BE, 2021, AM J GASTROENTEROL, V116, P17, DOI 10.14309/ajg.0000000000001036
   Larraufie P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18259-0
   Lee JE, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100557
   Lenoir M, 2020, GUT MICROBES, V12, P1, DOI 10.1080/19490976.2020.1826748
   Carreras NL, 2018, BENEF MICROBES, V9, P629, DOI [10.3920/bm2017.0141, 10.3920/BM2017.0141]
   Lopez-Santamarina A, 2021, FOODS, V10, DOI 10.3390/foods10040701
   Lu WW, 2022, FOOD FUNCT, V13, P3704, DOI [10.1039/D1FO03520G, 10.1039/d1fo03520g]
   Lu YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37589
   Ma JY, 2019, J FUNCT FOODS, V55, P65, DOI 10.1016/j.jff.2019.02.010
   Markowiak-Kopec P, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041107
   Martorell P, 2016, J AGR FOOD CHEM, V64, P3462, DOI 10.1021/acs.jafc.5b05934
   McCarville JL, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01323-17
   McCracken E, 2018, CLIN DERMATOL, V36, P14, DOI 10.1016/j.clindermatol.2017.09.004
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   Meyer F, 2019, BRIEF BIOINFORM, V20, P1151, DOI 10.1093/bib/bbx105
   Motta JP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004212
   Moya-Perez A, 2017, BRAIN BEHAV IMMUN, V65, P43, DOI 10.1016/j.bbi.2017.05.011
   Mu GQ, 2019, J DAIRY SCI, V102, P6863, DOI 10.3168/jds.2019-16447
   Nami Y, 2018, ADV PHARM BULL, V8, P683, DOI 10.15171/apb.2018.077
   Natividad JM, 2018, CELL METAB, V28, P737, DOI 10.1016/j.cmet.2018.07.001
   Nilsson RH, 2019, NUCLEIC ACIDS RES, V47, pD259, DOI 10.1093/nar/gky1022
   Nishida A, 2018, CLIN J GASTROENTEROL, V11, P1, DOI 10.1007/s12328-017-0813-5
   Nissen L, 2020, FOOD RES INT, V131, DOI 10.1016/j.foodres.2020.109029
   O'Connell TM, 2020, METABOLITES, V10, DOI 10.3390/metabo10030120
   Oksaharju A, 2011, WORLD J GASTROENTERO, V17, P750, DOI 10.3748/wjg.v17.i6.750
   Ozen M, 2015, BENEF MICROBES, V6, P159, DOI 10.3920/BM2014.0103
   Park S, 2017, APPL MICROBIOL BIOT, V101, P1605, DOI 10.1007/s00253-016-7953-2
   Pingitore A, 2019, DIABETES OBES METAB, V21, P330, DOI 10.1111/dom.13529
   Pittayanon R, 2020, GASTROENTEROLOGY, V158, P930, DOI 10.1053/j.gastro.2019.11.294
   Prete R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73201-1
   Psichas A, 2015, INT J OBESITY, V39, P424, DOI 10.1038/ijo.2014.153
   Qu SW, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00730-21
   R Core Team, 2016, R LANG ENV STAT COMP
   Rasmussen JA, 2022, MICROBIOME, V10, DOI 10.1186/s40168-021-01221-8
   Rohrbeck L, 2021, IMMUNOL CELL BIOL, V99, P234, DOI 10.1111/imcb.12399
   Ruiz L, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02345
   Salinas E, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9081634
   Sampson HA, 2018, J ALLERGY CLIN IMMUN, V141, P11, DOI 10.1016/j.jaci.2017.11.005
   Santos SS, 2021, PROBIOTICS ANTIMICRO, DOI 10.1007/s12602-021-09846-9
   Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09
   SCHREIBER S, 1995, GASTROENTEROLOGY, V108, P1434, DOI 10.1016/0016-5085(95)90692-4
   Seol D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01683
   Shin HS, 2018, J MICROBIOL BIOTECHN, V28, P65, DOI 10.4014/jmb.1708.08051
   Shoaie S, 2013, SCI REP-UK, V3, DOI 10.1038/srep02532
   Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105
   Subramanian I, 2020, BIOINFORM BIOL INSIG, V14, DOI 10.1177/1177932219899051
   Sun MM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05901-2
   Sun Y, 2022, BRIEF BIOINFORM, V23, DOI 10.1093/bib/bbab477
   Tabssum F, 2018, J BASIC MICROB, V58, P918, DOI 10.1002/jobm.201800319
   Tan-Lim CSC, 2018, WORLD ALLERGY ORGAN, V11, DOI 10.1186/s40413-018-0204-5
   Tian PJ, 2021, FOOD FUNCT, V12, P646, DOI [10.1039/d0fo02307h, 10.1039/D0FO02307H]
   Tian T, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/4535194
   Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863
   Tomaro-Duchesneau C., 2012, International Journal of Probiotics and Prebiotics, V7, P23
   Tomaro-Duchesneau C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/380316
   Torres S, 2019, EUR J NUTR, V58, P27, DOI 10.1007/s00394-018-1790-2
   Tulyeu J, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7100463
   Vahora IS, 2020, CUREUS, V12, DOI 10.7759/cureus.9871
   Van Hoorde K, 2008, DAIRY SCI TECHNOL, V88, P445, DOI 10.1051/dst:2008011
   Van Spaendonk H, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.682065
   Vanderpool C, 2008, INFLAMM BOWEL DIS, V14, P1585, DOI 10.1002/ibd.20525
   Vergnolle N, 2016, GUT, V65, P1215, DOI 10.1136/gutjnl-2015-309147
   Vila AV, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8914
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wang YS, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9020452
   WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531
   Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007
   Wu YP, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02185
   Xie HL, 2016, CELL SYST, V3, P572, DOI 10.1016/j.cels.2016.10.004
   Xiong YM, 2004, P NATL ACAD SCI USA, V101, P1045, DOI 10.1073/pnas.2637002100
   Xu HY, 2019, FOOD FUNCT, V10, P2618, DOI 10.1039/c9fo00087a
   Yang B, 2018, MOL IMMUNOL, V103, P71, DOI 10.1016/j.molimm.2018.09.001
   Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047
   You JL, 2014, IMMUNOBIOLOGY, V219, P138, DOI 10.1016/j.imbio.2013.08.012
   Zhang F, 2017, J DAIRY SCI, V100, P1618, DOI 10.3168/jds.2016-11870
   Zhao CJ, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009774
   Zhao Y, 2018, MUCOSAL IMMUNOL, V11, P752, DOI 10.1038/mi.2017.118
   Zheng JS, 2020, INT J SYST EVOL MICR, V70, P2782, DOI 10.1099/ijsem.0.004107
NR 147
TC 0
Z9 0
U1 8
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD JUL
PY 2022
VL 10
IS 7
AR 1389
DI 10.3390/microorganisms10071389
PG 21
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA 3J2TK
UT WOS:000833252700001
PM 35889107
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Kisuse, J
   La-ongkham, O
   Nakphaichit, M
   Therdtatha, P
   Momoda, R
   Tanaka, M
   Fukuda, S
   Popluechai, S
   Kespechara, K
   Sonomoto, K
   Lee, YK
   Nitisinprasert, S
   Nakayama, J
AF Kisuse, Juma
   La-ongkham, Orawan
   Nakphaichit, Massalin
   Therdtatha, Phatthanaphong
   Momoda, Rie
   Tanaka, Masaru
   Fukuda, Shinji
   Popluechai, Siam
   Kespechara, Kongkiat
   Sonomoto, Kenji
   Lee, Yuan-Kun
   Nitisinprasert, Sunee
   Nakayama, Jiro
TI Urban Diets Linked to Gut Microbiome and Metabolome Alterations in
   Children: A Comparative Cross-Sectional Study in Thailand
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE gut microbiota; 16S rRNA gene sequencing; fecal metabolomics;
   short-chain fatty acid; Peptostreptococcaceae; high-fat diet;
   vegetable-based diet; Thailand
ID CHAIN FATTY-ACIDS; ULCERATIVE-COLITIS; AFRICAN-AMERICANS; RURAL
   AFRICANS; CANCER-RISK; OBESITY; DIVERSITY; BACTERIA; ECOLOGY; IMPACT
AB Loss of traditional diets by food globalization may have adverse impact on the health of human being through the alteration of gut microbial ecosystem. To address this notion, we compared the gut microbiota of urban (n = 17) and rural (n = 28) school-aged children in Thailand in association with their dietary habits. Dietary records indicated that children living in urban Bangkok tended to consume modern high-fat diets, whereas children in rural Buriram tended to consume traditional vegetable-based diets. Sequencing of 16S rRNA genes amplified from stool samples showed that children in Bangkok have less Clostridiales and more Bacteroidales and Selenomonadales compared to children in Buriram and bacterial diversity is significantly less in Bangkok children than in Buriram children. In addition, fecal butyrate and propionate levels decreased in Bangkok children in association with changes in their gut microbial communities. Stool samples of these Thai children were classified into five metabolotypes (MTs) based on their metabolome profiles, each characterized by high concentrations of short and middle chain fatty acids (MT1, n = 17), amino acids (MT2, n = 7), arginine (MT3, n = 6), amino acids, and amines (MT5, n = 8), or an overall low level of metabolites (MT4, n = 4). MT1 and MT4 mainly consisted of samples from Buriram, and MT2 and MT3 mainly consisted of samples from Bangkok, whereas MT5 contained three samples from Bangkok and five from Buriram samples. According to the profiles of microbiota and diets, MT1 and MT2 are characteristic of children in Buriram and Bangkok, respectively. Predicted metagenomics indicated the underrepresentation in MT2 of eight genes involved in pathways of butyrate biosynthesis, notably including paths from glutamate as well as pyruvate. Taken together, this study shows the benefit of high-vegetable Thai traditional diets on gut microbiota and suggests that high-fat and less-vegetable urban dietary habits alter gut microbial communities in Thai children, which resulted in the reduction of colonic short chain fatty acid fermentation.
C1 [Kisuse, Juma; Therdtatha, Phatthanaphong; Momoda, Rie; Tanaka, Masaru; Sonomoto, Kenji; Nakayama, Jiro] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka, Fukuoka, Japan.
   [La-ongkham, Orawan] Kasetsart Univ, Inst Food Res & Prod Dev, Bangkok, Thailand.
   [Nakphaichit, Massalin; Nitisinprasert, Sunee] Kasetsart Univ, Fac Agroind, Specialized Res Unit Probiot & Prebiot Hlth, Bangkok, Thailand.
   [Fukuda, Shinji] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan.
   [Fukuda, Shinji] Kanagawa Inst Ind Sci & Technol, Intestinal Microbiota Project, Kawasaki, Kanagawa, Japan.
   [Fukuda, Shinji] Univ Tsukuba, Transborder Med Res Ctr, Tsukuba, Ibaraki, Japan.
   [Fukuda, Shinji] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan.
   [Popluechai, Siam] Mae Fah Luang Univ, Sch Sci, Chiang Rai, Thailand.
   [Popluechai, Siam] Mae Fah Luang Univ, Human Gut Microbiome Hlth Res Unit, Chiang Rai, Thailand.
   [Kespechara, Kongkiat] Sooksathanana Co Ltd, Bangkok, Thailand.
   [Lee, Yuan-Kun] Natl Univ Singapore, Dept Microbiol, Singapore, Singapore.
C3 Kyushu University; Kasetsart University; Kasetsart University; Keio
   University; Kanagawa Academy Science & Technology; University of
   Tsukuba; Japan Science & Technology Agency (JST); Mae Fah Luang
   University; Mae Fah Luang University; National University of Singapore
RP Nakayama, J (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Fukuoka, Fukuoka, Japan.
EM nakayama@agr.kyyshu-u.ac.jp
OI Fukuda, Shinji/0000-0001-5161-9880; POPLUECHAI,
   SIAM/0000-0002-4431-2810; Kespechara, kongkiat/0000-0003-4228-3486
FU JSPS KAKENHI Grant [JP25304006, JP 15H04480, JP 17H04620, JP 16H04901,
   JP 17H05654]; JST PRESTO [JPMJPR1537]; Japan Society for the Promotion
   of Science (JSPS); National Research Council of Thailand (NRCT); Kieikai
   Research Foundation in Japan
FX This study was supported in part by JSPS KAKENHI Grant Numbers
   JP25304006, JP 15H04480, and JP 17H04620 to JN, and JP 16H04901 and JP
   17H05654 to SF, and JST PRESTO JPMJPR1537 to SF. Part of this study was
   performed through a collaboration within the Core to Core Program, which
   was supported by the Japan Society for the Promotion of Science (JSPS)
   and the National Research Council of Thailand (NRCT). This study was
   also partially supported by the Kieikai Research Foundation in Japan.
CR Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128
   Castellarin M, 2012, GENOME RES, V22, P299, DOI 10.1101/gr.126516.111
   CHEN GJ, 1988, APPL ENVIRON MICROB, V54, P2742, DOI 10.1128/AEM.54.11.2742-2749.1988
   Dai ZL, 2011, FRONT BIOSCI-LANDMRK, V16, P1768, DOI 10.2741/3820
   Daniel H, 2014, ISME J, V8, P295, DOI 10.1038/ismej.2013.155
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05
   Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155
   Edgar R.C., 2016, BIORXIV, DOI [DOI 10.1101/074161, 10.1101/074161]
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   FAO, 2008, 91 FAO
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Figliuolo VR, 2017, LIFE SCI, V189, P29, DOI 10.1016/j.lfs.2017.09.014
   Flint HJ, 2015, P NUTR SOC, V74, P13, DOI 10.1017/S0029665114001463
   Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721
   Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042
   Kangsadalampai K., 2008, P 1 NAT C TOX BANGK
   Kelly BJ, 2015, BIOINFORMATICS, V31, P2461, DOI 10.1093/bioinformatics/btv183
   Kimura I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2852
   Kosulwat V, 2002, PUBLIC HEALTH NUTR, V5, P183, DOI 10.1079/PHN2001292
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Kuczynski J, 2012, CURR PROTOC MICROBIO, V27, p1E
   La-ongkham O, 2015, ARCH MICROBIOL, V197, P561, DOI 10.1007/s00203-015-1089-0
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Lin A., 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053838PONE-D-12, DOI 10.1371/JOURNAL.PONE.0053838PONE-D-12]
   Llorente C, 2015, CELL MOL GASTROENTER, V1, P275, DOI 10.1016/j.jcmgh.2015.04.003
   Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x
   Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049
   Mishima E, 2017, KIDNEY INT, V92, P634, DOI 10.1016/j.kint.2017.02.011
   Morrison DJ, 2016, GUT MICROBES, V7, P189, DOI 10.1080/19490976.2015.1134082
   Murakami A, 1994, Asia Pac J Clin Nutr, V3, P185
   Nakayama J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00197
   Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397
   Ni J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah6888
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ohkusa T, 2003, GUT, V52, P79, DOI 10.1136/gut.52.1.79
   Ou JH, 2013, AM J CLIN NUTR, V98, P111, DOI 10.3945/ajcn.112.056689
   Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055
   Rios-Covian D, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00185
   Rowan F, 2010, DIS COLON RECTUM, V53, P1530, DOI 10.1007/DCR.0b013e3181f1e620
   Ruengsomwong S, 2016, J MICROBIOL BIOTECHN, V26, P1723, DOI 10.4014/jmb.1603.03057
   Santoru ML, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10034-5
   Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Seubsman SA, 2009, WOODHEAD PUBL FOOD S, P413, DOI 10.1533/9781845695712.6.413
   Seubsman SA, 2009, INT J CONSUM STUD, V33, P669, DOI 10.1111/j.1470-6431.2009.00795.x
   Shen J, 2013, MOL ASPECTS MED, V34, P39, DOI 10.1016/j.mam.2012.11.001
   Simpson HL, 2015, ALIMENT PHARM THER, V42, P158, DOI 10.1111/apt.13248
   Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165
   Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m
   Statovci D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00838
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Turroni S, 2016, SCI REP-UK, V6, DOI 10.1038/srep32826
   United States Department of Agriculture [USDA], 2009, CONV PATT GLOB FOOD
   Velasquez MT, 2016, TOXINS, V8, DOI 10.3390/toxins8110326
   West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012
   Wibulpolprasert S, 2008, THAILAND HLTH PROFIL
   Wilson MJ, 2000, J MED MICROBIOL, V49, P747, DOI 10.1099/0022-1317-49-8-747
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Zhang CH, 2012, ISME J, V6, P1848, DOI 10.1038/ismej.2012.27
NR 65
TC 38
Z9 38
U1 2
U2 25
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 22
PY 2018
VL 9
AR 1345
DI 10.3389/fmicb.2018.01345
PG 16
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA GK4CC
UT WOS:000436100800001
PM 29988433
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Boudreau, MD
   Olson, GR
   Tryndyak, VP
   Bryant, MS
   Felton, RP
   Beland, FA
AF Boudreau, Mary D.
   Olson, Greg R.
   Tryndyak, Volodymyr P.
   Bryant, Matthew S.
   Felton, Robert P.
   Beland, Frederick A.
TI Aloin, a Component of the Aloe Vera Plant Leaf, Induces Pathological
   Changes and Modulates the Composition of Microbiota in the Large
   Intestines of F344/N Male Rats
SO TOXICOLOGICAL SCIENCES
LA English
DT Article
DE aloe vera; aloin; gut microbiota; gastrointestinal; systems toxicology;
   food safety/nutrition; safety evaluation
ID C-GLYCOSYL COMPOUNDS; GUT MICROBIOTA; COLORECTAL-CANCER; BARBADENSIS
   MILLER; DOSE LEVELS; BACTERIA; BARBALOIN; METABOLISM; COMMUNITY; EXTRACT
AB In a previous study, the oral administration of an Aloe vera whole leaf extract induced dose-related mucosal and goblet cell hyperplasia in the rat colon after 13 weeks and colon cancer after 2 years. The primary goal of this study was to determine whether or not the administration of aloin, a component of the Aloe vera plant leaf, would replicate the pathophysiological effects that were observed in rats in the previous study with an Aloe vera whole leaf extract. Groups of 10 male F344/N rats were administered aloin at 0, 6.95, 13.9, 27.8, 55.7, 111, 223, and 446 mg/kg drinking water for 13 weeks. At the end of study, rat feces were collected, and the composition of fecal bacteria was investigated by next generation sequencing of the PCR-amplified V3/V4 region of the 16S rRNA gene. At necropsy, blood was collected by cardiac puncture and organs and sections of the large intestine were collected for histopathology. Aloin induced dose-related increased incidences and severities of mucosal and goblet cell hyperplasia that extended from the cecum to the rectum, with increased incidences and severities detected at aloin doses >= 55.7 mg/kg drinking water. Analysis of the 16S rRNA metagenomics sequencing data revealed marked shifts in the structure of the gut microbiota in aloin-treated rats at each taxonomic rank. This study highlights the similarities in effects observed for aloin and the Aloe vera whole leaf extract, and points to a potential mechanism of action to explain the observed pathological changes via modulation of the gut microbiota composition.
C1 [Boudreau, Mary D.; Tryndyak, Volodymyr P.; Bryant, Matthew S.; Beland, Frederick A.] US FDA, Div Biochem Toxicol, Natl Ctr Toxicol Res, Jefferson, AR USA.
   [Felton, Robert P.] US FDA, Div Informat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR USA.
   [Olson, Greg R.] Toxicol Pathol Associates Inc, Jefferson Labs, Jefferson, AR USA.
C3 US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)
RP Boudreau, MD (corresponding author), Natl Ctr Toxicol Res, Div Biochem Toxicol, 3900 NCTR Rd,Bldg 53B,HFT 110, Jefferson, AR 72079 USA.
EM mary.boudreau@fda.hhs.gov
OI Bryant, Matthew/0000-0002-0812-5700; Tryndyak,
   Volodymyr/0000-0002-8319-2954
FU US Food and Drug Administration/National Center for Toxicological
   Research, National Institutes of Health (FDA IAG) [224-12-003/NIEHS IAG,
   AES12013]; US Department of Health and Human Services, National
   Institutes of Health (FDA IAG) [224-12-003/NIEHS IAG, AES12013];
   National Institute of Environmental Health Sciences/National Toxicology
   Program, National Institutes of Health (FDA IAG) [224-12-003/NIEHS IAG,
   AES12013]
FX This work was supported by an Interagency Agreement (IAG) between the US
   Food and Drug Administration/National Center for Toxicological Research,
   US Department of Health and Human Services and the National Institute of
   Environmental Health Sciences/National Toxicology Program, National
   Institutes of Health (FDA IAG # 224-12-003/NIEHS IAG # AES12013).
CR Alles MS, 1999, AM J CLIN NUTR, V69, P980
   ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775
   Arthur JC, 2011, INFLAMM BOWEL DIS, V17, P396, DOI 10.1002/ibd.21354
   Atherton P, 1998, Nurs Stand, V12, P49
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Borges-Canha M, 2015, REV ESP ENFERM DIG, V107, P659, DOI 10.17235/reed.2015.3830/2015
   Boudreau MD, 2006, J ENVIRON SCI HEAL C, V24, P103, DOI 10.1080/10590500600614303
   Boudreau MD, 2016, TOXICOL SCI, V150, P131, DOI 10.1093/toxsci/kfv318
   Boudreau MD, 2013, TOXICOL SCI, V131, P26, DOI 10.1093/toxsci/kfs275
   BRIGGS C, 1995, CANADIAN PHARM J, V128, P48
   Brooks SPJ, 2003, CAN J MICROBIOL, V49, P589, DOI [10.1139/w03-075, 10.1139/W03-075]
   Brunner E., 2002, NONPARAMETRIC ANAL L
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   CHE QM, 1991, PLANTA MED, V57, P15, DOI 10.1055/s-2006-960007
   COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616
   Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017
   CRL, 1984, BAS HEM CLIN CHEM VA, P7
   Cummings J H, 1998, Curr Opin Clin Nutr Metab Care, V1, P409, DOI 10.1097/00075197-199809000-00007
   Cummings JH, 1998, BMJ-BRIT MED J, V317, P1636, DOI 10.1136/bmj.317.7173.1636
   DEWITTE P, 1990, HEPATO-GASTROENTEROL, V37, P601
   Ding WJ, 2014, INT J FOOD SCI TECH, V49, P1773, DOI [10.1111/ijfs.12500, 10.1111/ijfs.125]
   Dolan KT, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600129
   Ericsson AC, 2015, ONCOTARGET, V6, P33689, DOI 10.18632/oncotarget.5604
   FRANZ G, 1983, PLANTA MED, V47, P131, DOI 10.1055/s-2007-969972
   Giknis M. L. A., 2006, CLIN LAB PARAMETERS, P14
   GRINDLAY D, 1986, J ETHNOPHARMACOL, V16, P117, DOI 10.1016/0378-8741(86)90085-1
   GROOM QJ, 1987, PLANTA MED, P345, DOI 10.1055/s-2006-962735
   Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957
   HATTORI M, 1988, CHEM PHARM BULL, V36, P4462
   HAY JE, 1956, J CHEM SOC, P3141, DOI 10.1039/jr9560003141
   HAYNES LJ, 1970, J CHEM SOC C, P2581, DOI 10.1039/j39700002581
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   IASC, 2012, CERT PROGR POL OP PR
   ISHII Y, 1994, BIOL PHARM BULL, V17, P651
   Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007
   Joshi S. P., 1998, Journal of Medicinal and Aromatic Plant Sciences, V20, P768
   Kalmokoff M, 2013, J APPL MICROBIOL, V114, P1516, DOI 10.1111/jam.12157
   Kalmokoff M, 2015, NUTRIENTS, V7, P3279, DOI 10.3390/nu7053279
   KLEIN AD, 1988, J AM ACAD DERMATOL, V18, P714, DOI 10.1016/S0190-9622(88)70095-X
   Lecomte V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126931
   Levine UY, 2013, APPL ENVIRON MICROB, V79, P3879, DOI 10.1128/AEM.00589-13
   Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725
   Manichanh C, 2010, GENOME RES, V20, P1411, DOI 10.1101/gr.107987.110
   MANITTO P, 1990, J CHEM SOC P1, V1, P1297
   MAPP RK, 1970, PLANTA MED, V18, P361, DOI 10.1055/s-0028-1099792
   MORI H, 1985, BRIT J CANCER, V52, P781, DOI 10.1038/bjc.1985.257
   Nehra V, 2016, PHYSIOLOGY, V31, P327, DOI 10.1152/physiol.00005.2016
   NTP, 2011, SPEC COND STUD EV TO
   Nusko G, 2000, GUT, V46, P651, DOI 10.1136/gut.46.5.651
   O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731
   OECD, 1998, FISH SHORT TERM TOX
   Ojeda P, 2016, J NUTR BIOCHEM, V28, P191, DOI 10.1016/j.jnutbio.2015.08.013
   Pan Q, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-69
   Pandiri AR, 2011, TOXICOL PATHOL, V39, P1065, DOI 10.1177/0192623311422081
   Pogribna M, 2008, LETT APPL MICROBIOL, V46, P575, DOI 10.1111/j.1472-765X.2008.02346.x
   Power SE, 2014, BRIT J NUTR, V111, P387, DOI 10.1017/S0007114513002560
   Rupa P, 2012, J AGR FOOD CHEM, V60, P8249, DOI 10.1021/jf301903t
   SHIRLEY E, 1977, BIOMETRICS, V33, P386, DOI 10.2307/2529789
   SMITH T, 1851, MONTHLY J MED SCI, V12, P127
   Sobhani I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016393
   Tabolacci C, 2013, AMINO ACIDS, V44, P293, DOI 10.1007/s00726-011-1166-x
   Upton R., 2012, ALOE VERA LEAF R UPT, P50
   Viljoen AM, 2001, BIOCHEM SYST ECOL, V29, P53, DOI 10.1016/S0305-1978(00)00024-7
   Walsh CJ, 2014, FEBS LETT, V588, P4120, DOI 10.1016/j.febslet.2014.03.035
   WELLS CL, 1987, INFECT IMMUN, V55, P2689, DOI 10.1128/IAI.55.11.2689-2694.1987
   WESTENDORF J, 1990, MUTAT RES, V240, P1, DOI 10.1016/0165-1218(90)90002-J
   Willems M, 2003, NETH J MED, V61, P22
   WILLIAMS DA, 1986, BIOMETRICS, V42, P183, DOI 10.2307/2531254
   Wong JMW, 2014, AM J CLIN NUTR, V100, p369S, DOI 10.3945/ajcn.113.071639
   Wu N, 2013, MICROB ECOL, V66, P462, DOI 10.1007/s00248-013-0245-9
   Xu ZJ, 2015, BRIT J NUTR, V113, pS1, DOI 10.1017/S0007114514004127
   Yang YW, 2015, APPL ENVIRON MICROB, V81, P6749, DOI 10.1128/AEM.01906-15
NR 72
TC 23
Z9 25
U1 0
U2 18
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1096-6080
EI 1096-0929
J9 TOXICOL SCI
JI Toxicol. Sci.
PD AUG
PY 2017
VL 158
IS 2
BP 302
EP 318
DI 10.1093/toxsci/kfx105
PG 17
WC Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Toxicology
GA FC9PH
UT WOS:000407173100007
PM 28525602
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Precup, G
   Vodnar, DC
AF Precup, Gabriela
   Vodnar, Dan-Cristian
TI Gut Prevotella as a possible biomarker of diet and its eubiotic versus
   dysbiotic roles: a comprehensive literature review
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Review
DE Dietary patterns; Gut microbiota; Prevotella
ID FECAL MICROBIOTA; MEDITERRANEAN DIET; METABOLISM; HEALTH; CONSUMPTION;
   OVERWEIGHT; BACTERIAL; CHILDREN; DISEASE; VEGETARIANS
AB The gut microbiota has a profound impact on human health. Emerging data show that dietary patterns are associated with different communities of bacterial species within the gut. Prevotella species have been correlated with plant-rich diets, abundant in carbohydrates and fibres. Dysbiosis within the gut ecosystem has been associated with the development of non-communicable diseases such as obesity, the metabolic syndrome, inflammatory bowel disease, irritable bowel syndrome, colorectal cancer, type 1 diabetes, allergies and other diseases. The purpose of this comprehensive literature review was to evaluate the available data on the impact of diet on the Prevotella genus, as a dietary fibre fermenter in the gut as well as its implications as a potential biomarker for homeostasis or disease state through its metabolite signature. Studies were identified by conducting PubMed, Web of Science Core Collection and Google Scholar electronic searches. We found eighty-five publications reporting the impact of dietary patterns on gut microbial communities, including Prevotella or Prevotella/Bacteroides ratio in particular. Moreover, the role of Prevotella species on health status was also evaluated. Prevotella possess a high genetic diversity, representing one of the important groups found in the oral cavity and large intestine of man. The gut commensal Prevotella bacteria contribute to polysaccharide breakdown, being dominant colonisers of agrarian societies. However, studies also suggested a potential role of Prevotella species as intestinal pathobionts. Further metagenomic studies are needed in order to reveal health- or disease-modulating properties of Prevotella species in the gut.
C1 [Precup, Gabriela; Vodnar, Dan-Cristian] Univ Agr Sci & Vet Med, Inst Life Sci, Fac Food Sci & Technol, Cluj Napoca 400372, Romania.
C3 University of Agricultural Sciences & Veterinary Medicine Cluj Napoca
RP Vodnar, DC (corresponding author), Univ Agr Sci & Vet Med, Inst Life Sci, Fac Food Sci & Technol, Cluj Napoca 400372, Romania.
EM dan.vodnar@usamvduj.ro
RI Vodnar, Dan C./K-5634-2019; Precup, Gabriela/G-2772-2019; Vodnar, Dan
   C./B-8423-2011
OI Precup, Gabriela/0000-0002-9505-3759; Vodnar, Dan C./0000-0001-5407-8071
FU Ministry of Research and Innovation, CNCS-UEFISCDI within PNCDI III
   [PN-III-P1-1.1-TE-2016-0661]
FX This work was supported by a grant of Ministry of Research and
   Innovation, CNCS-UEFISCDI, project number PN-III-P1-1.1-TE-2016-0661,
   within PNCDI III.
CR Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1
   Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1
   Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1
   Actis Giovanni C., 2014, Inflammation & Allergy Drug Targets, V13, P217
   Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058
   [Anonymous], 2017, LANCET HIV, V2, pe115
   [Anonymous], 2018, OBSTET GYNECOL, V13, pe49
   [Anonymous], 2018, DIABETES CARE S1, V41, P1, DOI DOI 10.1016/J.INFFUS.2017.07.002
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Balfego M, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0245-0
   Bank IEM, 2017, JACC-HEART FAIL, V5, P14, DOI 10.1016/j.jchf.2016.09.015
   Bibbo S, 2017, ANN MED, V49, P11, DOI 10.1080/07853890.2016.1222449
   Borgo F, 2017, CHILD OBES, V13, P78, DOI 10.1089/chi.2015.0194
   Cecchini DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072766
   Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15
   Chen T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45671
   Conlon MA, 2015, NUTRIENTS, V7, P17, DOI 10.3390/nu7010017
   Costabile A, 2010, BRIT J NUTR, V104, P1007, DOI 10.1017/S0007114510001571
   Costea PI, 2018, NAT MICROBIOL, V3, P388, DOI 10.1038/s41564-018-0114-x
   De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957
   De Filippo C, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01979
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   de Moraes ACF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00047
   De Palma G, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-63
   De Vadder F, 2016, CELL METAB, V24, P151, DOI 10.1016/j.cmet.2016.06.013
   Dehingia M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18563
   den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012
   Deschasaux M, 2018, NAT MED, V24, P1526, DOI 10.1038/s41591-018-0160-1
   Dubois G, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0370-7
   Egshatyan L, 2016, ENDOCR CONNECT, V5, P1, DOI 10.1530/EC-15-0094
   Mejia-Leon ME, 2014, SCI REP-UK, V4, DOI 10.1038/srep03814
   Fernandes J, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.23
   Fernandez-Navarro T, 2017, NUTRIENTS, V9, DOI 10.3390/nu9060551
   Fernandez-Raudales D, 2012, GUT MICROBES, V3, P490, DOI 10.4161/gmic.21578
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Franco-de-Moraes AC, 2017, DIABETOL METAB SYNDR, V9, DOI 10.1186/s13098-017-0261-x
   Frost G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4611
   Gargari G, 2016, APPL ENVIRON MICROB, V82, P5850, DOI 10.1128/AEM.01753-16
   Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022
   Gomes AC, 2014, NUTR J, V13, DOI 10.1186/1475-2891-13-60
   Gomez A, 2016, CELL REP, V14, P2142, DOI 10.1016/j.celrep.2016.02.013
   Gorvitovskaia A, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0160-7
   Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164
   Grzeskowiak L, 2012, J PEDIATR GASTR NUTR, V54, P812, DOI 10.1097/MPG.0b013e318249039c
   Gutierrez-Diaz I, 2016, FOOD FUNCT, V7, P2347, DOI [10.1039/c6fo00105j, 10.1039/C6FO00105J]
   Haro C, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700300
   Haro C, 2016, J NUTR BIOCHEM, V27, P27, DOI 10.1016/j.jnutbio.2015.08.011
   Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809
   Hjorth MF, 2018, INT J OBESITY, V42, P284, DOI [10.1038/ijo.2018.1, 10.1038/ijo.2017.220]
   Hobbs ME, 2014, BIOCHEMISTRY-US, V53, P4661, DOI 10.1021/bi500656m
   Queipo-Ortuno MI, 2012, AM J CLIN NUTR, V95, P1323, DOI 10.3945/ajcn.111.027847
   Jain A, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0632-1
   Kang C, 2016, J CLIN ENDOCR METAB, V101, P4681, DOI 10.1210/jc.2016-2786
   Kao CC, 2016, J NUTR, V146, P706, DOI 10.3945/jn.115.227579
   Karl JP, 2015, AM J CLIN NUTR, V102, P84, DOI 10.3945/ajcn.115.109496
   Kashtanova DA, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6040098
   Kelly TN, 2016, CIRC RES, V119, P956, DOI 10.1161/CIRCRESAHA.116.309219
   Kobyliak N, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0166-9
   Kovatcheva-Datchary P, 2015, CELL METAB, V22, P971, DOI 10.1016/j.cmet.2015.10.001
   Kumbhare SV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11215-y
   Kushugulova A, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021682
   La-ongkham O, 2015, ARCH MICROBIOL, V197, P561, DOI 10.1007/s00203-015-1089-0
   Lan DL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17194-4
   Larsen JM, 2017, IMMUNOLOGY, V151, P363, DOI 10.1111/imm.12760
   Ley RE, 2016, NAT REV GASTRO HEPAT, V13, P69, DOI 10.1038/nrgastro.2016.4
   Li H, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01745
   Li K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155863
   Liao M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17851-8
   Liu HN, 2017, DIGEST LIVER DIS, V49, P331, DOI 10.1016/j.dld.2017.01.142
   Lopez-Legarrea P, 2014, ASIA PAC J CLIN NUTR, V23, P360, DOI 10.6133/apjcn.2014.23.3.16
   Mancabelli L, 2017, ENVIRON MICROBIOL, V19, P1379, DOI 10.1111/1462-2920.13692
   Martinez I, 2015, CELL REP, V11, P527, DOI 10.1016/j.celrep.2015.03.049
   Marungruang N, 2018, EUR J NUTR, V57, P2927, DOI 10.1007/s00394-017-1563-3
   Matijasic BB, 2014, EUR J NUTR, V53, P1051, DOI 10.1007/s00394-013-0607-6
   Michail S, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu002
   Moher David, 2010, Int J Surg, V8, P336, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]
   Moreno-Indias I, 2016, AM J TRANSL RES, V8, P5672
   Nakayama J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00197
   Nakayama J, 2015, SCI REP-UK, V5, DOI 10.1038/srep08397
   Neis EPJG, 2015, NUTRIENTS, V7, P2930, DOI 10.3390/nu7042930
   Obregon-Tito AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7505
   Pedersen HK, 2016, NATURE, V535, P376, DOI 10.1038/nature18646
   Portune KJ, 2016, TRENDS FOOD SCI TECH, V57, P213, DOI 10.1016/j.tifs.2016.08.011
   Prieto I, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190368
   Qian LM, 2018, EXP THER MED, V16, P856, DOI 10.3892/etm.2018.6249
   Ramakrishna BS, 2013, J GASTROEN HEPATOL, V28, P9, DOI 10.1111/jgh.12294
   Reichardt N, 2014, ISME J, V8, P1323, DOI 10.1038/ismej.2014.14
   Requena T, 2018, FOOD FUNCT, V9, P688, DOI [10.1039/C7FO01820G, 10.1039/c7fo01820g]
   Ruengsomwong S, 2014, J MICROBIOL BIOTECHN, V24, P1026, DOI 10.4014/jmb.1310.10043
   Sandberg J, 2018, EUR J NUTR
   Santoro A, 2014, MECH AGEING DEV, V136, P3, DOI 10.1016/j.mad.2013.12.001
   Schnorr SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4654
   Schugar RC, 2017, CELL REP, V19, P2451, DOI 10.1016/j.celrep.2017.05.077
   Senghor B., 2018, HUM MICROBIOME J, V7, P1, DOI [DOI 10.1016/J.HUMIC.2018.01.001, 10.1016/j.humic.2018.01.001]
   Shankar V, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00169-16
   Shortt C, 2018, EUR J NUTR, V57, P25, DOI 10.1007/s00394-017-1546-4
   Tap J, 2015, ENVIRON MICROBIOL, V17, P4954, DOI 10.1111/1462-2920.13006
   Tosti V, 2018, J GERONTOL A-BIOL, V73, P318, DOI 10.1093/gerona/glx227
   Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552
   Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444
   Vitaglione P, 2015, AM J CLIN NUTR, V101, P251, DOI 10.3945/ajcn.114.088120
   Wang BH, 2017, ENGINEERING, V3, P71, DOI 10.1016/J.ENG.2017.01.008
   Wang YA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00129
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053
   Yilmaz E, 2014, GRASAS ACEITES, V65, pe040
   Zhang J, 2015, ISME J, V9, P1979, DOI 10.1038/ismej.2015.11
   Zhang JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05001
   Zhu A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0646-9
   Zhu LX, 2014, PHYSIOL GENOMICS, V46, P679, DOI 10.1152/physiolgenomics.00082.2014
   Zhu WF, 2016, CELL, V165, P111, DOI 10.1016/j.cell.2016.02.011
   2014, J AM COLL CARDIOL, V64
NR 112
TC 98
Z9 100
U1 19
U2 68
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD JUL 28
PY 2019
VL 122
IS 2
BP 131
EP 140
AR PII S0007114519000680
DI 10.1017/S0007114519000680
PG 10
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA IS0HZ
UT WOS:000481831300002
PM 30924428
OA Bronze
DA 2022-11-22
ER

PT J
AU Bassaganya-Riera, J
   Hontecillas, R
AF Bassaganya-Riera, Josep
   Hontecillas, Raquel
TI Dietary conjugated linoleic acid and n-3 polyunsaturated fatty acids in
   inflammatory bowel disease
SO CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
LA English
DT Article
DE conjugated linoleic acid; immune regulation; inflammatory bowel disease;
   omega-3 PUFA; peroxisome proliferator-activated receptors
ID ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; GENE-EXPRESSION; METAGENOMIC
   ANALYSIS; ULCERATIVE-COLITIS; PIG MODEL; COMMUNITY; TRANS-10; OBESITY;
   CLA
AB Purpose of review
   Inflammatory bowel disease (IBD) is a debilitating and widespread immune-mediated illness of unknown etiology. Current treatments are modestly successful and with significant side-effects. The purpose of this review is to summarize the current understanding of mechanisms of action underlying the anti-inflammatory actions of conjugated linoleic acid (CLA) and n-3 polyunsaturated fatty acids (PUFAs) in IBD.
   Recent findings
   Nutrition-based interventions that target peroxisome proliferator-activated receptors (PPARs) such as dietary CLA and n-3 PUFA have demonstrated anti-inflammatory efficacy in animal models of IBD. Clinical data on n-3 PUFA in IBD remains generally unimpressive, although results of a recent human study demonstrate that IBD remission can be maintained by maintaining the n-3 : n-6 ratio more than 0.65 via n-3 PUFA intervention. In mice, CLA prevented inflammation-driven colorectal cancer by activating PPAR g and modulating regulatory T cells and macrophages. CLA is the subject of an ongoing clinical study in Crohn's disease patients.
   Summary
   Compelling evidence demonstrates that n-3 PUFA and CLA prevent or ameliorate IBD in animal models. However, this basic knowledge has not been translated into novel nutrition-based clinical interventions. For both compounds there is an urgent need for placebo-controlled, large-scale, multicenter clinical trials.
C1 [Bassaganya-Riera, Josep; Hontecillas, Raquel] Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Lab Nutr Immunol & Mol Nutr, Blacksburg, VA 24061 USA.
C3 Virginia Polytechnic Institute & State University
RP Bassaganya-Riera, J (corresponding author), Virginia Polytech Inst & State Univ, Virginia Bioinformat Inst, Lab Nutr Immunol & Mol Nutr, Blacksburg, VA 24061 USA.
EM jbassaga@vt.edu
FU NCCIH NIH HHS [R01 AT004308, R01 AT004308-04] Funding Source: Medline;
   NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004308]
   Funding Source: NIH RePORTER
CR Albers R, 2003, EUR J CLIN NUTR, V57, P595, DOI 10.1038/sj.ejcn.1601585
   Bassaganya-Riera J, 2004, GASTROENTEROLOGY, V127, P777, DOI 10.1053/j.gastro.2004.06.049
   Bassaganya-Riera J, 2003, J NUTR, V133, P3204, DOI 10.1093/jn/133.10.3204
   Bassaganya-Riera J, 2002, CLIN NUTR, V21, P451, DOI 10.1054/clnu.2002.0594
   Bassaganya-Riera J, 2002, VACCINE, V20, P1435, DOI 10.1016/S0264-410X(01)00465-0
   Bassaganya-Riera J, 2001, J NUTR, V131, P2370, DOI 10.1093/jn/131.9.2370
   Bassaganya-Riera J, 2006, CLIN NUTR, V25, P454, DOI 10.1016/j.clnu.2005.12.008
   Brandebourg TD, 2005, J ANIM SCI, V83, P2096
   Brix S, 2010, IMMUNOLOGY, V129, P338, DOI 10.1111/j.1365-2567.2009.03163.x
   Camilleri M, 2003, CLIN GASTROENTEROL H, V1, P415, DOI 10.1016/S1542-3565(03)00220-9
   *CDC, EP INFL BOW DIS
   Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364
   DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250
   Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649
   Evans NP, 2010, J NUTR, V140, P515, DOI 10.3945/jn.109.115642
   Ewaschuk JB, 2006, J NUTR, V136, P1483, DOI 10.1093/jn/136.6.1483
   Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Guri AJ, 2010, CLIN NUTR, V29, P824, DOI 10.1016/j.clnu.2010.02.009
   Hontecillas R, 2002, J NUTR, V132, P2019, DOI 10.1093/jn/132.7.2019
   Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940
   Jump DB, 1999, ANNU REV NUTR, V19, P63, DOI 10.1146/annurev.nutr.19.1.63
   Kelley DS, 1999, LIPIDS, V34, P317, DOI 10.1007/s11745-999-0369-5
   Kennedy A, 2008, J NUTR, V138, P455, DOI 10.1093/jn/138.3.455
   Kew S, 2003, BRIT J NUTR, V90, P1071, DOI 10.1079/BJN2003996
   KOHNO H, 2002, 2002 AOCS ANN M MINN
   Kong SC, 2005, J CLIN GASTROENTEROL, V39, P138
   Lakatos PL, 2006, WORLD J GASTROENTERO, V12, P6102, DOI 10.3748/wjg.v12.i38.6102
   Lewis JD, 2008, GASTROENTEROLOGY, V134, P688, DOI 10.1053/j.gastro.2007.12.012
   LEY R, 2006, NATURE, V444, P1023
   Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Lichtenstein G. R., 2003, RECENT ADV TREATMENT
   MacLean CH, 2005, AM J CLIN NUTR, V82, P611, DOI 10.1093/ajcn/82.3.611
   Maconi G, 2005, DIGEST LIVER DIS, V37, P418, DOI 10.1016/j.dld.2005.01.011
   Mahowald MA, 2009, P NATL ACAD SCI USA, V106, P5859, DOI 10.1073/pnas.0901529106
   MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X
   Marcy TR, 2004, ANN PHARMACOTHER, V38, P1419, DOI 10.1345/aph.1E072
   Meadus WJ, 2002, J MOL ENDOCRINOL, V28, P79, DOI 10.1677/jme.0.0280079
   Miller JR, 2008, J LIPID RES, V49, P550, DOI 10.1194/jlr.M700275-JLR200
   Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195
   NcNeel RL, 2003, IN VITRO CELL DEV-AN, V39, P375, DOI 10.1290/1543-706X(2003)039<0375:IOCLAM>2.0.CO;2
   Nesto RW, 2003, CIRCULATION, V108, P2941, DOI 10.1161/01.CIR.0000103683.99399.7E
   Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11
   Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894
   Rondon MR, 2000, APPL ENVIRON MICROB, V66, P2541, DOI 10.1128/AEM.66.6.2541-2547.2000
   Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948
   SCHMIDT TM, 1991, J BACTERIOL, V173, P4371, DOI 10.1128/JB.173.14.4371-4378.1991
   Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197
   Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996
   Strous M, 2006, NATURE, V440, P790, DOI 10.1038/nature04647
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   Turnbaugh PJ, 2008, CELL, V134, P708, DOI 10.1016/j.cell.2008.08.025
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340
   Uchiyama K, 2010, INFLAMM BOWEL DIS, V16, P1696, DOI 10.1002/ibd.21251
   WENDELSDORF K, J THEOR BIO IN PRESS, DOI DOI 10.1016/J.JTB.2010.03.027
   Whigham LD, 2004, FOOD CHEM TOXICOL, V42, P1701, DOI 10.1016/j.fct.2004.06.008
   Whigham LD, 2002, AM J PHYSIOL-REG I, V282, pR1104, DOI 10.1152/ajpregu.00075.2001
   Whigham LD, 2001, AM J PHYSIOL-REG I, V280, pR908, DOI 10.1152/ajpregu.2001.280.3.R908
   Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129
   Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192
   Yang MD, 2003, EXP BIOL MED, V228, P51, DOI 10.1177/153537020322800107
   Yu Y, 2002, BBA-MOL CELL BIOL L, V1581, P89, DOI 10.1016/S1388-1981(02)00126-9
NR 64
TC 75
Z9 78
U1 0
U2 37
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1363-1950
EI 1473-6519
J9 CURR OPIN CLIN NUTR
JI Curr. Opin. Clin. Nutr. Metab. Care
PD SEP
PY 2010
VL 13
IS 5
BP 569
EP 573
DI 10.1097/MCO.0b013e32833b648e
PG 5
WC Endocrinology & Metabolism; Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 641BA
UT WOS:000281097600010
PM 20508519
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Wu, YQ
   Li, A
   Liu, HW
   Zhang, Z
   Zhang, CC
   Ma, CC
   Zhang, L
   Zhang, JC
AF Wu, Yuqing
   Li, Ao
   Liu, Huanwei
   Zhang, Zeng
   Zhang, Chengcheng
   Ma, Chenchen
   Zhang, Lin
   Zhang, Jiachao
TI Lactobacillus plantarum HNU082 alleviates dextran sulfate sodium-induced
   ulcerative colitis in mice through regulating gut microbiome
SO FOOD & FUNCTION
LA English
DT Article
ID INFLAMMATORY-BOWEL-DISEASE; MUCOSAL MICROBIOTA; SIGNALING PATHWAY;
   BARRIER FUNCTION; CONTROLLED-TRIAL; EXPRESSION; IBD; ACTIVATION;
   CYTOKINES; CELLS
AB Probiotics have shown good efficacy in the prevention of ulcerative colitis (UC), but the specific mechanism remains unclear. Therefore, shotgun metagenomic and transcriptome analyses were performed to explore the preventive effect of a potential probiotic Lactobacillus plantarum HNU082 (Lp082) on UC and its specific mechanism. The results showed that Lp082 intervention ameliorated dextran sulfate sodium (DSS)-induced UC in mice, which was manifested in the increase in body weight, water intake, food intake, and colon length and the decrease in the DAI index, immune organ index, inflammatory factors and histopathological scores after Lp082 intake. The mechanism is deeply studied and it is discovered that Lp082 improves the intestinal mucosal barrier by co-optimizing biological barriers, chemical barriers, mechanical barriers, and immune barriers. Specifically, Lp082 improved the biological barrier by increasing the diversity, optimizing the species composition and the structure of the gut microbiota, increasing bacteria producing short chain fatty acids (SCFAs), and activating microbial metabolic pathways producing SCFAs so as to enhance the content of SCFAs. Lp082 optimized the chemical barrier by decreasing the mRNA expression of ICAM-1 and VCAM and by increasing the content of goblet cells and the mRNA expression and immunofluorescent protein content of mucin2. Lp082 ameliorated the mechanical barrier by decreasing the mRNA expression of claudin-1 and claudin-2, and by increasing the mRNA expression of ZO-1 and ZO-2 and the immunofluorescent protein content of ZO-1. Lp082 also optimized the immune barrier by increasing the mRNA expression of IL-10, TGF-beta 1, and TGF-beta 2 and by decreasing the mRNA expression and protein contents of IL-6, tumour necrosis factor-alpha (TNF-alpha) and myeloperoxidase (MPO). In addition, Lp082 can also regulate the metabolic pathways of inflammation and disease in mice, and notably, Lp082 inhibits the NF-kappa B signaling pathway by inhibiting NF-kappa B signaling molecules to alleviate UC. In conclusion, improving gut microbiota dysbiosis, protecting the intestinal mucosal barrier, regulating inflammatory and disease pathways, and affecting neutrophil infiltration are the potential mechanisms of probiotic Lp082 in alleviating UC. Our study enriches the mechanism and provides a new prospect for Lactobacillus plantarum HNU082 in the prevention of colitis, provides support for the development of probiotic-based microbial products as an alternative prevention strategy for UC, and provides guidance for the future probiotic prevention of human colitis.
C1 [Wu, Yuqing; Li, Ao; Liu, Huanwei; Zhang, Zeng; Ma, Chenchen; Zhang, Lin; Zhang, Jiachao] Hainan Univ, Coll Food Sci & Engn, Key Lab Food Nutr & Funct Food Hainan Prov, Haikou 570228, Hainan, Peoples R China.
   [Zhang, Jiachao] Hainan Univ, One Hlth Inst, Haikou 570228, Hainan, Peoples R China.
   [Zhang, Chengcheng] Jiangnan Univ, Sch Food Sci & Technol, Wuxi, Jiangsu, Peoples R China.
C3 Hainan University; Hainan University; Jiangnan University
RP Zhang, L; Zhang, JC (corresponding author), Hainan Univ, Coll Food Sci & Engn, Key Lab Food Nutr & Funct Food Hainan Prov, Haikou 570228, Hainan, Peoples R China.; Zhang, JC (corresponding author), Hainan Univ, One Hlth Inst, Haikou 570228, Hainan, Peoples R China.
EM zhanglinmailbox@163.com; zhjch321123@163.com
OI Zhang, Jiachao/0000-0001-8099-6749; Ma, Chenchen/0000-0003-0449-1911
FU Innovation Platform for Academicians of Hainan Province [YSPTZX202121]
FX This work was supported by the specific research fund of "The Innovation
   Platform for Academicians of Hainan Province (YSPTZX202121)".
CR Bhatia R, 2022, FRONT MICROBIOL, V13, DOI 10.3389/fmicb.2022.930928
   Bryant RV, 2016, GUT, V65, P408, DOI 10.1136/gutjnl-2015-309598
   Chin AC, 2006, ANN NY ACAD SCI, V1072, P276, DOI 10.1196/annals.1326.018
   Choi KH, 2022, APPL SCI-BASEL, V12, DOI 10.3390/app12052602
   Cook L, 2019, GASTROENTEROLOGY, V157, P1584, DOI 10.1053/j.gastro.2019.09.002
   Costello SP, 2019, JAMA-J AM MED ASSOC, V321, P156, DOI 10.1001/jama.2018.20046
   Dargenio VN, 2022, GASTROENTEROLOGY, V163, pE1, DOI 10.1053/j.gastro.2021.11.038
   Debnath T, 2013, MOLECULES, V18, P7253, DOI 10.3390/molecules18067253
   Fedorak RN, 2008, J CLIN GASTROENTEROL, V42, pS111, DOI 10.1097/MCG.0b013e31816d922c
   Francescone R, 2015, INFLAMM BOWEL DIS, V21, P409, DOI 10.1097/MIB.0000000000000236
   Garg P, 2007, GASTROENTEROLOGY, V132, P1877, DOI 10.1053/j.gastro.2007.02.048
   Goldberg R, 2019, GASTROENTEROLOGY, V156, P1775, DOI 10.1053/j.gastro.2019.01.025
   Goudarzi R, 2020, J FOOD BIOCHEM, V44, DOI 10.1111/jfbc.13244
   Gu ZP, 2020, FOOD FUNCT, V11, P3245, DOI [10.1039/D0FO00116C, 10.1039/d0fo00116c]
   Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005
   Hasannejad-Bibalan M, 2020, ACTA MICROBIOL IMM H, V67, P138, DOI 10.1556/030.2020.00834
   Hernandez L, 2010, CANCER RES, V70, P4005, DOI 10.1158/0008-5472.CAN-09-3912
   Hosseinkhani F, 2021, GUT MICROBES, V13, P1, DOI 10.1080/19490976.2021.1882927
   Hu LH, 2021, KAOHSIUNG J MED SCI, V37, P812, DOI 10.1002/kjm2.12400
   Huang S, 2021, MICROBIOME, V9, DOI 10.1186/s40168-021-01102-0
   Hume GE, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.040477
   Je IG, 2018, J MED FOOD, V21, P858, DOI 10.1089/jmf.2017.4152
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   Lee Y, 2020, NAT MATER, V19, P118, DOI 10.1038/s41563-019-0462-9
   Li HS, 2011, BLOOD, V118, P3879, DOI 10.1182/blood-2011-04-349761
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Ma CC, 2020, GUT MICROBES, V12, DOI 10.1080/19490976.2020.1785252
   Mao BY, 2016, J AGR FOOD CHEM, V64, P6240, DOI 10.1021/acs.jafc.6b02305
   NAKAMURA S, 1993, LAB INVEST, V69, P77
   Pan YN, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/9416794
   Piovezani Ramos Guilherme, 2021, Gastroenterol Hepatol (N Y), V17, P211
   Prantera C, 2002, GUT, V51, P405, DOI 10.1136/gut.51.3.405
   Qiu SJ, 2020, INT IMMUNOPHARMACOL, V78, DOI 10.1016/j.intimp.2019.106018
   Ray Katrina, 2015, Nat Rev Gastroenterol Hepatol, V12, P122, DOI 10.1038/nrgastro.2015.26
   Schober P, 2018, ANESTH ANALG, V126, P1763, DOI 10.1213/ANE.0000000000002864
   Shao YY, 2017, FOOD FUNCT, V8, P4508, DOI [10.1039/c7fo00902j, 10.1039/C7FO00902J]
   Shen J, 2019, INT IMMUNOPHARMACOL, V73, P193, DOI 10.1016/j.intimp.2019.04.052
   Shi JL, 2021, FOOD FUNCT, V12, P5130, DOI [10.1039/d1fo00317h, 10.1039/D1FO00317H]
   Si XM, 2021, FOOD FUNCT, V12, P10983, DOI [10.1039/D1FO01477C, 10.1039/d1fo01477c]
   Singh UP, 2016, CYTOKINE, V77, P44, DOI 10.1016/j.cyto.2015.10.008
   Sun MY, 2020, FOOD FUNCT, V11, P5205, DOI [10.1039/d0fo00007h, 10.1039/D0FO00007H]
   Vivinus-Nebot M, 2013, GASTROENTEROLOGY, V144, pS538
   Wang J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01953
   Wang R, 2021, GUT MICROBES, V13, DOI 10.1080/19490976.2021.1887720
   Wang YY, 2021, FOOD FUNCT, V12, P10728, DOI [10.1039/d1fo01388b, 10.1039/D1FO01388B]
   Wang ZY, 2020, BRIEF BIOINFORM, V21, P777, DOI 10.1093/bib/bbz025
   Weber CR, 2008, LAB INVEST, V88, P1110, DOI 10.1038/labinvest.2008.78
   White R, 2017, GUT MICROBES, V8, P451, DOI 10.1080/19490976.2017.1334754
   Woo SH, 2019, DIGEST DIS SCI, V64, P421, DOI 10.1007/s10620-018-5246-6
   Xiao B, 2013, BIOMATERIALS, V34, P7471, DOI 10.1016/j.biomaterials.2013.06.008
   Yang YZ, 2017, GASTROENTEROLOGY, V152, P851, DOI 10.1053/j.gastro.2016.11.018
   Yuan YY, 2018, GASTROENTEROL REP, V6, P167, DOI 10.1093/gastro/goy011
   Zhai QX, 2013, APPL ENVIRON MICROB, V79, P1508, DOI 10.1128/AEM.03417-12
   Zhang JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep32524
   Zhang JY, 2016, J SCI FOOD AGR, V96, P4907, DOI 10.1002/jsfa.7786
   Zhou YL, 2021, AMB EXPRESS, V11, DOI 10.1186/s13568-021-01197-6
NR 56
TC 0
Z9 0
U1 21
U2 21
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2042-6496
EI 2042-650X
J9 FOOD FUNCT
JI Food Funct.
PD OCT 3
PY 2022
VL 13
IS 19
BP 10171
EP 10185
DI 10.1039/d2fo02303b
EA SEP 2022
PG 15
WC Biochemistry & Molecular Biology; Food Science & Technology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Food Science & Technology
GA 5B1XZ
UT WOS:000854087200001
PM 36111438
DA 2022-11-22
ER

PT J
AU Gao, B
   Bian, XM
   Mahbub, R
   Lu, K
AF Gao, Bei
   Bian, Xiaoming
   Mahbub, Ridwan
   Lu, Kun
TI Sex-Specific Effects of Organophosphate Diazinon on the Gut Microbiome
   and Its Metabolic Functions
SO ENVIRONMENTAL HEALTH PERSPECTIVES
LA English
DT Article
ID LITHOCHOLIC ACID; COLON-CANCER; EXPOSURE; TAURINE; RATS; NEUROTOXICITY;
   BRAIN; METAGENOMICS; MODULATION; PESTICIDE
AB BACKGROUND: There is growing recognition of the significance of the gut microbiome to human health, and the association between a perturbed gut microbiome with human diseases has been established. Previous studies also show the role of environmental toxicants in perturbing the gut microbiome and its metabolic functions. The wide agricultural use of diazinon, an organophosphate insecticide, has raised serious environmental health concerns since it is a potent neurotoxicant. With studies demonstrating the presence of a microbiome-gut-brain axis, it is possible that gut microbiome perturbation may also contribute to diazinon toxicity.
   OBJECTIVES: We investigated the impact of diazinon exposure on the gut microbiome composition and its metabolic functions in C57BL/6 mice.
   METHODS: We used a combination of 16S rRNA gene sequencing, metagenomics sequencing, and mass spectrometry-based metabolomics profiling in a mouse model to examine the functional impact of diazinon on the gut microbiome.
   RESULTS: 16S rRNA gene sequencing revealed that diazinon exposure significantly perturbed the gut microbiome, and metagenomic sequencing found that diazinon exposure altered the functional metagenome. Moreover, metabolomics profiling revealed an altered metabolic profile arising from exposure. Of particular significance, these changes were more pronounced for male mice than for female mice.
   CONCLUSIONS: Diazinon exposure perturbed the gut microbiome community structure, functional metagenome, and associated metabolic profiles in a sex-specific manner. These findings may provide novel insights regarding perturbations of the gut microbiome and its functions as a potential new mechanism contributing to diazinon neurotoxicity and, in particular, its sex-selective
C1 [Gao, Bei; Bian, Xiaoming; Mahbub, Ridwan; Lu, Kun] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA.
C3 University System of Georgia; University of Georgia
RP Lu, K (corresponding author), Univ Georgia, 140 Environm Hlth Sci Bldg, Athens, GA 30602 USA.
EM kunlu@uga.edu
OI Gao, Bei/0000-0002-3321-2339
FU National Institutes of Health [ES024950]; UGA (University of Georgia);
   NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024950]
   Funding Source: NIH RePORTER
FX National Institutes of Health grant ES024950 and UGA (University of
   Georgia) Startup grants provided partial financial support for this
   work.
CR Aggarwal V, 2013, REV ENVIRON CONTAM T, V223, P107, DOI 10.1007/978-1-4614-5577-6_5
   Akande MG, 2014, ENVIRON TOXICOL PHAR, V37, P315, DOI 10.1016/j.etap.2013.11.023
   Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356
   Bjorling-Poulsen M, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-50
   Cani PD, 2013, CURR OPIN PHARMACOL, V13, P935, DOI 10.1016/j.coph.2013.09.008
   Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8
   Casida JE, 2004, CHEM RES TOXICOL, V17, P983, DOI 10.1021/tx0499259
   Chan ECY, 2011, NAT PROTOC, V6, P1483, DOI 10.1038/nprot.2011.375
   Choi JJ, 2013, ENVIRON HEALTH PERSP, V121, P725, DOI 10.1289/ehp.1306534
   Colovic MB, 2015, TOXICOL LETT, V233, P29, DOI 10.1016/j.toxlet.2015.01.003
   Cui L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002373
   Degirolamo C, 2011, TRENDS MOL MED, V17, P564, DOI 10.1016/j.molmed.2011.05.010
   Dirican M, 2007, CLIN EXP PHARMACOL P, V34, P833, DOI 10.1111/j.1440-1681.2007.04615.x
   Egeghy PP, 2011, INT J ENV RES PUB HE, V8, P1727, DOI 10.3390/ijerph8051727
   El Idrissi A, 2004, NEUROCHEM RES, V29, P189, DOI 10.1023/B:NERE.0000010448.17740.6e
   Flores GE, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0531-y
   Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005
   Galland L, 2014, J MED FOOD, V17, P1261, DOI 10.1089/jmf.2014.7000
   Jansen KL, 2009, TOXICOL APPL PHARM, V236, P142, DOI 10.1016/j.taap.2009.02.001
   Jiang HY, 2015, BRAIN BEHAV IMMUN, V48, P186, DOI 10.1016/j.bbi.2015.03.016
   Lee BJ, 2011, J NEUROGASTROENTEROL, V17, P252, DOI 10.5056/jnm.2011.17.3.252
   Levinskaya N, 2006, ADV EXP MED BIOL, V583, P411
   Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005
   Lu K, 2014, ENVIRON HEALTH PERSP, V122, P284, DOI 10.1289/ehp.1307429
   Lu K, 2014, CHEM RES TOXICOL, V27, P172, DOI 10.1021/tx400454z
   Lu K, 2013, CHEM RES TOXICOL, V26, P1893, DOI 10.1021/tx4002868
   Lu K, 2012, J PROTEOME RES, V11, P4916, DOI 10.1021/pr300429x
   Markle JGM, 2013, SCIENCE, V339, P1084, DOI 10.1126/science.1233521
   Martin FPJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100190
   Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386
   Narrowe AB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0069-6
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Okazaki Y, 2012, J NUTR SCI VITAMINOL, V58, P366, DOI 10.3177/jnsv.58.366
   Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177
   Qin N, 2014, NATURE, V513, P59, DOI 10.1038/nature13568
   RAJENDRA W, 1986, DRUG CHEM TOXICOL, V9, P117, DOI 10.3109/01480548608998270
   Razavi BM, 2014, DRUG CHEM TOXICOL, V37, P378, DOI 10.3109/01480545.2013.866139
   Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200
   Roegge CS, 2008, BRAIN RES BULL, V75, P166, DOI 10.1016/j.brainresbull.2007.08.008
   Sim WH, 2010, J CLIN MICROBIOL, V48, P1939, DOI 10.1128/JCM.02261-09
   Slotkin TA, 2008, BRAIN RES BULL, V75, P640, DOI 10.1016/j.brainresbull.2007.10.008
   Swann JR, 2011, P NATL ACAD SCI USA, V108, P4523, DOI 10.1073/pnas.1006734107
   Timofeeva OA, 2008, NEUROTOXICOL TERATOL, V30, P38, DOI 10.1016/j.ntt.2007.10.002
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352
   Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106
   Woolbright BL, 2014, TOXICOL LETT, V228, P56, DOI 10.1016/j.toxlet.2014.04.001
   Wu JY, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-S1-S1
   Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047
   Zafiropoulos A, 2014, HUM EXP TOXICOL, V33, P1241, DOI 10.1177/0960327114532384
NR 50
TC 70
Z9 73
U1 1
U2 83
PU US DEPT HEALTH HUMAN SCIENCES PUBLIC HEALTH SCIENCE
PI RES TRIANGLE PK
PA NATL INST HEALTH, NATL INST ENVIRONMENTAL HEALTH SCIENCES, PO BOX 12233,
   RES TRIANGLE PK, NC 27709-2233 USA
SN 0091-6765
EI 1552-9924
J9 ENVIRON HEALTH PERSP
JI Environ. Health Perspect.
PD FEB
PY 2017
VL 125
IS 2
BP 198
EP 206
DI 10.1289/EHP202
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health;
   Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health; Toxicology
GA EK5ZF
UT WOS:000394004000013
PM 27203275
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Wang, XQ
   Zhang, AH
   Miao, JH
   Sun, H
   Yan, GL
   Wu, FF
   Wang, XJ
AF Wang, Xiang-qian
   Zhang, Ai-hua
   Miao, Jian-hua
   Sun, Hui
   Yan, Guang-li
   Wu, Fang-fang
   Wang, Xi-jun
TI Gut microbiota as important modulator of metabolism in health and
   disease
SO RSC ADVANCES
LA English
DT Review
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; SPECTROMETRY-BASED METABOLOMICS;
   POTENTIAL THERAPEUTIC TARGETS; HIGH-THROUGHPUT METABOLOMICS; FATTY
   LIVER-DISEASE; BACTERIAL TRANSLOCATION; CHEMICAL-CONSTITUENTS;
   ALZHEIMERS-DISEASE; COLORECTAL-CANCER; CHINESE MEDICINE
AB The human gastrointestinal tract colonizes a large number of microbial microflora, forms a host-microbiota co-metabolism structure with the host to participate in various metabolic processes in the human body, and plays a major role in the host immune response. In addition, the dysbiosis of intestinal microbial homeostasis is closely related to many diseases. Thus, an in-depth understanding of the relationship between them is of importance for disease pathogenesis, prevention and treatment. The combined use of metagenomics, transcriptomics, proteomics and metabolomics techniques for the analysis of gut microbiota can reveal the relationship between microbiota and the host in many ways, which has become a hot topic of analysis in recent years. This review describes the mechanism of co-metabolites in host health, including short-chain fatty acids (SCFA) and bile acid metabolism. The metabolic role of gut microbiota in obesity, liver diseases, gastrointestinal diseases and other diseases is also summarized, and the research methods for multi-omics combined application on gut microbiota are summarized. According to the studies of the interaction mechanism between gut microbiota and the host, we have a better understanding of the use of intestinal microflora in the treatment of related diseases. It is hoped that the gut microbiota can be utilized to maintain human health, providing a reference for future research.
C1 [Wang, Xiang-qian; Miao, Jian-hua; Wu, Fang-fang; Wang, Xi-jun] Natl Engn Lab Dev Southwestern Endangered Med Mat, Guangxi Bot Garden Med Plant, Nanning, Guangxi, Peoples R China.
   [Wang, Xiang-qian; Zhang, Ai-hua; Sun, Hui; Yan, Guang-li; Wang, Xi-jun] Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem,Lab Metab, Chinmed Res Ctr State Adm TCM,Dept Pharmaceut Ana, Natl Chinmed Res Ctr,Sino Amer Chinmed Technol Co, Heping Rd 24, Harbin, Heilongjiang, Peoples R China.
C3 Heilongjiang University of Chinese Medicine
RP Wang, XJ (corresponding author), Natl Engn Lab Dev Southwestern Endangered Med Mat, Guangxi Bot Garden Med Plant, Nanning, Guangxi, Peoples R China.; Wang, XJ (corresponding author), Heilongjiang Univ Chinese Med, Natl TCM Key Lab Serum Pharmacochem,Lab Metab, Chinmed Res Ctr State Adm TCM,Dept Pharmaceut Ana, Natl Chinmed Res Ctr,Sino Amer Chinmed Technol Co, Heping Rd 24, Harbin, Heilongjiang, Peoples R China.
EM xijunwangls@126.com
RI Wang, Xijun/C-4477-2014
OI Wang, Xijun/0000-0002-0949-3492
FU Key Program of Natural Science Foundation of State [81830110, 81430093,
   81373930, 81673586, 81703685, 81302905, 81473584, 81503386]; National
   Key Subject of Drug Innovation [2015ZX09101043-005, 2015ZX09101043-011];
   TCM State Administration Subject of Public Welfare [2015468004];
   University Nursing Program for Young Scholars with Creative Talents in
   Heilongjiang Province [UNPYSCT-2015118, UNPYSCT-2016213]; Major Projects
   of Application Technology Research and Development Plan in Heilongjiang
   Province [GX16C003]; Specialized Research Fund for the Doctoral Program
   of Higher Education [20132327130001, 20122327120006]; Application
   Technology and Development of Youth Talents Project in Harbin
   [2014RFQXJ116]; Young Talent Lift Engineering Project of China
   Association of Traditional Chinese Medicine [QNRC2-B06]; Outstanding
   Talents Foundation of Heilongjiang University of Chinese Medicine
   [2018jc01]; Doctoral Innovation Fund of Heilongjiang University of
   Chinese Medicine [2018bs02]; Chinese Postdoctoral Science Foundation
   [2017M621319b]
FX This work was supported by grants from the Key Program of Natural
   Science Foundation of State (Grant No. 81830110, 81430093, 81373930,
   81673586, 81703685, 81302905, 81473584, 81503386), National Key Subject
   of Drug Innovation (Grant No. 2015ZX09101043-005, 2015ZX09101043-011),
   TCM State Administration Subject of Public Welfare of (Grant No.
   2015468004), University Nursing Program for Young Scholars with Creative
   Talents in Heilongjiang Province (UNPYSCT-2015118, UNPYSCT-2016213),
   Major Projects of Application Technology Research and Development Plan
   in Heilongjiang Province (GX16C003), TCM State Administration Subject of
   Public Welfare (Grant No. 2015468004), Specialized Research Fund for the
   Doctoral Program of Higher Education (20132327130001, 20122327120006),
   Application Technology and Development of Youth Talents Project in
   Harbin (2014RFQXJ116), University Nursing Program for Young Scholars
   with Creative Talents in Heilongjiang Province (UNPYSCT-2015118,
   UNPYSCT-2016213), Young Talent Lift Engineering Project of China
   Association of Traditional Chinese Medicine (QNRC2-B06), Outstanding
   Talents Foundation of Heilongjiang University of Chinese Medicine
   (2018jc01), Doctoral Innovation Fund of Heilongjiang University of
   Chinese Medicine (2018bs02), Chinese Postdoctoral Science Foundation
   (2017M621319b).
CR Ahn J, 2013, JNCI-J NATL CANCER I, V105, P1907, DOI 10.1093/jnci/djt300
   Al-Ghalith GA, 2015, DISCOV MED, V19, P81
   Alvarez-Curto E, 2016, BIOCHEM PHARMACOL, V114, P3, DOI 10.1016/j.bcp.2016.03.017
   Ambalam P, 2016, BEST PRACT RES CL GA, V30, P119, DOI 10.1016/j.bpg.2016.02.009
   [Anonymous], 2018, MEDIAT INFLAMM
   Asarat M, 2016, IMMUNOL INVEST, V45, P205, DOI 10.3109/08820139.2015.1122613
   Aw W, 2018, J DIABETES INVEST, V9, P5, DOI 10.1111/jdi.12673
   Bears A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31695-w
   Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2
   Boursier J, 2016, HEPATOLOGY, V63, P764, DOI 10.1002/hep.28356
   Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949
   Cani PD, 2016, MOL NUTR FOOD RES, V60, P58, DOI 10.1002/mnfr.201500406
   Cao HX, 2015, PHYTOTHER RES, V29, P159, DOI 10.1002/ptr.5240
   Cao HX, 2014, BIOMED CHROMATOGR, V28, P1774, DOI 10.1002/bmc.3220
   Chassard C, 2013, CURR OPIN CLIN NUTR, V16, P453, DOI 10.1097/MCO.0b013e3283619e63
   Chen YX, 2016, WORLD J GASTROENTERO, V22, P2949, DOI 10.3748/wjg.v22.i10.2949
   Chi L, 2017, TOXICOL APPL PHARM, V331, P142, DOI 10.1016/j.taap.2017.06.008
   CHU H, 2015, J TRADIT CHIN MED, V1, P26, DOI DOI 10.15806/J.ISSN.2311-8571.2015.0022
   Chu H, 2016, J CHROMATOGR B, V1015, P50, DOI 10.1016/j.jchromb.2016.02.007
   Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052
   Davenport ER, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0454-7
   Del Chierico F, 2017, HEPATOLOGY, V65, P451, DOI 10.1002/hep.28572
   Di Ciaula A, 2017, ANN HEPATOL, V16, pS4, DOI 10.5604/01.3001.0010.5493
   Drissi F, 2017, MICROB PATHOGENESIS, V106, P182, DOI 10.1016/j.micpath.2016.03.006
   Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103
   El Aidy S, 2014, BENEF MICROBES, V5, P67, DOI 10.3920/BM2013.0018
   El Hage R, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01889
   Feng Q, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7528
   Feng QQ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00151
   Ferrer M, 2013, ENVIRON MICROBIOL, V15, P211, DOI 10.1111/j.1462-2920.2012.02845.x
   Fischbach MA, 2016, CELL, V164, P1288, DOI 10.1016/j.cell.2016.02.037
   Fletcher JR, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00089-18
   Fukui H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30943-3
   Gao HL, 2018, J CHROMATOGR B, V1092, P286, DOI 10.1016/j.jchromb.2018.06.032
   Giannelli V, 2014, WORLD J GASTROENTERO, V20, P16795, DOI 10.3748/wjg.v20.i45.16795
   Graham C, 2015, NUTR REV, V73, P376, DOI 10.1093/nutrit/nuv004
   Han H, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040995
   Han Y, 2018, RSC ADV, V8, P11983, DOI 10.1039/c8ra01029c
   Harper A, 2018, FOODS, V7, DOI 10.3390/foods7020013
   Heath RD, 2018, NORTH CLIN ISTANB, V5, P79, DOI 10.14744/nci.2017.10692
   Heimann E, 2016, ADIPOCYTE, V5, P359, DOI 10.1080/21623945.2016.1252011
   Huang H, 2014, IMMUNOL LETT, V162, P62, DOI 10.1016/j.imlet.2014.07.014
   Janssen AF, 2017, J PHYSIOL-LONDON, V595, P477, DOI 10.1113/JP272476
   Jiang N, 2015, ACTA PHARMACOL SIN, V36, P689, DOI 10.1038/aps.2014.169
   Kasselman LJ, 2018, ATHEROSCLEROSIS, V271, P203, DOI 10.1016/j.atherosclerosis.2018.02.036
   Kieffer DA, 2016, J NUTR, V146, P2476, DOI 10.3945/jn.116.238931
   Korem T, 2015, SCIENCE, V349, P1101, DOI 10.1126/science.aac4812
   Krishnan S, 2015, CURR OPIN BIOTECH, V36, P137, DOI 10.1016/j.copbio.2015.08.015
   Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102
   Lazar V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01830
   Lederberg J, 2000, SCIENCE, V288, P287, DOI 10.1126/science.288.5464.287
   Li DY, 2018, SEMIN NEPHROL, V38, P193, DOI 10.1016/j.semnephrol.2018.01.008
   Li XN, 2017, SCI REP-UK, V7, DOI 10.1038/srep46234
   Li XN, 2016, J SEP SCI, V39, P4700, DOI 10.1002/jssc.201600812
   Li XN, 2017, J SEP SCI, V40, P4102, DOI 10.1002/jssc.201700568
   Liu C, 2017, J SEP SCI, V40, P663, DOI 10.1002/jssc.201600624
   Liu Q, 2016, SCI REP-UK, V6, DOI 10.1038/srep38437
   Lopetuso LR, 2017, DIGEST DIS, V36, P56, DOI 10.1159/000477205
   Louis S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149564
   Mandal P, 2018, ANAEROBE, V49, P63, DOI 10.1016/j.anaerobe.2017.12.008
   Mantegazza C, 2018, PHARMACOL RES, V128, P63, DOI 10.1016/j.phrs.2017.08.001
   Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021
   Marzano V, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005916
   McCabe LR, 2018, CALCIFIED TISSUE INT, V102, P480, DOI 10.1007/s00223-018-0403-7
   Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813
   Nikolaus S, 2017, GASTROENTEROLOGY, V153, P1504, DOI 10.1053/j.gastro.2017.08.028
   Okumura R, 2018, INFLAMM REGEN, V38, DOI 10.1186/s41232-018-0063-z
   Ouwerkerk JP, 2016, INT J SYST EVOL MICR, V66, P4614, DOI 10.1099/ijsem.0.001399
   Pan WH, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0534-5
   Pathak P, 2018, HEPATOLOGY, V68, P1574, DOI 10.1002/hep.29857
   Petriz BA, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00004
   Poeta M, 2017, CHILDREN-BASEL, V4, DOI 10.3390/children4080066
   Qin YF, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1389-1
   Rajpoot M, 2018, SEMIN CANCER BIOL, V52, P1, DOI 10.1016/j.semcancer.2018.02.003
   Ralston JC, 2017, ANNU REV NUTR, V37, P77, DOI 10.1146/annurev-nutr-071816-064836
   Ren JL, 2018, RSC ADV, V8, P22335, DOI 10.1039/c8ra01574k
   Ruiz L, 2016, J PROTEOMICS, V147, P28, DOI 10.1016/j.jprot.2016.03.023
   Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333
   Sen T, 2017, PHYSIOL BEHAV, V173, P305, DOI 10.1016/j.physbeh.2017.02.027
   Sharkey KA, 2018, NAT REV GASTRO HEPAT, V15, P765, DOI 10.1038/s41575-018-0051-4
   Sharpton S. R., 2018, CLIN GASTROENTEROL H
   Shinji S, 2018, ONCOTARGET, V9, P2553, DOI 10.18632/oncotarget.23510
   Sirisinha S, 2016, ASIAN PAC J ALLERGY, V34, P249, DOI 10.12932/AP0803
   Smirnov KS, 2016, INT J MED MICROBIOL, V306, P266, DOI 10.1016/j.ijmm.2016.03.006
   Song Q, 2017, RSC ADV, V7, P53516, DOI 10.1039/c7ra02056b
   Spencer MD, 2011, GASTROENTEROLOGY, V140, P976, DOI 10.1053/j.gastro.2010.11.049
   Stanimirov B, 2015, HEPATOB PANCREAT DIS, V14, P18, DOI 10.1016/S1499-3872(14)60307-6
   Sun H, 2012, J SEP SCI, V35, P3477, DOI 10.1002/jssc.201200791
   Sun H, 2012, PHYTOTHER RES, V26, P1466, DOI 10.1002/ptr.4613
   Tuddenham S, 2015, CURR OPIN INFECT DIS, V28, P464, DOI 10.1097/QCO.0000000000000196
   Turroni F, 2016, ISME J, V10, P1656, DOI 10.1038/ismej.2015.236
   Vemuri RC, 2017, BENEF MICROBES, V8, P179, DOI 10.3920/BM2016.0115
   Verma MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19862-5
   Volynets V, 2012, DIGEST DIS SCI, V57, P1932, DOI 10.1007/s10620-012-2112-9
   Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Wang J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02222
   Wang JJ, 2015, ISME J, V9, P1, DOI 10.1038/ismej.2014.99
   Wang XJ, 2016, CHIN HERB MED, V8, P299, DOI 10.1016/S1674-6384(16)60055-2
   Wang XJ, 2016, TRAC-TREND ANAL CHEM, V76, P86, DOI 10.1016/j.trac.2015.11.010
   Wang XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep18997
   Wang XJ, 2014, TRAC-TREND ANAL CHEM, V63, P180, DOI 10.1016/j.trac.2014.05.013
   Whitfield-Cargile CM, 2016, GUT MICROBES, V7, P246, DOI 10.1080/19490976.2016.1156827
   Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202
   Woting A, 2015, MOL NUTR FOOD RES, V59, P2267, DOI 10.1002/mnfr.201500249
   Woting A, 2014, MBIO, V5, DOI 10.1128/mBio.01530-14
   Wu HL, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2936257
   Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015
   Wu XH, 2018, RSC ADV, V8, P19238, DOI 10.1039/c8ra00978c
   Xie GX, 2013, ELECTROPHORESIS, V34, P2787, DOI 10.1002/elps.201300017
   Xie J, 2018, RSC ADV, V8, P812, DOI 10.1039/c7ra09475b
   Yadav H, 2013, J BIOL CHEM, V288, P25088, DOI 10.1074/jbc.M113.452516
   Yan GL, 2013, J SEP SCI, V36, P3191, DOI 10.1002/jssc.201300529
   Yang JY, 2016, IMMUNITY, V44, P889, DOI 10.1016/j.immuni.2016.03.009
   Yu JB, 2017, J PROTEOME RES, V16, P3219, DOI 10.1021/acs.jproteome.7b00206
   Yu M, 2017, J PHARMACEUT BIOMED, V138, P231, DOI 10.1016/j.jpba.2017.02.008
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zhang A., 2013, J EVIDENCE BASED COM, V3, P78
   Zhang AH, 2018, PHYTOMEDICINE, V45, P84, DOI 10.1016/j.phymed.2018.04.004
   Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/402159
   Zhang AH, 2017, RSC ADV, V7, P51069, DOI 10.1039/c7ra09522h
   Zhang AH, 2018, MASS SPECTROM REV, V37, P307, DOI 10.1002/mas.21529
   Zhang AH, 2016, SCI REP-UK, V6, DOI 10.1038/srep19333
   Zhang AH, 2016, BIOMED CHROMATOGR, V30, P7, DOI 10.1002/bmc.3453
   Zhang AH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/354671
   Zhang AH, 2014, J SEP SCI, V37, P1742, DOI 10.1002/jssc.201400105
   Zhang AH, 2013, EUR J MED CHEM, V63, P570, DOI 10.1016/j.ejmech.2012.12.062
   Zhang AH, 2010, PLANTA MED, V76, P2026, DOI 10.1055/s-0030-1250542
   Zhang TL, 2016, CRIT REV ANAL CHEM, V46, P342, DOI 10.1080/10408347.2015.1079475
   Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774
   Zhao QQ, 2016, RSC ADV, V6, P112534, DOI 10.1039/c6ra24267g
NR 130
TC 40
Z9 40
U1 1
U2 20
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 2046-2069
J9 RSC ADV
JI RSC Adv.
PY 2018
VL 8
IS 74
BP 42380
EP 42389
DI 10.1039/c8ra08094a
PG 10
WC Chemistry, Multidisciplinary
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Chemistry
GA HG2ZP
UT WOS:000454838000015
PM 35558413
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Ryu, G
   Kim, H
   Koh, A
AF Ryu, Gaeun
   Kim, Hyojin
   Koh, Ara
TI Approaching precision medicine by tailoring the microbiota
SO MAMMALIAN GENOME
LA English
DT Article
ID DEOXYCHOLIC-ACID CONCENTRATION; COLONIC BACTERIAL COMPOSITION;
   METAGENOME-WIDE ASSOCIATION; HUMAN GUT MICROBIOTA; SECONDARY BILE-ACID;
   CHAIN FATTY-ACIDS; PARKINSONS-DISEASE; BREAST-CANCER; INTESTINAL
   MICROBIOTA; AKKERMANSIA-MUCINIPHILA
AB Accumulating evidence has revealed the link between the microbiota and various human diseases. Advances in high-throughput sequencing technologies have identified some consistent disease-associated microbial features, leading to the emerging concept of microbiome-based therapeutics. However, it is also becoming clear that there are considerable variations in the microbiota among patients with the same disease. Variations in the microbial composition and function contribute to substantial differences in metabolic status of the host via production of a myriad of biochemically and functionally different microbial metabolites. Indeed, compelling evidence indicates that individuality of the microbiome may result in individualized responses to microbiome-based therapeutics and other interventions. Mechanistic understanding of the role of the microbiota in diseases and drug metabolism would help us to identify causal relationships and thus guide the development of microbiome-based precision or personalized medicine. In this review, we provide an overview of current efforts to use microbiome-based interventions for the treatment of diseases such as cancer, neurological disorders, and diabetes to approach precision medicine.
C1 [Ryu, Gaeun; Kim, Hyojin; Koh, Ara] Sungkyunkwan Univ SKKU, Sch Med, Dept Precis Med, Suwon 16419, South Korea.
   [Koh, Ara] Samsung Med Ctr, Samsung Biomed Res Inst, Seoul 06351, South Korea.
C3 Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Samsung
   Medical Center
RP Koh, A (corresponding author), Sungkyunkwan Univ SKKU, Sch Med, Dept Precis Med, Suwon 16419, South Korea.; Koh, A (corresponding author), Samsung Med Ctr, Samsung Biomed Res Inst, Seoul 06351, South Korea.
EM arakoh@g.skku.edu
OI Koh, Ara/0000-0001-7673-034X
FU National Research Foundation of Korea (NRF) - Korea government (MSIT)
   [2020R1C1C1003241]; POSCO Science Fellowship of POSCO TJ Park Foundation
FX The authors are grateful to Rosie Perkins for editing the manuscript.
   This work is supported by the National Research Foundation of Korea
   (NRF) grant funded by the Korea government (MSIT) (No. 2020R1C1C1003241)
   and by POSCO Science Fellowship of POSCO TJ Park Foundation.
CR Alanee S, 2019, PROSTATE, V79, P81, DOI 10.1002/pros.23713
   Andreux PA, 2019, NAT METAB, V1, P595, DOI 10.1038/s42255-019-0073-4
   Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08
   Arora T, 2016, MOL METAB, V5, P725, DOI 10.1016/j.molmet.2016.06.006
   Baldini F, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00775-7
   Baldwin C, 2010, NUTR CANCER, V62, P371, DOI 10.1080/01635580903407197
   Barrett E, 2012, J APPL MICROBIOL, V113, P411, DOI 10.1111/j.1365-2672.2012.05344.x
   BAYERDORFFER E, 1993, GASTROENTEROLOGY, V104, P145, DOI 10.1016/0016-5085(93)90846-5
   Bedarf JR, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0428-y
   Bhatt AP, 2020, P NATL ACAD SCI USA, V117, P7374, DOI 10.1073/pnas.1918095117
   Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043
   Boertien JM, 2019, J PARKINSON DIS, V9, pS297, DOI 10.3233/JPD-191711
   Cammarota G, 2020, NAT REV GASTRO HEPAT, V17, P635, DOI 10.1038/s41575-020-0327-3
   Cao HL, 2017, INT J CANCER, V140, P2545, DOI 10.1002/ijc.30643
   Cao HL, 2014, FAM CANCER, V13, P563, DOI 10.1007/s10689-014-9742-3
   Espin JC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/270418
   Cattaneo A, 2017, NEUROBIOL AGING, V49, P60, DOI 10.1016/j.neurobiolaging.2016.08.019
   Cerda B, 2005, J AGR FOOD CHEM, V53, P5571, DOI 10.1021/jf050384i
   Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825
   Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108
   Cheng ZY, 2018, J NUTR BIOCHEM, V54, P1, DOI 10.1016/j.jnutbio.2017.10.004
   Costarelli V, 2002, EUR J CLIN NUTR, V56, P925, DOI 10.1038/sj.ejcn.1601396
   Daillere R, 2016, IMMUNITY, V45, P931, DOI 10.1016/j.immuni.2016.09.009
   Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107
   Devlin AS, 2016, CELL HOST MICROBE, V20, P709, DOI 10.1016/j.chom.2016.10.021
   Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661
   Dunn AR, 2019, NEUROSCI BIOBEHAV R, V103, P73, DOI 10.1016/j.neubiorev.2019.06.018
   Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110
   Febvre HP, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030666
   Feng J, 2019, INT J CANCER, V144, P2728, DOI 10.1002/ijc.32007
   Frankel AE, 2017, NEOPLASIA, V19, P848, DOI 10.1016/j.neo.2017.08.004
   Friedman GD, 2006, CANCER EPIDEM BIOMAR, V15, P2102, DOI 10.1158/1055-9965.EPI-06-0401
   Gao JJ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00202
   Gao ZG, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00020
   Geller LT, 2017, SCIENCE, V357, P1156, DOI 10.1126/science.aah5043
   Gerhardt S, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060708
   Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517
   Goedert JJ, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv147
   Golombos DM, 2018, UROLOGY, V111, P122, DOI 10.1016/j.urology.2017.08.039
   Golubeva AV, 2017, EBIOMEDICINE, V24, P166, DOI 10.1016/j.ebiom.2017.09.020
   Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236
   Haiser HJ, 2013, SCIENCE, V341, P295, DOI 10.1126/science.1235872
   Half E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53041-4
   Haro C, 2016, J CLIN ENDOCR METAB, V101, P232, DOI 10.1210/jc.2015-3351
   Hashim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112330
   Heintz-Buschart A, 2018, MOVEMENT DISORD, V33, P88, DOI 10.1002/mds.27105
   Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942
   Hopfner F, 2017, BRAIN RES, V1667, P41, DOI 10.1016/j.brainres.2017.04.019
   Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024
   Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527
   Isabella VM, 2018, NAT BIOTECHNOL, V36, P857, DOI 10.1038/nbt.4222
   Jia LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07335-0
   Johnson AJ, 2019, CELL HOST MICROBE, V25, P789, DOI 10.1016/j.chom.2019.05.005
   Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198
   Kato S, 2017, CLIN EXP PHARMACOL P, V44, P1017, DOI 10.1111/1440-1681.12792
   Kawano A, 2010, ASIAN PAC J CANCER P, V11, P1541
   Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307
   Khanna S, 2016, J INFECT DIS, V214, P173, DOI 10.1093/infdis/jiv766
   Kim YS, 2017, EXP NEUROBIOL, V26, P122, DOI 10.5607/en.2017.26.3.122
   Koh A, 2020, CELL METAB, V32, P643, DOI 10.1016/j.cmet.2020.07.012
   Koh A, 2020, MOL CELL, V78, P584, DOI 10.1016/j.molcel.2020.03.005
   Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055
   Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041
   Kootte RS, 2017, CELL METAB, V26, P611, DOI 10.1016/j.cmet.2017.09.008
   Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007
   KOVACS T, 2019, SCI REP-UK
   Lankelma JM, 2017, GUT, V66, P1623, DOI 10.1136/gutjnl-2016-312132
   Lawrence MS, 2014, NATURE, V505, P495, DOI 10.1038/nature12912
   Li W, 2017, SCI CHINA LIFE SCI, V60, P1223, DOI 10.1007/s11427-016-9001-4
   Lin AQ, 2018, PARKINSONISM RELAT D, V53, P82, DOI 10.1016/j.parkreldis.2018.05.007
   Lin CH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1528-y
   Lin XB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039764
   Liss MA, 2018, EUR UROL, V74, P575, DOI 10.1016/j.eururo.2018.06.033
   Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003
   Liu FT, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0389-6
   Liu P, 2019, BRAIN BEHAV IMMUN, V80, P633, DOI 10.1016/j.bbi.2019.05.008
   Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358
   Liu Y, 2020, CELL METAB, V31, P77, DOI 10.1016/j.cmet.2019.11.001
   Luna RA, 2017, CELL MOL GASTROENTER, V3, P218, DOI 10.1016/j.jcmgh.2016.11.008
   Ma WC, 2017, ENGINEERING, V3, P308, DOI 10.1016/J.ENG.2017.03.012
   Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290
   Miko E, 2018, BBA-BIOENERGETICS, V1859, P958, DOI 10.1016/j.bbabio.2018.04.002
   Miller-Fleming L, 2015, J MOL BIOL, V427, P3389, DOI 10.1016/j.jmb.2015.06.020
   Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P945, DOI 10.1097/00042737-200108000-00012
   Miyamoto J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11978-0
   Mo ZC, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00138-20
   Mukherjee S, 2019, CANCER BIOTHER RADIO, V34, P487, DOI 10.1089/cbr.2018.2758
   Natividad JM, 2018, CELL METAB, V28, P737, DOI 10.1016/j.cmet.2018.07.001
   Neff T, 1996, EXP HEMATOL, V24, P1340
   Niehues M, 2009, J PHARM PHARMACOL, V61, P1303, DOI 10.1211/jpp/61.10.0005
   NUSSINOV R, 2019, PLOS COMPUT BIOL, V15
   Onesti CE, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1984-2
   Pai R, 2004, MOL BIOL CELL, V15, P2156, DOI 10.1091/mbc.E03-12-0894
   Panebianco C, 2018, CANCER CHEMOTH PHARM, V81, P773, DOI 10.1007/s00280-018-3549-0
   Payne CM, 2009, J TOXICOL-US, V2009, DOI 10.1155/2009/785907
   Petrov VA, 2017, B EXP BIOL MED+, V162, P734, DOI 10.1007/s10517-017-3700-7
   Pietrucci D, 2019, PARKINSONISM RELAT D, V65, P124, DOI 10.1016/j.parkreldis.2019.06.003
   Ponziani FR, 2019, HEPATOLOGY, V69, P107, DOI 10.1002/hep.30036
   Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134
   Qian YW, 2018, BRAIN BEHAV IMMUN, V70, P194, DOI 10.1016/j.bbi.2018.02.016
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Rekdal VM, 2019, SCIENCE, V364, P1055, DOI 10.1126/science.aau6323
   Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084
   Ren ZG, 2017, ONCOTARGET, V8, P95176, DOI 10.18632/oncotarget.18820
   Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008
   Robert S, 2014, DIABETES, V63, P2876, DOI 10.2337/db13-1236
   Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973
   Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706
   Rubinstein MR, 2019, EMBO REP, V20, DOI 10.15252/embr.201847638
   Rubinstein MR, 2013, CELL HOST MICROBE, V14, P195, DOI 10.1016/j.chom.2013.07.012
   Ryu D, 2016, NAT MED, V22, P879, DOI 10.1038/nm.4132
   Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018
   Sanchez-Alcoholado L, 2020, CANCERS, V12, DOI 10.3390/cancers12061406
   Sari Z, 2020, PHYSIOL INT, V107, P349, DOI 10.1556/2060.2020.00016
   Sari Z, 2020, CANCERS, V12, DOI 10.3390/cancers12092411
   Sarker SA, 2016, ANN NY ACAD SCI, V1372, P42, DOI 10.1111/nyas.13087
   Sausset R, 2020, MUCOSAL IMMUNOL, V13, P205, DOI 10.1038/s41385-019-0250-5
   Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069
   Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020
   Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185
   Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z
   Sharon G, 2019, CELL, V177, P1600, DOI 10.1016/j.cell.2019.05.004
   Shen L, 2020, MICROB CELL FACT, V19, DOI 10.1186/s12934-020-01313-4
   Shin NR, 2014, GUT, V63, P727, DOI 10.1136/gutjnl-2012-303839
   Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007
   Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255
   Strandwitz P, 2019, NAT MICROBIOL, V4, P396, DOI 10.1038/s41564-018-0307-3
   Strandwitz P, 2018, BRAIN RES, V1693, P128, DOI 10.1016/j.brainres.2018.03.015
   SUEZ J, 2018, CELL
   SUMMERTON J, 1985, DIGESTION, V31, P77, DOI 10.1159/000199183
   Sun LL, 2018, NAT MED, V24, P1919, DOI 10.1038/s41591-018-0222-4
   Sun MF, 2018, BRAIN BEHAV IMMUN, V70, P48, DOI 10.1016/j.bbi.2018.02.005
   Sutton TDS, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00784
   T P Aneesh, 2009, J Clin Med Res, V1, P191, DOI 10.4021/jocmr2009.08.1255
   Tamim HM, 2008, PHARMACOEPIDEM DR S, V17, P144, DOI 10.1002/pds.1512
   Thomas AM, 2019, NAT MED, V25, P667, DOI 10.1038/s41591-019-0405-7
   Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019
   van Kessel SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08294-y
   van Vliet MJ, 2009, CLIN INFECT DIS, V49, P262, DOI 10.1086/599346
   Vande Voorde J, 2014, J BIOL CHEM, V289, P13054, DOI 10.1074/jbc.M114.558924
   Vatanen T, 2018, NATURE, V562, P589, DOI 10.1038/s41586-018-0620-2
   Velicer CM, 2004, JAMA-J AM MED ASSOC, V291, P827, DOI 10.1001/jama.291.7.827
   Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329
   Viaud S, 2013, SCIENCE, V342, P971, DOI 10.1126/science.1240537
   Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y
   Vrieze A, 2014, J HEPATOL, V60, P824, DOI 10.1016/j.jhep.2013.11.034
   Wang J, 2016, NAT REV MICROBIOL, V14, P508, DOI 10.1038/nrmicro.2016.83
   Wang L, 2011, APPL ENVIRON MICROB, V77, P6718, DOI 10.1128/AEM.05212-11
   Wang ZN, 2015, CELL, V163, P1585, DOI 10.1016/j.cell.2015.11.055
   Williams BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024585
   Wlodarska M, 2017, CELL HOST MICROBE, V22, P25, DOI 10.1016/j.chom.2017.06.007
   Wu H, 2020, CELL METAB, V32, P379, DOI 10.1016/j.cmet.2020.06.011
   Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345
   Wu PL, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000014474
   WU S, 2018, NAT COMMUN
   Wu Y, 2020, IDENTIFICATION MICRO
   Xuan CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083744
   Yu J, 2017, GUT, V66, P70, DOI 10.1136/gutjnl-2015-309800
   Yu TC, 2017, CELL, V170, P548, DOI 10.1016/j.cell.2017.07.008
   Zeevi D, 2015, CELL, V163, P1079, DOI 10.1016/j.cell.2015.11.001
   Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003
   Zeller G, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145645
   Zhang JM, 2019, ENDOCRINE, V64, P564, DOI 10.1007/s12020-018-1831-x
   Zhang X, 2015, SCI REP-UK, V5, DOI 10.1038/srep14405
   Zhao LP, 2018, SCIENCE, V359, P1151, DOI 10.1126/science.aao5774
   Zheng Y, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0650-9
   Zhu J, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0515-3
   Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172
   Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176
   Zimmermann M, 2019, NATURE, V570, P462, DOI 10.1038/s41586-019-1291-3
NR 170
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0938-8990
EI 1432-1777
J9 MAMM GENOME
JI Mamm. Genome
PD AUG
PY 2021
VL 32
IS 4
SI SI
BP 206
EP 222
DI 10.1007/s00335-021-09859-3
EA MAR 2021
PG 17
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA TM2SJ
UT WOS:000623778400001
PM 33646347
DA 2022-11-22
ER

PT J
AU Wang, GF
   Cong, DY
   Ju, HY
   Sun, JB
   Li, CZ
   Zhang, ZP
   Chu, YJ
   Wu, XQ
AF Wang, Gaofeng
   Cong, Deyu
   Ju, Hongyu
   Sun, Jiabao
   Li, Chaozheng
   Zhang, Zepeng
   Chu, Yunjie
   Wu, Xingquan
TI Community intervention study of viscera massage in overweight/obese type
   2 diabetes high-risk population
SO MEDICINE
LA English
DT Article
DE abdominal massage; community intervention study; gut microbiota;
   prediabetes; viscera massage
ID GUT MICROBIOTA; MECHANICAL MASSAGE; ABDOMINAL MASSAGE; MANAGEMENT
AB Background: Prediabetes is an intermediate metabolic state between normoglycemia and diabetes. Without intervention, prediabetes often progresses to diabetes and prediabetes is associated with increased risk of cardiovascular disease, cancer, renal disease, and dementia. Lifestyle modification play a major role in controlling prediabetes. But lifestyle interventions are often with poor compliance and side effects of drugs are often be dislike by people. As a non-invasive therapy with no side effects, abdominal massage (AM), also called viscera massage in China, has been used to treat prediabetes and obesity-associated diseases. The gut microbiota has been recognized as an important factor in the development of metabolic diseases. Individuals with prediabetes have aberrant intestinal microbiota character. Colonic transport time and stool consistency are strongly associated with gut microbiota. Viscera massage can ease constipation by reducing colonic transport time and promoting intestinal motility. We can infer that viscera massage can modulate composition of gut microbiota affects human metabolism. So, in this trial, we will explore the mechanism of viscera massage on prediabetes from the perspective of intestinal microbiota. Methods and design: Eighty prediabetes individuals will be recruited for this study. Eighty prediabetes individuals will be divided into lifestyle intervention group and viscera massage + lifestyle intervention group by a simple random method. Each group will have 40 individuals. The manipulation of the viscera massage + lifestyle intervention group will be mainly carried out through rubbing the abdomen, kneading abdomen, vibrating abdomen, and pressing the abdomen, 30 minutes per time, once a day, with 2 days off every 5 days. Lifestyle interventions will be performed by combining pushing healthy lifestyle guidance information through Wechat application and giving face-to-face advice together daily. The lifestyle intervention group will receive healthy lifestyle intervention only. All the intervention will be conducted for 4 weeks. Weight, body mass index (BMI), waist circumference, waist-to-hip ratio, and waist-to-height ratio will be measured at the last day of every week. Triglycerides, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, fasting blood-glucose, 2-hour post-meal blood glucose (2hPG) and glycosylated hemoglobin, fasting insulin and insulin resistance index will be tested at the first day and last day of the intervention course. The fecal samples of subjects will be gathered at the first day and last day of the intervention course and will be performed 16S rRNA gene sequencing and metagenomic detection. Finally, the effect and potential mechanism of viscera massage on prediabetes will be discussed in combination with all the results. Discussion: The results of this study will be used to verify the effect of AM on prediabetes and explore the mechanism of AM on prediabetes from the perspective of gut microbiota.
C1 [Wang, Gaofeng; Sun, Jiabao; Zhang, Zepeng] Changchun Univ Chinese Med, Coll Acupuncture & Tuina, Changchun, Jilin, Peoples R China.
   [Wang, Gaofeng] Baicheng Med Coll, Dept Hlth Management, Baicheng, Jilin, Peoples R China.
   [Cong, Deyu; Chu, Yunjie; Wu, Xingquan] Changchun Univ Chinese Med, Dept Tuina, Affiliated Hosp, Changchun, Jilin, Peoples R China.
   [Ju, Hongyu] Baicheng Municipal Hosp, Dept Endocrine & Metab Dis, Baicheng, Jilin, Peoples R China.
   [Li, Chaozheng] Changchun Univ Chinese Med, Coll Tradit Chinese Med, Changchun, Jilin, Peoples R China.
C3 Changchun University of Chinese Medicine; Changchun University of
   Chinese Medicine; Changchun University of Chinese Medicine
RP Wu, XQ (corresponding author), Changchun Univ Chinese Med, Dept Tuina, Affiliated Hosp, Changchun, Jilin, Peoples R China.; Wu, XQ (corresponding author), Changchun Univ Chinese Med, Jilin Prov Hosp Chinese Med, Affiliated Hosp 1, Changchun, Peoples R China.
EM wuxingquan2005@163.com
FU National Key Research and Development Program [2019YFC1709904];
   Education Department of Jilin Province [JJKH20210959KJ]; Health and
   Health Technology Innovation Project of Jilin Province [2020J065];
   Postdoctoral Research program of Jilin Province [[2020]498]; Science and
   Technology Development Plan of Jilin Province [20200403124SF]
FX Ethical approval and participation License: The proposal was approved by
   the Ethics Committee of Affiliated Hospital of Changchun University of
   Traditional Chinese Medicine (CCZYFYLL2021 Standard word -002), and this
   project was funded by National Key Research and Development Program
   (2019YFC1709904), Education Department of Jilin Province
   (JJKH20210959KJ), Health and Health Technology Innovation Project of
   Jilin Province (2020J065), Postdoctoral Research program of Jilin
   Province ([2020]498), and Science and Technology Development Plan of
   Jilin Province (20200403124SF).
CR Allen JM, 2018, MED SCI SPORT EXER, V50, P747, DOI [10.1249/MSS.0000000000001495, 10.1249/mss.0000000000001495]
   Allin KH, 2018, DIABETOLOGIA, V61, P810, DOI 10.1007/s00125-018-4550-1
   [Anonymous], 2021, INT J CLIN PRACT, V75
   Boey GE, 2014, LASER SURG MED, V46, P20, DOI 10.1002/lsm.22209
   Brightman L, 2009, LASER SURG MED, V41, P791, DOI 10.1002/lsm.20872
   Busnelli M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10091249
   Canfora EE, 2019, NAT REV ENDOCRINOL, V15, P261, DOI 10.1038/s41574-019-0156-z
   Chen XP, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1104-3
   Dehghan M, 2020, COMPLEMENT THER MED, V54, DOI 10.1016/j.ctim.2020.102553
   Edwards CM, 2016, ENDOCRIN METAB CLIN, V45, P751, DOI 10.1016/j.ecl.2016.06.007
   Ferrannini E, 2011, MED CLIN N AM, V95, P327, DOI 10.1016/j.mcna.2010.11.005
   Foster KW, 2008, J DRUGS DERMATOL, V7, P113
   Gomes AC, 2018, GUT MICROBES, V9, P308, DOI 10.1080/19490976.2018.1465157
   Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002
   Guevara-Cruz M, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012401
   [国生 Guo Sheng], 2019, [中华中医药杂志, China Journal of Traditional Chinese Medicine and Pharmacy], V34, P861
   Huang YL, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5953
   Lamas K, 2009, INT J NURS STUD, V46, P759, DOI 10.1016/j.ijnurstu.2009.01.007
   Lee KJ, 2021, ANN MED SURG, V63, DOI 10.1016/j.amsu.2021.01.005
   Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7
   Mirasol R, 2017, J ASEAN FED ENDOCR S, V32, P6, DOI 10.15605/jafes.032.01.02
   Patterson E, 2016, POSTGRAD MED J, V92, P286, DOI 10.1136/postgradmedj-2015-133285
   Roager HM, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.93, 10.1038/nmicrobiol.2016.93]
   Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9
   Tunay VB, 2010, J EUR ACAD DERMATOL, V24, P138, DOI 10.1111/j.1468-3083.2009.03355.x
   Vandeputte D, 2016, GUT, V65, P57, DOI 10.1136/gutjnl-2015-309618
   Vikram NK, 2016, METAB SYNDR RELAT D, V14, P492, DOI 10.1089/met.2016.0041
   Wang K., 2017, GLOBAL TRAD CHIN MED, V10, P1324
   Wang K., 2018, WORLD J TRAD CHIN ME, V13, P3108
   Wasserman DH, 2018, CIRC RES, V122, P1135, DOI 10.1161/CIRCRESAHA.118.311912
   Xue T., 2019, EFF ABD MASS THER IN
   Zhou WY, 2019, NATURE, V569, P663, DOI 10.1038/s41586-019-1236-x
   中华医学会内分泌学分会, 2020, [中华内分泌代谢杂志, Chinese Journal of Endocrinology and Metabolism], V36, P371
NR 33
TC 2
Z9 2
U1 7
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD DEC 3
PY 2021
VL 100
IS 48
AR e27932
DI 10.1097/MD.0000000000027932
PG 6
WC Medicine, General & Internal
WE Science Citation Index Expanded (SCI-EXPANDED)
SC General & Internal Medicine
GA XH9CB
UT WOS:000725722600056
PM 35049196
OA gold, Green Published
DA 2022-11-22
ER

PT J
AU Ogino, S
   Nishihara, R
   Vander Weele, TJ
   Wang, ML
   Nishi, A
   Lochhead, P
   Qian, ZR
   Zhang, XH
   Wu, KN
   Nan, HM
   Yoshida, K
   Milner, DA
   Chan, AT
   Field, AE
   Camargo, CA
   Williams, MA
   Giovannucci, EL
AF Ogino, Shuji
   Nishihara, Reiko
   Vander Weele, Tyler J.
   Wang, Molin
   Nishi, Akihiro
   Lochhead, Paul
   Qian, Zhi Rong
   Zhang, Xuehong
   Wu, Kana
   Nan, Hongmei
   Yoshida, Kazuki
   Milner, Danny A., Jr.
   Chan, Andrew T.
   Field, Alison E.
   Camargo, Carlos A., Jr.
   Williams, Michelle A.
   Giovannucci, Edward L.
TI The Role of Molecular Pathological Epidemiology in the Study of
   Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine
SO EPIDEMIOLOGY
LA English
DT Review
ID ISLAND METHYLATOR PHENOTYPE; COLORECTAL-CANCER RISK; LIFE-STYLE FACTORS;
   BODY-MASS INDEX; MICROSATELLITE INSTABILITY; CLINICOPATHOLOGICAL
   FACTORS; CELLULAR-METABOLISM; FAMILY-HISTORY; KRAS MUTATION; ASPIRIN USE
AB Molecular pathology diagnostics to subclassify diseases based on pathogenesis are increasingly common in clinical translational medicine. Molecular pathological epidemiology (MPE) is an integrative transdisciplinary science based on the unique disease principle and the disease continuum theory. While it has been most commonly applied to research on breast, lung, and colorectal cancers, MPE can investigate etiologic heterogeneity in non-neoplastic diseases, such as cardiovascular diseases, obesity, diabetes mellitus, drug toxicity, and immunity-related and infectious diseases. This science can enhance causal inference by linking putative etiologic factors to specific molecular biomarkers as outcomes. Technological advances increasingly enable analyses of various -omics, including genomics, epigenomics, transcriptomics, proteomics, metabolomics, metagenomics, microbiome, immunomics, interactomics, etc. Challenges in MPE include sample size limitations (depending on availability of biospecimens or biomedical/radiological imaging), need for rigorous validation of molecular assays and study findings, and paucities of interdisciplinary experts, education programs, international forums, and standardized guidelines. To address these challenges, there are ongoing efforts such as multidisciplinary consortium pooling projects, the International Molecular Pathological Epidemiology Meeting Series, and the Strengthening the Reporting of Observational Studies in Epidemiology-MPE guideline project. Efforts should be made to build biorepository and biobank networks, and worldwide population-based MPE databases. These activities match with the purposes of the Big Data to Knowledge (BD2K), Genetic Associations and Mechanisms in Oncology (GAME-ON), and Precision Medicine Initiatives of the United States National Institute of Health. Given advances in biotechnology, bioinformatics, and computational/systems biology, there are wide open opportunities in MPE to contribute to public health.
C1 [Ogino, Shuji; Nishihara, Reiko; Vander Weele, Tyler J.; Wang, Molin; Yoshida, Kazuki; Field, Alison E.; Camargo, Carlos A., Jr.; Williams, Michelle A.; Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA.
   [Ogino, Shuji] Brigham & Womens Hosp, Div MPE Mol Pathol Epidemiol, 450 Brookline Ave,Room M422, Boston, MA 02215 USA.
   [Ogino, Shuji; Milner, Danny A., Jr.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA.
   [Ogino, Shuji; Nishihara, Reiko; Qian, Zhi Rong; Zhang, Xuehong; Yoshida, Kazuki; Milner, Danny A., Jr.; Chan, Andrew T.; Field, Alison E.; Camargo, Carlos A., Jr.; Giovannucci, Edward L.] Harvard Med Sch, Boston, MA USA.
   [Ogino, Shuji; Nishihara, Reiko; Qian, Zhi Rong] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.
   [Nishihara, Reiko; Wu, Kana; Giovannucci, Edward L.] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA USA.
   [Nishihara, Reiko; Vander Weele, Tyler J.; Wang, Molin] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA.
   [Nishi, Akihiro] Yale Univ, Yale Inst Network Sci, New Haven, CT USA.
   [Lochhead, Paul] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland.
   [Lochhead, Paul; Chan, Andrew T.] Massachusetts Gen Hosp, Div Gastroenterol, Boston, MA 02114 USA.
   [Zhang, Xuehong; Chan, Andrew T.; Field, Alison E.; Camargo, Carlos A., Jr.; Giovannucci, Edward L.] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.
   [Nan, Hongmei] Indiana Univ, Melvin & Bren Simon Canc Ctr, Richard M Fairbanks Sch Publ, Dept Epidemiol, Indianapolis, IN 46204 USA.
   [Yoshida, Kazuki] Brigham & Womens Hosp, Dept Med, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.
   [Milner, Danny A., Jr.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA.
   [Field, Alison E.] Boston Childrens Hosp, Div Adolescent Young Adult Med, Boston, MA USA.
   [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA.
C3 Harvard University; Harvard T.H. Chan School of Public Health; Harvard
   University; Brigham & Women's Hospital; Harvard University; Brigham &
   Women's Hospital; Harvard University; Harvard Medical School; Harvard
   University; Dana-Farber Cancer Institute; Harvard University; Harvard
   T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan
   School of Public Health; Yale University; University of Aberdeen;
   Harvard University; Massachusetts General Hospital; Harvard University;
   Brigham & Women's Hospital; Indiana University System; Indiana
   University-Purdue University Indianapolis; Harvard University; Brigham &
   Women's Hospital; Harvard University; Harvard T.H. Chan School of Public
   Health; Harvard University; Boston Children's Hospital; Harvard
   University; Massachusetts General Hospital
RP Ogino, S (corresponding author), Brigham & Womens Hosp, Div MPE Mol Pathol Epidemiol, 450 Brookline Ave,Room M422, Boston, MA 02215 USA.
EM shuji_ogino@dfci.harvard.edu
RI ; Camargo, Carlos/C-2145-2008
OI Ogino, Shuji/0000-0002-3909-2323; Nishi, Akihiro/0000-0003-1629-5985;
   Milner, Jr, Danny Arnold/0000-0002-6685-8208; Camargo,
   Carlos/0000-0002-5071-7654; Yoshida, Kazuki/0000-0002-2030-3549
FU USA National Institute of Health (NIH) [R35 CA197735, R01 CA151993, K07
   CA190673, R01 CA137178, K24 DK098311]; Japan Society for Promotion of
   Science; NATIONAL CANCER INSTITUTE [R01CA151993, K07CA190673,
   R01CA137178, R35CA197735] Funding Source: NIH RePORTER; NATIONAL CENTER
   FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001108] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY
   DISEASES [K24DK098311] Funding Source: NIH RePORTER
FX Supported by grants from the USA National Institute of Health (NIH) (R35
   CA197735 [to SO], R01 CA151993 [to SO], K07 CA190673 [to RN], R01
   CA137178 [to ATC], and K24 DK098311 [to ATC]). AN was supported by a
   Fellowship Grant from Japan Society for Promotion of Science. PL is a
   Scottish Government Clinical Academic Fellow. ATC is Damon Runyon
   Clinical Investigator. The content is solely the responsibility of the
   authors and does not necessarily represent the official views of NIH.
   Funding agencies did not have any role in the decision to submit the
   manuscript for publication, or the writing of the manuscript.
CR Abbenhardt C, 2013, INT J MOL EPIDEMIOL, V4, P140
   Alvarez MC, 2013, WORLD J GASTROENTERO, V19, P3043, DOI 10.3748/wjg.v19.i20.3043
   Amirian ES, 2013, INFECT AGENTS CANCER, V8, DOI 10.1186/1750-9378-8-42
   Araujo RF, 2013, PATHOL RES PRACT, V209, P753, DOI 10.1016/j.prp.2013.08.007
   Bae JM, 2013, BRIT J CANCER, V109, P1004, DOI 10.1038/bjc.2013.430
   Begg CB, 2015, CANCER MED-US, V4, P1432, DOI 10.1002/cam4.456
   Bishehsari F, 2014, WORLD J GASTROENTERO, V20, P6055, DOI 10.3748/wjg.v20.i20.6055
   Brandstedt J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-371
   Buchanan DD, 2013, CANCER EPIDEM BIOMAR, V22, P917, DOI 10.1158/1055-9965.EPI-12-1211
   Burnett-Hartman AN, 2013, CANCER RES, V73, P2863, DOI 10.1158/0008-5472.CAN-12-3462
   Caiazza F, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00019
   Campbell PT, 2015, CANCER EPIDEM BIOMAR, V24, P1229, DOI 10.1158/1055-9965.EPI-15-0094
   Campbell PT, 2014, CANCER EPIDEM BIOMAR, V23, P2694, DOI 10.1158/1055-9965.EPI-14-0541
   Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208
   Chan AT, 2009, JAMA-J AM MED ASSOC, V302, P649, DOI 10.1001/jama.2009.1112
   Chatterjee N, 2010, BIOMETRIKA, V97, P683, DOI 10.1093/biomet/asq036
   Chia WK, 2012, NAT REV CLIN ONCOL, V9, P561, DOI 10.1038/nrclinonc.2012.137
   Cisyk AL, 2015, NEOPLASIA, V17, P306, DOI 10.1016/j.neo.2015.02.001
   Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365
   Coppede F, 2014, EXPERT REV GASTROENT, V8, P935, DOI 10.1586/17474124.2014.924397
   Cross AJ, 2014, CANCER-AM CANCER SOC, V120, P3049, DOI 10.1002/cncr.28799
   Curtin Karen, 2011, Patholog Res Int, V2011, P902674, DOI 10.4061/2011/902674
   Dogan S, 2012, CLIN CANCER RES, V18, P6169, DOI 10.1158/1078-0432.CCR-11-3265
   Domingo E, 2013, J CLIN ONCOL, V31, P4297, DOI 10.1200/JCO.2013.50.0322
   Epplein M, 2014, CANCER EPIDEM BIOMAR, V23, P2613, DOI 10.1158/1055-9965.EPI-14-0848
   Esterhuyse MM, 2013, EXPERT REV MOL DIAGN, V13, P625, DOI 10.1586/14737159.2013.811897
   Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137
   Field AE, 2013, JAMA-J AM MED ASSOC, V310, P2147, DOI 10.1001/jama.2013.281501
   Fini L, 2012, COLORECTAL CANC BIOL, P323
   Fink SP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008481
   Galon J, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-205
   Gao C, 2015, AUSTIN J GASTROENTER, V2, P1040
   Gay LJ, 2012, J PATHOL, V228, P405, DOI 10.1002/path.4085
   Hagland HR, 2015, CANCER LETT, V356, P273, DOI 10.1016/j.canlet.2014.02.026
   Hagland HR, 2013, DIGEST SURG, V30, P12, DOI 10.1159/000347166
   Haque TR, 2014, DIGEST DIS SCI, V59, P2874, DOI 10.1007/s10620-014-3277-1
   Hoffmeister M, 2013, CANCER EPIDEM BIOMAR, V22, P2303, DOI 10.1158/1055-9965.EPI-13-0239
   Hughes LAE, 2013, CANCER RES, V73, P5858, DOI 10.1158/0008-5472.CAN-12-4306
   Hughes LAE, 2012, INT J EPIDEMIOL, V41, P1060, DOI 10.1093/ije/dys055
   Hughes LAE, 2012, BBA-REV CANCER, V1825, P77, DOI 10.1016/j.bbcan.2011.10.005
   Hughes LAE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018571
   Huser V, 2014, PHARMACOGN PERS MED, V7, P275, DOI 10.2147/PGPM.S49904
   Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V310, P2401, DOI 10.1001/jama.2013.280927
   Iwagami S, 2012, ANN SURG ONCOL, V19, P2726, DOI 10.1245/s10434-011-2176-3
   Jacobs RJ, 2012, CURR OPIN PHARMACOL, V12, P690, DOI 10.1016/j.coph.2012.07.010
   Koshiol J, 2012, ANN EPIDEMIOL, V22, P520, DOI 10.1016/j.annepidem.2012.03.001
   Ku CS, 2012, MODERN PATHOL, V25, P1055, DOI 10.1038/modpathol.2012.62
   Kuller LH, 2013, AM J EPIDEMIOL, V178, P1350, DOI 10.1093/aje/kwt239
   Lee JE, 2011, CANCER PREV RES, V4, P1808, DOI 10.1158/1940-6207.CAPR-11-0113
   Li PW, 2015, GUT, V64, P1419, DOI 10.1136/gutjnl-2014-308260
   Liao XY, 2012, NEW ENGL J MED, V367, P1596, DOI 10.1056/NEJMoa1207756
   Limburg PJ, 2012, CANCER EPIDEM BIOMAR, V21, P681, DOI 10.1158/1055-9965.EPI-11-1168
   Lin JH, 2014, CURR COLORECT CANC R, V10, P94, DOI 10.1007/s11888-014-0208-7
   Lochhead P, 2015, MODERN PATHOL, V28, P14, DOI 10.1038/modpathol.2014.81
   Lochhead P, 2014, AM J GASTROENTEROL, V109, P1205, DOI 10.1038/ajg.2014.153
   Mehta AM, 2015, ANAL CELL PATHOL, V2015, DOI 10.1155/2015/367837
   Mikeska T, 2014, GENES-BASEL, V5, P821, DOI 10.3390/genes5030821
   Mima K, 2015, JAMA ONCOL, V1, P653, DOI 10.1001/jamaoncol.2015.1377
   Ng JMK, 2015, INT J MOL SCI, V16, P2472, DOI 10.3390/ijms16022472
   Ng K, 2011, JNCI-J NATL CANCER I, V103, P1540, DOI 10.1093/jnci/djr307
   Nishi A, 2015, AM J PREV MED, V48, P116, DOI 10.1016/j.amepre.2014.09.031
   Nishihara R, 2013, NEW ENGL J MED, V369, P1095, DOI 10.1056/NEJMoa1301969
   Nosho K, 2009, GASTROENTEROLOGY, V137, P1609, DOI 10.1053/j.gastro.2009.08.002
   Ogino S, 2014, ONCOGENE, V33, P2949, DOI 10.1038/onc.2013.244
   Ogino S, 2013, CANCER PREV RES, V6, pCN06
   Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082
   Ogino S, 2015, CANCER CAUSE CONTROL, V26, P959, DOI 10.1007/s10552-015-0596-2
   Ogino S, 2013, MODERN PATHOL, V26, P465, DOI 10.1038/modpathol.2012.214
   Ogino S, 2012, AM J EPIDEMIOL, V176, P659, DOI 10.1093/aje/kws226
   Ogino S, 2012, INT J EPIDEMIOL, V41, P1072, DOI 10.1093/ije/dys076
   Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]
   Ogino S, 2011, NAT REV CLIN ONCOL, V8, P711, DOI 10.1038/nrclinonc.2011.122
   Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182
   Ogino S, 2010, J NATL CANCER I, V102, P365, DOI 10.1093/jnci/djq031
   Rex DK, 2012, AM J GASTROENTEROL, V107, P1315, DOI 10.1038/ajg.2012.161
   Rosner B, 2013, AM J EPIDEMIOL, V178, P296, DOI 10.1093/aje/kws457
   Rosty C, 2013, MODERN PATHOL, V26, P825, DOI 10.1038/modpathol.2012.240
   Ryan BM, 2014, CANCER EPIDEMIOL, V38, P583, DOI 10.1016/j.canep.2014.07.003
   Shaheen NJ, 2014, AM J GASTROENTEROL, V109, P345, DOI 10.1038/ajg.2014.35
   Shanmuganathan R, 2013, J MOL DIAGN, V15, P17, DOI 10.1016/j.jmoldx.2012.06.007
   Simons CCJM, 2014, CANCER EPIDEM BIOMAR, V23, P1852, DOI 10.1158/1055-9965.EPI-13-1285
   Song M., 2015, J NATL CANC I, V107
   Song MY, 2016, GUT, V65, P296, DOI 10.1136/gutjnl-2014-308852
   Spitz MR, 2012, CANCER DISCOV, V2, P1087, DOI 10.1158/2159-8290.CD-12-0424
   Suzuki H, 2014, BIOCHEM BIOPH RES CO, V455, P35, DOI 10.1016/j.bbrc.2014.07.007
   Szylberg L, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/573814
   Tillmans LS, 2015, CANCER EPIDEM BIOMAR, V24, P713, DOI 10.1158/1055-9965.EPI-14-0756
   Tougeron D, 2014, CLIN CANCER RES, V20, P1087, DOI 10.1158/1078-0432.CCR-13-2563
   van Winkel R, 2015, EPIDEMIOL PSYCH SCI, V24, P6, DOI 10.1017/S2045796014000559
   Wang ML, 2015, AM J EPIDEMIOL, V182, P263, DOI 10.1093/aje/kwv040
   Weijenberg Matty P, 2013, Curr Nutr Rep, V2, P19
   Weisenberger DJ, 2015, CANCER EPIDEM BIOMAR, V24, P512, DOI 10.1158/1055-9965.EPI-14-1161
   Wennersten C, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0189-5
   Wild CP, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju353
   Witvliet MI, 2014, AUSTIN J PUBLIC HLTH, V1, pid1012
   Wong EYT, 2015, EXPERT REV ANTICANC, V15, P639, DOI 10.1586/14737140.2015.1038248
   Yamauchi M, 2012, GUT, V61, P794, DOI 10.1136/gutjnl-2012-302014
   Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865
   Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005
   Zhu Y, 2014, BRIT J CANCER, V110, P1359, DOI 10.1038/bjc.2014.6
NR 100
TC 136
Z9 138
U1 9
U2 210
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1044-3983
EI 1531-5487
J9 EPIDEMIOLOGY
JI Epidemiology
PD JUL
PY 2016
VL 27
IS 4
BP 602
EP 611
DI 10.1097/EDE.0000000000000471
PG 10
WC Public, Environmental & Occupational Health
WE Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)
SC Public, Environmental & Occupational Health
GA DR4BX
UT WOS:000379847600026
PM 26928707
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Zheng, JL
   Hoffman, KL
   Chen, JS
   Shivappa, N
   Sood, A
   Browman, GJ
   Dirba, DD
   Hanash, S
   Wei, P
   Hebert, JR
   Petrosino, JF
   Schembre, SM
   Daniel, CR
AF Zheng, Jiali
   Hoffman, Kristi L.
   Chen, Jiun-Sheng
   Shivappa, Nitin
   Sood, Akhil
   Browman, Gladys J.
   Dirba, Danika D.
   Hanash, Samir
   Wei, Peng
   Hebert, James R.
   Petrosino, Joseph F.
   Schembre, Susan M.
   Daniel, Carrie R.
TI Dietary inflammatory potential in relation to the gut microbiome:
   results from a cross-sectional study
SO BRITISH JOURNAL OF NUTRITION
LA English
DT Article
DE Diet; Inflammation; Gut microbiota; Cross-sectional studies; Circulating
   markers
ID COLORECTAL-CANCER; BILE-ACIDS; SP NOV.; ASSOCIATION; PATTERNS;
   NUTRITION; IMPACT; RISK; METABOLITES; EVOLUTION
AB Diet has direct and indirect effects on health through inflammation and the gut microbiome. We investigated total dietary inflammatory potential via the literature-derived index (Dietary Inflammatory Index (DII(R))) with gut microbiota diversity, composition and function. In cancer-free patient volunteers initially approached at colonoscopy and healthy volunteers recruited from the medical centre community, we assessed 16S ribosomal DNA in all subjects who provided dietary assessments and stool samples (n101) and the gut metagenome in a subset of patients with residual fasting blood samples (n34). Associations of energy-adjusted DII scores with microbial diversity and composition were examined using linear regression, permutational multivariate ANOVA and linear discriminant analysis. Spearman correlation was used to evaluate associations of species and pathways with DII and circulating inflammatory markers. Across DII levels,alpha- and beta-diversity did not significantly differ; however,Ruminococcus torques, Eubacterium nodatum, Acidaminococcus intestiniandClostridium leptumwere more abundant in the most pro-inflammatory diet group, whileAkkermansia muciniphilawas enriched in the most anti-inflammatory diet group. With adjustment for age and BMI,R. torques, E. nodatumandA. intestiniremained significantly associated with a more pro-inflammatory diet. In the metagenomic and fasting blood subset,A. intestiniwas correlated with circulating plasminogen activator inhibitor-1, a pro-inflammatory marker (rho = 0 center dot 40), but no associations remained significant upon correction for multiple testing. An index reflecting overall inflammatory potential of the diet was associated with specific microbes, but not overall diversity of the gut microbiome in our study. Findings from this preliminary study warrant further research in larger samples and prospective cohorts.
C1 [Zheng, Jiali; Hoffman, Kristi L.; Chen, Jiun-Sheng; Sood, Akhil; Browman, Gladys J.; Daniel, Carrie R.] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA.
   [Hoffman, Kristi L.; Petrosino, Joseph F.] Baylor Coll Med, Dept Mol Virol & Microbiol, Alkek Ctr Metagenom & Microbiome Res, Houston, TX 77030 USA.
   [Chen, Jiun-Sheng; Wei, Peng; Daniel, Carrie R.] Univ Texas Houston, Grad Sch Biomed Sci Houston, Quantitat Sci Program, Houston, TX 77030 USA.
   [Chen, Jiun-Sheng; Wei, Peng; Daniel, Carrie R.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA.
   [Shivappa, Nitin; Hebert, James R.] Univ South Carolina, Arnold Sch Publ Hlth, Dept Epidemiol & Biostat, Columbia, SC 29208 USA.
   [Sood, Akhil] Univ Texas Med Branch, Internal Med, Galveston, TX 77555 USA.
   [Dirba, Danika D.; Schembre, Susan M.] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Behav Sci, Houston, TX 77030 USA.
   [Hanash, Samir] Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Clin Canc Prevent, Houston, TX 77030 USA.
   [Wei, Peng] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA.
   [Schembre, Susan M.] Univ Arizona, Dept Family & Community Med, Tucson, AZ 85721 USA.
C3 University of Texas System; UTMD Anderson Cancer Center; Baylor College
   of Medicine; University of Texas System; University of Texas Health
   Science Center Houston; University of Texas System; UTMD Anderson Cancer
   Center; University of South Carolina System; University of South
   Carolina Columbia; University of Texas System; University of Texas
   Medical Branch Galveston; University of Texas System; UTMD Anderson
   Cancer Center; University of Texas System; UTMD Anderson Cancer Center;
   University of Texas System; UTMD Anderson Cancer Center; University of
   Arizona
RP Daniel, CR (corresponding author), Univ Texas MD Anderson Canc Ctr, Div Canc Prevent & Populat Sci, Dept Epidemiol, Houston, TX 77030 USA.; Daniel, CR (corresponding author), Univ Texas Houston, Grad Sch Biomed Sci Houston, Quantitat Sci Program, Houston, TX 77030 USA.
EM cdaniel@mdanderson.org
RI Zheng, Jiali/I-5084-2019
OI Zheng, Jiali/0000-0003-1434-2856
FU University of Texas MD Anderson Cancer Center Duncan Family Institute
   for Cancer Prevention and Risk Assessment; American Cancer Society
   [RSG-17-049-01-NEC]; Cancer Prevention and Research Institute of Texas
   [RP170259]; Chandler Cox Foundation; National Cancer Institute Cancer
   Prevention Research Training Program [R25 CA056452, R25 CA057730];
   National Cancer Institute Cancer Center Support Grant [CCSG5P30
   CA016672-37]
FX This work was supported by a grant from The University of Texas MD
   Anderson Cancer Center Duncan Family Institute for Cancer Prevention and
   Risk Assessment (to C. R. D.). The authors were supported by grants from
   the American Cancer Society RSG-17-049-01-NEC (C. R. D.), the Cancer
   Prevention and Research Institute of Texas RP170259 Postdoctoral
   Training Fellowship (J. Z.), Chandler Cox Foundation (S. M. S.), the
   National Cancer Institute Cancer Prevention Research Training Program
   R25 CA056452 (A. S.) and R25 CA057730 (K. L. H.) and the National Cancer
   Institute Cancer Center Support Grant to MD Anderson CCSG5P30
   CA016672-37 Risk, Detection and Outcomes Program (C. R. D., S. H.). The
   funders had no role in the design, analysis or writing of this article.
CR Abstracts from The Academy of Breastfeeding Medicine, 2015, BREASTFEED MED, V10, pS1
   [Anonymous], 2018, OBSTET GYNECOL, V13, pe49
   [Anonymous], 2016, ACTA PHYS SINICA, V65, P63
   Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820
   BLOCK G, 1994, AM J EPIDEMIOL, V139, P1190, DOI 10.1093/oxfordjournals.aje.a116965
   Bowyer RCE, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0455-y
   Candela M, 2014, WORLD J GASTROENTERO, V20, P908, DOI 10.3748/wjg.v20.i4.908
   Cao HL, 2017, INT J CANCER, V140, P2545, DOI 10.1002/ijc.30643
   Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   Daniel CR, 2019, TRENDS CANCER, V5, P521, DOI 10.1016/j.trecan.2019.07.003
   Dao MC, 2016, GUT, V65, P426, DOI 10.1136/gutjnl-2014-308778
   De Filippis F, 2016, GUT, V65, P1812, DOI 10.1136/gutjnl-2015-309957
   de Moraes ACF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00047
   Depommier C, 2019, NAT MED, V25, P1096, DOI 10.1038/s41591-019-0495-2
   Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]
   Finkmann W, 2000, INT J SYST EVOL MICR, V50, P273, DOI 10.1099/00207713-50-1-273
   Flint HJ, 2012, NAT REV GASTRO HEPAT, V9, P577, DOI 10.1038/nrgastro.2012.156
   Flint HJ, 2012, NUTR REV, V70, pS10, DOI 10.1111/j.1753-4887.2012.00499.x
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Garcia-Mantrana I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00890
   Gauthier MS, 2011, BIOCHEM BIOPH RES CO, V404, P382, DOI 10.1016/j.bbrc.2010.11.127
   Ghimire S, 2020, RICE BRAN QUERCETIN
   Haffajee AD, 2006, ORAL MICROBIOL IMMUN, V21, P269, DOI 10.1111/j.1399-302X.2006.00287.x
   Haidet Jaime, 2009, Rev Diabet Stud, V6, P168, DOI 10.1900/RDS.2009.6.168
   Halmos EP, 2015, GUT, V64, P93, DOI 10.1136/gutjnl-2014-307264
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hardman WE, 2014, NUTR RES PRACT, V8, P233, DOI 10.4162/nrp.2014.8.3.233
   Inoue R, 2019, J CLIN BIOCHEM NUTR, V64, P217, DOI 10.3164/jcbn.18-105
   Jumas-Bilak E, 2007, INT J SYST EVOL MICR, V57, P2314, DOI 10.1099/ijs.0.64883-0
   Kabeerdoss J, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-20
   Kabeerdoss J, 2012, BRIT J NUTR, V108, P953, DOI 10.1017/S0007114511006362
   Kakiyama G, 2014, AM J PHYSIOL-GASTR L, V306, pG929, DOI 10.1152/ajpgi.00315.2013
   Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228
   Kong LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109434
   Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978
   Liszt K, 2009, ANN NUTR METAB, V54, P253, DOI 10.1159/000229505
   Liu L, 2018, CLIN GASTROENTEROL H, V16, P1622, DOI 10.1016/j.cgh.2018.04.030
   Liu YH, 2019, AM J CLIN NUTR, V110, P701, DOI 10.1093/ajcn/nqz139
   Lombo F, 2006, APPL MICROBIOL BIOT, V73, P1, DOI 10.1007/s00253-006-0511-6
   Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344
   Maskarinec G, 2019, J NUTR, V149, P1575, DOI 10.1093/jn/nxz065
   Mehta RS, 2017, JAMA ONCOL, V3, P921, DOI 10.1001/jamaoncol.2016.6374
   Melkonian SC, 2014, AM J EPIDEMIOL, V180, P499, DOI 10.1093/aje/kwu158
   Modi SR, 2014, J CLIN INVEST, V124, P4212, DOI 10.1172/JCI72333
   Moen K, 2006, CLIN EXP RHEUMATOL, V24, P656
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   O'Keefe SJD, 2016, NAT REV GASTRO HEPAT, V13, P691, DOI 10.1038/nrgastro.2016.165
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Phillips CM, 2018, NUTRIENTS, V10, DOI 10.3390/nu10081033
   Prosberg M, 2016, SCAND J GASTROENTERO, V51, P1407, DOI 10.1080/00365521.2016.1216587
   Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020
   Schneeberger M, 2015, SCI REP-UK, V5, DOI 10.1038/srep16643
   Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60
   Seidell JC, 1997, BRIT MED BULL, V53, P238, DOI 10.1093/oxfordjournals.bmb.a011611
   Shivappa N, 2019, EUR J NUTR, V58, P797, DOI 10.1007/s00394-018-1690-5
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1825, DOI 10.1017/S1368980013002565
   Shivappa N, 2014, PUBLIC HEALTH NUTR, V17, P1689, DOI 10.1017/S1368980013002115
   Sinha R, 2016, CANCER EPIDEM BIOMAR, V25, P407, DOI 10.1158/1055-9965.EPI-15-0951
   Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x
   Subar AF, 2000, AM J EPIDEMIOL, V152, P279, DOI 10.1093/aje/152.3.279
   Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047
   Tabung FK, 2016, BRIT J CANCER, V114, P1277, DOI 10.1038/bjc.2016.98
   Tabung FK, 2015, ANN EPIDEMIOL, V25, P398, DOI 10.1016/j.annepidem.2015.03.009
   Takaishi H, 2008, INT J MED MICROBIOL, V298, P463, DOI 10.1016/j.ijmm.2007.07.016
   Tindall AM, 2018, J NUTR, V148, P1402, DOI 10.1093/jn/nxy141
   Venook AP, 2010, ONCOLOGIST, V15, P5, DOI 10.1634/theoncologist.2010-S4-05
   Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005
   Wang ZQ, 2012, INT J NANOMED, V7, P2999, DOI 10.2147/IJN.S30887
   Wirth MD, 2017, J NUTR HEALTH AGING, V21, P487, DOI 10.1007/s12603-016-0775-1
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
   Yang J, 2018, PROTEIN CELL, V9, P474, DOI 10.1007/s13238-018-0543-6
   Yarmolinsky J, 2016, SCI REP-UK, V6, DOI 10.1038/srep17714
   Zhan Jixun, 2009, Curr Top Med Chem, V9, P1958
   Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478
   Zimmer J, 2012, EUR J CLIN NUTR, V66, P53, DOI 10.1038/ejcn.2011.141
   Zitvogel L, 2017, NAT IMMUNOL, V18, P843, DOI 10.1038/ni.3754
NR 79
TC 23
Z9 23
U1 3
U2 33
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 0007-1145
EI 1475-2662
J9 BRIT J NUTR
JI Br. J. Nutr.
PD NOV 14
PY 2020
VL 124
IS 9
BP 931
EP 942
AR PII S0007114520001853
DI 10.1017/S0007114520001853
PG 12
WC Nutrition & Dietetics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Nutrition & Dietetics
GA NZ9QS
UT WOS:000577434400006
PM 32475373
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Lundy, SD
   Sangwan, N
   Parekh, NV
   Selvam, MKP
   Gupta, S
   McCaffrey, P
   Bessoff, K
   Vala, A
   Agarwal, A
   Sabanegh, ES
   Vij, SC
   Eng, C
AF Lundy, Scott D.
   Sangwan, Naseer
   Parekh, Neel, V
   Selvam, Manesh Kumar Panner
   Gupta, Sajal
   McCaffrey, Peter
   Bessoff, Kovi
   Vala, Ayin
   Agarwal, Ashok
   Sabanegh, Edmund S.
   Vij, Sarah C.
   Eng, Charis
TI Functional and Taxonomic Dysbiosis of the Gut, Urine, and Semen
   Microbiomes in Male Infertility
SO EUROPEAN UROLOGY
LA English
DT Article
DE 16S rRNA; Bacteriospermia; Leukocytospermia; Male infertility;
   Metagenomics; Microbiome; Microbiota; Semen; Seminal oxidative stress;
   Varicocele
ID OXIDATIVE STRESS; SPERM; LEUKOCYTOSPERMIA; BACTERIA
AB Background: Little is known about the role of the genitourinary and gastrointestinal microbiota in the pathogenesis of male infertility.
   Objective: To compare the taxonomic and functional profiles of the gut, semen, and urine microbiomes of infertile and fertile men.
   Design, setting, and participants: We prospectively enrolled 25 men with primary idiopathic infertility and 12 healthy men with proven paternity, and we collected rectal swabs, semen samples, midstream urine specimens, and experimental controls.
   Outcome measurements and statistical analysis: We performed comprehensive semen analysis, 16S rRNA sequencing for quantitative high-resolution taxonomy, and shotgun metagenomics with a median of 140 million reads per sample for functional metabolic pathway profiling.
   Results and limitations: We identified a diverse semen microbiome with modest similarity to the urinary microbiome. Infertile men harbored increased seminal alpha-diversity and distinct beta-diversity, increased seminal Aerococcus, and decreased rectal Anaerococcus. Prevotella abundance was inversely associated with sperm concentration, and Pseudomonas was directly associated with total motile sperm count. Vasectomy appeared to alter the seminal microbiome, suggesting a testicular or epididymal contribution. Anaerobes were highly over-represented in the semen of infertile men with a varicocele, but oxidative stress and leukocytospermia were associated with only subtle differences. Metagenomics data identified significant alterations in the S-ade-nosyl-L-methionine cycle, which may play a multifaceted role in the pathogenesis of infertility via DNA methylation, oxidative stress, and/or polyamine synthesis.
   Conclusions: This pilot study represents the first comprehensive investigation into the microbiome in male infertility. These findings provide the foundation for future investigations to explore causality and identify novel microbiome-based diagnostics and therapeutics for men with this complex and emotionally devastating disease.
   Patient summary: We explored the resident populations of bacteria living in the gut, semen, and urine of infertile and fertile men. We found several important bacterial and metabolic pathway differences with the potential to aid in diagnosing and treating male infertility in the future. (C) 2021 The Authors. Published by Elsevier B.V. on behalf of European Association of Urology.
C1 [Lundy, Scott D.; Parekh, Neel, V; Selvam, Manesh Kumar Panner; Gupta, Sajal; Agarwal, Ashok; Sabanegh, Edmund S.; Vij, Sarah C.] Cleveland Clin, Dept Urol, Glickman Urol & Kidney Inst, Cleveland, OH 44106 USA.
   [Lundy, Scott D.; Eng, Charis] Cleveland Clin, Lerner Res Inst, Genom Med Inst, Cleveland, OH 44106 USA.
   [Sangwan, Naseer] Cleveland Clin, Lerner Res Inst, Ctr Microbiome & Human Hlth, Cleveland, OH 44106 USA.
   [McCaffrey, Peter; Bessoff, Kovi; Vala, Ayin] Vastbiome, Millbrae, CA USA.
   [Eng, Charis] Case Western Reserve Univ, Sch Med, Dept Genet, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA.
   [Eng, Charis] Case Western Reserve Univ, Sch Med, Genome Sci & Germline High Risk Canc Focus Grp, Case Comprehens Canc Ctr, Cleveland, OH USA.
C3 Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland
   Clinic Foundation; Case Western Reserve University; Case Western Reserve
   University
RP Lundy, SD (corresponding author), Cleveland Clin Fdn, Q10-125,9500 Euclid Ave, Cleveland, OH 44195 USA.
EM lundys@ccf.org
RI Panner Selvam, Manesh Kumar/GRN-7828-2022; Bessoff, Kovi/AGL-0501-2022
OI Mccaffrey, Peter/0000-0002-4450-8143; Sangwan,
   Naseer/0000-0002-2407-769X; Lundy, Scott/0000-0002-0127-4295
FU Cleveland Clinic Foundation Research Program Committee Grant
FX This study was supported by the Cleveland Clinic Foundation Research
   Program Committee Grant. The authors assert that Vastbiome had no
   influence over the study design or data collection for these
   experiments.
CR Agarwal A, 2017, ANDROLOGY-US, V5, P939, DOI 10.1111/andr.12395
   Agarwal A, 2019, WORLD J MENS HEALTH, V37, P296, DOI 10.5534/wjmh.190055
   Agarwal A, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0032-1
   Alfano M, 2018, HUM REPROD, V33, P1212, DOI 10.1093/humrep/dey116
   Altmae S, 2019, NAT REV UROL, V16, P703, DOI 10.1038/s41585-019-0250-y
   Bajic P, 2020, EUR UROL FOCUS, V6, P376, DOI 10.1016/j.euf.2018.08.001
   Baud D, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00234
   Bisht S, 2017, NAT REV UROL, V14, P470, DOI 10.1038/nrurol.2017.69
   Bottiglieri T, 2002, AM J CLIN NUTR, V76, p1151S, DOI 10.1093/ajcn/76.5.1151S
   Chen HY, 2018, EXP THER MED, V15, P2884, DOI 10.3892/etm.2018.5778
   Engeli KM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211679
   Franzosa EA, 2018, NAT METHODS, V15, P962, DOI 10.1038/s41592-018-0176-y
   Hamada A, 2011, UROLOGY, V78, P1320, DOI 10.1016/j.urology.2011.08.062
   Hou DS, 2013, FERTIL STERIL, V100, P1261, DOI 10.1016/j.fertnstert.2013.07.1991
   Jung JH, 2016, WORLD J MENS HEALTH, V34, P165, DOI 10.5534/wjmh.2016.34.3.165
   Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808
   Knight R, 2018, NAT REV MICROBIOL, V16, P410, DOI 10.1038/s41579-018-0029-9
   LENZI A, 1993, HUM REPROD, V8, P1657, DOI 10.1093/oxfordjournals.humrep.a137909
   Levine H, 2017, HUM REPROD UPDATE, V23, P646, DOI 10.1093/humupd/dmx022
   Lundy SD, 2018, ARAB J UROL, V16, P157, DOI 10.1016/j.aju.2017.11.003
   Marques CJ, 2008, MOL HUM REPROD, V14, P67, DOI 10.1093/molehr/gam093
   Monteiro C, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12838
   Nelson DE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036298
   Ohwaki K, 2009, ANDROLOGIA, V41, P100, DOI 10.1111/j.1439-0272.2008.00896.x
   Pearce MM, 2014, MBIO, V5, DOI 10.1128/mBio.01283-14
   Punab M, 2017, HUM REPROD, V32, P18, DOI 10.1093/humrep/dew284
   SanMiguel AJ, 2018, J INVEST DERMATOL, V138, P2234, DOI 10.1016/j.jid.2018.04.022
   Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5
   Wade W, 2002, J ROY SOC MED, V95, P81, DOI 10.1258/jrsm.95.2.81
   Weng SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110152
NR 30
TC 25
Z9 26
U1 3
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0302-2838
EI 1873-7560
J9 EUR UROL
JI Eur. Urol.
PD JUN
PY 2021
VL 79
IS 6
BP 826
EP 836
DI 10.1016/j.eururo.2021.01.014
EA MAY 2021
PG 11
WC Urology & Nephrology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Urology & Nephrology
GA SD5YX
UT WOS:000651453500004
PM 33573862
OA hybrid
DA 2022-11-22
ER

PT J
AU Telalovic, JH
   Music, A
AF Hasic Telalovic, Jasminka
   Music, Azra
TI Using data science for medical decision making case: role of gut
   microbiome in multiple sclerosis
SO BMC MEDICAL INFORMATICS AND DECISION MAKING
LA English
DT Article
DE Machine learning; Microbiome; Data science; Multiple sclerosis
AB Background A decade ago, the advancements in the microbiome data sequencing techniques initiated the development of research of the microbiome and its relationship with the host organism. The development of sophisticated bioinformatics and data science tools for the analysis of large amounts of data followed. Since then, the analyzed gut microbiome data, where microbiome is defined as a network of microorganisms inhabiting the human intestinal system, has been associated with several conditions such as irritable bowel syndrome - IBS, colorectal cancer, diabetes, obesity, and metabolic syndrome, and lately in the study of Parkinson's and Alzheimer's diseases as well. This paper aims to provide an understanding of differences between microbial data of individuals who have been diagnosed with multiple sclerosis and those who were not by exploiting data science techniques on publicly available data. Methods This study examines the relationship between multiple sclerosis (MS), an autoimmune central nervous system disease, and gut microbial community composition, using the samples acquired by 16s rRNA sequencing technique. We have used three different sets of MS samples sequenced during three independent studies (Jangi et al, Nat Commun 7:1-11, 2016), (Miyake et al, PLoS ONE 10:0137429, 2015), (McDonald et al, Msystems 3:00031-18, 2018) and this approach strengthens our results. Analyzed sequences were from healthy control and MS groups of sequences. The extracted set of statistically significant bacteria from the (Jangi et al, Nat Commun 7:1-11, 2016) dataset samples and their statistically significant predictive functions were used to develop a Random Forest classifier. In total, 8 models based on two criteria: bacteria abundance (at six taxonomic levels) and predictive functions (at two levels), were constructed and evaluated. These include using taxa abundances at different taxonomy levels as well as predictive function analysis at different hierarchical levels of KEGG pathways. Results The highest accuracy of the classification model was obtained at the genus level of taxonomy (76.82%) and the third hierarchical level of KEGG pathways (70.95%). The second dataset's 18 MS samples (Miyake et al, PLoS ONE 10:0137429, 2015) and 18 self-reported healthy samples from the (McDonald et al, Msystems 3:00031-18, 2018) dataset were used to validate the developed classification model. The significance of this step is to show that the model is not overtrained for a specific dataset but can also be used on other independent datasets. Again, the highest classification model accuracy for both validating datasets combined was obtained at the genus level of taxonomy (70.98%) and third hierarchical level of KEGG pathways (67.24%). The accuracy of the independent set remained very relevant. Conclusions Our results demonstrate that the developed classification model provides a good tool that can be used to suggest the presence or absence of MS condition by collecting and analyzing gut microbiome samples. The accuracy of the model can be further increased by using sequencing methods that allow higher taxa resolution (i.e. shotgun metagenomic sequencing).
C1 [Hasic Telalovic, Jasminka; Music, Azra] Univ Sarajevo, Sch Sci & Technol, Hrasnicka Cesta 3a, Ilidza 71210, Bosnia & Herceg.
C3 University of Sarajevo
RP Telalovic, JH (corresponding author), Univ Sarajevo, Sch Sci & Technol, Hrasnicka Cesta 3a, Ilidza 71210, Bosnia & Herceg.
EM jasminka.hasic@ssst.edu.ba
RI Hasic, Jasminka/S-9016-2019
OI Hasic Telalovic, Jasminka/0000-0002-8540-5052
CR Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Branton WG, 2016, SCI REP-UK, V6, DOI 10.1038/srep37344
   Budhram A, 2017, MULT SCLER J, V23, P628, DOI 10.1177/1352458516682105
   Cantarel BL, 2015, J INVEST MED, V63, P729, DOI 10.1097/JIM.0000000000000192
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Chenge J, 2016, SCI REP-UK, V6, DOI 10.1038/srep26628
   Chu FN, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8168717
   Fraune S, 2010, BIOESSAYS, V32, P571, DOI 10.1002/bies.200900192
   Hasic Telalovic J, 2019, INT C MED BIOL ENG, P349
   Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234
   Jangi S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12015
   Jovel J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00459
   Karlsson FH, 2014, SYSTEMS BIOL GUT MIC
   Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213
   Knights D, 2011, FEMS MICROBIOL REV, V35, P343, DOI 10.1111/j.1574-6976.2010.00251.x
   L. WH, GUT MICROBIOME MAY A
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a
   Louppe G., 2014, THESIS U LIEGE LIEGE
   Miyake S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137429
   Morgan XC, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002808
   Morton JT, 2018, ROB KNIGHT MSYSTEMS, V3, pe00031
   Parashar A, 2017, PARKINSONISM RELAT D, V38, P1, DOI 10.1016/j.parkreldis.2017.02.002
   Plummer E., 2015, J PROTEOM BIOINFORM, V8, P283, DOI DOI 10.4172/JPB.1000381
   Prados A., GUT MICROBIOTA RES P
   Proctor L, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0620-y
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Singh RK, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1175-y
   Statnikov A, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-11
   Suresh Kp, 2012, J Hum Reprod Sci, V5, P7, DOI 10.4103/0974-1208.97779
   Tremlett H, 2016, EUR J NEUROL, V23, P1308, DOI 10.1111/ene.13026
   Westfall S, 2017, CELL MOL LIFE SCI, V74, P3769, DOI 10.1007/s00018-017-2550-9
   Zhang X, 2015, NAT MED, V21, P895, DOI 10.1038/nm.3914
   Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089
   Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212
NR 35
TC 1
Z9 1
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6947
J9 BMC MED INFORM DECIS
JI BMC Med. Inform. Decis. Mak.
PD OCT 12
PY 2020
VL 20
IS 1
AR 262
DI 10.1186/s12911-020-01263-2
PG 11
WC Medical Informatics
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Medical Informatics
GA NZ0ZS
UT WOS:000576822300001
PM 33046051
OA Green Published, gold
DA 2022-11-22
ER

PT J
AU Zhang, GL
   Zhang, PY
   Li, W
   Hao, FQ
   Chen, FM
   Yang, Y
   Hou, Y
   Tao, YT
AF Zhang Guilin
   Zhang Pengyu
   Li Wei
   Hao Fengqi
   Chen, Fangmei
   Yang Yu
   Hou Yue
   Tao Yuting
TI Reduction of gut microbial diversity and short chain fatty acids in
   BALB/c mice exposure to microcystin-LR
SO ECOTOXICOLOGY
LA English
DT Article
DE Microcystin; Gut microbiota; Metagenomics; Short-chain fatty acid
ID COLORECTAL-CANCER; DIETARY FIBER; BUTYRATE; GROWTH; DETOXIFICATION;
   CYANOBACTERIA; GLUTATHIONE; EXPRESSION; METFORMIN; RELEASE
AB Gut microbiota has been shown to play critical roles in host health. The present study was to determine the toxicological effects of microcystin-LR (MCLR) on gut microbial community and metabolites using 16S rDNA sequencing and gas chromatography-mass spectrometry (GC-MS). MCLR was administered to BALB/c mice by gavage for eight weeks. Results of the microbial alpha-diversity (Sobs, Chao1, ACE and Shannon indexes) decreased in MCLR-treated group versus controls. PhylumCandidatus Saccharibacteriadecreased significantly in MCLR-treated group versus controls. Correspondingly, more than thirties genera in relative abundance decreased, especially short chain fatty acid (SCFA)-producing bacteria (e.g.,AlistipesandRuminococcus). These results indicated that the gut microbial community structure was remarkably changed by MCLR. Furthermore, concentrations of SCFAs were significantly decreased after MCLR exposure (P < 0.01), where butyrate decreased as high as 4.9-fold. Consequently, sub-chronic exposure to MCLR could not only alter the microbial composition but metabolites. This study offered novel insights into the toxic mechanism of MCs from gut microbiota, and facilitated further clarification of risks to human health from MCs exposure.
C1 [Zhang Guilin; Zhang Pengyu; Li Wei; Hao Fengqi; Chen, Fangmei; Yang Yu; Hou Yue; Tao Yuting] Changchun Univ Sci & Technol, Sch Life Sci & Technol, Changchun 130022, Peoples R China.
   [Li Wei] Wuhan Haidian Foreign Language Shi Yan Sch, Wuhan 430220, Peoples R China.
C3 Changchun University of Science & Technology
RP Li, W (corresponding author), Changchun Univ Sci & Technol, Sch Life Sci & Technol, Changchun 130022, Peoples R China.; Li, W (corresponding author), Wuhan Haidian Foreign Language Shi Yan Sch, Wuhan 430220, Peoples R China.
EM liwei5695084@163.com
FU Youth Foundations of Changchun University of Science and Technology,
   China [XQNJJ-2016-16]; Science and Technology Research Project of Jilin
   Province, China [JJKH20181128KJ]; Undergraduate Innovation and
   Entrepreneurship Training Program of JiLin Province [201910186177,
   201910186187]
FX The project was supported by Youth Foundations of Changchun University
   of Science and Technology, China (XQNJJ-2016-16), Science and Technology
   Research Project of Jilin Province, China (JJKH20181128KJ) and
   Undergraduate Innovation and Entrepreneurship Training Program of JiLin
   Province (201910186177, 201910186187).
CR Amado LL, 2010, ENVIRON INT, V36, P226, DOI 10.1016/j.envint.2009.10.010
   Barcelo A, 2000, GUT, V46, P218, DOI 10.1136/gut.46.2.218
   Bates JM, 2007, CELL HOST MICROBE, V2, P371, DOI 10.1016/j.chom.2007.10.010
   Bingham SA, 2003, LANCET, V361, P1496, DOI 10.1016/S0140-6736(03)13174-1
   Botha N, 2004, TOXICON, V43, P251, DOI 10.1016/j.toxicon.2003.11.026
   Caliz J, 2012, CHEMOSPHERE, V89, P494, DOI 10.1016/j.chemosphere.2012.05.002
   Chen J, 2015, J TOXICOL SCI, V40, P485, DOI 10.2131/jts.40.485
   Chi YL, 2018, ENVIRON POLLUT, V239, P332, DOI 10.1016/j.envpol.2018.04.001
   Christen V, 2013, ENVIRON SCI TECHNOL, V47, P3378, DOI 10.1021/es304886y
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   Daien CI, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00548
   Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06
   Ding WX, 2001, J TOXICOL ENV HEAL A, V64, P507, DOI 10.1080/152873901753215966
   Dixon RA, 2004, FEMS MICROBIOL LETT, V230, P167, DOI 10.1016/S0378-1097(03)00910-8
   Forslund K, 2017, NATURE, V545, P116, DOI 10.1038/nature22318
   Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766
   Foxall TL, 1998, ALGAL TOXINS HLTH
   Goel A, 2014, J GASTROEN HEPATOL, V29, P1139, DOI 10.1111/jgh.12556
   Guo MZ, 2014, TOXICOL SCI, V141, P314, DOI 10.1093/toxsci/kfu128
   Guo XC, 2014, CHEMOSPHERE, V112, P1, DOI 10.1016/j.chemosphere.2014.03.068
   Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x
   Hatayama H, 2007, BIOCHEM BIOPH RES CO, V356, P599, DOI 10.1016/j.bbrc.2007.03.025
   He J, 2017, ARCH TOXICOL, V91, P465, DOI 10.1007/s00204-016-1681-3
   He J, 2012, AQUAT TOXICOL, V116, P61, DOI 10.1016/j.aquatox.2012.03.004
   Horng YT, 2018, J MICROBIOL IMMUNOL, V51, P174, DOI 10.1016/j.jmii.2017.01.007
   Ito E, 2000, TOXICON, V38, P37, DOI 10.1016/S0041-0101(99)00084-7
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Li HY, 2012, ENVIRON TOXICOL PHAR, V34, P324, DOI 10.1016/j.etap.2012.04.011
   Li W, 2018, CHEMOSPHERE, V191, P357, DOI 10.1016/j.chemosphere.2017.09.083
   Lin J., 2015, THESIS
   Liu LuYi, 2014, Acta Hydrobiologica Sinica, V38, P533
   Lloyd CR, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00869-16
   Loh G, 2012, GUT MICROBES, V3, P544, DOI 10.4161/gmic.22156
   Looft T, 2012, P NATL ACAD SCI USA, V109, P1691, DOI 10.1073/pnas.1120238109
   Mardinoglu A, 2016, CELL METAB, V23, P10, DOI 10.1016/j.cmet.2015.12.012
   Meijer HP, 2000, DIS COLON RECTUM, V43, P1427, DOI 10.1007/BF02236640
   Merel S, 2013, ENVIRON INT, V59, P303, DOI 10.1016/j.envint.2013.06.013
   Moreno IM, 2003, J PHYSIOL BIOCHEM, V59, P293, DOI 10.1007/BF03179887
   Mutlu EA, 2018, ENVIRON POLLUT, V240, P817, DOI 10.1016/j.envpol.2018.04.130
   NISHIWAKIMATSUSHIMA R, 1992, J CANCER RES CLIN, V118, P420, DOI 10.1007/BF01629424
   Park Y, 2005, JAMA-J AM MED ASSOC, V294, P2849, DOI 10.1001/jama.294.22.2849
   Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450
   Ren ZG, 2019, GUT, V68, P1014, DOI 10.1136/gutjnl-2017-315084
   Roda A, 2007, WORLD J GASTROENTERO, V13, P1079, DOI 10.3748/wjg.v13.i7.1079
   Sands BE, 2007, J GASTROENTEROL, V42, P16, DOI 10.1007/s00535-006-1995-7
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791
   Valdor R, 2007, TOXICON, V49, P769, DOI 10.1016/j.toxicon.2006.11.025
   Veldee MV, 1931, AM J PUBLIC HEALTH N, V21, P1227, DOI 10.2105/AJPH.21.11.1227
   Vonaesch P, 2018, P NATL ACAD SCI USA, V115, pE8489, DOI 10.1073/pnas.1806573115
   Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628
   Wood R, 2016, ENVIRON INT, V91, P276, DOI 10.1016/j.envint.2016.02.026
   Wu BY, 2014, ECOTOX ENVIRON SAFE, V109, P70, DOI 10.1016/j.ecoenv.2014.08.002
   WU Y, 2018, SCI REP, V8
   Yang Cui-Yun, 2008, Acta Hydrobiologica Sinica, V32, P818, DOI [10.3724/SP.J.1035.2008.00818, 10.3724/SP.J.0000.2008.60818]
   Yin NY, 2017, CHEMOSPHERE, V168, P358, DOI 10.1016/j.chemosphere.2016.10.091
   Yoshida Toshinori, 1997, Natural Toxins, V5, P91, DOI 10.1002/nt.1
   Zhang SQ, 2018, CHEMOSPHERE, V195, P108, DOI 10.1016/j.chemosphere.2017.12.067
   Zhang X, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040320, 10.1371/journal.pone.0042529]
   Zhao XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167032
   Zhou Lun, 2000, Zhonghua Yufang Yixue Zazhi, V34, P224
NR 61
TC 8
Z9 8
U1 1
U2 22
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0963-9292
EI 1573-3017
J9 ECOTOXICOLOGY
JI Ecotoxicology
PD NOV
PY 2020
VL 29
IS 9
BP 1347
EP 1357
DI 10.1007/s10646-020-02254-9
EA AUG 2020
PG 11
WC Ecology; Environmental Sciences; Toxicology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Environmental Sciences & Ecology; Toxicology
GA OF6YU
UT WOS:000557727500001
PM 32772242
DA 2022-11-22
ER

PT J
AU Zhang, GR
   Wang, Q
   Tao, WY
   Jiang, W
   Elinav, E
   Wang, YC
   Zhu, S
AF Zhang, Guorong
   Wang, Qin
   Tao, Wanyin
   Jiang, Wei
   Elinav, Eran
   Wang, Yucai
   Zhu, Shu
TI Glucosylated nanoparticles for the oral delivery of antibiotics to the
   proximal small intestine protect mice from gut dysbiosis
SO NATURE BIOMEDICAL ENGINEERING
LA English
DT Article
ID HUMAN PLASMA; LC-MS/MS; RESISTANCE; MICROBIOTA; BACTERIA;
   SUSCEPTIBILITY; VALIDATION; MECHANISMS; AMPICILLIN; COMMUNITY
AB Orally delivered antibiotics can reach the caecum and colon, and induce gut dysbiosis. Here we show that the encapsulation of antibiotics in orally administered positively charged polymeric nanoparticles with a glucosylated surface enhances absorption by the proximal small intestine through specific interactions of glucose and the abundantly expressed sodium-dependent glucose transporter 1. This improves bioavailability of the antibiotics, and limits their exposure to flora in the large intestine and their accumulation in caecal and faecal contents. Compared with the standard administration of the same antibiotics, the oral administration of nanoparticle-encapsulated ampicillin, chloramphenicol or vancomycin in mice with bacterial infections in the lungs effectively eliminated the infections, decreased adverse effects on the intestinal microbiota by protecting the animals from dysbiosis-associated metabolic syndromes and from opportunistic pathogen infections, and reduced the accumulation of known antibiotic-resistance genes in commensal bacteria. Glucosylated nanocarriers may be suitable for the oral delivery of other drugs causing gut dysbiosis.
   The encapsulation of antibiotics in glucosylated polymeric nanoparticles that are readily absorbed by the proximal small intestine improves the bioavailability of the antibiotics and limits their exposure to flora in the large intestine.
C1 [Zhang, Guorong; Wang, Qin; Tao, Wanyin; Jiang, Wei; Wang, Yucai; Zhu, Shu] Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Digest Dis, Hefei, Peoples R China.
   [Zhang, Guorong; Wang, Qin; Tao, Wanyin; Jiang, Wei; Wang, Yucai; Zhu, Shu] Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Intelligent Nanomed Inst, Hefei, Peoples R China.
   [Zhang, Guorong; Wang, Qin; Tao, Wanyin; Jiang, Wei; Wang, Yucai; Zhu, Shu] Univ Sci & Technol China, Inst Immunol, Hefei, Peoples R China.
   [Zhang, Guorong; Wang, Qin; Tao, Wanyin; Jiang, Wei; Wang, Yucai; Zhu, Shu] Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med, CAS Key Lab Innate Immun & Chron Dis, Hefei, Peoples R China.
   [Elinav, Eran] Weizmann Inst Sci, Syst Immunol Dept, Rehovot, Israel.
   [Elinav, Eran] DKFZ, Microbiome & Canc Div, Heidelberg, Germany.
   [Wang, Yucai; Zhu, Shu] Hefei Comprehens Natl Sci Ctr, Inst Hlth & Med, Hefei, Peoples R China.
   [Zhu, Shu] Univ Sci & Technol China, Sch Data Sci, Hefei, Peoples R China.
C3 Chinese Academy of Sciences; University of Science & Technology of
   China, CAS; Chinese Academy of Sciences; University of Science &
   Technology of China, CAS; Chinese Academy of Sciences; University of
   Science & Technology of China, CAS; Chinese Academy of Sciences;
   University of Science & Technology of China, CAS; Weizmann Institute of
   Science; Helmholtz Association; German Cancer Research Center (DKFZ);
   Chinese Academy of Sciences; University of Science & Technology of
   China, CAS
RP Wang, YC; Zhu, S (corresponding author), Univ Sci & Technol China, Affiliated Hosp USTC 1, Dept Digest Dis, Hefei, Peoples R China.; Wang, YC; Zhu, S (corresponding author), Univ Sci & Technol China, Div Life Sci & Med, Affiliated Hosp USTC 1, Intelligent Nanomed Inst, Hefei, Peoples R China.; Wang, YC; Zhu, S (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei, Peoples R China.; Wang, YC; Zhu, S (corresponding author), Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med, CAS Key Lab Innate Immun & Chron Dis, Hefei, Peoples R China.; Wang, YC; Zhu, S (corresponding author), Hefei Comprehens Natl Sci Ctr, Inst Hlth & Med, Hefei, Peoples R China.; Zhu, S (corresponding author), Univ Sci & Technol China, Sch Data Sci, Hefei, Peoples R China.
EM yucaiwang@ustc.edu.cn; zhushu@ustc.edu.cn
RI Zhu, Shu/P-6163-2018
OI Zhu, Shu/0000-0002-8163-0869; Wang, Qin/0000-0002-5947-875X; Wang,
   Yucai/0000-0001-6046-2934
FU National Key R&D Program of China [2017YFA0205600, 2018YFA0508000];
   Strategic Priority Research Program of the Chinese Academy of Sciences
   [XDB29030101]; National Natural Science Foundation of China [52025036,
   82061148013, 81821001, 51903105]; Shanghai Municipal Science and
   Technology Major Project
FX We thank Y. Yang for analysing the metagenomic sequencing results, J.
   Wang for helping with animal experiments, H. Tan for helping with
   microbial experiments, Q. Liang, H. Pan and C. Zeng for helping with the
   material experiments; Z. Tian, R. Zhou, W. Pan, R. Flavell, X. Song, K.
   Zhang, H. Ma and W. Wen for helpful discussion and comments on this
   patent-pending work. This work was supported by grants from the National
   Key R&D Program of China (2017YFA0205600 to Y.W. and 2018YFA0508000 to
   S.Z.), the Strategic Priority Research Program of the Chinese Academy of
   Sciences (XDB29030101 to S.Z.), the National Natural Science Foundation
   of China (52025036 to Y.W., 82061148013 and 81821001 to S.Z. and
   51903105 to W.J.) and the Shanghai Municipal Science and Technology
   Major Project (S.Z.).
CR Baumler AJ, 2016, NATURE, V535, P85, DOI 10.1038/nature18849
   Bockelmann U, 2009, APPL ENVIRON MICROB, V75, P154, DOI 10.1128/AEM.01649-08
   Brown KA, 2013, ANTIMICROB AGENTS CH, V57, P2326, DOI 10.1128/AAC.02176-12
   Buffie CG, 2012, INFECT IMMUN, V80, P62, DOI 10.1128/IAI.05496-11
   Chen LH, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010043
   Cherazard R, 2017, AM J THER, V24, pE361, DOI 10.1097/MJT.0000000000000551
   Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400
   Cox LM, 2014, CELL, V158, P705, DOI 10.1016/j.cell.2014.05.052
   de Gunzburg J, 2015, J CLIN PHARMACOL, V55, P10, DOI 10.1002/jcph.359
   Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385
   Fernando DM, 2016, APPL ENVIRON MICROB, V82, P4767, DOI 10.1128/AEM.00798-16
   Goncalves TM, 2008, ARZNEIMITTEL-FORSCH, V58, P91, DOI 10.1055/s-0031-1296474
   Han XF, 2020, NAT NANOTECHNOL, V15, P605, DOI 10.1038/s41565-020-0693-6
   Khoder M, 2010, EUR J PHARM SCI, V41, P281, DOI 10.1016/j.ejps.2010.06.018
   Kim YG, 2014, CELL HOST MICROBE, V15, P95, DOI 10.1016/j.chom.2013.12.010
   Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701
   Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772
   LEONARD F, 1989, J INFECT DIS, V160, P274, DOI 10.1093/infdis/160.2.274
   Levison ME, 2009, INFECT DIS CLIN N AM, V23, P791, DOI 10.1016/j.idc.2009.06.008
   Li JJ, 2019, ACS NANO, V13, P5002, DOI 10.1021/acsnano.9b01002
   Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266
   McGlone ER, 2019, ANN CLIN BIOCHEM, V56, P326, DOI 10.1177/0004563218817798
   Mowat AM, 2014, NAT REV IMMUNOL, V14, P667, DOI 10.1038/nri3738
   Nalbant D, 2021, J PHARMACEUT BIOMED, V196, DOI [10.1016/j.jpha.2021.113899, 10.1016/j.jpba.2021.113899]
   Palleja A, 2018, NAT MICROBIOL, V3, P1255, DOI 10.1038/s41564-018-0257-9
   Peng Z, 2017, J CLIN MICROBIOL, V55, P1998, DOI 10.1128/JCM.02250-16
   Pernigoni N, 2021, SCIENCE, V374, P216, DOI 10.1126/science.abf8403
   Ramos M, 2003, J CHROMATOGR B, V791, P31, DOI 10.1016/S1570-0232(03)00186-7
   Recordati Camilla, 2016, PART FIBRE TOXICOL, V13, DOI [DOI 10.1186/S12989-016-0149-1, 10.1186/s12989-016-0124-x, DOI 10.1186/S12989-016-0124-X]
   Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004
   Schuijt TJ, 2016, GUT, V65, P575, DOI 10.1136/gutjnl-2015-309728
   Smith KM, 1997, CRIT CARE MED, V25, P1888, DOI 10.1097/00003246-199711000-00030
   Sommer MOA, 2009, SCIENCE, V325, P1128, DOI 10.1126/science.1176950
   Stiefel U, 2003, J INFECT DIS, V188, P1605, DOI 10.1086/379153
   Suez J, 2018, CELL, V174, P1406, DOI 10.1016/j.cell.2018.08.047
   Sun CY, 2016, ANGEW CHEM INT EDIT, V55, P1010, DOI 10.1002/anie.201509507
   Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619
   Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414
   Vangay P, 2015, CELL HOST MICROBE, V17, P553, DOI 10.1016/j.chom.2015.04.006
   Wahlstrom A, 2017, J LIPID RES, V58, P412, DOI 10.1194/jlr.M072819
   Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10
   Zhang L, 2013, ANTIMICROB AGENTS CH, V57, P3659, DOI 10.1128/AAC.00670-13
   Zhao JP, 2014, POLYM CHEM-UK, V5, P3750, DOI 10.1039/c4py00429a
   Zhao LP, 2013, NAT REV MICROBIOL, V11, P639, DOI 10.1038/nrmicro3089
NR 44
TC 1
Z9 1
U1 94
U2 94
PU NATURE PORTFOLIO
PI BERLIN
PA HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY
SN 2157-846X
J9 NAT BIOMED ENG
JI Nat. Biomed. Eng
PD JUL
PY 2022
VL 6
IS 7
DI 10.1038/s41551-022-00903-4
EA JUL 2022
PG 29
WC Engineering, Biomedical
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Engineering
GA 2Z4NK
UT WOS:000824916900001
PM 35798834
DA 2022-11-22
ER

PT J
AU Koo, H
   Hakim, JA
   Powell, ML
   Kumar, R
   Eipers, PG
   Morrow, CD
   Crowley, M
   Lefkowitz, EJ
   Watts, SA
   Bej, AK
AF Koo, Hyunmin
   Hakim, Joseph A.
   Powell, Mickie L.
   Kumar, Ranjit
   Eipers, Peter G.
   Morrow, Casey D.
   Crowley, Michael
   Lefkowitz, Elliot J.
   Watts, Stephen A.
   Bej, Asim K.
TI Metagenomics approach to the study of the gut microbiome structure and
   function in zebrafish Danio rerio fed with gluten formulated diet
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE NextGen sequencing; 16S rRNA; QIIME; PICRUSt; Pathogens
ID CETOBACTERIUM-SOMERAE; BILE-ACIDS; SP-NOV; METABOLISM; SEARCH; SERINE;
   COLON; CHOLESTEROL; DIVERSITY; SEQUENCES
AB In this study, we report the gut microbial composition and predictive functional profiles of zebrafish, Danio rerio, fed with a control formulated diet (CFD), and a gluten formulated diet (GFD) using a metagenomics approach and bioinformatics tools. The microbial communities of the GFD-fed D. rerio displayed heightened abundances of Legionellales, Rhizobiaceae, and Rhodobacter, as compared to the CFD-fed counterparts. Predicted metagenomics of microbial communities (PICRUSt) in GFD-fed D. rerio showed KEGG functional categories corresponding to bile secretion, secondary bile acid biosynthesis, and the metabolism of glycine, serine, and threonine. The CFD-fed D. rerio exhibited KEGG functional categories of bacteria-mediated cobalamin biosynthesis, which was supported by the presence of cobalamin synthesizers such as Bacteroides and Lactobacillus. Though these bacteria were absent in GFD-fed D. rerio, a comparable level of the cobalamin biosynthesis KEGG functional category was observed, which could be contributed by the compensatory enrichment of Cetobacterium. Based on these results, we conclude D. rerio to be a suitable alternative animal model for the use of a targeted metagenomics approach along with bioinformatics tools to further investigate the relationship between the gluten diet and microbiome profile in the gut ecosystem leading to gastrointestinal diseases and other undesired adverse health effects. (C) 2017 Published by-Elsevier B.V.
C1 [Koo, Hyunmin; Hakim, Joseph A.; Powell, Mickie L.; Watts, Stephen A.; Bej, Asim K.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL USA.
   [Kumar, Ranjit; Lefkowitz, Elliot J.] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Biomed Informat, Birmingham, AL USA.
   [Eipers, Peter G.; Morrow, Casey D.] Univ Alabama Birmingham, Cell Dev & Integrat Biol, Birmingham, AL USA.
   [Crowley, Michael] Univ Alabama Birmingham, Heflin Ctr Genom Sci, Birmingham, AL USA.
   [Lefkowitz, Elliot J.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL USA.
C3 University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham;
   University of Alabama System; University of Alabama Birmingham
RP Watts, SA; Bej, AK (corresponding author), Univ Alabama Birmingham, 1300 Univ Blvd,CH464, Birmingham, AL 35294 USA.
EM sawatts@uab.edu; abej@uab.edu
OI Lefkowitz, Elliot/0000-0002-4748-4925; Koo, Hyunmin/0000-0001-6630-2165
FU UAB Institutional Animal Care and Use Committee; Comprehensive Cancer
   Center [P30AR050948]; Center for Clinical Translational Science [UL1
   TR001417]; Center for AIDS Research [5P30AI027767]; UAB NORC [NIH
   P30DK056336]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES
   [UL1TR001417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASES [P30AI027767] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN
   DISEASES [P30AR050948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE
   OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding
   Source: NIH RePORTER
FX We thank the UAB Institutional Animal Care and Use Committee for their
   support in this research. We thank Edward Partridge, MD (Comprehensive
   Cancer Center; grant P30AR050948), Robert Kimberly, MD (Center for
   Clinical Translational Science; grant UL1 TR001417), Michael Saag, MD
   (Center for AIDS Research; grant 5P30AI027767), and David Allison, PhD
   (UAB NORC; grant NIH P30DK056336) for providing support with the center
   grants and core facilities for this work. We also thank Matthew Pace and
   T.D. Todd of CAS IT for computer support; Cheaha UABgrid by UAB ITRC for
   providing the HPC support necessary for bioinformatics analyses of the
   NGS data.
CR Afrose S, 2010, CHOLESTEROL, DOI 10.1155/2010/272731
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004
   Andrews S., 2010, FASTQC QUALITY CONTR
   Barut BA, 2000, PHYSIOL GENOMICS, V2, P49, DOI 10.1152/physiolgenomics.2000.2.2.49
   Bashir M, 2016, EUR J NUTR, V55, P1479, DOI 10.1007/s00394-015-0966-2
   Beres N.J., 2014, INT J CELIAC DIS, V2, P150, DOI DOI 10.12691/ijcd-2-4-4
   Bonder MJ, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0295-y
   Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303
   Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636
   Chen J, 2014, J FOOD SCI, V79, pR442, DOI 10.1111/1750-3841.12397
   Dahele A, 2001, AM J GASTROENTEROL, V96, P745, DOI 10.1111/j.1572-0241.2001.03616.x
   Daulatzai MA, 2015, CNS NEUROL DISORD-DR, V14, P110, DOI 10.2174/1871527314666150202152436
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   Duncan SH, 2007, LETT APPL MICROBIOL, V44, P343, DOI 10.1111/j.1472-765X.2007.02129.x
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Elli L, 2015, WORLD J GASTROENTERO, V21, P8221, DOI 10.3748/wjg.v21.i27.8221
   Finegold SM, 2003, SYST APPL MICROBIOL, V26, P177, DOI 10.1078/072320203322346010
   FOSTER G, 1995, LETT APPL MICROBIOL, V21, P202, DOI 10.1111/j.1472-765X.1995.tb01041.x
   Freeman HJ., 2013, INT J CELIAC DIS, V1, P19, DOI DOI 10.12691/IJCD-1-1-8
   Hannon G.J., 2010, FASTX TOOLKIT
   HILL MJ, 1990, MUTAT RES, V238, P313, DOI 10.1016/0165-1110(90)90023-5
   Howdle PD, 2006, EUR J GASTROEN HEPAT, V18, P703, DOI 10.1097/01.meg.0000221847.09792.34
   Huse SM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-5
   Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076
   Kimura Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06545
   Kopecny J, 2008, FOLIA MICROBIOL, V53, P214, DOI 10.1007/s12223-008-0028-8
   Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13
   Kumar R., 2014, CURR PROTOC HUM GENE, V18
   Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676
   Li KF, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/976914
   Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557
   Lotta N., 2016, CLIN NUTR EXPT
   Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371
   Maddocks ODK, 2013, NATURE, V493, P542, DOI 10.1038/nature11743
   McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139
   McKnight SL, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-S1-O7
   Momozawa Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016952
   Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322
   Murray JA, 1999, AM J CLIN NUTR, V69, P354
   NAGENGAST FM, 1995, EUR J CANCER, V31A, P1067, DOI 10.1016/0959-8049(95)00216-6
   Narrowe AB, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0069-6
   Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09
   Newton I.L., 2013, MICROBIOME SCI MED, V1
   Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29
   Oka Takehiko, 2010, BMC Physiol, V10, P21, DOI 10.1186/1472-6793-10-21
   Oksanen J., 2019, **DATA OBJECT**
   Parks DH, 2014, BIOINFORMATICS, V30, P3123, DOI 10.1093/bioinformatics/btu494
   Ridlon JM, 2006, CANCER BIOL THER, V5, P273, DOI 10.4161/cbt.5.3.2728
   Ridlon JM, 2014, CURR OPIN GASTROEN, V30, P332, DOI 10.1097/MOG.0000000000000057
   Roeselers G, 2011, ISME J, V5, P1595, DOI 10.1038/ismej.2011.38
   Sadler KC, 2013, ZEBRAFISH, V10, P129, DOI 10.1089/zeb.2013.1500
   Salma U, 2007, POULTRY SCI, V86, P714, DOI 10.1093/ps/86.4.714
   Samsel Anthony, 2013, Interdiscip Toxicol, V6, P159, DOI 10.2478/intox-2013-0026
   SANDERSON JD, 1992, GUT, V33, P145, DOI 10.1136/gut.33.2.145
   Sanz Y, 2015, ANN NUTR METAB, V67, P28, DOI 10.1159/000440991
   Sapone A, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-13
   Savarese M, 2014, FASEB J, V28
   Shannon C., 1964, MATH THEORY COMMUNIC, V10th
   Siccardi AJ, 2009, ZEBRAFISH, V6, P275, DOI 10.1089/zeb.2008.0553
   Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111
   Tavana O, 2013, CELL METAB, V17, P159, DOI 10.1016/j.cmet.2013.01.012
   Thompson T, 2005, J HUM NUTR DIET, V18, P163, DOI 10.1111/j.1365-277X.2005.00607.x
   Tojo R, 2014, WORLD J GASTROENTERO, V20, P15163, DOI 10.3748/wjg.v20.i41.15163
   Tsuchiya C, 2008, LETT APPL MICROBIOL, V46, P43, DOI 10.1111/j.1472-765X.2007.02258.x
   Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322
   Umu OCO, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0078-5
   Valko M, 2001, BBA-GEN SUBJECTS, V1527, P161, DOI 10.1016/S0304-4165(01)00163-5
   van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41
   VUORISTO M, 1988, CLIN CHIM ACTA, V174, P213, DOI 10.1016/0009-8981(88)90388-9
   Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07
   Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-392
   Watts S.A., 2016, VITAL RELATIONSHIP N
   Watts SA, 2012, ILAR J, V53, P144, DOI 10.1093/ilar.53.2.144
   Xia Y, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0348-2
NR 75
TC 25
Z9 26
U1 1
U2 57
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-7012
EI 1872-8359
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD APR
PY 2017
VL 135
BP 69
EP 76
DI 10.1016/j.mimet.2017.01.016
PG 8
WC Biochemical Research Methods; Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Biochemistry & Molecular Biology; Microbiology
GA EP7HA
UT WOS:000397547600013
PM 28167213
OA Green Accepted
DA 2022-11-22
ER

PT J
AU Awoniyi, M
   Wang, J
   Ngo, B
   Meadows, V
   Tam, J
   Viswanathan, A
   Lai, YJ
   Montgomery, S
   Farmer, M
   Kummen, M
   Thingholm, L
   Schramm, C
   Bang, C
   Franke, A
   Lu, K
   Zhou, HP
   Bajaj, JS
   Hylemon, PB
   Ting, J
   Popov, YV
   Hov, JR
   Francis, HL
   Sartor, RB
AF Awoniyi, Muyiwa
   Wang, Jeremy
   Ngo, Billy
   Meadows, Vik
   Tam, Jason
   Viswanathan, Amba
   Lai, Yunjia
   Montgomery, Stephanie
   Farmer, Morgan
   Kummen, Martin
   Thingholm, Louise
   Schramm, Christoph
   Bang, Corinna
   Franke, Andre
   Lu, Kun
   Zhou, Huiping
   Bajaj, Jasmohan S.
   Hylemon, Phillip B.
   Ting, Jenny
   Popov, Yury, V
   Hov, Johannes Roksund
   Francis, Heather L.
   Sartor, Ryan Balfour
TI Protective and aggressive bacterial subsets and metabolites modify
   hepatobiliary inflammation and fibrosis in a murine model of PSC
SO GUT
LA English
DT Article; Early Access
DE intestinal microbiology; primary sclerosing cholangitis; antibiotics;
   short chain fatty acids; cholestatic liver diseases
ID PRIMARY SCLEROSING CHOLANGITIS; GUT MICROBIOTA; BILE-ACIDS; ABSENCE;
   INJURY; COLON
AB Objective Conflicting microbiota data exist for primary sclerosing cholangitis (PSC) and experimental models. Goal: define the function of complex resident microbes and their association relevant to PSC patients by studying germ-free (GF) and antibiotic-treated specific pathogen-free (SPF) multidrug-resistant 2 deficient (mdr2(-/-) ) mice and microbial profiles in PSC patient cohorts. Design We measured weights, liver enzymes, RNA expression, histological, immunohistochemical and fibrotic biochemical parameters, faecal 16S rRNA gene profiling and metabolomic endpoints in gnotobiotic and antibiotic-treated SPF mdr2(-/-) mice and targeted metagenomic analysis in PSC patients. Results GF mdr2(-/-) mice had 100% mortality by 8 weeks with increasing hepatic bile acid (BA) accumulation and cholestasis. Early SPF autologous stool transplantation rescued liver-related mortality. Inhibition of ileal BA transport attenuated antibiotic-accelerated liver disease and decreased total serum and hepatic BAs. Depletion of vancomycin-sensitive microbiota exaggerated hepatobiliary disease. Vancomycin selectively decreased Lachnospiraceae and short-chain fatty acids (SCFAs) but expanded Enterococcus and Enterobacteriaceae. Antibiotics increased Enterococcus faecalis and Escherichia coli liver translocation. Colonisation of GF mdr2(-/-) mice with translocated E. faecalis and E. coli strains accelerated hepatobiliary inflammation and mortality. Lachnospiraceae colonisation of antibiotic pretreated mdr2(-/-) mice reduced liver fibrosis, inflammation and translocation of pathobionts, and SCFA-producing Lachnospiraceae and purified SCFA decreased fibrosis. Faecal Lachnospiraceae negatively associated, and E. faecalis/ Enterobacteriaceae positively associated, with PSC patients' clinical severity by Mayo risk scores. Conclusions We identified novel functionally protective and detrimental resident bacterial species in mdr2(-/-) mice and PSC patients with associated clinical risk score. These insights may guide personalised targeted therapeutic interventions in PSC patients.
C1 [Awoniyi, Muyiwa; Sartor, Ryan Balfour] Univ North Carolina Syst, Div Gastroenterol & Hepatol, Chapel Hill, NC USA.
   [Awoniyi, Muyiwa; Wang, Jeremy; Ngo, Billy; Viswanathan, Amba; Farmer, Morgan; Sartor, Ryan Balfour] Univ North Carolina Syst, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27517 USA.
   [Wang, Jeremy] Univ North Carolina Syst, Dept Genet, Chapel Hill, NC USA.
   [Meadows, Vik] Indiana Univ, Sch Med, Dept Gastroenterol, Indianapolis, IN USA.
   [Tam, Jason; Sartor, Ryan Balfour] Univ North Carolina Syst, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Lai, Yunjia; Lu, Kun] Univ North Carolina Syst, Gillings Sch, Dept Environm Sci & Engn, Global Sch Publ Hlth, Chapel Hill, NC USA.
   [Montgomery, Stephanie] Univ North Carolina Syst, Dept Pathol, Div Comparat Med, Chapel Hill, NC USA.
   [Montgomery, Stephanie] Univ North Carolina Syst, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA.
   [Kummen, Martin] Oslo Univ Hosp, Norwegian PSC Res Ctr, Rikshosp, Oslo, Norway.
   [Kummen, Martin; Hov, Johannes Roksund] Univ Oslo, Inst Clin Med, Oslo, Norway.
   [Thingholm, Louise] Zentrums Mol Biowissensch, Inst Clin Mol Biol, Kiel, Germany.
   [Schramm, Christoph] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany.
   [Bang, Corinna; Franke, Andre] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Kiel, Germany.
   [Lu, Kun] Univ N Carolina, Dept Environm Sci & Engn, Chapel Hill, NC 27515 USA.
   [Zhou, Huiping; Bajaj, Jasmohan S.; Hylemon, Phillip B.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Sch Med, Richmond, VA USA.
   [Zhou, Huiping; Bajaj, Jasmohan S.; Hylemon, Phillip B.] McGuire Vet Affairs Med Cr, Dept Res, Richmond, VA USA.
   [Zhou, Huiping; Bajaj, Jasmohan S.; Hylemon, Phillip B.] Virginia Commonwealth Univ, Med Ctr, Richmond, VA USA.
   [Ting, Jenny] Univ N Carolina, UNC Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Chapel Hill, NC 27515 USA.
   [Popov, Yury, V] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Gastroenterol, Boston, MA 02115 USA.
   [Hov, Johannes Roksund] Oslo Univ Hosp, Dept Transplantat Med, Norwegian PSC Res Ctr, Oslo, Norway.
   [Francis, Heather L.] Indiana Univ, Sch Med, Indianapolis, IN 46202 USA.
   [Sartor, Ryan Balfour] Richard L Roudebush VA Med Ctr, Indianapolis, IN USA.
C3 Indiana University System; Indiana University-Purdue University
   Indianapolis; University of Oslo; National Hospital Norway; University
   of Oslo; University of Hamburg; University Medical Center
   Hamburg-Eppendorf; University of Kiel; University of North Carolina;
   University of North Carolina Chapel Hill; Virginia Commonwealth
   University; Virginia Commonwealth University; University of North
   Carolina; University of North Carolina Chapel Hill; Harvard University;
   Beth Israel Deaconess Medical Center; Harvard Medical School; University
   of Oslo; Indiana University System; Indiana University-Purdue University
   Indianapolis; US Department of Veterans Affairs; Veterans Health
   Administration (VHA); Richard L. Roudebush VA Medical Center
RP Sartor, RB (corresponding author), Univ North Carolina Syst, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC 27517 USA.
EM ryan_balfour_sartor@med.unc.edu
FU National Institute Health (NIH) [P01DK094779, P40OD10995, P30DK034987,
   K01DK119582, T32DK07737, T322A1007273]; Crohn's and Colitis Foundation
   [2434, CA232109, DK094779, AI067798]; European Research Council
   [802544]; DFG; Helmut and Hannelore Greve Foundation; BiomX; Galapagos;
   VA Merit Award [I01BX004033, DBX001328]; Research Career Scientist Award
   [IK6BX004477]; VA ShEEP Grant [1 IS1 BX004777]; NIH [R01 DK104893, R01
   DK057543]; VA Merit Review [2I0CX001076, R21TR003095]; VA [1I01BX003031,
   IK6BX005226, DK108959, DK119421]
FX National Institute Health (NIH) grants P01DK094779, P40OD10995 and
   P30DK034987 (to RBS), K01DK119582 (to JW); T32DK07737 and T322A1007273
   (to MA), The Crohn's and Colitis Foundation #2434 (to RBS); CA232109,
   DK094779 and AI067798 (to JT); VA 1I01BX003031 and IK6BX005226; DK108959
   and DK119421 (to HLF). JRH is funded by the European Research Council,
   grant no. 802544. CS is supported by the DFG, CRU306, and by the Helmut
   and Hannelore Greve Foundation and grant support from BiomX and
   Galapagos. VA Merit Award I01BX004033; Research Career Scientist Award
   (IK6BX004477); VA ShEEP Grant (1 IS1 BX004777); NIH Grants R01 DK104893,
   R01 DK057543 (to HZ). VA Merit Review 2I0CX001076, R21TR003095 (NCATS)
   (to JSB). VA Merit Award DBX001328 (to PBH).
CR Allegretti JR, 2019, AM J GASTROENTEROL, V114, P1071, DOI 10.14309/ajg.0000000000000115
   Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331
   Baghdasaryan A, 2011, HEPATOLOGY, V54, P1303, DOI 10.1002/hep.24537
   Chand D, 2018, BBA-PROTEINS PROTEOM, V1866, P507, DOI 10.1016/j.bbapap.2018.01.003
   Chen L, 2017, NAT IMMUNOL, V18, P541, DOI 10.1038/ni.3690
   Duan Y, 2019, NATURE, V575, P505, DOI 10.1038/s41586-019-1742-x
   Fickert P, 2004, GASTROENTEROLOGY, V127, P261, DOI 10.1053/j.gastro.2004.04.009
   Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104
   Franz CMAP, 2001, J FOOD PROTECT, V64, P725, DOI 10.4315/0362-028X-64.5.725
   Ghallab A, 2019, HEPATOLOGY, V69, P666, DOI 10.1002/hep.30213
   Guicciardi ME, 2018, J HEPATOL, V69, P676, DOI 10.1016/j.jhep.2018.05.018
   Hoentjen F, 2003, GUT, V52, P1721, DOI 10.1136/gut.52.12.1721
   Ikeda Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00476-2
   Ikenaga N, 2015, AM J PATHOL, V185, P325, DOI 10.1016/j.ajpath.2014.10.013
   Katt J, 2013, HEPATOLOGY, V58, P1084, DOI 10.1002/hep.26447
   Krones E, 2015, HEPATOLOGY, V62, P981, DOI 10.1002/hep.27622
   Kummen M, 2021, GASTROENTEROLOGY, V160, P1784, DOI 10.1053/j.gastro.2020.12.058
   Kunzmann LK, 2020, HEPATOLOGY, V72, P1310, DOI 10.1002/hep.31140
   Linder CH, 2013, BONE, V53, P399, DOI 10.1016/j.bone.2012.12.048
   Liwinski T, 2020, GUT, V69, P665, DOI 10.1136/gutjnl-2019-318416
   Madsen KL, 2000, GASTROENTEROLOGY, V118, P1094, DOI 10.1016/S0016-5085(00)70362-3
   Mazagova M, 2015, FASEB J, V29, P1043, DOI 10.1096/fj.14-259515
   Nakamoto N, 2019, NAT MICROBIOL, V4, P492, DOI 10.1038/s41564-018-0333-1
   Out C, 2015, J HEPATOL, V63, P697, DOI 10.1016/j.jhep.2015.04.030
   Peng ZW, 2017, HEPATOL COMMUN, V1, P957, DOI 10.1002/hep4.1084
   Schneider KM, 2021, NAT METAB, V3, P1228, DOI 10.1038/s42255-021-00452-1
   Shah A, 2019, SEMIN LIVER DIS, V39, P432, DOI 10.1055/s-0039-1688501
   SMIT JJM, 1993, CELL, V75, P451, DOI 10.1016/0092-8674(93)90380-9
   Tabibian JH, 2016, HEPATOLOGY, V63, P185, DOI 10.1002/hep.27927
   Tedesco D, 2018, GASTROENTEROLOGY, V154, P2178, DOI 10.1053/j.gastro.2018.02.019
   Torres J, 2018, UNITED EUR GASTROENT, V6, P112, DOI 10.1177/2050640617708953
   Truax AD, 2018, CELL HOST MICROBE, V24, P364, DOI 10.1016/j.chom.2018.08.009
   Vleggaar FR, 2008, EUR J GASTROEN HEPAT, V20, P688, DOI 10.1097/MEG.0b013e3282f5197e
   Wang RX, 2019, J LIPID RES, V60, P85, DOI 10.1194/jlr.M088070
   Weismuller TJ, 2017, GASTROENTEROLOGY, V152, P1975, DOI 10.1053/j.gastro.2017.02.038
NR 35
TC 2
Z9 2
U1 13
U2 13
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0017-5749
EI 1468-3288
J9 GUT
JI Gut
DI 10.1136/gutjnl-2021-326500
EA JUN 2022
PG 15
WC Gastroenterology & Hepatology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Gastroenterology & Hepatology
GA 2E6ZH
UT WOS:000812374900001
PM 35705368
OA Green Published, hybrid
DA 2022-11-22
ER

PT J
AU Tap, J
   Furet, JP
   Bensaada, M
   Philippe, C
   Roth, H
   Rabot, S
   Lakhdari, O
   Lombard, V
   Henrissat, B
   Corthier, G
   Fontaine, E
   Dore, J
   Leclerc, M
AF Tap, Julien
   Furet, Jean-Pierre
   Bensaada, Martine
   Philippe, Catherine
   Roth, Hubert
   Rabot, Sylvie
   Lakhdari, Omar
   Lombard, Vincent
   Henrissat, Bernard
   Corthier, Gerard
   Fontaine, Eric
   Dore, Joel
   Leclerc, Marion
TI Gut microbiota richness promotes its stability upon increased dietary
   fibre intake in healthy adults
SO ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID PLANT POLYSACCHARIDES; CANCER-RISK; HUMAN COLON; BACTERIA; COMMUNITY;
   METAGENOMICS; FERMENTATION; STRAINS; QUALITY; OBESITY
AB Gut microbiota richness and stability are important parameters in host-microbe symbiosis. Diet modification, notably using dietary fibres, might be a way to restore a high richness and stability in the gut microbiota. In this work, during a 6-week nutritional trial, 19 healthy adults consumed a basal diet supplemented with 10 or 40 g dietary fibre per day for 5 days, followed by 15-day washout periods. Fecal samples were analysed by a combination of 16S rRNA gene pyrosequencing, intestinal cell genotoxicity assay, metatranscriptomics sequencing approach and short-chain fatty analysis. This short-term change in the dietary fibre level did not have the same impact for all individuals but remained significant within each individual gut microbiota at genus level. Higher microbiota richness was associated with higher microbiota stability upon increased dietary fibre intake. Increasing fibre modulated the expression of numerous microbiota metabolic pathways such as glycan metabolism, with genes encoding carbohydrate-active enzymes active on fibre or host glycans. High microbial richness was also associated with high proportions of Prevotella and Coprococcus species and high levels of caproate and valerate. This study provides new insights on the role of gut microbial richness in healthy adults upon dietary changes and host microbes' interaction
C1 [Tap, Julien; Furet, Jean-Pierre; Bensaada, Martine; Philippe, Catherine; Rabot, Sylvie; Lakhdari, Omar; Corthier, Gerard; Dore, Joel; Leclerc, Marion] INRA, Micalis Inst, UMR1319, F-78350 Jouy En Josas, France.
   [Roth, Hubert; Fontaine, Eric] Univ Grenoble 1, CHU Grenoble, INSERM U1055, Bioenerget, F-38000 Grenoble, France.
   [Roth, Hubert; Fontaine, Eric] CRNH Rhone Alpes, F-69310 Pierre Benite, France.
   [Lombard, Vincent; Henrissat, Bernard] Aix Marseille Univ, CNRS UMR 7257, Architecture & Fonct Macromol Biol, F-13288 Marseille, France.
C3 AgroParisTech; INRAE; UDICE-French Research Universities; Universite
   Paris Saclay; CHU Grenoble Alpes; Institut National de la Sante et de la
   Recherche Medicale (Inserm); UDICE-French Research Universities;
   Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA);
   Centre National de la Recherche Scientifique (CNRS); CNRS - National
   Institute for Biology (INSB); UDICE-French Research Universities;
   Aix-Marseille Universite
RP Leclerc, M (corresponding author), INRA, Micalis Inst, UMR1319, F-78350 Jouy En Josas, France.
EM marion.leclerc@jouy.inra.fr
RI Fontaine, Eric/ABA-8853-2020; Leclerc, Marion/AAZ-3950-2021; Henrissat,
   Bernard/J-2475-2012; Dore, Joel/ABA-8921-2020; Tap, Julien/E-5760-2010
OI Fontaine, Eric/0000-0002-5204-9477; Leclerc, Marion/0000-0001-8684-2847;
   Henrissat, Bernard/0000-0002-3434-8588; Tap, Julien/0000-0001-8998-5413;
   Rabot, Sylvie/0000-0002-4603-2038; Lombard, Vincent/0000-0002-9684-7067
FU French National Agency for Research within the AlimIntest program
   [ANR/DEDD/PNRA/PROJ/200206-01-01]; University Hospital of Grenoble
FX Julien Tap and this project were supported by the French National Agency
   for Research, ANR/DEDD/PNRA/PROJ/200206-01-01, within the AlimIntest
   program. The clinical study was sponsored by University Hospital of
   Grenoble and carried out in its Clinical Research Center CIC1406. We are
   very grateful to Marie-France Nguyen Vaillant for designing all the
   menus. We thank Herve Blottiere for providing us with HT29 cells,
   Aurelia Bruneau for contributing to faecal sample collection and Deborah
   Jardet for her technical support. We are grateful to Timothy Swartz for
   reading the manuscript.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944
   Burkitt D P, 1972, Lancet, V2, P1408
   Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663
   Chassard C, 2007, FEMS MICROBIOL ECOL, V61, P121, DOI 10.1111/j.1574-6941.2007.00314.x
   Chassard C, 2010, FEMS MICROBIOL ECOL, V74, P205, DOI 10.1111/j.1574-6941.2010.00941.x
   Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480
   CUMMINGS JH, 1992, GASTROENTEROLOGY, V103, P1783, DOI 10.1016/0016-5085(92)91435-7
   David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820
   De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107
   Dodd D, 2011, MOL MICROBIOL, V79, P292, DOI 10.1111/j.1365-2958.2010.07473.x
   FINEGOLD SM, 1974, AM J CLIN NUTR, V27, P1456, DOI 10.1093/ajcn/27.12.1456
   Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817
   Flint HJ, 2007, ENVIRON MICROBIOL, V9, P1101, DOI 10.1111/j.1462-2920.2007.01281.x
   Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x
   GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401
   Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234
   Graf Daniela, 2015, Microbial Ecology in Health and Disease, V26, P26164, DOI 10.3402/mehd.v26.26164
   Hayashi H, 2007, INT J SYST EVOL MICR, V57, P941, DOI 10.1099/ijs.0.64778-0
   Hildebrand F, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-30
   Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709
   Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868
   Huang Y, 2009, BIOINFORMATICS, V25, P1338, DOI 10.1093/bioinformatics/btp161
   Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143
   Gosalbes MJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017447
   Kristiansson E, 2009, BIOINFORMATICS, V25, P2737, DOI 10.1093/bioinformatics/btp508
   Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018
   Lan A, 2007, BRIT J NUTR, V97, P714, DOI 10.1017/S0007114507433001
   Langen MACLV, 2009, INFLAMM BOWEL DIS, V15, P454, DOI 10.1002/ibd.20737
   Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506
   Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102
   Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007
   MILLER TL, 1982, ARCH MICROBIOL, V131, P14, DOI 10.1007/BF00451492
   Miron J, 2001, J DAIRY SCI, V84, P1294, DOI 10.3168/jds.S0022-0302(01)70159-2
   O'Keefe SJD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7342
   POCHART P, 1993, GASTROENTEROLOGY, V105, P1281, DOI 10.1016/0016-5085(93)90129-Z
   Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1111/j.1574-6968.2002.tb11467.x
   Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821
   Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055
   Robert C, 2003, FEMS MICROBIOL ECOL, V46, P81, DOI 10.1016/S0168-6496(03)00207-1
   ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257
   Salonen A, 2014, ISME J, V8, P2218, DOI 10.1038/ismej.2014.63
   SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977
   SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977
   Tasse L, 2010, GENOME RES, V20, P1605, DOI 10.1101/gr.108332.110
   Thioulouse J., 2004, R NEWS, V4, P5, DOI DOI 10.2307/3780087
   Topping DL, 2001, PHYSIOL REV, V81, P1031, DOI 10.1152/physrev.2001.81.3.1031
   Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015
   van Hijum SAFT, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-77
   Walker AW, 2011, ISME J, V5, P220, DOI [10.1038/ismej.2010.118, 10.1038/ISMEJ.2010.118]
   Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344
NR 51
TC 206
Z9 213
U1 7
U2 107
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-2912
EI 1462-2920
J9 ENVIRON MICROBIOL
JI Environ. Microbiol.
PD DEC
PY 2015
VL 17
IS 12
BP 4954
EP 4964
DI 10.1111/1462-2920.13006
PG 11
WC Microbiology
WE Science Citation Index Expanded (SCI-EXPANDED)
SC Microbiology
GA DB4BN
UT WOS:000368457800012
PM 26235304
OA Green Published, hybrid
DA 2022-11-22
ER

EF